,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-35,"October 01, 2011 -  September 30, 2012",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Takashi  Furusawa|Yuri  Postnikov; MD, PhD|Tao  Deng|Jamie Elyse Kugler|Fenfei  Leng|Eric Dante Ciappio|Show all 7","Melinda K Duncan; PhD (Biological Sciences, The University of Delaware)|Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Jefferey  Hayes (University of Rochester medical Center)|Eran  Meshorer (Hebrew University)|Leon  Mullenders (Radiation Genetics, University of Leiden)|Joseph  Orly (Hebrew University)",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Rafael Cristian Casellas; PhD (NIAMS) |David  Landsman; PhD (NLM),"1. Cuddapah S, Schones DE, Cui K, Roh TY, Barski A, Wei G, Rochman M, Bustin M, Zhao K (2011). Genomic profiling of HMGN1 reveals an association with chromatin at regulatory regions. Mol Cell Biol  31, 700-9.   https://doi.org/10.1128/MCB.00740-10|2. Kato H, van Ingen H, Zhou BR, Feng H, Bustin M, Kay LE, Bai Y (2011). Architecture of the high mobility group nucleosomal protein 2-nucleosome complex as revealed by methyl-based NMR. Proc Natl Acad Sci U S A  108, 12283-8.   https://doi.org/10.1073/pnas.1105848108|3. Malicet C, Rochman M, Postnikov Y, Bustin M (2011). Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein. Mol Cell Biol  31, 2742-55.   https://doi.org/10.1128/MCB.05216-11|4. Oh KS, Bustin M, Mazur SJ, Appella E, Kraemer KH (2011). UV-induced histone H2AX phosphorylation and DNA damage related proteins accumulate and persist in nucleotide excision repair-deficient XP-B cells. DNA Repair (Amst)  10, 5-15.   https://doi.org/10.1016/j.dnarep.2010.09.004|5. Rochman M, Taher L, Kurahashi T, Cherukuri S, Uversky VN, Landsman D, Ovcharenko I, Bustin M (2011). Effects of HMGN variants on the cellular transcription profile. Nucleic Acids Res  39, 4076-87.   https://doi.org/10.1093/nar/gkq1343",https://intramural.nih.gov/search/searchview.taf?ipid=73199
1,BC004504-40,"October 01, 2011 -  September 30, 2012",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ulrike F Lichti; PhD|Joanna  Anders|Luowei  Li|Lisa A Nolan|Mary Ann A Stepp|Francesca  Mascia|Show all 10,"David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)|Mary Ann Stepp; PhD (Anatomy and Cell Biology, George Washington University)",Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Elise C Kohn; MD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),Maria Irene Morasso; PhD (NIAMS),"1. Mascia F, Denning M, Kopan R, Yuspa SH (2012). The black box illuminated: signals and signaling. J Invest Dermatol  132, 811-9.   https://doi.org/10.1038/jid.2011.406|2. Okano J, Lichti U, Mamiya S, Aronova M, Zhang G, Yuspa SH, Hamada H, Sakai Y, Morasso MI (2012). Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development. J Cell Sci  125, 1827-36.   https://doi.org/10.1242/jcs.101550|3. Patel GK, Yee CL, Terunuma A, Telford WG, Voong N, Yuspa SH, Vogel JC (2012). Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma. J Invest Dermatol  132, 401-9.   https://doi.org/10.1038/jid.2011.317|4. Patel GK, Yee CL, Yuspa SH, Vogel JC (2012). A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice. J Invest Dermatol  132, 284-90.   https://doi.org/10.1038/jid.2011.284|5. Wright LN, Ryscavage A, Merlino G, Yuspa SH (2012). Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Clin Cancer Res  18, 170-83.   https://doi.org/10.1158/1078-0432.CCR-11-1349|6. Yang D, Tao J, Li L, Kedei N, Tóth ZE, Czap A, Velasquez JF, Mihova D, Michalowski AM, Yuspa SH, Blumberg PM (2011). RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene  30, 4590-4600.   https://doi.org/10.1038/onc.2011.166",https://intramural.nih.gov/search/searchview.taf?ipid=73200
2,BC004517-36,"October 01, 2011 -  September 30, 2012",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Carole L Yee|John  Digiovanna|Sikandar  Khan|Deborah E Schmidt|Taro  Masaki|Christiane  Kuschal|Show all 9,"Douglas  Brash (Neurology, Yale Univ)|Steffen  Emmert|Vera  Price (Univ of California, SF)|Engin  Gozukara (Malatya Univ)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Show all 15","Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Michael  Bustin; PhD (Protein Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD) |Suvimol  Hill; MD (CC)","1. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki S, Emmert S, Pike KM, Raziuddin A, Plona TM, DiGiovanna JJ, Tucker MA, Kraemer KH (2011). Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet  48, 168-76.   https://doi.org/10.1136/jmg.2010.083022|2. Brooks BP, Thompson AH, Clayton JA, Chan CC, Tamura D, Zein WM, Blain D, Hadsall C, Rowan J, Bowles KE, Khan SG, Ueda T, Boyle J, Oh KS, DiGiovanna JJ, Kraemer KH (2011). Ocular manifestations of trichothiodystrophy. Ophthalmology  118, 2335-42.   https://doi.org/10.1016/j.ophtha.2011.05.036|3. Kraemer K, DiGiovanna J (2011) Xeroderma Pigmentosum GeneReviews at GeneTests: Medical Genetics Information Resource August:[online publication]|4. Niedernhofer LJ, Bohr VA, Sander M, Kraemer KH (2011). Xeroderma pigmentosum and other diseases of human premature aging and DNA repair: molecules to patients. Mech Ageing Dev  132, 340-7.   https://doi.org/10.1016/j.mad.2011.06.004|5. Oh KS, Bustin M, Mazur SJ, Appella E, Kraemer KH (2011). UV-induced histone H2AX phosphorylation and DNA damage related proteins accumulate and persist in nucleotide excision repair-deficient XP-B cells. DNA Repair (Amst)  10, 5-15.   https://doi.org/10.1016/j.dnarep.2010.09.004|6. Oh KS, Emmert S, Tamura D, DiGiovanna JJ, Kraemer KH (2011). Multiple skin cancers in adults with mutations in the XP-E (DDB2) DNA repair gene. J Invest Dermatol  131, 785-8.   https://doi.org/10.1038/jid.2010.352|7. Oh KS, Imoto K, Emmert S, Tamura D, DiGiovanna JJ, Kraemer KH (2011). Nucleotide excision repair proteins rapidly accumulate but fail to persist in human XP-E (DDB2 mutant) cells. Photochem Photobiol  87, 729-33.   https://doi.org/10.1111/j.1751-1097.2011.00909.x|8. Tamura D, Merideth M, DiGiovanna JJ, Zhou X, Tucker MA, Goldstein AM, Brooks BP, Khan SG, Oh KS, Ueda T, Boyle J, Moslehi R, Kraemer KH (2011). High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies. Prenat Diagn  31, 1046-53.   https://doi.org/10.1002/pd.2829|9. Tock CL, Turner LR, Altiner A, Batra P, Booher SL, Coelho SG, Warner JA, Therrien JP, Turner ML, Miller SA, Beer JZ, Kraemer KH, Udey MC, Vogel JC, Terunuma A (2011). Transcriptional signatures of full-spectrum and non-UVB-spectrum solar irradiation in human skin. Pigment Cell Melanoma Res  24, 972-4.   https://doi.org/10.1111/j.1755-148X.2011.00899.x",https://intramural.nih.gov/search/searchview.taf?ipid=73201
3,BC005093-34,"October 01, 2011 -  September 30, 2012",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Yili D Yang|Nirmala D Sharma|Shunsuke  Tanigawa|Kangsun  Yun|Michael David Hall|Caroline Amanda Murray|Show all 7,Frank  Costantini; PhD (Columbia University)|Olga  Timofeeva (Georgetown University)|Harold  Lovvorn (Vanderbilt University)|Thomas C Carroll|Seppo  Vainio (University of Oulu),Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Nadya I Tarasova; PhD (Cancer Inflammation Program),Lothar  Hennighausen; PhD (NIDDK),"1. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R, Yamaguchi TP, Rodriguez LG, Perantoni AO (2011). Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Dev Biol  352, 58-69.   https://doi.org/10.1016/j.ydbio.2011.01.012",https://intramural.nih.gov/search/searchview.taf?ipid=73202
4,BC005148-33,"October 01, 2011 -  September 30, 2012",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sharon A Bargo|David M Mccurdy|Ahmed M Raafat|Barry  Chestnut|Massod  Rahimi|Arun  Vaidyanath,Sean M Egan|Spyros  ArtavanisTsakonas (Harvard Medical School),"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Greer YE, Rubin JS, Callahan R (2012). Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol  227, 1960-71.   https://doi.org/10.1002/jcp.22924",https://intramural.nih.gov/search/searchview.taf?ipid=73203
5,BC005177-32,"October 01, 2011 -  September 30, 2012",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ofelia  Olivero; PhD|Elena Estela Hernandez-Ramon|Andrea V Rivera|Nancy N Si,"Maria Eugenia  Gonsebatt (UNAM)|Francis  Martin (Biological Sciences, Lancaster University)|Igor  Pogribny (National Center for Toxicological Research, FDA)|Frederick  Beland (NCTR)",Qing  Lan (Occupational and Environmental Epidemiology Branch),NULL,"1. Einem Lindeman T, Poirier MC, Divi RL (2011). The resveratrol analogue, 2,3',4,5'-tetramethoxystilbene, does not inhibit CYP gene expression, enzyme activity and benzo[a]pyrene-DNA adduct formation in MCF-7 cells exposed to benzo[a]pyrene. Mutagenesis  26, 629-35.   https://doi.org/10.1093/mutage/ger024|2. García-Suástegui WA, Huerta-Chagoya A, Carrasco-Colín KL, Pratt MM, John K, Petrosyan P, Rubio J, Poirier MC, Gonsebatt ME (2011). Seasonal variations in the levels of PAH-DNA adducts in young adults living in Mexico City. Mutagenesis  26, 385-91.   https://doi.org/10.1093/mutage/geq104|3. Pratt MM, John K, MacLean AB, Afework S, Phillips DH, Poirier MC (2011). Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. Int J Environ Res Public Health  8, 2675-91.   https://doi.org/10.3390/ijerph8072675|4. Pratt MM, King LC, Adams LD, John K, Sirajuddin P, Olivero OA, Manchester DK, Sram RJ, DeMarini DM, Poirier MC (2011). Assessment of multiple types of DNA damage in human placentas from smoking and nonsmoking women in the Czech Republic. Environ Mol Mutagen  52, 58-68.   https://doi.org/10.1002/em.20581",https://intramural.nih.gov/search/searchview.taf?ipid=73204
6,BC005258-33,"October 01, 2011 -  September 30, 2012",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Qin  Wei|Ananda  Ravulapalli|Lili  Qin|Yikang  Rong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73205
7,BC005263-31,"October 01, 2011 -  September 30, 2012",Eukaryotic Chromatin Structure and Gene Regulation,Carl  Wu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Manabu  Mizuguchi|Debbie  Wei|Hua  Xiao; PhD|Anand  Ranjan|Feng  Wang|Yawen  Bai; PhD,NULL,NULL,NULL,"1. Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C (2011). Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev  25, 275-86.   https://doi.org/10.1101/gad.2007311|2. Li X, Wang S, Li Y, Deng C, Steiner LA, Xiao H, Wu C, Bungert J, Gallagher PG, Felsenfeld G, Qiu Y, Huang S (2011). Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood  118, 1386-94.   https://doi.org/10.1182/blood-2010-11-319111|3. Zhou Z, Feng H, Zhou BR, Ghirlando R, Hu K, Zwolak A, Miller Jenkins LM, Xiao H, Tjandra N, Wu C, Bai Y (2011). Structural basis for recognition of centromere histone variant CenH3 by the chaperone Scm3. Nature  472, 234-7.   https://doi.org/10.1038/nature09854",https://intramural.nih.gov/search/searchview.taf?ipid=73206
8,BC005268-25,"October 01, 2011 -  September 30, 2012",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Robert A Shroff|Tamara  Goldfarb|Darpan Kaustuv Medhi|James Mcclure Staben; MBA|Hardeep  Kaur; PhD|Jianhong  Chen; PhD|Show all 7,Alastair  Goldman (University of Sheffield)|Galina  Petukhova (USUHS)|Alain  Nicolas,NULL,"Rafael  Camerini-Otero; MD, PhD (NIDDK)","1. Dayani Y, Simchen G, Lichten M (2011). Meiotic recombination intermediates are resolved with minimal crossover formation during return-to-growth, an analogue of the mitotic cell cycle. PLoS Genet  7, e1002083.   https://doi.org/10.1371/journal.pgen.1002083|2. Lichten M, de Massy B (2011). The impressionistic landscape of meiotic recombination. Cell  147, 267-70.   https://doi.org/10.1016/j.cell.2011.09.038",https://intramural.nih.gov/search/searchview.taf?ipid=73207
9,BC005270-31,"October 01, 2011 -  September 30, 2012",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Noemi  Kedei|Nancy E Lewin|Larry V Pearce|Tamas  Geczy|Daniel J Lundberg|Ian Anthony Deandrea-Lazarus|Show all 11,"James  Stone (Dept. of Cardiology, University of Alberta)|Gary  Keck (Dept. of Chemistry, University of Utah)|Tamas  Biro (Debrecen Medical School)|Raz  Jelinek|Alan  Kozikowski (University of Illinois at Chicago)|Patricia  Lorenzo (University of Hawaii Cancer Center)|Show all 14",Victor  Marquez; PhD (Chemical Biology Laboratory)|Megan L Peach (Chemical Biology Laboratory)|Susan H Garfield (Laboratory of Experimental Carcinogenesis),NULL,"1. Blumberg PM, Pearce LV, Lee J (2011). TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation. Curr Top Med Chem  11, 2151-8.   https://doi.org/10.2174/156802611796904825|2. Gal N, Kolusheva S, Kedei N, Telek A, Naeem T, Lewin N, Lim L, Mannan P, Garfield S, El Kazzouli S, Sigano D, Marquez V, Blumberg P, Jelinek R (2011) N-Methyl-substituted fluorescent DAG-indolactone isomers exhibit dramatic differences in membrane interactions and biological activity. ChemBioChem 12(15):2331-2340.|3. Kedei N, Lubart E, Lewin NE, Telek A, Lim L, Mannan P, Garfield SH, Kraft MB, Keck GE, Kolusheva S, Jelinek R, Blumberg PM (2011). Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells. Chembiochem  12, 1242-51.   https://doi.org/10.1002/cbic.201100064|4. Kedei N, Telek A, Czap A, Lubart ES, Czifra G, Yang D, Chen J, Morrison T, Goldsmith PK, Lim L, Mannan P, Garfield SH, Kraft MB, Li W, Keck GE, Blumberg PM (2011). The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line. Biochem Pharmacol  81, 1296-308.   https://doi.org/10.1016/j.bcp.2011.03.018|5. Lee JH, Lee Y, Ryu H, Kang DW, Lee J, Lazar J, Pearce LV, Pavlyukovets VA, Blumberg PM, Choi S (2011). Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies. J Comput Aided Mol Des  25, 317-27.   https://doi.org/10.1007/s10822-011-9421-5|6. Lim KS, Kang DW, Kim YS, Kim MS, Park SG, Choi S, Pearce LV, Blumberg PM, Lee J (2011). Receptor activity and conformational analysis of 5'-halogenated resiniferatoxin analogs as TRPV1 ligands. Bioorg Med Chem Lett  21, 299-302.   https://doi.org/10.1016/j.bmcl.2010.11.012|7. Ohashi N, Nomura W, Narumi T, Lewin NE, Itotani K, Blumberg PM, Tamamura H (2011). Fluorescent-responsive synthetic C1b domains of protein kinase Cδ as reporters of specific high-affinity ligand binding. Bioconjug Chem  22, 82-7.   https://doi.org/10.1021/bc100414a|8. Yang D, Tao J, Li L, Kedei N, Tóth ZE, Czap A, Velasquez JF, Mihova D, Michalowski AM, Yuspa SH, Blumberg PM (2011). RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene  30, 4590-4600.   https://doi.org/10.1038/onc.2011.166",https://intramural.nih.gov/search/searchview.taf?ipid=73208
10,BC005271-21,"October 01, 2011 -  September 30, 2012",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,NULL,Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Michael  Bustin; PhD (Protein Section)|Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73209
11,BC005317-29,"October 01, 2011 -  September 30, 2012",Role of Selenium in Development and Health,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Min-Hyuk  Yoo|Petra Akiko Tsuji|Ryuta  Tobe,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Marcus  Conrad (Institute of Clinical Molecular Biology and Tumor Genetics)|Jin Mo  Park (Massachusetts General Hospital and Harvard Medical School)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,"1. Carlson B, Yoo M, Tsuji P, Tobe R, Naranjo-Suarez S, Chen F, Feigenbaum L, Tessarollo L, Lee B, Gladyshev V, Hatfield D (2011) Mouse models that target removal or over-expression of the selenocysteine tRNA[Ser]Sec gene to elucidate the role of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health., in press.|2. Yoo M, Carlson B, Tsuji P, Tobe R, Naranjo-Suarez S, Lee B, Davis C, Gladyshev V, Hatfield D (2011) Selenoproteins harboring a split personality in both preventing and promoting cancer, in Selenium: Its molecular biology and role in human health., in press.|3. Carlson BA, Yoo MH, Conrad M, Gladyshev VN, Hatfield DL, Park JM (2011). Protein kinase-regulated expression and immune function of thioredoxin reductase 1 in mouse macrophages. Mol Immunol  49, 311-6.   https://doi.org/10.1016/j.molimm.2011.09.001|4. Kasaikina MV, Fomenko DE, Labunskyy VM, Lachke SA, Qiu W, Moncaster JA, Zhang J, Wojnarowicz MW, Natarajan SK, Malinouski M, Schweizer U, Tsuji PA, Carlson BA, Maas RL, Lou MF, Goldstein LE, Hatfield DL, Gladyshev VN (2011). Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J Biol Chem  286, 33203-12.   https://doi.org/10.1074/jbc.M111.259218|5. Kasaikina MV, Kravtsova MA, Lee BC, Seravalli J, Peterson DA, Walter J, Legge R, Benson AK, Hatfield DL, Gladyshev VN (2011). Dietary selenium affects host selenoproteome expression by influencing the gut microbiota. FASEB J  25, 2492-9.   https://doi.org/10.1096/fj.11-181990|6. Kasaikina MV, Lobanov AV, Malinouski MY, Lee BC, Seravalli J, Fomenko DE, Turanov AA, Finney L, Vogt S, Park TJ, Miller RA, Hatfield DL, Gladyshev VN (2011). Reduced utilization of selenium by naked mole rats due to a specific defect in GPx1 expression. J Biol Chem  286, 17005-14.   https://doi.org/10.1074/jbc.M110.216267|7. Labunskyy VM, Lee BC, Handy DE, Loscalzo J, Hatfield DL, Gladyshev VN (2011). Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal  14, 2327-36.   https://doi.org/10.1089/ars.2010.3526|8. Mariotti M, Ridge PG, Zhang Y, Lobanov AV, Pringle TH, Guigo R, Hatfield DL, Gladyshev VN (2012). Composition and evolution of the vertebrate and mammalian selenoproteomes. PLoS One  7, e33066.   https://doi.org/10.1371/journal.pone.0033066|9. Shchedrina VA, Kabil H, Vorbruggen G, Lee BC, Turanov AA, Hirosawa-Takamori M, Kim HY, Harshman LG, Hatfield DL, Gladyshev VN (2011). Analyses of fruit flies that do not express selenoproteins or express the mouse selenoprotein, methionine sulfoxide reductase B1, reveal a role of selenoproteins in stress resistance. J Biol Chem  286, 29449-61.   https://doi.org/10.1074/jbc.M111.257600",https://intramural.nih.gov/search/searchview.taf?ipid=73210
12,BC005445-28,"October 01, 2011 -  September 30, 2012",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Luowei  Li|Anjali  Shukla|Mariam Q Malik|Mary Ann A Stepp|Christophe  Cataisson|Show all 9,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention),NULL,"1. Malik M, Jividen K, Padmakumar VC, Cataisson C, Li L, Lee J, Howard OM, Yuspa SH (2012). Inducible NOS-induced chloride intracellular channel 4 (CLIC4) nuclear translocation regulates macrophage deactivation. Proc Natl Acad Sci U S A  109, 6130-5.   https://doi.org/10.1073/pnas.1201351109",https://intramural.nih.gov/search/searchview.taf?ipid=73213
13,BC005450-29,"October 01, 2011 -  September 30, 2012",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Thomas A Johnson|Lyuba  Varticovski|Rodney Louis Schiltz; PhD|Ty Cole Voss|Myong-Hee  Sung|Tina Branscombe Miranda|Show all 11,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Fahri  Saatcioglu (Department of Biology, University of Oslo)|John  Stamatoyanopolus (Genome Sciences, University of Washington)|Michael  Stallcup (Univ of Southern California)|Susanne  Mandrup (University of Southern Denmark)|Michael J Garabedian; PhD (Microbiology and Kaplan Cancer Center, New York University Medical Center)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Charles  Vinson; PhD (Laboratory of Metabolism)|David  Levens; PhD (Laboratory of Pathology)|John Carl Oberholtzer (Laboratory of Pathology)",Kenneth Steven Korach; PhD (NIEHS),"1. Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, Miranda TB, Sung MH, Trump S, Lightman SL, Vinson C, Stamatoyannopoulos JA, Hager GL (2011). Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell  43, 145-55.   https://doi.org/10.1016/j.molcel.2011.06.016|2. Conway-Campbell BL, George CL, Pooley JR, Knight DM, Norman MR, Hager GL, Lightman SL (2011). The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment. Mol Endocrinol  25, 944-54.   https://doi.org/10.1210/me.2010-0073|3. Grøntved L, Hager GL (2012). Impact of chromatin structure on PR signaling: transition from local to global analysis. Mol Cell Endocrinol  357, 30-6.   https://doi.org/10.1016/j.mce.2011.09.006|4. Hager GL, Varticovski L (2012). Chromatin in time and space. Biochim Biophys Acta  1819, 631.   https://doi.org/10.1016/j.bbagrm.2012.05.002|5. John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, Johnson TA, Hager GL, Stamatoyannopoulos JA (2011). Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet  43, 264-8.   https://doi.org/10.1038/ng.759|6. Siersbæk R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S (2011). Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J  30, 1459-72.   https://doi.org/10.1038/emboj.2011.65|7. Voss TC, Schiltz RL, Sung MH, Yen PM, Stamatoyannopoulos JA, Biddie SC, Johnson TA, Miranda TB, John S, Hager GL (2011). Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell  146, 544-54.   https://doi.org/10.1016/j.cell.2011.07.006|8. Wiench M, John S, Baek S, Johnson TA, Sung MH, Escobar T, Simmons CA, Pearce KH, Biddie SC, Sabo PJ, Thurman RE, Stamatoyannopoulos JA, Hager GL (2011). DNA methylation status predicts cell type-specific enhancer activity. EMBO J  30, 3028-39.   https://doi.org/10.1038/emboj.2011.210|9. Wiench M, Miranda TB, Hager GL (2011). Control of nuclear receptor function by local chromatin structure. FEBS J  278, 2211-30.   https://doi.org/10.1111/j.1742-4658.2011.08126.x",https://intramural.nih.gov/search/searchview.taf?ipid=73214
14,BC005453-28,"October 01, 2011 -  September 30, 2012",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Marian E Durkin|Valentina  Factor|Tanya N Hoang|Daekwan  Seo; PhD, MS, BA","Hanne  Bisgaard (Medical Biochemistry and Genetics, University of Copenhagen)|Peter  Nagy (Pathology, Sammelweiss University)|Steve  Duncan (Medical College of Wisconsin)|Seung  Lee (Korea Institute of Radiological and Medical Sciences)|Aranzazu  Sanchezmunoz (Complutense University of Madrid)",NULL,NULL,"1. Lee SB, Seo D, Choi D, Park KY, Holczbauer A, Marquardt JU, Conner EA, Factor VM, Thorgeirsson SS (2012). Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells  30, 997-1007.   https://doi.org/10.1002/stem.1074",https://intramural.nih.gov/search/searchview.taf?ipid=73215
15,BC005480-27,"October 01, 2011 -  September 30, 2012",Molecular Epidemiology of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Elisa A Spillare|Judith A Welsh|Sharon R Pine|Aaron Joseph Schetter|Show all 13,NULL,"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Akagi I, Okayama H, Schetter AJ, Robles AI, Kohno T, Bowman ED, Kazandjian D, Welsh JA, Oue N, Saito M, Miyashita M, Uchida E, Takizawa T, Takenoshita S, Skaug V, Mollerup S, Haugen A, Yokota J, Harris CC (2013). Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. Cancer Res  73, 3821-32.   https://doi.org/10.1158/0008-5472.CAN-13-0031|2. Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, et al. [34 more authors] (2012). Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer  48, 1957-68.   https://doi.org/10.1016/j.ejca.2012.01.038|3. Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T (2012). The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res  18, 4919-30.   https://doi.org/10.1158/1078-0432.CCR-12-0016|4. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, Park JY, Harris CC, Yang P, Jen J (2012). Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res  18, 3658-67.   https://doi.org/10.1158/1078-0432.CCR-11-2857|5. Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, et al. [4 more authors] (2012). KIF5B-RET fusions in lung adenocarcinoma. Nat Med  18, 375-7.   https://doi.org/10.1038/nm.2644|6. Okayama H, Schetter AJ, Harris CC (2012). MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis  30 Suppl 2, 9-15.   https://doi.org/10.1159/000341882|7. Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC (2011). Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst  103, 1112-22.   https://doi.org/10.1093/jnci/djr216|8. Ryan BM, Calhoun KM, Pine SR, Bowman ED, Robles AI, Ambs S, Harris CC (2012). MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer  131, 2710-6.   https://doi.org/10.1002/ijc.27573|9. Schetter AJ, Harris CC (2011). MicroRNAs as molecular classifiers for cancer. Cell Cycle  10, 2827-8.   https://doi.org/10.4161/cc.10.17.16574|10. Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM, McKeigue PM (2011). Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis  32, 312-7.   https://doi.org/10.1093/carcin/bgq252|11. Yanaihara N, Harris CC (2013). MicroRNA Involvement in Human Cancers. Clin Chem  59, 1811-2.   https://doi.org/10.1373/clinchem.2012.198176|12. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC (2012). 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res  72, 1467-77.   https://doi.org/10.1158/0008-5472.CAN-11-3073|13. Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, Li P, Cai H, Yu L, Liu F, Hang D, Yang H, Wang XW, Ke Y, Harris CC (2013). microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer  132, 2901-9.   https://doi.org/10.1002/ijc.27954",https://intramural.nih.gov/search/searchview.taf?ipid=73216
16,BC005522-25,"October 01, 2011 -  September 30, 2012",Thyroid StemProgenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Suguru  Hayase,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)",NULL,"1. Dranovsky A, Picchini AM, Moadel T, Sisti AC, Yamada A, Kimura S, Leonardo ED, Hen R (2011). Experience dictates stem cell fate in the adult hippocampus. Neuron  70, 908-23.   https://doi.org/10.1016/j.neuron.2011.05.022|2. Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, Pritchard C, Marais R, Davies TF, Weinstein LS, Chen M, Rosen N, Ghossein R, Knauf JA, Fagin JA (2011). Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci U S A  108, 1615-20.   https://doi.org/10.1073/pnas.1015557108|3. Gilbert-Sirieix M, Makoukji J, Kimura S, Talbot M, Caillou B, Massaad C, Massaad-Massade L (2011). Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells. PLoS One  6, e22280.   https://doi.org/10.1371/journal.pone.0022280|4. Kimura S (2011). Thyroid-specific transcription factors and their roles in thyroid cancer. J Thyroid Res  2011, 710213.   https://doi.org/10.4061/2011/710213|5. Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD, Ruan DT (2011). Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. Surgery  150, 1295-302.   https://doi.org/10.1016/j.surg.2011.09.014|6. Magno L, Kretz O, Bert B, Ersözlü S, Vogt J, Fink H, Kimura S, Vogt A, Monyer H, Nitsch R, Naumann T (2011). The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1. Eur J Neurosci  34, 1767-82.   https://doi.org/10.1111/j.1460-9568.2011.07890.x|7. Ock S, Lee SH, Ahn J, Lee TJ, Cho CH, Abel ED, Kimura S, Kim J (2011). Conditional deletion of insulin receptor in thyrocytes does not affect thyroid structure and function. Endocr J  58, 1013-9.   https://doi.org/10.1507/endocrj.ej11-0007",https://intramural.nih.gov/search/searchview.taf?ipid=73217
17,BC005562-25,"October 01, 2011 -  September 30, 2012",Xenobiotic-Metabolizing Enzymes,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Linda G Byrd|Kristopher W Krausz|Jessica  Bonzo|Jie  Cheng|Fei  Li|Soumen Kanti Manna|Show all 11,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Tami  Nakajima (Nagoya University)|Jeffrey  Idle (University of Bern)|Xiaochao  Ma (NCI)|Andrew  Patterson (Pennsylvania State University)|John  Schuetz (St. Jude Childrens Research Hospital)|Show all 7",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section),Byoungjoon  Song; PhD (NIAAA),"1. Jiang XL, Gonzalez FJ, Yu AM (2011). Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models. Drug Metab Rev  43, 27-40.   https://doi.org/10.3109/03602532.2010.512294|2. Johnson CH, Gonzalez FJ (2012). Challenges and opportunities of metabolomics. J Cell Physiol  227, 2975-81.   https://doi.org/10.1002/jcp.24002|3. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ (2012). Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol Toxicol  52, 37-56.   https://doi.org/10.1146/annurev-pharmtox-010611-134748|4. Li F, Patterson AD, Höfer CC, Krausz KW, Gonzalez FJ, Idle JR (2011). A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochem Pharmacol  81, 1043-53.   https://doi.org/10.1016/j.bcp.2011.01.024|5. Li F, Patterson AD, Krausz KW, Dick B, Frey FJ, Gonzalez FJ, Idle JR (2012). Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem Pharmacol  83, 1435-44.   https://doi.org/10.1016/j.bcp.2012.02.013|6. Manna SK, Patterson AD, Yang Q, Krausz KW, Idle JR, Fornace AJ, Gonzalez FJ (2011). UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res  10, 4120-33.   https://doi.org/10.1021/pr200310s|7. Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ (2011). Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology  53, 1282-93.   https://doi.org/10.1002/hep.24193|8. Pang XY, Cheng J, Kim JH, Matsubara T, Krausz KW, Gonzalez FJ (2012). Expression and regulation of human fetal-specific CYP3A7 in mice. Endocrinology  153, 1453-63.   https://doi.org/10.1210/en.2011-1020|9. Patterson AD, Bonzo JA, Li F, Krausz KW, Eichler GS, Aslam S, Tigno X, Weinstein JN, Hansen BC, Idle JR, Gonzalez FJ (2011). Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem  286, 19511-22.   https://doi.org/10.1074/jbc.M111.221739|10. Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, Gonzalez FJ, Dufour JF, Idle JR (2011). Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res  71, 6590-600.   https://doi.org/10.1158/0008-5472.CAN-11-0885|11. Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ (2012). Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology  56, 281-90.   https://doi.org/10.1002/hep.25645|12. Shen HW, Jiang XL, Gonzalez FJ, Yu AM (2011). Humanized transgenic mouse models for drug metabolism and pharmacokinetic research. Curr Drug Metab  12, 997-1006.   https://doi.org/10.2174/138920011798062265|13. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012). Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology  56, 118-29.   https://doi.org/10.1002/hep.25630|14. Zhang Y, Li F, Patterson AD, Wang Y, Krausz KW, Neale G, Thomas S, Nachagari D, Vogel P, Vore M, Gonzalez FJ, Schuetz JD (2012). Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in mice. J Biol Chem  287, 24784-94.   https://doi.org/10.1074/jbc.M111.329318",https://intramural.nih.gov/search/searchview.taf?ipid=73218
18,BC005597-23,"October 01, 2011 -  September 30, 2012",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Yang  Zhang|Jeong Han  Kang|Ramatoulaye Kane Deme|Poorva  Dharkar|Serhiy Volodymirovych Surkov; PhD,"Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Sun-Shin  Cha (Korea Ocean Research and Development Institute)|Anuradha  Janakiraman (The City College of CUNY)|Alfred  Goldberg (Department Cell Biology, Harvard University Medical School)|Show all 7","Di S Xia; PhD, MS, BS (Crystallography Section)|Timothy D Veenstra (Office Of The Director)",Alasdair C Steven; PhD (NIAMS) |Grzegorz  Piszczek; PhD (NHLBI),"1. Maurizi M (2011) Endopeptidase Clp, in Handbook of Proteolytic Enzymes., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73219
19,BC005598-23,"October 01, 2011 -  September 30, 2012",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Carol O Cardarelli|Wilfred D Vieira|Matthew David Hall|Jean-Pierre  Gillet|King Leung Fung|Kristen M Pluchino|Show all 7,NULL,"Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)","Christopher P Austin; AB, MD (NCATS) |Robert  Innis; MD (NIMH) |Yardena Rachel Samuels; PhD (NHGRI)","1. Gillet JP, Gottesman MM (2011). Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer. Curr Pharm Biotechnol  12, 686-92.   https://doi.org/10.2174/138920111795163931|2. Goldsborough AS, Handley MD, Dulcey AE, Pluchino KM, Kannan P, Brimacombe KR, Hall MD, Griffiths G, Gottesman MM (2011). Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin. J Med Chem  54, 4987-97.   https://doi.org/10.1021/jm2001663|3. Hall MD, Brimacombe KR, Varonka MS, Pluchino KM, Monda JK, Li J, Walsh MJ, Boxer MB, Warren TH, Fales HM, Gottesman MM (2011). Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein. J Med Chem  54, 5878-89.   https://doi.org/10.1021/jm2006047|4. Kannan P, Brimacombe KR, Kreisl WC, Liow JS, Zoghbi SS, Telu S, Zhang Y, Pike VW, Halldin C, Gottesman MM, Innis RB, Hall MD (2011). Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET. Proc Natl Acad Sci U S A  108, 2593-8.   https://doi.org/10.1073/pnas.1014641108|5. Lucia MB, Anu R, Handley M, Gillet JP, Wu CP, De Donatis GM, Cauda R, Gottesman MM (2011). Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells. Br J Cancer  105, 513-22.   https://doi.org/10.1038/bjc.2011.275|6. Macadangdang B, Zhang N, Lund PE, Marple AH, Okabe M, Gottesman MM, Appella DH, Kimchi-Sarfaty C (2011). Inhibition of multidrug resistance by SV40 pseudovirion delivery of an antigene peptide nucleic acid (PNA) in cultured cells. PLoS One  6, e17981.   https://doi.org/10.1371/journal.pone.0017981|7. Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AM, Fung KL, Wu CP, Gottesman MM, Bauer B, Thomas CJ, Ambudkar SV (2011). Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Mol Pharm  8, 1292-302.   https://doi.org/10.1021/mp2001022",https://intramural.nih.gov/search/searchview.taf?ipid=73220
20,BC005599-22,"October 01, 2011 -  September 30, 2012","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI","Sharlyn  Mazur; PhD|Lisa Marie Jenkins|Kan  Tanoue|Pramita  Chatterjee|Kazushige  Ishida|Hiroyasu  Sakai; MD, PhD","Donald  Hunt (Department of Chemistry, University of Minnesota)|Yang  Xu (University of California)|Tatiana  Kutateladze (University of Colorado Denver School of Medicine)",Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73221
21,BC005645-23,"October 01, 2011 -  September 30, 2012",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Cynthia  Masison|Dustin  Edwards|Robyn M Washington Parks|Maria Fernanda  Amarante|Claudio  Fenizia,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)|Jacek  Skowronski (Case School of Medicine)",Kathryn  Jones; PhD (Laboratory of Experimental Immunology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology),Steven J Jacobson; PhD (NINDS) |Klaus  Strebel; PhD (NIAID),"1. Andresen V, Pise-Masison CA, Sinha-Datta U, Bellon M, Valeri V, Washington Parks R, Cecchinato V, Fukumoto R, Nicot C, Franchini G (2011). Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood  118, 1549-59.   https://doi.org/10.1182/blood-2010-06-293340|2. Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G (2011) Orf-I and Orf-II-Encoded Proteins in HTLV-1 Infection and Persistence. Viruses 3:861-85.|3. Tosi G, Forlani G, Andresen V, Turci M, Bertazzoni U, Franchini G, Poli G, Accolla RS (2011). Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication. J Virol  85, 10719-29.   https://doi.org/10.1128/JVI.00813-11",https://intramural.nih.gov/search/searchview.taf?ipid=73223
22,BC005657-23,"October 01, 2011 -  September 30, 2012",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Charlotte A Hanson|Monika  Kaczmarek|Jami A Wolfe|Stephen  Lavanier,NULL,Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Ruscetti S, Cmarik J (2011) Deregulation of signal transduction pathways by oncogenic retroviruses, in Retroviruses and Insights into Cancer., pp. 53-94.|2. Cmarik JL, Troxler JA, Hanson CA, Zhang X, Ruscetti SK (2011). The human lung adenocarcinoma cell line EKVX produces an infectious xenotropic murine leukemia virus. Viruses  3, 2442-61.   https://doi.org/10.3390/v3122442|3. Li X, Zhang X, Cmarik JL, Ruscetti S (2011). Importance of macrophage inflammatory protein-1α and splenic macrophages in neurodegeneration induced by PVC-211 murine leukemia virus. Virology  409, 198-203.   https://doi.org/10.1016/j.virol.2010.10.012|4. Macpherson GR, Hanson CA, Thompson DM, Perella CM, Cmarik JL, Ruscetti SK (2012). Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia. Leuk Res  36, 369-76.   https://doi.org/10.1016/j.leukres.2011.08.019",https://intramural.nih.gov/search/searchview.taf?ipid=73224
23,BC005673-22,"October 01, 2011 -  September 30, 2012",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",Joseph A. Hrabie; PhD|Joseph  Saavedra|Laura  Fornwald|Anna E Maciag|Debanjan  Biswas|Ryan John Holland; PhD|Show all 9,"Melina  Kibbe (Division of Vascular Surgery, Northwestern University)|Jeffrey  Deschamps (Naval Research Laboratory)|Sonia  Donzelli|Katrina  Miranda (University of Arizona)|Robert  Prud'homme (Princeton University)|Paul  Shami (Medical Oncology, U of Utah)|Show all 7","Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|James Ming Phang; MD (Basic Research Laboratory)|David Anderson Wink (Radiation Biology Branch)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology)",Michael  Waalkes; PhD (NIEHS),"1. Keefer LK (2011). Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances. ACS Chem Biol  6, 1147-55.   https://doi.org/10.1021/cb200274r|2. Nandurdikar RS, Keefer LK, Saavedra JE (2011). Novel protection-deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA/NO. Chem Commun (Camb)  47, 6710-2.   https://doi.org/10.1039/c1cc12130h|3. Salmon DJ, Torres de Holding CL, Thomas L, Peterson KV, Goodman GP, Saavedra JE, Srinivasan A, Davies KM, Keefer LK, Miranda KM (2011). HNO and NO release from a primary amine-based diazeniumdiolate as a function of pH. Inorg Chem  50, 3262-70.   https://doi.org/10.1021/ic101736e",https://intramural.nih.gov/search/searchview.taf?ipid=73225
24,BC005688-22,"October 01, 2011 -  September 30, 2012",Understanding the Role of the Host Response in HIVSIV Infection,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Monica  Vaccari|Shari  Gordon; PhD|Melvin Nelson Doster|Poonam  Poonam,"Eckhard  Podack (Department of Microbiology, University of Miami)|Savita  Pahwa (Miller School of Medicine, University of Miami)",Gene  Shearer; PhD (Experimental Immunology Branch),Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID),"1. Pallikkuth S, Rogers K, Villinger F, Dosterii M, Vaccari M, Franchini G, Pahwa R, Pahwa S (2011). Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication. Vaccine  29, 9229-38.   https://doi.org/10.1016/j.vaccine.2011.09.118|2. Vaccari M, Boasso A, Fenizia C, Fuchs D, Hryniewicz A, Morgan T, Weiss D, Doster MN, Heraud JM, Shearer GM, Franchini G (2012). Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade. J Virol  86, 108-13.   https://doi.org/10.1128/JVI.05609-11",https://intramural.nih.gov/search/searchview.taf?ipid=73226
25,BC005708-21,"October 01, 2011 -  September 30, 2012",Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Linda G Byrd|Jessica  Bonzo|Jie  Cheng|Aijuan  Qu|Changtao  Jiang|Jung Hwan  Kim|Show all 7,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Tami  Nakajima (Nagoya University)|Jeffrey  Idle (University of Bern)|Bart  Staels (University of Lille Nord de France)|Masahiko  Kurabayashi (Gunma University Graduate School of Health Sciences)|Show all 10",Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention),"Kevin Graham Becker; BS, MAS, PhD (NIA) |Oksana  Gavrilova; PhD (NIDDK) |Gregory George Germino; MD (NIDDK) |Lothar  Hennighausen; PhD (NIDDK) |Byoungjoon  Song; PhD (NIAAA)","1. Baghdasaryan A, Claudel T, Gumhold J, Silbert D, Adorini L, Roda A, Vecchiotti S, Gonzalez FJ, Schoonjans K, Strazzabosco M, Fickert P, Trauner M (2011). Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output. Hepatology  54, 1303-12.   https://doi.org/10.1002/hep.24537|2. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ (2012). Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem  287, 7345-56.   https://doi.org/10.1074/jbc.M111.334599|3. Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM (2011). Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes. Cell Signal  23, 2039-50.   https://doi.org/10.1016/j.cellsig.2011.07.020|4. Cheng J, Ma X, Gonzalez FJ (2011). Pregnane X receptor- and CYP3A4-humanized mouse models and their applications. Br J Pharmacol  163, 461-8.   https://doi.org/10.1111/j.1476-5381.2010.01129.x|5. Cheng J, Shah YM, Gonzalez FJ (2012). Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci  33, 323-30.   https://doi.org/10.1016/j.tips.2012.03.003|6. Chennamsetty I, Claudel T, Kostner KM, Baghdasaryan A, Kratky D, Levak-Frank S, Frank S, Gonzalez FJ, Trauner M, Kostner GM (2011). Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest  121, 3724-34.   https://doi.org/10.1172/JCI45277|7. Elizondo G, Rodríguez-Sosa M, Estrada-Muñiz E, Gonzalez FJ, Vega L (2011). Deletion of the aryl hydrocarbon receptor enhances the inflammatory response to Leishmania major infection. Int J Biol Sci  7, 1220-9.   https://doi.org/10.7150/ijbs.7.1220|8. Foreman JE, Chang WC, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM (2011). Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer. Mol Carcinog  50, 884-900.   https://doi.org/10.1002/mc.20757|9. Hondares E, Iglesias R, Giralt A, Gonzalez FJ, Giralt M, Mampel T, Villarroya F (2011). Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem  286, 12983-90.   https://doi.org/10.1074/jbc.M110.215889|10. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, Riedl M, Diaz-Sanchez D, Kleerup E, Tashkin DP, Gonzalez FJ, Bonavida B, Zeidler M, Hankinson O (2011). Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy  66, 909-18.   https://doi.org/10.1111/j.1398-9995.2011.02594.x|11. Kim JH, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ (2013). Implication of intestinal VDR deficiency in inflammatory bowel disease. Biochim Biophys Acta  1830, 2118-28.   https://doi.org/10.1016/j.bbagen.2012.09.020|12. Li Y, Ramdhan DH, Naito H, Yamagishi N, Ito Y, Hayashi Y, Yanagiba Y, Okamura A, Tamada H, Gonzalez FJ, Nakajima T (2011). Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα. Toxicol Lett  205, 265-72.   https://doi.org/10.1016/j.toxlet.2011.06.015|13. Matsubara T, Li F, Gonzalez FJ (2013). FXR signaling in the enterohepatic system. Mol Cell Endocrinol  368, 17-29.   https://doi.org/10.1016/j.mce.2012.05.004|14. Nakagawa K, Tanaka N, Morita M, Sugioka A, Miyagawa S, Gonzalez FJ, Aoyama T (2012). PPARα is down-regulated following liver transplantation in mice. J Hepatol  56, 586-94.   https://doi.org/10.1016/j.jhep.2011.08.021|15. Nakagawa T, Ramdhan DH, Tanaka N, Naito H, Tamada H, Ito Y, Li Y, Hayashi Y, Yamagishi N, Yanagiba Y, Aoyama T, Gonzalez FJ, Nakajima T (2012). Modulation of ammonium perfluorooctanoate-induced hepatic damage by genetically different PPARα in mice. Arch Toxicol  86, 63-74.   https://doi.org/10.1007/s00204-011-0704-3|16. Pang XY, Cheng J, Kim JH, Matsubara T, Krausz KW, Gonzalez FJ (2012). Expression and regulation of human fetal-specific CYP3A7 in mice. Endocrinology  153, 1453-63.   https://doi.org/10.1210/en.2011-1020|17. Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ (2012). Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology  56, 281-90.   https://doi.org/10.1002/hep.25645|18. Peters JM, Shah YM, Gonzalez FJ (2012). The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer  12, 181-95.   https://doi.org/10.1038/nrc3214|19. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B (2011). Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes  60, 1861-71.   https://doi.org/10.2337/db11-0030|20. Qu A, Shah YM, Manna SK, Gonzalez FJ (2012). Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol  32, 65-73.   https://doi.org/10.1161/ATVBAHA.111.239137|21. Qu A, Taylor M, Xue X, Matsubara T, Metzger D, Chambon P, Gonzalez FJ, Shah YM (2011). Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology  54, 472-83.   https://doi.org/10.1002/hep.24400|22. Sarkar K, Rey S, Zhang X, Sebastian R, Marti GP, Fox-Talbot K, Cardona AV, Du J, Tan YS, Liu L, Lay F, Gonzalez FJ, Harmon JW, Semenza GL (2012). Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells. Cardiovasc Res  93, 162-9.   https://doi.org/10.1093/cvr/cvr282|23. Sato Y, Hatta M, Karim MF, Sawa T, Wei FY, Sato S, Magnuson MA, Gonzalez FJ, Tomizawa K, Akaike T, Yoshizawa T, Yamagata K (2012). Anks4b, a novel target of HNF4α protein, interacts with GRP78 protein and regulates endoplasmic reticulum stress-induced apoptosis in pancreatic β-cells. J Biol Chem  287, 23236-45.   https://doi.org/10.1074/jbc.M112.368779|24. Takahashi K, Kamijo Y, Hora K, Hashimoto K, Higuchi M, Nakajima T, Ehara T, Shigematsu H, Gonzalez FJ, Aoyama T (2011). Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration. Toxicol Appl Pharmacol  252, 237-49.   https://doi.org/10.1016/j.taap.2011.02.012|25. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012). Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology  56, 118-29.   https://doi.org/10.1002/hep.25630|26. Taylor M, Qu A, Anderson ER, Matsubara T, Martin A, Gonzalez FJ, Shah YM (2011). Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology  140, 2044-55.   https://doi.org/10.1053/j.gastro.2011.03.007|27. Xue X, Taylor M, Anderson E, Hao C, Qu A, Greenson JK, Zimmermann EM, Gonzalez FJ, Shah YM (2012). Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res  72, 2285-93.   https://doi.org/10.1158/0008-5472.CAN-11-3836|28. Zhang H, Zhang G, Gonzalez FJ, Park SM, Cai D (2011). Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation. PLoS Biol  9, e1001112.   https://doi.org/10.1371/journal.pbio.1001112|29. Zhang Y, Li F, Patterson AD, Wang Y, Krausz KW, Neale G, Thomas S, Nachagari D, Vogel P, Vore M, Gonzalez FJ, Schuetz JD (2012). Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in mice. J Biol Chem  287, 24784-94.   https://doi.org/10.1074/jbc.M111.329318|30. Zhu B, Khozoie C, Bility MT, Ferry CH, Blazanin N, Glick AB, Gonzalez FJ, Peters JM (2012). Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells. Mol Cell Biol  32, 2065-82.   https://doi.org/10.1128/MCB.00092-12",https://intramural.nih.gov/search/searchview.taf?ipid=73227
26,BC005740-20,"October 01, 2011 -  September 30, 2012",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Olga  Aprelikova; PhD|Tinghu  Qiu|Constance Emmanuelle Brignatz-Guittard|Aleksandra M Michalowska|Kent W Hunter; PhD|Lalage  Wakefield; PhD,Alfonso  Calvo (University of Pamplona)|Tamaro  Hudson (Howard University)|Kartiki  Desai (Genome Institute of Singapore)|Joe  Gray (Lawrence Berkeley National Labs)|Eleanor  Blakely (Lawrence Berkeley National Laboratory),"Melinda  Hollingshead (Biological Testing Branch)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thorkell  Andresson (Office Of The Director)|Young S Kim (Nutritional Science Research Group)","Chuxia  Deng; PhD (NIDDK) |Mark  Hoenerhoff; DVM, PhD (NIEHS)","1. Zhu M, Michalowski A, Green J (2011) Expression Profiling of Mouse Models of Human Cancer: model categorization and guidance for preclinical testing, in Genetically-engineered Mice for Cancer Research: design, analysis, pathways, validation and pre-clinical testing., in press.|2. Chu IM, Michalowski AM, Hoenerhoff M, Szauter KM, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green JE (2012). GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. Oncogene  31, 2017-27.   https://doi.org/10.1038/onc.2011.382|3. Hoenerhoff M, Chu IM, Green JE (2011). BMI1 suffers a degrading experience. Cell Cycle  10, 1894-5.   https://doi.org/10.4161/cc.10.12.15688|4. Murphy EA, Davis JM, Barrilleaux TL, McClellan JL, Steiner JL, Carmichael MD, Pena MM, Hebert JR, Green JE (2011). Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice. Cytokine  55, 274-9.   https://doi.org/10.1016/j.cyto.2011.04.007|5. Reindl W, Bowen BP, Balamotis MA, Green JE, Northen TR (2011). Multivariate analysis of a 3D mass spectral image for examining tissue heterogeneity. Integr Biol (Camb)  3, 460-7.   https://doi.org/10.1039/c0ib00091d|6. Rodriguez V, Vasudevan S, Noma A, Carlson BA, Green JE, Suzuki T, Chandrasekharappa SC (2012). Structure-function analysis of human TYW2 enzyme required for the biosynthesis of a highly modified Wybutosine (yW) base in phenylalanine-tRNA. PLoS One  7, e39297.   https://doi.org/10.1371/journal.pone.0039297|7. Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE (2011). Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biol  12, R77.   https://doi.org/10.1186/gb-2011-12-8-r77",https://intramural.nih.gov/search/searchview.taf?ipid=73228
27,BC005785-18,"October 01, 2011 -  September 30, 2012",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Binwu  Tang|Kathleen C Flanders; PhD|Yu-an  Yang|Yoshiko  Nagano|Samuel Lee Dengler|Jia  Weng|Show all 7,NULL,Miriam R Anver (Office Of The Director)|Christina  Stuelten (Laboratory of Cellular and Molecular Biology)|Chand  Khanna; MD (Pediatric Oncology Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Dominic  Esposito; PhD (Office Of The Director)|Maxwell P Lee; PhD (Laboratory of Population Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73229
28,BC005793-18,"October 01, 2011 -  September 30, 2012",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Xuelian  Zhao,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73230
29,BC005795-18,"October 01, 2011 -  September 30, 2012",p53 Tumor Suppressor Pathway,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Izumi  Horikawa|Elise Dawn Bowman|Mohammed A. Khan; PhD|Judith A Welsh|Giang Huong Nguyen|Brid Mairead Ryan|Show all 11,NULL,NULL,NULL,"1. Horikawa I, Fujita K, Harris CC (2011). p53 governs telomere regulation feedback too, via TRF2. Aging (Albany NY)  3, 26-32.   https://doi.org/10.18632/aging.100271|2. Schetter AJ, Harris CC (2012). Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome. Proc Natl Acad Sci U S A  109, 7955-6.   https://doi.org/10.1073/pnas.1205457109|3. Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM, Stauffer JK, Zheng ZM, Harris CC (2013). Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene  32, 2792-8.   https://doi.org/10.1038/onc.2012.288",https://intramural.nih.gov/search/searchview.taf?ipid=73231
30,BC006140-36,"October 01, 2011 -  September 30, 2012",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe  Redon|Allison  Burrell|Palak Rajendra Parekh|Daisuke  Maeda|Urbain Sossou  Weyemi|Dejun  Huang|Show all 11,"Olga  Kovalchuk (Department of Biological Sciences, University of Lethbridge)|David  Brenner (Columbia University)|Igor  Koturbash (Department of Biological Sciences, University of Lethbridge)|Stephen  Marino (Radiological Research Accelerator Facility, Center for Radiological Research, College of Physicians and Surgeons, Columbia University)|Stephen  Mitchell (Radiological Research Accelerator Facility, Center for Radiological Research, College of Physicians and Surgeons, Columbia University)|Yuri  Griko (NASA)|Show all 24",Scott Michael Lawrence (Office of the Director)|Lionel  Feigenbaum (Office Of The Director)|Jiuping  Ji (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),"Karen P Usdin; PhD (NIDDK) |Daman  Kumari; PhD (NIDDK) |Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Baird BJ, Dickey JS, Nakamura AJ, Redon CE, Parekh P, Griko YV, Aziz K, Georgakilas AG, Bonner WM, Martin OA (2011). Hypothermia postpones DNA damage repair in irradiated cells and protects against cell killing. Mutat Res  711, 142-9.   https://doi.org/10.1016/j.mrfmmm.2010.12.006|2. Dickey JS, Zemp FJ, Altamirano A, Sedelnikova OA, Bonner WM, Kovalchuk O (2011). H2AX phosphorylation in response to DNA double-strand break formation during bystander signalling: effect of microRNA knockdown. Radiat Prot Dosimetry  143, 264-9.   https://doi.org/10.1093/rpd/ncq470|3. Ivashkevich AN, Martin OA, Smith AJ, Redon CE, Bonner WM, Martin RF, Lobachevsky PN (2011). γH2AX foci as a measure of DNA damage: a computational approach to automatic analysis. Mutat Res  711, 49-60.   https://doi.org/10.1016/j.mrfmmm.2010.12.015|4. Martin OA, Redon CE, Dickey JS, Nakamura AJ, Bonner WM (2011). Para-inflammation mediates systemic DNA damage in response to tumor growth. Commun Integr Biol  4, 78-81.   https://doi.org/10.4161/cib.4.1.13942|5. Martin OA, Redon CE, Nakamura AJ, Dickey JS, Georgakilas AG, Bonner WM (2011). Systemic DNA damage related to cancer. Cancer Res  71, 3437-41.   https://doi.org/10.1158/0008-5472.CAN-10-4579|6. Redon CE, Bonner WM (2011). High salt and DNA double-strand breaks. Proc Natl Acad Sci U S A  108, 20281-2.   https://doi.org/10.1073/pnas.1117713109|7. Redon CE, Nakamura AJ, Gouliaeva K, Rahman A, Blakely WF, Bonner WM (2011). Q(γ-H2AX), an analysis method for partial-body radiation exposure using γ-H2AX in nonhuman primate lymphocytes. Radiat Meas  46, 877-881.   https://doi.org/10.1016/j.radmeas.2011.02.017|8. Redon CE, Nakamura AJ, Martin OA, Parekh PR, Weyemi US, Bonner WM (2011). Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker. Aging (Albany NY)  3, 168-74.   https://doi.org/10.18632/aging.100284|9. Redon CE, Nakamura AJ, Sordet O, Dickey JS, Gouliaeva K, Tabb B, Lawrence S, Kinders RJ, Bonner WM, Sedelnikova OA (2011). γ-H2AX detection in peripheral blood lymphocytes, splenocytes, bone marrow, xenografts, and skin. Methods Mol Biol  682, 249-70.   https://doi.org/10.1007/978-1-60327-409-8_18",https://intramural.nih.gov/search/searchview.taf?ipid=73232
31,BC006150-31,"October 01, 2011 -  September 30, 2012","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Ann  Orr|William Curtis Reinhold|Margot  Sunshine|Keli  Agama|Barry R Zeeberg; PhD|Show all 25,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yoshi  Shiloh (Tel Aviv University)|Show all 8",Robert  Shoemaker (Screening Technologies Branch)|Robert J Fisher (Office Of The Director)|Alexander  Wlodawer; PhD (Protein Structure Section)|Marc C Nicklaus (Chemical Biology Laboratory)|Joseph E Tomaszewski (Office of the Director)|Melinda  Hollingshead (Biological Testing Branch),"Christopher P Austin; AB, MD (NCATS) |Weidong  Wang; PhD (NIA)","1. Aris SM, Pommier Y (2012). Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762. Cancer Res  72, 979-89.   https://doi.org/10.1158/0008-5472.CAN-11-2579|2. Chen CF, He X, Arslan AD, Mo YY, Reinhold WC, Pommier Y, Beck WT (2011). Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness. Mol Pharmacol  79, 735-41.   https://doi.org/10.1124/mol.110.069633|3. Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ (2011). Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia  13, 145-53.   https://doi.org/10.1593/neo.101202|4. Huang SN, Pommier Y, Marchand C (2011). Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat  21, 1285-92.   https://doi.org/10.1517/13543776.2011.604314|5. Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, Jia L, Weil M, Speranza G, Murgo AJ, Kinders R, Wang L, Parchment RE, Carter J, Stotler H, Rubinstein L, Hollingshead M, Melillo G, Pommier Y, Bonner W, Tomaszewski JE, Doroshow JH (2011). Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Res  71, 5626-34.   https://doi.org/10.1158/0008-5472.CAN-11-1227|6. Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS (2011). Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy. J Struct Biol  176, 292-301.   https://doi.org/10.1016/j.jsb.2011.09.008|7. Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS (2011). X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket. FEBS Lett  585, 3245-9.   https://doi.org/10.1016/j.febslet.2011.08.050|8. Métifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y (2013). Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem Biol  8, 209-17.   https://doi.org/10.1021/cb300471n|9. Martin MM, Ryan M, Kim R, Zakas AL, Fu H, Lin CM, Reinhold WC, Davis SR, Bilke S, Liu H, Doroshow JH, Reimers MA, Valenzuela MS, Pommier Y, Meltzer PS, Aladjem MI (2011). Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res  21, 1822-32.   https://doi.org/10.1101/gr.124644.111|10. Martin SE, Wu ZH, Gehlhaus K, Jones TL, Zhang YW, Guha R, Miyamoto S, Pommier Y, Caplen NJ (2011). RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors. Curr Cancer Drug Targets  11, 976-86.   https://doi.org/10.2174/156800911797264734|11. Nguyen D, Zajac-Kaye M, Rubinstein L, Voeller D, Tomaszewski JE, Kummar S, Chen AP, Pommier Y, Doroshow JH, Yang SX (2011). Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent. Cell Cycle  10, 4074-82.   https://doi.org/10.4161/cc.10.23.18170|12. Regairaz M, Zhang YW, Fu H, Agama KK, Tata N, Agrawal S, Aladjem MI, Pommier Y (2011). Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes. J Cell Biol  195, 739-49.   https://doi.org/10.1083/jcb.201104003|13. Solier S, Pommier Y (2011). MDC1 cleavage by caspase-3: a novel mechanism for inactivating the DNA damage response during apoptosis. Cancer Res  71, 906-13.   https://doi.org/10.1158/0008-5472.CAN-10-3297|14. Zeeberg BR, Liu H, Kahn AB, Ehler M, Rajapakse VN, Bonner RF, Brown JD, Brooks BP, Larionov VL, Reinhold W, Weinstein JN, Pommier YG (2011). RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis. BMC Bioinformatics  12, 52.   https://doi.org/10.1186/1471-2105-12-52|15. Zhang YW, Regairaz M, Seiler JA, Agama KK, Doroshow JH, Pommier Y (2011). Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells. Nucleic Acids Res  39, 3607-20.   https://doi.org/10.1093/nar/gkq1304",https://intramural.nih.gov/search/searchview.taf?ipid=73233
32,BC006161-29,"October 01, 2011 -  September 30, 2012",DNA Topoisomerases as Target of Action of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Hongliang  Zhang|Keli  Agama|Rui  Gao|Benu Brata  Das|Dhriti K Sooryakumar|Show all 16,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch)|Joseph E Tomaszewski (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch),NULL,"1. Aris SM, Pommier Y (2012). Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762. Cancer Res  72, 979-89.   https://doi.org/10.1158/0008-5472.CAN-11-2579|2. Chen CF, He X, Arslan AD, Mo YY, Reinhold WC, Pommier Y, Beck WT (2011). Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness. Mol Pharmacol  79, 735-41.   https://doi.org/10.1124/mol.110.069633|3. Drwal MN, Agama K, Wakelin LP, Pommier Y, Griffith R (2011). Exploring DNA topoisomerase I ligand space in search of novel anticancer agents. PLoS One  6, e25150.   https://doi.org/10.1371/journal.pone.0025150|4. Eddy J, Vallur AC, Varma S, Liu H, Reinhold WC, Pommier Y, Maizels N (2011). G4 motifs correlate with promoter-proximal transcriptional pausing in human genes. Nucleic Acids Res  39, 4975-83.   https://doi.org/10.1093/nar/gkr079|5. Kim N, Huang SN, Williams JS, Li YC, Clark AB, Cho JE, Kunkel TA, Pommier Y, Jinks-Robertson S (2011). Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science  332, 1561-4.   https://doi.org/10.1126/science.1205016|6. Kobayashi M, Sabouri Z, Sabouri S, Kitawaki Y, Pommier Y, Abe T, Kiyonari H, Honjo T (2011). Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation. Proc Natl Acad Sci U S A  108, 19305-10.   https://doi.org/10.1073/pnas.1114522108|7. Peterson KE, Cinelli MA, Morrell AE, Mehta A, Dexheimer TS, Agama K, Antony S, Pommier Y, Cushman M (2011). Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity. J Med Chem  54, 4937-53.   https://doi.org/10.1021/jm101338z|8. Sooryakumar D, Dexheimer TS, Teicher BA, Pommier Y (2011). Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282. Mol Cancer Ther  10, 1490-9.   https://doi.org/10.1158/1535-7163.MCT-10-1043",https://intramural.nih.gov/search/searchview.taf?ipid=73234
33,BC006192-24,"October 01, 2011 -  September 30, 2012",Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Sohyoung  Kim|Augustin  Luna|Mirit I Aladjem; PhD|Geoffrey B Mcfadden,Evrim Itir Karac|Martijn  van Iersel (Netherlands Consortium for Systems Biology),Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73235
34,BC006198-23,"October 01, 2011 -  September 30, 2012",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Medhanit  Bahta|Wen-Jian  Qian; PhD|Christopher George Nelson; PhD,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Michael  Yaffe (Massachusetts Institute of Technology)",David S Waugh; PhD (Protein Engineering Section)|Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)|Kyung  Lee; PhD (Chemistry Section),NULL,"1. Bahta M, Burke TR (2011). Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH. ChemMedChem  6, 1363-70.   https://doi.org/10.1002/cmdc.201100200|2. Bahta M, Lountos GT, Dyas B, Kim SE, Ulrich RG, Waugh DS, Burke TR (2011). Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. J Med Chem  54, 2933-43.   https://doi.org/10.1021/jm200022g|3. Kim SE, Bahta M, Lountos GT, Ulrich RG, Burke TR, Waugh DS (2011). Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH. Acta Crystallogr D Biol Crystallogr  67, 639-45.   https://doi.org/10.1107/S0907444911018610|4. Kim SE, Liu F, Im YJ, Stephen AG, Fivash MJ, Waheed AA, Freed EO, Fisher RJ, Hurley JH, Burke TR (2011). Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands. ACS Med Chem Lett  2, 337-341.   https://doi.org/10.1021/ml1002579|5. Liu F, Giubellino A, Simister PC, Qian W, Giano MC, Feller SM, Bottaro DP, Burke TR (2011). Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides. Biopolymers  96, 780-8.   https://doi.org/10.1002/bip.21692|6. Liu F, Park JE, Qian WJ, Lim D, Gräber M, Berg T, Yaffe MB, Lee KS, Burke TR (2011). Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. Nat Chem Biol  7, 595-601.   https://doi.org/10.1038/nchembio.614|7. Nelson CG, Burke TR (2012). Samarium iodide-mediated Reformatsky reactions for the stereoselective preparation of β-hydroxy-γ-amino acids: synthesis of isostatine and dolaisoleucine. J Org Chem  77, 733-8.   https://doi.org/10.1021/jo202091r|8. Qian W, Liu F, Burke TR (2011). Investigation of unanticipated alkylation at the N(π) position of a histidyl residue under Mitsunobu conditions and synthesis of orthogonally protected histidine analogues. J Org Chem  76, 8885-90.   https://doi.org/10.1021/jo201599c|9. Saio T, Ogura K, Shimizu K, Yokochi M, Burke TR, Inagaki F (2011). An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe. J Biomol NMR  51, 395-408.   https://doi.org/10.1007/s10858-011-9566-5|10. Thomas JD, Burke TR (2011). Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation. Tetrahedron Lett  52, 4316-4319.   https://doi.org/10.1016/j.tetlet.2011.06.042",https://intramural.nih.gov/search/searchview.taf?ipid=73236
35,BC007333-21,"October 01, 2011 -  September 30, 2012",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Ann  Orr|Keli  Agama|Mathieu Albert Metifiot,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Hare S, Smith SJ, Métifiot M, Jaxa-Chamiec A, Pommier Y, Hughes SH, Cherepanov P (2011). Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol  80, 565-72.   https://doi.org/10.1124/mol.111.073189|2. Métifiot M, Johnson B, Smith S, Zhao XZ, Marchand C, Burke T, Hughes S, Pommier Y (2011). MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrob Agents Chemother  55, 5127-33.   https://doi.org/10.1128/AAC.05288-11|3. Tang J, Maddali K, Dreis CD, Sham YY, Vince R, Pommier Y, Wang Z (2011). 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase. Bioorg Med Chem Lett  21, 2400-2.   https://doi.org/10.1016/j.bmcl.2011.02.069|4. Tang J, Maddali K, Dreis CD, Sham YY, Vince R, Pommier Y, Wang Z (2011). N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase. ACS Med Chem Lett  2, 63-67.   https://doi.org/10.1021/ml1002162|5. Tang J, Maddali K, Metifiot M, Sham YY, Vince R, Pommier Y, Wang Z (2011). 3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase. J Med Chem  54, 2282-92.   https://doi.org/10.1021/jm1014378|6. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2011). Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  21, 2986-90.   https://doi.org/10.1016/j.bmcl.2011.03.047",https://intramural.nih.gov/search/searchview.taf?ipid=73237
36,BC007363-18,"October 01, 2011 -  September 30, 2012",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Xue Zhi  Zhao,"Peter  Cherepanov (Imperial College London)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Kim SE, Liu F, Im YJ, Stephen AG, Fivash MJ, Waheed AA, Freed EO, Fisher RJ, Hurley JH, Burke TR (2011). Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands. ACS Med Chem Lett  2, 337-341.   https://doi.org/10.1021/ml1002579|2. Métifiot M, Johnson B, Smith S, Zhao XZ, Marchand C, Burke T, Hughes S, Pommier Y (2011). MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrob Agents Chemother  55, 5127-33.   https://doi.org/10.1128/AAC.05288-11|3. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2011). Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  21, 2986-90.   https://doi.org/10.1016/j.bmcl.2011.03.047",https://intramural.nih.gov/search/searchview.taf?ipid=73238
37,BC007365-18,"October 01, 2011 -  September 30, 2012",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Xiaoying  Jian; PhD|Ruibai  Luo|Pei-Wen  Chen|Yoko  Shiba|Marek  Sramko|Peng  Zhai; PhD,Richard  Kahn (Emory University)|Elizabeth  Sztul (University of Alabama)|Sylvain  Bourgain (University of Laval),Lino  Tessarollo (Mouse Cancer Genetics Program)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory),"J Silvio  Gutkind; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |Kenneth Manao Yamada; MD, PhD (NIDCR)","1. Lowery J, Szul T, Seetharaman J, Jian X, Su M, Forouhar F, Xiao R, Acton TB, Montelione GT, Lin H, Wright JW, Lee E, Holloway ZG, Randazzo PA, Tong L, Sztul E (2011). Novel C-terminal motif within Sec7 domain of guanine nucleotide exchange factors regulates ADP-ribosylation factor (ARF) binding and activation. J Biol Chem  286, 36898-906.   https://doi.org/10.1074/jbc.M111.230631|2. Sakurai A, Jian X, Lee CJ, Manavski Y, Chavakis E, Donaldson J, Randazzo PA, Gutkind JS (2011). Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein. J Biol Chem  286, 34335-45.   https://doi.org/10.1074/jbc.M111.259499|3. Shiba Y, Luo R, Hinshaw JE, Szul T, Hayashi R, Sztul E, Nagashima K, Baxa U, Randazzo PA (2011). ArfGAP1 promotes COPI vesicle formation by facilitating coatomer polymerization. Cell Logist  1, 139-154.   https://doi.org/10.4161/cl.1.4.18896|4. Shiba Y, Randazzo PA (2011). GEFH1 binds ASAP1 and regulates podosome formation. Biochem Biophys Res Commun  406, 574-9.   https://doi.org/10.1016/j.bbrc.2011.02.093|5. Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA (2011). ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol Cell  103, 171-84.   https://doi.org/10.1042/BC20100154",https://intramural.nih.gov/search/searchview.taf?ipid=73239
38,BC008303-40,"October 01, 2011 -  September 30, 2012",Mechanisms of Viral Fusion and Inactivation,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Anu  Puri; PhD|Yossef  Raviv|Mathias  Viard|Dimiter Stanchev Dimitrov; PhD,"Yechiel  Shai (Biological Chemistry, Weizmann  Institute, Israel)|Assaf  Friedler (Hebrew University)|Mark  Tomkins (University of Georgia)|Thomas  Luke; MD (Naval Medical Research Institute)|Jeeseong  Hwang (NIST)|Richard  Wyatt (The Scripps Research Institute)","Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Stephen J Lockett; PhD (Office Of The Director)|Timothy D Veenstra (Office Of The Director)","Bernard  Moss; MD, PhD (NIAID) |Alasdair C Steven; PhD (NIAMS)","1. Ashkenazi A, Viard M, Wexler-Cohen Y, Blumenthal R, Shai Y (2011). Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41. FASEB J  25, 2156-66.   https://doi.org/10.1096/fj.10-175752|2. Belanger JM, Raviv Y, Viard M, de la Cruz MJ, Nagashima K, Blumenthal R (2011). Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1). Virology  417, 221-8.   https://doi.org/10.1016/j.virol.2011.06.007|3. Garg H, Viard M, Jacobs A, Blumenthal R (2011). Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy. Curr Top Med Chem  11, 2947-58.   https://doi.org/10.2174/156802611798808479",https://intramural.nih.gov/search/searchview.taf?ipid=73240
39,BC008382-29,"October 01, 2011 -  September 30, 2012",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kazimierz Wojcieck Kasprzak|Shu Yun  Le|Eckart  Bindewald|Arti  Santhanam|Tae Jin  Kim|Praneet Sai Puppala,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luiz  Penalva (Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)",Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Yun Xing M Wang (Structural Biophysics Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Bindewald E, Wendeler M, Legiewicz M, Bona MK, Wang Y, Pritt MJ, Le Grice SF, Shapiro BA (2011). Correlating SHAPE signatures with three-dimensional RNA structures. RNA  17, 1688-96.   https://doi.org/10.1261/rna.2640111|2. Boutz DR, Collins PJ, Suresh U, Lu M, Ramírez CM, Fernández-Hernando C, Huang Y, Abreu Rde S, Le SY, Shapiro BA, Liu AM, Luk JM, Aldred SF, Trinklein ND, Marcotte EM, Penalva LO (2011). Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem  286, 18066-78.   https://doi.org/10.1074/jbc.M110.196451|3. Kim T, Shapiro B (2012) The role of salt concentration and magnesium binding in HIV-1 subtype-A and subtype-B kissing loop monomer structures. Journal of Biomolecular Structure and Dynamics, in press.|4. Le S, Shapiro B (2011) Data mining of functional RNA structures in genomic sequences. WIREs Data Mining and Knowledge Discovery 1:88-95.|5. Manzano M, Reichert ED, Polo S, Falgout B, Kasprzak W, Shapiro BA, Padmanabhan R (2011). Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J Biol Chem  286, 22521-34.   https://doi.org/10.1074/jbc.M111.234302",https://intramural.nih.gov/search/searchview.taf?ipid=73241
40,BC008710-35,"October 01, 2011 -  September 30, 2012",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Joel R Hoskins|Shannon M Doyle|Jodi  Camberg|Danielle M Johnston|Olivier Patrick Genest,George  Stan (University of Cincinnati)|David  Agard (UCSF),Susan  Gottesman; PhD (Biochemical Genetics Section)|Leonard  Neckers; PhD (Urologic Oncology Branch),"Daniel C Masison; PhD (NIDDK) |Kenneth Manao Yamada; MD, PhD (NIDCR)","1. Camberg JL, Hoskins JR, Wickner S (2011). The interplay of ClpXP with the cell division machinery in Escherichia coli. J Bacteriol  193, 1911-8.   https://doi.org/10.1128/JB.01317-10|2. Camberg JL, Wickner S (2012). Regulated proteolysis as a force to control the cell cycle. Structure  20, 1128-30.   https://doi.org/10.1016/j.str.2012.06.004|3. Evans ML, Schmidt JC, Ilbert M, Doyle SM, Quan S, Bardwell JC, Jakob U, Wickner S, Chapman MR (2011). E. coli chaperones DnaK, Hsp33 and Spy inhibit bacterial functional amyloid assembly. Prion  5, 323-34.   https://doi.org/10.4161/pri.18555|4. Genest O, Hoskins JR, Camberg JL, Doyle SM, Wickner S (2011). Heat shock protein 90 from Escherichia coli collaborates with the DnaK chaperone system in client protein remodeling. Proc Natl Acad Sci U S A  108, 8206-11.   https://doi.org/10.1073/pnas.1104703108|5. Miot M, Reidy M, Doyle SM, Hoskins JR, Johnston DM, Genest O, Vitery MC, Masison DC, Wickner S (2011). Species-specific collaboration of heat shock proteins (Hsp) 70 and 100 in thermotolerance and protein disaggregation. Proc Natl Acad Sci U S A  108, 6915-20.   https://doi.org/10.1073/pnas.1102828108|6. Reidy M, Miot M, Masison DC (2012). Prokaryotic chaperones support yeast prions and thermotolerance and define disaggregation machinery interactions. Genetics  192, 185-93.   https://doi.org/10.1534/genetics.112.142307",https://intramural.nih.gov/search/searchview.taf?ipid=73195
41,BC008714-35,"October 01, 2011 -  September 30, 2012",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nadim  Majdalani|Nicholas  de Lay|Daniel Joseph Schu|Song  Tong|Hyun-Jung  Lee|Ashley S Parker|Show all 8,"Linda  Kenney (Microbiology, U. of Illinois School of Medicine)|Maude  Guillier|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Ben  Luisi (University of Cambridge)|Christian  Raetz (Duke University)",Peter C Fitzgerald (Office of the Director),Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID),"1. De Lay N, Gottesman S (2011). Role of polynucleotide phosphorylase in sRNA function in Escherichia coli. RNA  17, 1172-89.   https://doi.org/10.1261/rna.2531211|2. Gottesman S (2011). Microbiology: Dicing defence in bacteria. Nature  471, 588-9.   https://doi.org/10.1038/471588a",https://intramural.nih.gov/search/searchview.taf?ipid=73242
42,BC008751-32,"October 01, 2011 -  September 30, 2012",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Dale  Lewis; PhD|Andrei  Trostel|Phuoc  Le|Mirjana Tomislav Macvanin; PhD|Amlanjyoti  Dhar|Zhong  Qian|Show all 7,"Laura  Finzi (University of Milan)|Kim  Sneppen (Center for Models of Life, Niels Bohr Institute)",Victor  Zhurkin; PhD (Laboratory of Cell Biology)|Peter C Fitzgerald (Office of the Director),NULL,"1. Csiszovszki Z, Krishna S, Orosz L, Adhya S, Semsey S (2011). Structure and function of the D-galactose network in enterobacteria. MBio  2, e00053-11.   https://doi.org/10.1128/mBio.00053-11|2. Csiszovszki Z, Lewis D, Le P, Sneppen K, Semsey S, Adhya S (2012) Specific contacts of the -35 region of the galP1 promoter by RNA polymerase inhibit GalR mediated DNA. Nucleic Acids Res, in press.|3. Koli P, Sudan S, Fitzgerald D, Adhya S, Kar S (2011). Conversion of commensal Escherichia coli K-12 to an invasive form via expression of a mutant histone-like protein. MBio  2.   https://doi.org/10.1128/mBio.00182-11|4. Lewis D, Le P, Zurla C, Finzi L, Adhya S (2011). Multilevel autoregulation of λ repressor protein CI by DNA looping in vitro. Proc Natl Acad Sci U S A  108, 14807-12.   https://doi.org/10.1073/pnas.1111221108|5. Mazumder A, Bandyopadhyay S, Dhar A, Lewis DE, Deb S, Dey S, Chakrabarti P, Roy S (2012) A genetic network that balances two outcomes utilizes asymmetric recognition of operator sites. Biophys J 102:1580-9|6. Qian Z, Dimitriadis EK, Edgar R, Eswaramoorthy P, Adhya S (2012). Galactose repressor mediated intersegmental chromosomal connections in Escherichia coli. Proc Natl Acad Sci U S A  109, 11336-41.   https://doi.org/10.1073/pnas.1208595109",https://intramural.nih.gov/search/searchview.taf?ipid=73243
43,BC008752-32,"October 01, 2011 -  September 30, 2012",Thyroid Hormone Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Li  Zhao|Laura  Fozzatti|Xuguang  Zhu|Dong Wook  Kim; PhD|Jeong-Won  Park|Won Gu  Kim,"G.R.  Williams (Imperial College London, Imperial College London)|Anthony  Hollenberg (Harvard University)|James  Lechleiter (University of Texas Health Science Center at San Antonio)","Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Fozzatti L, Lu C, Kim DW, Cheng SY (2011). Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors. Mol Endocrinol  25, 908-21.   https://doi.org/10.1210/me.2010-0474|2. Fozzatti L, Lu C, Kim DW, Park JW, Astapova I, Gavrilova O, Willingham MC, Hollenberg AN, Cheng SY (2011). Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc Natl Acad Sci U S A  108, 17462-7.   https://doi.org/10.1073/pnas.1107474108|3. Zhu XG, Kim DW, Goodson ML, Privalsky ML, Cheng SY (2011). NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis. J Mol Endocrinol  46, 233-44.   https://doi.org/10.1530/JME-10-0163",https://intramural.nih.gov/search/searchview.taf?ipid=73244
44,BC008753-30,"October 01, 2011 -  September 30, 2012",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Masanori  Onda|Richard A Beers|Laiman  Xiang|Tapan K Bera|Xiu Fen Liu|Ronit  Jolles Mazor; MSc|Show all 12,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Satoshi  Nagata (Sanford Research/USD)|Itai  Benhar (Tel Aviv University)|Ulrich  Brinkmann (NCI)|Yoonsoo  Hahn (Chung-Ang University)|Iekuni  Ichikawa (Vanderbilt University School of Medicine)|Show all 10","Alan S Wayne; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|David J Fitzgerald; PhD (Biotherapy Section)|Byungkook  Lee; PhD (Molecular Modeling Section)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)",Chang Hum  Paik; PhD (CC),"1. Du X, Xiang L, Mackall C, Pastan I (2011). Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody. Clin Cancer Res  17, 5926-34.   https://doi.org/10.1158/1078-0432.CCR-11-1235|2. Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I (2011). Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. Leuk Lymphoma  52 Suppl 2, 79-81.   https://doi.org/10.3109/10428194.2011.569961|3. Jang BS, Lee SM, Kim HS, Shin IS, Razjouyan F, Wang S, Yao Z, Pastan I, Dreher MR, Paik CH (2012). Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab. Nucl Med Biol  39, 472-83.   https://doi.org/10.1016/j.nucmedbio.2011.10.020|4. Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, Pastan I (2011). The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan. MAbs  3, 479-86.   https://doi.org/10.4161/mabs.3.5.17228|5. Kelly RJ, Sharon E, Pastan I, Hassan R (2012). Mesothelin-targeted agents in clinical trials and in preclinical development. Mol Cancer Ther  11, 517-25.   https://doi.org/10.1158/1535-7163.MCT-11-0454|6. Kuan CT, Wakiya K, Keir ST, Li J, Herndon JE, Pastan I, Bigner DD (2011). Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas. Int J Cancer  129, 111-21.   https://doi.org/10.1002/ijc.25645|7. Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I (2011). Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol  300, F792-800.   https://doi.org/10.1152/ajprenal.00570.2010|8. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I (2011). Podocyte injury damages other podocytes. J Am Soc Nephrol  22, 1275-85.   https://doi.org/10.1681/ASN.2010090963|9. Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH (2011). Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts. Clin Cancer Res  17, 3697-705.   https://doi.org/10.1158/1078-0432.CCR-11-0493|10. Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I (2011). Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes. Proc Natl Acad Sci U S A  108, 5742-7.   https://doi.org/10.1073/pnas.1102746108|11. Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R (2011). Immunotoxins with decreased immunogenicity and improved activity. Leuk Lymphoma  52 Suppl 2, 87-90.   https://doi.org/10.3109/10428194.2011.573039|12. Shin IS, Lee SM, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH (2011). Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody. Nucl Med Biol  38, 1119-27.   https://doi.org/10.1016/j.nucmedbio.2011.05.003|13. Singh R, Zhang Y, Pastan I, Kreitman RJ (2012). Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. Clin Cancer Res  18, 152-60.   https://doi.org/10.1158/1078-0432.CCR-11-1839|14. Weldon JE, Pastan I (2011). A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J  278, 4683-700.   https://doi.org/10.1111/j.1742-4658.2011.08182.x|15. Zhang Y, Chertov O, Zhang J, Hassan R, Pastan I (2011). Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding. Cancer Res  71, 5915-22.   https://doi.org/10.1158/0008-5472.CAN-11-0466",https://intramural.nih.gov/search/searchview.taf?ipid=73245
45,BC008756-25,"October 01, 2011 -  September 30, 2012",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu|Muhammad R Zaidi|Chi-Ping  Day|Jennifer D Rieker|Prasun J Mishra|Pravin J Mishra|Show all 7,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Scott  Lowe (Cold Spring Harbor Laboratory)|Norman  Sharpless (University of North Carolina)|Show all 11","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Miriam R Anver (Office Of The Director)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Margaret Anne Tucker (Human Genetics Program)","Heinz  Arnheiter; MD (NINDS) |Francis S Collins; MD, PhD (OD)","1. Andreu-Pérez P, Esteve-Puig R, de Torre-Minguela C, López-Fauqued M, Bech-Serra JJ, Tenbaum S, García-Trevijano ER, Canals F, Merlino G, Avila MA, Recio JA (2011). Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal  4, ra58.   https://doi.org/10.1126/scisignal.2001936|2. Wright LN, Ryscavage A, Merlino G, Yuspa SH (2012). Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Clin Cancer Res  18, 170-83.   https://doi.org/10.1158/1078-0432.CCR-11-1349|3. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|4. Zaidi MR, Day CP, Merlino G (2011). Fluorescent protein-assisted purification for gene expression profiling. Methods Mol Biol  699, 393-405.   https://doi.org/10.1007/978-1-61737-950-5_19|5. Zaidi MR, Merlino G (2011). The two faces of interferon-γ in cancer. Clin Cancer Res  17, 6118-24.   https://doi.org/10.1158/1078-0432.CCR-11-0482",https://intramural.nih.gov/search/searchview.taf?ipid=73246
46,BC008757-25,"October 01, 2011 -  September 30, 2012",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Robert J Sarnovsky|Abid Rasheed Mattoo; PhD|Antonella  Antignani; BS, PhD|Matteo  Pasetto|Taylor  Burke",NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director)|Alan S Wayne; MD (Pediatric Oncology Branch),Scott E Martin (NCATS) |Craig Joseph Thomas (NCATS),"1. Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I (2011). Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. Leuk Lymphoma  52 Suppl 2, 79-81.   https://doi.org/10.3109/10428194.2011.569961|2. Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leuk Lymphoma  52 Suppl 2, 82-6.   https://doi.org/10.3109/10428194.2011.565843|3. Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R (2011). Immunotoxins with decreased immunogenicity and improved activity. Leuk Lymphoma  52 Suppl 2, 87-90.   https://doi.org/10.3109/10428194.2011.573039",https://intramural.nih.gov/search/searchview.taf?ipid=73247
47,BC008905-31,"October 01, 2011 -  September 30, 2012",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|William C Vass|Xi  Liu|Brajendra  Tripathi; MS, PhD|Show all 7",Igor  Barsukov (University of Liverpool)|Steven J Carr|Pierre  Lavigne (University of Liverpool),Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Nicolae C Popescu; PhD (Molecular Cytogenetics Section),NULL,"1. Li G, Du X, Vass WC, Papageorge AG, Lowy DR, Qian X (2011). Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci U S A  108, 17129-34.   https://doi.org/10.1073/pnas.1112122108",https://intramural.nih.gov/search/searchview.taf?ipid=73248
48,BC009003-30,"October 01, 2011 -  September 30, 2012",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Laboratory of Cancer Prevention, NCI",NULL,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73249
49,BC009052-23,"October 01, 2011 -  September 30, 2012",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Cynthia D Thompson|Patricia  Day; PhD|Nicolas  Cuburu; PhD|Rebecca  Cerio|Yuk Ying S Pang|Alessandra  Handisurya|Show all 7,"Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Ari  Helenius (Institute of Biochemistry, ETH)|Reinhard  Glueck (Etna Biotech)|Denise  NardelliHaefliger (Universitaire Vaudois)",Ligia  Pinto (Infection & Immunoepidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Genoveffa  Franchini; MD (Vaccine Branch),"Barney S Graham; MD, PhD (NIAID)","1. Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D (2011). Parenteral is more efficient than mucosal immunization to  induce regression of human papillomavirus-associated genital  tumors. Int J Cancer  129, 762-72.   https://doi.org/10.1002/ijc.25973|2. Hanumantha Rao N, Baji Babu P, Rajendra L, Sriraman R, Pang YY, Schiller JT, Srinivasan VA (2011). Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles. Vaccine  29, 7326-34.   https://doi.org/10.1016/j.vaccine.2011.07.071|3. Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA (2011). HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine  29, 2011-4.   https://doi.org/10.1016/j.vaccine.2011.01.001|4. Longet S, Schiller JT, Bobst M, Jichlinski P, Nardelli-Haefliger D (2011). A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection. J Virol  85, 13253-9.   https://doi.org/10.1128/JVI.06093-11|5. Mitsunaga M, Kosaka N, Kines RC, Roberts JN, Lowy DR, Schiller JT, Ishihara Y, Hasegawa A, Choyke PL, Kobayashi H (2011). In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system. Cancer Prev Res (Phila)  4, 767-73.   https://doi.org/10.1158/1940-6207.CAPR-10-0334|6. Roberts JN, Kines RC, Katki HA, Lowy DR, Schiller JT (2011). Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J Natl Cancer Inst  103, 737-43.   https://doi.org/10.1093/jnci/djr061|7. Schiller JT, Buck CB (2011). Cutaneous squamous cell carcinoma: a smoking gun but still no suspects. J Invest Dermatol  131, 1595-6.   https://doi.org/10.1038/jid.2011.151",https://intramural.nih.gov/search/searchview.taf?ipid=73250
50,BC009254-38,"October 01, 2011 -  September 30, 2012",Structure and Function of Toll-like Receptors,David M Segal; PhD,NULL,"Immune Targeting Section, NCI",Yan  Wang|Kevin Neal Brown,NULL,NULL,David R Davies; PhD (NIDDK),"1. Botos I, Segal DM, Davies DR (2011). The structural biology of Toll-like receptors. Structure  19, 447-59.   https://doi.org/10.1016/j.str.2011.02.004|2. Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, Wang Y, Venzon D, Epstein SL, Segal DM (2011). TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol  186, 2422-9.   https://doi.org/10.4049/jimmunol.1002845",https://intramural.nih.gov/search/searchview.taf?ipid=73252
51,BC009257-37,"October 01, 2011 -  September 30, 2012",Mechanisms of Cellular Immune Responses,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Genaro  Patino Lopez,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73253
52,BC009262-30,"October 01, 2011 -  September 30, 2012",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",John R Ortaldo; PhD|Timothy  Back|Jeffrey J Subleski|Jonathan  Weiss|Anthony J Scarzello|Qun  Jiang|Show all 8,"Bruce  Blazar (University of Minnesota)|Bill  Murphy (Clinical Research, University of Nevada at Reno)|Jon Marc Wigginton; MD (NCI)|Sylvie  Guichard (AstraZeneca)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|William Marston Linehan; MD (Urologic Oncology Branch)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)|David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Barao I, Alvarez M, Redelman D, Weiss JM, Ortaldo JR, Wiltrout RH, Murphy WJ (2011). Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant  17, 1754-64.   https://doi.org/10.1016/j.bbmt.2011.08.023|2. Chan T, Wiltrout RH, Weiss JM (2011). Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol  11, 879-89.   https://doi.org/10.1016/j.intimp.2010.12.024",https://intramural.nih.gov/search/searchview.taf?ipid=73254
53,BC009264-29,"October 01, 2011 -  September 30, 2012",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Yi  Huang|Sadowski  Cari,"Steven  Bartelmez (stem cell biology, Betastem Therapeutics)|Pat  Iversen (AVI-Biopharma)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73255
54,BC009265-30,"October 01, 2011 -  September 30, 2012",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Karen  Hathcock|Joy A Williams|Masashi  Watanabe|Chiharu  Fujihara|Steven Edward Bowen,"Ferenc  Livak (School of Medicine, University of Maryland)|Gail  Bishop (University of Iowa)|Yousuke  Takahama (Tokushima)",Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),Ranjan  Sen; PhD (NIA),"1. Hathcock KS, Farrington L, Ivanova I, Livak F, Selimyan R, Sen R, Williams J, Tai X, Hodes RJ (2011). The requirement for pre-TCR during thymic differentiation enforces a developmental pause that is essential for V-DJβ rearrangement. PLoS One  6, e20639.   https://doi.org/10.1371/journal.pone.0020639",https://intramural.nih.gov/search/searchview.taf?ipid=73256
55,BC009273-25,"October 01, 2011 -  September 30, 2012",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Xuguang C Tai|Motoko  Kimura|Leonid  Popezinsky,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Arlene  Sharpe (Dept of Pathology, Harvard Medical School)|Sophia D Sarafova (NCI)|Show all 7","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Molecular Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD) |Lothar  Hennighausen; PhD (NIDDK)","1. Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C (2011). Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev  25, 275-86.   https://doi.org/10.1101/gad.2007311",https://intramural.nih.gov/search/searchview.taf?ipid=73257
56,BC009279-27,"October 01, 2011 -  September 30, 2012",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Jocelyn D Weissman|Aparna  Kotekar|Zohar Sara Barbash|John A Campbell,NULL,Brian  Lewis (Lymphoid Malignancies Branch)|Susan  Sharrow (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73258
57,BC009281-26,"October 01, 2011 -  September 30, 2012",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Yungping  Chiang|Chiharu  Fujihara,NULL,Lionel  Feigenbaum (Office Of The Director),NULL,"1. Chiang J, Hodes RJ (2011). Cbl enforces Vav1 dependence and a restricted pathway of T cell development. PLoS One  6, e18542.   https://doi.org/10.1371/journal.pone.0018542",https://intramural.nih.gov/search/searchview.taf?ipid=73259
58,BC009283-28,"October 01, 2011 -  September 30, 2012",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Deborah L Hodge|Della A Reynolds|Michael E Sanford|Fan Ching  Lin|Sarah Elizabeth Turner|Kristen Bo-Ra Knickman|Show all 9,Rivkah  Gonsky (UCLA)|Ram  Savan|Andrew  Welcher (Amgen),Lino  Tessarollo (Mouse Cancer Genetics Program)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation),"Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73260
59,BC009285-26,"October 01, 2011 -  September 30, 2012",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Devaiah Nanjappa Ballachanda|Katherine Chelsea Soe,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73261
60,BC009287-28,"October 01, 2011 -  September 30, 2012",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Wenqing  Li|Julie  Hixon|Arthur A Hurwitz,andrew  farr (university of washington)|Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Alan S Wayne; MD (Pediatric Oncology Branch),Warren J Leonard; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73262
61,BC009297-21,"October 01, 2011 -  September 30, 2012",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Prashant  Sharma|Margaret M O'Toole-Lualdi|Allan M Weissman; MD,NULL,Stephen J Lockett; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73263
62,BC009304-18,"October 01, 2011 -  September 30, 2012",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Boopathy  Ramakrishna|Yuko  Tsutsui; PhD,NULL,NULL,NULL,"1. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey AE, Griffiths GL, Qasba PK (2012). The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. Glycobiology  22, 379-88.   https://doi.org/10.1093/glycob/cwr110",https://intramural.nih.gov/search/searchview.taf?ipid=73264
63,BC009322-24,"October 01, 2011 -  September 30, 2012",Mechanisms Used by NKT Cells in the Control of Liver Tumors,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",John R Ortaldo; PhD|Timothy  Back|Jeffrey J Subleski|Tim  Chan|Anthony J Scarzello|Qun  Jiang|Show all 7,NULL,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"1. Chan T, Wiltrout RH, Weiss JM (2011). Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol  11, 879-89.   https://doi.org/10.1016/j.intimp.2010.12.024|2. Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH (2011). TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells. J Immunol  186, 838-47.   https://doi.org/10.4049/jimmunol.1001735|3. Subleski JJ, Jiang Q, Weiss JM, Wiltrout RH (2011). The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy  3, 1167-84.   https://doi.org/10.2217/imt.11.117",https://intramural.nih.gov/search/searchview.taf?ipid=73265
64,BC009369-22,"October 01, 2011 -  September 30, 2012",Studies of Chemokine-Receptor Interactions with Chemokines and alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|De  Yang|Poonam  Tewary|Anna Lee  Trivett|Feng  Wei,Robert  Goldman (Peprotech)|Gonzalo  De La Rosa|Theresa  Gioannini (University of Iowa)|Yana  Li|Jerrold  Weiss (University of Iowa),"Michael  Bustin; PhD (Protein Section)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Takashi  Furusawa (Laboratory of Metabolism)|Yuri  Postnikov; MD, PhD (Laboratory of Metabolism)|Sergey G Tarasov (Structural Biophysics Laboratory)",NULL,"1. Chan J, Oppenheim J, Vogl T, Bianchi M, Horwood N, Nanchahal J (2012) Alarmins: Friend or Foe. Immunity, in press.|2. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J (2012). Alarmins: awaiting a clinical response. J Clin Invest  122, 2711-9.   https://doi.org/10.1172/JCI62423|3. Chen X, Oppenheim JJ (2011). Comment on ""Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis"". J Immunol  187, 1527; author reply 1527-8.   https://doi.org/10.4049/jimmunol.1190029|4. Yang D, Postnikov YV, Li Y, Tewary P, de la Rosa G, Wei F, Klinman D, Gioannini T, Weiss JP, Furusawa T, Bustin M, Oppenheim JJ (2012). High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med  209, 157-71.   https://doi.org/10.1084/jem.20101354",https://intramural.nih.gov/search/searchview.taf?ipid=73266
65,BC009392-20,"October 01, 2011 -  September 30, 2012",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Jennifer B Mariano|Yien-Che  Tsai|Mei  Yang; MD|Daniel Kenneth Stringer,"Michael  Glickman (Technion)|Kazuhiro  Iwai (Department of Molecular Cell Biology, Osaka City Medical University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Chand  Khanna; MD (Pediatric Oncology Branch)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Cohen MM, Amiott EA, Day AR, Leboucher GP, Pryce EN, Glickman MH, McCaffery JM, Shaw JM, Weissman AM (2011). Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion. J Cell Sci  124, 1403-10.   https://doi.org/10.1242/jcs.079293|2. Tsai YC, Weissman AM (2011). Dissecting the diverse functions of the metastasis suppressor CD82/KAI1. FEBS Lett  585, 3166-73.   https://doi.org/10.1016/j.febslet.2011.08.031|3. Tsai YC, Weissman AM (2011). Ubiquitylation in ERAD: reversing to go forward? PLoS Biol  9, e1001038.   https://doi.org/10.1371/journal.pbio.1001038",https://intramural.nih.gov/search/searchview.taf?ipid=73188
66,BC009404-18,"October 01, 2011 -  September 30, 2012",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul|Kazuyuki  Furuta|Berta  Bosch Pages|Erica Lynn Heipertz|Sharad Kumar Mittal; PhD,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Oddmund  Bakke (Biology, Univ. of Oslo)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)",Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73267
67,BC009405-18,"October 01, 2011 -  September 30, 2012",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Yungping  Chiang|Karen  Hathcock|Masashi  Watanabe|Daniel Augustus Triner,NULL,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Karl Thomas Ried; MD (Cancer Genetics Branch),Herbert Carpenter Morse; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73268
68,BC010001-17,"October 01, 2011 -  September 30, 2012",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Kimberly D Klarmann|Bjorg  Gudmundsdottir|Emily  Bowers|Wonil  Kim|Amaritpal S Matharu|Peter F Johnson; PhD|Show all 7,NULL,Laura  Schmidt (Urologic Oncology Branch)|Serguei V Kozlov (Office of the Director)|Masaya  Baba (Urologic Oncology Branch)|Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program)|Philipp  Oberdoerffer (Mouse Cancer Genetics Program)|Shyam K Sharan (Mouse Cancer Genetics Program),NULL,"1. Gudmundsson KO, Stull SW, Keller JR (2012). Transplantation of mouse fetal liver cells for analyzing the function of hematopoietic stem and progenitor cells. Methods Mol Biol  879, 123-33.   https://doi.org/10.1007/978-1-61779-815-3_8|2. Oakley K, Han Y, Vishwakarma BA, Chu S, Bhatia R, Gudmundsson KO, Keller J, Chen X, Vasko V, Jenkins NA, Copeland NG, Du Y (2012). Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood  119, 6099-108.   https://doi.org/10.1182/blood-2011-10-388710|3. Satyanarayana A, Klarmann KD, Gavrilova O, Keller JR (2012). Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis. FASEB J  26, 309-23.   https://doi.org/10.1096/fj.11-190892",https://intramural.nih.gov/search/searchview.taf?ipid=73269
69,BC010006-17,"October 01, 2011 -  September 30, 2012",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kathleen T Soria|Emily Frances Winterbottom|Yoo-Seok  Hwang|Nicolas Qiang Homble|Hee Jun  Cho; PhD,"Sally  Moody (George Washington University Medical Center)|Ken  Cho (University of California, Irvine)|Christof  Niehrs; PhD (DKFZ Heidelberg)|Aykut  Uren (Georgetown University Medical Center)",NULL,NULL,"1. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A (2012). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene  31, 269-81.   https://doi.org/10.1038/onc.2011.245|2. Singh A, Winterbottom E, Daar IO (2012). Eph/ephrin signaling in cell-cell and cell-substrate adhesion. Front Biosci (Landmark Ed)  17, 473-97.   https://doi.org/10.2741/3939",https://intramural.nih.gov/search/searchview.taf?ipid=73270
70,BC010008-17,"October 01, 2011 -  September 30, 2012",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","John K Simmons|Shuling  Zhang; MD, PhD|Ke  Zhang|Joy Michelle Gary|Dena Hoa Tran|Robert Mark Simpson; DVM, PhD",NULL,NULL,Rafael Cristian Casellas; PhD (NIAMS) |Alasdair M Gilfillan; PhD (NIAID),"1. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187|2. Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM (2011). mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. Blood  118, 6803-13.   https://doi.org/10.1182/blood-2011-06-359984|3. Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood  117, 1228-38.   https://doi.org/10.1182/blood-2010-05-287821",https://intramural.nih.gov/search/searchview.taf?ipid=73271
71,BC010012-17,"October 01, 2011 -  September 30, 2012",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks|Marcella Ali Kaddoura|Robert  Wiltrout; PhD,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Hyam  Levitsky (Department of Oncology, Johns Hopkins University)|Linda A Sherman",William  Farrar (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73272
72,BC010013-17,"October 01, 2011 -  September 30, 2012",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Paul  Wright|Neeraj  Sharma|Hong-Chuan  Li|Aastha  Kaul|Mary  Carrington; MS, PhD|Daniel  McVicar; PhD|Show all 7","Jeffrey  Miller (University of Minnesota Cancer Center)|Andrew  Makrigiannis (ICRM)|Dan  Kaufman (Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)|Colin  Brooks (School of Biosciences, University of Newcastle)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)",NULL,NULL,"1. Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier LL, Anderson SK, Redelman D, Murphy WJ (2011). Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood  117, 7032-41.   https://doi.org/10.1182/blood-2010-11-316653|2. Cichocki F, Miller JS, Anderson SK (2011). Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters. J Innate Immun  3, 242-8.   https://doi.org/10.1159/000323929",https://intramural.nih.gov/search/searchview.taf?ipid=73273
73,BC010014-17,"October 01, 2011 -  September 30, 2012",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI",Theresa M Geiman,NULL,Robert M Leighty (Office Of The Director)|Robert  Stephens (Office Of The Director),Keji  Zhao; PhD (NHLBI),"1. von Eyss B, Maaskola J, Memczak S, Möllmann K, Schuetz A, Loddenkemper C, Tanh MD, Otto A, Muegge K, Heinemann U, Rajewsky N, Ziebold U (2012). The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. EMBO J  31, 972-85.   https://doi.org/10.1038/emboj.2011.451",https://intramural.nih.gov/search/searchview.taf?ipid=73274
74,BC010015-17,"October 01, 2011 -  September 30, 2012",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Wang Hua  Gong|Ming Yong  Liu; MD|Chunyan  Wang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)|Thomas  Rogers (Temple University)",Keqiang  Chen (Laboratory of Molecular Immunoregulation),Philip M Murphy; MD (NIAID),"1. Liu M, Zhao J, Chen K, Bian X, Wang C, Shi Y, Wang JM (2012). G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma. Int Immunopharmacol  14, 283-8.   https://doi.org/10.1016/j.intimp.2012.07.015",https://intramural.nih.gov/search/searchview.taf?ipid=73275
75,BC010017-17,"October 01, 2011 -  September 30, 2012","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Andrei  Trostel|Phuoc  Le|Francisco Jesus Malagon Bautista,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73276
76,BC010020-17,"October 01, 2011 -  September 30, 2012",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Sonya C Duke|Rita  Mincemoyer; RN|Barbara  Debrah|Elizabeth J Maestri|Barbara S Schuler|Yvonne D Mallory|Show all 7,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Ramy A Ibrahim|Carl  June (University of PA School of Medicine)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I (2011). Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates. Cancer Res  71, 6300-9.   https://doi.org/10.1158/0008-5472.CAN-11-1374|2. Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leuk Lymphoma  52 Suppl 2, 82-6.   https://doi.org/10.3109/10428194.2011.565843|3. Kreitman RJ, Pastan I (2011). Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox. Clin Cancer Res  17, 6398-405.   https://doi.org/10.1158/1078-0432.CCR-11-0487|4. Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH (2011). Imaging of convection enhanced delivery of toxins in humans. Toxins (Basel)  3, 201-6.   https://doi.org/10.3390/toxins3030201|5. Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R (2011). Immunotoxins with decreased immunogenicity and improved activity. Leuk Lymphoma  52 Suppl 2, 87-90.   https://doi.org/10.3109/10428194.2011.573039",https://intramural.nih.gov/search/searchview.taf?ipid=73277
77,BC010021-17,"October 01, 2011 -  September 30, 2012",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Corinne A Boulanger-Espeut|Robert D Bruno|Sonia Menin Rosenfield|Robert  Callahan; PhD,"Cathrin  Brisken (ISREC/EPFL)|Christine  Watson (Cambridge Univ.)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)",David  Salomon; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73278
78,BC010022-17,"October 01, 2011 -  September 30, 2012",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Andrew  Taverner|Sophie Mh Limou,"Sudha  Iyengar (Case Western Reserve University)|Gregory D Kirk|David  Gasser (Department of Genetics, University of Pennsylvania)|Barry  Freedman (Wake Forest University)|Linda  Kao (Dept. of Epidemiology, Johns Hopkins University)|Rulan  Parekh (Johns Hopkins University)|Show all 9",George  Nelson (Office of the Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW (2011). Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet  7, e1002150.   https://doi.org/10.1371/journal.pgen.1002150|2. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011). APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol  22, 2129-37.   https://doi.org/10.1681/ASN.2011040388|3. Wester CW, Eden SK, Shepherd BE, Bussmann H, Novitsky V, Samuels DC, Hendrickson SL, Winkler CA, O'Brien SJ, Essex M, D'Aquila RT, DeGruttola V, Marlink RG (2012). Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses  28, 759-65.   https://doi.org/10.1089/AID.2011.0303",https://intramural.nih.gov/search/searchview.taf?ipid=73279
79,BC010025-17,"October 01, 2011 -  September 30, 2012",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Matthew R Young; PhD|Qiou  Wei|Noriko  Yoshikawa; PhD|Christopher  Dextras,"Myung  Cho (Laboratory of Toxicology, Seoul National University)|Powel  Brown (Baylor Breast Center, Baylor College of Medicine)",James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|John A Beutler (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Devkota KP, Ratnayake R, Colburn NH, Wilson JA, Henrich CJ, McMahon JB, Beutler JA (2011). Inhibitors of the oncogenic transcription factor AP-1 from Podocarpus latifolius. J Nat Prod  74, 374-7.   https://doi.org/10.1021/np100736y|2. Diyabalanage T, Ratnayake R, Wilson JA, Henrich CJ, Beutler JA, Colburn NH, McMahon JB, Gustafson KR (2011). Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii. Bioorg Med Chem Lett  21, 4397-9.   https://doi.org/10.1016/j.bmcl.2011.06.044|3. Dong S, Cahill KJ, Kang MI, Colburn NH, Henrich CJ, Wilson JA, Beutler JA, Johnson RP, Porco JA (2011). Microwave-based reaction screening: tandem retro-Diels-Alder/Diels-Alder cycloadditions of o-quinol dimers. J Org Chem  76, 8944-54.   https://doi.org/10.1021/jo201658y|4. Mentor-Marcel RA, Bobe G, Sardo C, Wang LS, Kuo CT, Stoner G, Colburn NH (2012). Plasma cytokines as potential response indicators to dietary freeze-dried black raspberries in colorectal cancer patients. Nutr Cancer  64, 820-5.   https://doi.org/10.1080/01635581.2012.697597|5. Narasimhan M, Rathinam M, Riar A, Patel D, Mummidi S, Yang HS, Colburn NH, Henderson GI, Mahimainathan L (2013). Programmed cell death 4 (PDCD4): a novel player in ethanol-mediated suppression of protein translation in primary cortical neurons and developing cerebral cortex. Alcohol Clin Exp Res  37, 96-109.   https://doi.org/10.1111/j.1530-0277.2012.01850.x|6. Popplewell WL, Ratnayake R, Wilson JA, Beutler JA, Colburn NH, Henrich CJ, McMahon JB, McKee TC (2011). Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula. J Nat Prod  74, 1686-91.   https://doi.org/10.1021/np2005083|7. Wei Q, Jiang H, Xiao Z, Baker A, Young MR, Veenstra TD, Colburn NH (2011). Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc Natl Acad Sci U S A  108, 7004-9.   https://doi.org/10.1073/pnas.1013012108",https://intramural.nih.gov/search/searchview.taf?ipid=73280
80,BC010026-17,"October 01, 2011 -  September 30, 2012","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression",Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Matthew R Young; PhD|Soon-Kyung  Hwang,"Myung  Cho (Laboratory of Toxicology, Seoul National University)|Heike  Allgayer (University of Munich)|Michele  Pagano (New York Univ)|Nahum  Sonenberg (McGill University)|Arti  Gaur (Dartmouth Med Sch)|Tobias  Schmid",Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,"1. Gaur AB, Holbeck SL, Colburn NH, Israel MA (2011). Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol  13, 580-90.   https://doi.org/10.1093/neuonc/nor033|2. Grkovic T, Blees JS, Colburn NH, Schmid T, Thomas CL, Henrich CJ, McMahon JB, Gustafson KR (2011). Cryptocaryols A-H, α-pyrone-containing 1,3-polyols from Cryptocarya sp. implicated in stabilizing the tumor suppressor Pdcd4. J Nat Prod  74, 1015-20.   https://doi.org/10.1021/np100918z|3. Schmid T, Bajer MM, Blees JS, Eifler LK, Milke L, Rübsamen D, Schulz K, Weigert A, Baker AR, Colburn NH, Brüne B (2011). Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation. Carcinogenesis  32, 1427-33.   https://doi.org/10.1093/carcin/bgr131|4. Zhao LX, Huang SX, Tang SK, Jiang CL, Duan Y, Beutler JA, Henrich CJ, McMahon JB, Schmid T, Blees JS, Colburn NH, Rajski SR, Shen B (2011). Actinopolysporins A-C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600. J Nat Prod  74, 1990-5.   https://doi.org/10.1021/np200603g",https://intramural.nih.gov/search/searchview.taf?ipid=73281
81,BC010027-18,"October 01, 2011 -  September 30, 2012",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Thomas A Johnson|Ty Cole Voss|Myong-Hee  Sung|Ofir  Hakim,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Paolo  SassoneCorsi (University of California)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Philipp  Oberdoerffer (Mouse Cancer Genetics Program),John J O'Shea; MD (NIAMS) |Rafael Cristian Casellas; PhD (NIAMS),"1. Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC, Potter M, Nussenzweig MC, Casellas R (2012). Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. Proc Natl Acad Sci U S A  109, 10972-7.   https://doi.org/10.1073/pnas.1200106109|2. Qiu Y, Stavreva DA, Luo Y, Indrawan A, Chang M, Hager GL (2011). Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter. J Biol Chem  286, 7641-7.   https://doi.org/10.1074/jbc.M110.185488",https://intramural.nih.gov/search/searchview.taf?ipid=73282
82,BC010030-17,"October 01, 2011 -  September 30, 2012",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",John E Golin|Suneet  Shukla|Eduardo Emilio Chufan; PhD|Jaya  Bhatnagar|Khyati  Kapoor; PhD|Hong-May  Sim|Show all 9,"Rajendra  Prasad (Jawaharlal Nehru University)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Bjorn  Bauer|Catherine  BoothGenthe (Amgen, Inc.)|Jack  Freed (Cornell University)|Liwu  Fu (Sun Yat-Sen University)","Di S Xia; PhD, MS, BS (Crystallography Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Susan  Bates; MD (Medical Oncology Branch)|Stewart  Durell (Laboratory of Cell Biology)",Craig Joseph Thomas (NCATS),"1. Chanmahasathien W, Ohnuma S, Ambudkar SV, Limtrakul P (2011). Biochemical mechanism of modulation of human P-glycoprotein by stemofoline. Planta Med  77, 1990-5.   https://doi.org/10.1055/s-0031-1280054|2. Ding PR, Tiwari AK, Ohnuma S, Lee JW, An X, Dai CL, Lu QS, Singh S, Yang DH, Talele TT, Ambudkar SV, Chen ZS (2011). The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter. PLoS One  6, e19329.   https://doi.org/10.1371/journal.pone.0019329|3. Kannan P, Telu S, Shukla S, Ambudkar SV, Pike VW, Halldin C, Gottesman MM, Innis RB, Hall MD (2011) The Specific P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRPABCG2). ACS Chem Neurosci 2:82-89.|4. Ohnuma S, Chufan E, Nandigama K, Jenkins LM, Durell SR, Appella E, Sauna ZE, Ambudkar SV (2011). Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites. Biochemistry  50, 3724-35.   https://doi.org/10.1021/bi200073f|5. Pitchakarn P, Ohnuma S, Pintha K, Pompimon W, Ambudkar SV, Limtrakul P (2012). Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance. J Nutr Biochem  23, 76-84.   https://doi.org/10.1016/j.jnutbio.2010.11.005|6. Shi Z, Tiwari AK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng X, Abraham I, Ambudkar SV, Talele TT, Fu LW, Chen ZS (2011). Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res  71, 3029-41.   https://doi.org/10.1158/0008-5472.CAN-10-3820|7. Shukla S, Ohnuma S, Ambudkar SV (2011) Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets 12:621-630.|8. Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AM, Fung KL, Wu CP, Gottesman MM, Bauer B, Thomas CJ, Ambudkar SV (2011). Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Mol Pharm  8, 1292-302.   https://doi.org/10.1021/mp2001022|9. Sim HM, Wu CP, Ambudkar SV, Go ML (2011). In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs. Biochem Pharmacol  82, 1562-71.   https://doi.org/10.1016/j.bcp.2011.08.002|10. Wu C, Ohnuma S, Ambudkar S (2011) Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr Pharmaceut Biotechnol 12:609-620.",https://intramural.nih.gov/search/searchview.taf?ipid=73283
83,BC010033-17,"October 01, 2011 -  September 30, 2012",Inflammation and  Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Elisa A Spillare|Judith A Welsh,NULL,Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|David Anderson Wink (Radiation Biology Branch),NULL,"1. Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC (2013). NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer  132, 9-18.   https://doi.org/10.1002/ijc.27644|2. Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC (2011). Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst  103, 1112-22.   https://doi.org/10.1093/jnci/djr216",https://intramural.nih.gov/search/searchview.taf?ipid=73284
84,BC010038-17,"October 01, 2011 -  September 30, 2012",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Molecular Cytogenetics Section, NCI",Drazen  Zimonjic; PhD|Xu-Yu  Yang|Veenu  Tripathi; PhD|Xiaoling  Zhou,NULL,NULL,NULL,"1. Zhou X, Yang XY, Popescu NC (2012). Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. Biochem Biophys Res Commun  420, 325-30.   https://doi.org/10.1016/j.bbrc.2012.02.158",https://intramural.nih.gov/search/searchview.taf?ipid=73285
85,BC010251-17,"October 01, 2011 -  September 30, 2012","R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signali","Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Aykut  Uren|Charles Peter Xavier|Juhi Hitendra Patel,"Ernest  Arenas (CEDB, Karolinska Institute)|Abbot  Clark (Alcon Labs, Alcon Research, Ltd.)|Robert  Weinberg (Whitehead Institute for Biomedical Research, MIT)",Robert  Callahan; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Olga  Aprelikova; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Greer YE, Rubin JS, Callahan R (2012). Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol  227, 1960-71.   https://doi.org/10.1002/jcp.22924|2. Martin-Manso G, Calzada MJ, Chuman Y, Sipes JM, Xavier CP, Wolf V, Kuznetsova SA, Rubin JS, Roberts DD (2011). sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch Biochem Biophys  509, 147-56.   https://doi.org/10.1016/j.abb.2011.03.004|3. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell  145, 926-40.   https://doi.org/10.1016/j.cell.2011.04.029",https://intramural.nih.gov/search/searchview.taf?ipid=73286
86,BC010252-17,"October 01, 2011 -  September 30, 2012",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Yi  Huang|Kathryn  Jones; PhD|Sadowski  Cari|Stig Moelgaard Rask Jensen; PhD,Claudine  Pique (Inserm)|Pat  Green (Ohio State University)|Judy  Mikovits (whittemore peterson inst),Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Gene  Shearer; PhD (Experimental Immunology Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)|Sandra  Ruscetti; PhD (Laboratory of Cancer Prevention),Steven J Jacobson; PhD (NINDS),"1. Jones KS, Lambert S, Bouttier M, Bénit L, Ruscetti FW, Hermine O, Pique C (2011). Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses  3, 794-810.   https://doi.org/10.3390/v3060794|2. Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM (2012). Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS One  7, e30889.   https://doi.org/10.1371/journal.pone.0030889|3. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP, Blood XMRV Scientific Research Working Group (SRWG) (2011). Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science  334, 814-7.   https://doi.org/10.1126/science.1213841",https://intramural.nih.gov/search/searchview.taf?ipid=73287
87,BC010253-17,"October 01, 2011 -  September 30, 2012",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73288
88,BC010256-17,"October 01, 2011 -  September 30, 2012",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Margaret M O'Toole-Lualdi|Acong  Yang,NULL,NULL,Amit  Kumar; PhD (NIDDK),"1. Lezin G, Kosaka Y, Yost HJ, Kuehn MR, Brunelli L (2011). A one-step miniprep for the isolation of plasmid DNA and lambda phage particles. PLoS One  6, e23457.   https://doi.org/10.1371/journal.pone.0023457|2. Lezin G, Kuehn MR, Brunelli L (2011). Hofmeister series salts enhance purification of plasmid DNA by non-ionic detergents. Biotechnol Bioeng  108, 1872-82.   https://doi.org/10.1002/bit.23116",https://intramural.nih.gov/search/searchview.taf?ipid=73289
89,BC010276-15,"October 01, 2011 -  September 30, 2012",Protein Folding Mechanism,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Jingjun  Hong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73290
90,BC010277-15,"October 01, 2011 -  September 30, 2012",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Tatiana B Venkova-Canova|Jonghwan  Baek|Jyoti Krishna Jha|Papri  Banerjee|Sarvesh Krishnan Ramprakash,"Petra  Levin; PhD (Biology, Washington U)|Rajagopala  Venkatappa (J Craig Ventor Institute)",NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Kadoya R, Baek JH, Sarker A, Chattoraj DK (2011). Participation of chromosome segregation protein ParAI of Vibrio cholerae in chromosome replication. J Bacteriol  193, 1504-14.   https://doi.org/10.1128/JB.01067-10|2. Venkova-Canova T, Chattoraj DK (2011). Transition from a plasmid to a chromosomal mode of replication entails additional regulators. Proc Natl Acad Sci U S A  108, 6199-204.   https://doi.org/10.1073/pnas.1013244108",https://intramural.nih.gov/search/searchview.taf?ipid=73291
91,BC010278-15,"October 01, 2011 -  September 30, 2012",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Martin  Kessel; BSc, PhD|Alberto  Bartesaghi|Lisa M. Hartnell|Kedar  Narayan|Thao Phuong Do","Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)|Chris  Szakal (NIST)",Vincent J. Hearing; PhD (Pigment Cell Biology Section),Donald F Bliss (NLM) |Terry S Yoo; PhD (NLM),"1. Butan C, Hartnell LM, Fenton AK, Bliss D, Sockett RE, Subramaniam S, Milne JL (2011). Spiral architecture of the nucleoid in Bdellovibrio bacteriovorus. J Bacteriol  193, 1341-50.   https://doi.org/10.1128/JB.01061-10|2. Frank GA, Bartesaghi A, Kuybeda O, Borgnia MJ, White TA, Sapiro G, Subramaniam S (2012). Computational separation of conformational heterogeneity using cryo-electron tomography and 3D sub-volume averaging. J Struct Biol  178, 165-76.   https://doi.org/10.1016/j.jsb.2012.01.004|3. Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW, Klasse PJ, Milne JL, Wilson IA, Olson WC, Moore JP, Subramaniam S (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A  108, 11440-5.   https://doi.org/10.1073/pnas.1101414108|4. Khursigara CM, Lan G, Neumann S, Wu X, Ravindran S, Borgnia MJ, Sourjik V, Milne J, Tu Y, Subramaniam S (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J  30, 1719-29.   https://doi.org/10.1038/emboj.2011.77|5. Li M, Khursigara CM, Subramaniam S, Hazelbauer GL (2011). Chemotaxis kinase CheA is activated by three neighbouring chemoreceptor dimers as effectively as by receptor clusters. Mol Microbiol  79, 677-85.   https://doi.org/10.1111/j.1365-2958.2010.07478.x|6. Meyerson JR, White TA, Bliss D, Moran A, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Schauder D, Hartnell LM, Nandwani R, Dawood M, Kim B, Kim JH, Sununu J, Yang L, Bhatia S, Subramaniam C, Hurt DE, Gaudreault L, Subramaniam S (2011). Determination of molecular structures of HIV envelope glycoproteins using cryo-electron tomography and automated sub-tomogram averaging. J Vis Exp  .  https://doi.org/10.3791/2770|7. Murphy GE, Narayan K, Lowekamp BC, Hartnell LM, Heymann JA, Fu J, Subramaniam S (2011). Correlative 3D imaging of whole mammalian cells with light and electron microscopy. J Struct Biol  176, 268-78.   https://doi.org/10.1016/j.jsb.2011.08.013|8. Nikolic DS, Lehmann M, Felts R, Garcia E, Blanchet FP, Subramaniam S, Piguet V (2011). HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood  118, 4841-52.   https://doi.org/10.1182/blood-2010-09-305417|9. Szakal C, Narayan K, Fu J, Lefman J, Subramaniam S (2011). Compositional mapping of the surface and interior of mammalian cells at submicrometer resolution. Anal Chem  83, 1207-13.   https://doi.org/10.1021/ac1030607|10. Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI (2011). Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles. Proc Natl Acad Sci U S A  108, 9798-803.   https://doi.org/10.1073/pnas.1014598108|11. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S (2012). Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog  8, e1002797.   https://doi.org/10.1371/journal.ppat.1002797|12. White TA, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Nandwani R, Hoxie JA, Bess JW, Lifson JD, Milne JL, Subramaniam S (2011). Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol  85, 12114-23.   https://doi.org/10.1128/JVI.05297-11",https://intramural.nih.gov/search/searchview.taf?ipid=73292
92,BC010283-15,"October 01, 2011 -  September 30, 2012",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Hua Tang  Chen|Samuel  Bunting|Nancy  Wong|Margarida Almeida Santos|Jacqueline H Barlow|Federica  Polato|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73293
93,BC010292-15,"October 01, 2011 -  September 30, 2012",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Jennifer B Mariano|Yien-Che  Tsai|Mei  Yang; MD|Ventzislava Alexandrova Hristova; PhD|Daniel Kenneth Stringer|Tanuja R Kashyap|Show all 7,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Lipkowitz S, Weissman AM (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer  11, 629-43.   https://doi.org/10.1038/nrc3120|2. Weissman AM, Shabek N, Ciechanover A (2011). The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol  12, 605-20.   https://doi.org/10.1038/nrm3173",https://intramural.nih.gov/search/searchview.taf?ipid=73189
94,BC010297-15,"October 01, 2011 -  September 30, 2012",Identification of Gene Polymorphisms Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Efe  Sezgin|Elizabeth  Binns-Roemer|Andrew  Taverner|Sophie Mh Limou,"Max  Essex (Department of Immuology and Infectious Diseases, Harvard Medical School)|Sharyne  Donfield (Hemophilia Growth and Development Study, Rho, Inc.)|John P Phair|Gregory D Kirk|James  Mullins; PhD (Microbiology, University of Washington)|Jean-Francois  Zagury (Conservatoire National des Arts et MÃ©tiers)|Show all 10",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)|George  Nelson (Office of the Director),NULL,"1. An P, Winkler C, Guan L, O'Brien SJ, Zeng Z, HBV Study Consortium (2011). A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis  203, 943-7.   https://doi.org/10.1093/infdis/jiq154|2. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011). APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol  22, 2129-37.   https://doi.org/10.1681/ASN.2011040388|3. Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S, An P, Martinson JJ, Spadoni JL, Therwath A, Veldink JH, van den Berg LH, Taing L, Labib T, Mellak S, Montes M, Delfraissy JF, Schächter F, Winkler C, Froguel P, Mullins JI, Schuitemaker H, Zagury JF (2011). Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS. J Acquir Immune Defic Syndr  56, 279-84.   https://doi.org/10.1097/QAI.0b013e318204982b|4. Madlala P, Gijsbers R, Christ F, Hombrouck A, Werner L, Mlisana K, An P, Abdool Karim SS, Winkler CA, Debyser Z, Ndung'u T (2011). Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression. AIDS  25, 1711-9.   https://doi.org/10.1097/QAD.0b013e328349c693|5. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, van Manen D, Bream JH, Gomperts ED, Buchbinder S, Goedert JJ, et al. [2 more authors] (2011). Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis  203, 1491-502.   https://doi.org/10.1093/infdis/jir046",https://intramural.nih.gov/search/searchview.taf?ipid=73294
95,BC010298-15,"October 01, 2011 -  September 30, 2012",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Laiman  Xiang|Tapan K Bera|Gregory  Raciti,NULL,Oleg Y Chertov (Office Of The Director)|Byungkook  Lee; PhD (Molecular Modeling Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),NULL,"1. Fei Z, Bera TK, Liu X, Xiang L, Pastan I (2011). Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts. J Biol Chem  286, 27761-8.   https://doi.org/10.1074/jbc.M111.248435|2. Liu XF, Xiang L, Zhang Y, Becker KG, Bera TK, Pastan I (2012). CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis. Oncogene  31, 1673-82.   https://doi.org/10.1038/onc.2011.355|3. Raciti GA, Bera TK, Gavrilova O, Pastan I (2011). Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice. Diabetologia  54, 2911-22.   https://doi.org/10.1007/s00125-011-2263-9",https://intramural.nih.gov/search/searchview.taf?ipid=73295
96,BC010300-15,"October 01, 2011 -  September 30, 2012",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Laura Ann R Quigley|Selinda Jane Orr|Geraldine Martina O'Connor|Jill Wallace Ford|Kimberly Covington Boelte|Walter A Baseler; PhD|Show all 7,"Weiguo  Zhang (NICHHD)|Thomas  Yankee (Microbiology, Univ. Kansas Medical Center)|Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Show all 8",Oleg Y Chertov (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Shyam K Sharan (Mouse Cancer Genetics Program)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),"Ivo  Francischetti; MD, PhD (NIAID) |Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Igal  Gery; PhD (NEI) |Suk See De Ravin; MD, PhD (NIAID) |Alasdair M Gilfillan; PhD (NIAID) |Doug B Kuhns; PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73296
97,BC010301-15,"October 01, 2011 -  September 30, 2012",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Sonya C Duke|Rita  Mincemoyer; RN|Barbara  Debrah|Elizabeth J Maestri|Barbara S Schuler|Show all 12,Arthur  Frankel (Texas A&M)|Michael  Grever (Ohio State Universithy)|Ramy A Ibrahim|Farhad  Ravandi (MD Anderson)|Martin  Tallman (Memorial Sloan Kettering Cancer Center),"Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Arons E, Kreitman RJ (2011). Molecular variant of hairy cell leukemia with poor prognosis. Leuk Lymphoma  52 Suppl 2, 99-102.   https://doi.org/10.3109/10428194.2011.565841|2. Arons E, Roth L, Sapolsky J, Suntum T, Stetler-Stevenson M, Kreitman RJ (2011). Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood  117, 4844-51.   https://doi.org/10.1182/blood-2010-11-316737|3. Blake-Haskins JA, Lechleider RJ, Kreitman RJ (2011). Thrombotic microangiopathy with targeted cancer agents. Clin Cancer Res  17, 5858-66.   https://doi.org/10.1158/1078-0432.CCR-11-0804|4. Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I (2011). Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. Leuk Lymphoma  52 Suppl 2, 79-81.   https://doi.org/10.3109/10428194.2011.569961|5. Kreitman RJ (2011). Synergistic targeting of leukemia with leukotoxin and chemotherapy. Leuk Res  35, 1438-9.   https://doi.org/10.1016/j.leukres.2011.06.028|6. Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leuk Lymphoma  52 Suppl 2, 82-6.   https://doi.org/10.3109/10428194.2011.565843|7. Kreitman RJ, Arons E, Stetler-Stevenson M, Miller KB (2011). Response of hairy cell leukemia to bendamustine. Leuk Lymphoma  52, 1153-6.   https://doi.org/10.3109/10428194.2011.562575|8. Kreitman RJ, Pastan I (2011). Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox. Clin Cancer Res  17, 6398-405.   https://doi.org/10.1158/1078-0432.CCR-11-0487|9. Kreitman RJ, Polliack A, Grever M (2011). Treatment of hairy cell leukemia in its second half-century: an international conference on hairy cell leukemia at the National Institutes of Health, April 26-27, 2010, Bethesda, MD. Leuk Lymphoma  52 Suppl 2, 1-2.|10. Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I (2011). Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes. Proc Natl Acad Sci U S A  108, 5742-7.   https://doi.org/10.1073/pnas.1102746108|11. Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R (2011). Immunotoxins with decreased immunogenicity and improved activity. Leuk Lymphoma  52 Suppl 2, 87-90.   https://doi.org/10.3109/10428194.2011.573039|12. Singh R, Zhang Y, Pastan I, Kreitman RJ (2012). Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. Clin Cancer Res  18, 152-60.   https://doi.org/10.1158/1078-0432.CCR-11-1839|13. Traini R, Kreitman RJ (2011). Renal excretion of recombinant immunotoxins containing pseudomonas exotoxin. Bioconjug Chem  22, 736-40.   https://doi.org/10.1021/bc1005152|14. Wang L, Abbasi F, Jasper GA, Kreitman RJ, Liewehr DJ, Marti GE, Stetler-Stevenson M (2011). Variables in the quantification of CD4 in normals and hairy cell leukemia patients. Cytometry B Clin Cytom  80, 51-6.   https://doi.org/10.1002/cyto.b.20541",https://intramural.nih.gov/search/searchview.taf?ipid=73297
98,BC010304-14,"October 01, 2011 -  September 30, 2012",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Connie  Sommers; PhD|Lakshmi  Balagopalan|Wenmei  Li; PhD|Alexandre Katchaz Oscar Antoine Rouquette-Jazdanian|Eilon  Sherman|Nathan  Coussens|Show all 12,NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)","Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73298
99,BC010307-13,"October 01, 2011 -  September 30, 2012",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Shikha  Sharan|Balamurugan  Kuppusamy|Su-Ryun  Kim|Daniel Yazmany Mendoza Villanueva; PhD,Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Ju-Ming  Wang (National Cheng Kung University)|Snehalata Anil Pawar|Thierry  Roger (Infectious Diseases Service)|Fiona  Yull (Vanderbilt University),Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73197
100,BC010308-14,"October 01, 2011 -  September 30, 2012",In vivo Imaging Analysis of SteroidNuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Diana  Stavreva|Rodney Louis Schiltz; PhD|Ty Cole Voss|Myong-Hee  Sung|Tina Branscombe Miranda|Songjoon  Baek,Stafford  Lightman (University of Bristol)|Luke  Iwanowicz (USGS-BRD),James  McMahon; PhD (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73301
101,BC010309-14,"October 01, 2011 -  September 30, 2012",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Stephen A Mabon|Paola  Scaffidi|Sara K Snyder|Karen J Meaburn|Maria Reina Fernandez De Luco|Travis  Dittmer|Show all 15,"John  Elliott (NIST)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Bas  van Steensel (Netherlands Cancer Center)",Stephen J Lockett; PhD (Office Of The Director),"Christopher P Austin; AB, MD (NCATS) |James  Inglese (NCATS) |Scott E Martin (NCATS) |Keji  Zhao; PhD (NHLBI)","1. Dittmer TA, Misteli T (2011). The lamin protein family. Genome Biol  12, 222.   https://doi.org/10.1186/gb-2011-12-5-222|2. Kubben N, Voncken JW, Konings G, van Weeghel M, van den Hoogenhof MM, Gijbels M, van Erk A, Schoonderwoerd K, van den Bosch B, Dahlmans V, Calis C, Houten SM, Misteli T, Pinto YM (2011). Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins. Nucleus  2, 195-207.   https://doi.org/10.4161/nucl.2.3.15731|3. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T (2011). Epigenetics in alternative pre-mRNA splicing. Cell  144, 16-26.   https://doi.org/10.1016/j.cell.2010.11.056|4. Luco RF, Misteli T (2011). More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev  21, 366-72.   https://doi.org/10.1016/j.gde.2011.03.004|5. Mazumdar M, Sung MH, Misteli T (2011). Chromatin maintenance by a molecular motor protein. Nucleus  2, 591-600.   https://doi.org/10.4161/nucl.2.6.18044|6. Misteli T (2011). HGPS-derived iPSCs for the ages. Cell Stem Cell  8, 4-6.   https://doi.org/10.1016/j.stem.2010.12.014|7. Misteli T (2011). The inner life of the genome. Sci Am  304, 66-73.   https://doi.org/10.1038/scientificamerican0211-66|8. Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, Shi H, Atefi M, Titz B, Gabay MT, Salton M, Dahlman KB, Tadi M, Wargo JA, Flaherty KT, Kelley MC, Misteli T, Chapman PB, Sosman JA, Graeber TG, Ribas A, Lo RS, Rosen N, Solit DB (2011). RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature  480, 387-90.   https://doi.org/10.1038/nature10662|9. Scaffidi P, Misteli T (2011). In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol  13, 1051-61.   https://doi.org/10.1038/ncb2308",https://intramural.nih.gov/search/searchview.taf?ipid=73302
102,BC010313-14,"October 01, 2011 -  September 30, 2012",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Stephanie  Roessler|Junfang  Ji|Naoki  Oishi|Show all 8,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Masao  Omata (University of Tokyo)|Show all 12,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, Park ES, Lim JY, Heo J, Kim YJ, Kim DG, Kaseb A, Park YN, Wang XW, Thorgeirsson SS, Lee JS (2012). Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology  55, 1443-52.   https://doi.org/10.1002/hep.24813|2. Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW (2012). Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology  142, 957-966.e12.   https://doi.org/10.1053/j.gastro.2011.12.039|3. Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, Revill K, Weissmueller S, Rappaport AR, Simon J, Zhang J, Luo W, Hicks J, Zender L, Wang XW, Powers S, Wigler M, Lowe SW (2012). A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci U S A  109, 8212-7.   https://doi.org/10.1073/pnas.1206062109",https://intramural.nih.gov/search/searchview.taf?ipid=73304
103,BC010319-14,"October 01, 2011 -  September 30, 2012",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Wai-Kwan  Tang|Rui  Bao|Yihui  Zhou|Fei  Zhou,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Susan  Bates; MD (Medical Oncology Branch),NULL,"1. Esser L, Xia D (2011) CrysPage: A program for displaying images of crystallization trials, rapid comparisons and analysis. J Appl Cryst 44:1130-1131.|2. Ma J, Tang W, Esser L, Pastan I, Xia D (2012) Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009. Acta Crystallographica Section F, in press.|3. Ma J, Tang WK, Esser L, Pastan I, Xia D (2012). Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights. J Biol Chem  287, 33123-31.   https://doi.org/10.1074/jbc.M112.381756|4. Rutledge RM, Esser L, Ma J, Xia D (2011). Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study. J Struct Biol  173, 333-44.   https://doi.org/10.1016/j.jsb.2010.10.012",https://intramural.nih.gov/search/searchview.taf?ipid=73307
104,BC010326-13,"October 01, 2011 -  September 30, 2012","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Gary X Shaw|Yuhe  Liang; PhD|Genbin  Shi|Jason R Stagno|Smita  Kakar; PhD|Vandana  Kumari; PhD,Honggao  Yan|Sherif  Abou Elela (University of Sherbrooke)|Jorge  CruzReyes (Texas A&M University)|Allen  Nicholson (Temple University),Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Larry K Keefer; PhD (Chemical Biology Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Jin DJ, Zhou YN, Shaw G, Ji X (2011). Structure and function of RapA: a bacterial Swi2/Snf2 protein required for RNA polymerase recycling in transcription. Biochim Biophys Acta  1809, 470-5.   https://doi.org/10.1016/j.bbagrm.2011.03.003|2. Madina BR, Kuppan G, Vashisht AA, Liang YH, Downey KM, Wohlschlegel JA, Ji X, Sze SH, Sacchettini JC, Read LK, Cruz-Reyes J (2011). Guide RNA biogenesis involves a novel RNase III family endoribonuclease in Trypanosoma brucei. RNA  17, 1821-30.   https://doi.org/10.1261/rna.2815911|3. Shi G, Ji X (2011). New ways to derivatize at position 6 of 7,7-dimethyl-7,8-dihydropterin. Tetrahedron Lett  52, 6174-6176.   https://doi.org/10.1016/j.tetlet.2011.09.047|4. Shi G, Shaw G, Liang YH, Subburaman P, Li Y, Wu Y, Yan H, Ji X (2012). Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties. Bioorg Med Chem  20, 47-57.   https://doi.org/10.1016/j.bmc.2011.11.032|5. Stagno JR, Altieri AS, Bubunenko M, Tarasov SG, Li J, Court DL, Byrd RA, Ji X (2011). Structural basis for RNA recognition by NusB and NusE in the initiation of transcription antitermination. Nucleic Acids Res  39, 7803-15.   https://doi.org/10.1093/nar/gkr418|6. Tu C, Zhou X, Tarasov SG, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2011). The Era GTPase recognizes the GAUCACCUCC sequence and binds helix 45 near the 3' end of 16S rRNA. Proc Natl Acad Sci U S A  108, 10156-61.   https://doi.org/10.1073/pnas.1017679108|7. Yan H, Ji X (2011). Role of protein conformational dynamics in the catalysis by 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. Protein Pept Lett  18, 328-35.   https://doi.org/10.2174/092986611794654003",https://intramural.nih.gov/search/searchview.taf?ipid=73308
105,BC010328-13,"October 01, 2011 -  September 30, 2012",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Nancy C Martin|Sook  Lee|Christopher Jack  Huggins|Jacqueline  Salotti; PhD|Karen Lynn Saylor|Mesfin Ademe Gonit|Show all 7,"Robert  Smart (North Carolina State University)|Richard  Schwartz (Michigan State University)|Maria  Hatzoglou (Dept of Nutrition, Case Western Reserve University School of Medicine)",Alexander  Wlodawer; PhD (Protein Structure Section)|Maria  Miller (Protein Structure Section)|Timothy D Veenstra (Office Of The Director),NULL,"1. Basu SK, Malik R, Huggins CJ, Lee S, Sebastian T, Sakchaisri K, Quiñones OA, Alvord WG, Johnson PF (2011). 3'UTR elements inhibit Ras-induced C/EBPβ post-translational activation and senescence in tumour cells. EMBO J  30, 3714-28.   https://doi.org/10.1038/emboj.2011.250",https://intramural.nih.gov/search/searchview.taf?ipid=73309
106,BC010329-13,"October 01, 2011 -  September 30, 2012",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Daniel A Ritt|Alyson Kara Freeman|Jeremy Scott Logue; PhD,Rebecca  Page (Brown Medical School)|Premkumar  Reddy (Mount Sinai School of Medicine)|Robert  Rottapel (University of Toronto)|Matthias  Tschp (University of Cincinnati),Timothy D Veenstra (Office Of The Director)|Udayan  Guha (Medical Oncology Branch)|Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology),NULL,"1. Freeman AK, Morrison DK (2011). 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol  22, 681-7.   https://doi.org/10.1016/j.semcdb.2011.08.009|2. McKay MM, Freeman AK, Morrison DK (2011). Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small GTPases  2, 276-281.   https://doi.org/10.4161/sgtp.2.5.17740|3. McKay MM, Ritt DA, Morrison DK (2011). RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling. Curr Biol  21, 563-8.   https://doi.org/10.1016/j.cub.2011.02.033",https://intramural.nih.gov/search/searchview.taf?ipid=73310
107,BC010331-13,"October 01, 2011 -  September 30, 2012",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Jingjing  Ma,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)",NULL,NULL,"1. Yonamine I, Bamba T, Nirala NK, Jesmin N, Kosakowska-Cholody T, Nagashima K, Fukusaki E, Acharya JK, Acharya U (2011). Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. J Cell Biol  192, 557-67.   https://doi.org/10.1083/jcb.201004098|2. Yuan C, Rao RP, Jesmin N, Bamba T, Nagashima K, Pascual A, Preat T, Fukusaki E, Acharya U, Acharya JK (2011). CDase is a pan-ceramidase in Drosophila. Mol Biol Cell  22, 33-43.   https://doi.org/10.1091/mbc.E10-05-0453",https://intramural.nih.gov/search/searchview.taf?ipid=73311
108,BC010333-13,"October 01, 2011 -  September 30, 2012",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI",Brenda L Youngren|Sujatha B Gowda,"Flemming  Hansen (BioCentrum, Technical University of Denmank)|Alba  Guarne; PhD|Suckjoon  Jun (Harvard University)",Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Sawitzke JA, Youngren B, Thomason LC, Baker T, Sengupta M, Court D, Austin S (2012). The segregation of Escherichia coli minichromosomes constructed in vivo by recombineering. Plasmid  67, 148-54.   https://doi.org/10.1016/j.plasmid.2012.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=73312
109,BC010334-13,"October 01, 2011 -  September 30, 2012",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Candido  Alicea; PhD|Rashmi  Jalah|Guy Robert Pilkington|Jenifer L Bear|Rachel Elizabeth Kelly Beach|Mollly Christine Saunders|Show all 9,NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol  85, 1528-40.   https://doi.org/10.1128/JVI.01709-10",https://intramural.nih.gov/search/searchview.taf?ipid=73313
110,BC010336-13,"October 01, 2011 -  September 30, 2012",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Nina C Costantino|Mikhail G Bubunenko|Lynn C Thomason|James A Sawitzke|Teresa L Baker|Xintian  Li|Show all 9,"David  Friedman (University of Michigan School of Medicine)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|Markus  Wahl (X-Ray Crystallography, Max-Planck-Institute for Biophysical Chemistry)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)",Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Sankar  Adhya; PhD (Developmental Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Sawitzke JA, Costantino N, Li XT, Thomason LC, Bubunenko M, Court C, Court DL (2011). Probing cellular processes with oligo-mediated recombination and using the knowledge gained to optimize recombineering. J Mol Biol  407, 45-59.   https://doi.org/10.1016/j.jmb.2011.01.030|2. Strader MB, Costantino N, Elkins CA, Chen CY, Patel I, Makusky AJ, Choy JS, Court DL, Markey SP, Kowalak JA (2011). A proteomic and transcriptomic approach reveals new insight into beta-methylthiolation of Escherichia coli ribosomal protein S12. Mol Cell Proteomics  10, M110.005199.   https://doi.org/10.1074/mcp.M110.005199",https://intramural.nih.gov/search/searchview.taf?ipid=73314
111,BC010338-13,"October 01, 2011 -  September 30, 2012",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Naiche L Adler|Matthew J Anderson|Alexander James Stuffer|Irene Hwang Hung,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)|Thomas  Schimmang (University of Valladolid)|Gary C Schoenwolf",Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),NULL,"1. Kitagaki J, Ueda Y, Chi X, Sharma N, Elder CM, Truffer E, Costantini F, Lewandoski M, Perantoni AO (2011). FGF8 is essential for formation of the ductal system in the male reproductive tract. Development  138, 5369-78.   https://doi.org/10.1242/dev.051888|2. Naiche LA, Arora R, Kania A, Lewandoski M, Papaioannou VE (2011). Identity and fate of Tbx4-expressing cells reveal developmental cell fate decisions in the allantois, limb, and external genitalia. Dev Dyn  240, 2290-300.   https://doi.org/10.1002/dvdy.22731|3. Naiche LA, Holder N, Lewandoski M (2011). FGF4 and FGF8 comprise the wavefront activity that controls somitogenesis. Proc Natl Acad Sci U S A  108, 4018-23.   https://doi.org/10.1073/pnas.1007417108|4. Zacharias AL, Lewandoski M, Rudnicki MA, Gage PJ (2011). Pitx2 is an upstream activator of extraocular myogenesis and survival. Dev Biol  349, 395-405.   https://doi.org/10.1016/j.ydbio.2010.10.028|5. Zhang Z, O'Rourke JR, McManus MT, Lewandoski M, Harfe BD, Sun X (2011). The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning. Dev Biol  351, 254-65.   https://doi.org/10.1016/j.ydbio.2011.01.005",https://intramural.nih.gov/search/searchview.taf?ipid=73315
112,BC010341-13,"October 01, 2011 -  September 30, 2012",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Danielle  Needle|Brian P Austin|Sreejith  Raran Kurussi; PhD|Shawn Michael Hess|Jason  Liu,Jozsef  Tozser|James  Williams (Nature Technology Corp.),NULL,NULL,"1. Austin BP, Tözsér J, Bagossi P, Tropea JE, Waugh DS (2011). The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: insights into their use as tools for the removal of affinity tags. Protein Expr Purif  77, 53-61.   https://doi.org/10.1016/j.pep.2010.11.005|2. Austin BP, Waugh DS (2012). Isolation of Metarhizium anisopliae carboxypeptidase A with native disulfide bonds from the cytosol of Escherichia coli BL21(DE3). Protein Expr Purif  82, 116-24.   https://doi.org/10.1016/j.pep.2011.11.015|3. Sun P, Tropea JE, Waugh DS (2011). Enhancing the solubility of recombinant proteins in Escherichia coli by using hexahistidine-tagged maltose-binding protein as a fusion partner. Methods Mol Biol  705, 259-74.   https://doi.org/10.1007/978-1-61737-967-3_16|4. Waugh DS (2011). An overview of enzymatic reagents for the removal of affinity tags. Protein Expr Purif  80, 283-93.   https://doi.org/10.1016/j.pep.2011.08.005",https://intramural.nih.gov/search/searchview.taf?ipid=73316
113,BC010342-13,"October 01, 2011 -  September 30, 2012",Structural Proteomics of the Yersinia Yop Virulon,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Danielle  Needle|Brian P Austin|George T Lountos|Sreejith  Raran Kurussi; PhD|Shawn Michael Hess|Jason  Liu,"Gregory  Plano; PhD (Microbiology and Immunology, University of Miami School of Medicine)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Alexander  Wlodawer; PhD (Protein Structure Section),NULL,"1. Bahta M, Lountos GT, Dyas B, Kim SE, Ulrich RG, Waugh DS, Burke TR (2011). Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. J Med Chem  54, 2933-43.   https://doi.org/10.1021/jm200022g|2. Kim SE, Bahta M, Lountos GT, Ulrich RG, Burke TR, Waugh DS (2011). Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH. Acta Crystallogr D Biol Crystallogr  67, 639-45.   https://doi.org/10.1107/S0907444911018610",https://intramural.nih.gov/search/searchview.taf?ipid=73317
114,BC010345-13,"October 01, 2011 -  September 30, 2012",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Kristin K Biris|Ravindra Babu  Chalamalasetty|Mark William Lorne Kennedy; PhD|Robert John Garriock|John Jeon Lee|Aldo Mendoza Giaimo,Deborah  Chapman (U. Pittsburgh)|Michael  Kyba (University of Minnesota),Mark B Lewandoski (Genetics of Vertebrate Development Section),Benjamin  Feldman; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73318
115,BC010346-13,"October 01, 2011 -  September 30, 2012",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yun Xing M Wang,NULL,NULL,Charles  Schwieters; PhD (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73319
116,BC010348-13,"October 01, 2011 -  September 30, 2012",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Protein Structure Section, NCI",Alla E Gustchina|Maria  Miller|Di  Zhang|Jamaine S Davis|Dongwen  Zhou|Zachary Jason Miknis,"Ben  Dunn (Biochem. & Mol. Biol., University of Florida)|Kohei  Oda (Dept. Applied Biology, Kyoto Inst. of Technology)|Mariusz  Jaskolski (Adam Mickiewicz University)|Yoshiaki  Kiso (Kyoto Pharmaceutical University)|David  Baker (University of Washington)|Jan  Pohl (CDC)",Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Bhaumik P, Gustchina A, Wlodawer A (2012). Structural studies of vacuolar plasmepsins. Biochim Biophys Acta  1824, 207-23.   https://doi.org/10.1016/j.bbapap.2011.04.008|2. Bhaumik P, Horimoto Y, Xiao H, Miura T, Hidaka K, Kiso Y, Wlodawer A, Yada RY, Gustchina A (2011). Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum. J Struct Biol  175, 73-84.   https://doi.org/10.1016/j.jsb.2011.04.009|3. Bhaumik P, Xiao H, Hidaka K, Gustchina A, Kiso Y, Yada RY, Wlodawer A (2011). Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum. Biochemistry  50, 8862-79.   https://doi.org/10.1021/bi201118z|4. Bryksa BC, Bhaumik P, Magracheva E, De Moura DC, Kurylowicz M, Zdanov A, Dutcher JR, Wlodawer A, Yada RY (2011). Structure and mechanism of the saposin-like domain of a plant aspartic protease. J Biol Chem  286, 28265-75.   https://doi.org/10.1074/jbc.M111.252619|5. DiMaio F, Terwilliger TC, Read RJ, Wlodawer A, Oberdorfer G, Wagner U, Valkov E, Alon A, Fass D, Axelrod HL, Das D, Vorobiev SM, Iwaï H, Pokkuluri PR, Baker D (2011). Improved molecular replacement by density- and energy-guided protein structure optimization. Nature  473, 540-3.   https://doi.org/10.1038/nature09964|6. Glesner J, Wünschmann S, Li M, Gustchina A, Wlodawer A, Himly M, Chapman MD, Pomés A (2011). Mechanisms of allergen-antibody interaction of cockroach allergen Bla g 2 with monoclonal antibodies that inhibit IgE antibody binding. PLoS One  6, e22223.   https://doi.org/10.1371/journal.pone.0022223|7. Li M, Dimaio F, Zhou D, Gustchina A, Lubkowski J, Dauter Z, Baker D, Wlodawer A (2011). Crystal structure of XMRV protease differs from the structures of other retropepsins. Nat Struct Mol Biol  18, 227-9.   https://doi.org/10.1038/nsmb.1964|8. Li M, Gustchina A, Glesner J, Wünschmann S, Vailes LD, Chapman MD, Pomés A, Wlodawer A (2011). Carbohydrates contribute to the interactions between cockroach allergen Bla g 2 and a monoclonal antibody. J Immunol  186, 333-40.   https://doi.org/10.4049/jimmunol.1002318|9. Li M, Gustchina A, Matúz K, Tözsér J, Namwong S, Goldfarb NE, Dunn BM, Wlodawer A (2011). Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease. FEBS J  278, 4413-24.   https://doi.org/10.1111/j.1742-4658.2011.08364.x|10. Lyskowski A, Oeemig JS, Jaakkonen A, Rommi K, DiMaio F, Zhou D, Kajander T, Baker D, Wlodawer A, Goldman A, Iwaï H (2011). Cloning, expression, purification, crystallization and preliminary X-ray diffraction data of the Pyrococcus horikoshii RadA intein. Acta Crystallogr Sect F Struct Biol Cryst Commun  67, 623-6.   https://doi.org/10.1107/S1744309111008372|11. Peletskaya E, Andrake M, Gustchina A, Merkel G, Alexandratos J, Zhou D, Bojja RS, Satoh T, Potapov M, Kogon A, Potapov V, Wlodawer A, Skalka AM (2011). Localization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysis. PLoS One  6, e27751.   https://doi.org/10.1371/journal.pone.0027751|12. Pletneva NV, Pletnev VZ, Shemiakina II, Chudakov DM, Artemyev I, Wlodawer A, Dauter Z, Pletnev S (2011). Crystallographic study of red fluorescent protein eqFP578 and its far-red variant Katushka reveals opposite pH-induced isomerization of chromophore. Protein Sci  20, 1265-74.   https://doi.org/10.1002/pro.654|13. Xu Q, Yao J, Wlodawer A, Guo H (2011). Clarification of the mechanism of acylation reaction and origin of substrate specificity of the serine-carboxyl peptidase sedolisin through QM/MM free energy simulations. J Phys Chem B  115, 2470-6.   https://doi.org/10.1021/jp1122294",https://intramural.nih.gov/search/searchview.taf?ipid=73320
117,BC010350-13,"October 01, 2011 -  September 30, 2012",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Candido  Alicea; PhD|Rashmi  Jalah|Viraj M Kulkarni|Jenifer L Bear|Rachel Elizabeth Kelly Beach|Konstantinos  Apostolakis|Show all 9,"Ruth  Ruprecht (Dana-Farber Cancer Institute)|David  Weiner (University of Pennsylvania)|Amitinder  Kaur (New England Primate Research Center)|Koen  Van Rompay (California National Primate Research Center)|Bette  Korber; PhD (Los Alamos National Laboratory)|James  Mullins; PhD (Microbiology, University of Washington)|Show all 9",NULL,NULL,"1. Niu L, Termini JM, Kanagavelu SK, Gupta S, Rolland MM, Kulkarni V, Pavlakis GN, Felber BK, Mullins JI, Fischl MA, Stone GW (2011). Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes. Vaccine  29, 2110-9.   https://doi.org/10.1016/j.vaccine.2010.12.131|2. Strbo N, Vaccari M, Pahwa S, Kolber MA, Fisher E, Gonzalez L, Doster MN, Hryniewicz A, Felber BK, Pavlakis GN, Franchini G, Podack ER (2011). Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa. Vaccine  29, 2619-25.   https://doi.org/10.1016/j.vaccine.2011.01.044|3. Winstone N, Wilson AJ, Morrow G, Boggiano C, Chiuchiolo MJ, Lopez M, Kemelman M, Ginsberg AA, Mullen K, Coleman JW, Wu CD, Narpala S, Ouellette I, Dean HJ, Lin F, Sardesai NY, Cassamasa H, McBride D, Felber BK, Pavlakis GN, Schultz A, Hudgens MG, King CR, Zamb TJ, Parks CL, et al. [1 more author] (2011). Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen. J Virol  85, 9578-87.   https://doi.org/10.1128/JVI.05060-11",https://intramural.nih.gov/search/searchview.taf?ipid=73321
118,BC010378-13,"October 01, 2011 -  September 30, 2012",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",John  Cobuzzi|Miroslawa  Dauter|Sergei V Pletnev|Vladimir Z Pletnev|Krzysztof  Brzezinski|Dorothee Claudia Liebschner,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Jozef  Kur (Microbiology, University of Technology)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Show all 7",Alexander  Wlodawer; PhD (Protein Structure Section),NULL,"1. Brzezinski K, Baj A, Wałejko P, Witkowski S, Dauter Z (2011). 6-Hy-droxy-2,5,7,8-tetra-methyl-3,4-dihydro-2H-1-benzopyran-2-carbonitrile, from synchrotron data. Acta Crystallogr Sect E Struct Rep Online  67, o1901.   https://doi.org/10.1107/S1600536811025517|2. Brzezinski K, Brzuszkiewicz A, Dauter M, Kubicki M, Jaskolski M, Dauter Z (2011). High regularity of Z-DNA revealed by ultra high-resolution crystal structure at 0.55 A. Nucleic Acids Res  39, 6238-48.   https://doi.org/10.1093/nar/gkr202|3. Brzezinski K, Dauter Z, Baj A, Wałejko P, Witkowski S (2011). rac-6-Hy-droxy-2,5,7,8-tetra-methyl-chroman-2-carboxamide from synchrotron data. Acta Crystallogr Sect E Struct Rep Online  67, o503-4.   https://doi.org/10.1107/S1600536811002807|4. Brzezinski K, Dauter Z, Jaskolski M (2012). High-resolution structures of complexes of plant S-adenosyl-L-homocysteine hydrolase (Lupinus luteus). Acta Crystallogr D Biol Crystallogr  68, 218-31.   https://doi.org/10.1107/S0907444911055090|5. Brzezinski K, Dauter Z, Jaskolski M (2012). Structures of NodZ α1,6-fucosyltransferase in complex with GDP and GDP-fucose. Acta Crystallogr D Biol Crystallogr  68, 160-8.   https://doi.org/10.1107/S0907444911053157|6. Brzezinski K, Lazny R, Sienkiewicz M, Wojtulewski S, Dauter Z (2012). (2R)-8-Benzyl-2-[(S)-hy-droxy(phen-yl)meth-yl]-8-aza-bicyclo-[3.2.1]octan-3-one. Acta Crystallogr Sect E Struct Rep Online  68, o149-50.   https://doi.org/10.1107/S1600536811053190|7. Brzezinski K, Wałejko P, Baj A, Witkowski S, Dauter Z (2011). 2,2,5,7,8-Penta-methyl-chroman-6-yl 2,3,4,6-tetra-O-acetyl-α-d-glucopyran-oside from synchrotron data. Acta Crystallogr Sect E Struct Rep Online  67, o718.   https://doi.org/10.1107/S160053681100626X|8. Dauter M, Dauter Z (2011). Deprotonated imidodiphosphate in AMPPNP-containing protein structures. Acta Crystallogr D Biol Crystallogr  67, 1073-5.   https://doi.org/10.1107/S0907444911046105|9. Jedrzejczak R, Wang J, Dauter M, Szczesny RJ, Stepien PP, Dauter Z (2011). Human Suv3 protein reveals unique features among SF2 helicases. Acta Crystallogr D Biol Crystallogr  67, 988-96.   https://doi.org/10.1107/S0907444911040248|10. Lazny R, Wolosewicz K, Dauter Z, Brzezinski K (2012). (1RS,2SR,5SR)-9-Benzyl-2-[(1RS)-1-hy-droxy-benz-yl]-9-aza-bicyclo-[3.3.1]nonan-3-one from synchrotron data. Acta Crystallogr Sect E Struct Rep Online  68, o1367.   https://doi.org/10.1107/S1600536812014754|11. Li M, Dimaio F, Zhou D, Gustchina A, Lubkowski J, Dauter Z, Baker D, Wlodawer A (2011). Crystal structure of XMRV protease differs from the structures of other retropepsins. Nat Struct Mol Biol  18, 227-9.   https://doi.org/10.1038/nsmb.1964|12. Pletneva NV, Pletnev VZ, Shemiakina II, Chudakov DM, Artemyev I, Wlodawer A, Dauter Z, Pletnev S (2011). Crystallographic study of red fluorescent protein eqFP578 and its far-red variant Katushka reveals opposite pH-induced isomerization of chromophore. Protein Sci  20, 1265-74.   https://doi.org/10.1002/pro.654|13. Weiss MS, Einspahr H, Baker T, Dauter Z (2012). Another case of fraud in structural biology. Acta Crystallogr Sect F Struct Biol Cryst Commun  68, 365.   https://doi.org/10.1107/S1744309112011852",https://intramural.nih.gov/search/searchview.taf?ipid=73322
119,BC010379-13,"October 01, 2011 -  September 30, 2012",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI","Ping  Yu; MD, PhD|Jinbu  Wang|Xianyang  Fang|Yu  Liu|Katherine X Shaw",NULL,Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Alan  Rein; PhD (Retroviral Replication Laboratory),Adriaan  Bax; PhD (NIDDK),"1. Chen B, Zuo X, Wang YX, Dayie TK (2012). Multiple conformations of SAM-II riboswitch detected with SAXS and NMR spectroscopy. Nucleic Acids Res  40, 3117-30.   https://doi.org/10.1093/nar/gkr1154|2. Datta SA, Zuo X, Clark PK, Campbell SJ, Wang YX, Rein A (2011). Solution properties of murine leukemia virus gag protein: differences from HIV-1 gag. J Virol  85, 12733-41.   https://doi.org/10.1128/JVI.05889-11|3. Ying J, Wang J, Grishaev A, Yu P, Wang YX, Bax A (2011). Measurement of (1)H-(15)N and (1)H-(13)C residual dipolar couplings in nucleic acids from TROSY intensities. J Biomol NMR  51, 89-103.   https://doi.org/10.1007/s10858-011-9544-y",https://intramural.nih.gov/search/searchview.taf?ipid=73323
120,BC010380-13,"October 01, 2011 -  September 30, 2012",Recombination and Regulation,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",Alison J Rattray|Brenda K Shafer|Deanna R Gotte|Hui  Yang,"Tanya  Paull (University of Texas, Austin)|Hisashi  Tanaka (Lerner Research Institute)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73324
121,BC010381-13,"October 01, 2011 -  September 30, 2012",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce|Sharon P Moore|Ken  Ishikawa,NULL,NULL,NULL,"1. Klar AJ (2011). Breast cancer predisposition and brain hemispheric laterality specification likely share a common genetic cause. Breast Dis  33, 49-52.   https://doi.org/10.3233/BD-2010-0318|2. Yu C, Bonaduce MJ, Klar AJ (2012). Going in the right direction: mating-type switching of Schizosaccharomyces pombe is controlled by judicious expression of two different swi2 transcripts. Genetics  190, 977-87.   https://doi.org/10.1534/genetics.111.137109|3. Yu C, Bonaduce MJ, Klar AJ (2012). Remarkably high rate of DNA amplification promoted by the mating-type switching mechanism in Schizosaccharomyces pombe. Genetics  191, 285-9.   https://doi.org/10.1534/genetics.112.138727",https://intramural.nih.gov/search/searchview.taf?ipid=73325
122,BC010385-13,"October 01, 2011 -  September 30, 2012",Studies on Imat1I Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce|Sharon P Moore|Ken  Ishikawa,NULL,NULL,NULL,"1. Klar AJ (2011). Breast cancer predisposition and brain hemispheric laterality specification likely share a common genetic cause. Breast Dis  33, 49-52.   https://doi.org/10.3233/BD-2010-0318|2. Yu C, Bonaduce MJ, Klar AJ (2012). Going in the right direction: mating-type switching of Schizosaccharomyces pombe is controlled by judicious expression of two different swi2 transcripts. Genetics  190, 977-87.   https://doi.org/10.1534/genetics.111.137109|3. Yu C, Bonaduce MJ, Klar AJ (2012). Remarkably high rate of DNA amplification promoted by the mating-type switching mechanism in Schizosaccharomyces pombe. Genetics  191, 285-9.   https://doi.org/10.1534/genetics.112.138727",https://intramural.nih.gov/search/searchview.taf?ipid=73326
123,BC010387-13,"October 01, 2011 -  September 30, 2012",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Suhwan  Chang|Thirthagiri  Eswary|Betty K Martin|Suzanne A Hartford,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Stauffer S, Sharan SK (2012). Using recombineering to generate point mutations:galK-based positive-negative selection method. Methods Mol Biol  852, 121-31.   https://doi.org/10.1007/978-1-61779-564-0_10|2. Chang S, Stauffer S, Sharan SK (2012). Using recombineering to generate point mutations: the oligonucleotide-based ""hit and fix"" method. Methods Mol Biol  852, 111-20.   https://doi.org/10.1007/978-1-61779-564-0_9|3. Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX, Sharan SK (2011). Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med  17, 1275-82.   https://doi.org/10.1038/nm.2459",https://intramural.nih.gov/search/searchview.taf?ipid=73328
124,BC010390-13,"October 01, 2011 -  September 30, 2012",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Mary Ellen  Palko|Sudhirkumar U Yanpallewar|Colleen A Barrick|Gianluca  Fulgenzi|Francesco  Tomassoni Ardori; PhD|Erkan  Kiris|Show all 7,"Susan  Dorsey (University of Maryland)|Francis  Lee (Bristol Myers Squibb Pharmaceutical Research Institute)|Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Uri  Saragovi (Pharmacology and Therapeutics, McGill University)|Barbara  Hempstead (Cornell University)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Avdoshina V, Becker J, Campbell LA, Parsadanian M, Mhyre T, Tessarollo L, Mocchetti I (2011). Neurotrophins modulate the expression of chemokine receptors in the brain. J Neurovirol  17, 58-62.   https://doi.org/10.1007/s13365-010-0004-3|2. Buttermore ED, Dupree JL, Cheng J, An X, Tessarollo L, Bhat MA (2011). The cytoskeletal adaptor protein band 4.1B is required for the maintenance of paranodal axoglial septate junctions in myelinated axons. J Neurosci  31, 8013-24.   https://doi.org/10.1523/JNEUROSCI.1015-11.2011|3. Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S (2011). Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res  6, 195-205.   https://doi.org/10.1016/j.scr.2011.01.002|4. Takeda H, Koso H, Tessarollo L, Copeland NG, Jenkins NA (2013). Musashi1-CreER(T2) : a new cre line for conditional mutagenesis in neural stem cells. Genesis  51, 128-34.   https://doi.org/10.1002/dvg.22357|5. Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L, Borchelt DR (2011). Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet  20, 2770-82.   https://doi.org/10.1093/hmg/ddr176|6. Tebbenkamp AT, Swing D, Tessarollo L, Borchelt DR (2011). Premature death and neurologic abnormalities in transgenic mice expressing a mutant huntingtin exon-2 fragment. Hum Mol Genet  20, 1633-42.   https://doi.org/10.1093/hmg/ddr040|7. Vaegter CB, Jansen P, Fjorback AW, Glerup S, Skeldal S, Kjolby M, Richner M, Erdmann B, Nyengaard JR, Tessarollo L, Lewin GR, Willnow TE, Chao MV, Nykjaer A (2011) Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 14:54-61.|8. Yu T, Calvo L, Anta B, López-Benito S, Southon E, Chao MV, Tessarollo L, Arévalo JC (2011). Regulation of trafficking of activated TrkA is critical for NGF-mediated functions. Traffic  12, 521-34.   https://doi.org/10.1111/j.1600-0854.2010.01156.x",https://intramural.nih.gov/search/searchview.taf?ipid=73329
125,BC010391-13,"October 01, 2011 -  September 30, 2012",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Mary Ellen  Palko|Sandrine Solange Marie Puverel; PhD|Colleen A Barrick|Gianluca  Fulgenzi|Erkan  Kiris|Ting  Wang,"Susan  Dorsey (University of Maryland)|Uri  Saragovi (Pharmacology and Therapeutics, McGill University)|Susanna  Dolci (University of Tor Vergata)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)",NULL,"1. Berquam-Vrieze KE, Swing DA, Tessarollo L, Dupuy AJ (2012). Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1. Genesis  50, 112-8.   https://doi.org/10.1002/dvg.20798|2. Dorsey SG, Lovering RM, Renn CL, Leitch CC, Liu X, Tallon LJ, Sadzewicz LD, Pratap A, Ott S, Sengamalay N, Jones KM, Barrick C, Fulgenzi G, Becker J, Voelker K, Talmadge R, Harvey BK, Wyatt RM, Vernon-Pitts E, Zhang C, Shokat K, Fraser-Liggett C, Balice-Gordon RJ, Tessarollo L, Ward CW (2012). Genetic deletion of trkB.T1 increases neuromuscular function. Am J Physiol Cell Physiol  302, C141-53.   https://doi.org/10.1152/ajpcell.00469.2010|3. Graciotti L, Becker J, Granata AL, Procopio AD, Tessarollo L, Fulgenzi G (2011). Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes. PLoS One  6, e27034.   https://doi.org/10.1371/journal.pone.0027034|4. Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S (2011). Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res  6, 195-205.   https://doi.org/10.1016/j.scr.2011.01.002|5. Puverel S, Barrick C, Dolci S, Coppola V, Tessarollo L (2011). RanBPM is essential for mouse spermatogenesis and oogenesis. Development  138, 2511-21.   https://doi.org/10.1242/dev.062505",https://intramural.nih.gov/search/searchview.taf?ipid=73330
126,BC010411-13,"October 01, 2011 -  September 30, 2012",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Chiimei (Cindy) L Tseng|Haiqing  Fu|Ya  Zhang|Koichi  Utani|Catherine J Redmond|Yves  Pommier; PhD,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Elsa  Bronze Da Rocha (University Do Porto)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Bronze-da-Rocha E, Lin CM, Shimura T, Aladjem MI (2011). Interactions of MCP1 with components of the replication machinery in mammalian cells. Int J Biol Sci  7, 193-208.   https://doi.org/10.7150/ijbs.7.193|2. Huang L, Fu H, Lin CM, Conner AL, Zhang Y, Aladjem MI (2011). Prevention of transcriptional silencing by a replicator-binding complex consisting of SWI/SNF, MeCP1, and hnRNP C1/C2. Mol Cell Biol  31, 3472-84.   https://doi.org/10.1128/MCB.05587-11|3. Kouprina N, Samoshkin A, Erliandri I, Fu H, Aladjem M, Earnshaw W, Larionov V (2012) Organization of Synthetic Alphoid DNA Array in Human Artificial Chromosome (HAC) with a Conditional Centromere. ACS Synth Biol, in press.|4. Martin MM, Ryan M, Kim R, Zakas AL, Fu H, Lin CM, Reinhold WC, Davis SR, Bilke S, Liu H, Doroshow JH, Reimers MA, Valenzuela MS, Pommier Y, Meltzer PS, Aladjem MI (2011). Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res  21, 1822-32.   https://doi.org/10.1101/gr.124644.111|5. Regairaz M, Zhang YW, Fu H, Agama KK, Tata N, Agrawal S, Aladjem MI, Pommier Y (2011). Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes. J Cell Biol  195, 739-49.   https://doi.org/10.1083/jcb.201104003|6. Valenzuela MS, Chen Y, Davis S, Yang F, Walker RL, Bilke S, Lueders J, Martin MM, Aladjem MI, Massion PP, Meltzer PS (2011). Preferential localization of human origins of DNA replication at the 5'-ends of expressed genes and at evolutionarily conserved DNA sequences. PLoS One  6, e17308.   https://doi.org/10.1371/journal.pone.0017308",https://intramural.nih.gov/search/searchview.taf?ipid=73331
127,BC010412-13,"October 01, 2011 -  September 30, 2012",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Alan Anthony Merk|Sriram  Subramaniam; PhD,NULL,NULL,NULL,"1. Butan C, Hartnell LM, Fenton AK, Bliss D, Sockett RE, Subramaniam S, Milne JL (2011). Spiral architecture of the nucleoid in Bdellovibrio bacteriovorus. J Bacteriol  193, 1341-50.   https://doi.org/10.1128/JB.01061-10|2. Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW, Klasse PJ, Milne JL, Wilson IA, Olson WC, Moore JP, Subramaniam S (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A  108, 11440-5.   https://doi.org/10.1073/pnas.1101414108|3. Khursigara CM, Lan G, Neumann S, Wu X, Ravindran S, Borgnia MJ, Sourjik V, Milne J, Tu Y, Subramaniam S (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J  30, 1719-29.   https://doi.org/10.1038/emboj.2011.77|4. White TA, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Nandwani R, Hoxie JA, Bess JW, Lifson JD, Milne JL, Subramaniam S (2011). Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol  85, 12114-23.   https://doi.org/10.1128/JVI.05297-11",https://intramural.nih.gov/search/searchview.taf?ipid=73332
128,BC010413-12,"October 01, 2011 -  September 30, 2012",Study of hereditary prostate cancer and human artificial chromosomes,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Natalay  Kouprina|Jung-Hyun  Kim|Hee-Sheung  Lee|Indri  Erliandri|Artem Vadimovich  Kononenko|Nicholas Cheng Ooi Lee; PhD|Show all 8,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Johanna  Schleutker (Institute of Medical Technology)|Hiroshi  Masumoto (NCI)",NULL,NULL,"1. Bergmann JH, Jakubsche JN, Martins NM, Kagansky A, Nakano M, Kimura H, Kelly DA, Turner BM, Masumoto H, Larionov V, Earnshaw WC (2012). Epigenetic engineering: histone H3K9 acetylation is compatible with kinetochore structure and function. J Cell Sci  125, 411-21.   https://doi.org/10.1242/jcs.090639|2. Bergmann JH, Rodríguez MG, Martins NM, Kimura H, Kelly DA, Masumoto H, Larionov V, Jansen LE, Earnshaw WC (2011). Epigenetic engineering shows H3K4me2 is required for HJURP targeting and CENP-A assembly on a synthetic human kinetochore. EMBO J  30, 328-40.   https://doi.org/10.1038/emboj.2010.329|3. Ebersole T, Kim JH, Samoshkin A, Kouprina N, Pavlicek A, White RJ, Larionov V (2011). tRNA genes protect a reporter gene from epigenetic silencing in mouse cells. Cell Cycle  10, 2779-91.   https://doi.org/10.4161/cc.10.16.17092|4. Kazuki Y, Hoshiya H, Takiguchi M, Abe S, Iida Y, Osaki M, Katoh M, Hiratsuka M, Shirayoshi Y, Hiramatsu K, Ueno E, Kajitani N, Yoshino T, Kazuki K, Ishihara C, Takehara S, Tsuji S, Ejima F, Toyoda A, Sakaki Y, Larionov V, Kouprina N, Oshimura M (2011). Refined human artificial chromosome vectors for gene therapy and animal transgenesis. Gene Ther  18, 384-93.   https://doi.org/10.1038/gt.2010.147|5. Kim JH, Kononenko A, Erliandri I, Kim TA, Nakano M, Iida Y, Barrett JC, Oshimura M, Masumoto H, Earnshaw WC, Larionov V, Kouprina N (2011). Human artificial chromosome (HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells. Proc Natl Acad Sci U S A  108, 20048-53.   https://doi.org/10.1073/pnas.1114483108|6. Kouprina N, Earnshaw WC, Masumoto H, Larionov V (2013). A new generation of human artificial chromosomes for functional genomics and gene therapy. Cell Mol Life Sci  70, 1135-48.   https://doi.org/10.1007/s00018-012-1113-3|7. Kouprina N, Lee NC, Pavlicek A, Samoshkin A, Kim JH, Lee HS, Varma S, Reinhold WC, Otstot J, Solomon G, Davis S, Meltzer PS, Schleutker J, Larionov V (2012). Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families. Genes Chromosomes Cancer  51, 933-48.   https://doi.org/10.1002/gcc.21977|8. Noskov VN, Lee NC, Larionov V, Kouprina N (2011). Rapid generation of long tandem DNA repeat arrays by homologous recombination in yeast to study their function in mammalian genomes. Biol Proced Online  13, 8.   https://doi.org/10.1186/1480-9222-13-8|9. Ohzeki J, Bergmann JH, Kouprina N, Noskov VN, Nakano M, Kimura H, Earnshaw WC, Larionov V, Masumoto H (2012). Breaking the HAC Barrier: histone H3K9 acetyl/methyl balance regulates CENP-A assembly. EMBO J  31, 2391-402.   https://doi.org/10.1038/emboj.2012.82|10. Reinhold WC, Erliandri I, Liu H, Zoppoli G, Pommier Y, Larionov V (2011). Identification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instability. PLoS One  6, e25991.   https://doi.org/10.1371/journal.pone.0025991|11. Zeeberg BR, Liu H, Kahn AB, Ehler M, Rajapakse VN, Bonner RF, Brown JD, Brooks BP, Larionov VL, Reinhold W, Weinstein JN, Pommier YG (2011). RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis. BMC Bioinformatics  12, 52.   https://doi.org/10.1186/1471-2105-12-52",https://intramural.nih.gov/search/searchview.taf?ipid=73198
129,BC010418-13,"October 01, 2011 -  September 30, 2012",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Colin P Mccann|Satarupa  Das|Wolfgang  Losert; PhD|Chenlu  Wang,NULL,NULL,NULL,"1. Das S, Rericha EC, Bagorda A, Parent CA (2011). Direct biochemical measurements of signal relay during Dictyostelium development. J Biol Chem  286, 38649-58.   https://doi.org/10.1074/jbc.M111.284182",https://intramural.nih.gov/search/searchview.taf?ipid=73333
130,BC010419-13,"October 01, 2011 -  September 30, 2012",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Yi  Tang|Liuya  Tang|Katherine M Sixt,"Di  Chen (University of Rochester Medical Center)|YU  LIRONG (FDA, National Center for Toxicological Research)",Ming  Zhou (Nucleic Acids Section)|Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C, Deng CX, Cheng SY, Zhang YE (2011). Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J  30, 4777-89.   https://doi.org/10.1038/emboj.2011.393|2. Tang LY, Zhang YE (2011). Non-degradative ubiquitination in Smad-dependent TGF-β signaling. Cell Biosci  1, 43.   https://doi.org/10.1186/2045-3701-1-43|3. Zhang YE (2011). A special issue on TGF-β signaling and biology. Cell Biosci  1, 39.   https://doi.org/10.1186/2045-3701-1-39|4. Zhang YE (2011). Stopped in translation: EMT control meets eukaryotic elongation. Dev Cell  20, 289-90.   https://doi.org/10.1016/j.devcel.2011.02.012",https://intramural.nih.gov/search/searchview.taf?ipid=73334
131,BC010425-13,"October 01, 2011 -  September 30, 2012",Strategies for Therapeutic Cancer Vaccine Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diane J Poole|Jianping  Huang|Benedetto Paolo Farsaci; PhD|Peter Sungwhan Kim; PhD|Kwong Yok Tsang|James L Gulley; MD, PhD|Show all 7","Philip  Kantoff (Dana-Farber Cancer Institute)|David  Apelian (GlobeImmune, Inc.)","William Laurence Dahut; MD (Medical Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Gulley JL, Madan RA, Schlom J (2011). Impact of tumour volume on the potential efficacy of therapeutic vaccines. Curr Oncol  18, e150-7.   https://doi.org/10.3747/co.v18i3.783|2. Gulley JL, Madan RA, Tsang KY, Arlen PM, Camphausen K, Mohebtash M, Kamrava M, Schlom J, Citrin D (2011). A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther  11, 1409-18.   https://doi.org/10.1517/14712598.2011.615741|3. Mohebtash M, Tsang KY, Madan RA, Huen NY, Poole DJ, Jochems C, Jones J, Ferrara T, Heery CR, Arlen PM, Steinberg SM, Pazdur M, Rauckhorst M, Jones EC, Dahut WL, Schlom J, Gulley JL (2011). A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer. Clin Cancer Res  17, 7164-73.   https://doi.org/10.1158/1078-0432.CCR-11-0649|4. Smith HA, Maricque BB, Eberhardt J, Petersen B, Gulley JL, Schlom J, McNeel DG (2011). IgG responses to tissue-associated antigens as biomarkers of immunological treatment efficacy. J Biomed Biotechnol  2011, 454861.   https://doi.org/10.1155/2011/454861|5. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762",https://intramural.nih.gov/search/searchview.taf?ipid=73335
132,BC010440-11,"October 01, 2011 -  September 30, 2012","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma|Hyunbum  Jang|Jin  Liu|David  Zanuy Gomara|Melissa Anne Cronin|Show all 8,"Carlos  Aleman (Engineering, Univ. Barcelona)|Turkan  Haliloglu|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Ratnesh  Lal (Medical School, University of Chicago)|David  Zanuy (Institute Polytechnical)|Bruce  Kagan (UCLA)|Show all 13",NULL,NULL,"1. Acuner Ozbabacan SE, Keskin O, Nussinov R, Gursoy A (2012). Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes. J Struct Biol  179, 338-46.   https://doi.org/10.1016/j.jsb.2012.02.002|2. Arce FT, Jang H, Ramachandran S, Landon PB, Nussinov R, Lal R (2011). Polymorphism of amyloid β peptide in different environments: implications for membrane insertion and pore formation. Soft Matter  7, 5267-5273.   https://doi.org/10.1039/C1SM05162H|3. Cohen-Gihon I, Fong JH, Sharan R, Nussinov R, Przytycka TM, Panchenko AR (2011). Evolution of domain promiscuity in eukaryotic genomes--a perspective from the inferred ancestral domain architectures. Mol Biosyst  7, 784-92.   https://doi.org/10.1039/c0mb00182a|4. Cohen-Gihon I, Sharan R, Nussinov R (2011). Processes of fungal proteome evolution and gain of function: gene duplication and domain rearrangement. Phys Biol  8, 035009.   https://doi.org/10.1088/1478-3975/8/3/035009|5. Dickin R, Marden C, Collings AM, Nussinov R, Bourne PE (2011). A Review of 2010 for PLoS Computational Biology. PLoS Comput Biol  7, e1002003.   https://doi.org/10.1371/journal.pcbi.1002003|6. Engin HB, Keskin O, Nussinov R, Gursoy A (2012). A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model  52, 2273-86.   https://doi.org/10.1021/ci300072q|7. Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Aleman C (2011). Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Biochemistry  50, 1755-62.   https://doi.org/10.1021/bi101662j|8. Jang H, Arce FT, Mustata M, Ramachandran S, Capone R, Nussinov R, Lal R (2011). Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. Biophys J  100, 1775-83.   https://doi.org/10.1016/j.bpj.2011.01.072|9. Kagan BL, Jang H, Capone R, Teran Arce F, Ramachandran S, Lal R, Nussinov R (2012). Antimicrobial properties of amyloid peptides. Mol Pharm  9, 708-17.   https://doi.org/10.1021/mp200419b|10. Kar G, Keskin O, Nussinov R, Gursoy A (2012). Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. J Proteome Res  11, 1196-207.   https://doi.org/10.1021/pr2009143|11. Kifer I, Nussinov R, Wolfson HJ (2011). GOSSIP: a method for fast and accurate global alignment of protein structures. Bioinformatics  27, 925-32.   https://doi.org/10.1093/bioinformatics/btr044|12. Kifer I, Nussinov R, Wolfson HJ (2011). Protein structure prediction using a docking-based hierarchical folding scheme. Proteins  79, 1759-73.   https://doi.org/10.1002/prot.22999|13. Korkmaz EN, Nussinov R, Haliloğlu T (2012). Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB. PLoS Comput Biol  8, e1002420.   https://doi.org/10.1371/journal.pcbi.1002420|14. Liu J, Nussinov R (2011). Flexible cullins in cullin-RING E3 ligases allosterically regulate ubiquitination. J Biol Chem  286, 40934-42.   https://doi.org/10.1074/jbc.M111.277236|15. Luna A, Karac EI, Sunshine M, Chang L, Nussinov R, Aladjem MI, Kohn KW (2011). A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method. BMC Bioinformatics  12, 167.   https://doi.org/10.1186/1471-2105-12-167|16. Ma B, Nussinov R (2011). Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide. J Biol Chem  286, 34244-53.   https://doi.org/10.1074/jbc.M111.241141|17. Ma B, Tsai CJ, Haliloğlu T, Nussinov R (2011). Dynamic allostery: linkers are not merely flexible. Structure  19, 907-17.   https://doi.org/10.1016/j.str.2011.06.002|18. Mashiach-Farkash E, Nussinov R, Wolfson HJ (2011). SymmRef: a flexible refinement method for symmetric multimers. Proteins  79, 2607-23.   https://doi.org/10.1002/prot.23082|19. Miller Y, Ma B, Nussinov R (2011). Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry  50, 5172-81.   https://doi.org/10.1021/bi200400u|20. Miller Y, Ma B, Nussinov R (2011). The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions. J Am Chem Soc  133, 2742-8.   https://doi.org/10.1021/ja1100273|21. Nussinov R, Panchenko AR, Przytycka T (2011). Physics approaches to protein interactions and gene regulation. Phys Biol  8, 030301.   https://doi.org/10.1088/1478-3975/8/3/030301|22. Pan Y, Nussinov R (2011). The role of response elements organization in transcription factor selectivity: the IFN-β enhanceosome example. PLoS Comput Biol  7, e1002077.   https://doi.org/10.1371/journal.pcbi.1002077|23. Parthasarathy S, Long F, Miller Y, Xiao Y, McElheny D, Thurber K, Ma B, Nussinov R, Ishii Y (2011). Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. J Am Chem Soc  133, 3390-400.   https://doi.org/10.1021/ja1072178|24. Puri A, Jang H, Yavlovich A, Masood MA, Veenstra TD, Luna C, Aranda-Espinoza H, Nussinov R, Blumenthal R (2011). Material properties of matrix lipids determine the conformation and intermolecular reactivity of diacetylenic phosphatidylcholine in the lipid bilayer. Langmuir  27, 15120-8.   https://doi.org/10.1021/la203453x|25. Revilla-López G, Rodríguez-Ropero F, Curcó D, Torras J, Isabel Calaza M, Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2011). Integrating the intrinsic conformational preferences of noncoded α-amino acids modified at the peptide bond into the noncoded amino acids database. Proteins  79, 1841-52.   https://doi.org/10.1002/prot.23009|26. Tsai CJ, Nussinov R (2011). A unified convention for biological assemblies with helical symmetry. Acta Crystallogr D Biol Crystallogr  67, 716-28.   https://doi.org/10.1107/S0907444911024024|27. Xu Y, Ma B, Nussinov R (2012). Structural and functional consequences of phosphate-arsenate substitutions in selected nucleotides: DNA, RNA, and ATP. J Phys Chem B  116, 4801-11.   https://doi.org/10.1021/jp300307u|28. Yuan P, Liang K, Ma B, Zheng N, Nussinov R, Huang J (2011). Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment. Chem Biol Drug Des  78, 137-49.   https://doi.org/10.1111/j.1747-0285.2011.01119.x",https://intramural.nih.gov/search/searchview.taf?ipid=73299
133,BC010441-11,"October 01, 2011 -  September 30, 2012",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma|Hyunbum  Jang|Jin  Liu|Ozlem Z Keskin,"Carlos  Aleman (Engineering, Univ. Barcelona)|Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Haim  Wolfson (Tel Aviv Univ)|Show all 13",Mirit I Aladjem; PhD (Developmental Therapeutics Branch)|Kurt  Kohn; PhD (Developmental Therapeutics Branch),Anna  Panchenko; PhD (NLM) |Teresa M Przytycka (NLM),"1. Arce FT, Jang H, Ramachandran S, Landon PB, Nussinov R, Lal R (2011). Polymorphism of amyloid β peptide in different environments: implications for membrane insertion and pore formation. Soft Matter  7, 5267-5273.   https://doi.org/10.1039/C1SM05162H|2. Capone R, Jang H, Kotler SA, Connelly L, Teran Arce F, Ramachandran S, Kagan BL, Nussinov R, Lal R (2012). All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers. J Chem Theory Comput  8, 1143-1152.   https://doi.org/10.1021/ct200885r|3. Capone R, Jang H, Kotler SA, Kagan BL, Nussinov R, Lal R (2012). Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions. Biochemistry  51, 776-85.   https://doi.org/10.1021/bi2017427|4. Cohen-Gihon I, Fong JH, Sharan R, Nussinov R, Przytycka TM, Panchenko AR (2011). Evolution of domain promiscuity in eukaryotic genomes--a perspective from the inferred ancestral domain architectures. Mol Biosyst  7, 784-92.   https://doi.org/10.1039/c0mb00182a|5. Cohen-Gihon I, Sharan R, Nussinov R (2011). Processes of fungal proteome evolution and gain of function: gene duplication and domain rearrangement. Phys Biol  8, 035009.   https://doi.org/10.1088/1478-3975/8/3/035009|6. Connelly L, Jang H, Arce FT, Capone R, Kotler SA, Ramachandran S, Kagan BL, Nussinov R, Lal R (2012). Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology. J Phys Chem B  116, 1728-35.   https://doi.org/10.1021/jp2108126|7. Dickin R, Marden C, Collings AM, Nussinov R, Bourne PE (2011). A Review of 2010 for PLoS Computational Biology. PLoS Comput Biol  7, e1002003.   https://doi.org/10.1371/journal.pcbi.1002003|8. Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Aleman C (2011). Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Biochemistry  50, 1755-62.   https://doi.org/10.1021/bi101662j|9. Jang H, Arce FT, Mustata M, Ramachandran S, Capone R, Nussinov R, Lal R (2011). Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. Biophys J  100, 1775-83.   https://doi.org/10.1016/j.bpj.2011.01.072|10. Kagan BL, Jang H, Capone R, Teran Arce F, Ramachandran S, Lal R, Nussinov R (2012). Antimicrobial properties of amyloid peptides. Mol Pharm  9, 708-17.   https://doi.org/10.1021/mp200419b|11. Kifer I, Nussinov R, Wolfson HJ (2011). GOSSIP: a method for fast and accurate global alignment of protein structures. Bioinformatics  27, 925-32.   https://doi.org/10.1093/bioinformatics/btr044|12. Kifer I, Nussinov R, Wolfson HJ (2011). Protein structure prediction using a docking-based hierarchical folding scheme. Proteins  79, 1759-73.   https://doi.org/10.1002/prot.22999|13. Liu J, Nussinov R (2011). Flexible cullins in cullin-RING E3 ligases allosterically regulate ubiquitination. J Biol Chem  286, 40934-42.   https://doi.org/10.1074/jbc.M111.277236|14. Luna A, Karac EI, Sunshine M, Chang L, Nussinov R, Aladjem MI, Kohn KW (2011). A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method. BMC Bioinformatics  12, 167.   https://doi.org/10.1186/1471-2105-12-167|15. Ma B, Nussinov R (2011). Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide. J Biol Chem  286, 34244-53.   https://doi.org/10.1074/jbc.M111.241141|16. Ma B, Nussinov R (2012). Selective molecular recognition in amyloid growth and transmission and cross-species barriers. J Mol Biol  421, 172-84.   https://doi.org/10.1016/j.jmb.2011.11.023|17. Ma B, Tsai CJ, Haliloğlu T, Nussinov R (2011). Dynamic allostery: linkers are not merely flexible. Structure  19, 907-17.   https://doi.org/10.1016/j.str.2011.06.002|18. Mashiach-Farkash E, Nussinov R, Wolfson HJ (2011). SymmRef: a flexible refinement method for symmetric multimers. Proteins  79, 2607-23.   https://doi.org/10.1002/prot.23082|19. Miller Y, Ma B, Nussinov R (2011). Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry  50, 5172-81.   https://doi.org/10.1021/bi200400u|20. Miller Y, Ma B, Nussinov R (2011). The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions. J Am Chem Soc  133, 2742-8.   https://doi.org/10.1021/ja1100273|21. Nussinov R, Panchenko AR, Przytycka T (2011). Physics approaches to protein interactions and gene regulation. Phys Biol  8, 030301.   https://doi.org/10.1088/1478-3975/8/3/030301|22. Pan Y, Nussinov R (2011). The role of response elements organization in transcription factor selectivity: the IFN-β enhanceosome example. PLoS Comput Biol  7, e1002077.   https://doi.org/10.1371/journal.pcbi.1002077|23. Parthasarathy S, Long F, Miller Y, Xiao Y, McElheny D, Thurber K, Ma B, Nussinov R, Ishii Y (2011). Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. J Am Chem Soc  133, 3390-400.   https://doi.org/10.1021/ja1072178|24. Revilla-López G, Rodríguez-Ropero F, Curcó D, Torras J, Isabel Calaza M, Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2011). Integrating the intrinsic conformational preferences of noncoded α-amino acids modified at the peptide bond into the noncoded amino acids database. Proteins  79, 1841-52.   https://doi.org/10.1002/prot.23009|25. Siddiqua A, Luo Y, Meyer V, Swanson MA, Yu X, Wei G, Zheng J, Eaton GR, Ma B, Nussinov R, Eaton SS, Margittai M (2012). Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau. J Am Chem Soc  134, 10271-8.   https://doi.org/10.1021/ja303498q|26. Tsai CJ, Nussinov R (2011). A unified convention for biological assemblies with helical symmetry. Acta Crystallogr D Biol Crystallogr  67, 716-28.   https://doi.org/10.1107/S0907444911024024|27. Yu X, Luo Y, Dinkel P, Zheng J, Wei G, Margittai M, Nussinov R, Ma B (2012). Cross-seeding and conformational selection between three- and four-repeat human Tau proteins. J Biol Chem  287, 14950-9.   https://doi.org/10.1074/jbc.M112.340794|28. Yuan P, Liang K, Ma B, Zheng N, Nussinov R, Huang J (2011). Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment. Chem Biol Drug Des  78, 137-49.   https://doi.org/10.1111/j.1747-0285.2011.01119.x",https://intramural.nih.gov/search/searchview.taf?ipid=73300
134,BC010442-11,"October 01, 2011 -  September 30, 2012",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma|Ozlem Z Keskin,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73303
135,BC010446-11,"October 01, 2011 -  September 30, 2012",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Natalia  Wesolowska|Yi  Zhang|Liang  Zhang|William Philip Schreiner|Netta  Golenberg,NULL,NULL,NULL,"1. Gao G, Cheng Y, Wesolowska N, Rong YS (2011). Paternal imprint essential for the inheritance of telomere identity in Drosophila. Proc Natl Acad Sci U S A  108, 4932-7.   https://doi.org/10.1073/pnas.1016792108",https://intramural.nih.gov/search/searchview.taf?ipid=73306
136,BC010448-11,"October 01, 2011 -  September 30, 2012",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kathleen L Decicco|Zhihong  Shan|Monika  Deshpande|Robert Mark Simpson; DVM, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73336
137,BC010449-11,"October 01, 2011 -  September 30, 2012",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yan  Cai|Mitsuhiro  Yoneda|Miyuki  Murata,NULL,Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"1. Kido T, Tomita T, Okamoto M, Cai Y, Matsumoto Y, Vinson C, Maru Y, Kimura S (2011). FOXA1 plays a role in regulating secretoglobin 1a1 expression in the absence of CCAAT/enhancer binding protein activities in lung in vivo. Am J Physiol Lung Cell Mol Physiol  300, L441-52.   https://doi.org/10.1152/ajplung.00435.2009|2. Kurotani R, Okumura S, Matsubara T, Yokoyama U, Buckley JR, Tomita T, Kezuka K, Nagano T, Esposito D, Taylor TE, Gillette WK, Ishikawa Y, Abe H, Ward JM, Kimura S (2011). Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation. J Biol Chem  286, 19682-92.   https://doi.org/10.1074/jbc.M111.239046",https://intramural.nih.gov/search/searchview.taf?ipid=73337
138,BC010450-11,"October 01, 2011 -  September 30, 2012",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Joell J Gills|Shigeru  Kawabata|Yoon Soo Chang; MD|Ajaikumar B Kunnamakkara|Colleen R Maier|Willie  Wilson|Show all 16,"Alan  Kozikowski (University of Illinois at Chicago)|Pasi  Janne (Oncology, Dana-Farber Cancer Center)|William  Pao (Memorial Sloan Kettering Cancer Center)",Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Susan L Holbeck (Information Technology Branch)|Melinda  Hollingshead (Biological Testing Branch)|Maria  Tsokos; MD (Laboratory of Pathology)|Timothy D Veenstra (Office Of The Director)|Daniel H Fowler (Experimental Transplantation and Immunology Branch),"Mones S Abu Asab (NEI) |J Silvio  Gutkind; PhD (NIDCR) |Carter  Van Waes; MD, PhD (NIDCD)","1. Hollander MC, Blumenthal GM, Dennis PA (2011). PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer  11, 289-301.   https://doi.org/10.1038/nrc3037|2. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA (2011). Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene  30, 1812-21.   https://doi.org/10.1038/onc.2010.556|3. West KA, Dennis PA (2011). Starting with the ABCs: Akt in breast cancer. Mol Cancer Ther  10, 2031.   https://doi.org/10.1158/1535-7163.MCT-11-0712|4. Zhang C, Elkahloun AG, Liao H, Delaney S, Saber B, Morrow B, Prendergast GC, Hollander MC, Gills JJ, Dennis PA (2011). Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cells. Mol Cancer Ther  10, 1137-48.   https://doi.org/10.1158/1535-7163.MCT-10-1028",https://intramural.nih.gov/search/searchview.taf?ipid=73338
139,BC010451-11,"October 01, 2011 -  September 30, 2012",Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines,Joseph John Barchi|IRP Faculty Profile,Joel Patrick Schneider; PhD,"Chemical Biology Laboratory, NCI",M A Siddiqui|Souvik  Biswas|Jeffrey  Gildersleeve,kate  RittenhouseOlson (University of Buffalo)|Lugang  Yu (University of Liverpool),Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Barchi J (2011) Glyco-Nanoparticles as Platforms for Antitumor Therapeutic Strategies, in Glyconanotechnology as a Bridge to New Medicines., in press.|2. Brinas R, Maetani M, Barchi J (2012) A Survey of Place-exchange Reaction for the Preparation of Water-Soluble Gold Nanoparticles. Journal of Colloid and Interface Science, in press.|3. Zhang Y, Muthana SM, Barchi JJ, Gildersleeve JC (2012). Divergent behavior of glycosylated threonine and serine derivatives in solid phase peptide synthesis. Org Lett  14, 3958-61.   https://doi.org/10.1021/ol301723e|4. Zhang Y, Muthana SM, Farnsworth D, Ludek O, Adams K, Barchi JJ, Gildersleeve JC (2012). Enhanced epimerization of glycosylated amino acids during solid-phase peptide synthesis. J Am Chem Soc  134, 6316-25.   https://doi.org/10.1021/ja212188r",https://intramural.nih.gov/search/searchview.taf?ipid=73434
140,BC010453-11,"October 01, 2011 -  September 30, 2012",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Douglas K Price|Kelie M Reece; PhD|Emily  Richardson|William Laurence Dahut; MD|Andrea Borghese Apolo|Show all 7,Romano  Danesi|Alan  Kristal (Fred Hutchinson Cancer Research Center)|Robin  Leach (UT Health Science Center San Antonio)|Jeanny  AragonChing (George Washington University)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Show all 16,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Ann  Hsing; PhD (Infection & Immunoepidemiology Branch)|Tawnya Carlene McKee; BA, PhD (Molecular Targets Laboratory)|Howard  Parnes (Prostate and Urologic Cancer Research Group)",NULL,"1. Gao R, Reece K, Sissung T, Reed E, Price DK, Figg WD (2011). The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity. Mutat Res  708, 21-7.   https://doi.org/10.1016/j.mrfmmm.2011.01.002|2. Pressler H, Sissung TM, Venzon D, Price DK, Figg WD (2011). Expression of OATP family members in hormone-related cancers: potential markers of progression. PLoS One  6, e20372.   https://doi.org/10.1371/journal.pone.0020372|3. Sissung TM, Danesi R, Kirkland CT, Baum CE, Ockers SB, Stein EV, Venzon D, Price DK, Figg WD (2011). Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J Clin Endocrinol Metab  96, E368-72.   https://doi.org/10.1210/jc.2010-2070|4. Sissung TM, Pressler H, Price DK, Figg WD (2011). SLCO transport genes in prostate cancer--letter. Cancer Epidemiol Biomarkers Prev  20, 2325; author reply 2326-7.   https://doi.org/10.1158/1055-9965.EPI-11-0606|5. Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin ME, Oh WK, Lee GS, Kantoff PW (2011). SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol  29, 2565-73.   https://doi.org/10.1200/JCO.2010.31.2405|6. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A (2011). Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control  22, 1121-31.   https://doi.org/10.1007/s10552-011-9787-7",https://intramural.nih.gov/search/searchview.taf?ipid=73339
141,BC010476-10,"October 01, 2011 -  September 30, 2012",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sankaran  Subramanian; MD|Shingo  Matsumoto|Keita  Saito|Masayuki  Matsuo|James B Mitchell; PhD,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Calvin A Johnson; PhD (CIT) |Thomas J Pohida; MS (CIT) |Anthony R Fletcher; PhD (CIT) |Jeeva P Munasinghe (NINDS),"1. Matsumoto S, Saito K, Yasui H, Morris HD, Munasinghe JP, Lizak M, Merkle H, Ardenkjaer-Larsen JH, Choudhuri R, Devasahayam N, Subramanian S, Koretsky AP, Mitchell JB, Krishna MC (2013). EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn Reson Med  69, 1443-50.   https://doi.org/10.1002/mrm.24355|2. Subramanian S, Chandramouli GV, McMillan A, Gullapalli RP, Devasahayam N, Mitchell JB, Matsumoto S, Krishna MC (2013) Evaluation of partial k-space strategies to speed up time-domain EPR imaging. Magn Reson Med 70:745-53|3. Thavavel V, Basha J, Krishna M, Murugesan R (2012) Heuristic wavelet approach for low-dose EPR tomographic reconstruction: An applicability analysis wth phantom and in vivo imaging. Expert Syst Appl 39:5717-5726.",https://intramural.nih.gov/search/searchview.taf?ipid=73355
142,BC010477-10,"October 01, 2011 -  September 30, 2012",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Shingo  Matsumoto|Keita  Saito|Masayuki  Matsuo|James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Day SE, Kettunen MI, Cherukuri MK, Mitchell JB, Lizak MJ, Morris HD, Matsumoto S, Koretsky AP, Brindle KM (2011). Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging. Magn Reson Med  65, 557-63.   https://doi.org/10.1002/mrm.22698|2. Matsumoto S, Saito K, Yasui H, Morris HD, Munasinghe JP, Lizak M, Merkle H, Ardenkjaer-Larsen JH, Choudhuri R, Devasahayam N, Subramanian S, Koretsky AP, Mitchell JB, Krishna MC (2013). EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn Reson Med  69, 1443-50.   https://doi.org/10.1002/mrm.24355",https://intramural.nih.gov/search/searchview.taf?ipid=73353
143,BC010478-10,"October 01, 2011 -  September 30, 2012",Continuous Wave Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sankaran  Subramanian; MD|Janusz W Koscielniak|Peter  Riesz; PhD|James B Mitchell; PhD,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Davis RM, Matsumoto S, Bernardo M, Sowers A, Matsumoto K, Krishna MC, Mitchell JB (2011). Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape. Free Radic Biol Med  50, 459-68.   https://doi.org/10.1016/j.freeradbiomed.2010.11.028|2. Davis RM, Sowers AL, DeGraff W, Bernardo M, Thetford A, Krishna MC, Mitchell JB (2011). A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic Biol Med  51, 780-90.   https://doi.org/10.1016/j.freeradbiomed.2011.05.019|3. Fabre KM, Saito K, DeGraff W, Sowers AL, Thetford A, Cook JA, Krishna MC, Mitchell JB (2011). The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther  12, 915-23.   https://doi.org/10.4161/cbt.12.10.17714",https://intramural.nih.gov/search/searchview.taf?ipid=73354
144,BC010479-10,"October 01, 2011 -  September 30, 2012",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,"1. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res  9, 418-29.   https://doi.org/10.1158/1541-7786.MCR-10-0511|2. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|3. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=73345
145,BC010481-10,"October 01, 2011 -  September 30, 2012",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Linda L Dunn|Andrea L Ferris|Patrick K Clark|Barry  Johnson|Janani  Varadarajan,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Michael  Parniak; PhD (Department of Medicine, McGill University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Dwight V Nissley (Genome Recombination and Regulation Section)|Gary T Pauly (Chemical Biology Laboratory)|William Gregory Alvord (Office Of The Director)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics),Craig Joseph Thomas (NCATS),"1. Davis CA, Parniak MA, Hughes SH (2011). The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC. Virology  419, 64-71.   https://doi.org/10.1016/j.virol.2011.08.010",https://intramural.nih.gov/search/searchview.taf?ipid=73349
146,BC010483-10,"October 01, 2011 -  September 30, 2012",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Lihong  Xu; PhD|Suresh R Volate|Mary B Hilton|Andrew Ryan Burke; PhD,NULL,NULL,NULL,"1. Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, Logsdon D, Hsiao E, Stein EV, Cuttitta F, Haines DC, Nagashima K, Tessarollo L, St Croix B (2011). GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc Natl Acad Sci U S A  108, 5759-64.   https://doi.org/10.1073/pnas.1017192108",https://intramural.nih.gov/search/searchview.taf?ipid=73364
147,BC010484-10,"October 01, 2011 -  September 30, 2012",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Amit Madhulal Chaudhary|Suresh R Volate|Mary B Hilton|Andrew Ryan Burke; PhD,NULL,NULL,NULL,"1. Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, Logsdon D, Hsiao E, Stein EV, Cuttitta F, Haines DC, Nagashima K, Tessarollo L, St Croix B (2011). GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc Natl Acad Sci U S A  108, 5759-64.   https://doi.org/10.1073/pnas.1017192108",https://intramural.nih.gov/search/searchview.taf?ipid=73365
148,BC010486-10,"October 01, 2011 -  September 30, 2012",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73366
149,BC010487-10,"October 01, 2011 -  September 30, 2012",Cytoplasmic-Nuclear Trafficking of HIV-1,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Wendy  Yuen|Laura Minji Choi|Hyun Jae  Yu|Christopher Lee Case; PhD|Guangai  Xue; PhD|Show all 8,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Zandrea  Ambrose (University of Pittsburgh)|Sara  Sawyer (University of Texas, Austin)",NULL,NULL,"1. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hué S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ (2011). HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog  7, e1002439.   https://doi.org/10.1371/journal.ppat.1002439",https://intramural.nih.gov/search/searchview.taf?ipid=73351
150,BC010488-10,"October 01, 2011 -  September 30, 2012",Animal Models for HIV-1 Replication and Pathogenesis,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Wendy  Yuen|Christopher Lee Case; PhD|Guangai  Xue; PhD,"John W Mellors|Paul  Bieniasz (Rockefeller University, Aaron Diamond AIDS Research Center)|Zandrea  Ambrose (University of Pittsburgh)|Theodora  Hatziioannou (Aaron Diamond AIDS Research Center)",Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch),NULL,"1. Kearney M, Spindler J, Shao W, Maldarelli F, Palmer S, Hu SL, Lifson JD, KewalRamani VN, Mellors JW, Coffin JM, Ambrose Z (2011). Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. J Virol  85, 1067-76.   https://doi.org/10.1128/JVI.01701-10",https://intramural.nih.gov/search/searchview.taf?ipid=73352
151,BC010493-10,"October 01, 2011 -  September 30, 2012",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jennifer T Miller|Jason William Rausch|Sabrina  Lusvarghi|Humeyra  Taskent; PhD|Joanna  Sztuba-Solinska; PhD,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Xiaowei  Zhuang (Chemistry and Biology, Harvard University)|John  Marino (Center for Advanced Research in Biotechnology)|Marie-Louise  Hammarskjold (University of Virginia)|Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|David  Garfinkel (University of Georgia)","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Yun Xing M Wang (Structural Biophysics Laboratory)",NULL,"1. Bindewald E, Wendeler M, Legiewicz M, Bona MK, Wang Y, Pritt MJ, Le Grice SF, Shapiro BA (2011). Correlating SHAPE signatures with three-dimensional RNA structures. RNA  17, 1688-96.   https://doi.org/10.1261/rna.2640111|2. Kenyon JC, Tanner SJ, Legiewicz M, Phillip PS, Rizvi TA, Le Grice SF, Lever AM (2011) SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res 39:6692-704.|3. Lusvarghi S, SztubaSolinska J, Purzycka K, Rausch J, Legrice S (2012) RNA secondary structure prediction using high-throughput SHAPE. Journal of Video Education, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73358
152,BC010494-10,"October 01, 2011 -  September 30, 2012",HIV-1 RNase H  as  a Therapeutic Target,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Jennifer T Miller|Jason William Rausch|Suhman  Chung|Katarzyna Joanna Purzycka; PhD|Humeyra  Taskent; PhD|Show all 8,Matthias  Goette (McGill University)|James  Cowan (Ohio State University)|Marcin  Nowotny (International Institute of Molecular and Cell Biology)|Graziella  Tocco (University of Cagliari),John A Beutler (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Barry R O'Keefe (Molecular Targets Laboratory),Craig Joseph Thomas (NCATS) |Wei  Yang; PhD (NIDDK),"1. Chung S, Rausch J, Le Grice S (2011) Targeting HIV reverse transcriptase-associated ribonuclease H function, in Proceedings of the 19th International Conference on AIDS, Cancer and Public Health (A. Kozlov, ed.)., in press.|2. Chung S, Himmel DM, Jiang JK, Wojtak K, Bauman JD, Rausch JW, Wilson JA, Beutler JA, Thomas CJ, Arnold E, Le Grice SF (2011). Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem  54, 4462-73.   https://doi.org/10.1021/jm2000757|3. Dash C, Ahmadibeni Y, Hanley MJ, Pandhare J, Gotte M, Le Grice SF, Parang K (2011) Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside -triphosphates. Bioorg Med Chem Lett 21:3519-22.|4. Kearney MF, Lee K, Bagni RK, Wiegand A, Spindler J, Maldarelli F, Pinto PA, Linehan WM, Vocke CD, Delviks-Frankenberry KA, Devere White RW, Del Prete GQ, Mellors JW, Lifson JD, Kewalramani VN, Pathak VK, Coffin JM, Le Grice SF (2011) Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples. Adv Virol 2011:272193|5. Legrice S (2012) Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J Biol Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73356
153,BC010495-10,"October 01, 2011 -  September 30, 2012",Unnatural Amino Acids as Probes of Protein Structure and Function,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Jennifer T Miller|Takashi  Masaoka|Vineet Narain KewalRamani; PhD,NULL,Deb  Chatterjee (Office Of The Director),NULL,"1. Legrice S (2012) Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J Biol Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73357
154,BC010499-10,"October 01, 2011 -  September 30, 2012",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Atsushi  Terunuma|Adrienne Michelle Starks,"Carlo  Croce (Ohio State University)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Feng  WangJohanning (University of Texas MD Anderson Cancer Center)",Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BA (2011). A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet  7, e1002165.   https://doi.org/10.1371/journal.pgen.1002165|2. Wallace TA, Martin DN, Ambs S (2011). Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis  32, 1107-21.   https://doi.org/10.1093/carcin/bgr066|3. Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H, Hurwitz AA (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest  121, 1361-72.   https://doi.org/10.1172/JCI44325",https://intramural.nih.gov/search/searchview.taf?ipid=73340
155,BC010504-10,"October 01, 2011 -  September 30, 2012",Elucidating the Mechanisms of Reverse Transcription and Recombination,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Na  Ni|Shih-Han  Tai|Vinay K Pathak; PhD|John Miller Coffin; PhD,NULL,Frank  Maldarelli (Host Virus Interaction Branch)|Mary  Kearney (Host Virus Interaction Branch),NULL,"1. Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, Hu WS, Pathak VK (2011). Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J Virol  85, 4888-97.   https://doi.org/10.1128/JVI.00046-11|2. Delviks-Frankenberry K, Galli A, Nikolaitchik O, Mens H, Pathak VK, Hu WS (2011). Mechanisms and factors that influence high frequency retroviral recombination. Viruses  3, 1650-80.   https://doi.org/10.3390/v3091650|3. Josefsson L, King MS, Makitalo B, Brännström J, Shao W, Maldarelli F, Kearney MF, Hu WS, Chen J, Gaines H, Mellors JW, Albert J, Coffin JM, Palmer SE (2011). Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A  108, 11199-204.   https://doi.org/10.1073/pnas.1107729108|4. Nikolaitchik OA, Galli A, Moore MD, Pathak VK, Hu WS (2011). Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assay. J Mol Biol  407, 521-31.   https://doi.org/10.1016/j.jmb.2011.01.052|5. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Coffin JM, Pathak VK (2011). Recombinant origin of the retrovirus XMRV. Science  333, 97-101.   https://doi.org/10.1126/science.1205292",https://intramural.nih.gov/search/searchview.taf?ipid=73347
156,BC010506-10,"October 01, 2011 -  September 30, 2012",Understanding Retroviral Gag and RNA Targeting and Virus Assembly,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Kari Ann Dilley|Steven Carter Hatch|Luca  Sardo|Sergey Sergeevich Plisov|Vinay K Pathak; PhD|Show all 8,NULL,Kunio  Nagashima (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director),George  Patterson; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73346
157,BC010511-10,"October 01, 2011 -  September 30, 2012",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Jane  Mirro|Silvia  Sanchez Martinez|Ina  O'Carroll,"Susan  Krueger (National Institute of Standards and Technology)|Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Walther  Mothes (Yale University)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)",Robert J Fisher (Office Of The Director)|Raul Eduardo Cachau (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory)|Robert  Gorelick (Office Of The Director),NULL,"1. Datta SA, Heinrich F, Raghunandan S, Krueger S, Curtis JE, Rein A, Nanda H (2011). HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J Mol Biol  406, 205-14.   https://doi.org/10.1016/j.jmb.2010.11.051|2. Datta SA, Temeselew LG, Crist RM, Soheilian F, Kamata A, Mirro J, Harvin D, Nagashima K, Cachau RE, Rein A (2011). On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J Virol  85, 4111-21.   https://doi.org/10.1128/JVI.00006-11|3. Goicochea NL, Datta SA, Ayaluru M, Kao C, Rein A, Dragnea B (2011). Structure and stoichiometry of template-directed recombinant HIV-1 Gag particles. J Mol Biol  410, 667-80.   https://doi.org/10.1016/j.jmb.2011.04.012|4. Jones CP, Datta SA, Rein A, Rouzina I, Musier-Forsyth K (2011). Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J Virol  85, 1594-603.   https://doi.org/10.1128/JVI.01809-10|5. Rein A, Datta SA, Jones CP, Musier-Forsyth K (2011). Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci  36, 373-80.   https://doi.org/10.1016/j.tibs.2011.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=73362
158,BC010512-10,"October 01, 2011 -  September 30, 2012",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro|Tania Bibiana Lombo Rodriguez|Ina  O'Carroll|Smita  Nair; PhD|Wei-Shau  Hu; PhD,Kevin  Weeks (University of North Carolina)|Mark  Williams (Northeastern University)|Karin  MusierForsyth (Ohio State University),Robert J Fisher (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory),Judith Goldstein Levin; PhD (NICHD),"1. Rein A, Datta SA, Jones CP, Musier-Forsyth K (2011). Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci  36, 373-80.   https://doi.org/10.1016/j.tibs.2011.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=73363
159,BC010516-10,"October 01, 2011 -  September 30, 2012",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|John  Ondos|Jason Yulin Cheng; PhD|Show all 7,"Alan  Huston (Naval Research Laboratory)|Brian  Justus (Optical Sciences Division, Naval Research Lab (NRL))|Maria  Plazas (Departmento de Fiscia, Universidad Nacional de Colombia)|Wei  Chen (University of Texas)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73369
160,BC010518-10,"October 01, 2011 -  September 30, 2012",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Ying  Zhang|Maria  Kaltcheva|Alexander James Stuffer,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Kawakami Y, Marti M, Kawakami H, Itou J, Quach T, Johnson A, Sahara S, O'Leary DD, Nakagawa Y, Lewandoski M, Pfaff S, Evans SM, Izpisua Belmonte JC (2011). Islet1-mediated activation of the β-catenin pathway is necessary for hindlimb initiation in mice. Development  138, 4465-73.   https://doi.org/10.1242/dev.065359|2. Naiche LA, Arora R, Kania A, Lewandoski M, Papaioannou VE (2011). Identity and fate of Tbx4-expressing cells reveal developmental cell fate decisions in the allantois, limb, and external genitalia. Dev Dyn  240, 2290-300.   https://doi.org/10.1002/dvdy.22731|3. Zhang Z, O'Rourke JR, McManus MT, Lewandoski M, Harfe BD, Sun X (2011). The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning. Dev Biol  351, 254-65.   https://doi.org/10.1016/j.ydbio.2011.01.005",https://intramural.nih.gov/search/searchview.taf?ipid=73374
161,BC010523-10,"October 01, 2011 -  September 30, 2012",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Martin  Zofall|Ke  Zhang|Francisca Eugenia Reyes Turcu|Namhoon  Lee|Sameet Satish Mehta; PhD|Soichiro  Yamanaka|Show all 8,NULL,Peter C Fitzgerald (Office of the Director)|Timothy D Veenstra (Office Of The Director)|Ming  Zhou (Nucleic Acids Section),NULL,"1. Reyes-Turcu FE, Zhang K, Zofall M, Chen E, Grewal SI (2011). Defects in RNA quality control factors reveal RNAi-independent nucleation of heterochromatin. Nat Struct Mol Biol  18, 1132-8.   https://doi.org/10.1038/nsmb.2122|2. Zhang K, Fischer T, Porter RL, Dhakshnamoorthy J, Zofall M, Zhou M, Veenstra T, Grewal SI (2011). Clr4/Suv39 and RNA quality control factors cooperate to trigger RNAi and suppress antisense RNA. Science  331, 1624-7.   https://doi.org/10.1126/science.1198712",https://intramural.nih.gov/search/searchview.taf?ipid=73190
162,BC010524-10,"October 01, 2011 -  September 30, 2012",HIV Integrase Modeling and Computer-Aided Inhibitor Development,Marc C Nicklaus|IRP Faculty Profile,Joel Patrick Schneider; PhD,"Chemical Biology Laboratory, NCI",Chenzhong  Liao|Alexey Vladimirovich Zakharov; PhD|Laura  Guasch Pamies|Terrence R Burke; PhD,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Chenzhong  Liao",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Liao C, Sitzmann M, Pugliese A, Nicklaus MC (2011). Software and resources for computational medicinal chemistry. Future Med Chem  3, 1057-85.   https://doi.org/10.4155/fmc.11.63",https://intramural.nih.gov/search/searchview.taf?ipid=73370
163,BC010525-10,"October 01, 2011 -  September 30, 2012",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Sarfraz A Memon|Francis  Flomerfelt; PhD|Philip J Lucas; PhD|Catherine Virginia Bare|Jiun  Wang|Kevin  Chua|Show all 8,NULL,Alfred  Singer; MD (Lymphocyte Development Section)|Richard J Hodes; MD (Immune Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Joy A Williams (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73343
164,BC010530-10,"October 01, 2011 -  September 30, 2012",Molecular Therapeutics for HIVAIDS,Dean H. Hamer; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",NULL,Laurel  Lagenaur; PhD|Dominik  Wodarz (U C Irvine),NULL,NULL,"1. Lagenaur LA, Lee PP, Hamer DH, Sanders-Beer BE (2011). Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques. Res Microbiol  162, 1006-10.   https://doi.org/10.1016/j.resmic.2011.08.003|2. Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y, Yu R, Venzon D, Lee PP, Hamer DH (2011). Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol  4, 648-57.   https://doi.org/10.1038/mi.2011.30",https://intramural.nih.gov/search/searchview.taf?ipid=73344
165,BC010538-10,"October 01, 2011 -  September 30, 2012",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Diane  Palmieri|Brunilde M Gril|Emily  Hua|Devin  Matthews|Ladawn Tiffany Reed|Stephan  Woditschka; PhD,"Andreas  Stark (University of Schleswig-Holstein Medical Center)|Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Paul  Lockman (Texas Tech University)|Renata  Duchnowska (Military Institute of Medicine,)|Jacek  Jassem (Medical University of Gdansk)|Maximillian  Murone (Debio Pharmaceuticals)|Show all 9",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Jo Anne N Zujewski (Clinical Investigations Branch)|Maria  Merino; PhD (Laboratory of Pathology)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, Chou CY, Lu Z, Xie K, Huang S (2011). Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res  71, 4932-43.   https://doi.org/10.1158/0008-5472.CAN-10-4249|2. Fitzgerald DP, Subramanian P, Deshpande M, Graves C, Gordon I, Qian Y, Snitkovsky Y, Liewehr DJ, Steinberg SM, Paltán-Ortiz JD, Herman MM, Camphausen K, Palmieri D, Becerra SP, Steeg PS (2012). Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage. Cancer Res  72, 144-53.   https://doi.org/10.1158/0008-5472.CAN-11-1904|3. Gril B, Palmieri D, Qian Y, Anwar T, Ileva L, Bernardo M, Choyke P, Liewehr DJ, Steinberg SM, Steeg PS (2011). The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models. PLoS One  6, e25625.   https://doi.org/10.1371/journal.pone.0025625|4. Gril B, Palmieri D, Qian Y, Smart D, Ileva L, Liewehr DJ, Steinberg SM, Steeg PS (2011). Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis. Clin Cancer Res  17, 142-53.   https://doi.org/10.1158/1078-0432.CCR-10-1603|5. McGowan PM, Simedrea C, Ribot EJ, Foster PJ, Palmieri D, Steeg PS, Allan AL, Chambers AF (2011). Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. Mol Cancer Res  9, 834-44.   https://doi.org/10.1158/1541-7786.MCR-10-0457|6. Ribot EJ, Martinez-Santiesteban FM, Simedrea C, Steeg PS, Chambers AF, Rutt BK, Foster PJ (2011). In vivo single scan detection of both iron-labeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5 T. J Magn Reson Imaging  34, 231-8.   https://doi.org/10.1002/jmri.22593|7. Taskar KS, Rudraraju V, Mittapalli RK, Samala R, Thorsheim HR, Lockman J, Gril B, Hua E, Palmieri D, Polli JW, Castellino S, Rubin SD, Lockman PR, Steeg PS, Smith QR (2012). Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Pharm Res  29, 770-81.   https://doi.org/10.1007/s11095-011-0601-8",https://intramural.nih.gov/search/searchview.taf?ipid=73367
166,BC010539-10,"October 01, 2011 -  September 30, 2012",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Robert  Tuskan|Georgette Nicole Jones; PhD|Min-Hyung  Lee; PhD|Kelly Lee Haas|Colin W Platt,Karl  Broman (University of Michigan)|David  Gutmann (Washington University)|Joshua  Rubin (Washington University)|Mark  Ellisman (UCSD)|Keiko  Akagi (NCI)|Melissa  Bondy (MD Anderson)|Show all 7,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Uma  Shankavaram; PhD (Radiation Oncology Branch)","John Keenam Park (NINDS) |Thanh truc B Huynh (NICHD) |Karel  Pacak; MD, PhD (NICHD)","1. Amlin-Van Schaick J, Kim S, Broman KW, Reilly KM (2012). Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. Mamm Genome  23, 277-85.   https://doi.org/10.1007/s00335-011-9380-0",https://intramural.nih.gov/search/searchview.taf?ipid=73360
167,BC010540-10,"October 01, 2011 -  September 30, 2012",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Robert  Tuskan|Min-Hyung  Lee; PhD|Kelly Lee Haas,David  Gutmann (Washington University)|Joshua  Rubin (Washington University),NULL,NULL,"1. Gürsel DB, Connell-Albert YS, Tuskan RG, Anastassiadis T, Walrath JC, Hawes JJ, Amlin-Van Schaick JC, Reilly KM (2011). Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies. Neuro Oncol  13, 610-21.   https://doi.org/10.1093/neuonc/nor035",https://intramural.nih.gov/search/searchview.taf?ipid=73361
168,BC010541-10,"October 01, 2011 -  September 30, 2012",Development of Mouse Astrocytoma Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Robert  Tuskan|Kelly Lee Haas|Colin W Platt|Terry Anne Van Dyke,"David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|Roger  Packer (CNMC)|Yetrib  Hathout",Brigitte  Widemann; MD (Pediatric Oncology Branch)|John A Beutler (Molecular Targets Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Thomas J Turbyville (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory)|James  McMahon; PhD (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73359
169,BC010547-10,"October 01, 2011 -  September 30, 2012",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau|Douglas K Price|Bamidele  Adesunloye|Xuan  Huang; MD, PhD|Kelie M Reece; PhD|Emily  Richardson|Show all 10",Jeanny  AragonChing (George Washington University)|Romano  Danesi|Min Hee Kang|Mark  Ratain (University of Chicago)|Christopher  Schofield (University of Oxford)|Ian Abban Thompson; MD|Show all 8,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|John J Wright (Investigational Drug Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)",Clara Chi Chen; MD (CC),"1. Campbell TJ, Tindall DJ, Figg WD (2012). Dihydrotestosterone synthesis from adrenal precursors does not involve testosterone in castration-resistant prostate cancer. Cancer Biol Ther  13, 237-8.   https://doi.org/10.4161/cbt.19608|2. Figg W, Chau C (2011) Investments in Prostate Cancer Research are Starting to Pay Off. Pharmacy Practice News 40.|3. Figg WD, Figg WD (2010). Cabazitaxel: filling one of the gaps in the treatment of prostate cancer. Cancer Biol Ther  10, 1233-4.   https://doi.org/10.4161/cbt.10.12.14085|4. Pressler H, Sissung TM, Venzon D, Price DK, Figg WD (2011). Expression of OATP family members in hormone-related cancers: potential markers of progression. PLoS One  6, e20372.   https://doi.org/10.1371/journal.pone.0020372|5. Sissung TM, Pressler H, Price DK, Figg WD (2011). SLCO transport genes in prostate cancer--letter. Cancer Epidemiol Biomarkers Prev  20, 2325; author reply 2326-7.   https://doi.org/10.1158/1055-9965.EPI-11-0606|6. Spencer S, Marini B, Figg W (2012) Novel Concepts in Pharmacotherapy of Skeletal-Related Events in Metastatic Castrate Resistant Prostate Cancer. Anticancer Research, in press.|7. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762",https://intramural.nih.gov/search/searchview.taf?ipid=73342
170,BC010549-10,"October 01, 2011 -  September 30, 2012",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Robert R West|Heather R Shive|Champa Damayanthi Golden,NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73191
171,BC010561-09,"October 01, 2011 -  September 30, 2012",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova|Waltraud  Mueller|Tatsuya  Morisaki|Ronit  Salomon|Sourav  Ganguly,David  Auble (Univ. Virginia)|Jason  Lieb (University North Carolina),NULL,NULL,"1. Kuipers MA, Stasevich TJ, Sasaki T, Wilson KA, Hazelwood KL, McNally JG, Davidson MW, Gilbert DM (2011). Highly stable loading of Mcm proteins onto chromatin in living cells requires replication to unload. J Cell Biol  192, 29-41.   https://doi.org/10.1083/jcb.201007111|2. Maiuri P, Knezevich A, De Marco A, Mazza D, Kula A, McNally JG, Marcello A (2011). Fast transcription rates of RNA polymerase II in human cells. EMBO Rep  12, 1280-5.   https://doi.org/10.1038/embor.2011.196",https://intramural.nih.gov/search/searchview.taf?ipid=73398
172,BC010562-09,"October 01, 2011 -  September 30, 2012",Molecular Interaction Maps and Analysis of Bioregulatory Networks,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Geoffrey B Mcfadden|Koichi  Utani|Yves  Pommier; PhD|Kurt  Kohn; PhD,NULL,NULL,NULL,"1. Luna A, Karac EI, Sunshine M, Chang L, Nussinov R, Aladjem MI, Kohn KW (2011). A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method. BMC Bioinformatics  12, 167.   https://doi.org/10.1186/1471-2105-12-167|2. Luna A, Sunshine ML, van Iersel MP, Aladjem MI, Kohn KW (2011). PathVisio-MIM: PathVisio plugin for creating and editing Molecular Interaction Maps (MIMs). Bioinformatics  27, 2165-6.   https://doi.org/10.1093/bioinformatics/btr336",https://intramural.nih.gov/search/searchview.taf?ipid=73380
173,BC010565-09,"October 01, 2011 -  September 30, 2012",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,"1. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res  9, 418-29.   https://doi.org/10.1158/1541-7786.MCR-10-0511|2. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|3. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=73387
174,BC010566-09,"October 01, 2011 -  September 30, 2012",Tumor and Metastasis Biology,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Ling  Ren|Anita C Epps|Michael Mark Lizardo; PhD|Lee Jay Helman; MD,"Aykut  Uren (Georgetown University Medical Center)|Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Danny  Welch (Department of Pathology, University of Alabama, Birmingham)","Timothy D Veenstra (Office Of The Director)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A (2012). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene  31, 269-81.   https://doi.org/10.1038/onc.2011.245",https://intramural.nih.gov/search/searchview.taf?ipid=73394
175,BC010578-09,"October 01, 2011 -  September 30, 2012",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Amit Madhulal Chaudhary|Lihong  Xu; PhD|Christopher William Larrimore|Mary B Hilton,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Yang MY, Chaudhary A, Seaman S, Dunty J, Stevens J, Elzarrad MK, Frankel AE, St Croix B (2011). The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim Biophys Acta  1813, 39-49.   https://doi.org/10.1016/j.bbamcr.2010.11.013",https://intramural.nih.gov/search/searchview.taf?ipid=73194
176,BC010579-09,"October 01, 2011 -  September 30, 2012",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Alexander G Papageorge|William C Vass|John  Schiller; PhD|Christopher  Buck,NULL,Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,"1. Buck CB, Lowy DR (2011). Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease. J Clin Oncol  29, 1506-8.   https://doi.org/10.1200/JCO.2010.34.0745|2. Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R, CVT Group (2011). Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis  203, 910-20.   https://doi.org/10.1093/infdis/jiq139|3. Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group (2011). Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sex Transm Dis  38, 976-82.   https://doi.org/10.1097/OLQ.0b013e31822545c0|4. Herrero R, Wacholder S, Rodríguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A, Costa Rica Vaccine Trial Group (2011). Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov  1, 408-19.   https://doi.org/10.1158/2159-8290.CD-11-0131|5. Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA (2011). HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine  29, 2011-4.   https://doi.org/10.1016/j.vaccine.2011.01.001|6. Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, Hildesheim A, Herrero R, CVT Vaccine Group (2011). Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol  12, 862-70.   https://doi.org/10.1016/S1470-2045(11)70213-3|7. Mitsunaga M, Kosaka N, Kines RC, Roberts JN, Lowy DR, Schiller JT, Ishihara Y, Hasegawa A, Choyke PL, Kobayashi H (2011). In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system. Cancer Prev Res (Phila)  4, 767-73.   https://doi.org/10.1158/1940-6207.CAPR-10-0334|8. Roberts JN, Kines RC, Katki HA, Lowy DR, Schiller JT (2011). Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J Natl Cancer Inst  103, 737-43.   https://doi.org/10.1093/jnci/djr061",https://intramural.nih.gov/search/searchview.taf?ipid=73396
177,BC010580-09,"October 01, 2011 -  September 30, 2012",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen|Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R, Shih J, Camphausen K (2012). A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma. Cancer  118, 3607-13.   https://doi.org/10.1002/cncr.26659",https://intramural.nih.gov/search/searchview.taf?ipid=73378
178,BC010589-09,"October 01, 2011 -  September 30, 2012",Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen,NULL,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Johan W Van Der Veen; PhD (NIMH) |Joelle  Sarlls; PhD (NINDS)","1. Hipp SJ, Steffen-Smith E, Hammoud D, Shih JH, Bent R, Warren KE (2011). Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol  13, 904-9.   https://doi.org/10.1093/neuonc/nor076|2. Steffen-Smith EA, Shih JH, Hipp SJ, Bent R, Warren KE (2011). Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol  105, 365-73.   https://doi.org/10.1007/s11060-011-0601-x",https://intramural.nih.gov/search/searchview.taf?ipid=73376
179,BC010590-09,"October 01, 2011 -  September 30, 2012",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Susan  Blaney (Baylor University/TCCC)|Roger  Packer (CNMC)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|James  Boyett (St Jude Children's Research Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)",NULL,NULL,"1. Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE (2012). A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. J Neurooncol  106, 643-9.   https://doi.org/10.1007/s11060-011-0709-z",https://intramural.nih.gov/search/searchview.taf?ipid=73377
180,BC010591-09,"October 01, 2011 -  September 30, 2012",Characterization of Xenograft Models of Childhood Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Xinyu  Wen|Jianbin Na He|Hongling  Liao|Carol J Thiele|Show all 7,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,"1. Gonzalez-Bosquet J, Calcei J, Wei JS, Garcia-Closas M, Sherman ME, Hewitt S, Vockley J, Lissowska J, Yang HP, Khan J, Chanock S (2011). Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One  6, e14522.   https://doi.org/10.1371/journal.pone.0014522|2. Tsang PS, Cheuk AT, Chen QR, Song YK, Badgett TC, Wei JS, Khan J (2012). Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma. BMC Cancer  12, 101.   https://doi.org/10.1186/1471-2407-12-101",https://intramural.nih.gov/search/searchview.taf?ipid=73392
181,BC010592-09,"October 01, 2011 -  September 30, 2012",Comparative Genomic Hybridization of Neuroblastoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Xinyu  Wen|Hongling  Liao|Rajesh  Patidar,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Daniel  Catchpoole (The Children's Hospital at Westmead)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73393
182,BC010595-09,"October 01, 2011 -  September 30, 2012",Structure and Function of APOBEC3 Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jessica  Smith|Ryan C Burdick|Ariel Nicole Hagedorn|Wei-Shau  Hu; PhD,Jean L Mbisa (NCI)|Yoshio  Koyanagi|Kei  Sato (Kyoto University)|Joseph  Wedekind (University of Rochester Medical Center)|Yong  Xiong (Yale University),Robert  Gorelick (Office Of The Director)|Andrew G Stephen (Office Of The Director)|Terrence R Burke; PhD (Chemical Biology Laboratory),James  Inglese (NCATS) |Scott E Martin (NCATS),"1. Pak V, Heidecker G, Pathak VK, Derse D (2011). The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. J Virol  85, 8538-47.   https://doi.org/10.1128/JVI.02645-10",https://intramural.nih.gov/search/searchview.taf?ipid=73401
183,BC010598-09,"October 01, 2011 -  September 30, 2012",Human Immune Responses to Tumor Antigens for Cancer Vaccine Development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jianping  Huang|Benedetto Paolo Farsaci; PhD|Sofia Ribeiro Gameiro|Romaine Ingrid Fernando|Alessandra  Jales|Renee Nicole Donahue|Show all 11,"Douglas  McNeel (University of Wisconsin)|David  Apelian (GlobeImmune, Inc.)",NULL,NULL,"1. Cereda V, Vergati M, Huen NY, di Bari MG, Jochems C, Intrivici C, Gulley JL, Apelian D, Schlom J, Tsang KY (2011). Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine  29, 4992-9.   https://doi.org/10.1016/j.vaccine.2011.04.101|2. Jochems C, Schlom J (2011). Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood)  236, 567-79.   https://doi.org/10.1258/ebm.2011.011007|3. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, Palena C (2012). Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res  18, 3868-79.   https://doi.org/10.1158/1078-0432.CCR-11-3211|4. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9|5. Vergati M, Schlom J, Tsang KY (2011). The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. J Biomed Biotechnol  2011, 182413.   https://doi.org/10.1155/2011/182413",https://intramural.nih.gov/search/searchview.taf?ipid=73192
184,BC010600-09,"October 01, 2011 -  September 30, 2012",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73379
185,BC010607-09,"October 01, 2011 -  September 30, 2012",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin|Benjamin Naylor Barrett,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),Alan Paul Koretsky; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73391
186,BC010612-09,"October 01, 2011 -  September 30, 2012",The Role of miRNA-mediated RNAI in the Biology of Cancer,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Tamara L Jones|Joshua Nazeer Omade|Suntae  Kim","Siegfried  Janz (University of Iowa)|Carol L Prives|Matthias  Wabl (Dept Microbiology and Immunology, UCSF)","Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)",NULL,"1. Huppi K, Pitt J, Wahlberg B, Caplen NJ (2011). Genomic instability and mouse microRNAs. Toxicol Mech Methods  21, 325-33.   https://doi.org/10.3109/15376516.2011.562759|2. Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, Caplen NJ (2011). Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res Treat  130, 663-79.   https://doi.org/10.1007/s10549-011-1690-0",https://intramural.nih.gov/search/searchview.taf?ipid=73410
187,BC010613-09,"October 01, 2011 -  September 30, 2012",The Induction of Gene-specific RNAi Against Cancer-associated Genes,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Tamara L Jones|Lihui  Ou; PhD|Suntae  Kim|Sirisha  Chakka|Karl Thomas Ried; MD","Eric  Lader (Gene Silencing, Qiagen Inc.)|John  Weinstein (MD Anderson)|Amanda  Hummon","Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Stefan  Ambs (Laboratory of Human Carcinogenesis)",NULL,"1. Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, Caplen NJ (2011). Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res Treat  130, 663-79.   https://doi.org/10.1007/s10549-011-1690-0|2. Martin SE, Wu ZH, Gehlhaus K, Jones TL, Zhang YW, Guha R, Miyamoto S, Pommier Y, Caplen NJ (2011). RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors. Curr Cancer Drug Targets  11, 976-86.   https://doi.org/10.2174/156800911797264734",https://intramural.nih.gov/search/searchview.taf?ipid=73411
188,BC010615-09,"October 01, 2011 -  September 30, 2012",RNAi Screening for the Systematic Discovery of Cancer Gene Function,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Tamara L Jones|Lihui  Ou; PhD|Suntae  Kim|Sirisha  Chakka|Karl Thomas Ried; MD","Eric  Lader (Gene Silencing, Qiagen Inc.)|Patrick  Grohar","Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)","Christopher P Austin; AB, MD (NCATS) |Scott E Martin (NCATS)","1. Martin SE, Wu ZH, Gehlhaus K, Jones TL, Zhang YW, Guha R, Miyamoto S, Pommier Y, Caplen NJ (2011). RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors. Curr Cancer Drug Targets  11, 976-86.   https://doi.org/10.2174/156800911797264734",https://intramural.nih.gov/search/searchview.taf?ipid=73412
189,BC010620-09,"October 01, 2011 -  September 30, 2012",Clinical Studies to Circumvent Drug Resistance,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey|Andrea R Eisch|Christine M Bryla|Antonio  Fojo; MD, PhD|William D Figg; PharmD","Thomas  Litman (University of Copenhagen)|Wilfred  Stein (Hebrew University, Jerusalem)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Jo Anne N Zujewski (Clinical Investigations Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch),Clara Chi Chen; MD (CC) |Robert  Innis; MD (NIMH),"1. Fojo T, Amiri-Kordestani L, Bates SE (2011). Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer. J Natl Cancer Inst  103, 1738-40.   https://doi.org/10.1093/jnci/djr386|2. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|3. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762|4. Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE (2011). The controversial role of ABC transporters in clinical oncology. Essays Biochem  50, 209-32.   https://doi.org/10.1042/bse0500209",https://intramural.nih.gov/search/searchview.taf?ipid=73383
190,BC010621-09,"October 01, 2011 -  September 30, 2012",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Robert W Robey|Victoria  Luchenko|Arup Ratan Chakraborty|Andrea R Eisch|Christine M Bryla|Agnes Marie Therese Basseville|Show all 10,"Stefania  Scala (Clinical Immunology, National Cancer Institute, G. Pascale Foundation)|Thomas  Litman (University of Copenhagen)","Patricia A Fetsch (Laboratory of Pathology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Maria L Turner; MD (Dermatology Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Danny L Sackett; PhD (NICHD) |Douglas R Rosing; MD (NHLBI) |Alexander  Ling (CC),"1. Luchenko VL, Salcido CD, Zhang Y, Agama K, Komlodi-Pasztor E, Murphy RF, Giaccone G, Pommier Y, Bates SE, Varticovski L (2011). Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer. Cell Cycle  10, 3119-28.   https://doi.org/10.4161/cc.10.18.17190|2. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|3. Robey RW, Chakraborty AR, Basseville A, Luchenko V, Bahr J, Zhan Z, Bates SE (2011). Histone deacetylase inhibitors: emerging mechanisms of resistance. Mol Pharm  8, 2021-31.   https://doi.org/10.1021/mp200329f|4. Sissung TM, Gardner ER, Piekarz RL, Howden R, Chen X, Woo S, Franke R, Clark JA, Miller-DeGraff L, Steinberg SM, Venzon D, Liewehr D, Kleeberger SR, Bates SE, Price DK, Rosing DR, Cabell C, Sparreboom A, Figg WD (2011). Impact of ABCB1 allelic variants on QTc interval prolongation. Clin Cancer Res  17, 937-46.   https://doi.org/10.1158/1078-0432.CCR-10-0925|5. Sissung TM, Troutman SM, Campbell TJ, Pressler HM, Sung H, Bates SE, Figg WD (2012). Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. Discov Med  13, 19-34.",https://intramural.nih.gov/search/searchview.taf?ipid=73381
191,BC010622-09,"October 01, 2011 -  September 30, 2012",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Robert W Robey|Agnes Marie Therese Basseville|William D Figg; PharmD,"Balazs  Sarkadi (Dept Cell Metabolism, National Insitute of Hematology and Immunology)|Thomas  Litman (University of Copenhagen)|Hendrik  van Veen (Department of Pharmacology, University of Cambridge)|Alex  Sparreboom","Michael  Dean; PhD (Laboratory of Experimental Immunology)|Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Patricia A Fetsch (Laboratory of Pathology)|Curtis  Henrich (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",NULL,"1. Arnaud O, Boumendjel A, Gèze A, Honorat M, Matera EL, Guitton J, Stein WD, Bates SE, Falson P, Dumontet C, Di Pietro A, Payen L (2011). The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. Eur J Cancer  47, 640-8.   https://doi.org/10.1016/j.ejca.2010.11.019|2. Basseville A, Bates SE (2011). Gout, genetics and ABC transporters. F1000 Biol Rep  3, 23.   https://doi.org/10.3410/B3-23|3. Robey RW, Ierano C, Zhan Z, Bates SE (2011). The challenge of exploiting ABCG2 in the clinic. Curr Pharm Biotechnol  12, 595-608.   https://doi.org/10.2174/138920111795163913|4. Shi Z, Tiwari AK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng X, Abraham I, Ambudkar SV, Talele TT, Fu LW, Chen ZS (2011). Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res  71, 3029-41.   https://doi.org/10.1158/0008-5472.CAN-10-3820|5. Versiani MA, Diyabalanage T, Ratnayake R, Henrich CJ, Bates SE, McMahon JB, Gustafson KR (2011). Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2. J Nat Prod  74, 262-6.   https://doi.org/10.1021/np100797y",https://intramural.nih.gov/search/searchview.taf?ipid=73382
192,BC010624-09,"October 01, 2011 -  September 30, 2012",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Atsushi  Terunuma|Adrienne Michelle Starks,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Johns Hopkins University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Bernhard  KwabiAddo (Howard University)|Feng  WangJohanning (University of Texas MD Anderson Cancer Center)",NULL,NULL,"1. Wallace TA, Martin DN, Ambs S (2011). Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis  32, 1107-21.   https://doi.org/10.1093/carcin/bgr066|2. Zhao J, Rycaj K, Geng S, Li M, Plummer JB, Yin B, Liu H, Xu X, Zhang Y, Yan Y, Glynn SA, Dorsey TH, Ambs S, Johanning GL, Gu L, Wang-Johanning F (2011). Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer. Genes Cancer  2, 914-22.   https://doi.org/10.1177/1947601911431841",https://intramural.nih.gov/search/searchview.taf?ipid=73404
193,BC010625-09,"October 01, 2011 -  September 30, 2012",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Shana Y Trostel|Susan  Bates; MD|William D Figg; PharmD|Andrea Borghese Apolo,NULL,Yvona  Ward; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),Danny L Sackett; PhD (NICHD),"1. Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T (2011). Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol  8, 244-50.   https://doi.org/10.1038/nrclinonc.2010.228|2. Murphy RF, Komlodi-Pasztor E, Robey R, Balis FM, Farrell NP, Fojo T (2012) Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin. Cell Cycle 11:963-73|3. Sackett DL, Fojo T (2011). Taccalonolides: a microtubule stabilizer poses a new puzzle with old pieces. Cell Cycle  10, 3233-4.   https://doi.org/10.4161/cc.10.19.17126",https://intramural.nih.gov/search/searchview.taf?ipid=73385
194,BC010626-09,"October 01, 2011 -  September 30, 2012","Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer","Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn Ann J Mickley|Marianne  Poruchynsky|Julia  Wilkerson|Susan  Bates; MD|Samuel A Wells|Ann Wild Gramza,NULL,Richard Lawrence Piekarz (Investigational Drug Branch)|Electron  Kebebew; MD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David  Schrump; MD (Surgery Branch),"Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC) |Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD)","1. Datrice NM, Langan RC, Ripley RT, Kemp CD, Steinberg SM, Wood BJ, Libutti SK, Fojo T, Schrump DS, Avital I (2012). Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol  105, 709-13.   https://doi.org/10.1002/jso.23015|2. Fonte JS, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, Mercado-Asis LB, Adams KT, Martucci V, Fojo T, Pacak K (2012). False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer  19, 83-93.   https://doi.org/10.1530/ERC-11-0243|3. King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K (2011). Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol  29, 4137-42.   https://doi.org/10.1200/JCO.2011.34.6353|4. Martiniova L, Perera SM, Brouwers FM, Alesci S, Abu-Asab M, Marvelle AF, Kiesewetter DO, Thomasson D, Morris JC, Kvetnansky R, Tischler AS, Reynolds JC, Fojo AT, Pacak K (2011). Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors. Endocr Relat Cancer  18, 143-57.   https://doi.org/10.1677/ERC-10-0090|5. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E (2011). MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer  117, 1630-9.   https://doi.org/10.1002/cncr.25724|6. Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK, Steinberg SM, Wood BJ, Kammula US, Fojo T, Avital I (2011). Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol  18, 1972-9.   https://doi.org/10.1245/s10434-011-1564-z",https://intramural.nih.gov/search/searchview.taf?ipid=73526
195,BC010627-09,"October 01, 2011 -  September 30, 2012",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Alesia J Holly|Tristan  Sissung|Stephen T Pisle|Heather M Pressler|Cody John Peer|Sarah M Troutman|Show all 7,Romano  Danesi|Alex  Sparreboom|John F Deeken|Michael  Pacanowski (FDA),Susan  Bates; MD (Medical Oncology Branch)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Heidi H Kong (Dermatology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch),NULL,"1. Gao R, Reece K, Sissung T, Reed E, Price DK, Figg WD (2011). The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity. Mutat Res  708, 21-7.   https://doi.org/10.1016/j.mrfmmm.2011.01.002|2. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|3. Sissung TM, Danesi R, Kirkland CT, Baum CE, Ockers SB, Stein EV, Venzon D, Price DK, Figg WD (2011). Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J Clin Endocrinol Metab  96, E368-72.   https://doi.org/10.1210/jc.2010-2070|4. Sissung TM, Gardner ER, Piekarz RL, Howden R, Chen X, Woo S, Franke R, Clark JA, Miller-DeGraff L, Steinberg SM, Venzon D, Liewehr D, Kleeberger SR, Bates SE, Price DK, Rosing DR, Cabell C, Sparreboom A, Figg WD (2011). Impact of ABCB1 allelic variants on QTc interval prolongation. Clin Cancer Res  17, 937-46.   https://doi.org/10.1158/1078-0432.CCR-10-0925|5. Sissung TM, Pressler H, Price DK, Figg WD (2011). SLCO transport genes in prostate cancer--letter. Cancer Epidemiol Biomarkers Prev  20, 2325; author reply 2326-7.   https://doi.org/10.1158/1055-9965.EPI-11-0606|6. Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin ME, Oh WK, Lee GS, Kantoff PW (2011). SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol  29, 2565-73.   https://doi.org/10.1200/JCO.2010.31.2405",https://intramural.nih.gov/search/searchview.taf?ipid=73384
196,BC010629-09,"October 01, 2011 -  September 30, 2012",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI",NULL,Alison  O'Brien (USUHS)|Stefan  Schtze (Institut fr Immunologie),Susan H Garfield (Laboratory of Experimental Carcinogenesis)|Timothy D Veenstra (Office Of The Director),Alan  Sher; PhD (NIAID),"1. Fujita K, Maeda D, Xiao Q, Srinivasula SM (2011). Nrf2-mediated induction of p62 controls Toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation. Proc Natl Acad Sci U S A  108, 1427-32.   https://doi.org/10.1073/pnas.1014156108|2. Fujita K, Srinivasula SM (2011). TLR4-mediated autophagy in macrophages is a p62-dependent type of selective autophagy of aggresome-like induced structures (ALIS). Autophagy  7, 552-4.   https://doi.org/10.4161/auto.7.5.15101",https://intramural.nih.gov/search/searchview.taf?ipid=73193
197,BC010632-09,"October 01, 2011 -  September 30, 2012",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Yan Ning H Zhou|Carolyn B McGill|Cedric Nicolas Lionel Cagliero|Pengfei  Guo|Sicong  Wang,Justin  O'Sullivan (University of Auckland)|Jie  Xiao (Johns Hopkins Universtity),Xinhua  Ji; PhD (Biomolecular Structure Section)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Jin DJ, Cagliero C, Zhou YN (2012). Growth rate regulation in Escherichia coli. FEMS Microbiol Rev  36, 269-87.   https://doi.org/10.1111/j.1574-6976.2011.00279.x|2. Jin DJ, Zhou YN, Shaw G, Ji X (2011). Structure and function of RapA: a bacterial Swi2/Snf2 protein required for RNA polymerase recycling in transcription. Biochim Biophys Acta  1809, 470-5.   https://doi.org/10.1016/j.bbagrm.2011.03.003",https://intramural.nih.gov/search/searchview.taf?ipid=73390
198,BC010638-09,"October 01, 2011 -  September 30, 2012",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Valentina  Factor|Tanya N Hoang|Daekwan  Seo; PhD, MS, BA|Jesper B Andersen; PhD|Mitsuteru  Kitade",Jens Uwe Marquardt|Aranzazu  Sanchezmunoz (Complutense University of Madrid),Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,"1. Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, Nikitin AY (2011). Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A  108, 14240-5.   https://doi.org/10.1073/pnas.1017536108|2. Ishikawa T, Factor VM, Marquardt JU, Raggi C, Seo D, Kitade M, Conner EA, Thorgeirsson SS (2012). Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology  55, 1215-26.   https://doi.org/10.1002/hep.24796",https://intramural.nih.gov/search/searchview.taf?ipid=73375
199,BC010646-09,"October 01, 2011 -  September 30, 2012",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Diana  Stavreva|Rodney Louis Schiltz; PhD|Stephanie  Morris|Songjoon  Baek,Dafna  Benayahu (Sackler School of Medicine Tel Aviv University)|Montse  SanchezCespedes (PEBC Bellvitge Biomedical Research),NULL,NULL,"1. Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M (2012). The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med  4, 603-16.   https://doi.org/10.1002/emmm.201200236",https://intramural.nih.gov/search/searchview.taf?ipid=73386
200,BC010647-08,"October 01, 2011 -  September 30, 2012",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Terrence R Burke; PhD (Chemical Biology Laboratory)|Crystal L. Mackall; MD (Pediatric Oncology Branch),Rose G Mage; PhD (NIAID) |Paul T Wingfield; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73428
201,BC010648-08,"October 01, 2011 -  September 30, 2012","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Steven  Pavletic; MD, MS","DANIEL  LEAHY (Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine)|Jeffrey A. Medin; PhD (University of Toronto)|NICHOLAS  CHIORAZZI (The Feinstein Institute for Medical Research)|JOHN  BYRD (The Ohio State University)|Stanley R Riddell (Fred Hutchinson Cancer Research Center)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Ira H Pastan; MD (Molecular Biology Section)|Alan S Wayne; MD (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73429
202,BC010649-08,"October 01, 2011 -  September 30, 2012",Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer,Udai S Kammula,NULL,"Surgery Branch, NCI",Biman  Paria|Smita Sarat Chandran,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)",Francesco M. Marincola; MD (CC),"1. Wang A, Chandran S, Shah S, Chiu Y, Paria B, Aghamolla T, AlvarezDowining M, Lee C, Singh S, Li T, Dudley M, Restifo N, Rosenberg S, Kammula U (2012) The stoichiometric production of IL-2 and IFN-#947; mRNA defines memory T cells that can self renew after adoptive transfer in humans. Science Translational Medicine 4:1-13.",https://intramural.nih.gov/search/searchview.taf?ipid=73420
203,BC010652-08,"October 01, 2011 -  September 30, 2012",Lipid-based Nanocapsules and Triggered Chemotherapy,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Anu  Puri; PhD|Yossef  Raviv|Mathias  Viard|Kshitij  Gupta|Abdul  Akram|Jessica Lynn Sine|Show all 10,Paul  Wang|Angela  Hight Walker|Sara  Grinberg (Ben Gurion University)|Jeeseong  Hwang (NIST)|Michael  Nantz (University of Louisville),Joseph John Barchi (Chemical Biology Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Stephen J Lockett; PhD (Office Of The Director)|Timothy D Veenstra (Office Of The Director)|Scott E McNeil (Office Of The Director)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Bradford J Wood; MD (CC),"1. Colantonio S, Simpson JT, Fisher RJ, Yavlovich A, Belanger JM, Puri A, Blumenthal R (2011). Quantitative analysis of phospholipids using nanostructured laser desorption ionization targets. Lipids  46, 469-77.   https://doi.org/10.1007/s11745-010-3493-1|2. Puri A, Blumenthal R (2011). Polymeric lipid assemblies as novel theranostic tools. Acc Chem Res  44, 1071-9.   https://doi.org/10.1021/ar2001843|3. Puri A, Jang H, Yavlovich A, Masood MA, Veenstra TD, Luna C, Aranda-Espinoza H, Nussinov R, Blumenthal R (2011). Material properties of matrix lipids determine the conformation and intermolecular reactivity of diacetylenic phosphatidylcholine in the lipid bilayer. Langmuir  27, 15120-8.   https://doi.org/10.1021/la203453x|4. Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capala J, Blumenthal R, Puri A (2011). Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes). J Control Release  153, 187-94.   https://doi.org/10.1016/j.jconrel.2011.04.005|5. Yavlovich A, Singh A, Blumenthal R, Puri A (2011). A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells. Biochim Biophys Acta  1808, 117-26.   https://doi.org/10.1016/j.bbamem.2010.07.030",https://intramural.nih.gov/search/searchview.taf?ipid=73409
204,BC010654-08,"October 01, 2011 -  September 30, 2012",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Hisataka  Kobayashi|Marcelino  Bernardo|Ismail Baris Turkbey,NULL,Martin W Brechbiel; PhD (Radiation Oncology Branch),NULL,"1. Kobayashi H, Longmire MR, Ogawa M, Choyke PL (2011). Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev  40, 4626-48.   https://doi.org/10.1039/c1cs15077d|2. Longmire MR, Ogawa M, Choyke PL, Kobayashi H (2011). Biologically optimized nanosized molecules and particles: more than just size. Bioconjug Chem  22, 993-1000.   https://doi.org/10.1021/bc200111p",https://intramural.nih.gov/search/searchview.taf?ipid=73414
205,BC010655-08,"October 01, 2011 -  September 30, 2012",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi|Marcelino  Bernardo|Jamie M Bishop|Michael  Green|Ismail Baris Turkbey|Karen A Kurdziel; MD|Show all 18,Anwar  Padhani (Mt Vernon Hospital)|Yasuteru  Urano|Francois  Cornud (Hopital Neckers),William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology),"Bradford J Wood; MD (CC) |Thomas J Pohida; MS (CIT) |Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Bouchelouche K, Tagawa ST, Goldsmith SJ, Turkbey B, Capala J, Choyke P (2011). PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. Semin Nucl Med  41, 29-44.   https://doi.org/10.1053/j.semnuclmed.2010.08.005|2. Chen L, Choyke PL, Chan TH, Chi CY, Wang G, Wang Y (2011). Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors. IEEE Trans Med Imaging  30, 2044-58.   https://doi.org/10.1109/TMI.2011.2160276|3. Daar D, Bernardo M, Choyke PL, McKinney Y, Turkbey B (2011). Prostate multiparameter MR imaging. Radiol Technol  82, 563MR-8MR.|4. Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL (2011). Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med  65, 1400-6.   https://doi.org/10.1002/mrm.22874|5. Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H (2011). Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem  22, 1700-5.   https://doi.org/10.1021/bc2002715|6. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|7. Türkbey B, Aras Ö, Karabulut N, Turgut AT, Akpinar E, Alibek S, Pang Y, Ertürk ŞM, El Khouli RH, Bluemke DA, Choyke PL (2012). Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagn Interv Radiol  18, 46-59.   https://doi.org/10.4261/1305-3825.DIR.4708-11.2|8. Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2012). MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol  18, 34-45.   https://doi.org/10.4261/1305-3825.DIR.4478-11.1|9. Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL (2011). Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology  258, 488-95.   https://doi.org/10.1148/radiol.10100667|10. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging  11, 31-6.   https://doi.org/10.1102/1470-7330.2011.0007",https://intramural.nih.gov/search/searchview.taf?ipid=73415
206,BC010656-08,"October 01, 2011 -  September 30, 2012",Growth Factor Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Hisataka  Kobayashi|Marcelino  Bernardo|Jamie M Bishop|Karen A Kurdziel; MD|Mark  Williams|Show all 17,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331|2. Kobayashi H, Choyke PL (2012). Recipe for a new imaging biomarker: carefully combine target, reagent, and technology. Kidney Int  81, 129-31.   https://doi.org/10.1038/ki.2011.374|3. Kobayashi H, Longmire MR, Ogawa M, Choyke PL (2011). Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev  40, 4626-48.   https://doi.org/10.1039/c1cs15077d|4. Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH (2011). Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Eur J Cancer  47, 997-1005.   https://doi.org/10.1016/j.ejca.2010.12.016|5. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H (2011). Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med  17, 1685-91.   https://doi.org/10.1038/nm.2554|6. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2012). In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Cancer Res  14, R61.   https://doi.org/10.1186/bcr3167|7. Shin IS, Lee SM, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH (2011). Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody. Nucl Med Biol  38, 1119-27.   https://doi.org/10.1016/j.nucmedbio.2011.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=73416
207,BC010657-08,"October 01, 2011 -  September 30, 2012",Intracellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Hisataka  Kobayashi|Mark  Williams|Noriko  Sato; PhD|Takahito  Nakajima; PhD,NULL,NULL,NULL,"1. Choyke PL (2011). Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins? Radiology  260, 1-2.   https://doi.org/10.1148/radiol.11110740|2. Choyke PL (2012). Science to practice: imaging of cellular microparticles--magic dust or just dirt? Radiology  263, 1-2.   https://doi.org/10.1148/radiol.12120076|3. Kobayashi H, Choyke PL (2011). Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res  44, 83-90.   https://doi.org/10.1021/ar1000633|4. Kobayashi H, Choyke PL (2012). Recipe for a new imaging biomarker: carefully combine target, reagent, and technology. Kidney Int  81, 129-31.   https://doi.org/10.1038/ki.2011.374|5. McCann TE, Kosaka N, Koide Y, Mitsunaga M, Choyke PL, Nagano T, Urano Y, Kobayashi H (2011). Activatable optical imaging with a silica-rhodamine based near infrared (SiR700) fluorophore: a comparison with cyanine based dyes. Bioconjug Chem  22, 2531-8.   https://doi.org/10.1021/bc2003617|6. McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H (2011). Molecular imaging of tumor invasion and metastases: the role of MRI. NMR Biomed  24, 561-8.   https://doi.org/10.1002/nbm.1590|7. Mitsunaga M, Kosaka N, Kines RC, Roberts JN, Lowy DR, Schiller JT, Ishihara Y, Hasegawa A, Choyke PL, Kobayashi H (2011). In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system. Cancer Prev Res (Phila)  4, 767-73.   https://doi.org/10.1158/1940-6207.CAPR-10-0334|8. Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H (2011). Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem  22, 1700-5.   https://doi.org/10.1021/bc2002715|9. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2012). In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Cancer Res  14, R61.   https://doi.org/10.1186/bcr3167",https://intramural.nih.gov/search/searchview.taf?ipid=73417
208,BC010660-08,"October 01, 2011 -  September 30, 2012",The Molecular Profile of Prostate Tumors in Smokers,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73405
209,BC010661-08,"October 01, 2011 -  September 30, 2012",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Andressa  Ardiani|Anna Ruth Kwilas; PhD|Jeffrey  Schlom; PhD,"Alex  Franzusoff (Research and Development, GlobeImmune)|Soldano  Ferrone (University of Pittsburgh)",NULL,NULL,"1. Farsaci B, Higgins JP, Hodge JW (2012). Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy. Int J Cancer  130, 1948-59.   https://doi.org/10.1002/ijc.26219|2. Gameiro SR, Caballero JA, Higgins JP, Apelian D, Hodge JW (2011). Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses. Cancer Immunol Immunother  60, 1227-42.   https://doi.org/10.1007/s00262-011-1020-8|3. Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR (2012). The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin Oncol  39, 323-39.   https://doi.org/10.1053/j.seminoncol.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=73431
210,BC010666-08,"October 01, 2011 -  September 30, 2012",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Philip M Arlen; MD|Mary P Pazdur|Myrna B Rauckhorst|Bonnie L Casey|Sheri A Mcmahon|Jennifer L Marte|Show all 14,"Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Douglas  McNeel (University of Wisconsin)|Carsten Goessl  Goessl (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch),NULL,"1. Zhu W, Chau C, Gulley J, Dahut W, Figg W (2011) Immunomodulating Drugs for the Treatment of Prostate Cancer, in Immunomodulating Drugs for the Treatment of Cancer., pp. 239-252.|2. Gulley J (2011) New frontiers in therapy for metastatic prostate cancer (editorial). Drug Discov Today: Ther Strategies 10:743-53.|3. Gulley JL, Drake CG (2011). Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research. Clin Cancer Res  17, 3884-91.   https://doi.org/10.1158/1078-0432.CCR-10-2656|4. Gulley JL, Madan RA, Schlom J (2011). Impact of tumour volume on the potential efficacy of therapeutic vaccines. Curr Oncol  18, e150-7.   https://doi.org/10.3747/co.v18i3.783|5. Kim JW, Madan RA, Gulley JL (2012) Initial PSA oscillations precede prolonged stable disease in a patient treated with a therapeutic cancer vaccine. Clin Genitourin Cancer 10:43-6|6. Madan RA, Aragon-Ching JB, Gulley JL, Dahut WL (2011). From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev Vaccines  10, 743-53.   https://doi.org/10.1586/erv.11.70|7. Madan RA, Gulley JL (2011). Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer. Expert Rev Vaccines  10, 141-50.   https://doi.org/10.1586/erv.10.173|8. Madan RA, Gulley JL (2011). Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer. Immunotherapy  3, 27-31.   https://doi.org/10.2217/imt.10.77|9. May KF, Gulley JL, Drake CG, Dranoff G, Kantoff PW (2011). Prostate cancer immunotherapy. Clin Cancer Res  17, 5233-8.   https://doi.org/10.1158/1078-0432.CCR-10-3402|10. Mohebtash M, Tsang KY, Madan RA, Huen NY, Poole DJ, Jochems C, Jones J, Ferrara T, Heery CR, Arlen PM, Steinberg SM, Pazdur M, Rauckhorst M, Jones EC, Dahut WL, Schlom J, Gulley JL (2011). A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer. Clin Cancer Res  17, 7164-73.   https://doi.org/10.1158/1078-0432.CCR-11-0649|11. Smith HA, Maricque BB, Eberhardt J, Petersen B, Gulley JL, Schlom J, McNeel DG (2011). IgG responses to tissue-associated antigens as biomarkers of immunological treatment efficacy. J Biomed Biotechnol  2011, 454861.   https://doi.org/10.1155/2011/454861|12. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762|13. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9|14. Whiteside TL, Gulley JL, Clay TM, Tsang KY (2011). Immunologic monitoring of cellular immune responses in cancer vaccine therapy. J Biomed Biotechnol  2011, 370374.   https://doi.org/10.1155/2011/370374",https://intramural.nih.gov/search/searchview.taf?ipid=73430
211,BC010668-08,"October 01, 2011 -  September 30, 2012",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Marcelino  Bernardo|Michael  Green|Jurgen  Seidel; PhD|Karen A Kurdziel; MD|Mark  Williams|Show all 15,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Chen L, Chan TH, Choyke PL, Hillman EM, Chi CY, Bhujwalla ZM, Wang G, Wang SS, Szabo Z, Wang Y (2011). CAM-CM: a signal deconvolution tool for in vivo dynamic contrast-enhanced imaging of complex tissues. Bioinformatics  27, 2607-9.   https://doi.org/10.1093/bioinformatics/btr436|2. Chen L, Choyke PL, Chan TH, Chi CY, Wang G, Wang Y (2011). Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors. IEEE Trans Med Imaging  30, 2044-58.   https://doi.org/10.1109/TMI.2011.2160276|3. Kobayashi H, Choyke PL (2012). Recipe for a new imaging biomarker: carefully combine target, reagent, and technology. Kidney Int  81, 129-31.   https://doi.org/10.1038/ki.2011.374",https://intramural.nih.gov/search/searchview.taf?ipid=73413
212,BC010670-08,"October 01, 2011 -  September 30, 2012",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Sanjeewani T Palayoor|Molykutty J Aryankalayil|Adeola Yetunde Makinde,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University),James B Mitchell; PhD (Radiation Biology Branch)|Sunghan  Yoo (Molecular Radiation Therapeutics Branch),NULL,"1. John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB, Falduto MT, Magnuson SR, Coleman CN (2012). Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res  178, 105-17.   https://doi.org/10.1667/rr2703.1|2. Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, Coleman CN (2013). Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res  11, 5-12.   https://doi.org/10.1158/1541-7786.MCR-12-0492|3. Palayoor ST, J-Aryankalayil M, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN (2012). Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects. J Cardiovasc Pharmacol  59, 487-99.   https://doi.org/10.1097/FJC.0b013e31824ba6b5",https://intramural.nih.gov/search/searchview.taf?ipid=73403
213,BC010671-08,"October 01, 2011 -  September 30, 2012",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Qi  Xiao|Andrea Christine Bohrer|Melanie S Vacchio; PhD|Jong Kyong  Kim|Sugata  Manna|Linus  Williams,"Albert  Bendelac (University of Chicago)|Jane A. Skok; PhD (Pathology, New York University School of Medicine)",Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Alfred  Singer; MD (Lymphocyte Development Section),"William E Paul; MD (NIAID) |Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |Wanjun  Chen; PhD (NIDCR) |John J O'Shea; MD (NIAMS) |Jinfang  Zhu; PhD (NIAID)","1. Collins A, Hewitt SL, Chaumeil J, Sellars M, Micsinai M, Allinne J, Parisi F, Nora EP, Bolland DJ, Corcoran AE, Kluger Y, Bosselut R, Ellmeier W, Chong MM, Littman DR, Skok JA (2011). RUNX transcription factor-mediated association of Cd4 and Cd8 enables coordinate gene regulation. Immunity  34, 303-14.   https://doi.org/10.1016/j.immuni.2011.03.004|2. Konkel JE, Maruyama T, Carpenter AC, Xiong Y, Zamarron BF, Hall BE, Kulkarni AB, Zhang P, Bosselut R, Chen W (2011). Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β. Nat Immunol  12, 312-9.   https://doi.org/10.1038/ni.1997|3. Wang L, Xiong Y, Bosselut R (2011). Maintaining CD4-CD8 lineage integrity in T cells: where plasticity serves versatility. Semin Immunol  23, 360-7.   https://doi.org/10.1016/j.smim.2011.08.008|4. Wohlfert EA, Grainger JR, Bouladoux N, Konkel JE, Oldenhove G, Ribeiro CH, Hall JA, Yagi R, Naik S, Bhairavabhotla R, Paul WE, Bosselut R, Wei G, Zhao K, Oukka M, Zhu J, Belkaid Y (2011). GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice. J Clin Invest  121, 4503-15.   https://doi.org/10.1172/JCI57456|5. Xiong Y, Bosselut R (2011). The enigma of CD4-lineage specification. Eur J Immunol  41, 568-74.   https://doi.org/10.1002/eji.201041098",https://intramural.nih.gov/search/searchview.taf?ipid=73402
214,BC010675-08,"October 01, 2011 -  September 30, 2012",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Yalong  Zhang|Joseph John Barchi,NULL,Luis G Rodriguez (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73419
215,BC010677-08,"October 01, 2011 -  September 30, 2012",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler",NULL,Joseph E Tomaszewski (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73418
216,BC010680-08,"October 01, 2011 -  September 30, 2012",Characterization of the hCenexin-Plk1 interaction at the centrosomes,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Lingjun  Meng|Jin Hyup Lee,Raymond L Erikson|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Kunsoo  Rhee (Seoul National University),Timothy D Veenstra (Office Of The Director),NULL,"1. Kang YH, Park CH, Kim TS, Soung NK, Bang JK, Kim BY, Park JE, Lee KS (2011). Mammalian polo-like kinase 1-dependent regulation of the PBIP1-CENP-Q complex at kinetochores. J Biol Chem  286, 19744-57.   https://doi.org/10.1074/jbc.M111.224105|2. Lee KH, Johmura Y, Yu LR, Park JE, Gao Y, Bang JK, Zhou M, Veenstra TD, Yeon Kim B, Lee KS (2012). Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway. EMBO J  31, 3104-17.   https://doi.org/10.1038/emboj.2012.144",https://intramural.nih.gov/search/searchview.taf?ipid=73424
217,BC010681-08,"October 01, 2011 -  September 30, 2012",Development of anti-polo-box therapeutic agents,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park|Sang Gwon  Seo|Sunho  Choi,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,James  McMahon; PhD (Molecular Targets Laboratory)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Timothy D Veenstra (Office Of The Director)|Marc C Nicklaus (Chemical Biology Laboratory),NULL,"1. Huong PT, Moon DO, Kim SO, Kim KE, Jeong SJ, Lee KW, Lee KS, Jang JH, Erikson RL, Ahn JS, Kim BY (2011). Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression. Cell Signal  23, 857-65.   https://doi.org/10.1016/j.cellsig.2011.01.010|2. Liu F, Park JE, Qian WJ, Lim D, Gräber M, Berg T, Yaffe MB, Lee KS, Burke TR (2011). Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. Nat Chem Biol  7, 595-601.   https://doi.org/10.1038/nchembio.614",https://intramural.nih.gov/search/searchview.taf?ipid=73425
218,BC010683-08,"October 01, 2011 -  September 30, 2012",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld|Alok  Mishra|Thomas L Prince|Naoto  Miyajima; MD, PhD|Harvey Grant Schwartz|Jeremy Schreiber Ruthberg|Show all 7",Sunil  Sudarshan|YunJin  Jung (Pusan National University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73427
219,BC010692-08,"October 01, 2011 -  September 30, 2012",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug|Valerie M Zgonc,NULL,Blanche P Alter (Clinical Genetics Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),Irina  Maric; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73406
220,BC010696-08,"October 01, 2011 -  September 30, 2012",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD|Maria  Tsokos; MD,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|2. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|3. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW (2011). Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene  30, 4697-706.   https://doi.org/10.1038/onc.2011.179|4. Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013). Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol  37, 74-80.   https://doi.org/10.1097/PAS.0b013e31825ec16f",https://intramural.nih.gov/search/searchview.taf?ipid=73426
221,BC010701-07,"October 01, 2011 -  September 30, 2012",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Yang  Feng|John  Owens|Zhongyu  Zhu|Weizao  Chen|Rui  Gong; PhD|Emily D Streaker|Show all 10,Kurt  Ghelsen (RCT)|Philip  Low (Perdue University)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute),Ira H Pastan; MD (Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Bradley D St Croix (Mouse Cancer Genetics Program)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Feng Y, Gong R, Dimitrov DS (2011). Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor. Protein Expr Purif  79, 66-71.   https://doi.org/10.1016/j.pep.2011.03.012|2. Feng Y, Shen J, Streaker ED, Lockwood M, Zhu Z, Low PS, Dimitrov DS (2011). A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity. Arthritis Res Ther  13, R59.   https://doi.org/10.1186/ar3312|3. Gong R, Chen W, Dimitrov DS (2012). Candidate antibody-based therapeutics against HIV-1. BioDrugs  26, 143-62.   https://doi.org/10.2165/11631400-000000000-00000|4. Gong R, Wang Y, Feng Y, Zhao Q, Dimitrov DS (2011). Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor. J Biol Chem  286, 27288-93.   https://doi.org/10.1074/jbc.M111.254219|5. Prabakaran P, Chen W, Singarayan MG, Stewart CC, Streaker E, Feng Y, Dimitrov DS (2012). Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations. Immunogenetics  64, 337-50.   https://doi.org/10.1007/s00251-011-0595-8|6. Prabakaran P, Streaker E, Chen W, Dimitrov DS (2011). 454 antibody sequencing - error characterization and correction. BMC Res Notes  4, 404.   https://doi.org/10.1186/1756-0500-4-404|7. Zhao Q, Feng Y, Zhu Z, Dimitrov DS (2011). Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity. Mol Cancer Ther  10, 1677-85.   https://doi.org/10.1158/1535-7163.MCT-11-0281",https://intramural.nih.gov/search/searchview.taf?ipid=73436
222,BC010707-07,"October 01, 2011 -  September 30, 2012",Role of T regulatory suppression in autoimmunity and cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Xin  Chen|Ola Mae Zack Howard|Anna Lee  Trivett,"Robert  Goldman (Peprotech)|Daniela  Maennel (Immunology, University of Regensburg)",Yinling  Hu (Laboratory of Experimental Immunology),NULL,"1. Chen X, Oppenheim JJ (2011). Comment on ""Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis"". J Immunol  187, 1527; author reply 1527-8.   https://doi.org/10.4049/jimmunol.1190029",https://intramural.nih.gov/search/searchview.taf?ipid=73439
223,BC010708-07,"October 01, 2011 -  September 30, 2012",Consequences of receptor cross talk on inflammation and algesia,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|Anna Lee  Trivett|Zhizheng  Zhao,NULL,"Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73440
224,BC010709-07,"October 01, 2011 -  September 30, 2012",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen|Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch),"Carlo  Pierpaoli; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73464
225,BC010714-07,"October 01, 2011 -  September 30, 2012",Angiogenesis imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Marcelino  Bernardo|Karen A Kurdziel; MD|Mark  Williams|Yolanda L Mckinney|Elaine Marie Jagoda; MS|Show all 14,Frederick  Giesel (University of Heidelberg)|Michael  Knopp (Ohio State University)|Anwar  Padhani (Mt Vernon Hospital),William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Ola Anders Landgren (Lymphoid Malignancies Branch),"David M Thomasson; PhD (NIAID) |Thomas J Pohida; MS (CIT) |Gary Leonard Griffiths; BSc, PhD (NHLBI) |Chang Hum  Paik; PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73450
226,BC010715-07,"October 01, 2011 -  September 30, 2012",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)","1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2012). Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom  82, 67-77.   https://doi.org/10.1002/cyto.b.20622|3. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|4. Dunleavy K, Roschewski M, Wilson WH (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep  7, 208-15.   https://doi.org/10.1007/s11899-012-0132-3|5. Dunleavy K, Wilson WH (2011). Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma. Clin Cancer Res  17, 7505-7.   https://doi.org/10.1158/1078-0432.CCR-11-2372|6. Dunleavy K, Wilson WH (2012). How I treat HIV-associated lymphoma. Blood  119, 3245-55.   https://doi.org/10.1182/blood-2011-08-373738|7. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|8. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|9. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|10. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|11. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011). NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood  117, 1447-52.   https://doi.org/10.1182/blood-2010-08-302737|12. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|13. Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses  54, e877-9.   https://doi.org/10.1111/j.1439-0507.2011.02016.x|14. Roschewski M, Wilson WH (2012). EBV-associated lymphomas in adults. Best Pract Res Clin Haematol  25, 75-89.   https://doi.org/10.1016/j.beha.2012.01.005|15. Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S (2012). Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia  26, 1895-8.   https://doi.org/10.1038/leu.2012.72|16. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|17. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|18. Weniger MA, Rizzatti EG, Pérez-Galán P, Liu D, Wang Q, Munson PJ, Raghavachari N, White T, Tweito MM, Dunleavy K, Ye Y, Wilson WH, Wiestner A (2011). Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res  17, 5101-12.   https://doi.org/10.1158/1078-0432.CCR-10-3367|19. Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED, Cancer Leukemia Group B (2012). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica  97, 758-65.   https://doi.org/10.3324/haematol.2011.056531",https://intramural.nih.gov/search/searchview.taf?ipid=73465
227,BC010716-07,"October 01, 2011 -  September 30, 2012",Phase I and II Study of BCL Family Inhibitors in Lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2012). Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom  82, 67-77.   https://doi.org/10.1002/cyto.b.20622|3. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|4. Dunleavy K, Roschewski M, Wilson WH (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep  7, 208-15.   https://doi.org/10.1007/s11899-012-0132-3|5. Dunleavy K, Wilson WH (2011). Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma. Clin Cancer Res  17, 7505-7.   https://doi.org/10.1158/1078-0432.CCR-11-2372|6. Dunleavy K, Wilson WH (2012). How I treat HIV-associated lymphoma. Blood  119, 3245-55.   https://doi.org/10.1182/blood-2011-08-373738|7. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|8. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|9. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|10. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|11. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|12. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011). NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood  117, 1447-52.   https://doi.org/10.1182/blood-2010-08-302737|13. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|14. Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses  54, e877-9.   https://doi.org/10.1111/j.1439-0507.2011.02016.x|15. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|16. Roschewski M, Wilson WH (2012). EBV-associated lymphomas in adults. Best Pract Res Clin Haematol  25, 75-89.   https://doi.org/10.1016/j.beha.2012.01.005|17. Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S (2012). Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia  26, 1895-8.   https://doi.org/10.1038/leu.2012.72|18. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|19. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|20. Weniger MA, Rizzatti EG, Pérez-Galán P, Liu D, Wang Q, Munson PJ, Raghavachari N, White T, Tweito MM, Dunleavy K, Ye Y, Wilson WH, Wiestner A (2011). Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res  17, 5101-12.   https://doi.org/10.1158/1078-0432.CCR-10-3367|21. Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED, Cancer Leukemia Group B (2012). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica  97, 758-65.   https://doi.org/10.3324/haematol.2011.056531",https://intramural.nih.gov/search/searchview.taf?ipid=73466
228,BC010717-07,"October 01, 2011 -  September 30, 2012",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73467
229,BC010719-07,"October 01, 2011 -  September 30, 2012",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73468
230,BC010720-07,"October 01, 2011 -  September 30, 2012","Isolation, Characterization, and Behavior of Melanocyte Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res  9, 418-29.   https://doi.org/10.1158/1541-7786.MCR-10-0511|2. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|3. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=73452
231,BC010725-07,"October 01, 2011 -  September 30, 2012",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Wang Hua  Gong|Keqiang  Chen|Ming Yong  Liu; MD|Chunyan  Wang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)|Thomas  Rogers (Temple University)|Gert  SchmidSchonbein (UC San Diego)",Jonathan  Keller; PhD (Laboratory of Cancer Prevention),"Philip M Murphy; MD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Ronald N Germain; MD, PhD (NIAID)","1. An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA (2011). Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet  7, e1002328.   https://doi.org/10.1371/journal.pgen.1002328|2. Liu M, Zhao J, Chen K, Bian X, Wang C, Shi Y, Wang JM (2012). G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma. Int Immunopharmacol  14, 283-8.   https://doi.org/10.1016/j.intimp.2012.07.015|3. Soria JA, Arroyo DS, Gaviglio EA, Rodriguez-Galan MC, Wang JM, Iribarren P (2011). Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism. Neurobiol Dis  43, 616-24.   https://doi.org/10.1016/j.nbd.2011.05.010",https://intramural.nih.gov/search/searchview.taf?ipid=73446
232,BC010728-07,"October 01, 2011 -  September 30, 2012",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2012). Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom  82, 67-77.   https://doi.org/10.1002/cyto.b.20622|3. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|4. Dunleavy K, Roschewski M, Wilson WH (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep  7, 208-15.   https://doi.org/10.1007/s11899-012-0132-3|5. Dunleavy K, Wilson WH (2011). Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma. Clin Cancer Res  17, 7505-7.   https://doi.org/10.1158/1078-0432.CCR-11-2372|6. Dunleavy K, Wilson WH (2012). How I treat HIV-associated lymphoma. Blood  119, 3245-55.   https://doi.org/10.1182/blood-2011-08-373738|7. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|8. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|9. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|10. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|11. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|12. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011). NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood  117, 1447-52.   https://doi.org/10.1182/blood-2010-08-302737|13. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|14. Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses  54, e877-9.   https://doi.org/10.1111/j.1439-0507.2011.02016.x|15. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|16. Roschewski M, Wilson WH (2012). EBV-associated lymphomas in adults. Best Pract Res Clin Haematol  25, 75-89.   https://doi.org/10.1016/j.beha.2012.01.005|17. Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S (2012). Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia  26, 1895-8.   https://doi.org/10.1038/leu.2012.72|18. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|19. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|20. Weniger MA, Rizzatti EG, Pérez-Galán P, Liu D, Wang Q, Munson PJ, Raghavachari N, White T, Tweito MM, Dunleavy K, Ye Y, Wilson WH, Wiestner A (2011). Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res  17, 5101-12.   https://doi.org/10.1158/1078-0432.CCR-10-3367|21. Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED, Cancer Leukemia Group B (2012). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica  97, 758-65.   https://doi.org/10.3324/haematol.2011.056531",https://intramural.nih.gov/search/searchview.taf?ipid=73469
233,BC010729-07,"October 01, 2011 -  September 30, 2012",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Wusheng  Yan|Michael D Armani|Michael  Tangrea|Qiang  Du; PhD|Adele R Blackler; PhD,"Benjamin  Shapiro (Engineering, University of Maryland)|Elisabeth  Smela (Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"1. Hipp J, Cheng J, Hanson JC, Yan W, Taylor P, Hu N, Rodriguez-Canales J, Hipp J, Tangrea MA, Emmert-Buck MR, Balis U (2011). SIVQ-aided laser capture microdissection: A tool for high-throughput expression profiling. J Pathol Inform  2, 19.   https://doi.org/10.4103/2153-3539.78500|2. Hipp J, Cheng J, Pantanowitz L, Hewitt S, Yagi Y, Monaco J, Madabhushi A, Rodriguez-Canales J, Hanson J, Roy-Chowdhuri S, Filie AC, Feldman MD, Tomaszewski JE, Shih NN, Brodsky V, Giaccone G, Emmert-Buck MR, Balis UJ (2011). Image microarrays (IMA): Digital pathology's missing tool. J Pathol Inform  2, 47.   https://doi.org/10.4103/2153-3539.86829|3. Hipp JD, Lucas DR, Emmert-Buck MR, Compton CC, Balis UJ (2011). Digital slide repositories for publications: lessons learned from the microarray community. Am J Surg Pathol  35, 783-6.   https://doi.org/10.1097/PAS.0b013e31821946b6|4. Nacev A, Kim SH, Rodriguez-Canales J, Tangrea MA, Shapiro B, Emmert-Buck MR (2011). A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. Int J Nanomedicine  6, 2907-23.   https://doi.org/10.2147/IJN.S23724|5. Tangrea MA, Hanson JC, Bonner RF, Pohida TJ, Rodriguez-Canales J, Emmert-Buck MR (2011). Immunoguided microdissection techniques. Methods Mol Biol  755, 57-66.   https://doi.org/10.1007/978-1-61779-163-5_4",https://intramural.nih.gov/search/searchview.taf?ipid=73437
234,BC010733-07,"October 01, 2011 -  September 30, 2012",Dermatoscopy in the Evaluation of Pigmented Lesions,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Kenneth H Kraemer; MD|John  Digiovanna,NULL,NULL,NULL,"1. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res  9, 418-29.   https://doi.org/10.1158/1541-7786.MCR-10-0511|2. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|3. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=73453
235,BC010734-07,"October 01, 2011 -  September 30, 2012",Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,"Brigitte  Widemann; MD (Pediatric Oncology Branch)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,"1. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res  9, 418-29.   https://doi.org/10.1158/1541-7786.MCR-10-0511|2. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666|3. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=73454
236,BC010735-07,"October 01, 2011 -  September 30, 2012",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Wai-Kwan  Tang|Rui  Bao,NULL,NULL,NULL,"1. Bao R, Esser L, Sadhukhan A, Nair M, Schifferli D, Xia D (2012) Crystallization and preliminary X-ray diffraction analysis of PsaA, the adhesive pilin subunit that forms the pH 6 antigen on the surface of Yersinia pestis. Act Crystallographica Section F, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73448
237,BC010736-07,"October 01, 2011 -  September 30, 2012",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Mi Young  Yang|Christopher William Larrimore|Mary B Hilton,Zissis  Chroneos (The Pennsylvania State University College of Medicine)|Joanna  Floros (The Pennsylvania State University College of Medicine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73463
238,BC010738-07,"October 01, 2011 -  September 30, 2012","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Hyunhee  Shin|Shree Ram  Singh|Xiankun  Zeng|Ying  Liu|Jiangsha  Zhao; PhD|Lino  Tessarollo,Neal  Copeland (Institute of Molecular and Cell Biology)|Nancy  Jenkins (Institute of Molecular and Cell Biology)|Xinhua  Lin (Children's Hospital Medical Center),Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,"1. Singh SR, Burnicka-Turek O, Chauhan C, Hou SX (2011). Spermatogonial stem cells, infertility and testicular cancer. J Cell Mol Med  15, 468-83.   https://doi.org/10.1111/j.1582-4934.2010.01242.x|2. Singh SR, Zeng X, Zheng Z, Hou SX (2011). The adult Drosophila gastric and stomach organs are maintained by a multipotent stem cell pool at the foregut/midgut junction in the cardia (proventriculus). Cell Cycle  10, 1109-20.   https://doi.org/10.4161/cc.10.7.14830",https://intramural.nih.gov/search/searchview.taf?ipid=73455
239,BC010740-07,"October 01, 2011 -  September 30, 2012",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sudipa  Chowdhury,"Lara  Mahal (Chemistry, University of Texas at Austin)|Cristina  Voss (Department of Chemistry, German Cancer Research Center)|Mai  Xu; PhD|Matthew  Zimmt (Brown University)|Mohamed  Shoreibah (Abeome Corp.)|Zeev  Pancer (University of Maryland School of Medicine)",Miriam R Anver (Office Of The Director),NULL,"1. Shoreibah MG, Jackson CL, Price PW, Meagher R, Godwin AK, Cai Q, Gildersleeve JC (2011). Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas. Stem Cells Dev  20, 515-25.   https://doi.org/10.1089/scd.2010.0172",https://intramural.nih.gov/search/searchview.taf?ipid=73451
240,BC010742-07,"October 01, 2011 -  September 30, 2012",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Boopathy  Ramakrishna|Natalia  Mercer,NULL,NULL,"Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Dulcey AE, Qasba PK, Lamb J, Griffiths GL (2011). Improved synthesis of UDP-2-(2-ketopropyl)galactose and a first synthesis of UDP-2-(2-ketopropyl)glucose for the site-specific linking of biomolecules via modified glycan residues using glycosyltransferases. Tetrahedron  67, 2013-2017.   https://doi.org/10.1016/j.tet.2011.01.081|2. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey AE, Griffiths GL, Qasba PK (2012). The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. Glycobiology  22, 379-88.   https://doi.org/10.1093/glycob/cwr110|3. Ramakrishnan B, Boeggeman E, Pasek M, Qasba PK (2011). Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles. Methods Mol Biol  751, 281-96.   https://doi.org/10.1007/978-1-61779-151-2_17",https://intramural.nih.gov/search/searchview.taf?ipid=73461
241,BC010743-07,"October 01, 2011 -  September 30, 2012",Metabolic Mechanisms for Programmed Cell Death,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Gregory L Borchert|Wei  Liu|Kyle  Christian|Chad Nathaniel Hancock; PhD|Elena Marie Donald,"Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|David  Valle (Johns Hopkins University School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Andrew  Lane (U. of Louisville)",Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Larry K Keefer; PhD (Chemical Biology Laboratory)|Michael L Nickerson (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73443
242,BC010744-07,"October 01, 2011 -  September 30, 2012",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Wei  Liu|Kyle  Christian|Chad Nathaniel Hancock; PhD,"David  Valle (Johns Hopkins University School of Medicine)|Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Kristine  Glunde (Johns Hopkins)",Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73444
243,BC010746-07,"October 01, 2011 -  September 30, 2012",Extracellular Matrix and Stress Substrates: the Role of Prolidase,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Gregory L Borchert,Antonella  Forlino (University of Pavia)|Teresa  Gunn (McLaughlin Research Institute),Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Jung S, Silvius D, Nolan KA, Borchert GL, Millet YH, Phang JM, Gunn TM (2011). Developmental cardiac hypertrophy in a mouse model of prolidase deficiency. Birth Defects Res A Clin Mol Teratol  91, 204-17.   https://doi.org/10.1002/bdra.20789",https://intramural.nih.gov/search/searchview.taf?ipid=73445
244,BC010747-07,"October 01, 2011 -  September 30, 2012",Charaterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Laura Ann R Quigley|Geraldine Martina O'Connor|Mary  Carrington; MS, PhD|Stephen K Anderson; PhD","Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|Paul  Bowness (University of Cambridge)|Bernardo  GalvaoCastro (Goncalo Moniz Research Center)",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),"Suk See De Ravin; MD, PhD (NIAID)","1. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, McVicar DW, Altfeld M (2011). Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol  85, 5970-4.   https://doi.org/10.1128/JVI.00412-11|2. O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW (2011). Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J Immunol  187, 2162-71.   https://doi.org/10.4049/jimmunol.1002906|3. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J (2011). Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature  479, 401-5.   https://doi.org/10.1038/nature10517",https://intramural.nih.gov/search/searchview.taf?ipid=73438
245,BC010748-07,"October 01, 2011 -  September 30, 2012",Clinical Investigation of Signal Transduction Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Takefumi  Komiya|William D Figg; PharmD|Giuseppe  Giaccone; MD,NULL,"Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Joanna H Shih (Biometrics Research Branch)",NULL,"1. Hollander MC, Blumenthal GM, Dennis PA (2011). PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer  11, 289-301.   https://doi.org/10.1038/nrc3037|2. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA (2011). Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene  30, 1812-21.   https://doi.org/10.1038/onc.2010.556|3. Hollander MC, Zhou X, Maier CR, Patterson AD, Ding X, Dennis PA (2011). A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. Carcinogenesis  32, 1279-84.   https://doi.org/10.1093/carcin/bgr097|4. Maier CR, Hollander MC, Hobbs EA, Dogan I, Linnoila RI, Dennis PA (2011). Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res (Phila)  4, 1743-51.   https://doi.org/10.1158/1940-6207.CAPR-11-0365|5. West KA, Dennis PA (2011). Starting with the ABCs: Akt in breast cancer. Mol Cancer Ther  10, 2031.   https://doi.org/10.1158/1535-7163.MCT-11-0712|6. West L, Vidwans SJ, Campbell NP, Shrager J, Simon GR, Bueno R, Dennis PA, Otterson GA, Salgia R (2012). A novel classification of lung cancer into molecular subtypes. PLoS One  7, e31906.   https://doi.org/10.1371/journal.pone.0031906|7. Zhang C, Elkahloun AG, Liao H, Delaney S, Saber B, Morrow B, Prendergast GC, Hollander MC, Gills JJ, Dennis PA (2011). Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cells. Mol Cancer Ther  10, 1137-48.   https://doi.org/10.1158/1535-7163.MCT-10-1028|8. Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J, Shih JH, Fukuoka J, Hollander MC, Harris CC, Travis WD, Jen J, Dennis PA (2011). Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PLoS One  6, e23849.   https://doi.org/10.1371/journal.pone.0023849",https://intramural.nih.gov/search/searchview.taf?ipid=73435
246,BC010749-07,"October 01, 2011 -  September 30, 2012",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Antonio L Valentin|Bhabadeb S Chowdhury; PhD|Rachel Elizabeth Kelly Beach|Jinyao  Li; PhD|Margherita  Rosati|Marjorie  Robert-Guroff; PhD|Show all 10,"Christian  Brander (AIDS Research Center, Massachusetts General Hospital)|David  Heckerman (Microsoft Research)|Amitinder  Kaur (New England Primate Research Center)|Wayne  Koff (IAVI)|Bette  Korber; PhD (Los Alamos National Laboratory)|Sylvie  Le Gall (Massachusetts General Hospital)|Show all 28",Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director),Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID) |Adrian Bernard McDermott; PhD (NIAID),"1. Lai L, Kwa SF, Kozlowski PA, Montefiori DC, Nolen TL, Hudgens MG, Johnson WE, Ferrari G, Hirsch VM, Felber BK, Pavlakis GN, Earl PL, Moss B, Amara RR, Robinson HL (2012). SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine  30, 1737-45.   https://doi.org/10.1016/j.vaccine.2011.12.026|2. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol  85, 1528-40.   https://doi.org/10.1128/JVI.01709-10|3. Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, Walker BD, Weiner D, Paredes R, Clotet B, Felber BK, Pavlakis GN, Mullins JI, Brander C (2012). CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One  7, e29717.   https://doi.org/10.1371/journal.pone.0029717|4. Niu L, Termini JM, Kanagavelu SK, Gupta S, Rolland MM, Kulkarni V, Pavlakis GN, Felber BK, Mullins JI, Fischl MA, Stone GW (2011). Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes. Vaccine  29, 2110-9.   https://doi.org/10.1016/j.vaccine.2010.12.131|5. Strbo N, Vaccari M, Pahwa S, Kolber MA, Fisher E, Gonzalez L, Doster MN, Hryniewicz A, Felber BK, Pavlakis GN, Franchini G, Podack ER (2011). Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa. Vaccine  29, 2619-25.   https://doi.org/10.1016/j.vaccine.2011.01.044|6. Winstone N, Wilson AJ, Morrow G, Boggiano C, Chiuchiolo MJ, Lopez M, Kemelman M, Ginsberg AA, Mullen K, Coleman JW, Wu CD, Narpala S, Ouellette I, Dean HJ, Lin F, Sardesai NY, Cassamasa H, McBride D, Felber BK, Pavlakis GN, Schultz A, Hudgens MG, King CR, Zamb TJ, Parks CL, et al. [1 more author] (2011). Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen. J Virol  85, 9578-87.   https://doi.org/10.1128/JVI.05060-11",https://intramural.nih.gov/search/searchview.taf?ipid=73441
247,BC010750-07,"October 01, 2011 -  September 30, 2012",Cytokines in AIDS and Cancer,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Antonio L Valentin|Cristina  Bergamaschi|Bhabadeb S Chowdhury; PhD|Rachel Elizabeth Kelly Beach|Jinyao  Li; PhD|Sin Man  Ng|Show all 11,David  Weiner (University of Pennsylvania)|Dirk  Daelemans|Karen  Gaensler (University of California)|Peter  Katsikis (Drexel University College of Medicine)|Amitinder  Kaur (New England Primate Research Center),Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Elena  Chertova (Office Of The Director)|Stephen  Creekmore; PhD (Biological Resources Branch),"Tomoshige  Kino; MD, PhD (NICHD) |Richard A Koup; MD (NIAID) |Konstantinos  Petrovas (NIAID)","1. Bergamaschi C, Bear J, Rosati M, Beach RK, Alicea C, Sowder R, Chertova E, Rosenberg SA, Felber BK, Pavlakis GN (2012). Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood  120, e1-8.   https://doi.org/10.1182/blood-2011-10-384362",https://intramural.nih.gov/search/searchview.taf?ipid=73442
248,BC010752-07,"October 01, 2011 -  September 30, 2012",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,"Anil  Sood (Gynecologic Oncology, MDACC)|Yousef  Rustun (Roswell Park Cancer Institute)",NULL,NULL,"1. Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, et al. [80 more authors] (2011) Defining the critical hurdles in cancer immunotherapy. J Transl Med 9:214.|2. Meyskens FL, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E, C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee (2011). Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic. Cancer Prev Res (Phila)  4, 311-23.   https://doi.org/10.1158/1940-6207.CAPR-09-0014|3. Rahma OE, Khleif SN (2011). Therapeutic vaccines for gastrointestinal cancers. Gastroenterol Hepatol (N Y)  7, 517-64.",https://intramural.nih.gov/search/searchview.taf?ipid=73456
249,BC010755-07,"October 01, 2011 -  September 30, 2012",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Masaki  Terabe,Vincent  Herrin; MD|emanuelle  Petricoin (George Mason University),John  Schiller; PhD (Laboratory of Cellular Oncology)|Yuk Ying S Pang (Laboratory of Cellular Oncology)|Barry  Gause; PhD (Office Of The Director)|Franklin R Grollman (Medical Oncology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section),Francesco M. Marincola; MD (CC),"1. Meyskens FL, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E, C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee (2011). Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic. Cancer Prev Res (Phila)  4, 311-23.   https://doi.org/10.1158/1940-6207.CAPR-09-0014|2. Rahma OE, Khleif SN (2011). Therapeutic vaccines for gastrointestinal cancers. Gastroenterol Hepatol (N Y)  7, 517-64.",https://intramural.nih.gov/search/searchview.taf?ipid=73457
250,BC010757-07,"October 01, 2011 -  September 30, 2012",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD","Vincent  Herrin; MD|Therresa  Whiteside (Immuunoligy, University of Pittsburg)|Joe  Lucci (Gynecologic Oncology, University of Florida)",Barry  Gause; PhD (Office Of The Director)|Franklin R Grollman (Medical Oncology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Meyskens FL, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E, C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee (2011). Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic. Cancer Prev Res (Phila)  4, 311-23.   https://doi.org/10.1158/1940-6207.CAPR-09-0014|2. Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN (2012). A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunol Immunother  61, 373-84.   https://doi.org/10.1007/s00262-011-1100-9|3. Rahma OE, Khleif SN (2011). Therapeutic vaccines for gastrointestinal cancers. Gastroenterol Hepatol (N Y)  7, 517-64.",https://intramural.nih.gov/search/searchview.taf?ipid=73458
251,BC010759-07,"October 01, 2011 -  September 30, 2012",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|John E Lueders|Yuan  Jiang; MD|Robert L Walker; BS|Arthur A Glatfelter; MS|Fan  Yang|Show all 12",Charles  Keller (University of Texas)|Heinrich  Kovar (St. Anna's Children's Hospital)|Jeffrey  Trent (TGen),Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Rubin BP, Nishijo K, Chen HI, Yi X, Schuetze DP, Pal R, Prajapati SI, Abraham J, Arenkiel BR, Chen QR, Davis S, McCleish AT, Capecchi MR, Michalek JE, Zarzabal LA, Khan J, Yu Z, Parham DM, Barr FG, Meltzer PS, Chen Y, Keller C (2011). Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell  19, 177-91.   https://doi.org/10.1016/j.ccr.2010.12.023",https://intramural.nih.gov/search/searchview.taf?ipid=73460
252,BC010763-07,"October 01, 2011 -  September 30, 2012",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Zhiya  Yu|Douglas  Palmer|Luca  Gattinoni|Yun  Ji|Madhusudhanan  Sukumar|Rahul  Roychoudhuri|Show all 14,Ton  Schumacher (Netherlands Cancer Institute)|Paul  Antony (Univeristy of Maryland)|Carl  June (Univesity of Pennsylvania)|Vincenzo  Bronte|Christopher  Touloukian (Indianna University),Giorgio  Trinchieri (Laboratory of Experimental Immunology),Robert L Danner; MD (CC) |Mario  Roederer; PhD (NIAID),"1. Amos SM, Pegram HJ, Westwood JA, John LB, Devaud C, Clarke CJ, Restifo NP, Smyth MJ, Darcy PK, Kershaw MH (2011). Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice. Cancer Immunol Immunother  60, 671-83.   https://doi.org/10.1007/s00262-011-0984-8|2. Ascierto ML, Worschech A, Yu Z, Adams S, Reinboth J, Chen NG, Pos Z, Roychoudhuri R, Di Pasquale G, Bedognetti D, Uccellini L, Rossano F, Ascierto PA, Stroncek DF, Restifo NP, Wang E, Szalay AA, Marincola FM (2011). Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68. BMC Cancer  11, 451.   https://doi.org/10.1186/1471-2407-11-451|3. Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA (2011). A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. J Immunol  186, 685-96.   https://doi.org/10.4049/jimmunol.1001775|4. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP (2011). A human memory T cell subset with stem cell-like properties. Nat Med  17, 1290-7.   https://doi.org/10.1038/nm.2446|5. Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, Klebanoff CA, Johnson LA, Kerkar SP, Yang S, Muranski P, Palmer DC, Scott CD, Morgan RA, Robbins PF, Rosenberg SA, Restifo NP (2011). Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood  117, 808-14.   https://doi.org/10.1182/blood-2010-05-286286|6. Hu G, Schones DE, Cui K, Ybarra R, Northrup D, Tang Q, Gattinoni L, Restifo NP, Huang S, Zhao K (2011). Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res  21, 1650-8.   https://doi.org/10.1101/gr.121145.111|7. Ji Y, Pos Z, Rao M, Klebanoff CA, Yu Z, Sukumar M, Reger RN, Palmer DC, Borman ZA, Muranski P, Wang E, Schrump DS, Marincola FM, Restifo NP, Gattinoni L (2011). Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat Immunol  12, 1230-7.   https://doi.org/10.1038/ni.2153|8. Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, Restifo NP (2011). IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest  121, 4746-57.   https://doi.org/10.1172/JCI58814|9. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP (2011). Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. J Immunother  34, 343-52.   https://doi.org/10.1097/CJI.0b013e3182187600|10. Klebanoff CA, Acquavella N, Yu Z, Restifo NP (2011). Therapeutic cancer vaccines: are we there yet? Immunol Rev  239, 27-44.   https://doi.org/10.1111/j.1600-065X.2010.00979.x|11. Klebanoff CA, Gattinoni L, Palmer DC, Muranski P, Ji Y, Hinrichs CS, Borman ZA, Kerkar SP, Scott CD, Finkelstein SE, Rosenberg SA, Restifo NP (2011). Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res  17, 5343-52.   https://doi.org/10.1158/1078-0432.CCR-11-0503|12. Liu Y, Tian X, Leitner WW, Aldridge ME, Zheng J, Yu Z, Restifo NP, Weiss R, Scheiblhofer S, Xie C, Sun R, Cheng G, Zeng G (2011). Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo. J Biol Chem  286, 37077-84.   https://doi.org/10.1074/jbc.M111.280123|13. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA (2011). T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther  19, 620-6.   https://doi.org/10.1038/mt.2010.272|14. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|15. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011). Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res  17, 4550-7.   https://doi.org/10.1158/1078-0432.CCR-11-0116|16. Yang S, Gattinoni L, Luca G, Liu F, Ji Y, Yu Z, Restifo NP, Rosenberg SA, Morgan RA (2011). In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells. Cancer Immunol Immunother  60, 739-49.   https://doi.org/10.1007/s00262-011-0977-7|17. Zhang L, Kerkar SP, Yu Z, Zheng Z, Yang S, Restifo NP, Rosenberg SA, Morgan RA (2011). Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol Ther  19, 751-9.   https://doi.org/10.1038/mt.2010.313|18. Zou W, Restifo NP (2012). Nine lives for TH9s? Nat Med  18, 1177-8.   https://doi.org/10.1038/nm.2868",https://intramural.nih.gov/search/searchview.taf?ipid=73462
253,BC010766-06,"October 01, 2011 -  September 30, 2012",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",Melissa Marie Alvarez Downing; MD|Biman  Paria|Syed A Shah|Sanmeet  Singh|Smita Sarat Chandran,NULL,NULL,NULL,"1. Wang A, Chandran S, Shah S, Chiu Y, Paria B, Aghamolla T, AlvarezDowining M, Lee C, Singh S, Li T, Dudley M, Restifo N, Rosenberg S, Kammula U (2012) The stoichiometric production of IL-2 and IFN-#947; mRNA defines memory T cells that can self renew after adoptive transfer in humans. Science Translational Medicine 4:1-13.",https://intramural.nih.gov/search/searchview.taf?ipid=73536
254,BC010767-06,"October 01, 2011 -  September 30, 2012",Biosynthesis of Selenocysteine and Its Incorporation into Protein,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Min-Hyuk  Yoo|Ryuta  Tobe|Fang  Chen,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Byeong Jae  Lee (Seoul National University)|Michael  Howard (University of Utah)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",John A Milner (Nutritional Science Research Group)|Harold  Seifried; PhD (Nutritional Science Research Group),NULL,"1. Carlson B, Yoo M, Tsuji P, Tobe R, Naranjo-Suarez S, Chen F, Feigenbaum L, Tessarollo L, Lee B, Gladyshev V, Hatfield D (2011) Mouse models that target removal or over-expression of the selenocysteine tRNA[Ser]Sec gene to elucidate the role of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health., in press.|2. Kim JY, Carlson BA, Xu XM, Zeng Y, Chen S, Gladyshev VN, Lee BJ, Hatfield DL (2011). Inhibition of selenocysteine tRNA[Ser]Sec aminoacylation provides evidence that aminoacylation is required for regulatory methylation of this tRNA. Biochem Biophys Res Commun  409, 814-9.   https://doi.org/10.1016/j.bbrc.2011.05.096|3. Lee BC, Lobanov AV, Marino SM, Kaya A, Seravalli J, Hatfield DL, Gladyshev VN (2011). A 4-selenocysteine, 2-selenocysteine insertion sequence (SECIS) element methionine sulfoxide reductase from Metridium senile reveals a non-catalytic function of selenocysteines. J Biol Chem  286, 18747-55.   https://doi.org/10.1074/jbc.M111.229807|4. Lee KH, Shim MS, Kim JY, Jung HK, Lee E, Carlson BA, Xu XM, Park JM, Hatfield DL, Park T, Lee BJ (2011). Drosophila selenophosphate synthetase 1 regulates vitamin B6 metabolism: prediction and confirmation. BMC Genomics  12, 426.   https://doi.org/10.1186/1471-2164-12-426|5. Shim MS, Kim JY, Lee KH, Jung HK, Carlson BA, Xu XM, Hatfield DL, Lee BJ (2011). l(2)01810 is a novel type of glutamate transporter that is responsible for megamitochondrial formation. Biochem J  439, 277-86.   https://doi.org/10.1042/BJ20110582|6. Turanov AA, Xu XM, Carlson BA, Yoo MH, Gladyshev VN, Hatfield DL (2011). Biosynthesis of selenocysteine, the 21st amino acid in the genetic code, and a novel pathway for cysteine biosynthesis. Adv Nutr  2, 122-8.   https://doi.org/10.3945/an.110.000265",https://intramural.nih.gov/search/searchview.taf?ipid=73537
255,BC010770-06,"October 01, 2011 -  September 30, 2012",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yongmin  Liu|Ofelia  Olivero; PhD|Andrea V Rivera|Eunwoo  Shim|Michael O Ongele|Daniel Dan Liu,"Kris  Oursler (Veterans Administration Hospital)|Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Vernon  Walker (University of Vermont)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73539
256,BC010773-06,"October 01, 2011 -  September 30, 2012",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro|Silvia  Sanchez Martinez|Smita  Nair; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73538
257,BC010774-06,"October 01, 2011 -  September 30, 2012",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD|Bei  Dong|Muhammad Shamsul Alam|Matthias Martin Gaida,Al  Fornace (Georgetown University)|Oded  Livnah (Hebrew University of Jerusalem),Ettore  Appella; MD (Chemical Immunology Section),Dragana  Jankovic; PhD (NIAID),"1. Jirmanova L, Giardino Torchia ML, Sarma ND, Mittelstadt PR, Ashwell JD (2011). Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation. Blood  118, 3280-9.   https://doi.org/10.1182/blood-2011-01-333039",https://intramural.nih.gov/search/searchview.taf?ipid=73470
258,BC010775-06,"October 01, 2011 -  September 30, 2012","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly",Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Abdul Latheef Abdul Waheed|Muthukumar  Balasubramaniam|Lillian Susanna Kuo; PhD|Philip Richard Tedbury|Sagar Bhalchandra Kudchodkar|Show all 11,"Michael  Summers (University of Maryland, Baltimore County)|Tatyana  Polenova; PhD (University of Delaware)|Tsutomu  Murakami (National Institute of Infectious Diseases)|Scott  Morham (Myriad Pharmaceuticals)|Michael  Brenner (Harvard Medical School)|Anjali  Joshi|Show all 8",Robert J Fisher (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Judith Goldstein Levin; PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD),"1. Balasubramaniam M, Freed EO (2011). New insights into HIV assembly and trafficking. Physiology (Bethesda)  26, 236-51.   https://doi.org/10.1152/physiol.00051.2010|2. Checkley MA, Luttge BG, Freed EO (2011). HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol  410, 582-608.   https://doi.org/10.1016/j.jmb.2011.04.042|3. Jiang J, Ablan SD, Derebail S, Hercík K, Soheilian F, Thomas JA, Tang S, Hewlett I, Nagashima K, Gorelick RJ, Freed EO, Levin JG (2011). The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability. Virology  421, 253-65.   https://doi.org/10.1016/j.virol.2011.09.012|4. Joshi A, Garg H, Ablan S, Freed EO, Nagashima K, Manjunath N, Shankar P (2011). Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy. Virology  415, 95-106.   https://doi.org/10.1016/j.virol.2011.03.028|5. Joshi A, Garg H, Ablan SD, Freed EO (2011). Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release. J Biol Chem  286, 29861-71.   https://doi.org/10.1074/jbc.M111.241521|6. Matreyek K, Oztop I, Freed E, Engelman A (2012) Viral latency and potential eradication of HIV-1. Expert Review of Anti-Infective Therapy, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73482
259,BC010776-06,"October 01, 2011 -  September 30, 2012",Retrovirus Budding and Endosomal Sorting,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Abdul Latheef Abdul Waheed|Muthukumar  Balasubramaniam|Lillian Susanna Kuo; PhD|Philip Richard Tedbury|Sagar Bhalchandra Kudchodkar|Show all 10,"Michael  Summers (University of Maryland, Baltimore County)|Scott  Morham (Myriad Pharmaceuticals)|Jeffrey  Aube; PhD (University of North Carolina)|Youla  Tsantrizos (McGill University)",Robert J Fisher (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),James H Hurley; PhD (NIDDK) |Anton  Simeonov (NCATS),"1. Kim SE, Liu F, Im YJ, Stephen AG, Fivash MJ, Waheed AA, Freed EO, Fisher RJ, Hurley JH, Burke TR (2011). Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands. ACS Med Chem Lett  2, 337-341.   https://doi.org/10.1021/ml1002579",https://intramural.nih.gov/search/searchview.taf?ipid=73483
260,BC010778-06,"October 01, 2011 -  September 30, 2012",Inhibition of HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Abdul Latheef Abdul Waheed|Christopher L Suiter|Emiko  Urano; PhD|Alan  Rein; PhD,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Tatyana  Polenova; PhD (University of Delaware)|Tsutomu  Murakami (National Institute of Infectious Diseases)|Catherine  Adamson (University of St. Andrews)|Scott P Butler|Show all 8",Elena  Chertova (Office Of The Director),Alasdair C Steven; PhD (NIAMS),"1. Keller PW, Adamson CS, Heymann JB, Freed EO, Steven AC (2011). HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice. J Virol  85, 1420-8.   https://doi.org/10.1128/JVI.01926-10|2. Lu W, Salzwedel K, Wang D, Chakravarty S, Freed EO, Wild CT, Li F (2011). A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat. Antimicrob Agents Chemother  55, 3324-9.   https://doi.org/10.1128/AAC.01435-10|3. Zhang H, Curreli F, Zhang X, Bhattacharya S, Waheed AA, Cooper A, Cowburn D, Freed EO, Debnath AK (2011). Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain. Retrovirology  8, 28.   https://doi.org/10.1186/1742-4690-8-28",https://intramural.nih.gov/search/searchview.taf?ipid=73481
261,BC010779-06,"October 01, 2011 -  September 30, 2012",Regulation and Consequences of Ubiquitination,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Maria Letizia  Giardino Torchia|Ivana  Munitic|Netra Pal Meena,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Srinivasula SM, Ashwell JD (2011). A20: more than one way to skin a cat. Mol Cell  44, 511-2.   https://doi.org/10.1016/j.molcel.2011.11.004",https://intramural.nih.gov/search/searchview.taf?ipid=73471
262,BC010780-06,"October 01, 2011 -  September 30, 2012",Structural studies of molecular cancer targets and drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Danielle  Needle|Brian P Austin|George T Lountos|Sreejith  Raran Kurussi; PhD|Shawn Michael Hess|Jason  Liu,"Julius  Rebek (The Scripps Research Institute)|Kamal  Saikh (USAMRIID)|Christopher  Self (Provide Pharma)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Screening Technologies Branch)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS (2011). Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy. J Struct Biol  176, 292-301.   https://doi.org/10.1016/j.jsb.2011.09.008|2. Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS (2011). X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket. FEBS Lett  585, 3245-9.   https://doi.org/10.1016/j.febslet.2011.08.050|3. Lountos GT, Tropea JE, Waugh DS (2011). Structure of human dual-specificity phosphatase 27 at 2.38 Å resolution. Acta Crystallogr D Biol Crystallogr  67, 471-9.   https://doi.org/10.1107/S090744491100970X",https://intramural.nih.gov/search/searchview.taf?ipid=73488
263,BC010782-06,"October 01, 2011 -  September 30, 2012",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Ombretta  Salvucci|Kan  Jiang|Inn-Inn  Chen|Hidetaka  Ohnuki|Hyeong Il  Kwak|David  Sanchez Martin; PhD|Show all 7,"Catherine  Porcher (Oxford Univ)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Maria  Cid (Univ. of Barcelona Medical School)|Elena  Pasquale (Burnham Inst)|James  Stone (Dept. of Cardiology, University of Alberta)|Show all 7",Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),"Dragan  Maric; PhD (NINDS) |William E Paul; MD (NIAID) |Jinfang  Zhu; PhD (NIAID) |Joshua  Farber; MD (NIAID) |Yosuke  Mukoyama; PhD (NHLBI) |Roberto  Weigert; MSc Chemistry, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73489
264,BC010783-06,"October 01, 2011 -  September 30, 2012","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Swati Suresh Choksi|Elena  Pobezinskaya|Yan  Zhang|Ilona  Linnoila; MD,NULL,NULL,J Silvio  Gutkind; PhD (NIDCR),"1. Pobezinskaya YL, Choksi S, Morgan MJ, Cao X, Liu ZG (2011). The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J Immunol  186, 5212-6.   https://doi.org/10.4049/jimmunol.1002374|2. Pobezinskaya YL, Liu Z (2012). The role of TRADD in death receptor signaling. Cell Cycle  11, 871-6.   https://doi.org/10.4161/cc.11.5.19300|3. Sun SC, Liu ZG (2011). A special issue on NF-κB signaling and function. Cell Res  21, 1-2.   https://doi.org/10.1038/cr.2011.1",https://intramural.nih.gov/search/searchview.taf?ipid=73490
265,BC010784-06,"October 01, 2011 -  September 30, 2012",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Won Seon  Choi|Sergio  Coelho|Lanlan  Yin,"Janusz  Beer (Center for Devices & Radiological Health, Food & Drug Administration)|Shosuke  Ito (Department of Chemistry, Fujita Health University)|Yuji  Yamaguchi|Ludger  Kolbe (Beiersdorf AG)",NULL,NULL,"1. Hearing VJ (2011). Determination of melanin synthetic pathways. J Invest Dermatol  131, E8-E11.   https://doi.org/10.1038/skinbio.2011.4|2. Hearing VJ (2011). Milestones in melanocytes/melanogenesis. J Invest Dermatol  131, E1.   https://doi.org/10.1038/skinbio.2011.1|3. Miller S, Coelho S, Miller S, Yamaguchi Y, Hearing V, Beer J (2012) A new paradigm for indoor tanning exposure schedules: a universal schedule that is phototype-independent. Photodermatol Photoimmunol Photomed 28:187-195.|4. Miyamura Y, Coelho SG, Schlenz K, Batzer J, Smuda C, Choi W, Brenner M, Passeron T, Zhang G, Kolbe L, Wolber R, Hearing VJ (2011). The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin. Pigment Cell Melanoma Res  24, 136-47.   https://doi.org/10.1111/j.1755-148X.2010.00764.x",https://intramural.nih.gov/search/searchview.taf?ipid=73491
266,BC010785-06,"October 01, 2011 -  September 30, 2012",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Julio C Valencia; MD|Taisuke  Kondo|Lanlan  Yin|Dominik David Ebsen; PhD,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Takeshi  Namiki|Thierry  Passeron",Michael Marc Gottesman; MD (Multidrug Resistence Section)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Kevin G Chen; MD (NINDS) |David R Adams (NHGRI) |Joseph A Mindell; BS, MD, PhD (NINDS)","1. Kawaguchi M, Hearing VJ (2011). The Roles of ADAMs Family Proteinases in Skin Diseases. Enzyme Res  2011, 482498.   https://doi.org/10.4061/2011/482498|2. Namiki T, Coelho SG, Hearing VJ (2011). NUAK2: an emerging acral melanoma oncogene. Oncotarget  2, 695-704.   https://doi.org/10.18632/oncotarget.325|3. Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ (2011). AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma. Proc Natl Acad Sci U S A  108, 6597-602.   https://doi.org/10.1073/pnas.1007694108",https://intramural.nih.gov/search/searchview.taf?ipid=73492
267,BC010786-06,"October 01, 2011 -  September 30, 2012",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Julio C Valencia; MD|Won Seon  Choi|Taisuke  Kondo|Lanlan  Yin|Dominik David Ebsen; PhD,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Ludger  Kolbe (Beiersdorf AG)|Takeshi  Namiki|Thierry  Passeron",NULL,NULL,"1. Kawaguchi M, Valencia JC, Namiki T, Suzuki T, Hearing VJ (2012) Diacylglycerol kinase regulates tyrosinase expression in human melanocytes. J Invest Dermatol, in press.|2. Kondo T, Hearing VJ (2011). Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol  6, 97-108.   https://doi.org/10.1586/edm.10.70",https://intramural.nih.gov/search/searchview.taf?ipid=73493
268,BC010787-06,"October 01, 2011 -  September 30, 2012",Redox Imaging using Nitroxides and MRI,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Anastasia L Sowers|Angela  Thetford|Murali  Krishna; PhD,NULL,NULL,NULL,"1. Davis RM, Matsumoto S, Bernardo M, Sowers A, Matsumoto K, Krishna MC, Mitchell JB (2011). Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape. Free Radic Biol Med  50, 459-68.   https://doi.org/10.1016/j.freeradbiomed.2010.11.028|2. Davis RM, Sowers AL, DeGraff W, Bernardo M, Thetford A, Krishna MC, Mitchell JB (2011). A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic Biol Med  51, 780-90.   https://doi.org/10.1016/j.freeradbiomed.2011.05.019",https://intramural.nih.gov/search/searchview.taf?ipid=73494
269,BC010788-06,"October 01, 2011 -  September 30, 2012",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhihui  Liu|Shuang  Yan|Doo-Yi  Oh|Chunxi  Wang|Luke Allister Wylie|Shiwei  He|Show all 8,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Lino  Tessarollo (Mouse Cancer Genetics Program)|Susan  Bates; MD (Medical Oncology Branch),Kai  Ge; PhD (NIDDK) |Yosuke  Mukoyama; PhD (NHLBI),"1. Lawlor ER, Thiele CJ (2012) Epigenetic changes in pediatric solid tumors: promising new targets. Clin Cancer Res 18:2768-79|2. Liu Z, Naranjo A, Thiele CJ (2011) CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth. PLoS One 6:e18557.|3. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187",https://intramural.nih.gov/search/searchview.taf?ipid=73495
270,BC010789-06,"October 01, 2011 -  September 30, 2012",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhihui  Liu|Shuang  Yan|Doo-Yi  Oh|Chunxi  Wang|Luke Allister Wylie|Shiwei  He|Show all 8,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Susan  Bates; MD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Li Z, Oh DY, Nakamura K, Thiele CJ (2011). Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer  117, 5412-22.   https://doi.org/10.1002/cncr.26133|2. Nakamura K, Tan F, Li Z, Thiele CJ (2011) NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1. Mol Cell Neurosci 46:498-506.|3. Thiele CJ, Cohn SL (2012) Genetically InFormed Therapies--A GIFT for Children with Cancer. Clin Cancer Res 18:2735-9.",https://intramural.nih.gov/search/searchview.taf?ipid=73496
271,BC010791-06,"October 01, 2011 -  September 30, 2012","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Maureen P Martin|Darlene M Marti|Xiaojiang  Gao|Fuh-Mei  Duh|Rasmi  Thomas; PhD|Smita V Kulkarni; PhD|Show all 11,"Amalio  Telenti (University Hospital of Lausanne)|Howard  Strickler (Albert Einstein College of Medicine)|Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Show all 15",Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),Barbara  Rehermann; MD (NIDDK),"1. Alter A, Huong NT, Singh M, Orlova M, Van Thuc N, Katoch K, Gao X, Thai VH, Ba NN, Carrington M, Abel L, Mehra N, Alcaïs A, Schurr E (2011). Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. J Infect Dis  203, 1274-81.   https://doi.org/10.1093/infdis/jir024|2. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, Carrington M, Allen TM, Altfeld M (2011). HIV-1 adaptation to NK-cell-mediated immune pressure. Nature  476, 96-100.   https://doi.org/10.1038/nature10237|3. Bashirova AA, Thomas R, Carrington M (2011). HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol  29, 295-317.   https://doi.org/10.1146/annurev-immunol-031210-101332|4. Chang J, Lindsay RJ, Kulkarni S, Lifson JD, Carrington M, Altfeld M (2011). Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1. AIDS  25, 715-7.   https://doi.org/10.1097/QAD.0b013e328343c186|5. Dahirel V, Shekhar K, Pereyra F, Miura T, Artyomov M, Talsania S, Allen TM, Altfeld M, Carrington M, Irvine DJ, Walker BD, Chakraborty AK (2011). Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc Natl Acad Sci U S A  108, 11530-5.   https://doi.org/10.1073/pnas.1105315108|6. Julg B, Moodley ES, Qi Y, Ramduth D, Reddy S, Mncube Z, Gao X, Goulder PJ, Detels R, Ndung'u T, Walker BD, Carrington M (2011) Possession of HLA class II DRB11303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis 203:803-9.|7. Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, Berical AC, Feller AJ, Johnson KL, Schulze zur Wiesch J, Robbins GK, Chung RT, Walker BD, Carrington M, Allen TM, Lauer GM (2011). Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology  140, 686-696.e1.   https://doi.org/10.1053/j.gastro.2010.09.042|8. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, Pereyra F, Goldstein D, Wolinsky S, Walker B, Young HA, Carrington M (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472:495-8.|9. Kuniholm MH, Gao X, Xue X, Kovacs A, Anastos K, Marti D, Greenblatt RM, Cohen MH, Minkoff H, Gange SJ, Fazzari M, Young MA, Strickler HD, Carrington M (2011). Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. J Virol  85, 10826-33.   https://doi.org/10.1128/JVI.00804-11|10. Li JZ, Brumme ZL, Brumme CJ, Wang H, Spritzler J, Robertson MN, Lederman MM, Carrington M, Walker BD, Schooley RT, Kuritzkes DR, AIDS Clinical Trials Group A5197 Study Team (2011). Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial. J Infect Dis  203, 976-83.   https://doi.org/10.1093/infdis/jiq143|11. Matthews PC, Adland E, Listgarten J, Leslie A, Mkhwanazi N, Carlson JM, Harndahl M, Stryhn A, Payne RP, Ogwu A, Huang KH, Frater J, Paioni P, Kloverpris H, Jooste P, Goedhals D, van Vuuren C, Steyn D, Riddell L, Chen F, Luzzi G, Balachandran T, Ndung'u T, Buus S, Carrington M, et al. [3 more authors] (2011). HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703. J Immunol  186, 5675-86.   https://doi.org/10.4049/jimmunol.1003711|12. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O'Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, et al. [5 more authors] (2011). HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med  364, 1134-43.   https://doi.org/10.1056/NEJMoa1013297|13. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM, Martinson JJ, Jamieson BD, Bream JH, Martin MP, Borrow P, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Carrington M, Goldstein DB, Alter G, NIAID Center for HIV/AIDS Vaccine Immunology (2011). Copy number variation of KIR genes influences HIV-1 control. PLoS Biol  9, e1001208.   https://doi.org/10.1371/journal.pbio.1001208",https://intramural.nih.gov/search/searchview.taf?ipid=73475
272,BC010792-06,"October 01, 2011 -  September 30, 2012",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Maureen P Martin|Darlene M Marti|Xiaojiang  Gao|Fuh-Mei  Duh|Rasmi  Thomas; PhD|Smita V Kulkarni; PhD|Show all 12,"John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Kenneth  Kidd (Yale University)|Bruce  Walker (Harvard Medical School)|Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Diogo  Meyer (Genetics and evolutionary biology, University of Sao Paulo)|Show all 9",NULL,NULL,"1. Abi-Rached L, Jobin MJ, Kulkarni S, McWhinnie A, Dalva K, Gragert L, Babrzadeh F, Gharizadeh B, Luo M, Plummer FA, Kimani J, Carrington M, Middleton D, Rajalingam R, Beksac M, Marsh SG, Maiers M, Guethlein LA, Tavoularis S, Little AM, Green RE, Norman PJ, Parham P (2011). The shaping of modern human immune systems by multiregional admixture with archaic humans. Science  334, 89-94.   https://doi.org/10.1126/science.1209202|2. Augusto DG, Zehnder-Alves L, Pincerati MR, Martin MP, Carrington M, Petzl-Erler ML (2012). Diversity of the KIR gene cluster in an urban Brazilian population. Immunogenetics  64, 143-52.   https://doi.org/10.1007/s00251-011-0565-1|3. Erlich RL, Jia X, Anderson S, Banks E, Gao X, Carrington M, Gupta N, DePristo MA, Henn MR, Lennon NJ, de Bakker PI (2011). Next-generation sequencing for HLA typing of class I loci. BMC Genomics  12, 42.   https://doi.org/10.1186/1471-2164-12-42|4. O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW (2011). Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J Immunol  187, 2162-71.   https://doi.org/10.4049/jimmunol.1002906|5. O'huigin C, Kulkarni S, Xu Y, Deng Z, Kidd J, Kidd K, Gao X, Carrington M (2011). The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet  89, 424-31.   https://doi.org/10.1016/j.ajhg.2011.07.024",https://intramural.nih.gov/search/searchview.taf?ipid=73474
273,BC010793-06,"October 01, 2011 -  September 30, 2012","Role of inflammation, innate resistance, and immunity in carcinogenesis.",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Robin T Winkler Pickett|Ren Ming  Dai|Loretta R Smith|Charles Andrew Marshall Stewart|Rosalba  Salcedo|Amiran  Dzutsev; PhD|Show all 10,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Mario  Colombo (Experimental Oncology, National Institute of Surgery and Cure of Tumors)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Franca  Gerosa (Pathology/Immunology, University of Verona)|Sergei A. Nedospasov; PhD, DSc|Dominique  Kaiserlian (U404, INSERM)","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",Alan  Sher; PhD (NIAID) |Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID),"1. Stewart C, Trinchieri G (2011) Turning on and off the immunological switch:  Immune response polarization and its control by IL-10 and STAT3, in Immunologic Signature of Rejection. .  Volume VII,  pp. 27-56.|2. Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL, Song W, Stroncek DF, Tahara H, Thurin M, et al. [8 more authors] (2011). Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res  17, 3064-76.   https://doi.org/10.1158/1078-0432.CCR-10-2234|3. Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD, Mayer-Barber KD, Myers TG, Rabin RL, Trinchieri G, Sher A, Feng CG (2011). Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol  187, 2540-7.   https://doi.org/10.4049/jimmunol.1100926|4. Reizis B, Colonna M, Trinchieri G, Barrat F, Gilliet M (2011). Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol  11, 558-65.   https://doi.org/10.1038/nri3027|5. Saleh M, Trinchieri G (2011). Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol  11, 9-20.   https://doi.org/10.1038/nri2891|6. Sisirak V, Vey N, Vanbervliet B, Duhen T, Puisieux I, Homey B, Bowman EP, Trinchieri G, Dubois B, Kaiserlian D, Lira SA, Puisieux A, Blay JY, Caux C, Bendriss-Vermare N (2011). CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood  118, 5130-40.   https://doi.org/10.1182/blood-2010-07-295626|7. Stewart CA, Trinchieri G (2011). At 17, in-10's passion need not inflame. Immunity  34, 460-2.   https://doi.org/10.1016/j.immuni.2011.04.004|8. Trinchieri G (2011). Inflammation in cancer: a therapeutic target? Oncology (Williston Park)  25, 418-20.|9. Trinchieri G (2011). Innate inflammation and cancer: Is it time for cancer prevention? F1000 Med Rep  3, 11.   https://doi.org/10.3410/M3-11",https://intramural.nih.gov/search/searchview.taf?ipid=73497
274,BC010794-06,"October 01, 2011 -  September 30, 2012",Characterization of Cancer Stem Cells,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",NULL,NULL,NULL,NULL,"1. Cabarcas SM, Mathews LA, Farrar WL (2011). The cancer stem cell niche--there goes the neighborhood? Int J Cancer  129, 2315-27.   https://doi.org/10.1002/ijc.26312|2. Crea F, Duhagon MA, Farrar WL, Danesi R (2011). Pharmacogenomics and cancer stem cells: a changing landscape? Trends Pharmacol Sci  32, 487-94.   https://doi.org/10.1016/j.tips.2011.03.010|3. Crea F, Hurt EM, Mathews LA, Cabarcas SM, Sun L, Marquez VE, Danesi R, Farrar WL (2011). Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer  10, 40.   https://doi.org/10.1186/1476-4598-10-40|4. Mathews LA, Cabarcas SM, Farrar WL (2011). DNA repair: the culprit for tumor-initiating cell survival? Cancer Metastasis Rev  30, 185-97.   https://doi.org/10.1007/s10555-011-9277-0|5. Mathews LA, Cabarcas SM, Hurt EM, Zhang X, Jaffee EM, Farrar WL (2011). Increased expression of DNA repair genes in invasive human pancreatic cancer cells. Pancreas  40, 730-9.   https://doi.org/10.1097/MPA.0b013e31821ae25b",https://intramural.nih.gov/search/searchview.taf?ipid=73476
275,BC010795-06,"October 01, 2011 -  September 30, 2012",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq|Masahiko  Imashimizu|Alexei Arkadievich Krainev,"Zachary  Burton (Department of Biochemistry and Molecular Biology, Michigan State University)|Jianhua  Fu (Cornell University)|Charles  Turnbough (Unversity of Alabama)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Benoit  Coulombe (Institut de recherches cliniques de Montreal)|Carlos  Bustamante (University of California - Berkeley)|Show all 7",Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section)|Shalini  Oberdoerffer (Mouse Cancer Genetics Program)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Bintu L, Kopaczynska M, Hodges C, Lubkowska L, Kashlev M, Bustamante C (2011). The elongation rate of RNA polymerase determines the fate of transcribed nucleosomes. Nat Struct Mol Biol  18, 1394-9.   https://doi.org/10.1038/nsmb.2164|2. Kireeva ML, Domecq C, Coulombe B, Burton ZF, Kashlev M (2011). Interaction of RNA polymerase II fork loop 2 with downstream non-template DNA regulates transcription elongation. J Biol Chem  286, 30898-910.   https://doi.org/10.1074/jbc.M111.260844",https://intramural.nih.gov/search/searchview.taf?ipid=73498
276,BC010800-06,"October 01, 2011 -  September 30, 2012",Convection enhanced delivery of agents into the brainstem of glioma patients,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski,NULL,NULL,"Russell R Lonser; MD (NINDS) |Ashok R Asthagiri; MD (NINDS) |Carlo  Pierpaoli; MD, PhD (NICHD) |Joelle  Sarlls; PhD (NINDS) |John D Heiss; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73500
277,BC010801-06,"October 01, 2011 -  September 30, 2012",Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other G,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Nalini M Jayaprakash|Andrea F Gillespie|Wendy J Goodspeed|Anne D Goodwin|Aerang  Kim|Eva  Dombi|Show all 11,"David  Viskochil (University of Utah)|John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Larry  Baker (SARC)|Susan  Blaney (Texas Children's Cancer Center)|Roger  Packer (Children's National Medical Center)|David  Gutmann (Washington University)|Show all 22","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Ann M Cohen-Berger; MD (CC) |Nicholas  Patronas; MD (CC) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73501
278,BC010802-06,"October 01, 2011 -  September 30, 2012",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Paul Gerard Hynes|Heather  Sheppard|Yen Nien  Liu|Benjamin Naylor Barrett,NULL,NULL,NULL,"1. Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu YN, Seng V, Lake R, Spurrier J, Kelly K (2011). Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. PLoS One  6, e26112.   https://doi.org/10.1371/journal.pone.0026112|2. Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K (2011). Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol  179, 422-35.   https://doi.org/10.1016/j.ajpath.2011.03.035",https://intramural.nih.gov/search/searchview.taf?ipid=73502
279,BC010803-06,"October 01, 2011 -  September 30, 2012",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang|Kenichi  Hanada,NULL,NULL,NULL,"1. Hanada K, Wang QJ, Inozume T, Yang JC (2011). Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptor. Blood  117, 4816-25.   https://doi.org/10.1182/blood-2010-11-317743|2. Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC (2011). Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods  366, 43-51.   https://doi.org/10.1016/j.jim.2011.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=73503
280,BC010804-06,"October 01, 2011 -  September 30, 2012",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Boopathy  Ramakrishna|Natalia  Mercer|Luke Anthony Verdi,NULL,NULL,NULL,"1. Mercer N, Ramakrishnan B, Boeggeman E, Qasba PK (2011). Applications of site-specific labeling to study HAMLET, a tumoricidal complex of α-lactalbumin and oleic acid. PLoS One  6, e26093.   https://doi.org/10.1371/journal.pone.0026093",https://intramural.nih.gov/search/searchview.taf?ipid=73504
281,BC010806-06,"October 01, 2011 -  September 30, 2012",Targeting High-risk Neuroblastoma using high through put siRNA screening,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Jianbin Na He|John Frederick Shern|Dominik  Bogen|Jianjun  Wang|Show all 9,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)",Malcolm A Smith (Clinical Investigations Branch),NULL,"1. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697|2. Guo X, Chen QR, Song YK, Wei JS, Khan J (2011). Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics  4, 35.   https://doi.org/10.1186/1755-8794-4-35|3. Tsang PS, Cheuk AT, Chen QR, Song YK, Badgett TC, Wei JS, Khan J (2012). Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma. BMC Cancer  12, 101.   https://doi.org/10.1186/1471-2407-12-101",https://intramural.nih.gov/search/searchview.taf?ipid=73505
282,BC010808-06,"October 01, 2011 -  September 30, 2012",Nucleosome Dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Jingjun  Hong|Bing-Rui  Zhou|Hongwei  Wu|Carl  Wu; PhD,NULL,Michael  Bustin; PhD (Protein Section),NULL,"1. Zhou BR, Feng H, Ghirlando R, Kato H, Gruschus J, Bai Y (2012). Histone H4 K16Q mutation, an acetylation mimic, causes structural disorder of its N-terminal basic patch in the nucleosome. J Mol Biol  421, 30-7.   https://doi.org/10.1016/j.jmb.2012.04.032",https://intramural.nih.gov/search/searchview.taf?ipid=73472
283,BC010814-06,"October 01, 2011 -  September 30, 2012",Regulation of Retroviral RNA Packaging and Dynamics of HIV-1 RNA Export,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Na  Ni|Kari Ann Dilley|Steven Carter Hatch|Aviva  Joseph|Vinay K Pathak; PhD|Show all 8,William W Fu|Roger  Ptak (Southern Research Institute)|David  Grnwald (Technical University of Delft),Stephen J Lockett; PhD (Office Of The Director),George  Patterson; PhD (NIBIB),"1. Dilley KA, Ni N, Nikolaitchik OA, Chen J, Galli A, Hu WS (2011). Determining the frequency and mechanisms of HIV-1 and HIV-2 RNA copackaging by single-virion analysis. J Virol  85, 10499-508.   https://doi.org/10.1128/JVI.05147-11|2. Ni N, Nikolaitchik OA, Dilley KA, Chen J, Galli A, Fu W, Prasad VV, Ptak RG, Pathak VK, Hu WS (2011). Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners. J Virol  85, 7603-12.   https://doi.org/10.1128/JVI.00562-11",https://intramural.nih.gov/search/searchview.taf?ipid=73506
284,BC010816-06,"October 01, 2011 -  September 30, 2012",Immunotherapy for Malignant Mesothelioma,Raffit  Hassan|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Sonya C Duke|Rita  Mincemoyer; RN|Jingli  Zhang|Elizabeth J Maestri|Barbara S Schuler|Yvonne D Mallory|Show all 9,NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch),NULL,"1. Feng M, Zhang J, Anver M, Hassan R, Ho M (2011). In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice. J Cancer  2, 123-31.   https://doi.org/10.7150/jca.2.123|2. Kelly RJ, Sharon E, Hassan R (2011). Chemotherapy and targeted therapies for unresectable malignant mesothelioma. Lung Cancer  73, 256-63.   https://doi.org/10.1016/j.lungcan.2011.04.014|3. Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH (2011). Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts. Clin Cancer Res  17, 3697-705.   https://doi.org/10.1158/1078-0432.CCR-11-0493|4. Shin IS, Lee SM, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH (2011). Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody. Nucl Med Biol  38, 1119-27.   https://doi.org/10.1016/j.nucmedbio.2011.05.003|5. Xiang X, Phung Y, Feng M, Nagashima K, Zhang J, Broaddus VC, Hassan R, Fitzgerald D, Ho M (2011). The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One  6, e14640.   https://doi.org/10.1371/journal.pone.0014640",https://intramural.nih.gov/search/searchview.taf?ipid=73508
285,BC010819-06,"October 01, 2011 -  September 30, 2012",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Shawn A Hill,"Anuradha  Ganesan (Henry M. Jackson Foundation)|Peter  Sklar (Drexel University)|Joseph  Margolick (School of Public Health, Johns Hopkins University)|Eric  Daar (Infectious Diseases, Harbor-UCL Medical Center)|John W Mellors|Deborah  Persaud (Johns Hopkins University)|Show all 18",Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Michael  Polis; MD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joseph A Kovacs; MD (CC)","1. International AIDS Society Scientific Working Group on HIV Cure, Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, Katlama C, Lafeuillade A, Landay A, Lederman M, Lewin SR, Maldarelli F, Margolis D, Markowitz M, Martinez-Picado J, Mullins JI, Mellors J, Moreno S, O'Doherty U, Palmer S, Penicaud MC, Peterlin M, et al. [11 more authors] (2012). Towards an HIV cure: a global scientific strategy. Nat Rev Immunol  12, 607-14.   https://doi.org/10.1038/nri3262|2. Josefsson L, King MS, Makitalo B, Brännström J, Shao W, Maldarelli F, Kearney MF, Hu WS, Chen J, Gaines H, Mellors JW, Albert J, Coffin JM, Palmer SE (2011). Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A  108, 11199-204.   https://doi.org/10.1073/pnas.1107729108|3. Mens H, Kearney M, Wiegand A, Spindler J, Maldarelli F, Mellors JW, Coffin JM (2011). Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assays. J Vis Exp  .  https://doi.org/10.3791/2960",https://intramural.nih.gov/search/searchview.taf?ipid=73511
286,BC010822-06,"October 01, 2011 -  September 30, 2012",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|John S Choy|Prashant  Mishra|Sultan Y Ciftci|Lars  Bockmann|Anthony Rohit Dawson|Show all 10,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Oliver J. Rando (Stanford University)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Show all 9",Timothy D Veenstra (Office Of The Director)|Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),Caroline C Philpott; MD (NIDDK),"1. Choy JS, Acuña R, Au WC, Basrai MA (2011). A role for histone H4K16 hypoacetylation in Saccharomyces cerevisiae kinetochore function. Genetics  189, 11-21.   https://doi.org/10.1534/genetics.111.130781|2. Mishra PK, Au WC, Choy JS, Kuich PH, Baker RE, Foltz DR, Basrai MA (2011). Misregulation of Scm3p/HJURP causes chromosome instability in Saccharomyces cerevisiae and human cells. PLoS Genet  7, e1002303.   https://doi.org/10.1371/journal.pgen.1002303",https://intramural.nih.gov/search/searchview.taf?ipid=73473
287,BC010824-06,"October 01, 2011 -  September 30, 2012",Molecular structure of the bacterial chemotaxis apparatus,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Martin  Kessel; BSc, PhD|Lisa M. Hartnell|Madhvi Jayalakshmi Venkatesh",NULL,NULL,Bernard R Brooks; PhD (NHLBI),"1. Butan C, Hartnell LM, Fenton AK, Bliss D, Sockett RE, Subramaniam S, Milne JL (2011). Spiral architecture of the nucleoid in Bdellovibrio bacteriovorus. J Bacteriol  193, 1341-50.   https://doi.org/10.1128/JB.01061-10|2. Khursigara CM, Lan G, Neumann S, Wu X, Ravindran S, Borgnia MJ, Sourjik V, Milne J, Tu Y, Subramaniam S (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J  30, 1719-29.   https://doi.org/10.1038/emboj.2011.77|3. Li M, Khursigara CM, Subramaniam S, Hazelbauer GL (2011). Chemotaxis kinase CheA is activated by three neighbouring chemoreceptor dimers as effectively as by receptor clusters. Mol Microbiol  79, 677-85.   https://doi.org/10.1111/j.1365-2958.2010.07478.x",https://intramural.nih.gov/search/searchview.taf?ipid=73514
288,BC010825-06,"October 01, 2011 -  September 30, 2012",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Audray  Harris; PhD|Erin E Tran|Joel Reuben Meyerson|Laurent A Gaudreault|Gabriel Abraham Frank|Prashant Arkalgud Rao|Show all 8,NULL,Jeffrey D Lifson; MD (Office Of The Director)|Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Eric O Freed; PhD (Retroviral Replication Laboratory),NULL,"1. Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW, Klasse PJ, Milne JL, Wilson IA, Olson WC, Moore JP, Subramaniam S (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A  108, 11440-5.   https://doi.org/10.1073/pnas.1101414108|2. Meyerson JR, White TA, Bliss D, Moran A, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Schauder D, Hartnell LM, Nandwani R, Dawood M, Kim B, Kim JH, Sununu J, Yang L, Bhatia S, Subramaniam C, Hurt DE, Gaudreault L, Subramaniam S (2011). Determination of molecular structures of HIV envelope glycoproteins using cryo-electron tomography and automated sub-tomogram averaging. J Vis Exp  .  https://doi.org/10.3791/2770|3. Murphy GE, Narayan K, Lowekamp BC, Hartnell LM, Heymann JA, Fu J, Subramaniam S (2011). Correlative 3D imaging of whole mammalian cells with light and electron microscopy. J Struct Biol  176, 268-78.   https://doi.org/10.1016/j.jsb.2011.08.013|4. Nikolic DS, Lehmann M, Felts R, Garcia E, Blanchet FP, Subramaniam S, Piguet V (2011). HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood  118, 4841-52.   https://doi.org/10.1182/blood-2010-09-305417|5. White TA, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Nandwani R, Hoxie JA, Bess JW, Lifson JD, Milne JL, Subramaniam S (2011). Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol  85, 12114-23.   https://doi.org/10.1128/JVI.05297-11",https://intramural.nih.gov/search/searchview.taf?ipid=73515
289,BC010826-06,"October 01, 2011 -  September 30, 2012",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Kedar  Narayan|Gabriel Abraham Frank|Andrei Radu Florescu|Lesley Ann Earl; PhD,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)|Chris  Szakal (NIST)",NULL,Bernard R Brooks; PhD (NHLBI) |Terry S Yoo; PhD (NLM),"1. Butan C, Hartnell LM, Fenton AK, Bliss D, Sockett RE, Subramaniam S, Milne JL (2011). Spiral architecture of the nucleoid in Bdellovibrio bacteriovorus. J Bacteriol  193, 1341-50.   https://doi.org/10.1128/JB.01061-10|2. Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW, Klasse PJ, Milne JL, Wilson IA, Olson WC, Moore JP, Subramaniam S (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A  108, 11440-5.   https://doi.org/10.1073/pnas.1101414108|3. Khursigara CM, Lan G, Neumann S, Wu X, Ravindran S, Borgnia MJ, Sourjik V, Milne J, Tu Y, Subramaniam S (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J  30, 1719-29.   https://doi.org/10.1038/emboj.2011.77|4. Li M, Khursigara CM, Subramaniam S, Hazelbauer GL (2011). Chemotaxis kinase CheA is activated by three neighbouring chemoreceptor dimers as effectively as by receptor clusters. Mol Microbiol  79, 677-85.   https://doi.org/10.1111/j.1365-2958.2010.07478.x|5. Meyerson JR, White TA, Bliss D, Moran A, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Schauder D, Hartnell LM, Nandwani R, Dawood M, Kim B, Kim JH, Sununu J, Yang L, Bhatia S, Subramaniam C, Hurt DE, Gaudreault L, Subramaniam S (2011). Determination of molecular structures of HIV envelope glycoproteins using cryo-electron tomography and automated sub-tomogram averaging. J Vis Exp  .  https://doi.org/10.3791/2770|6. Murphy GE, Narayan K, Lowekamp BC, Hartnell LM, Heymann JA, Fu J, Subramaniam S (2011). Correlative 3D imaging of whole mammalian cells with light and electron microscopy. J Struct Biol  176, 268-78.   https://doi.org/10.1016/j.jsb.2011.08.013|7. Nikolic DS, Lehmann M, Felts R, Garcia E, Blanchet FP, Subramaniam S, Piguet V (2011). HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood  118, 4841-52.   https://doi.org/10.1182/blood-2010-09-305417|8. Szakal C, Narayan K, Fu J, Lefman J, Subramaniam S (2011). Compositional mapping of the surface and interior of mammalian cells at submicrometer resolution. Anal Chem  83, 1207-13.   https://doi.org/10.1021/ac1030607|9. Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI (2011). Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles. Proc Natl Acad Sci U S A  108, 9798-803.   https://doi.org/10.1073/pnas.1014598108|10. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S (2012). Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog  8, e1002797.   https://doi.org/10.1371/journal.ppat.1002797|11. White TA, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Nandwani R, Hoxie JA, Bess JW, Lifson JD, Milne JL, Subramaniam S (2011). Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol  85, 12114-23.   https://doi.org/10.1128/JVI.05297-11",https://intramural.nih.gov/search/searchview.taf?ipid=73516
290,BC010827-06,"October 01, 2011 -  September 30, 2012",Structural Studies of Bacterial Architecture Using Electron Tomography,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Sriram  Subramaniam; PhD,NULL,NULL,NULL,"1. Butan C, Hartnell LM, Fenton AK, Bliss D, Sockett RE, Subramaniam S, Milne JL (2011). Spiral architecture of the nucleoid in Bdellovibrio bacteriovorus. J Bacteriol  193, 1341-50.   https://doi.org/10.1128/JB.01061-10|2. Khursigara CM, Lan G, Neumann S, Wu X, Ravindran S, Borgnia MJ, Sourjik V, Milne J, Tu Y, Subramaniam S (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J  30, 1719-29.   https://doi.org/10.1038/emboj.2011.77",https://intramural.nih.gov/search/searchview.taf?ipid=73517
291,BC010830-06,"October 01, 2011 -  September 30, 2012",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Carol O Cardarelli|Rajalakshm L Padmanabhan|Matthew David Hall|Jean-Pierre  Gillet|King Leung Fung|Lynn Margaret Pouliot|Show all 10,"Jacob  Hochman (Hebrew University)|Michael  Seiden (Hematology Oncology, Dana-Farber/Partners Cancer Care Program)|Ram  Ganapathy (Cleveland Clinic)|Ben  Davidson (Norwegian Radium Hospital)|Bo  Rueda (Massachusetts General Hospital)|Robert  Hollingsworth (MedImmune)",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Vincent J. Hearing; PhD (Pigment Cell Biology Section)|Ola Anders Landgren (Lymphoid Malignancies Branch),"Kevin G Chen; MD (NINDS) |Joshua  Zimmerberg; PhD, MD (NICHD)","1. Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM (2012). Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clin Cancer Res  18, 3197-206.   https://doi.org/10.1158/1078-0432.CCR-12-0056|2. Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM (2011). Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A  108, 18708-13.   https://doi.org/10.1073/pnas.1111840108|3. Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, Gottesman MM (2011). Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions. Mol Pharm  8, 2080-8.   https://doi.org/10.1021/mp200240a|4. Padmanabhan R, Chen KG, Gillet JP, Handley M, Mallon BS, Hamilton RS, Park K, Varma S, Mehaffey MG, Robey PG, McKay RD, Gottesman MM (2012). Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells  30, 2175-87.   https://doi.org/10.1002/stem.1195|5. Shaffer BC, Gillet JP, Patel C, Baer MR, Bates SE, Gottesman MM (2012). Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updat  15, 62-9.   https://doi.org/10.1016/j.drup.2012.02.001",https://intramural.nih.gov/search/searchview.taf?ipid=73518
292,BC010832-06,"October 01, 2011 -  September 30, 2012",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,Joel Patrick Schneider; PhD,"Chemical Biology Laboratory, NCI",Igor V Filippov|Markus  Sitzmann|Iwona Elzbieta Weidlich,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Iwona Elzbieta Weidlich,Raul Eduardo Cachau (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73519
293,BC010833-06,"October 01, 2011 -  September 30, 2012",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Nicole E Mcneil|Hesed M Padilla Nash|Damrong M Wangsa|Chi Chung  Cheng|Darawalee  Wangsa|Show all 13,NULL,NULL,NULL,"1. Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T (2012). The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res  18, 4919-30.   https://doi.org/10.1158/1078-0432.CCR-12-0016|2. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187|3. Olnes MJ, Poon A, Miranda SJ, Pfannes L, Tucker Z, Loeliger K, Padilla-Nash H, Yau YY, Ried T, Leitman SF, Young NS, Sloand EM (2012). Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors. Transfusion  52, 537-41.   https://doi.org/10.1111/j.1537-2995.2011.03313.x|4. Sharon E, Zhang J, Hollevoet K, Steinberg SM, Pastan I, Onda M, Gaedcke J, Ghadimi BM, Ried T, Hassan R (2012). Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers. Clin Chem Lab Med  50, 721-5.   https://doi.org/10.1515/CCLM.2011.816|5. Xie Y, Tobin LA, Camps J, Wangsa D, Yang J, Rao M, Witasp E, Awad KS, Yoo N, Ried T, Kwong KF (2013). MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene  32, 2442-51.   https://doi.org/10.1038/onc.2012.258|6. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP (2012). DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One  7, e31507.   https://doi.org/10.1371/journal.pone.0031507",https://intramural.nih.gov/search/searchview.taf?ipid=73520
294,BC010834-06,"October 01, 2011 -  September 30, 2012","Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Kerstin  Heselmeyer|Chi Chung  Cheng|Yue  Hu|Amanda Iris Bradley|Hua  Zou,Gert  Auer|Elisabeth  Unger,NULL,NULL,"1. Gemoll T, Roblick UJ, Szymczak S, Braunschweig T, Becker S, Igl BW, Bruch HP, Ziegler A, Hellman U, Difilippantonio MJ, Ried T, Jörnvall H, Auer G, Habermann JK (2011). HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers. Cell Mol Life Sci  68, 3261-74.   https://doi.org/10.1007/s00018-011-0628-3",https://intramural.nih.gov/search/searchview.taf?ipid=73521
295,BC010835-06,"October 01, 2011 -  September 30, 2012",Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer Tran,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Nicole E Mcneil|Hesed M Padilla Nash|Damrong M Wangsa|Kerstin  Heselmeyer|Chi Chung  Cheng|Show all 13,Yuri  Lazebnik (Cold Spring Harbor Laboratories)|Thomas  Cremer (University of Munich),Yamini Praful Dalal (Laboratory of Receptor Biology and Gene Expression),Danny L Sackett; PhD (NICHD),"1. Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T, Sartorelli V (2011). Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis  32, 1607-14.   https://doi.org/10.1093/carcin/bgr184|2. Goldenberg DM, Zagzag D, Heselmeyer-Haddad KM, Berroa Garcia LY, Ried T, Loo M, Chang CH, Gold DV (2012). Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer  131, 49-58.   https://doi.org/10.1002/ijc.26327|3. Habermann JK, Bündgen NK, Gemoll T, Hautaniemi S, Lundgren C, Wangsa D, Doering J, Bruch HP, Nordstroem B, Roblick UJ, Jörnvall H, Auer G, Ried T (2011). Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Mol Cancer  10, 132.   https://doi.org/10.1186/1476-4598-10-132|4. Hirsch D, Camps J, Varma S, Kemmerling R, Stapleton M, Ried T, Gaiser T (2012) A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps. Genes Chromosomes Cancer 51:490-500|5. Padilla-Nash HM, Hathcock K, McNeil NE, Mack D, Hoeppner D, Ravin R, Knutsen T, Yonescu R, Wangsa D, Dorritie K, Barenboim L, Hu Y, Ried T (2012) Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances. Genes Chromosomes Cancer 51:353-74",https://intramural.nih.gov/search/searchview.taf?ipid=73522
296,BC010837-06,"October 01, 2011 -  September 30, 2012",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Nicole E Mcneil|Chi Chung  Cheng|Jordi  Camps Polo|Yue  Hu|Natasha  Caplen,NULL,NULL,NULL,"1. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T (2011). Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol  178, 1478-88.   https://doi.org/10.1016/j.ajpath.2010.12.036|2. Kendziorra E, Ahlborn K, Spitzner M, Rave-Fränk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beissbarth T, Ebner R, Ghadimi BM, Pukrop T, Ried T, Grade M (2011). Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis  32, 1824-31.   https://doi.org/10.1093/carcin/bgr222",https://intramural.nih.gov/search/searchview.taf?ipid=73525
297,BC010839-06,"October 01, 2011 -  September 30, 2012",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Svetlana  Kotliarova|Aiguo  Li|Jennifer  Walling|Susie  Ahn|Natalia N Ogurtsova|Show all 16,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73477
298,BC010840-06,"October 01, 2011 -  September 30, 2012",Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Svetlana  Kotliarova|Aiguo  Li|Jennifer  Walling|Susie  Ahn|Natalia N Ogurtsova|Show all 16,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73478
299,BC010844-06,"October 01, 2011 -  September 30, 2012",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Tatiana Vladimirovna Nikitina|Nikolai Borisovich Ulianov; PhD,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)",Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),"1. Olson WK, Zhurkin VB (2011). Working the kinks out of nucleosomal DNA. Curr Opin Struct Biol  21, 348-57.   https://doi.org/10.1016/j.sbi.2011.03.006|2. Zhurkin VB (2011). The first thirty years of nucleosome positioning: comment on ""Cracking the chromatin code: precise rule of nucleosome positioning"" by Trifonov. Phys Life Rev  8, 64-6; discussion 69-72.   https://doi.org/10.1016/j.plrev.2011.02.001",https://intramural.nih.gov/search/searchview.taf?ipid=73527
300,BC010845-06,"October 01, 2011 -  September 30, 2012",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Ettore  Appella; MD (Chemical Immunology Section),Ronald D Neumann; MD (CC),"1. Cui F, Sirotin MV, Zhurkin VB (2011). Impact of Alu repeats on the evolution of human p53 binding sites. Biol Direct  6, 2.   https://doi.org/10.1186/1745-6150-6-2",https://intramural.nih.gov/search/searchview.taf?ipid=73486
301,BC010846-06,"October 01, 2011 -  September 30, 2012",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Jesse F Quintero|Jung Shin  Byun|Madeline Mei Fong Wong; PhD|Clay Torao Wakano; PhD|Paul S Meltzer; MD, PhD",NULL,William D Figg; PharmD (Medical Oncology Branch)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section),Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73484
302,BC010847-06,"October 01, 2011 -  September 30, 2012",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Jesse F Quintero|Lijun  Di|Jung Shin  Byun|Clay Torao Wakano; PhD|Paul S Meltzer; MD, PhD",NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Kevin A Camphausen; MD (Radiation Oncology Branch),Dan L Longo; MD (NIA),"1. De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A (2011). BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer. Mol Cancer Res  9, 1078-90.   https://doi.org/10.1158/1541-7786.MCR-11-0155|2. Wakano C, Byun JS, Di LJ, Gardner K (2012). The dual lives of bidirectional promoters. Biochim Biophys Acta  1819, 688-93.   https://doi.org/10.1016/j.bbagrm.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=73485
303,BC010849-06,"October 01, 2011 -  September 30, 2012",Evaluation of Novel Radiation Modifiers,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Bradley T Scroggins|Eunjoo Serena Chung|Ayla Oksuz White|Luz Marina Giordano,NULL,James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Citrin D, Camphausen KA (2013). Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all? Biomark Med  7, 823-5.   https://doi.org/10.2217/bmm.13.127|2. Citrin D, Hudak K, Camphausen KA (2013). Biomarkers to guide therapy or surveillance for prostate cancer. Biomark Med  7, 827-9.   https://doi.org/10.2217/bmm.13.123|3. Kelly RJ, Lopez-Chavez A, Citrin D, Janik JE, Morris JC (2011). Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol Cancer  10, 35.   https://doi.org/10.1186/1476-4598-10-35|4. Urick ME, Chung EJ, Shield WP, Gerber N, White A, Sowers A, Thetford A, Camphausen K, Mitchell J, Citrin DE (2011). Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res  17, 5038-47.   https://doi.org/10.1158/1078-0432.CCR-11-0358",https://intramural.nih.gov/search/searchview.taf?ipid=73528
304,BC010850-06,"October 01, 2011 -  September 30, 2012",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Bradley T Scroggins|Eunjoo Serena Chung|Ayla Oksuz White|Luz Marina Giordano|Kathryn Elizabeth Hudak,David  Gaffney (University of Utah)|Radaition  Oncology (Unniversity of Pennsylvania),James B Mitchell; PhD (Radiation Biology Branch),Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73529
305,BC010852-06,"October 01, 2011 -  September 30, 2012",Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Debra  Tross|Hidekazu  Shirota|Yuko  Shirota; MD|Gan  Zhao|Christian Hans Bode; MD|Jing  Wang|Show all 10,"Ihsan  Gursel|Jay  Hooper (USAMRIID)|Yoshiaki  Ishigatsubo; MD, PhD (Yokohama City Univ Medical School)|Sven  Klaschik","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",Igal  Gery; PhD (NEI),"1. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM (2011). CpG DNA as a vaccine adjuvant. Expert Rev Vaccines  10, 499-511.   https://doi.org/10.1586/erv.10.174|2. Qi J, Buzas K, Fan H, Cohen JI, Wang K, Mont E, Klinman D, Oppenheim JJ, Howard OM (2011). Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol  186, 6417-26.   https://doi.org/10.4049/jimmunol.1001241|3. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|4. Shirota H, Klinman DM (2011). CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity. Cancer Immunol Immunother  60, 659-69.   https://doi.org/10.1007/s00262-011-0973-y|5. Steinhagen F, Kinjo T, Bode C, Klinman DM (2011). TLR-based immune adjuvants. Vaccine  29, 3341-55.   https://doi.org/10.1016/j.vaccine.2010.08.002|6. Yamamoto M, Sato T, Beren J, Verthelyi D, Klinman DM (2011). The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides. Biomaterials  32, 4238-42.   https://doi.org/10.1016/j.biomaterials.2011.02.043",https://intramural.nih.gov/search/searchview.taf?ipid=73534
306,BC010853-06,"October 01, 2011 -  September 30, 2012",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Debra  Tross|Gan  Zhao|Christian Hans Bode; MD|Jing  Wang|Yan  Wang; PhD, MD|Takashi  Sato|Show all 7",NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Igal  Gery; PhD (NEI),"1. Ikeuchi H, Kinjo T, Klinman DM (2011). Effect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomas. Cancer Prev Res (Phila)  4, 752-7.   https://doi.org/10.1158/1940-6207.CAPR-10-0290",https://intramural.nih.gov/search/searchview.taf?ipid=73535
307,BC010870-05,"October 01, 2011 -  September 30, 2012",Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert R West|Jeanelle M Spencer,NULL,NULL,Steven M Holland; MD (NIAID),"1. Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM (2011). Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica  96, 1221-5.   https://doi.org/10.3324/haematol.2011.041152|2. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2011). Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood  118, 2653-5.   https://doi.org/10.1182/blood-2011-05-356352",https://intramural.nih.gov/search/searchview.taf?ipid=73601
308,BC010871-05,"October 01, 2011 -  September 30, 2012",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,"Ron  DePinho (Dana Farber, Harvard)|Tim  Triche (UCLA)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Miriam R Anver (Office Of The Director)|Melinda  Hollingshead (Biological Testing Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73716
309,BC010872-05,"October 01, 2011 -  September 30, 2012",High throughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Keisuke  Hasegawa,NULL,NULL,Min  Shen (NCATS) |Cordelle D Tanega (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73680
310,BC010873-05,"October 01, 2011 -  September 30, 2012",Underlying Cause of Radiation-induced Fibrosis,Nicole L Simone; MD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),"1. Argiris A, Duffy AG, Kummar S, Simone NL, Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C (2011). Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. Clin Cancer Res  17, 5755-64.   https://doi.org/10.1158/1078-0432.CCR-11-0861|2. Simone CB, Lonser RR, Ondos J, Oldfield EH, Camphausen K, Simone NL (2011). Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol  13, 1030-6.   https://doi.org/10.1093/neuonc/nor085|3. Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL (2011). Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol  101, 376-82.   https://doi.org/10.1016/j.radonc.2011.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=73623
311,BC010874-05,"October 01, 2011 -  September 30, 2012",Biomarkers of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Elise Dawn Bowman|Elisa A Spillare|Judith A Welsh|Sharon R Pine|Jane J Sohn|Aaron Joseph Schetter|Show all 15,Jun  Yokota (National Cancer Center Research Institute)|Aage  Haugen (National Institute of Occupational Health)|Carlo  Croce (Ohio State University)|Roger  Reddel (Children's Medical Research Institute),"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC, Reddel RR (2011). Telomerase activity in pleural malignant mesotheliomas. Lung Cancer  73, 283-8.   https://doi.org/10.1016/j.lungcan.2010.12.023|2. Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, et al. [34 more authors] (2012). Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer  48, 1957-68.   https://doi.org/10.1016/j.ejca.2012.01.038|3. Gill RK, Yang SH, Meerzaman D, Mechanic LE, Bowman ED, Jeon HS, Roy Chowdhuri S, Shakoori A, Dracheva T, Hong KM, Fukuoka J, Zhang JH, Harris CC, Jen J (2011). Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene  30, 3784-91.   https://doi.org/10.1038/onc.2011.98|4. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC (2012). Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer  130, 1378-86.   https://doi.org/10.1002/ijc.26153|5. Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, et al. [4 more authors] (2012). KIF5B-RET fusions in lung adenocarcinoma. Nat Med  18, 375-7.   https://doi.org/10.1038/nm.2644|6. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, Harris CC (2011). The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res  17, 1875-82.   https://doi.org/10.1158/1078-0432.CCR-10-2961|7. Schetter AJ, Harris CC (2011). MicroRNAs as molecular classifiers for cancer. Cell Cycle  10, 2827-8.   https://doi.org/10.4161/cc.10.17.16574|8. Taga M, Mechanic LE, Hagiwara N, Vähäkangas KH, Bennett WP, Alavanja MC, Welsh JA, Khan MA, Lee A, Diasio R, Edell E, Bungum A, Jang JS, Yang P, Jen J, Harris CC (2012). EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women. Cancer Epidemiol Biomarkers Prev  21, 988-92.   https://doi.org/10.1158/1055-9965.EPI-12-0166",https://intramural.nih.gov/search/searchview.taf?ipid=73596
312,BC010876-05,"October 01, 2011 -  September 30, 2012",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Stephanie  Roessler|Junfang  Ji|Xuelian  Zhao|Show all 9,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute)|Show all 7,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Mitchell  Ho (Laboratory of Molecular Biology)",NULL,"1. Ji J, Yamashita T, Wang XW (2011). Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci  1, 4.   https://doi.org/10.1186/2045-3701-1-4|2. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, Qin LX, Yamashita T, Woo HG, Kim YJ, Kaneko S, Tang ZY, Thorgeirsson SS, Wang XW (2012). Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology  56, 1792-803.   https://doi.org/10.1002/hep.25890|3. Oishi N, Wang XW (2011). Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci  7, 517-35.   https://doi.org/10.7150/ijbs.7.517|4. Wang XW, Heegaard NH, Orum H (2012). MicroRNAs in liver disease. Gastroenterology  142, 1431-43.   https://doi.org/10.1053/j.gastro.2012.04.007",https://intramural.nih.gov/search/searchview.taf?ipid=73659
313,BC010877-05,"October 01, 2011 -  September 30, 2012",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Sonya Teresa Parpart,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73658
314,BC010878-05,"October 01, 2011 -  September 30, 2012",Human Colon Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Elisa A Spillare|Judith A Welsh|Krista Anne Zanetti|Aaron Joseph Schetter|Show all 7,Suet  Leung (Hong Kong University)|Carlo  Croce (Ohio State University),NULL,NULL,"1. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W (2011). Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One  6, e17745.   https://doi.org/10.1371/journal.pone.0017745|2. Ryan BM, McClary AC, Valeri N, Robinson D, Paone A, Bowman ED, Robles AI, Croce C, Harris CC (2012). rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One  7, e36306.   https://doi.org/10.1371/journal.pone.0036306|3. Schetter AJ, Harris CC (2011). Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol  38, 734-42.   https://doi.org/10.1053/j.seminoncol.2011.08.009|4. Schetter AJ, Okayama H, Harris CC (2012). The role of microRNAs in colorectal cancer. Cancer J  18, 244-52.   https://doi.org/10.1097/PPO.0b013e318258b78f",https://intramural.nih.gov/search/searchview.taf?ipid=73598
315,BC010879-05,"October 01, 2011 -  September 30, 2012",Role of Toll-like receptors in the generation of acquired immunity,David M Segal; PhD,NULL,"Immune Targeting Section, NCI",Yan  Wang|Kevin Neal Brown,NULL,NULL,NULL,"1. Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, Wang Y, Venzon D, Epstein SL, Segal DM (2011). TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol  186, 2422-9.   https://doi.org/10.4049/jimmunol.1002845",https://intramural.nih.gov/search/searchview.taf?ipid=73617
316,BC010880-05,"October 01, 2011 -  September 30, 2012",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,Cory  AbateShen (Columbia University Medical Center)|Steven  Clinton (Ohio State University),Philip L Martin (Office of the Director)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73653
317,BC010881-05,"October 01, 2011 -  September 30, 2012",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Yu-an  Yang|Dror  Luger; PhD|Jia  Weng|Jeffrey E Green; MD|Robert Mark Simpson; DVM, PhD","Scott  Lonning (Gene Therapy, Genzyme Corp.)|John  McPherson (Genzyme Corp.)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Miriam R Anver (Office Of The Director)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73656
318,BC010885-05,"October 01, 2011 -  September 30, 2012",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Victoria Y Wang|Kathleen M Wyvill|Thomas S Uldrick|Mark Niccolo Polizzotto; MD|Ravindra P Veeranna|Show all 11,NULL,Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Kang JG, Majerciak V, Uldrick TS, Wang X, Kruhlak M, Yarchoan R, Zheng ZM (2011). Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol  225, 378-89.   https://doi.org/10.1002/path.2962",https://intramural.nih.gov/search/searchview.taf?ipid=73672
319,BC010886-05,"October 01, 2011 -  September 30, 2012",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Robert Scott Hudson|Adrienne Michelle Starks,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, Caplen NJ (2011). Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res Treat  130, 663-79.   https://doi.org/10.1007/s10549-011-1690-0",https://intramural.nih.gov/search/searchview.taf?ipid=73540
320,BC010887-05,"October 01, 2011 -  September 30, 2012",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Atsushi  Terunuma|Adrienne Michelle Starks|Prachi  Mishra,"Arun  Sreekumar (Baylor College of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Bernhard  KwabiAddo (Howard University)|Olufunmilayo  Olopade (University of Chicago)|Feng  WangJohanning (University of Texas MD Anderson Cancer Center)",David Anderson Wink (Radiation Biology Branch),NULL,"1. Ambs S, Glynn SA (2011). Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer. Cell Cycle  10, 619-24.   https://doi.org/10.4161/cc.10.4.14864",https://intramural.nih.gov/search/searchview.taf?ipid=73541
321,BC010888-05,"October 01, 2011 -  September 30, 2012",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Victoria Y Wang|Kathleen M Wyvill|Karen O Aleman|Thomas S Uldrick|Mark Niccolo Polizzotto; MD|Armenak A Martirosov|Show all 8,NULL,"Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|Frank  Maldarelli (Host Virus Interaction Branch)",Amir Hossein Gandjbakhche; PhD (NICHD) |Moinuddin  Hassan; PhD (NICHD) |H. Clifford  Lane; MD (NIAID) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID),"1. O'Mahony D, Little R, Yarchoan R (2011) AIDS and cancer, in Cancer - The Outlaw Cell., in press.|2. Jain L, Woo S, Gardner ER, Dahut WL, Kohn EC, Kummar S, Mould DR, Giaccone G, Yarchoan R, Venitz J, Figg WD (2011). Population pharmacokinetic analysis of sorafenib in patients with solid tumours. Br J Clin Pharmacol  72, 294-305.   https://doi.org/10.1111/j.1365-2125.2011.03963.x|3. Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, Aboobaker J, Coovadia HM (2012). A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr  60, 150-7.   https://doi.org/10.1097/QAI.0b013e318251aedd|4. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA (2011). Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst  103, 753-62.   https://doi.org/10.1093/jnci/djr076|5. Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R (2011). High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood  117, 6977-86.   https://doi.org/10.1182/blood-2010-11-317610",https://intramural.nih.gov/search/searchview.taf?ipid=73671
322,BC010889-05,"October 01, 2011 -  September 30, 2012",Role of Selenium-containing Proteins in Cancer,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Min-Hyuk  Yoo|Petra Akiko Tsuji|Ryuta  Tobe,Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)|Salvador  NaranjoSuarez (Johns Hopkins University),John A Milner (Nutritional Science Research Group)|Harold  Seifried; PhD (Nutritional Science Research Group),NULL,"1. Yoo M, Carlson B, Tsuji P, Tobe R, Naranjo-Suarez S, Lee B, Davis C, Gladyshev V, Hatfield D (2011) Selenoproteins harboring a split personality in both preventing and promoting cancer, in Selenium: Its molecular biology and role in human health., in press.|2. Kasaikina MV, Fomenko DE, Labunskyy VM, Lachke SA, Qiu W, Moncaster JA, Zhang J, Wojnarowicz MW, Natarajan SK, Malinouski M, Schweizer U, Tsuji PA, Carlson BA, Maas RL, Lou MF, Goldstein LE, Hatfield DL, Gladyshev VN (2011). Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J Biol Chem  286, 33203-12.   https://doi.org/10.1074/jbc.M111.259218|3. Lee BC, Lobanov AV, Marino SM, Kaya A, Seravalli J, Hatfield DL, Gladyshev VN (2011). A 4-selenocysteine, 2-selenocysteine insertion sequence (SECIS) element methionine sulfoxide reductase from Metridium senile reveals a non-catalytic function of selenocysteines. J Biol Chem  286, 18747-55.   https://doi.org/10.1074/jbc.M111.229807|4. Malinouski M, Zhou Y, Belousov VV, Hatfield DL, Gladyshev VN (2011). Hydrogen peroxide probes directed to different cellular compartments. PLoS One  6, e14564.   https://doi.org/10.1371/journal.pone.0014564|5. Naranjo-Suarez S, Carlson BA, Tsuji PA, Yoo MH, Gladyshev VN, Hatfield DL (2012). HIF-independent regulation of thioredoxin reductase 1 contributes to the high levels of reactive oxygen species induced by hypoxia. PLoS One  7, e30470.   https://doi.org/10.1371/journal.pone.0030470|6. Shchedrina VA, Everley RA, Zhang Y, Gygi SP, Hatfield DL, Gladyshev VN (2011). Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J Biol Chem  286, 42937-48.   https://doi.org/10.1074/jbc.M111.310920|7. Shim MS, Kim JY, Lee KH, Jung HK, Carlson BA, Xu XM, Hatfield DL, Lee BJ (2011). l(2)01810 is a novel type of glutamate transporter that is responsible for megamitochondrial formation. Biochem J  439, 277-86.   https://doi.org/10.1042/BJ20110582|8. Tobe R, Yoo MH, Fradejas N, Carlson BA, Calvo S, Gladyshev VN, Hatfield DL (2012). Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J  445, 423-30.   https://doi.org/10.1042/BJ20120618",https://intramural.nih.gov/search/searchview.taf?ipid=73599
323,BC010891-05,"October 01, 2011 -  September 30, 2012",Antibody Therapy of Cancer,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Mingqian  Feng|Zhewei  Tang|Wei  Gao|Yifan  Zhang|Angela C Gauthier|Raffit  Hassan,Min  Qian (East China Normal University)|V. Courtney  Broaddus (UCSF),Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),NULL,"1. Feng M, Kim H, Phung Y, Ho M (2011). Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro. Int J Cancer  128, 2246-7.   https://doi.org/10.1002/ijc.25549|2. Feng M, Zhang J, Anver M, Hassan R, Ho M (2011). In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice. J Cancer  2, 123-31.   https://doi.org/10.7150/jca.2.123|3. Gao W, Ho M (2011). The role of glypican-3 in regulating Wnt in hepatocellular carcinomas. Cancer Rep  1, 14-19.|4. Ho M (2011). Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin. BioDrugs  25, 275-84.   https://doi.org/10.2165/11595360-000000000-00000|5. Ho M, Feng M, Fisher RJ, Rader C, Pastan I (2011). A novel high-affinity human monoclonal antibody to mesothelin. Int J Cancer  128, 2020-30.   https://doi.org/10.1002/ijc.25557|6. Ho M, Kim H (2011). Glypican-3: a new target for cancer immunotherapy. Eur J Cancer  47, 333-8.   https://doi.org/10.1016/j.ejca.2010.10.024|7. Phung YT, Barbone D, Broaddus VC, Ho M (2011). Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J Cancer  2, 507-14.   https://doi.org/10.7150/jca.2.507|8. Xiang X, Feng M, Felder M, Connor JP, Man YG, Patankar MS, Ho M (2011). HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy. J Cancer  2, 280-91.   https://doi.org/10.7150/jca.2.280|9. Xiang X, Phung Y, Feng M, Nagashima K, Zhang J, Broaddus VC, Hassan R, Fitzgerald D, Ho M (2011). The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One  6, e14640.   https://doi.org/10.1371/journal.pone.0014640",https://intramural.nih.gov/search/searchview.taf?ipid=73602
324,BC010892-05,"October 01, 2011 -  September 30, 2012",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Jeffrey J Subleski|Jonathan  Weiss|Tim  Chan|Qun  Jiang|John R Ortaldo; PhD|Show all 8,"Bruce  Blazar (University of Minnesota)|Bill  Murphy (Clinical Research, University of Nevada at Reno)|Jon Marc Wigginton; MD (NCI)",David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Chemical Biology Laboratory)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis),NULL,"1. Chan T, Back TC, Subleski JJ, Weiss JM, Ortaldo JR, Wiltrout RH (2012). Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities. PLoS One  7, e33303.   https://doi.org/10.1371/journal.pone.0033303|2. Chan T, Wiltrout RH, Weiss JM (2011). Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol  11, 879-89.   https://doi.org/10.1016/j.intimp.2010.12.024|3. Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, Wiltrout RH (2011). mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res  71, 4074-84.   https://doi.org/10.1158/0008-5472.CAN-10-3968|4. Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH (2011). TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells. J Immunol  186, 838-47.   https://doi.org/10.4049/jimmunol.1001735|5. Subleski JJ, Jiang Q, Weiss JM, Wiltrout RH (2011). The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy  3, 1167-84.   https://doi.org/10.2217/imt.11.117",https://intramural.nih.gov/search/searchview.taf?ipid=73664
325,BC010893-05,"October 01, 2011 -  September 30, 2012",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",John R Ortaldo; PhD|Timothy  Back|Jeffrey J Subleski|Tim  Chan|Jimmy  Stauffer|Anthony J Scarzello|Show all 8,NULL,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)",NULL,"1. Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH (2011). Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res  71, 2718-27.   https://doi.org/10.1158/0008-5472.CAN-10-2705",https://intramural.nih.gov/search/searchview.taf?ipid=73665
326,BC010898-05,"October 01, 2011 -  September 30, 2012",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Yuk Sing Robert Cheng|Julie Lynn Heinecke; PhD|Murali  Krishna; PhD,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, Wink DA, Colton CA (2011). Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence. J Neuroinflammation  8, 115.   https://doi.org/10.1186/1742-2094-8-115",https://intramural.nih.gov/search/searchview.taf?ipid=73666
327,BC010899-05,"October 01, 2011 -  September 30, 2012",Properties of redox modified NSAIDs in cancer prevention and treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Christopher H Switzer|Yuk Sing Robert Cheng|Wilmarie  Flores-santana|Julie Lynn Heinecke; PhD|James B Mitchell; PhD|Show all 7,NULL,Larry K Keefer; PhD (Chemical Biology Laboratory)|Grace  Yeh; PhD (Office of the Director)|David D Roberts; PhD (Laboratory of Pathology),NULL,"1. Flores-Santana W, Moody T, Chen W, Gorczynski MJ, Shoman ME, Velázquez C, Thetford A, Mitchell JB, Cherukuri MK, King SB, Wink DA (2012). Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells. Br J Pharmacol  165, 1058-67.   https://doi.org/10.1111/j.1476-5381.2011.01527.x|2. Moody TW, Osefo N, Nuche-Berenguer B, Ridnour L, Wink D, Jensen RT (2012). Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. J Pharmacol Exp Ther  341, 873-81.   https://doi.org/10.1124/jpet.111.190033|3. Mukhopadhyay P, Rajesh M, Horváth B, Bátkai S, Park O, Tanchian G, Gao RY, Patel V, Wink DA, Liaudet L, Haskó G, Mechoulam R, Pacher P (2011). Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med  50, 1368-81.   https://doi.org/10.1016/j.freeradbiomed.2011.02.021|4. Switzer CH, Cheng RY, Vitek TM, Christensen DJ, Wink DA, Vitek MP (2011). Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene  30, 2504-13.   https://doi.org/10.1038/onc.2010.622|5. Switzer CH, Glynn SA, Ridnour LA, Cheng RY, Vitek MP, Ambs S, Wink DA (2011). Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharmacol Sci  32, 644-51.   https://doi.org/10.1016/j.tips.2011.07.001|6. Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N (2011). Playing with cardiac ""redox switches"": the ""HNO way"" to modulate cardiac function. Antioxid Redox Signal  14, 1687-98.   https://doi.org/10.1089/ars.2010.3859",https://intramural.nih.gov/search/searchview.taf?ipid=73667
328,BC010910-05,"October 01, 2011 -  September 30, 2012",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Yulia  Demchenko|Gina Young Kim|Wei-Dong  Chen|Kavin  Tamizhmani,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|John  Shaughnessy (Universiy of Arkansas for Medical Sciences)|Jeffrey  Sawyer (University of Arkansas for Medical Sciences)|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Zingone A, Kuehl WM (2011). Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. Semin Hematol  48, 4-12.   https://doi.org/10.1053/j.seminhematol.2010.11.003",https://intramural.nih.gov/search/searchview.taf?ipid=73694
329,BC010914-05,"October 01, 2011 -  September 30, 2012",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73688
330,BC010932-05,"October 01, 2011 -  September 30, 2012",Functional and developmental T cell subsets,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Ivana  Munitic|Mirela  Kuka,NULL,NULL,Dragana  Jankovic; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73545
331,BC010935-05,"October 01, 2011 -  September 30, 2012",Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,Mary  Stracke,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Russell William Bandle|Michael L Pendrak,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73642
332,BC010938-05,"October 01, 2011 -  September 30, 2012",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN|Deborah  Truman|Martin  Glatz; MD",NULL,NULL,Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID) |Robert A Sokolic (NHGRI) |Alexandra  Freeman (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Steven M Holland; MD (NIAID),"1. Human Microbiome Project Consortium (2012) A framework for human microbiome research. Nature 486:215-21|2. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207-14|3. Kong HH (2011). Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends Mol Med  17, 320-8.   https://doi.org/10.1016/j.molmed.2011.01.013|4. Kong HH, Segre JA (2012). Skin microbiome: looking back to move forward. J Invest Dermatol  132, 933-9.   https://doi.org/10.1038/jid.2011.417",https://intramural.nih.gov/search/searchview.taf?ipid=73690
333,BC010939-05,"October 01, 2011 -  September 30, 2012",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Tamara L Jones|Lihui  Ou; PhD|Suntae  Kim|Sirisha  Chakka,John  Weinstein (MD Anderson)|Shigeki  Miyamoto (University of Wisconsin)|Philip L Lorenzi|Patrick  Grohar,"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)","Christopher P Austin; AB, MD (NCATS) |Scott E Martin (NCATS)","1. Martin SE, Wu ZH, Gehlhaus K, Jones TL, Zhang YW, Guha R, Miyamoto S, Pommier Y, Caplen NJ (2011). RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors. Curr Cancer Drug Targets  11, 976-86.   https://doi.org/10.2174/156800911797264734",https://intramural.nih.gov/search/searchview.taf?ipid=73565
334,BC010940-05,"October 01, 2011 -  September 30, 2012",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",NULL,"1. Brooks S, Linehan WM, Srinivasan R, Kong HH (2011). Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol  147, 364-5.   https://doi.org/10.1001/archdermatol.2011.30",https://intramural.nih.gov/search/searchview.taf?ipid=73687
335,BC010944-05,"October 01, 2011 -  September 30, 2012",Strategies for Cancer Vaccine Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Bertina L Gibbs|Lajuan  Chase|Sofia Ribeiro Gameiro|Curtis  Randolph|Romaine Ingrid Fernando|Alessandra  Jales|Show all 14,"Shenda  Baker (Syndegen, Inc)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|Helen B Sabzevari",NULL,NULL,"1. Palena C, Schlom J (2011) Target: Brachyury, a master driver of epithelial-to-mesenchymal transition (EMT), in Encyclopedia of Cancer Therapeutic Targets., in press.|2. Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW (2011). In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials  32, 926-32.   https://doi.org/10.1016/j.biomaterials.2010.09.058|3. Larocca C, Schlom J (2011). Viral vector-based therapeutic cancer vaccines. Cancer J  17, 359-71.   https://doi.org/10.1097/PPO.0b013e3182325e63|4. Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, Schlom J (2011). Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp Biol Med (Maywood)  236, 537-45.   https://doi.org/10.1258/ebm.2011.010367|5. Franzusoff A, Guo Z, Schlom J, Tsang K (submitted in 2011) Yeast-muc1 Immunotherapy Compositions And Uses Thereof. Patents issued: 622335 (NZ in 2017); 9,533,031 (US in 2017); 2012296425 (AU in 2018). Patents pending: BR112014003477-0 (BR application); 2844500 (CA application); 201280051154.2 (CN application); 12824638.6 (EP application); 230863 (IL application); 257533 (IL application); 1981/DELNP/2014 (IN application); 2014-526241 (JP application); 2017-067243 (JP application); 10-2014-7006872 (KR application); MX/A/2014/001717 (MX application); MX/A/2017/012601 (MX application); PCT/US2012/051299 (PC application); 2014109741 (RU application); 2017143985 (RU application); 201400975-7 (SG application); 15/358,797 (US application); 2017248462 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=73614
336,BC010945-05,"October 01, 2011 -  September 30, 2012",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Philip M Arlen; MD|Mary P Pazdur|Myrna B Rauckhorst|Bonnie L Casey|Sheri A Mcmahon|Jennifer L Marte|Show all 13,"Robert  DiPaola (The Cancer Institute of New Jersey)|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)|Carsten Goessl  Goessl (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Ravi  Madan (Medical Oncology Branch),NULL,"1. Gulley JL, Madan RA, Tsang KY, Arlen PM, Camphausen K, Mohebtash M, Kamrava M, Schlom J, Citrin D (2011). A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther  11, 1409-18.   https://doi.org/10.1517/14712598.2011.615741|2. Madan R, Heery C, Gulley J (2012) Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity. OncoImmunology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73593
337,BC010946-05,"October 01, 2011 -  September 30, 2012",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Rajani  Choudhuri|Angela  Thetford|Kristin  Askin|Show all 7,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73717
338,BC010954-05,"October 01, 2011 -  September 30, 2012",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Stephanie K Watkins|Katherine  Stagliano|Ziqiang  Zhu|Bonnie Brown Douglas|Jennifer Lynne Shoe|Ashley Simone Triplett; PhD|Show all 8,"Hideo  Yagita (Immunology, Juntendo University)|Mary Jo  Turk (Dartmouth Medical School)|Viktor  Umansky (DKFZ)",Stefan  Ambs (Laboratory of Human Carcinogenesis)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology),Alasdair M Gilfillan; PhD (NIAID),"1. Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H, Hurwitz AA (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest  121, 1361-72.   https://doi.org/10.1172/JCI44325",https://intramural.nih.gov/search/searchview.taf?ipid=73677
339,BC010955-05,"October 01, 2011 -  September 30, 2012",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Katherine  Stagliano|Ziqiang  Zhu|Bonnie Brown Douglas|Jennifer Lynne Shoe,Vincenzo  Bronte|Mary Jo  Turk (Dartmouth Medical School)|Viktor  Umansky (DKFZ),Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Nicholas Phillip Restifo; MD (Surgery Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology),NULL,"1. Hurwitz AA, Watkins SK (2012). Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother  61, 289-293.   https://doi.org/10.1007/s00262-011-1181-5",https://intramural.nih.gov/search/searchview.taf?ipid=73676
340,BC010956-05,"October 01, 2011 -  September 30, 2012",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Xu  Feng; PhD|Michael C Lu|Chuanjin  Wu|Takeshi  Ouchi; MD,"Daniel M Kaplan|Frank  Costanti (Columbia University Medical Center)|Nicholas  Greene (Institute of Child Health, UCL)","Lino  Tessarollo (Mouse Cancer Genetics Program)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)","Ronald N Germain; MD, PhD (NIAID) |Maria Irene Morasso; PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73651
341,BC010957-05,"October 01, 2011 -  September 30, 2012",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Anthony David Foster; PhD,NULL,NULL,Michael  Eckhaus; DVM (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73591
342,BC010958-05,"October 01, 2011 -  September 30, 2012","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kathleen T Soria|Yon Ju  Ji|Emily Frances Winterbottom|Yoo-Seok  Hwang|Nicolas Qiang Homble,"Christof  Niehrs; PhD (DKFZ Heidelberg)|Ken  Cho (University of California, Irvine)|Herbert  Steinbeisser (University of Heidelberg)|Colin  Stewart (Institute of medical biology)|Aykut  Uren (Georgetown University Medical Center)|Sally  Moody (George Washington University Medical Center)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Daar IO (2012). Human cancer. Preface. Adv Cancer Res  114, xi.   https://doi.org/10.1016/B978-0-12-386503-8.00011-9|2. Daar IO (2012). Non-SH2/PDZ reverse signaling by ephrins. Semin Cell Dev Biol  23, 65-74.   https://doi.org/10.1016/j.semcdb.2011.10.012|3. Neilson KM, Klein SL, Mhaske P, Mood K, Daar IO, Moody SA (2012). Specific domains of FoxD4/5 activate and repress neural transcription factor genes to control the progression of immature neural ectoderm to differentiating neural plate. Dev Biol  365, 363-75.   https://doi.org/10.1016/j.ydbio.2012.03.004|4. Singh A, Winterbottom E, Daar IO (2012). Eph/ephrin signaling in cell-cell and cell-substrate adhesion. Front Biosci (Landmark Ed)  17, 473-97.   https://doi.org/10.2741/3939",https://intramural.nih.gov/search/searchview.taf?ipid=73566
343,BC010959-05,"October 01, 2011 -  September 30, 2012",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Hua Tang  Chen|Samuel  Bunting|Nancy  Wong|Margarida Almeida Santos|Jacqueline H Barlow|Federica  Polato|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73725
344,BC010960-05,"October 01, 2011 -  September 30, 2012",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Claude  Sportes|Daniele N Avila|Jennifer Sproul Wilder|Bazetta A Blacklock-Schuver|Judy Liliana Baruffaldi|Tiffani Nicole Taylor|Show all 13,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73592
345,BC010969-05,"October 01, 2011 -  September 30, 2012",The use of chitosan for cancer vaccine delivery,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Shinji  Takai|Jonathan Kroemer Fallon; PhD,"David A Zaharoff|Connie  Rogers (Penn State University)|Shenda  Baker (Syndegen, Inc)",Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW (2011). In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials  32, 926-32.   https://doi.org/10.1016/j.biomaterials.2010.09.058",https://intramural.nih.gov/search/searchview.taf?ipid=73588
346,BC010970-05,"October 01, 2011 -  September 30, 2012",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Shinji  Takai|Jonathan Kroemer Fallon; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73589
347,BC010972-05,"October 01, 2011 -  September 30, 2012",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Caroline Mikaela Maria Jochems; PhD|Jo Anne Tucker; PhD|Claudia Mercedes Palena|James L Gulley; MD, PhD|James W Hodge; PhD","David  Apelian (GlobeImmune, Inc.)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)",Ira H Pastan; MD (Molecular Biology Section)|William Laurence Dahut; MD (Medical Oncology Branch),NULL,"1. Whiteside TL, Gulley JL, Clay TM, Tsang KY (2011). Immunologic monitoring of cellular immune responses in cancer vaccine therapy. J Biomed Biotechnol  2011, 370374.   https://doi.org/10.1155/2011/370374|2. Franzusoff A, Guo Z, Schlom J, Tsang K (submitted in 2011) Yeast-muc1 Immunotherapy Compositions And Uses Thereof. Patents issued: 622335 (NZ in 2017); 9,533,031 (US in 2017); 2012296425 (AU in 2018). Patents pending: BR112014003477-0 (BR application); 2844500 (CA application); 201280051154.2 (CN application); 12824638.6 (EP application); 230863 (IL application); 257533 (IL application); 1981/DELNP/2014 (IN application); 2014-526241 (JP application); 2017-067243 (JP application); 10-2014-7006872 (KR application); MX/A/2014/001717 (MX application); MX/A/2017/012601 (MX application); PCT/US2012/051299 (PC application); 2014109741 (RU application); 2017143985 (RU application); 201400975-7 (SG application); 15/358,797 (US application); 2017248462 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=73649
348,BC010973-05,"October 01, 2011 -  September 30, 2012",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Caroline Mikaela Maria Jochems; PhD|Jo Anne Tucker; PhD|James L Gulley; MD, PhD|James W Hodge; PhD|Claudia Mercedes Palena",NULL,William Laurence Dahut; MD (Medical Oncology Branch),NULL,"1. Cereda V, Vergati M, Huen NY, di Bari MG, Jochems C, Intrivici C, Gulley JL, Apelian D, Schlom J, Tsang KY (2011). Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine  29, 4992-9.   https://doi.org/10.1016/j.vaccine.2011.04.101|2. Tsang KY, Gulley JL (2011). Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer. Asian J Androl  13, 657-8.   https://doi.org/10.1038/aja.2011.78|3. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9|4. Vergati M, Schlom J, Tsang KY (2011). The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. J Biomed Biotechnol  2011, 182413.   https://doi.org/10.1155/2011/182413",https://intramural.nih.gov/search/searchview.taf?ipid=73650
349,BC010974-05,"October 01, 2011 -  September 30, 2012",The development of Saccharomyces (yeast) vaccines for cancer therapy,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Andressa  Ardiani|Anna Ruth Kwilas; PhD|Jeffrey  Schlom; PhD|John  Greiner; PhD,NULL,NULL,NULL,"1. Gameiro SR, Caballero JA, Higgins JP, Apelian D, Hodge JW (2011). Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses. Cancer Immunol Immunother  60, 1227-42.   https://doi.org/10.1007/s00262-011-1020-8|2. Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR (2012). The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin Oncol  39, 323-39.   https://doi.org/10.1053/j.seminoncol.2012.02.006|3. Schlom J, Hodge JW (2012). Introduction: Therapeutic cancer vaccines. Semin Oncol  39, 243-4.   https://doi.org/10.1053/j.seminoncol.2012.02.009",https://intramural.nih.gov/search/searchview.taf?ipid=73673
350,BC010975-05,"October 01, 2011 -  September 30, 2012",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Andressa  Ardiani|Anna Ruth Kwilas; PhD|Jeffrey  Schlom; PhD,"Alex  Franzusoff (Research and Development, GlobeImmune)|Eric  Reits (Netherlands Cancer Institute)",Kevin A Camphausen; MD (Radiation Oncology Branch),Bradford J Wood; MD (CC),"1. Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR (2012). The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin Oncol  39, 323-39.   https://doi.org/10.1053/j.seminoncol.2012.02.006|2. Schlom J, Hodge JW (2012). Introduction: Therapeutic cancer vaccines. Semin Oncol  39, 243-4.   https://doi.org/10.1053/j.seminoncol.2012.02.009",https://intramural.nih.gov/search/searchview.taf?ipid=73674
351,BC010976-05,"October 01, 2011 -  September 30, 2012",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu|Yoichi  Ogawa,Harvey  Florman (Universty of Massachusetts Medical School)|George  Hajishengallis (University of Pennsylvanis School of Dental Medicine)|Nicholas  MarshArmstrong (Johns Hopkins University)|Seiichiro  Motegi (Gunma University School of Medicine),NULL,Jeffrey Burnett Kopp; MD (NIDDK),"1. Motegi S, Leitner WW, Lu M, Tada Y, Sárdy M, Wu C, Chavakis T, Udey MC (2011). Pericyte-derived MFG-E8 regulates pathologic angiogenesis. Arterioscler Thromb Vasc Biol  31, 2024-34.   https://doi.org/10.1161/ATVBAHA.111.232587",https://intramural.nih.gov/search/searchview.taf?ipid=73652
352,BC010977-05,"October 01, 2011 -  September 30, 2012",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Marion M Nau|Philip  Ryan|Stephen Charles Kales|Ke  Ma|Rajgopal  Yadavalli|Paul A Randazzo; MD, PhD",Marcus Ramsay Clark|Jian  Zhang (University of Chicago),"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Lipkowitz S, Weissman AM (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer  11, 629-43.   https://doi.org/10.1038/nrc3120|2. Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA (2011). ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol Cell  103, 171-84.   https://doi.org/10.1042/BC20100154",https://intramural.nih.gov/search/searchview.taf?ipid=73705
353,BC010982-05,"October 01, 2011 -  September 30, 2012",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Sarah H Beachy; PhD|Sheryl Maxine Gough|Masahiro  Onozawa|Paul S Meltzer; MD, PhD",Donald  Small (Johns Hopkins University School of Medicine)|Steven  Nimer (MSKCC),Lino  Tessarollo (Mouse Cancer Genetics Program)|Linda  Wolff; PhD (Laboratory of Cellular Oncology),NULL,"1. Aplan P, Khan J (2011) Molecular and Genetic Basis of Childhood Cancer, in Principles and Practice of Pediatric Oncology, 6th Edition., pp. 38-77.|2. Slape C, Aplan P (2011) Retroviral Insertional Mutagenesis, in Encyclopedia of Cancer. .  Volume 2,  pp. 1767.|3. Novak R, Harper D, Caudell D, Slape C, Beachy S, Aplan P (2012) Gene expression profiling and candidate gene re-sequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Experimental Hematology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73543
354,BC010983-05,"October 01, 2011 -  September 30, 2012",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Sheryl Maxine Gough,Steven  Nimer (MSKCC)|JP  Issa (MD Anderson)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73544
355,BC010984-05,"October 01, 2011 -  September 30, 2012",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Maria  Parkhurst|Mark E Dudley|Joyce G Landry|Lien T Ngo|Susan L Schwarz|Ellen E Douglas|Show all 19,NULL,NULL,Yardena Rachel Samuels; PhD (NHGRI),"1. Chinnasamy D, Yu Z, Kerkar SP, Zhang L, Morgan RA, Restifo NP, Rosenberg SA (2012). Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clin Cancer Res  18, 1672-83.   https://doi.org/10.1158/1078-0432.CCR-11-3050|2. Dalet A, Robbins PF, Stroobant V, Vigneron N, Li YF, El-Gamil M, Hanada K, Yang JC, Rosenberg SA, Van den Eynde BJ (2011). An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc Natl Acad Sci U S A  108, E323-31.   https://doi.org/10.1073/pnas.1101892108|3. Friedman KM, Devillier LE, Feldman SA, Rosenberg SA, Dudley ME (2011). Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancement. J Immunother  34, 651-61.   https://doi.org/10.1097/CJI.0b013e31823284c3|4. Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, Klebanoff CA, Johnson LA, Kerkar SP, Yang S, Muranski P, Palmer DC, Scott CD, Morgan RA, Robbins PF, Rosenberg SA, Restifo NP (2011). Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood  117, 808-14.   https://doi.org/10.1182/blood-2010-05-286286|5. Huang J, Wang QJ, Yang S, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2011). Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro. J Immunother  34, 327-35.   https://doi.org/10.1097/CJI.0b013e318216983d|6. June C, Rosenberg SA, Sadelain M, Weber JS (2012). T-cell therapy at the threshold. Nat Biotechnol  30, 611-4.   https://doi.org/10.1038/nbt.2305|7. Klebanoff CA, Gattinoni L, Palmer DC, Muranski P, Ji Y, Hinrichs CS, Borman ZA, Kerkar SP, Scott CD, Finkelstein SE, Rosenberg SA, Restifo NP (2011). Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res  17, 5343-52.   https://doi.org/10.1158/1078-0432.CCR-11-0503|8. Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol  25, 854-8.   https://doi.org/10.1038/modpathol.2012.31|9. Langan RC, Prieto PA, Sherry RM, Zlott D, Wunderlich J, Csako G, Costello R, White DE, Rosenberg SA, Yang JC (2011). Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. J Immunother  34, 397-402.   https://doi.org/10.1097/CJI.0b013e3182187508|10. Lonser RR, Song DK, Klapper J, Hagan M, Auh S, Kerr PB, Citrin DE, Heiss JD, Camphausen K, Rosenberg SA (2011). Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg  115, 30-6.   https://doi.org/10.3171/2011.3.JNS091107|11. Parkhurst MR, Riley JP, Dudley ME, Rosenberg SA (2011). Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res  17, 6287-97.   https://doi.org/10.1158/1078-0432.CCR-11-1347|12. Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A, Davies MA, Gershenwald JE, Stemke-Hale K, Rosenberg SA, Margulies EH, Samuels Y (2011). Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet  43, 1119-26.   https://doi.org/10.1038/ng.950|13. Rosenberg SA (2011). Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know. Nat Rev Clin Oncol  8, 577-85.   https://doi.org/10.1038/nrclinonc.2011.116|14. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011). Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res  17, 4550-7.   https://doi.org/10.1158/1078-0432.CCR-11-0116|15. Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, et al. [1 more author] (2011). gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med  364, 2119-27.   https://doi.org/10.1056/NEJMoa1012863|16. Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, Van Waes C, Morgan RA, Dudley ME, Yang JC, Rosenberg SA, Kim HJ (2012). Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma. Otolaryngol Head Neck Surg  147, 744-9.   https://doi.org/10.1177/0194599812448356|17. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, Samuels Y, James CD, Yu H, Kim JS, Waldman T (2011). Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science  333, 1039-43.   https://doi.org/10.1126/science.1203619|18. Turcotte S, Rosenberg SA (2011). Immunotherapy for metastatic solid cancers. Adv Surg  45, 341-60.   https://doi.org/10.1016/j.yasu.2011.04.003|19. Wei X, Moncada-Pazos A, Cal S, Soria-Valles C, Gartner J, Rudloff U, Lin JC, NISC Comparative Sequencing Program, Rosenberg SA, López-Otín C, Samuels Y (2011). Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma. Hum Mutat  32, E2148-75.   https://doi.org/10.1002/humu.21477|20. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, NISC Comparative Sequencing Program, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Samuels Y (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet  43, 442-6.   https://doi.org/10.1038/ng.810|21. Yang S, Gattinoni L, Luca G, Liu F, Ji Y, Yu Z, Restifo NP, Rosenberg SA, Morgan RA (2011). In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells. Cancer Immunol Immunother  60, 739-49.   https://doi.org/10.1007/s00262-011-0977-7|22. Yang S, Liu F, Wang QJ, Rosenberg SA, Morgan RA (2011). The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS One  6, e22560.   https://doi.org/10.1371/journal.pone.0022560",https://intramural.nih.gov/search/searchview.taf?ipid=73612
356,BC010985-05,"October 01, 2011 -  September 30, 2012",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Maria  Parkhurst|Mark E Dudley|Joyce G Landry|Lien T Ngo|Susan L Schwarz|Zhili  Zheng|Show all 22,NULL,NULL,NULL,"1. Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G (2012). Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther  20, 246-9.   https://doi.org/10.1038/mt.2011.288|2. Chinnasamy D, Yu Z, Kerkar SP, Zhang L, Morgan RA, Restifo NP, Rosenberg SA (2012). Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clin Cancer Res  18, 1672-83.   https://doi.org/10.1158/1078-0432.CCR-11-3050|3. Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA (2011). A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. J Immunol  186, 685-96.   https://doi.org/10.4049/jimmunol.1001775|4. Ertl HC, Zaia J, Rosenberg SA, June CH, Dotti G, Kahn J, Cooper LJ, Corrigan-Curay J, Strome SE (2011). Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010. Cancer Res  71, 3175-81.   https://doi.org/10.1158/0008-5472.CAN-10-4035|5. Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA (2011). Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a ""modified"" step-filtration process for clearance of packaging cells. Hum Gene Ther  22, 107-15.   https://doi.org/10.1089/hum.2010.064|6. Friedman KM, Devillier LE, Feldman SA, Rosenberg SA, Dudley ME (2011). Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancement. J Immunother  34, 651-61.   https://doi.org/10.1097/CJI.0b013e31823284c3|7. June C, Rosenberg SA, Sadelain M, Weber JS (2012). T-cell therapy at the threshold. Nat Biotechnol  30, 611-4.   https://doi.org/10.1038/nbt.2305|8. Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, Restifo NP (2011). IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest  121, 4746-57.   https://doi.org/10.1172/JCI58814|9. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP (2011). Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. J Immunother  34, 343-52.   https://doi.org/10.1097/CJI.0b013e3182187600|10. Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C, Rosenberg SA (2012). B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood  119, 2709-20.   https://doi.org/10.1182/blood-2011-10-384388|11. Kochenderfer JN, Rosenberg SA (2011). Chimeric antigen receptor-modified T cells in CLL. N Engl J Med  365, 1937-8; author reply 1938.   https://doi.org/10.1056/NEJMc1111004|12. Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol  25, 854-8.   https://doi.org/10.1038/modpathol.2012.31|13. Langan RC, Prieto PA, Sherry RM, Zlott D, Wunderlich J, Csako G, Costello R, White DE, Rosenberg SA, Yang JC (2011). Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. J Immunother  34, 397-402.   https://doi.org/10.1097/CJI.0b013e3182187508|14. Park TS, Rosenberg SA, Morgan RA (2011). Treating cancer with genetically engineered T cells. Trends Biotechnol  29, 550-7.   https://doi.org/10.1016/j.tibtech.2011.04.009|15. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA (2011). T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther  19, 620-6.   https://doi.org/10.1038/mt.2010.272|16. Restifo NP, Dudley ME, Rosenberg SA (2012). Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol  12, 269-81.   https://doi.org/10.1038/nri3191|17. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|18. Rosenberg SA (2011). Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know. Nat Rev Clin Oncol  8, 577-85.   https://doi.org/10.1038/nrclinonc.2011.116|19. Rosenberg SA, Kochenderfer JN (2011). Personalized cell transfer immunotherapy for B-cell malignancies and solid cancers. Mol Ther  19, 1928-30.   https://doi.org/10.1038/mt.2011.223|20. Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, Van Waes C, Morgan RA, Dudley ME, Yang JC, Rosenberg SA, Kim HJ (2012). Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma. Otolaryngol Head Neck Surg  147, 744-9.   https://doi.org/10.1177/0194599812448356|21. Yang S, Karne NK, Goff SL, Black MA, Xu H, Bischof D, Cornetta K, Rosenberg SA, Morgan RA, Feldman SA (2012). A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes. Hum Gene Ther Methods  23, 73-83.   https://doi.org/10.1089/hgtb.2011.199|22. Zhang L, Feldman SA, Zheng Z, Chinnasamy N, Xu H, Nahvi AV, Dudley ME, Rosenberg SA, Morgan RA (2012). Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. J Immunother  35, 430-9.   https://doi.org/10.1097/CJI.0b013e31825898e8|23. Zhang L, Kerkar SP, Yu Z, Zheng Z, Yang S, Restifo NP, Rosenberg SA, Morgan RA (2011). Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol Ther  19, 751-9.   https://doi.org/10.1038/mt.2010.313",https://intramural.nih.gov/search/searchview.taf?ipid=73611
357,BC010986-05,"October 01, 2011 -  September 30, 2012",Allele-specific gene expression and epigenetic information,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Sheryl A Gere|Mitsutaka  Kadota|Howard H Yang|Beverly W Duncan|Hailong  Wu|Guohong  Song|Show all 7,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Jiuping  Ji (Office of the Director)",NULL,"1. Lee MP (2012). Allele-specific gene expression and epigenetic modifications and their application to understanding inheritance and cancer. Biochim Biophys Acta  1819, 739-42.   https://doi.org/10.1016/j.bbagrm.2012.02.007|2. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724",https://intramural.nih.gov/search/searchview.taf?ipid=73697
358,BC010992-05,"October 01, 2011 -  September 30, 2012",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",Alison J Rattray|Brenda K Shafer|Deanna R Gotte|Mary K Ernst|Ashley Suzanne Denney|Grant H Thompson|Show all 7,NULL,Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73643
359,BC010993-05,"October 01, 2011 -  September 30, 2012",Molecular architecture of lymphocyte cortex,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Genaro  Patino Lopez|Khadija  Ben-aissa,"E. Michael  Ostap (Pennsylvania Muscle Institute, University of Pennsylvania)|Matthew  Krummel; PhD|(UCSF)|Matthew  Tyska (Vanderbilt University School of Medicine)",Michael John Kruhlak; PhD (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73622
360,BC010994-05,"October 01, 2011 -  September 30, 2012",Lymphocyte membrane-proximal basophilic kinases,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina,"Luc  Sabourin; PhD (Ottawa Hospital Research Institute, Canada)|Siu-Pok  Yee (University of Connecticut Health Center)",James L Hartley (Office Of The Director)|Dominic  Esposito; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73619
361,BC010995-05,"October 01, 2011 -  September 30, 2012",ERM phosphorylation in lymphocytes,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina|Genaro  Patino Lopez|Khadija  Ben-aissa,"Hajime  Karasuyama (Department of Immunology, Tokyo Metropolitan Institute of Medical Science)|Ulrich  Von Andrian (Harvard University)",Jung-Hyun  Park (Experimental Immunology Branch),John H Kehrl; MD (NIAID) |Chung  Park (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73620
362,BC010996-05,"October 01, 2011 -  September 30, 2012",Molecular mechanisms of ERM regulation,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina|Genaro  Patino Lopez|Khadija  Ben-aissa,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch),Tilman J Rosales (NHLBI) |Jay Robert Knutson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73621
363,BC010997-05,"October 01, 2011 -  September 30, 2012",Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)",NULL,"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73547
364,BC010998-05,"October 01, 2011 -  September 30, 2012",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Xinyu  Wen|Jianbin Na He|John Frederick Shern|Hongling  Liao|Jianjun  Wang|Show all 12,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|David  Azorsa (NHGRI)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Jason  Shohet (Baylor College of Medicine)|Show all 8","Malcolm A Smith (Clinical Investigations Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",James G Taylor; MD (NHLBI),"1. Gonzalez-Bosquet J, Calcei J, Wei JS, Garcia-Closas M, Sherman ME, Hewitt S, Vockley J, Lissowska J, Yang HP, Khan J, Chanock S (2011). Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One  6, e14522.   https://doi.org/10.1371/journal.pone.0014522",https://intramural.nih.gov/search/searchview.taf?ipid=73683
365,BC010999-05,"October 01, 2011 -  September 30, 2012",Characterization of FGFR4 mutations in Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|John Frederick Shern|Chand  Khanna; MD,NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",James G Taylor; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73684
366,BC011001-05,"October 01, 2011 -  September 30, 2012",Micro RNA  Profiling in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Xinyu  Wen|Jianbin Na He|Catherine A House|Hongling  Liao|Show all 8,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,"1. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697",https://intramural.nih.gov/search/searchview.taf?ipid=73685
367,BC011002-05,"October 01, 2011 -  September 30, 2012",BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Xinyu  Wen|Laura Beth Hurd|Rajesh  Patidar,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)","Timothy D Veenstra (Office Of The Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Briggs J, Paoloni M, Chen QR, Wen X, Khan J, Khanna C (2011). A compendium of canine normal tissue gene expression. PLoS One  6, e17107.   https://doi.org/10.1371/journal.pone.0017107|2. Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, Rahim S, Bulut G, Zhou M, Veenstra TD, Chen Q, Wei JS, Khan J, Uren A, Khanna C (2012). The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia  14, 297-310.   https://doi.org/10.1593/neo.11518|3. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697|4. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|5. Guo X, Chen QR, Song YK, Wei JS, Khan J (2011). Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics  4, 35.   https://doi.org/10.1186/1755-8794-4-35|6. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187|7. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, Ge K, Thiele CJ (2012). EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res  72, 315-24.   https://doi.org/10.1158/0008-5472.CAN-11-0961",https://intramural.nih.gov/search/searchview.taf?ipid=73682
368,BC011003-05,"October 01, 2011 -  September 30, 2012",Asymmetric Division and Self Renewal of Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)",NULL,"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73548
369,BC011004-05,"October 01, 2011 -  September 30, 2012",Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis,Itzhak  Avital,NULL,"Surgery Branch, NCI",Udo  Rudloff|Udai S Kammula,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Deborah E Citrin (Radiation Oncology Branch)",NULL,"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73549
370,BC011005-05,"October 01, 2011 -  September 30, 2012",Isolation and Purification of Cancer Stem Cells Based on Functional Approaches,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)",NULL,"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73546
371,BC011006-05,"October 01, 2011 -  September 30, 2012",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Hong  Zhao|Yandan  Yang; PhD|Weihong  Xu|Wyndham H Wilson; MD, PhD",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Biometrics Research Branch),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, Liu Y, Lim MS, Perkins SL, Fu K, Smith L, Lynch J, Staudt LM, Rimsza LM, Jaffe E, Rosenwald A, Ott GK, Delabie J, Campo E, Gascoyne RD, Cairo MS, Weisenburger DD, Greiner TC, Gross TG, Chan WC (2012). Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood  119, 3757-66.   https://doi.org/10.1182/blood-2011-05-349662|2. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|3. Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, Liu Z, Lachel CM, Deffenbacher K, Greiner TC, Vose JM, Bhagavathi S, Staudt LM, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, McKeithan TW, et al. [1 more author] (2012). Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood  119, 4939-48.   https://doi.org/10.1182/blood-2011-07-370122|4. Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, Rimsza LM, Valentino C, Brunhoeber P, Grogan TM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, Rosenwald A, et al. [6 more authors] (2012) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30:3452-9|5. Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernández L, Rosenwald A (2011). MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood  118, 5550-8.   https://doi.org/10.1182/blood-2011-06-361972|6. Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD (2011). Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol  29, 200-7.   https://doi.org/10.1200/JCO.2010.30.0368|7. Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, López-Guillermo A, Campo E, Chan WC, Weisenburger DD (2012). A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood  120, 2290-6.   https://doi.org/10.1182/blood-2012-05-430389|8. Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR, Tubbs RR, Braziel RM, Delabie J, Miller TP, Staudt LM (2011). Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues. Clin Cancer Res  17, 3727-32.   https://doi.org/10.1158/1078-0432.CCR-10-2573|9. Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB, McPherson A, Meissner B, Okoye UC, Diepstra A, van den Berg A, Sun M, Leung G, Jones SJ, Connors JM, Huntsman DG, Savage KJ, Rimsza LM, Horsman DE, Staudt LM, Steidl U, et al. [2 more authors] (2011). MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature  471, 377-81.   https://doi.org/10.1038/nature09754",https://intramural.nih.gov/search/searchview.taf?ipid=73635
372,BC011007-05,"October 01, 2011 -  September 30, 2012",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Hong  Zhao|Yandan  Yang; PhD,NULL,George W Wright (Biometrics Research Branch),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, et al. [6 more authors] (2011). Oncogenically active MYD88 mutations in human lymphoma. Nature  470, 115-9.   https://doi.org/10.1038/nature09671|2. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514",https://intramural.nih.gov/search/searchview.taf?ipid=73636
373,BC011008-05,"October 01, 2011 -  September 30, 2012",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Hong  Zhao|Weihong  Xu|Lixin  Rui|Ryan Matthew Young|Michele  Ceribelli; PhD|Show all 13,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB, McPherson A, Meissner B, Okoye UC, Diepstra A, van den Berg A, Sun M, Leung G, Jones SJ, Connors JM, Huntsman DG, Savage KJ, Rimsza LM, Horsman DE, Staudt LM, Steidl U, et al. [2 more authors] (2011). MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature  471, 377-81.   https://doi.org/10.1038/nature09754",https://intramural.nih.gov/search/searchview.taf?ipid=73633
374,BC011010-05,"October 01, 2011 -  September 30, 2012",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Laurence  Lamy|Ryan Matthew Young|Ola Anders Landgren,NULL,"Walter M Kuehl; MD, PhD (Cancer Genetics Branch)|Christina M Annunziata (Medical Oncology Branch)",NULL,"1. Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM (2011). A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood  117, 2396-404.   https://doi.org/10.1182/blood-2010-04-278788|2. Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer AL, Louie T, Chen I, Randolph S, Hahn WC, Staudt LM, Niesvizky R, Moore MA, Chen-Kiang S (2012). Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood  120, 1095-106.   https://doi.org/10.1182/blood-2012-03-415984|3. Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD (2011). The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood  117, 211-20.   https://doi.org/10.1182/blood-2010-07-298349",https://intramural.nih.gov/search/searchview.taf?ipid=73634
375,BC011011-05,"October 01, 2011 -  September 30, 2012",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Laura  Baranello|Paul David Myers,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73699
376,BC011012-05,"October 01, 2011 -  September 30, 2012",Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,"Gary  Siskin (Albany Medical Center)|Eric  Whitman (Morristown Memorial Hospital)|H. Denis Alexander; PhD (Department of Hematology, Belfast City Hospital)|Charles  Nutting (Sweedish Medical Center)|Sanjiv  Agarwla (St. Luke's Hospital and Health System)|Mark  Faries (John Wayne Cancer Institute)|Show all 8",William D Figg; PharmD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73675
377,BC011017-05,"October 01, 2011 -  September 30, 2012",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Leroy E Hood|Patrick  Paddison (University of Seattle)|David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73654
378,BC011018-05,"October 01, 2011 -  September 30, 2012",Differential Gene Expression and Targeting of Gliomas Using Radiation,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Ira  Gordon (Radiation Oncology Branch),Russell R Lonser; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73662
379,BC011019-05,"October 01, 2011 -  September 30, 2012",Diffuse Intrinsic Pontine Glioma Genomic Study,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Javad  Nazarian (Children's National Medical Center)|Eric H Raabe","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Jonathan Keith Killian (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73661
380,BC011024-05,"October 01, 2011 -  September 30, 2012",Tumor and Metastasis Therapy,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Ling  Ren|Anita C Epps|Michael Mark Lizardo; PhD|Lee Jay Helman; MD,"Aykut  Uren (Georgetown University Medical Center)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Timothy  Green (AstraZeneca)|Stephen  Lesnick (Huntsman Cancer Center)","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A (2012). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene  31, 269-81.   https://doi.org/10.1038/onc.2011.245|2. Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ (2011). Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia  13, 145-53.   https://doi.org/10.1593/neo.101202|3. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|4. McCleese JK, Bear MD, Kulp SK, Mazcko C, Khanna C, London CA (2013). Met interacts with EGFR and Ron in canine osteosarcoma. Vet Comp Oncol  11, 124-39.   https://doi.org/10.1111/j.1476-5829.2011.00309.x|5. Osborne TS, Ren L, Healey JH, Shapiro LQ, Chou AJ, Gorlick RG, Hewitt SM, Khanna C (2011). Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue Microarray. J Pediatr Hematol Oncol  33, 524-528.   https://doi.org/10.1097/MPH.0b013e318223d0c1",https://intramural.nih.gov/search/searchview.taf?ipid=73686
381,BC011025-05,"October 01, 2011 -  September 30, 2012",Regulation of RANTES expression in T lymphocytes,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Carol  Clayberger|Tianhong  Wang|Wei  Zhang; PhD|Seok Joo  Kwon; PhD|Juan Manuel Crespo-Barreto; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),"1. Kim DS, Zhang W, Millman SE, Hwang BJ, Kwon SJ, Clayberger C, Pagano M, Krensky AM (2012). Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. Blood  120, 1658-67.   https://doi.org/10.1182/blood-2012-03-415968|2. Lai D, Zhu J, Wang T, Hu-Li J, Terabe M, Berzofsky JA, Clayberger C, Krensky AM (2011). KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med  208, 1093-103.   https://doi.org/10.1084/jem.20101527",https://intramural.nih.gov/search/searchview.taf?ipid=73691
382,BC011026-05,"October 01, 2011 -  September 30, 2012",Function of granulysin,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Carol  Clayberger|Tianhong  Wang|Wei  Zhang; PhD|Vanesa Cecilia Sanchez; PhD|Carole A Parent; PhD|Paul A Randazzo; MD, PhD",NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Jeffrey D Lifson; MD (Office Of The Director),David F Stroncek; MD (CC) |Francesco M. Marincola; MD (CC),"1. Castiello L, Sabatino M, Jin P, Clayberger C, Marincola FM, Krensky AM, Stroncek DF (2011). Monocyte-derived DC maturation strategies and related pathways: a transcriptional view. Cancer Immunol Immunother  60, 457-66.   https://doi.org/10.1007/s00262-010-0954-6|2. Castiello L, Stroncek DF, Finn MW, Wang E, Marincola FM, Clayberger C, Krensky AM, Sabatino M (2011). 15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level. J Transl Med  9, 41.   https://doi.org/10.1186/1479-5876-9-41|3. Clayberger C, Finn MW, Wang T, Saini R, Wilson C, Barr VA, Sabatino M, Castiello L, Stroncek D, Krensky AM (2012). 15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity. J Immunol  188, 6119-26.   https://doi.org/10.4049/jimmunol.1200570|4. Finn MW, Clayberger C, Krensky AM (2011). Expression and purification of 15 kDa granulysin utilizing an insect cell secretion system. Protein Expr Purif  75, 70-4.   https://doi.org/10.1016/j.pep.2010.07.009|5. Saini RV, Wilson C, Finn MW, Wang T, Krensky AM, Clayberger C (2011). Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells. J Immunol  186, 3497-504.   https://doi.org/10.4049/jimmunol.1003409|6. Semple PL, Watkins M, Davids V, Krensky AM, Hanekom WA, Kaplan G, Ress S (2011). Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol  2011, 438463.   https://doi.org/10.1155/2011/438463",https://intramural.nih.gov/search/searchview.taf?ipid=73692
383,BC011027-05,"October 01, 2011 -  September 30, 2012",Animal models to study the role of INK4b loss in human acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Juraj  Bies|Richard P Koller|Rita  Humeniuk|Joanna  Fares,NULL,NULL,NULL,"1. Fares J, Koller R, Humeniuk R, Wolff L, Bies J (2012). The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells. Blood  119, 5005-15.   https://doi.org/10.1182/blood-2011-10-387613",https://intramural.nih.gov/search/searchview.taf?ipid=73669
384,BC011028-05,"October 01, 2011 -  September 30, 2012",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Lindsay A. Middelton|James Q Peterson|Masaya  Baba|Sarah M Fowler; RN|Cristiane  Leite|Laura  Schmidt|Show all 29,NULL,"Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)","Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)","1. Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol  60, 118-24.   https://doi.org/10.1016/j.eururo.2011.03.046|2. Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G (2011). Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol  2011, 658767.   https://doi.org/10.1155/2011/658767|3. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011). Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer  50, 466-77.   https://doi.org/10.1002/gcc.20872|4. Bokesch HR, Gardella RS, Rabe DC, Bottaro DP, Linehan WM, McMahon JB, McKee TC (2011). A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum. Chem Pharm Bull (Tokyo)  59, 1178-9.   https://doi.org/10.1248/cpb.59.1178|5. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|6. Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology  77, 775-80.   https://doi.org/10.1016/j.urology.2010.07.501|7. Bratslavsky G, Linehan WM (2011). Surgery: Routine adrenalectomy in renal cancer--an antiquated practice. Nat Rev Urol  8, 534-6.   https://doi.org/10.1038/nrurol.2011.136|8. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|9. Brooks S, Linehan WM, Srinivasan R, Kong HH (2011). Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol  147, 364-5.   https://doi.org/10.1001/archdermatol.2011.30|10. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW (2011). Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene  30, 4697-706.   https://doi.org/10.1038/onc.2011.179|11. Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G (2012). Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature. Urol Oncol  30, 476-81.   https://doi.org/10.1016/j.urolonc.2010.04.010|12. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K (2012). Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer  48, 1739-49.   https://doi.org/10.1016/j.ejca.2011.07.016|13. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K (2011). Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem  57, 411-20.   https://doi.org/10.1373/clinchem.2010.153320|14. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW (2011). Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer  18, 97-111.   https://doi.org/10.1677/ERC-10-0211|15. Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011). Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab  96, 375-84.   https://doi.org/10.1210/jc.2010-1588|16. Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G (2011). Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol  185, 49-53.   https://doi.org/10.1016/j.juro.2010.09.032|17. Filson CP, Miller DC, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Schwartz K (2012). Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol  30, 856-63.   https://doi.org/10.1016/j.urolonc.2010.08.024|18. Grkovic T, Whitson EL, Rabe DC, Gardella RS, Bottaro DP, Linehan WM, McMahon JB, Gustafson KR, McKee TC (2011). Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression. Bioorg Med Chem Lett  21, 2113-5.   https://doi.org/10.1016/j.bmcl.2011.01.127|19. Gupta GN, Boris R, Chung P, Marston Linehan W, Pinto PA, Bratslavsky G (2013) Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 31:51-6|20. Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA (2012). Image guidance in the focal treatment of prostate cancer. Curr Opin Urol  22, 328-35.   https://doi.org/10.1097/MOU.0b013e32835482cc|21. Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E (2011). Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery  150, 1122-8.   https://doi.org/10.1016/j.surg.2011.09.048|22. Linehan W (2012) Genetic Basis of Kidney Cancer: Critical Opportunity for a Genomic Future. Genome Research, in press.|23. Linguraru MG, Wang S, Shah F, Gautam R, Peterson J, Linehan WM, Summers RM (2011). Automated noninvasive classification of renal cancer on multiphase CT. Med Phys  38, 5738-46.   https://doi.org/10.1118/1.3633898|24. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|25. Middelton LA (2013). Birt-Hogg-Dubé: beyond the clinical manifestations. Fam Cancer  12, 97-9.   https://doi.org/10.1007/s10689-012-9583-x|26. Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ (2011). Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol  186, 1281-5.   https://doi.org/10.1016/j.juro.2011.05.078|27. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|28. Sanford T, Chung PH, Reinish A, Valera V, Srinivasan R, Linehan WM, Bratslavsky G (2011). Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays. PLoS One  6, e21260.   https://doi.org/10.1371/journal.pone.0021260|29. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G (2011). Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int  107, 571-5.   https://doi.org/10.1111/j.1464-410X.2010.09568.x|30. Shuch B, Linehan WM, Bratslavsky G (2011). Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol  21, 368-75.   https://doi.org/10.1097/MOU.0b013e32834964ea|31. Shuch B, Pacak K, Linehan WM, Bratslavsky G (2011). Editorial comment. J Urol  185, 1589-90; author reply 1590.   https://doi.org/10.1016/j.juro.2010.12.107|32. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM (2011). Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep  12, 47-55.   https://doi.org/10.1007/s11934-010-0156-y|33. Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284-90.|34. Tong WH, Sourbier C, Kovtunovych G, Jeong SY, Vira M, Ghosh M, Romero VV, Sougrat R, Vaulont S, Viollet B, Kim YS, Lee S, Trepel J, Srinivasan R, Bratslavsky G, Yang Y, Linehan WM, Rouault TA (2011). The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell  20, 315-27.   https://doi.org/10.1016/j.ccr.2011.07.018|35. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|36. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA (2011). Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol  186, 1818-24.   https://doi.org/10.1016/j.juro.2011.07.013|37. Valera VA, Walter BA, Linehan WM, Merino MJ (2011). Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer  2, 515-26.   https://doi.org/10.7150/jca.2.515|38. Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB (2011). Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells. Cancer Res  71, 134-42.   https://doi.org/10.1158/0008-5472.CAN-10-0757",https://intramural.nih.gov/search/searchview.taf?ipid=73703
385,BC011031-05,"October 01, 2011 -  September 30, 2012",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Marian E Durkin|Valentina  Factor|Phuongnga  Ton|Daekwan  Seo; PhD, MS, BA|Agnes  Holczbauer|Jesper B Andersen; PhD|Show all 8","Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)|Jens Uwe Marquardt","Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Marquardt JU, Raggi C, Andersen JB, Seo D, Avital I, Geller D, Lee YH, Kitade M, Holczbauer A, Gillen MC, Conner EA, Factor VM, Thorgeirsson SS (2011). Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology  54, 1031-42.   https://doi.org/10.1002/hep.24454|2. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS (2011). Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology  140, 1063-70.   https://doi.org/10.1053/j.gastro.2010.11.034",https://intramural.nih.gov/search/searchview.taf?ipid=73647
386,BC011032-05,"October 01, 2011 -  September 30, 2012",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Wanping  Xu|Shinji  Tsutsumi|Kristin  Eckfeld|Mehdi  Mollapour|Alok  Mishra|Thomas L Prince|Show all 10,"Brian  Blagg (Chemistry, University of Kansas)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Nicolas  Winssinger (University of Strassbourg)|Gabriela X Chiosis|Show all 11",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)|Jane Beth Trepel (Medical Oncology Branch),NULL,"1. Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, Blagg BS (2011). A systematic protocol for the characterization of Hsp90 modulators. Bioorg Med Chem  19, 684-92.   https://doi.org/10.1016/j.bmc.2010.10.029|2. Mollapour M, Neckers L (2012). Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta  1823, 648-55.   https://doi.org/10.1016/j.bbamcr.2011.07.018|3. Mollapour M, Tsutsumi S, Kim YS, Trepel J, Neckers L (2011). Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity. Oncotarget  2, 407-17.|4. Mollapour M, Tsutsumi S, Truman AW, Xu W, Vaughan CK, Beebe K, Konstantinova A, Vourganti S, Panaretou B, Piper PW, Trepel JB, Prodromou C, Pearl LH, Neckers L (2011). Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell  41, 672-81.   https://doi.org/10.1016/j.molcel.2011.02.011|5. Prince T, Neckers L (2011). A network of its own: the unique interactome of the Hsp90 cochaperone, Sba1/p23. Mol Cell  43, 159-60.   https://doi.org/10.1016/j.molcel.2011.07.005",https://intramural.nih.gov/search/searchview.taf?ipid=73723
387,BC011033-05,"October 01, 2011 -  September 30, 2012",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sanjay  Khandelwal|Berta  Bosch Pages,Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI),Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73609
388,BC011035-05,"October 01, 2011 -  September 30, 2012",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul|Berta  Bosch Pages|Sharad Kumar Mittal; PhD,NULL,Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),"1. Suh YH, Yoshimoto-Furusawa A, Weih KA, Tessarollo L, Roche KW, Mackem S, Roche PA (2011). Deletion of SNAP-23 results in pre-implantation embryonic lethality in mice. PLoS One  6, e18444.   https://doi.org/10.1371/journal.pone.0018444",https://intramural.nih.gov/search/searchview.taf?ipid=73608
389,BC011037-05,"October 01, 2011 -  September 30, 2012",Developing new immunotherapies based of CD4+ T cells,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,NULL,NULL,Robert L Danner; MD (CC),"1. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP (2011). A human memory T cell subset with stem cell-like properties. Nat Med  17, 1290-7.   https://doi.org/10.1038/nm.2446|2. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP (2011). Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. J Immunother  34, 343-52.   https://doi.org/10.1097/CJI.0b013e3182187600|3. Klebanoff CA, Acquavella N, Yu Z, Restifo NP (2011). Therapeutic cancer vaccines: are we there yet? Immunol Rev  239, 27-44.   https://doi.org/10.1111/j.1600-065X.2010.00979.x|4. Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, Gattinoni L, Heath JR, Kalos M, Marincola FM, Miller JS, Mostoslavsky G, Powell DJ, Rao M, Restifo NP, Rosenberg SA, O'Shea J, Melief CJ (2012). New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med  10, 48.   https://doi.org/10.1186/1479-5876-10-48",https://intramural.nih.gov/search/searchview.taf?ipid=73603
390,BC011038-05,"October 01, 2011 -  September 30, 2012",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Lindsay A. Middelton|James Q Peterson|Sarah M Fowler; RN|Laura  Schmidt|Ramaprasad  Srinivasan; MD, PhD|Gennady  Bratslavsky|Show all 30",NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|James  McMahon; PhD (Molecular Targets Laboratory),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)","1. Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol  60, 118-24.   https://doi.org/10.1016/j.eururo.2011.03.046|2. Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G (2011). Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol  2011, 658767.   https://doi.org/10.1155/2011/658767|3. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011). Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer  50, 466-77.   https://doi.org/10.1002/gcc.20872|4. Bokesch HR, Gardella RS, Rabe DC, Bottaro DP, Linehan WM, McMahon JB, McKee TC (2011). A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum. Chem Pharm Bull (Tokyo)  59, 1178-9.   https://doi.org/10.1248/cpb.59.1178|5. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|6. Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology  77, 775-80.   https://doi.org/10.1016/j.urology.2010.07.501|7. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|8. Bratslavsky G, Linehan WM (2011). Surgery: Routine adrenalectomy in renal cancer--an antiquated practice. Nat Rev Urol  8, 534-6.   https://doi.org/10.1038/nrurol.2011.136|9. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|10. Brooks S, Linehan WM, Srinivasan R, Kong HH (2011). Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol  147, 364-5.   https://doi.org/10.1001/archdermatol.2011.30|11. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW (2011). Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene  30, 4697-706.   https://doi.org/10.1038/onc.2011.179|12. Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G (2012). Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature. Urol Oncol  30, 476-81.   https://doi.org/10.1016/j.urolonc.2010.04.010|13. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K (2012). Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer  48, 1739-49.   https://doi.org/10.1016/j.ejca.2011.07.016|14. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K (2011). Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem  57, 411-20.   https://doi.org/10.1373/clinchem.2010.153320|15. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW (2011). Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer  18, 97-111.   https://doi.org/10.1677/ERC-10-0211|16. Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011). Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab  96, 375-84.   https://doi.org/10.1210/jc.2010-1588|17. Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G (2011). Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol  185, 49-53.   https://doi.org/10.1016/j.juro.2010.09.032|18. Filson CP, Miller DC, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Schwartz K (2012). Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol  30, 856-63.   https://doi.org/10.1016/j.urolonc.2010.08.024|19. Grkovic T, Whitson EL, Rabe DC, Gardella RS, Bottaro DP, Linehan WM, McMahon JB, Gustafson KR, McKee TC (2011). Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression. Bioorg Med Chem Lett  21, 2113-5.   https://doi.org/10.1016/j.bmcl.2011.01.127|20. Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA (2012). Image guidance in the focal treatment of prostate cancer. Curr Opin Urol  22, 328-35.   https://doi.org/10.1097/MOU.0b013e32835482cc|21. Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E (2011). Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery  150, 1122-8.   https://doi.org/10.1016/j.surg.2011.09.048|22. Linehan W (2012) Genetic Basis of Kidney Cancer: Critical Opportunity for a Genomic Future. Genome Research, in press.|23. Linguraru MG, Wang S, Shah F, Gautam R, Peterson J, Linehan WM, Summers RM (2011). Automated noninvasive classification of renal cancer on multiphase CT. Med Phys  38, 5738-46.   https://doi.org/10.1118/1.3633898|24. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|25. Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ (2011). Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol  186, 1281-5.   https://doi.org/10.1016/j.juro.2011.05.078|26. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|27. Sanford T, Chung PH, Reinish A, Valera V, Srinivasan R, Linehan WM, Bratslavsky G (2011). Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays. PLoS One  6, e21260.   https://doi.org/10.1371/journal.pone.0021260|28. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G (2011). Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int  107, 571-5.   https://doi.org/10.1111/j.1464-410X.2010.09568.x|29. Shuch B, Linehan WM, Bratslavsky G (2011). Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol  21, 368-75.   https://doi.org/10.1097/MOU.0b013e32834964ea|30. Shuch B, Pacak K, Linehan WM, Bratslavsky G (2011). Editorial comment. J Urol  185, 1589-90; author reply 1590.   https://doi.org/10.1016/j.juro.2010.12.107|31. Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R (2012). Targeting the mTOR pathway in Chromophobe Kidney Cancer. J Cancer  3, 152-7.   https://doi.org/10.7150/jca.4378|32. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM (2011). Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep  12, 47-55.   https://doi.org/10.1007/s11934-010-0156-y|33. Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284-90.|34. Tong WH, Sourbier C, Kovtunovych G, Jeong SY, Vira M, Ghosh M, Romero VV, Sougrat R, Vaulont S, Viollet B, Kim YS, Lee S, Trepel J, Srinivasan R, Bratslavsky G, Yang Y, Linehan WM, Rouault TA (2011). The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell  20, 315-27.   https://doi.org/10.1016/j.ccr.2011.07.018|35. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|36. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA (2011). Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol  186, 1818-24.   https://doi.org/10.1016/j.juro.2011.07.013|37. Valera VA, Walter BA, Linehan WM, Merino MJ (2011). Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer  2, 515-26.   https://doi.org/10.7150/jca.2.515|38. Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB (2011). Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells. Cancer Res  71, 134-42.   https://doi.org/10.1158/0008-5472.CAN-10-0757|39. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D (2012). Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol  36, 654-62.   https://doi.org/10.1097/PAS.0b013e31824f24a6",https://intramural.nih.gov/search/searchview.taf?ipid=73704
391,BC011039-05,"October 01, 2011 -  September 30, 2012",Long distant regulation of c-myb in normal cells and acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Richard P Koller|Junfang  Zhang,NULL,NULL,NULL,"1. Zhang J, Markus J, Bies J, Paul T, Wolff L (2012). Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping. J Virol  86, 10524-32.   https://doi.org/10.1128/JVI.01077-12",https://intramural.nih.gov/search/searchview.taf?ipid=73668
392,BC011043-05,"October 01, 2011 -  September 30, 2012",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Lindsay A. Middelton|James Q Peterson|Masaya  Baba|Sarah M Fowler; RN|Cristiane  Leite|Laura  Schmidt|Show all 33,Mutsuo  Furihata|Yoshihiko  Kakinuma (Kochi Medical School)|Alessio  Nencioni (University of Genoa)|Junichi  Sadoshima (UMDNJ)|Eric  Miska (Gurdon Institute)|Masahiro  Yao MD (Yokohama City University Medical School),Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),David R Davies; PhD (NIDDK),"1. Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol  60, 118-24.   https://doi.org/10.1016/j.eururo.2011.03.046|2. Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G (2011). Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol  2011, 658767.   https://doi.org/10.1155/2011/658767|3. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011). Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer  50, 466-77.   https://doi.org/10.1002/gcc.20872|4. Bokesch HR, Gardella RS, Rabe DC, Bottaro DP, Linehan WM, McMahon JB, McKee TC (2011). A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum. Chem Pharm Bull (Tokyo)  59, 1178-9.   https://doi.org/10.1248/cpb.59.1178|5. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|6. Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology  77, 775-80.   https://doi.org/10.1016/j.urology.2010.07.501|7. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|8. Bratslavsky G, Linehan WM (2011). Surgery: Routine adrenalectomy in renal cancer--an antiquated practice. Nat Rev Urol  8, 534-6.   https://doi.org/10.1038/nrurol.2011.136|9. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|10. Brooks S, Linehan WM, Srinivasan R, Kong HH (2011). Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol  147, 364-5.   https://doi.org/10.1001/archdermatol.2011.30|11. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW (2011). Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene  30, 4697-706.   https://doi.org/10.1038/onc.2011.179|12. Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G (2012). Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature. Urol Oncol  30, 476-81.   https://doi.org/10.1016/j.urolonc.2010.04.010|13. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K (2012). Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer  48, 1739-49.   https://doi.org/10.1016/j.ejca.2011.07.016|14. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K (2011). Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem  57, 411-20.   https://doi.org/10.1373/clinchem.2010.153320|15. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW (2011). Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer  18, 97-111.   https://doi.org/10.1677/ERC-10-0211|16. Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011). Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab  96, 375-84.   https://doi.org/10.1210/jc.2010-1588|17. Eisenhofer G, Vocke CD, Elkahloun A, Huynh TT, Prodanov T, Lenders JW, Timmers HJ, Benhammou JN, Linehan WM, Pacak K (2012). Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution. Horm Metab Res  44, 343-8.   https://doi.org/10.1055/s-0032-1304662|18. Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G (2011). Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol  185, 49-53.   https://doi.org/10.1016/j.juro.2010.09.032|19. Filson CP, Miller DC, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Schwartz K (2012). Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol  30, 856-63.   https://doi.org/10.1016/j.urolonc.2010.08.024|20. Grkovic T, Whitson EL, Rabe DC, Gardella RS, Bottaro DP, Linehan WM, McMahon JB, Gustafson KR, McKee TC (2011). Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression. Bioorg Med Chem Lett  21, 2113-5.   https://doi.org/10.1016/j.bmcl.2011.01.127|21. Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA (2012). Image guidance in the focal treatment of prostate cancer. Curr Opin Urol  22, 328-35.   https://doi.org/10.1097/MOU.0b013e32835482cc|22. Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E (2011). Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery  150, 1122-8.   https://doi.org/10.1016/j.surg.2011.09.048|23. Linehan W (2012) Genetic Basis of Kidney Cancer: Critical Opportunity for a Genomic Future. Genome Research, in press.|24. Linguraru MG, Wang S, Shah F, Gautam R, Peterson J, Linehan WM, Summers RM (2011). Automated noninvasive classification of renal cancer on multiphase CT. Med Phys  38, 5738-46.   https://doi.org/10.1118/1.3633898|25. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|26. Middelton LA (2013). Birt-Hogg-Dubé: beyond the clinical manifestations. Fam Cancer  12, 97-9.   https://doi.org/10.1007/s10689-012-9583-x|27. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM (2012). Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis  1, e14.   https://doi.org/10.1038/oncsis.2012.14|28. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ (2011). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature  481, 385-8.   https://doi.org/10.1038/nature10642|29. Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ (2011). Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol  186, 1281-5.   https://doi.org/10.1016/j.juro.2011.05.078|30. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|31. Sanford T, Chung PH, Reinish A, Valera V, Srinivasan R, Linehan WM, Bratslavsky G (2011). Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays. PLoS One  6, e21260.   https://doi.org/10.1371/journal.pone.0021260|32. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G (2011). Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int  107, 571-5.   https://doi.org/10.1111/j.1464-410X.2010.09568.x|33. Shuch B, Linehan WM, Bratslavsky G (2011). Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol  21, 368-75.   https://doi.org/10.1097/MOU.0b013e32834964ea|34. Shuch B, Pacak K, Linehan WM, Bratslavsky G (2011). Editorial comment. J Urol  185, 1589-90; author reply 1590.   https://doi.org/10.1016/j.juro.2010.12.107|35. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM (2011). Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep  12, 47-55.   https://doi.org/10.1007/s11934-010-0156-y|36. Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284-90.|37. Tong WH, Sourbier C, Kovtunovych G, Jeong SY, Vira M, Ghosh M, Romero VV, Sougrat R, Vaulont S, Viollet B, Kim YS, Lee S, Trepel J, Srinivasan R, Bratslavsky G, Yang Y, Linehan WM, Rouault TA (2011). The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell  20, 315-27.   https://doi.org/10.1016/j.ccr.2011.07.018|38. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|39. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA (2011). Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol  186, 1818-24.   https://doi.org/10.1016/j.juro.2011.07.013|40. Valera VA, Walter BA, Linehan WM, Merino MJ (2011). Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer  2, 515-26.   https://doi.org/10.7150/jca.2.515|41. Weisbrod AB, Kitano M, Gesuwan K, Millo C, Herscovitch P, Nilubol N, Linehan WM, Kebebew E (2012). Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. J Clin Endocrinol Metab  97, E613-7.   https://doi.org/10.1210/jc.2011-2626|42. Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB (2011). Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells. Cancer Res  71, 134-42.   https://doi.org/10.1158/0008-5472.CAN-10-0757|43. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001",https://intramural.nih.gov/search/searchview.taf?ipid=73700
393,BC011046-05,"October 01, 2011 -  September 30, 2012",Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Yili  Xie|Lisa Ann Tobin,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch)|Jordi  Camps Polo (Cancer Genetics Branch)|Ashish Kumar Lal (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73695
394,BC011049-05,"October 01, 2011 -  September 30, 2012",Development and evaluation of apoptosis targeted therapies in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Yili  Xie|Lisa Ann Tobin,Matthias  Epple (University of Duisburg-Essen)|Viktoriya  Sokolova (University of Duisburg-Essen),Maria  Tsokos; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73696
395,BC011053-05,"October 01, 2011 -  September 30, 2012",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Orla Majella Casey|Paul Gerard Hynes|Heather  Sheppard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73681
396,BC011054-05,"October 01, 2011 -  September 30, 2012",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Anna Maartje Aalbers|Marianne K-H Kim|Elise C Kohn; MD,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73542
397,BC011055-05,"October 01, 2011 -  September 30, 2012",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD|Saddam Musleh Muthana; PhD|Sudipa  Chowdhury",Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases),"Lisa  Mcshane (Biometrics Research Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73587
398,BC011056-05,"October 01, 2011 -  September 30, 2012",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Avi  Ashkenazi (Genentech, Inc.)|Noako  Seki (Kurume University)|Neil  Cross (Sheffield Hallam University)","Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|James  McMahon; PhD (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|William  Farrar (Laboratory of Cancer Prevention)",NULL,"1. Sayers TJ (2011). Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol Immunother  60, 1173-80.   https://doi.org/10.1007/s00262-011-1008-4",https://intramural.nih.gov/search/searchview.taf?ipid=73613
399,BC011058-05,"October 01, 2011 -  September 30, 2012",Development of a Vaccine for HIVAIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Janet M Dipasquale|Thorsten  Demberg|Michael Anthony Thomas; PhD|Diego Antonio Vargas-Inchaustegui; PhD|Iskra  Tuero; PhD|Venkatramanan  Mohanram; PhD|Show all 12,"Susan  Barnett (Chiron Corporation)|Ruth  Ruprecht (Dana Farber Cancer Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Timothy  Fouts (Profectus BioSciences, Inc.)|David C Montefiori; PhD (Department of Surgery, NIAID)|Qingsheng  Li (University of Nebraska Lincoln)|Show all 8",David J Venzon; PhD (Biostatistics and Data Management Section)|Jeffrey  Gildersleeve (Chemical Biology Laboratory)|Brandon Frank Keele (Office Of The Director),"Terence Martyn Phillips; PhD, DSc (NIBIB) |Vanessa  Hirsch (NIAID)","1. Bialuk J, Whitney S, Andresen V, Florese R, Nacsa J, Cecchinato V, Valeri V, Heraud J, Gordon S, Parks R, Montefiori D, Venzon D, Demberg T, Robert-Guroff M, Landucci G, Forthal D, Franchini G (2011) Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120 mediate antibody-dependent virus inhibition in macaques. Vaccine 30:78-94.|2. Brocca-Cofano E, McKinnon K, Demberg T, Venzon D, Hidajat R, Xiao P, Daltabuit-Test M, Patterson LJ, Robert-Guroff M (2011). Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia. Vaccine  29, 3310-9.   https://doi.org/10.1016/j.vaccine.2011.02.066|3. Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G (2012). Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. J Immunol  188, 714-23.   https://doi.org/10.4049/jimmunol.1101404|4. Lakhashe SK, Velu V, Sciaranghella G, Siddappa NB, Dipasquale JM, Hemashettar G, Yoon JK, Rasmussen RA, Yang F, Lee SJ, Montefiori DC, Novembre FJ, Villinger F, Amara RR, Kahn M, Hu SL, Li S, Li Z, Frankel FR, Robert-Guroff M, Johnson WE, Lieberman J, Ruprecht RM (2011). Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine  29, 5611-22.   https://doi.org/10.1016/j.vaccine.2011.06.017|5. Palermo RE, Patterson LJ, Aicher LD, Korth MJ, Robert-Guroff M, Katze MG (2011). Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy. J Virol  85, 1099-116.   https://doi.org/10.1128/JVI.01522-10|6. Patterson LJ, Daltabuit-Test M, Xiao P, Zhao J, Hu W, Wille-Reece U, Brocca-Cofano E, Kalyanaraman VS, Kalisz I, Whitney S, Lee EM, Pal R, Montefiori DC, Dandekar S, Seder R, Roederer M, Wiseman RW, Hirsch V, Robert-Guroff M (2011). Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge. Virology  411, 87-102.   https://doi.org/10.1016/j.virol.2010.12.033",https://intramural.nih.gov/search/searchview.taf?ipid=73606
400,BC011059-05,"October 01, 2011 -  September 30, 2012",Biologic Pathway Analysis,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Cu  Nguyen|Ying  Hu; PhD|Hongen  Zhang|Sol  Efroni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73556
401,BC011061-05,"October 01, 2011 -  September 30, 2012",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kazimierz Wojcieck Kasprzak|Shu Yun  Le|Eckart  Bindewald|Tae Jin  Kim|Kirill Andreevich Afonin|Praneet Sai Puppala|Show all 7,"Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luc  Jaeger (University of California Santa Barbara)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)|Robert L Jernigan; PhD (NCI)|Hanan  Samet (University of Maryland)",Yun Xing M Wang (Structural Biophysics Laboratory)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Joseph John Barchi (Chemical Biology Laboratory)|Marina A Dobrovolskaia (Office Cancer Nanotechnology Research),NULL,"1. Afonin KA, Grabow WW, Walker FM, Bindewald E, Dobrovolskaia MA, Shapiro BA, Jaeger L (2011). Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc  6, 2022-34.   https://doi.org/10.1038/nprot.2011.418|2. Bindewald E, Afonin K, Jaeger L, Shapiro BA (2011). Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano  5, 9542-51.   https://doi.org/10.1021/nn202666w|3. Grabow WW, Zakrevsky P, Afonin KA, Chworos A, Shapiro BA, Jaeger L (2011). Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett  11, 878-87.   https://doi.org/10.1021/nl104271s|4. Kasprzak W, Bindewald E, Kim TJ, Jaeger L, Shapiro BA (2011). Use of RNA structure flexibility data in nanostructure modeling. Methods  54, 239-50.   https://doi.org/10.1016/j.ymeth.2010.12.010|5. Kim T, Barchi JJ, Marquez VE, Shapiro BA (2011). Understanding the effects of carbocyclic sugars constrained to north and south conformations on RNA nanodesign. J Mol Graph Model  29, 624-34.   https://doi.org/10.1016/j.jmgm.2010.11.007|6. Shukla GC, Haque F, Tor Y, Wilhelmsson LM, Toulmé JJ, Isambert H, Guo P, Rossi JJ, Tenenbaum SA, Shapiro BA (2011). A boost for the emerging field of RNA nanotechnology. ACS Nano  5, 3405-18.   https://doi.org/10.1021/nn200989r",https://intramural.nih.gov/search/searchview.taf?ipid=73618
402,BC011062-05,"October 01, 2011 -  September 30, 2012",Development of a Vaccine for HIVAIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Michael Anthony Thomas; PhD|Diego Antonio Vargas-Inchaustegui; PhD|Iskra  Tuero; PhD,Ashley  Haase (University of Minnesota)|Sol  Langermann (Amplimmune)|Joseph  Mattapallil (Uniformed Services University),David J Venzon; PhD (Biostatistics and Data Management Section)|Brandon Frank Keele (Office Of The Director),Vanessa  Hirsch (NIAID),"1. Demberg T, Ettinger AC, Aladi S, McKinnon K, Kuddo T, Venzon D, Patterson LJ, Phillips TM, Robert-Guroff M (2011). Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory. Vaccine  29, 6017-28.   https://doi.org/10.1016/j.vaccine.2011.06.032|2. George J, Cofano EB, Lybarger E, Louder M, Lafont BA, Mascola JR, Robert-Guroff M, Mattapallil JJ (2011). Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques. AIDS Res Hum Retroviruses  27, 763-75.   https://doi.org/10.1089/AID.2010.0251|3. Lakhashe SK, Velu V, Sciaranghella G, Siddappa NB, Dipasquale JM, Hemashettar G, Yoon JK, Rasmussen RA, Yang F, Lee SJ, Montefiori DC, Novembre FJ, Villinger F, Amara RR, Kahn M, Hu SL, Li S, Li Z, Frankel FR, Robert-Guroff M, Johnson WE, Lieberman J, Ruprecht RM (2011). Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine  29, 5611-22.   https://doi.org/10.1016/j.vaccine.2011.06.017|4. Palermo RE, Patterson LJ, Aicher LD, Korth MJ, Robert-Guroff M, Katze MG (2011). Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy. J Virol  85, 1099-116.   https://doi.org/10.1128/JVI.01522-10|5. Patterson LJ, Daltabuit-Test M, Xiao P, Zhao J, Hu W, Wille-Reece U, Brocca-Cofano E, Kalyanaraman VS, Kalisz I, Whitney S, Lee EM, Pal R, Montefiori DC, Dandekar S, Seder R, Roederer M, Wiseman RW, Hirsch V, Robert-Guroff M (2011). Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge. Virology  411, 87-102.   https://doi.org/10.1016/j.virol.2010.12.033|6. Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M (2011). A CD8α(-)  subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology  134, 326-40.   https://doi.org/10.1111/j.1365-2567.2011.03493.x",https://intramural.nih.gov/search/searchview.taf?ipid=73607
403,BC011063-05,"October 01, 2011 -  September 30, 2012",Development of a Vaccine for HIVAIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Janet M Dipasquale|Michael Anthony Thomas; PhD|Rui  Song,"Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Christopher  Miller (University of California, Davis)|Timothy  Fouts (Profectus BioSciences, Inc.)",NULL,Mark  Connors; MD (NIAID),"1. Demberg T, Robert-Guroff M (2012) Controlling the HIVAIDS epidemic: current status and global challenges. Frontiers in Immunotherapies and Vaccines, in press.|2. Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M (2012). Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route. Clin Vaccine Immunol  19, 629-37.   https://doi.org/10.1128/CVI.00010-12",https://intramural.nih.gov/search/searchview.taf?ipid=73605
404,BC011064-05,"October 01, 2011 -  September 30, 2012",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",John K Simmons|Ke  Zhang,NULL,NULL,NULL,"1. Simmons JK, Amlin-Van Schaick JC, Geiger TR, Reilly K, Hunter K, Mock BA (2012). Mouse genetics 2011: meeting report. Mamm Genome  23, 225-31.   https://doi.org/10.1007/s00335-012-9390-6",https://intramural.nih.gov/search/searchview.taf?ipid=73720
405,BC011065-05,"October 01, 2011 -  September 30, 2012",Preclinical Testing of HDAC and mTOR Inhibitors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","John K Simmons|Robert Mark Simpson; DVM, PhD",NULL,Ola Anders Landgren (Lymphoid Malignancies Branch),NULL,"1. Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM (2011). mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. Blood  118, 6803-13.   https://doi.org/10.1182/blood-2011-06-359984|2. Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood  117, 1228-38.   https://doi.org/10.1182/blood-2010-05-287821",https://intramural.nih.gov/search/searchview.taf?ipid=73721
406,BC011069-05,"October 01, 2011 -  September 30, 2012",Biology and Therapy of Lymphopenia,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Donna B Bernstein|Hua  Zhang|Melinda S Merchant|Wangko Pieter Henning Lundstrom,NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Claude  Sportes (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73708
407,BC011070-05,"October 01, 2011 -  September 30, 2012",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Stefania  Pittaluga|Theresa M Davies Hill|Nancy Ellen Diener|Alison Rozmus Huppmann; MD|Ewa Beata Bajor-Dattilo; MD, PhD|Madhu Parameswar Menon|Show all 14","Wing  Chan (Pathology, University of Nebraska)|Andreas  Chott (Pathology, University of Vienna)|Elias  Campo (University of Barcelona)|Nancy  Harris|Steven  Swerdlow (University of Pittsburgh Med Center)|Falko  Fend|Show all 7","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Susan  Bates; MD (Medical Oncology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) |Katherine Rainsford Calvo (CC) |Vemulkonda Koneti Rao; MD, FRCPA (NIAID) |Jeffrey  Cohen; MD (NIAID) |Raul Cipriano Braylan; MD (CC) |Irina  Maric; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73678
408,BC011073-05,"October 01, 2011 -  September 30, 2012",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Daniel W Lee|Yongzhi  Cui; MD|Rimas Jonas Orentas|Waleed M Haso|Steven Lorenz Highfill|Adrienne Hart Smith|Show all 9,Malcolm  Brenner (Baylor College of Medicine)|Laurence  Cooper (MD Anderson Cancer Center)|Carl  June (University of Pennsylvania)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Delores  Schendel (Max-Delbruck-Center for Molecular Medicine),"Maria  Tsokos; MD (Laboratory of Pathology)|Peter D Aplan; MD (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Du X, Xiang L, Mackall C, Pastan I (2011). Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody. Clin Cancer Res  17, 5926-34.   https://doi.org/10.1158/1078-0432.CCR-11-1235|2. Orentas RJ, Mackall CJ, Pastan IJ (submitted in 2011) Anti-cd22 Chimeric Antigen Receptors. Patents issued: 2768863 (CH in 2017); 2768863 (EP in 2017); 2768863 (ES in 2017); 2768863 (IT in 2017); 2768863 (LI in 2017); 2768863 (NL in 2017); 6267644 (JP in 2018); 9,868,774 (US in 2018). Patents pending: 112014008849-7 (BR application); 2851795 (CA application); 201280051365.6 (CN application); 12781544.7 (DE application); 12781544.7 (FR application); 12781544.7 (GB application); 2906/CHENP/2014 (IN application); 132749/2017 (JP application); PCT/US2012/061025 (PC application); 2014118555 (RU application); 61/549,516 (US application); 2012325915 (AU application); 2017225049 (AU application). Tracking numbers: E-265-2011-0-JP-12 (JP application); E-265-2011-0-US-23 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=73706
409,BC011074-05,"October 01, 2011 -  September 30, 2012",Clinical Program in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Richard J Saunders|Donna B Bernstein|Hua  Zhang|Kristin  Baird|Melinda S Merchant|Lee Jay Helman; MD,"Nai-Kong  Cheung (Memorial Sloan Kettering Cancer Center)|Carl  June (University of Pennsylvania)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)","Maria  Tsokos; MD (Laboratory of Pathology)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL (2012). Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas. Biol Blood Marrow Transplant  18, 698-707.   https://doi.org/10.1016/j.bbmt.2011.08.020|2. Du X, Xiang L, Mackall C, Pastan I (2011). Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody. Clin Cancer Res  17, 5926-34.   https://doi.org/10.1158/1078-0432.CCR-11-1235|3. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537",https://intramural.nih.gov/search/searchview.taf?ipid=73707
410,BC011076-05,"October 01, 2011 -  September 30, 2012",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Smitha  Antony|Yongzhong  Wu|Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler",NULL,NULL,NULL,"1. Esworthy R, Kim B, Rivas G, Leto T, Doroshow J, Chu F (2012) Analysis of Candidate Colitis Genes in the Gdac1 Locus of Mice Deficient in Glutatione Peroxidase 1 and 2. PLoS ONE, in press.|2. Wu Y, Antony S, Juhasz A, Lu J, Ge Y, Jiang G, Roy K, Doroshow JH (2011). Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines. J Biol Chem  286, 12245-56.   https://doi.org/10.1074/jbc.M110.191031",https://intramural.nih.gov/search/searchview.taf?ipid=73567
411,BC011078-05,"October 01, 2011 -  September 30, 2012",Phase 01 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS|Yves  Pommier; PhD|William M Bonner; PhD",NULL,Joseph E Tomaszewski (Office of the Director)|Ralph  Parchment (Toxicology and Pharmacology Branch),NULL,"1. Humphrey RW, Brockway-Lunardi LM, Bonk DT, Dohoney KM, Doroshow JH, Meech SJ, Ratain MJ, Topalian SL, Pardoll DM (2011). Opportunities and challenges in the development of experimental drug combinations for cancer. J Natl Cancer Inst  103, 1222-6.   https://doi.org/10.1093/jnci/djr246|2. Ji J, Kinders RJ, Zhang Y, Rubinstein L, Kummar S, Parchment RE, Tomaszewski JE, Doroshow JH (2011). Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells. PLoS One  6, e26152.   https://doi.org/10.1371/journal.pone.0026152|3. Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, Jia L, Weil M, Speranza G, Murgo AJ, Kinders R, Wang L, Parchment RE, Carter J, Stotler H, Rubinstein L, Hollingshead M, Melillo G, Pommier Y, Bonner W, Tomaszewski JE, Doroshow JH (2011). Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Res  71, 5626-34.   https://doi.org/10.1158/0008-5472.CAN-11-1227|4. Kummar S, Doroshow JH (2011). Phase 0 trials: expediting the development of chemoprevention agents. Cancer Prev Res (Phila)  4, 288-92.   https://doi.org/10.1158/1940-6207.CAPR-11-0013|5. Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH (2011). Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Eur J Cancer  47, 997-1005.   https://doi.org/10.1016/j.ejca.2010.12.016|6. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682|7. Martin MM, Ryan M, Kim R, Zakas AL, Fu H, Lin CM, Reinhold WC, Davis SR, Bilke S, Liu H, Doroshow JH, Reimers MA, Valenzuela MS, Pommier Y, Meltzer PS, Aladjem MI (2011). Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res  21, 1822-32.   https://doi.org/10.1101/gr.124644.111|8. Nguyen D, Zajac-Kaye M, Rubinstein L, Voeller D, Tomaszewski JE, Kummar S, Chen AP, Pommier Y, Doroshow JH, Yang SX (2011). Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent. Cell Cycle  10, 4074-82.   https://doi.org/10.4161/cc.10.23.18170|9. Speranza G, Gutierrez ME, Kummar S, Strong JM, Parker RJ, Collins J, Yu Y, Cao L, Murgo AJ, Doroshow JH, Chen A (2012). Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors. Cancer Chemother Pharmacol  69, 431-8.   https://doi.org/10.1007/s00280-011-1712-y|10. Zhang YW, Regairaz M, Seiler JA, Agama KK, Doroshow JH, Pommier Y (2011). Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells. Nucleic Acids Res  39, 3607-20.   https://doi.org/10.1093/nar/gkq1304|11. Zoppoli G, Regairaz M, Leo E, Reinhold W, Varma S, Ballestrero A, Doroshow J, Pommier Y (2012) The Putative DNARNA Helicase SLFN-11 Sensitizes Cancer Cells to DNA Damaging Agents. Proc.Natl.Acad.Science USA, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73568
412,BC011081-05,"October 01, 2011 -  September 30, 2012",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Donald P Bottaro; PhD|Leonard  Neckers; PhD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|William Laurence Dahut; MD (Medical Oncology Branch)",Bradford J Wood; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73729
413,BC011084-05,"October 01, 2011 -  February 01, 2010",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sung Jin  Ryu|Keisuke  Hasegawa|Yilan  Shi,Rebecca  Heald (University of California at Berkeley)|John  Yates (The Scripps Research Institute),NULL,NULL,"1. Halpin D, Kalab P, Wang J, Weis K, Heald R (2011). Mitotic spindle assembly around RCC1-coated beads in Xenopus egg extracts. PLoS Biol  9, e1001225.   https://doi.org/10.1371/journal.pbio.1001225|2. Soderholm JF, Bird SL, Kalab P, Sampathkumar Y, Hasegawa K, Uehara-Bingen M, Weis K, Heald R (2011). Importazole, a small molecule inhibitor of the transport receptor importin-β. ACS Chem Biol  6, 700-8.   https://doi.org/10.1021/cb2000296",https://intramural.nih.gov/search/searchview.taf?ipid=73679
414,BC011088-05,"October 01, 2011 -  September 30, 2012",Functional genomics of breast cancer,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Mark  Mackiewicz|John E Lueders|Yuan  Jiang; MD|Robert L Walker; BS|Arthur A Glatfelter; MS|Show all 9",NULL,Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Killian JK, Bilke S, Davis S, Walker RL, Jaeger E, Killian MS, Waterfall JJ, Bibikova M, Fan JB, Smith WI, Meltzer PS (2011). A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology. Am J Pathol  179, 55-65.   https://doi.org/10.1016/j.ajpath.2011.03.022|2. Killian JK, Walker RL, Bilke S, Chen Y, Davis S, Cornelison R, Smith WI, Meltzer PS (2012). Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples. Methods Mol Biol  823, 107-18.   https://doi.org/10.1007/978-1-60327-216-2_8",https://intramural.nih.gov/search/searchview.taf?ipid=73714
415,BC011090-05,"October 01, 2011 -  September 30, 2012",Merkel Cell Carcinoma Polyomavirus,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Rachel  Schowalter; PhD|Upasana  Ray,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School),Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Alison Anne McBride; PhD (NIAID),"1. Buck CB, Lowy DR (2011). Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease. J Clin Oncol  29, 1506-8.   https://doi.org/10.1200/JCO.2010.34.0745|2. Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB (2012). Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog  8, e1002650.   https://doi.org/10.1371/journal.ppat.1002650|3. Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H (2012). Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med Microbiol Immunol  201, 17-23.   https://doi.org/10.1007/s00430-011-0200-7|4. Schiller JT, Buck CB (2011). Cutaneous squamous cell carcinoma: a smoking gun but still no suspects. J Invest Dermatol  131, 1595-6.   https://doi.org/10.1038/jid.2011.151|5. Schowalter RM, Pastrana DV, Buck CB (2011). Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog  7, e1002161.   https://doi.org/10.1371/journal.ppat.1002161",https://intramural.nih.gov/search/searchview.taf?ipid=73555
416,BC011091-05,"October 01, 2011 -  September 30, 2012",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|John E Lueders|Yuan  Jiang; MD|Robert L Walker; BS|Arthur A Glatfelter; MS|Yuelin  Zhu|Show all 13",NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Elaine S Jaffe; MD (Laboratory of Pathology)|Kenneth H Kraemer; MD (Dermatology Branch),Jeffery L Miller; MD (NIDDK) |Leslie Glenn Biesecker; MD (NHGRI),"1. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|2. Lu C, Mishra A, Zhu YJ, Meltzer P, Cheng SY (2011). Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma. Am J Cancer Res  1, 1-13.|3. Lu C, Mishra A, Zhu YJ, Meltzer P, Cheng SY (2011). Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis. Am J Cancer Res  1, 168-191.|4. Martin MM, Ryan M, Kim R, Zakas AL, Fu H, Lin CM, Reinhold WC, Davis SR, Bilke S, Liu H, Doroshow JH, Reimers MA, Valenzuela MS, Pommier Y, Meltzer PS, Aladjem MI (2011). Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res  21, 1822-32.   https://doi.org/10.1101/gr.124644.111|5. Valenzuela MS, Chen Y, Davis S, Yang F, Walker RL, Bilke S, Lueders J, Martin MM, Aladjem MI, Massion PP, Meltzer PS (2011). Preferential localization of human origins of DNA replication at the 5'-ends of expressed genes and at evolutionarily conserved DNA sequences. PLoS One  6, e17308.   https://doi.org/10.1371/journal.pone.0017308|6. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G (2011). Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature  469, 548-53.   https://doi.org/10.1038/nature09666",https://intramural.nih.gov/search/searchview.taf?ipid=73715
417,BC011095-05,"October 01, 2011 -  September 30, 2012",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Kristen Elizabeth Raffensperger|Kevin Y Luo|Cara Elizabeth Wright|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Peter A Pinto; MD",NULL,"Tawnya Carlene McKee; BA, PhD (Molecular Targets Laboratory)",NULL,"1. Grkovic T, Whitson EL, Rabe DC, Gardella RS, Bottaro DP, Linehan WM, McMahon JB, Gustafson KR, McKee TC (2011). Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression. Bioorg Med Chem Lett  21, 2113-5.   https://doi.org/10.1016/j.bmcl.2011.01.127",https://intramural.nih.gov/search/searchview.taf?ipid=73551
418,BC011099-05,"October 01, 2011 -  September 30, 2012",Canine Glioma and Embryonic Neural Stem Cell Project,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Kevin D Woolard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73583
419,BC011100-05,"October 01, 2011 -  September 30, 2012",SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Svetlana  Kotliarova|Aiguo  Li|Jennifer  Walling|Susie  Ahn|Natalia N Ogurtsova|Show all 16,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73578
420,BC011101-05,"October 01, 2011 -  September 30, 2012",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Svetlana  Kotliarova|Aiguo  Li|Jennifer  Walling|Susie  Ahn|Natalia N Ogurtsova|Show all 16,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73579
421,BC011102-05,"October 01, 2011 -  September 30, 2012",The Role of miRNAs in Glioma Stem Cell and Glioma Biology,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Svetlana  Kotliarova|Aiguo  Li|Jennifer  Walling|Susie  Ahn|Natalia N Ogurtsova|Show all 16,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73580
422,BC011105-05,"October 01, 2011 -  September 30, 2012",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Ravikiran S Yedidi|Kenji  Maeda|Darshan  Desai; BS|David A Davis; MD|Robert  Yarchoan; MD,"Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)|Hiromi  OgataAoki (Kumamoto University School of Medicine)",NULL,NULL,"1. Ghosh AK, Chapsal BD, Baldridge A, Steffey MP, Walters DE, Koh Y, Amano M, Mitsuya H (2011). Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. J Med Chem  54, 622-34.   https://doi.org/10.1021/jm1012787|2. Ghosh AK, Chapsal BD, Parham GL, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2011). Design of HIV-1 protease inhibitors with C3-substituted hexahydrocyclopentafuranyl urethanes as P2-ligands: synthesis, biological evaluation, and protein-ligand X-ray crystal structure. J Med Chem  54, 5890-901.   https://doi.org/10.1021/jm200649p|3. Ide K, Aoki M, Amano M, Koh Y, Yedidi RS, Das D, Leschenko S, Chapsal B, Ghosh AK, Mitsuya H (2011). Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. Antimicrob Agents Chemother  55, 1717-27.   https://doi.org/10.1128/AAC.01540-10|4. Koh Y, Aoki M, Danish ML, Aoki-Ogata H, Amano M, Das D, Shafer RW, Ghosh AK, Mitsuya H (2011). Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1. J Virol  85, 10079-89.   https://doi.org/10.1128/JVI.05121-11",https://intramural.nih.gov/search/searchview.taf?ipid=73718
423,BC011106-05,"October 01, 2011 -  September 30, 2012",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Xuguang C Tai|Motoko  Kimura|Tejas Bharat Kadakia|Ruth  Etzensperger; PhD,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)","Paul E Love; MD, PhD (NICHD)","1. Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C (2011). Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev  25, 275-86.   https://doi.org/10.1101/gad.2007311",https://intramural.nih.gov/search/searchview.taf?ipid=73631
424,BC011107-05,"October 01, 2011 -  September 30, 2012",Analysis of the Function and Regulation of Protein Scaffolds and Signal Modulato,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Daniel A Ritt|Junghwa  Lim|Jeremy Scott Logue; PhD|Ira  Daar; PhD,John  Scott (Oregon Health and Science University)|Robert  Lewis (Univeristy of Nebraska Medical Center)|Rebecca  Page (Brown Medical School)|Natalie  Ahn (University of Colorodo at Boulder)|Robert  Rottapel (University of Toronto),Timothy D Veenstra (Office Of The Director)|Peter F Johnson; PhD (Laboratory of Cancer Prevention),NULL,"1. Freeman AK, Morrison DK (2011). 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol  22, 681-7.   https://doi.org/10.1016/j.semcdb.2011.08.009|2. McKay MM, Freeman AK, Morrison DK (2011). Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small GTPases  2, 276-281.   https://doi.org/10.4161/sgtp.2.5.17740|3. McKay MM, Ritt DA, Morrison DK (2011). RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling. Curr Biol  21, 563-8.   https://doi.org/10.1016/j.cub.2011.02.033",https://intramural.nih.gov/search/searchview.taf?ipid=73722
425,BC011108-05,"October 01, 2011 -  September 30, 2012",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathleen L Decicco|Zhihong  Shan|Monika  Deshpande,NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)",NULL,"1. Decicco-Skinner KL, Trovato EL, Simmons JK, Lepage PK, Wiest JS (2011). Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis. Oncogene  30, 389-97.   https://doi.org/10.1038/onc.2010.447",https://intramural.nih.gov/search/searchview.taf?ipid=73663
426,BC011109-05,"October 01, 2011 -  September 30, 2012",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Kenji  Maeda|Darshan  Desai; BS,Arun  Ghosh|Yoshikazu  Takaoka (Ono Pharmaceutical Co. Ltd.)|Hiromi  OgataAoki (Kumamoto University School of Medicine),Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73719
427,BC011111-05,"October 01, 2011 -  September 30, 2012",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Gil  Katz|Tejas Bharat Kadakia|James  Disanto; PhD|Ruth  Etzensperger; PhD,NULL,Lionel  Feigenbaum (Office Of The Director),Lothar  Hennighausen; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73632
428,BC011112-05,"October 01, 2011 -  September 30, 2012",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Xuguang C Tai,NULL,Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Molecular Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73628
429,BC011113-05,"October 01, 2011 -  September 30, 2012",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Motoko  Kimura,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73629
430,BC011114-05,"October 01, 2011 -  September 30, 2012",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Leonid  Popezinsky,NULL,Lionel  Feigenbaum (Office Of The Director),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73630
431,BC011115-05,"October 01, 2011 -  September 30, 2012",Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Julie A Hong|Mahadev  Rao|Yuwei  Zhang|Mary R Zhang|Scott M Atay; MD,"Xinmin  Li (Functional Genomics, University of Chicago)|Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Raphael  Bueno (Brigham and Women's Hosp)",Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,"1. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS (2012). Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res  18, 77-90.   https://doi.org/10.1158/1078-0432.CCR-11-0962|2. Rao M, Chinnasamy N, Hong JA, Zhang Y, Zhang M, Xi S, Liu F, Marquez VE, Morgan RA, Schrump DS (2011). Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. Cancer Res  71, 4192-204.   https://doi.org/10.1158/0008-5472.CAN-10-2442",https://intramural.nih.gov/search/searchview.taf?ipid=73615
432,BC011116-05,"October 01, 2011 -  September 30, 2012",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Francois  Van Laethem|Anastassia  Tikhonova,NULL,Lionel  Feigenbaum (Office Of The Director)|Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73626
433,BC011117-05,"October 01, 2011 -  September 30, 2012",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Terry I Guinter|Leonid  Popezinsky,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73627
434,BC011118-05,"October 01, 2011 -  September 30, 2012",Role of Shh in developmental patterning and proliferation of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianjian  Zhu|Xiaozhong  Bao|Victoria E Elliott,"Gerard  Evan (UCSF)|Licia  Selleri (Cornell Univ Weill Medical College)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)|Alexandra L Joyner",Stephen J Lockett; PhD (Office Of The Director),Yosuke  Mukoyama; PhD (NHLBI) |Sohyun  Ahn; PhD (NICHD),"1. Gildea DE, Luetkemeier ES, Bao X, Loftus SK, Mackem S, Yang Y, Pavan WJ, Biesecker LG (2011). The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling. FASEB J  25, 1596-605.   https://doi.org/10.1096/fj.10-169771|2. Zhu J, Mackem S (2011). Analysis of mutants with altered shh activity and posterior digit loss supports a biphasic model for shh function as a morphogen and mitogen. Dev Dyn  240, 1303-10.   https://doi.org/10.1002/dvdy.22637",https://intramural.nih.gov/search/searchview.taf?ipid=73711
435,BC011119-05,"October 01, 2011 -  September 30, 2012",Hoxd gene functions in digit morphogenesis and role of Gli3-Hoxd interaction,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Rebecca A Moriarty|Anna Marie Trofka,"Denis  Duboule (Zoology and Animal Biology, Univ. of Geneva)|John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Alexandra L Joyner|Steve  Vokes (U. Texas, Austin)",Stephen J Lockett; PhD (Office Of The Director)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),"Yingzi  Yang; PhD (NHGRI) |Richa  Agarwala; BTech, MS, PhD (NLM) |Ivan  Ovcharenko; PhD (NLM) |Leslie Glenn Biesecker; MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73712
436,BC011120-05,"October 01, 2011 -  September 30, 2012",Genome-wide identification of target promoters of developmental regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,"Benoit  Bruneau (UCSF)|Steve  Vokes (U. Texas, Austin)",NULL,"Ivan  Ovcharenko; PhD (NLM) |Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73709
437,BC011121-05,"October 01, 2011 -  September 30, 2012",RNA interference approach to dissect roles of notochord regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianjian  Zhu|Xiaozhong  Bao,NULL,Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73710
438,BC011122-05,"October 01, 2011 -  September 30, 2012",Epigenetic Alterations Induced by Tobacco Smoke,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Sichuan  Xi|Mahadev  Rao|Yuwei  Zhang|Fang  Liu|Suzanne M Inchauste,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Victor  Marquez; PhD (Chemical Biology Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73616
439,BC011123-05,"October 01, 2011 -  September 30, 2012",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Kristen Elizabeth Raffensperger|Kevin Y Luo|Cara Elizabeth Wright|Peter A Pinto; MD,NULL,Jane Beth Trepel (Medical Oncology Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Ettore  Appella; MD (Chemical Immunology Section)|Melinda  Hollingshead (Biological Testing Branch)|Lawrence R Phillips (Developmental Therapeutics Program)|Robert J Fisher (Office Of The Director),NULL,"1. Liu F, Giubellino A, Simister PC, Qian W, Giano MC, Feller SM, Bottaro DP, Burke TR (2011). Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides. Biopolymers  96, 780-8.   https://doi.org/10.1002/bip.21692",https://intramural.nih.gov/search/searchview.taf?ipid=73552
440,BC011124-05,"October 01, 2011 -  September 30, 2012",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi|Young Hwan Lee|Kristen Elizabeth Raffensperger|Cara Elizabeth Wright|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Show all 7","Stuart  Aaronson (Research, Mount Sinai Medical Center)|Ascoli  Carl (Clinical Development Oncology, Rockland Immunologicals, Inc)|Teresa  Burgess (Preclinical Development, Amgen)|Isabelle  Desault (Research Oncology, Amgen)|Angela  Coxon (Amgen)|James  Christensen (Oncology Research, Pfizer)|Show all 24","Maria  Merino; PhD (Laboratory of Pathology)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Terrence R Burke; PhD (Chemical Biology Laboratory)",NULL,"1. Cecchi F, Rabe DC, Bottaro DP (2012). Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets  16, 553-72.   https://doi.org/10.1517/14728222.2012.680957",https://intramural.nih.gov/search/searchview.taf?ipid=73553
441,BC011126-05,"October 01, 2011 -  September 30, 2012",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Monica  Vaccari|Shari  Gordon; PhD|Melvin Nelson Doster|Poonam  Poonam|Claudio  Fenizia|Namal Prasanna Malimbada-Liyanage|Show all 7,"Donald  Forthal (School of Medicine, Univ of CA)|Eckhard  Podack (Department of Microbiology, University of Miami)|Chris  Miller; MS|David C Montefiori; PhD (Department of Surgery, NIAID)|Guido  Ferrari (Duke University)|Savita  Pahwa (Miller School of Medicine, University of Miami)|Show all 9",John  Schiller; PhD (Laboratory of Cellular Oncology)|Jeffrey  Roberts (Laboratory of Cellular Oncology)|Christopher  Buck (Laboratory of Cellular Oncology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Gene  Shearer; PhD (Experimental Immunology Branch),Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |Daniel C Douek; MD (NIAID),"1. Fenizia C, Keele BF, Nichols D, Cornara S, Binello N, Vaccari M, Pegu P, Robert-Guroff M, Ma ZM, Miller CJ, Venzon D, Hirsch V, Franchini G (2011). TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure. J Virol  85, 12399-409.   https://doi.org/10.1128/JVI.05707-11",https://intramural.nih.gov/search/searchview.taf?ipid=73584
442,BC011131-05,"October 01, 2011 -  September 30, 2012",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Ranabir  Das|Aaren  Gonzales|Yinghua  Chen|Tao  Huang,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73559
443,BC011132-05,"October 01, 2011 -  September 30, 2012",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Ranabir  Das|Shangjin  Sun|Mitchell  Huang|Yun Xing M Wang,NULL,NULL,Charles  Schwieters; PhD (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73557
444,BC011150-04,"October 01, 2011 -  September 30, 2012",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Wenqing  Li|Julie  Hixon|Wei  Shen|Miranda L Hanson|Katherine Emily Hardey|Mairi Hall McLean,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology),NULL,"1. Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ, Roychoudhuri R, Ferreyra GA, Shen W, Durum SK, Feigenbaum L, Palmer DC, Antony PA, Chan CC, Laurence A, Danner RL, Gattinoni L, Restifo NP (2011). Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity  35, 972-85.   https://doi.org/10.1016/j.immuni.2011.09.019",https://intramural.nih.gov/search/searchview.taf?ipid=73749
445,BC011152-04,"October 01, 2011 -  September 30, 2012",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Anna T Mason|Robin T Winkler Pickett|Lyudmila A Lyakh|Marco  Cardone|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Show all 7,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Franca  Gerosa (Pathology/Immunology, University of Verona)","Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)",NULL,"1. Berezhnoy A, Stewart CA, Mcnamara JO, Thiel W, Giangrande P, Trinchieri G, Gilboa E (2012). Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther  20, 1242-50.   https://doi.org/10.1038/mt.2012.18|2. Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD, Mayer-Barber KD, Myers TG, Rabin RL, Trinchieri G, Sher A, Feng CG (2011). Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol  187, 2540-7.   https://doi.org/10.4049/jimmunol.1100926",https://intramural.nih.gov/search/searchview.taf?ipid=73799
446,BC011153-04,"October 01, 2011 -  September 30, 2012",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Robin T Winkler Pickett|Ren Ming  Dai|Loretta R Smith|Charles Andrew Marshall Stewart|Rosalba  Salcedo|Noriho  Iida; MD, PhD|Show all 11",NULL,NULL,Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID),"1. Stewart C, Trinchieri G (2011) Turning on and off the immunological switch:  Immune response polarization and its control by IL-10 and STAT3, in Immunologic Signature of Rejection. .  Volume VII,  pp. 27-56.|2. Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, Kelsall B, Trinchieri G, Sher A (2012). NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity  36, 1047-59.   https://doi.org/10.1016/j.immuni.2012.03.026|3. Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD, Mayer-Barber KD, Myers TG, Rabin RL, Trinchieri G, Sher A, Feng CG (2011). Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol  187, 2540-7.   https://doi.org/10.4049/jimmunol.1100926|4. Saleh M, Trinchieri G (2011). Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol  11, 9-20.   https://doi.org/10.1038/nri2891|5. Sisirak V, Vey N, Vanbervliet B, Duhen T, Puisieux I, Homey B, Bowman EP, Trinchieri G, Dubois B, Kaiserlian D, Lira SA, Puisieux A, Blay JY, Caux C, Bendriss-Vermare N (2011). CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood  118, 5130-40.   https://doi.org/10.1182/blood-2010-07-295626|6. Trinchieri G (2012). Lymphocyte choriomeningitis virus plays hide-and-seek with type 1 interferon. Cell Host Microbe  11, 553-5.   https://doi.org/10.1016/j.chom.2012.05.007",https://intramural.nih.gov/search/searchview.taf?ipid=73798
447,BC011154-04,"October 01, 2011 -  September 30, 2012",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Takashi  Furusawa|Yuri  Postnikov; MD, PhD|Tao  Deng|Jamie Elyse Kugler|Fenfei  Leng|Eric Dante Ciappio|Show all 7","Leon  Mullenders (Radiation Genetics, University of Leiden)|Melinda K Duncan; PhD (Biological Sciences, The University of Delaware)|Joseph  Orly (Hebrew University)|Eran  Meshorer (Hebrew University)|Sanjoy  Das (Pediatrics and Cancer Biology, Vanderbilt University Medical Center)",Kenneth H Kraemer; MD (Dermatology Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Abuhatzira L, Shamir A, Schones DE, Schäffer AA, Bustin M (2011). The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice. J Biol Chem  286, 42051-62.   https://doi.org/10.1074/jbc.M111.300541|2. Oh KS, Bustin M, Mazur SJ, Appella E, Kraemer KH (2011). UV-induced histone H2AX phosphorylation and DNA damage related proteins accumulate and persist in nucleotide excision repair-deficient XP-B cells. DNA Repair (Amst)  10, 5-15.   https://doi.org/10.1016/j.dnarep.2010.09.004|3. Rochman M, Taher L, Kurahashi T, Cherukuri S, Uversky VN, Landsman D, Ovcharenko I, Bustin M (2011). Effects of HMGN variants on the cellular transcription profile. Nucleic Acids Res  39, 4076-87.   https://doi.org/10.1093/nar/gkq1343",https://intramural.nih.gov/search/searchview.taf?ipid=73739
448,BC011155-04,"October 01, 2011 -  September 30, 2012",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Yang  Feng|John  Owens|Zhongyu  Zhu|Weizao  Chen|Rui  Gong; PhD|Emily D Streaker|Show all 10,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Barton  Haynes (Duke University)|Ruth  Ruprecht (Harvard Medical School)|Gerald  Quinnan (Uniformed Services University of the Health Sciences)|MeiYun  Zhang (University of Hong Kong)",NULL,Peter D Kwong; PhD (NIAID),"1. Chen W, Feng Y, Gong R, Zhu Z, Wang Y, Zhao Q, Dimitrov DS (2011). Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens. J Virol  85, 9395-405.   https://doi.org/10.1128/JVI.05119-11|2. Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS (2012). Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens. Biochem Biophys Res Commun  417, 1164-9.   https://doi.org/10.1016/j.bbrc.2011.12.089|3. Feng Y, Gong R, Dimitrov DS (2011). Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor. Protein Expr Purif  79, 66-71.   https://doi.org/10.1016/j.pep.2011.03.012|4. Gift SK, McFadden K, Zentner IJ, Rajagopal S, Zhang MY, Dimitrov DS, Chaiken IM (2011). Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120. Biochemistry  50, 2769-79.   https://doi.org/10.1021/bi101161j|5. Gift SK, Zentner IJ, Schön A, McFadden K, Umashankara M, Rajagopal S, Contarino M, Duffy C, Courter JR, Zhang MY, Gershoni JM, Cocklin S, Dimitrov DS, Smith AB, Freire E, Chaiken IM (2011). Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18. Biochemistry  50, 2756-68.   https://doi.org/10.1021/bi101160r|6. Gong R, Wang Y, Feng Y, Zhao Q, Dimitrov DS (2011). Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor. J Biol Chem  286, 27288-93.   https://doi.org/10.1074/jbc.M111.254219|7. Prabakaran P, Chen W, Singarayan MG, Stewart CC, Streaker E, Feng Y, Dimitrov DS (2012). Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations. Immunogenetics  64, 337-50.   https://doi.org/10.1007/s00251-011-0595-8|8. Prabakaran P, Streaker E, Chen W, Dimitrov DS (2011). 454 antibody sequencing - error characterization and correction. BMC Res Notes  4, 404.   https://doi.org/10.1186/1756-0500-4-404|9. Ying T, Chen W, Gong R, Feng Y, Dimitrov DS (2012). Soluble monomeric IgG1 Fc. J Biol Chem  287, 19399-408.   https://doi.org/10.1074/jbc.M112.368647|10. Yuan T, Li J, Zhang Y, Wang Y, Streaker E, Dimitrov DS, Zhang MY (2011). Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development. Vaccine  29, 6903-10.   https://doi.org/10.1016/j.vaccine.2011.07.046|11. Zhu Z, Qin HR, Chen W, Zhao Q, Shen X, Schutte R, Wang Y, Ofek G, Streaker E, Prabakaran P, Fouda GG, Liao HX, Owens J, Louder M, Yang Y, Klaric KA, Moody MA, Mascola JR, Scott JK, Kwong PD, Montefiori D, Haynes BF, Tomaras GD, Dimitrov DS (2011). Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J Virol  85, 11401-8.   https://doi.org/10.1128/JVI.05312-11",https://intramural.nih.gov/search/searchview.taf?ipid=73748
449,BC011156-04,"October 01, 2011 -  September 30, 2012",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Yang  Feng|John  Owens|Zhongyu  Zhu|Yanping  Wang|Vinita  Puri|Prabakaran  Ponraj,NULL,NULL,NULL,"1. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B (2011). A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Sci Transl Med  3, 105ra103.   https://doi.org/10.1126/scitranslmed.3002901|2. Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS (2012). Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens. Biochem Biophys Res Commun  417, 1164-9.   https://doi.org/10.1016/j.bbrc.2011.12.089|3. Prabakaran P, Streaker E, Chen W, Dimitrov DS (2011). 454 antibody sequencing - error characterization and correction. BMC Res Notes  4, 404.   https://doi.org/10.1186/1756-0500-4-404|4. Xiao X, Feng Y, Zhu Z, Dimitrov DS (2011). Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem Biophys Res Commun  411, 253-8.   https://doi.org/10.1016/j.bbrc.2011.06.109",https://intramural.nih.gov/search/searchview.taf?ipid=73747
450,BC011158-04,"October 01, 2011 -  September 30, 2012",Study the role(s) of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mangmang  Li|Shunlin  Jiang|Min Hwa  Shin,NULL,Jianxin  Shi (Biostatistics Branch)|Michael  Bustin; PhD (Protein Section),NULL,"1. Liu F, Barsyte-Lovejoy D, Allali-Hassani A, He Y, Herold JM, Chen X, Yates CM, Frye SV, Brown PJ, Huang J, Vedadi M, Arrowsmith CH, Jin J (2011). Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J Med Chem  54, 6139-50.   https://doi.org/10.1021/jm200903z",https://intramural.nih.gov/search/searchview.taf?ipid=73760
451,BC011159-04,"October 01, 2011 -  September 30, 2012",Identification of Biomarkers for Response to Chemoprevention of Colon Cancer,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Matthew R Young; PhD|Christopher  Dextras|Shakir M Saud|Weidong  Li,Robert  Chapkin (Texas A&M)|Terry  Hartman (Penn State Univ)|Gerd  Bobe,Amanda  Cross (Nutritional Epidemiology Branch)|John A Milner (Nutritional Science Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73743
452,BC011160-04,"October 01, 2011 -  September 30, 2012",Mechanisms in development and regulation of metastasis in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Yili  Xie|Lisa Ann Tobin|John R Wunderlich,NULL,Maria  Tsokos; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73777
453,BC011162-04,"October 01, 2011 -  September 30, 2012",Molecular Profiling of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Geng  Zhang|Jian  Wang,Jochen  Gaedcke|Anirban  Maitra (Johns Hopkins University School of Medicine),Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73762
454,BC011163-04,"October 01, 2011 -  September 30, 2012",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mary  Hollander|Bhagelu Ram  Achyut|Hangyi  Yan|Sudheer Kumar Gara|Weiye  Wang,NULL,Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73804
455,BC011165-04,"October 01, 2011 -  September 30, 2012",Role of immature myeloid cells in premetastatic lung,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Bhagelu Ram  Achyut|Hangyi  Yan|Weiye  Wang,NULL,Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73805
456,BC011167-04,"October 01, 2011 -  September 30, 2012",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Jennifer D Rieker,Martin  McMahon (University of Californial at San Francisco)|Marcus  Bosenberg (Yale University),Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,"1. Day CP, Carter J, Bonomi C, Hollingshead M, Merlino G (2012). Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin. Int J Cancer  130, 190-9.   https://doi.org/10.1002/ijc.25978|2. Day CP, Merlino G (2011). Illuminating progression: tracking melanoma  metastasis in a gene therapy setting. Pigment Cell Melanoma Res  24, 260-1.   https://doi.org/10.1111/j.1755-148X.2011.00826.x",https://intramural.nih.gov/search/searchview.taf?ipid=73782
457,BC011168-04,"October 01, 2011 -  September 30, 2012",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Michael  Blank|Yi  Tang|Nikhil  Teja,"Lianping  Xing (Department of Pathology, University of Rochester)|Beth  Levine; MD (UT Southwestern Medical Center)|MarieDominique  Filippi (Cincinnati Children's Research Foundation)",Miriam R Anver (Office Of The Director)|Ming  Zhou (Nucleic Acids Section),Chuxia  Deng; PhD (NIDDK),"1. Cheng SY, Zhang YE (2011). Smurfs have ""fused"" into the asymmetric division of stem cells. Protein Cell  2, 2-4.   https://doi.org/10.1007/s13238-011-1005-6|2. Orvedahl A, Sumpter R, Xiao G, Ng A, Zou Z, Tang Y, Narimatsu M, Gilpin C, Sun Q, Roth M, Forst CV, Wrana JL, Zhang YE, Luby-Phelps K, Xavier RJ, Xie Y, Levine B (2011). Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature  480, 113-7.   https://doi.org/10.1038/nature10546|3. Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C, Deng CX, Cheng SY, Zhang YE (2011). Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J  30, 4777-89.   https://doi.org/10.1038/emboj.2011.393|4. Tang LY, Zhang YE (2011). Non-degradative ubiquitination in Smad-dependent TGF-β signaling. Cell Biosci  1, 43.   https://doi.org/10.1186/2045-3701-1-43",https://intramural.nih.gov/search/searchview.taf?ipid=73809
458,BC011169-04,"October 01, 2011 -  September 30, 2012",Inflammation and Prostate Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Katherine  Stagliano|Jennifer Lynne Shoe,NULL,William  Farrar (Laboratory of Cancer Prevention)|Lionel  Feigenbaum (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73761
459,BC011170-04,"October 01, 2011 -  September 30, 2012",Comparative Functional Genomics,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Phuongnga  Ton|Jesper B Andersen; PhD|Matthew C Gillen|Matthias Sebastian Matter; MD, PhD","Hanne  Bisgaard (Medical Biochemistry and Genetics, University of Copenhagen)|Diego F Calvisi (NCI)|Cedric  Coulouarn",Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Douglas  Lowy; MD (Laboratory of Cellular Oncology)|Nicolae C Popescu; PhD (Molecular Cytogenetics Section),NULL,"1. Coulouarn C, Corlu A, Glaise D, Guénon I, Thorgeirsson SS, Clément B (2012). Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res  72, 2533-42.   https://doi.org/10.1158/0008-5472.CAN-11-3317|2. Coulouarn C, Factor VM, Conner EA, Thorgeirsson SS (2011). Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer. Carcinogenesis  32, 1434-40.   https://doi.org/10.1093/carcin/bgr133|3. Thomas HE, Mercer CA, Carnevalli LS, Park J, Andersen JB, Conner EA, Tanaka K, Matsutani T, Iwanami A, Aronow BJ, Manway L, Maira SM, Thorgeirsson SS, Mischel PS, Thomas G, Kozma SC (2012). mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med  4, 139ra84.   https://doi.org/10.1126/scitranslmed.3003923",https://intramural.nih.gov/search/searchview.taf?ipid=73797
460,BC011173-04,"October 01, 2011 -  September 30, 2012",Genomic Classification of Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Valentina  Factor|Phuongnga  Ton|Tanya N Hoang|Daekwan  Seo; PhD, MS, BA|Jesper B Andersen; PhD|Matthew C Gillen","Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)|Peter  Galle|Derek  Chiang (University of North Carolina)|Jens Uwe Marquardt|Young  Park (Yonsei University College of Medicine)|Show all 7",Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,"1. Andersen JB, Thorgeirsson SS (2012). Genetic profiling of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol  28, 266-72.   https://doi.org/10.1097/MOG.0b013e3283523c7e|2. Calvisi DF, Ladu S, Conner EA, Seo D, Hsieh JT, Factor VM, Thorgeirsson SS (2011). Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol  54, 311-9.   https://doi.org/10.1016/j.jhep.2010.06.036|3. Woo HG, Park ES, Thorgeirsson SS, Kim YJ (2011). Exploring genomic profiles of hepatocellular carcinoma. Mol Carcinog  50, 235-43.   https://doi.org/10.1002/mc.20691|4. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS (2011). Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology  140, 1063-70.   https://doi.org/10.1053/j.gastro.2010.11.034|5. Yang JD, Seol SY, Leem SH, Kim YH, Sun Z, Lee JS, Thorgeirsson SS, Chu IS, Roberts LR, Kang KJ (2011). Genes associated with recurrence of hepatocellular carcinoma: integrated analysis by gene expression and methylation profiling. J Korean Med Sci  26, 1428-38.   https://doi.org/10.3346/jkms.2011.26.11.1428|6. Yang JD, Sun Z, Hu C, Lai J, Dove R, Nakamura I, Lee JS, Thorgeirsson SS, Kang KJ, Chu IS, Roberts LR (2011). Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival. Genes Chromosomes Cancer  50, 122-35.   https://doi.org/10.1002/gcc.20838",https://intramural.nih.gov/search/searchview.taf?ipid=73795
461,BC011175-04,"October 01, 2011 -  September 30, 2012",Validation of Therapeutic Target Genes in Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Valentina  Factor|Phuongnga  Ton|Daekwan  Seo; PhD, MS, BA|Thomas Michel Herve Decaens","Ian  MacLachlan (Protiva, Protiva Biotherapeutics, Inc)|Lars  Zender (University of Tubingen)","Udai S Kammula (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Lee YH, Judge AD, Seo D, Kitade M, Gómez-Quiroz LE, Ishikawa T, Andersen JB, Kim BK, Marquardt JU, Raggi C, Avital I, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS (2011). Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response. Oncogene  30, 4175-84.   https://doi.org/10.1038/onc.2011.126",https://intramural.nih.gov/search/searchview.taf?ipid=73796
462,BC011176-04,"October 01, 2011 -  September 30, 2012",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Philippe Cedric Kieffer-Kwon|Amelia Mcfarlane Gallaher; BA|Dhivya  Ramalingam|Christine  Happel; PhD|Thomas S Uldrick,NULL,NULL,NULL,"1. Ziegelbauer JM (2011). Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta  1809, 623-30.   https://doi.org/10.1016/j.bbagrm.2011.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=73810
463,BC011177-04,"October 01, 2011 -  September 30, 2012",Botulinum Toxin for Painful Cutaneous Leiomyomas,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN|Edward W Cowen",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73776
464,BC011181-04,"October 01, 2011 -  September 30, 2012",Functional Analysis of Variants Identified in Human Breast Cancer Susceptibility,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Susan L North|Stacey S Stauffer|Suhwan  Chang|Thirthagiri  Eswary|Suzanne A Hartford|Waheed Saadiya Sehareen,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)|Stephen  Byers (Georgetown University)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Das R, Alter BP, Kuznetsov SG, Stauffer S, North SL, Burkett S, Brody LC, Meyer S, Byrd RA, Sharan SK (2011). A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Blood  118, 2430-42.   https://doi.org/10.1182/blood-2010-12-324541|2. Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX, Sharan SK (2011). Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med  17, 1275-82.   https://doi.org/10.1038/nm.2459",https://intramural.nih.gov/search/searchview.taf?ipid=73790
465,BC011184-04,"October 01, 2011 -  September 30, 2012",Mechanism of Radiation Affects on microRNA,Nicole L Simone; MD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),"1. Argiris A, Duffy AG, Kummar S, Simone NL, Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C (2011). Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. Clin Cancer Res  17, 5755-64.   https://doi.org/10.1158/1078-0432.CCR-11-0861|2. Simone CB, Lonser RR, Ondos J, Oldfield EH, Camphausen K, Simone NL (2011). Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol  13, 1030-6.   https://doi.org/10.1093/neuonc/nor085|3. Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL (2011). Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol  101, 376-82.   https://doi.org/10.1016/j.radonc.2011.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=73792
466,BC011185-04,"October 01, 2011 -  September 30, 2012",Role of Inflammation in the Development and Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Geng  Zhang|Jian  Wang,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Anirban  Maitra (Johns Hopkins University School of Medicine),David Anderson Wink (Radiation Biology Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73763
467,BC011186-04,"October 01, 2011 -  September 30, 2012",Animal model of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Geng  Zhang,NULL,Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73764
468,BC011187-04,"October 01, 2011 -  September 30, 2012",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Teresa  Kosakowska Cholo|Jing  Lin|Meena  Sharma|Zachary Thomas Daar|Srideshikan  Sargur Madabushi,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program)|Shyam K Sharan (Mouse Cancer Genetics Program)|Sarangan  Ravichandran (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73734
469,BC011188-04,"October 01, 2011 -  September 30, 2012",Diazeniumdiolates as Broad-Spectrum Anticancer Agents,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",Joseph A. Hrabie; PhD|Joseph  Saavedra|Laura  Fornwald|Anna E Maciag|Debanjan  Biswas|Ryan John Holland; PhD|Show all 9,"Paul  Shami (Medical Oncology, U of Utah)|Robert  Prud'homme (Princeton University)|Astrid  Weyerbrock (UNIVERSITÃTSKLINIKUM FREIBURG)",Xinhua  Ji; PhD (Biomolecular Structure Section)|James Ming Phang; MD (Basic Research Laboratory)|Jonathan  Weiss (Laboratory of Experimental Immunology),NULL,"1. Kogias E, Osterberg N, Baumer B, Psarras N, Koentges C, Papazoglou A, Saavedra JE, Keefer LK, Weyerbrock A (2012). Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. Int J Cancer  130, 1184-94.   https://doi.org/10.1002/ijc.26106|2. Maciag AE, Chakrapani H, Saavedra JE, Morris NL, Holland RJ, Kosak KM, Shami PJ, Anderson LM, Keefer LK (2011). The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species. J Pharmacol Exp Ther  336, 313-20.   https://doi.org/10.1124/jpet.110.174904|3. Maciag AE, Nandurdikar RS, Hong SY, Chakrapani H, Diwan B, Morris NL, Shami PJ, Shiao YH, Anderson LM, Keefer LK, Saavedra JE (2011). Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs. J Med Chem  54, 7751-8.   https://doi.org/10.1021/jm2004128|4. Nandurdikar RS, Maciag AE, Holland RJ, Cao Z, Shami PJ, Anderson LM, Keefer LK, Saavedra JE (2012). Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugs. Bioorg Med Chem  20, 3094-9.   https://doi.org/10.1016/j.bmc.2012.02.045|5. Weyerbrock A, Osterberg N, Psarras N, Baumer B, Kogias E, Werres A, Bette S, Saavedra JE, Keefer LK, Papazoglou A (2012). JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas. Neurosurgery  70, 497-510; discussion 510.   https://doi.org/10.1227/NEU.0b013e31823209cf|6. Weyerbrock A, Walbridge S, Saavedra JE, Keefer LK, Oldfield EH (2011). Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas. Neuro Oncol  13, 203-11.   https://doi.org/10.1093/neuonc/noq161",https://intramural.nih.gov/search/searchview.taf?ipid=73771
470,BC011189-04,"October 01, 2011 -  September 30, 2012",Molecular Pathogenic Mechanism of Rhabdomyosarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73740
471,BC011190-04,"October 01, 2011 -  September 30, 2012",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Yuk Sing Robert Cheng|Julie Lynn Heinecke; PhD|James B Mitchell; PhD|Murali  Krishna; PhD,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Flores-Santana W, Salmon DJ, Donzelli S, Switzer CH, Basudhar D, Ridnour L, Cheng R, Glynn SA, Paolocci N, Fukuto JM, Miranda KM, Wink DA (2011). The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems. Antioxid Redox Signal  14, 1659-74.   https://doi.org/10.1089/ars.2010.3841|2. Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N (2011). Playing with cardiac ""redox switches"": the ""HNO way"" to modulate cardiac function. Antioxid Redox Signal  14, 1687-98.   https://doi.org/10.1089/ars.2010.3859",https://intramural.nih.gov/search/searchview.taf?ipid=73803
472,BC011191-04,"October 01, 2011 -  September 30, 2012",Preclinical Mouse Model of Thyroid Carcinogenesis,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Li  Zhao|Laura  Fozzatti|Xuguang  Zhu|Dong Wook  Kim; PhD|Jeong-Won  Park|Won Gu  Kim,"Mark  Willingham (Wake Forest University School of Medicine)|GZ  Zhu (Marshall University)|Frances  Carr (University of Vermont College of Medicine)|Young  Jo (Chungnam national University Hospital)|THOMAS  KLONISCH (University of Manitoba)|Matthew D Ringel; MD (Lab. of Molec. Endocrinol., Washington Hospital Center)",Electron  Kebebew; MD (Surgery Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"1. Guigon CJ, Kim DW, Willingham MC, Cheng SY (2011). Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors. Oncogene  30, 3381-90.   https://doi.org/10.1038/onc.2011.50|2. Lu C, Cheng SY (2011). Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis. Steroids  76, 885-91.   https://doi.org/10.1016/j.steroids.2011.03.016|3. Lu C, Mishra A, Zhu YJ, Meltzer P, Cheng SY (2011). Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma. Am J Cancer Res  1, 1-13.|4. Lu C, Mishra A, Zhu YJ, Meltzer P, Cheng SY (2011). Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis. Am J Cancer Res  1, 168-191.",https://intramural.nih.gov/search/searchview.taf?ipid=73742
473,BC011192-04,"October 01, 2011 -  September 30, 2012",The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73802
474,BC011194-04,"October 01, 2011 -  September 30, 2012",Modeling the MET Oncogene in Osteosarcoma,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73773
475,BC011195-04,"October 01, 2011 -  September 30, 2012",Sequencing the Osteosarcoma Kinome,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73774
476,BC011196-04,"October 01, 2011 -  September 30, 2012",The NIH Pediatric and wildtype GIST Clinic,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Carly Jean Smith,NULL,NULL,"Constantine Argyrios Stratakis; MD, DSc (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73775
477,BC011197-04,"October 01, 2011 -  September 30, 2012",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI","Sharlyn  Mazur; PhD|Lisa Marie Jenkins|Kan  Tanoue|Hiroyasu  Sakai; MD, PhD",NULL,Stewart  Durell (Laboratory of Cell Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73735
478,BC011199-04,"October 01, 2011 -  September 30, 2012",Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,John M Jessup,NULL,"Cellular and Molecular Biology Section, NCI","Veenu  Tripathi; PhD|Jingyu  Zhang|Snorri S. Thorgeirsson; MD, PhD",Dean  Tang (UT M D Anderson Cancer Center)|Karine  Breckpot (Vrije Universiteit Brussel)|Jakob  Reiser (FDA),"Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Robert  Kinders (Toxicology and Pharmacology Branch)|Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73766
479,BC011202-04,"October 01, 2011 -  September 30, 2012",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,Michelle  Wang (Cornell University)|Patrick  Cramer (LM University),Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73770
480,BC011203-04,"October 01, 2011 -  September 30, 2012",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nadim  Majdalani|Aurelia  Battesti|Song  Tong|Yodit  Tsegaye,NULL,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73753
481,BC011204-04,"October 01, 2011 -  September 30, 2012",Preclinical development of Ala+TIMP-2 as an cancer therapeutic,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Beiyang  Wei|Sandra  Jensen-Taubman|Liliana  Guedez; PhD|Dimitra  Bourmpoulia; PhD|Huiying  Han|Laurie Ann  Shuman Moss|Show all 7,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Bourboulia D, Jensen-Taubman S, Rittler MR, Han HY, Chatterjee T, Wei B, Stetler-Stevenson WG (2011). Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment. Am J Pathol  179, 2589-600.   https://doi.org/10.1016/j.ajpath.2011.07.035|2. Bourboulia D, JensenTaubman S, Stetler-Stevenson W (2012) TIMP-2 An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties. Treatment Strategies-Hemat 2:31-35.|3. Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A, Stetler-Stevenson WG (2011). An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides  32, 1840-8.   https://doi.org/10.1016/j.peptides.2011.08.010|4. Stetler-Stevenson W, Bourboulia D, Guedex L, JensenTaubman S (2012) Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development. Current Angiogenesis 1:148-156.",https://intramural.nih.gov/search/searchview.taf?ipid=73794
482,BC011205-04,"October 01, 2011 -  September 30, 2012",Population based studies,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",NULL,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Magnus  Bjorkholm (Karolinska)|Sigurdur  Kristinsson (Karolinska),"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Anderson LA, Moore SC, Gridley G, Stone BJ, Landgren O (2011). Concomitant and antecedent deep venous thrombosis and cancer survival in male US veterans. Leuk Lymphoma  52, 764-70.   https://doi.org/10.3109/10428194.2010.551572|2. Auner HW, Pavlu J, Szydlo R, Giles C, Kanfer E, Macdonald D, Marin D, Milojkovic D, Rezvani K, Goldman JM, Apperley JF, Landgren O, Rahemtulla A (2012). Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system. Br J Haematol  157, 125-7.   https://doi.org/10.1111/j.1365-2141.2011.08906.x|3. Chang CM, Landgren O, Koshiol J, BjÃ¶rkholm M, LÃ¶ve TJ, Kristinsson SY (2012). Re: Risk of malignancy associated with Lyme disease: Still up in the air. Int J Cancer  131, 2718.|4. Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH (2011). Cancer risk among patients with myotonic muscular dystrophy. JAMA  306, 2480-6.   https://doi.org/10.1001/jama.2011.1796|5. Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Björkholm M, Landgren O, Giaccone G (2011). A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer  128, 2688-94.   https://doi.org/10.1002/ijc.25583|6. Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Björkholm M (2012). Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol  30, 179-83.   https://doi.org/10.1200/JCO.2011.37.1203|7. Goldin LR, Landgren O, Kristinsson SY, Björkholm M, Paltiel O (2011). Infection in infancy and subsequent risk of developing lymphoma in children and young adults. Blood  117, 1670-2.   https://doi.org/10.1182/blood-2010-09-306274|8. Koshiol J, Lam TK, Gridley G, Check D, Brown LM, Landgren O (2011). Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol  29, 378-85.   https://doi.org/10.1200/JCO.2010.30.1515|9. Kristinsson SY, Björkholm M, Hultcrantz M, Derolf ÅR, Landgren O, Goldin LR (2011). Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol  29, 2897-903.   https://doi.org/10.1200/JCO.2011.34.8540|10. Kristinsson SY, Landgren O (2012). Thromboprophylaxis in multiple myeloma: is the evidence there? Expert Rev Anticancer Ther  12, 291-4.   https://doi.org/10.1586/era.11.214|11. Kristinsson SY, Pfeiffer RM, Björkholm M, Schulman S, Landgren O (2012). Thrombosis is associated with inferior survival in multiple myeloma. Haematologica  97, 1603-7.   https://doi.org/10.3324/haematol.2012.064444|12. Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM (2011). Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer  117, 1163-71.   https://doi.org/10.1002/cncr.25524|13. Landgren O, Korde N (2011). Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities. Oncology (Williston Park)  25, 589-90.|14. Lindqvist EK, Goldin LR, Landgren O, Blimark C, Mellqvist UH, Turesson I, Wahlin A, Björkholm M, Kristinsson SY (2011). Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood  118, 6284-91.   https://doi.org/10.1182/blood-2011-04-347559|15. Tadmor T, Liphshitz I, Aviv A, Landgren O, Barchana M, Polliack A (2012). Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumour. Br J Haematol  157, 457-62.   https://doi.org/10.1111/j.1365-2141.2012.09087.x|16. Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O (2012). Second malignancies after multiple myeloma: from 1960s to 2010s. Blood  119, 2731-7.   https://doi.org/10.1182/blood-2011-12-381426",https://intramural.nih.gov/search/searchview.taf?ipid=73778
483,BC011206-04,"October 01, 2011 -  September 30, 2012",Genome wide profiling of histone variants in colorectal cancer cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rajbir K Gill|Song  Fu|Marcin Piotr Walkiewicz,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),Emilios K Dimitriadis; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73744
484,BC011207-04,"October 01, 2011 -  September 30, 2012",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rajbir K Gill|Minh  Bui|Delphine Chantal Anne Marie Quenet; PhD,Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)|Jennifer  Otteson (Ohio State University),NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Quénet D, Dalal Y (2012). The CENP-A nucleosome: a dynamic structure and role at the centromere. Chromosome Res  20, 465-79.   https://doi.org/10.1007/s10577-012-9301-4",https://intramural.nih.gov/search/searchview.taf?ipid=73745
485,BC011208-04,"October 01, 2011 -  September 30, 2012",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Takeshi  Mizuguchi|Namhoon  Lee|Emiko  Matsuda|Ozan  Aygun|Vanivilasini  Balachandran|Sameet Satish Mehta; PhD|Show all 8,NULL,Peter C Fitzgerald (Office of the Director)|Timothy D Veenstra (Office Of The Director)|Ming  Zhou (Nucleic Acids Section),Henry L Levin; PhD (NICHD),"1. AygÃ¼n O, Grewal SI (2011) The assembly and functions of heterochromatin in fission yeast genome. Cold Spring Harb Symp Quant Biol 75:259-267.|2. Matsuda E, Sugioka-Sugiyama R, Mizuguchi T, Mehta S, Cui B, Grewal SI (2011). A homolog of male sex-determining factor SRY cooperates with a transposon-derived CENP-B protein to control sex-specific directed recombination. Proc Natl Acad Sci U S A  108, 18754-9.   https://doi.org/10.1073/pnas.1109988108|3. Reyes-Turcu FE, Grewal SI (2012). Different means, same end-heterochromatin formation by RNAi and RNAi-independent RNA processing factors in fission yeast. Curr Opin Genet Dev  22, 156-63.   https://doi.org/10.1016/j.gde.2011.12.004|4. Yamane K, Mizuguchi T, Cui B, Zofall M, Noma K, Grewal SI (2011). Asf1/HIRA facilitate global histone deacetylation and associate with HP1 to promote nucleosome occupancy at heterochromatic loci. Mol Cell  41, 56-66.   https://doi.org/10.1016/j.molcel.2010.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=73755
486,BC011209-04,"October 01, 2011 -  September 30, 2012",Kinetochore Interaction with Centromere Chromatin in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Delphine Chantal Anne Marie Quenet; PhD|Daniel  Yarmovsky,NULL,"Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)",Aleksandra Urszula Nita-Lazar; PhD (NIAID) |Emilios K Dimitriadis; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73746
487,BC011210-04,"October 01, 2011 -  September 30, 2012",Magnetic Drug Delivery for Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"1. Nacev A, Kim SH, Rodriguez-Canales J, Tangrea MA, Shapiro B, Emmert-Buck MR (2011). A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. Int J Nanomedicine  6, 2907-23.   https://doi.org/10.2147/IJN.S23724",https://intramural.nih.gov/search/searchview.taf?ipid=73750
488,BC011211-04,"October 01, 2011 -  September 30, 2012",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Jean-Philippe  Castaing|Prahathees  Eswara Moorthy|Irene S Tan,"Joseph  Pogliano (University of California, San Diego)|Douglas  Weibel (University of Wisconsin-Madison)|Fang  Tian (Penn State University, College of Medicine)",NULL,Aravind L Iyer; PhD (NLM) |Hari  Shroff; PhD (NIBIB),"1. Eswaramoorthy P, Erb ML, Gregory JA, Silverman J, Pogliano K, Pogliano J, Ramamurthi KS (2011). Cellular architecture mediates DivIVA ultrastructure and regulates min activity in Bacillus subtilis. MBio  2.   https://doi.org/10.1128/mBio.00257-11|2. Ramamurthi KS (2011). Molecular biology. mRNA delivers the goods. Science  331, 1021-2.   https://doi.org/10.1126/science.1201001",https://intramural.nih.gov/search/searchview.taf?ipid=73788
489,BC011212-04,"October 01, 2011 -  September 30, 2012",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Jami D Willette brown|Zuoxiang  Xiao|Maheshvarma Rvs Datla|Feng  Zhu; PhD|Howard A Young; PhD|Robert  Wiltrout; PhD,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Balkhi MY, Willette-Brown J, Zhu F, Chen Z, Liu S, Guttridge DC, Karin M, Hu Y (2012). IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis. Blood  119, 5467-77.   https://doi.org/10.1182/blood-2012-01-401547|2. Liu B, Willette-Brown J, Liu S, Chen X, Fischer SM, Hu Y (2011). IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin. Cell Death Differ  18, 1854-64.   https://doi.org/10.1038/cdd.2011.56",https://intramural.nih.gov/search/searchview.taf?ipid=73759
490,BC011214-04,"October 01, 2011 -  September 30, 2012",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Changwan  Hong|Davinna Lachelle Ligons|Hilary Rachel Keller,Thomas  Hunig (University of Wuerzburg)|Scott  Walsh (University of Maryland)|Batu M Erman,NULL,Marta Liliana Catalfamo; PhD (NIAID) |Bibiana  Bielekova; MD (NINDS),"1. Kim GY, Hong C, Park JH (2011). Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw  11, 1-10.   https://doi.org/10.4110/in.2011.11.1.1|2. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH (2012). An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol  188, 5859-66.   https://doi.org/10.4049/jimmunol.1102328",https://intramural.nih.gov/search/searchview.taf?ipid=73786
491,BC011215-04,"October 01, 2011 -  September 30, 2012",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Changwan  Hong|Davinna Lachelle Ligons|Hilary Rachel Keller,NULL,Alfred  Singer; MD (Lymphocyte Development Section)|James Stephen Shaw; PhD (Human Immunology Section),NULL,"1. Hong C, Luckey MA, Park JH (2012). Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin Immunol  24, 151-8.   https://doi.org/10.1016/j.smim.2012.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=73787
492,BC011216-04,"October 01, 2011 -  September 30, 2012",CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Lunhua  Liu|Christina  Stuelten|Philippe  Afonso|Satarupa  Das|Wolfgang  Losert; PhD|Show all 8,NULL,NULL,NULL,"1. Aerbajinai W, Liu L, Chin K, Zhu J, Parent CA, Rodgers GP (2011). Glia maturation factor-γ mediates neutrophil chemotaxis. J Leukoc Biol  90, 529-38.   https://doi.org/10.1189/jlb.0710424|2. Afonso PV, Parent CA (2011). PI3K and chemotaxis: a priming issue? Sci Signal  4, pe22.   https://doi.org/10.1126/scisignal.2002019|3. Liu L, Parent CA (2011). Review series: TOR kinase complexes and cell migration. J Cell Biol  194, 815-24.   https://doi.org/10.1083/jcb.201102090|4. Sixt M, Parent CA (2011). Cells on the move in Philadelphia. Mol Biol Cell  22, 724.   https://doi.org/10.1091/mbc.E10-12-0958",https://intramural.nih.gov/search/searchview.taf?ipid=73785
493,BC011217-04,"October 01, 2011 -  September 30, 2012",Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Zoe W Ohler|Serguei V Kozlov,"Kwok-Kin  Wong (Harvard University)|Neal  Goodwin (Jackson Laboratory, West)|David  Gandara (University of Califormia at Davis)|Colin  Hill (GNS Healthcare, Inc.)|Annette  Walter (Clovis Oncology, Inc.)",NULL,NULL,"1. Weaver Z, Difilippantonio S, Carretero J, Martin P, El Meskini R, Iacovelli A, Gumprecht M, Kulaga A, Guerin T, Schlomer J, Baran M, Kozlov S, McCann T, Mena S, Alshahrour F, Alexander D, Wong K, Van Dyke T (2012) Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73800
494,BC011219-04,"October 01, 2011 -  September 30, 2012",Combination Gene Therapy and Th1Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",J  Foley|Shoba M Amarnath|Miriam E Mossoba|Tania Cristina Felizardo,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)",NULL,David F Stroncek; MD (CC),"1. Amarnath S, Mangus CW, Wang JC, Wei F, He A, Kapoor V, Foley JE, Massey PR, Felizardo TC, Riley JL, Levine BL, June CH, Medin JA, Fowler DH (2011). The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med  3, 111ra120.   https://doi.org/10.1126/scitranslmed.3003130|2. Felizardo TC, Wang JC, McGray RA, Evelegh C, Spaner DE, Fowler DH, Bramson JL, Medin JA (2011). Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model. Gene Ther  18, 986-95.   https://doi.org/10.1038/gt.2011.53",https://intramural.nih.gov/search/searchview.taf?ipid=73751
495,BC011220-04,"October 01, 2011 -  September 30, 2012",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",Shoba M Amarnath|Tania Cristina Felizardo,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73752
496,BC011222-04,"October 01, 2011 -  September 30, 2012",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Alexandra  Lin|Sadhanshu  Shukla; PhD,NULL,Jane Beth Trepel (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73793
497,BC011223-04,"October 01, 2011 -  September 30, 2012",Function of O-GlcNAc-modified Human RNA Polymerase II in Transcription,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Stella Maris  Ranuncolo|Jason Alexander Piotrowski; BA, MS",Gerald  Hart (Johns Hopkins University School of Medicine)|Alma  Burlingame (UCSF),Pradman  Qasba; PhD (Center for Cancer Research Nanobiology Program),John Allan Hanover; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73781
498,BC011224-04,"October 01, 2011 -  September 30, 2012",Casein Kinase 1 Delta in Wnt Signaling and Beyond,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Bolormaa  Baljinnyam|Yoshimi Endo Greer|Charles Peter Xavier|Stanley  Lipkowitz; MD, PhD",NULL,Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),Kapil  Bharti; PhD (NINDS) |Yingzi  Yang; PhD (NHGRI),"1. Greer YE, Rubin JS (2011). Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth. J Cell Biol  192, 993-1004.   https://doi.org/10.1083/jcb.201011111",https://intramural.nih.gov/search/searchview.taf?ipid=73789
499,BC011225-04,"October 01, 2011 -  September 30, 2012",Identification of Molecular Factors Associated with Response to Interleukin-2,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,Francesco M. Marincola; MD (CC) |Ena  Wang (CC) |Marianna  Sabatino (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73807
500,BC011226-04,"October 01, 2011 -  September 30, 2012",Optimization of tissue depletion for LCM-MS coupling,Donald J Johann,NULL,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73768
501,BC011227-04,"October 01, 2011 -  September 30, 2012",Estrogen metabolite profiling of thin tissue sections,Donald J Johann,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",NULL,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73769
502,BC011229-04,"October 01, 2011 -  September 30, 2012",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Lara Helmi el Touny|Aleksandra M Michalowska,Dalit  Barkan (Haifa University)|Pepper  Schedin (University of Colorado),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Aprelikova O, Green JE (2012). MicroRNA regulation in cancer-associated fibroblasts. Cancer Immunol Immunother  61, 231-237.   https://doi.org/10.1007/s00262-011-1139-7|2. Barkan D, Green JE (2011). An in vitro system to study tumor dormancy and the switch to metastatic growth. J Vis Exp  .  https://doi.org/10.3791/2914|3. O'Brien J, Hansen K, Barkan D, Green J, Schedin P (2011) NSAIDs target pro-tumorigenic extracellular matrix of the postpartum mammary gland. International Journal of Developmental Biology 745-755.",https://intramural.nih.gov/search/searchview.taf?ipid=73754
503,BC011231-04,"October 01, 2011 -  September 30, 2012",Clinical Trial of AZD0530 in Recurrent Osteosarcoma,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73772
504,BC011232-04,"October 01, 2011 -  September 30, 2012",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,Joel Patrick Schneider; PhD,"Chemical Biology Laboratory, NCI",M A Siddiqui|Piotr  Kaczmarek,"Susan  Keay|Alex  Mackerell Jr (University of Maryland)|Inka  Brockhausen (Queen's University, Human Mobility Research Centre)|Myriam Louise Cotten|Jennifer  Elisseeff; PhD",NULL,NULL,"1. Koch K, Zhang C, Kaczmarek P, Barchi J, Guo L, Shahjee H, Keay S (2011) The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion. Investigational New Drugs, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73737
505,BC011233-04,"October 01, 2011 -  September 30, 2012",Structural Bioinformatics,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Bangalore K Sathyanarayana|Chin-Hsien  Tai|Todd J Taylor|Hongjun  Bai,"Andriy  Kryshtafovych (University of California, Davis)|Gaetano  Montelione (Northeast Structural Genomics Consortium, CABM, Rutgers University)|John  Moult (University of Maryland Biotechnology Institute)",NULL,NULL,"1. Tai CH, Sam V, Gibrat JF, Garnier J, Munson PJ, Lee B (2011). Protein domain assignment from the recurrence of locally similar structures. Proteins  79, 853-66.   https://doi.org/10.1002/prot.22923",https://intramural.nih.gov/search/searchview.taf?ipid=73780
506,BC011238-04,"October 01, 2011 -  September 30, 2012",Computational Biology,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Hal H Zhang,NULL,Ira H Pastan; MD (Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73779
507,BC011240-04,"October 01, 2011 -  September 30, 2012",Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Serguei V Kozlov,Leroy E Hood|KuoChen  Wei (Chang Gung Memorial Hospital),"Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Scott E McNeil (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73801
508,BC011250-03,"October 01, 2011 -  September 30, 2012",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Howard H Yang|Kenneth  Buetow; PhD,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Molecular Regulation Section)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724",https://intramural.nih.gov/search/searchview.taf?ipid=73812
509,BC011251-03,"October 01, 2011 -  September 30, 2012",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Michael N Edmonson|Cu  Nguyen|Ying  Hu; PhD|Richard Phillip Finney|Jenny M Kelley|Constance M Cultraro|Show all 12,NULL,Dinah  Singer; PhD (Molecular Regulation Section)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73813
510,BC011252-03,"October 01, 2011 -  September 30, 2012",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Cu  Nguyen|Jenny M Kelley|Hongen  Zhang|Maxwell P Lee; PhD,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Molecular Regulation Section)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73814
511,BC011253-03,"October 01, 2011 -  September 30, 2012",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Sheryl A Gere|Mitsutaka  Kadota|Howard H Yang|Beverly W Duncan|Hailong  Wu|Guohong  Song|Show all 7,Junya  Fukuoka (Toyama University)|Charles  Adisa (Abia State University Teaching Hospital),"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Molecular Regulation Section)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Jiuping  Ji (Office of the Director)",NULL,"1. Lee MP (2012). Allele-specific gene expression and epigenetic modifications and their application to understanding inheritance and cancer. Biochim Biophys Acta  1819, 739-42.   https://doi.org/10.1016/j.bbagrm.2012.02.007|2. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724",https://intramural.nih.gov/search/searchview.taf?ipid=73815
512,BC011255-03,"October 01, 2011 -  September 30, 2012",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jude  Alsarraj|Renard Cerrell Walker|Scott F Winter|Thomas Rudolf Geiger|Ling  Bai|Farhoud  Faraji|Show all 7,"Pier Paolo  Pandolfi (Harvard University)|David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)|Fernando  PardoManuel de la Villena (UNC)|Thomas  Sellers","Kevin  Gardner; MD, PhD (Cancer Genetics Branch)",Keiko  Ozato; PhD (NICHD),"1. Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW (2011). Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res  71, 3121-31.   https://doi.org/10.1158/0008-5472.CAN-10-4417|2. Collaborative Cross Consortium T (2012) The genome architecture of the collaborative cross mouse genetic reference population. Genetics 190:389-401.",https://intramural.nih.gov/search/searchview.taf?ipid=73816
513,BC011258-03,"October 01, 2011 -  September 30, 2012",Analysis of tumor cell death on antigen-specific immune responses,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Jaba  Gamrekelashvili|Chi  Ma,"Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)|Lothar  Jntsch (Helmholtz Centre for Infection Research)",NULL,NULL,"1. Gamrekelashvili J, Ormandy L, Heimesaat M, Kirschning C, Manns M, Korangy F, Greten T (2012) Primary sterile necrotic cells fail to cross-prime CD8+ T cells. Oncoimmunology In Press.",https://intramural.nih.gov/search/searchview.taf?ipid=73818
514,BC011259-03,"October 01, 2011 -  September 30, 2012",Effect of the Ras oncogene on genomic stability,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Meng-Tzu  Weng|Dennis  Hsu|Christina M Annunziata|Giuseppe  Giaccone; MD,Chad  Creighton (Baylor College of Medicine)|ShuChen  Wei (National Taiwan University Hospital and College of Medicine),Susan H Garfield (Laboratory of Experimental Carcinogenesis)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section),Marjan  Gucek; PhD (NHLBI),"1. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73819
515,BC011261-03,"October 01, 2011 -  September 30, 2012",Biological Implications and Translational Applications of HDMX Inhibition,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Elisabeth Avery Russell|Joseph J Mitala,Loren  Walensky (Dana-Farber Cancer Institute)|Jean-Christophe  Marine (KU Leuven)|Paul  Neilsen (University of Adelaide),NULL,Craig Joseph Thomas (NCATS),"1. Gembarska A, Luciani F, Fedele C, Russell E, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh J, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo R, Ghanem G, Shackleton M, Bernal F, Marine J (2012) MDM4 is a key therapeutic target in cutaneous melanoma. Nature Medicine 18:1239-1247.",https://intramural.nih.gov/search/searchview.taf?ipid=73821
516,BC011262-03,"October 01, 2011 -  September 30, 2012",Broadening the Utility of Stapled Peptides through Chemical Optimization,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Joseph J Mitala|Bethanie Lynn Morrison; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73822
517,BC011264-03,"October 01, 2011 -  September 30, 2012",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD|Bei  Dong|Caiyi  Li,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Mittelstadt P, Monteiro J, Ashwell J (2012) Endogenous glucocorticoids regulate thymocyte selection and are required for immunologic fitness. Journal of Clinical Investigation, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73823
518,BC011267-03,"October 01, 2011 -  September 30, 2012",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Anne Michele Miermont-Eltejaye|Yaroslav  Teper|Pflicke  Holger,Umesh  Bhanot (Memorial Sloan-Kettering Cancer Center)|Duncan  Jodrell (CRUK Cambridge Research Institute),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Scott E Martin (NCATS) |Yardena Rachel Samuels; PhD (NHGRI) |Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73825
519,BC011269-03,"October 01, 2011 -  September 30, 2012",Thoracic Cancer Research Laboratory,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73827
520,BC011275-03,"October 01, 2011 -  September 30, 2012",Gene expression and regulation in endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI","Mei  He|Neelam  Gulati|Meenu  Jain|Yin  Xiong; PhD|Lisa J Zhang; MD, PhD|Krisana  Gesuwan|Show all 11",NULL,"Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Jain M, Rechache N, Kebebew E (2012). Molecular markers of adrenocortical tumors. J Surg Oncol  106, 549-56.   https://doi.org/10.1002/jso.23119|2. Jain M, Zhang L, He M, Patterson EE, Nilubol N, Fojo AT, Joshi B, Puri R, Kebebew E (2012). Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer  118, 5698-708.   https://doi.org/10.1002/cncr.27629|3. Jain M, Zhang L, Patterson EE, Kebebew E (2011). KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS One  6, e26866.   https://doi.org/10.1371/journal.pone.0026866|4. Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Kebebew E (2011). Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol  18, 3443-52.   https://doi.org/10.1245/s10434-011-1766-4|5. Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O, Kebebew E (2011). Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer  117, 4390-5.   https://doi.org/10.1002/cncr.26072|6. Nilubol N, Sukchotrat C, Zhang L, He M, Kebebew E (2011). Molecular pathways associated with mortality in papillary thyroid cancer. Surgery  150, 1023-31.   https://doi.org/10.1016/j.surg.2011.09.021|7. Patterson E, Webb R, Weisbrod A, Bian B, He M, Zhang L, Holloway AK, Krishna R, Nilubol N, Pacak K, Kebebew E (2012). The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr Relat Cancer  19, 157-66.   https://doi.org/10.1530/ERC-11-0308|8. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E (2011). MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer  117, 1630-9.   https://doi.org/10.1002/cncr.25724|9. Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, Pollock BH, Indelicato DJ, Hwang J, Kebebew E (2011) Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117:259-67.|10. Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E (2012). MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer  118, 3426-32.   https://doi.org/10.1002/cncr.26587|11. Xekouki P, Hatch MM, Lin L, Rodrigo de A, Azevedo M, de la Luz Sierra M, Levy I, Saloustros E, Moraitis A, Horvath A, Kebebew E, Hoffman DA, Stratakis CA (2012). KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr Relat Cancer  19, 255-60.   https://doi.org/10.1530/ERC-12-0022|12. Xiong Y, Zhang L, Holloway AK, Wu X, Su L, Kebebew E (2011). MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One  6, e24717.   https://doi.org/10.1371/journal.pone.0024717|13. Zhang L, Rahbari R, He M, Kebebew E (2011). CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer. Endocr Relat Cancer  18, 731-42.   https://doi.org/10.1530/ERC-11-0181|14. Kebebew E, Patterson E (submitted in 2011) Diagnosis And Treatment Of Adrenocortical Tumors Using Human Microrna-483. Patent issued: 9,150,926 (US in 2016). Patent pending: PCT/US2011/040648 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=73829
521,BC011277-03,"October 01, 2011 -  September 30, 2012",Procaspase 3 activator compounds combined with X-ray irradiation,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht|Naga Venkata Gopal  Abbineni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73830
522,BC011278-03,"October 01, 2011 -  September 30, 2012",Mechanisms of Early Stage Mammary Tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Joseph D Kalen (Office Of The Director),"Roberto  Weigert; MSc Chemistry, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73831
523,BC011280-03,"October 01, 2011 -  September 30, 2012",Cancer Therapy Trials using novel vaccine platforms,Ravi  Madan|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD|Antonio  Fojo; MD, PhD",NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Gulley JL, Madan RA, Schlom J (2011). Impact of tumour volume on the potential efficacy of therapeutic vaccines. Curr Oncol  18, e150-7.   https://doi.org/10.3747/co.v18i3.783|2. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762|3. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9",https://intramural.nih.gov/search/searchview.taf?ipid=73832
524,BC011281-03,"October 01, 2011 -  September 30, 2012",Combination therapies involving novel cancer vaccines,Ravi  Madan|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD|Andrea Borghese Apolo|Antonio  Fojo; MD, PhD",Robert  DiPaola (Cancer Center of New Jersey)|Mark  Stein (The Cancer Institute of New Jersey),"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Aradhana  Kaushal (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Karen A Kurdziel; MD (Molecular Imaging Program)",NULL,"1. Gulley JL, Madan RA, Tsang KY, Arlen PM, Camphausen K, Mohebtash M, Kamrava M, Schlom J, Citrin D (2011). A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther  11, 1409-18.   https://doi.org/10.1517/14712598.2011.615741",https://intramural.nih.gov/search/searchview.taf?ipid=73833
525,BC011282-03,"October 01, 2011 -  September 30, 2012",RNAi screen for chromatin modifiers in DNA repair and aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner|Satyendra Kumar Singh|Simran  Khurana|Sandra  Burkett,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Ofir  Hakim (Laboratory of Receptor Biology and Gene Expression)|Eric Alan Stahlberg (Biostatistics and Data Management Section),NULL,"1. Shi L, Oberdoerffer P (2012). Chromatin dynamics in DNA double-strand break repair. Biochim Biophys Acta  1819, 811-9.   https://doi.org/10.1016/j.bbagrm.2012.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=73834
526,BC011283-03,"October 01, 2011 -  September 30, 2012",Investigating the role of DNA breaks in mammalian aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner|Satyendra Kumar Singh|Carrie Antoinette Williams|Simran  Khurana,NULL,NULL,NULL,"1. Shi L, Oberdoerffer P (2012). Chromatin dynamics in DNA double-strand break repair. Biochim Biophys Acta  1819, 811-9.   https://doi.org/10.1016/j.bbagrm.2012.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=73835
527,BC011286-03,"October 01, 2011 -  September 30, 2012",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI","Mei  He|Neelam  Gulati|Meenu  Jain|Yin  Xiong; PhD|Lisa J Zhang; MD, PhD|Krisana  Gesuwan|Show all 9",NULL,NULL,NULL,"1. Gramza A, Kebebew E (2012). Cancer: thyroid cancer bone metastases and high morbidity rates. Nat Rev Endocrinol  8, 454-5.   https://doi.org/10.1038/nrendo.2012.112|2. Jain M, Zhang L, He M, Patterson EE, Nilubol N, Fojo AT, Joshi B, Puri R, Kebebew E (2012). Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer  118, 5698-708.   https://doi.org/10.1002/cncr.27629|3. Nilubol N, Kebebew E (2011). Personalizing thyroid cancer care: are we there yet? Ann Surg Oncol  18, 1819-20.   https://doi.org/10.1245/s10434-011-1735-y|4. Webb R, Mathur A, Chang R, Baid S, Nilubol N, Libutti SK, Stratakis CA, Kebebew E (2012). What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism? Ann Surg Oncol  19, 1881-6.   https://doi.org/10.1245/s10434-011-2121-5|5. Zhang L, He M, Zhang Y, Nilubol N, Shen M, Kebebew E (2012). Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing. J Clin Endocrinol Metab  97, E319-28.   https://doi.org/10.1210/jc.2011-2671",https://intramural.nih.gov/search/searchview.taf?ipid=73837
528,BC011287-03,"October 01, 2011 -  September 30, 2012",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Mei  He|Neelam  Gulati|Krisana  Gesuwan|Naris  Nilubol; MD,NULL,NULL,NULL,"1. Moses W, Weng J, Kebebew E (2011). Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid  21, 367-71.   https://doi.org/10.1089/thy.2010.0256|2. Xiong Y, Zhang L, Holloway AK, Wu X, Su L, Kebebew E (2011). MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One  6, e24717.   https://doi.org/10.1371/journal.pone.0024717",https://intramural.nih.gov/search/searchview.taf?ipid=73838
529,BC011293-03,"October 01, 2011 -  September 30, 2012",Impact of chromatin structure on alternative splicing of CD45 pre-mRNA,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Sanjeev  Shukla|Maria Fernanda Prigge|Nazmul  Haque|Rebecca Deering Brose,NULL,Mikhail V Kashlev (Molecular Mechanisms of Transcription Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73841
530,BC011294-03,"October 01, 2011 -  September 30, 2012",Conditional manipulation of hnRNPLL expression in murine models,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Maria Fernanda Prigge|Rebecca Deering Brose,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73842
531,BC011295-03,"October 01, 2011 -  September 30, 2012",Optimizing the graft versus leukemia effect for pediatric ALL,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiying  Qin|Jessica Carolyn Shand|Christopher Daniel Chien; PhD|Tolu E Ariyo|Crystal L. Mackall; MD|Alan S Wayne; MD,"Janetta  Bijl (HÃ´pital Maisonneuve-Rosemont)|Boro  Dropulic|SYD  JOHNSON (MacroGenics, Inc.)|Duane A Mitchell",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73843
532,BC011296-03,"October 01, 2011 -  September 30, 2012",Development of dipeptidyl peptidase inhibitors as novel immune adjuvants,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD,NULL,James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Maria  Tsokos; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73844
533,BC011298-03,"October 01, 2011 -  September 30, 2012",Ph I Radiation and Lenalidomide in pediatric malignant glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73845
534,BC011299-03,"October 01, 2011 -  September 30, 2012",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Karen A Kurdziel; MD (Molecular Imaging Program),NULL,"1. Hipp SJ, Steffen-Smith E, Hammoud D, Shih JH, Bent R, Warren KE (2011). Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol  13, 904-9.   https://doi.org/10.1093/neuonc/nor076|2. Ko C, Kaushal A, Hammoud DA, Steffen-Smith EA, Bent R, Citrin D, Camphausen K, Warren KE (2012). Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  83, 1252-1256.   https://doi.org/10.1016/j.ijrobp.2011.09.046|3. Steffen-Smith EA, Shih JH, Hipp SJ, Bent R, Warren KE (2011). Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol  105, 365-73.   https://doi.org/10.1007/s11060-011-0601-x|4. Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE (2012). Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  84, 774-9.   https://doi.org/10.1016/j.ijrobp.2012.01.032",https://intramural.nih.gov/search/searchview.taf?ipid=73846
535,BC011300-03,"October 01, 2011 -  September 30, 2012",CANCER AND INFLAMMATION GENETICS,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Albert M Gold|Lisa  Maslan|Julie  Sawitzke|Kate M McGee|Michael L Nickerson|Silvia  Jimenez-Morales|Show all 10,Lorena  Orozco (INMEGEN)|Federico  Antillon (UNOP)|Ana  Ortiz (University of Puerto Rico Comprehensive Cancer Center)|Walter  Guerra (Instituto Cancerologia)|Taras K Oleksyk|Dan  Theodorescu (University of Colorado)|Show all 10,"Nadya I Tarasova; PhD (Cancer Inflammation Program)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,"1. Fredericks WJ, McGarvey T, Wang H, Lal P, Puthiyaveettil R, Tomaszewski J, Sepulveda J, Labelle E, Weiss JS, Nickerson ML, Kruth HS, Brandt W, Wessjohann LA, Malkowicz SB (2011). The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol  30, 851-64.   https://doi.org/10.1089/dna.2011.1315|2. Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, He M, Li Z, Sun X, Jia W, Chen J, Yang S, Zhou F, Zhao X, Wan S, Ye R, Liang C, Liu Z, Huang P, Liu C, Jiang H, et al. [28 more authors] (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43:875-8|3. Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS, HEBON, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, kConFab, Ontario Cancer Genetics Network, SWE-BRCA, UKFOCR, EMBRACE, et al. [90 more authors] (2011). Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet  130, 685-99.   https://doi.org/10.1007/s00439-011-1003-z|4. Léger A, Le Guiner C, Nickerson ML, McGee Im K, Ferry N, Moullier P, Snyder RO, Penaud-Budloo M (2011). Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle. PLoS One  6, e20881.   https://doi.org/10.1371/journal.pone.0020881",https://intramural.nih.gov/search/searchview.taf?ipid=73847
536,BC011301-03,"October 01, 2011 -  September 30, 2012",CANCER AND INFLAMMATION: FUNCTION AND THERAPY,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Albert M Gold|Lisa  Maslan|Julie  Sawitzke|Wei  Tan|Karobi  Moitra|Kate M McGee|Show all 10,"Ken  Offitt (Medicine, Sloan Kettering Cancer Center)|Rando  Allikmets (Columbia University)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Susan  Bates; MD (Medical Oncology Branch)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)",Daniel R. Weinberger; MD (NIMH),"1. Fukuda Y, Aguilar-Bryan L, Vaxillaire M, Dechaume A, Wang Y, Dean M, Moitra K, Bryan J, Schuetz JD (2011). Conserved intramolecular disulfide bond is critical to trafficking and fate of ATP-binding cassette (ABC) transporters ABCB6 and sulfonylurea receptor 1 (SUR1)/ABCC8. J Biol Chem  286, 8481-92.   https://doi.org/10.1074/jbc.M110.174516|2. McKay GJ, Patterson CC, Chakravarthy U, Dasari S, Klaver CC, Vingerling JR, Ho L, de Jong PT, Fletcher AE, Young IS, Seland JH, Rahu M, Soubrane G, Tomazzoli L, Topouzis F, Vioque J, Hingorani AD, Sofat R, Dean M, Sawitzke J, Seddon JM, Peter I, Webster AR, Moore AT, Yates JR, et al. [25 more authors] (2011). Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat  32, 1407-16.   https://doi.org/10.1002/humu.21577|3. McKay GJ, Silvestri G, Chakravarthy U, Dasari S, Fritsche LG, Weber BH, Keilhauer CN, Klein ML, Francis PJ, Klaver CC, Vingerling JR, Ho L, De Jong PT, Dean M, Sawitzke J, Baird PN, Guymer RH, Stambolian D, Orlin A, Seddon JM, Peter I, Wright AF, Hayward C, Lotery AJ, Ennis S, et al. [23 more authors] (2011). Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol  173, 1357-64.   https://doi.org/10.1093/aje/kwr015|4. Moitra K, Dean M (2011). Evolution of ABC transporters by gene duplication and their role in human disease. Biol Chem  392, 29-37.   https://doi.org/10.1515/BC.2011.006|5. Moitra K, Lou H, Dean M (2011). Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin Pharmacol Ther  89, 491-502.   https://doi.org/10.1038/clpt.2011.14|6. Moitra K, Scally M, McGee K, Lancaster G, Gold B, Dean M (2011). Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms. PLoS One  6, e16318.   https://doi.org/10.1371/journal.pone.0016318|7. Sawitzke J, Im KM, Kostiha B, Dean M, Gold B (2011). Association assessment of copy number polymorphism and risk of age-related macular degeneration. Ophthalmology  118, 2442-6.   https://doi.org/10.1016/j.ophtha.2011.05.027|8. Zernant J, Schubert C, Im KM, Burke T, Brown CM, Fishman GA, Tsang SH, Gouras P, Dean M, Allikmets R (2011). Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci  52, 8479-87.   https://doi.org/10.1167/iovs.11-8182",https://intramural.nih.gov/search/searchview.taf?ipid=73848
537,BC011302-03,"October 01, 2011 -  September 30, 2012",Screen for Ras inhibitors,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee|Dennis  Hsu,NULL,NULL,Anton  Simeonov (NCATS),"1. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73849
538,BC011303-03,"October 01, 2011 -  September 30, 2012",Ras oncogene induced protein SUMOylation changes,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Bing  Yu,"Ann  DeJean (Institut Louis Pasteur)|Thomas  Westbrook; PhD (Department of Biochemistry, Baylor College of Medicine)",NULL,Marjan  Gucek; PhD (NHLBI),"1. Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, et al. [2 more authors] (2012). A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science  335, 348-53.   https://doi.org/10.1126/science.1212728|2. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73850
539,BC011304-03,"October 01, 2011 -  September 30, 2012",New shRNA vectors for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee|Chih-Shia  Lee,NULL,NULL,NULL,"1. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73851
540,BC011306-03,"October 01, 2011 -  September 30, 2012",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Joanna Ray-Jia Yeh|Lyuba Aleksandrovna Khavrutskii,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University),Michael  Dean; PhD (Laboratory of Experimental Immunology)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Joseph John Barchi (Chemical Biology Laboratory)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Johannessen L, Remsberg J, Gaponenko V, Adams KM, Barchi JJ, Tarasov SG, Jiang S, Tarasova NI (2011). Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors. Chembiochem  12, 914-21.   https://doi.org/10.1002/cbic.201000563|2. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R, Yamaguchi TP, Rodriguez LG, Perantoni AO (2011). Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Dev Biol  352, 58-69.   https://doi.org/10.1016/j.ydbio.2011.01.012",https://intramural.nih.gov/search/searchview.taf?ipid=73852
541,BC011307-03,"October 01, 2011 -  September 30, 2012",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Yuhong  Chen; PhD,Joseph R Kates|Vadim  Gaponenko,Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,"1. Lee Y, Chen Y, Tarasova NI, Gaponenko V (2011). The structure of monomeric components of self-assembling CXCR4 antagonists determines the architecture of resulting nanostructures. Nanotechnology  22, 505101.   https://doi.org/10.1088/0957-4484/22/50/505101|2. Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI (2011). Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles. Proc Natl Acad Sci U S A  108, 9798-803.   https://doi.org/10.1073/pnas.1014598108",https://intramural.nih.gov/search/searchview.taf?ipid=73853
542,BC011311-03,"October 01, 2011 -  September 30, 2012",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Xia  Ding,Stephen  Byers (Georgetown University)|William  Foulkes (McGill University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73856
543,BC011312-03,"October 01, 2011 -  September 30, 2012",Protein regulation in multiple myeloma,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",NULL,NULL,Ola Anders Landgren (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM (2011). A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood  117, 2396-404.   https://doi.org/10.1182/blood-2010-04-278788|2. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73857
544,BC011313-03,"October 01, 2011 -  September 30, 2012",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Cem  Sonmez|Chomdao  Sinthuvanich|Daniel James Smith|Michael Christopher Giano|Katelyn Jean Nagy,Darrin  Pochan (University of Delaware)|Norm  Wagner (University of Delaware),Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ (2011). Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials  32, 5906-14.   https://doi.org/10.1016/j.biomaterials.2011.04.069|2. Branco MC, Sigano DM, Schneider JP (2011). Materials from peptide assembly: towards the treatment of cancer and transmittable disease. Curr Opin Chem Biol  15, 427-34.   https://doi.org/10.1016/j.cbpa.2011.03.021|3. Geisler I, Schneider J (2012) Evolution Based Design of an Injectable Hydrogel. Advanced Functional Materials 22:259.|4. Giano MC, Pochan DJ, Schneider JP (2011). Controlled biodegradation of self-assembling β-hairpin peptide hydrogels by proteolysis with matrix metalloproteinase-13. Biomaterials  32, 6471-7.   https://doi.org/10.1016/j.biomaterials.2011.05.052|5. Knerr P, Branco M, Nagarkar R, Pochan D, Schneider J (2012) Heavy Metal Ion Hydrogelation of a Self-Assembling Peptide via Cysteinyl Chelation. J Materials Chemistry 22:1352.|6. Micklitsch CM, Knerr PJ, Branco MC, Nagarkar R, Pochan DJ, Schneider JP (2011). Zinc-triggered hydrogelation of a self-assembling β-hairpin peptide. Angew Chem Int Ed Engl  50, 1577-9.   https://doi.org/10.1002/anie.201006652|7. Nagy KJ, Giano MC, Jin A, Pochan DJ, Schneider JP (2011). Enhanced mechanical rigidity of hydrogels formed from enantiomeric peptide assemblies. J Am Chem Soc  133, 14975-7.   https://doi.org/10.1021/ja206742m|8. Smith DJ, Yap GP, Kelley JA, Schneider JP (2011). Enhanced stereoselectivity of a Cu(II) complex chiral auxiliary in the synthesis of Fmoc-L-γ-carboxyglutamic acid. J Org Chem  76, 1513-20.   https://doi.org/10.1021/jo101940k",https://intramural.nih.gov/search/searchview.taf?ipid=73858
545,BC011314-03,"October 01, 2011 -  September 30, 2012",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Cem  Sonmez|Chomdao  Sinthuvanich,NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73859
546,BC011315-03,"October 01, 2011 -  September 30, 2012",Molecular characterization of endometrial cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Anne Mary Noonan; MD|Elise C Kohn; MD|Larry  Maxwell,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73860
547,BC011316-03,"October 01, 2011 -  September 30, 2012",Role of the human transcription factor T in chordoma growth,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73861
548,BC011319-03,"October 01, 2011 -  September 30, 2012",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73864
549,BC011320-03,"October 01, 2011 -  September 30, 2012",Targeting dendritic cells for selective modulation of Graft-versus-Host Disease,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiying  Qin|Crystal L. Mackall; MD,NULL,NULL,NULL,"1. Capitini CM, Davis JP, Larabee SM, Herby S, Nasholm NM, Fry TJ (2011). Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination. Biol Blood Marrow Transplant  17, 790-9.   https://doi.org/10.1016/j.bbmt.2010.12.712",https://intramural.nih.gov/search/searchview.taf?ipid=73865
550,BC011321-03,"October 01, 2011 -  September 30, 2012",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Ying  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73866
551,BC011322-03,"October 01, 2011 -  September 30, 2012",Molecular profiling of  tumor tissue using targeted clinical proteomics,Donald J Johann,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73867
552,BC011324-03,"October 01, 2011 -  September 30, 2012",Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park|Tae Sung  Kim,Kunsoo  Rhee (Seoul National University)|Raymond L Erikson|Jeong Kyu Bang|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Michael  Yaffe (Massachusetts Institute of Technology),Timothy D Veenstra (Office Of The Director),NULL,"1. Johmura Y, Soung NK, Park JE, Yu LR, Zhou M, Bang JK, Kim BY, Veenstra TD, Erikson RL, Lee KS (2011). Regulation of microtubule-based microtubule nucleation by mammalian polo-like kinase 1. Proc Natl Acad Sci U S A  108, 11446-51.   https://doi.org/10.1073/pnas.1106223108|2. Kang YH, Park CH, Kim TS, Soung NK, Bang JK, Kim BY, Park JE, Lee KS (2011). Mammalian polo-like kinase 1-dependent regulation of the PBIP1-CENP-Q complex at kinetochores. J Biol Chem  286, 19744-57.   https://doi.org/10.1074/jbc.M111.224105|3. Park EJ, Erikson RL, Lee KS (2011). A self-propelled biological process: Plk1-dependent, product-activated feedforward mechanism. Cell Cycle  10, 3411-2.   https://doi.org/10.4161/cc.10.20.17522|4. Park JE, Erikson RL, Lee KS (2011). Feed-forward mechanism of converting biochemical cooperativity to mitotic processes at the kinetochore plate. Proc Natl Acad Sci U S A  108, 8200-5.   https://doi.org/10.1073/pnas.1102020108",https://intramural.nih.gov/search/searchview.taf?ipid=73868
553,BC011325-03,"October 01, 2011 -  September 30, 2012",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro|Silvia  Sanchez Martinez|Gisela H Fanning-Heidecker,Kenneth  Cornetta (Indiana University)|Edward  Gabrielson (Johns Hopkins Medical Institution)|John W Mellors,Robert  Shoemaker (Screening Technologies Branch),NULL,"1. Rein A (2011). Murine leukemia viruses: objects and organisms. Adv Virol  2011, 403419.   https://doi.org/10.1155/2011/403419|2. Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, Shao W, Sanchez-Martinez S, Yegnasubramanian S, Burns KH, Rein A, De Marzo AM (2011). Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One  6, e20874.   https://doi.org/10.1371/journal.pone.0020874",https://intramural.nih.gov/search/searchview.taf?ipid=73869
554,BC011326-03,"October 01, 2011 -  September 30, 2012",Sensitization of chordoma cell lines to ionizing radiation,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,"Menghang  Xia (NCATS) |Christopher P Austin; AB, MD (NCATS) |Ruili  Huang (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73870
555,BC011328-03,"October 01, 2011 -  September 30, 2012",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Mark  Mackiewicz|John E Lueders|Yuan  Jiang; MD|Robert L Walker; BS|Arthur A Glatfelter; MS|Show all 12","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Jeffrey  Trent (TGen)",Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73871
556,BC011330-03,"October 01, 2011 -  September 30, 2012",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart|IRP Faculty Profile,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Alejandra  Garcia-Glaessner,NULL,Patricia  Steeg; PhD (Developmental Therapeutics Branch),NULL,"1. Gril B, Palmieri D, Qian Y, Smart D, Ileva L, Liewehr DJ, Steinberg SM, Steeg PS (2011). Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis. Clin Cancer Res  17, 142-53.   https://doi.org/10.1158/1078-0432.CCR-10-1603",https://intramural.nih.gov/search/searchview.taf?ipid=73872
557,BC011332-03,"October 01, 2011 -  September 30, 2012",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Miki B Kasai|Christianne  Persenaire|Amber Jin Giles|Javed  Khan; MD|Carol J Thiele|Chand  Khanna; MD|Show all 9,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73874
558,BC011333-03,"October 01, 2011 -  September 30, 2012",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73875
559,BC011334-03,"October 01, 2011 -  September 30, 2012",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Miki B Kasai|Christianne  Persenaire|Amber Jin Giles|Javed  Khan; MD|Chand  Khanna; MD|Crystal L. Mackall; MD|Show all 10,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 7",Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Acharya SS, Kaplan RN, Macdonald D, Fabiyi OT, DiMichele D, Lyden D (2011). Neoangiogenesis contributes to the development of hemophilic synovitis. Blood  117, 2484-93.   https://doi.org/10.1182/blood-2010-05-284653",https://intramural.nih.gov/search/searchview.taf?ipid=73876
560,BC011336-03,"October 01, 2011 -  September 30, 2012",Tools for Prediction of Drug Metabolism and Metabolites,Marc C Nicklaus|IRP Faculty Profile,Joel Patrick Schneider; PhD,"Chemical Biology Laboratory, NCI",Igor V Filippov|Megan L Peach|Markus  Sitzmann|Chenzhong  Liao|Alexey Vladimirovich Zakharov; PhD,Anders  Wallqvist (Department of Defense)|Layton  Smith (Sanford Burnham Medical Research Institute),NULL,"Christopher P Austin; AB, MD (NCATS)","1. Peach M, Zakharov A, Liu R, Pugliese A, Tawa G, Wallqvist A, Nicklaus M (2012) Computational Tools and Resources for Metabolism-Related Property Predictions. 1. Overview of Publicly Available (Free and Commercial) Databases and Software. Future Medicinal Chemistry, in press.|2. Zakharov A, Peach M, Sitzmann M, Filippov I, McCartney H, Smith L, Pugliese A, Nicklaus M (2012) Computational Tools and Resources for Metabolism-Related Property Predictions. 2. Application to Prediction of Half-Life Time in Human Liver Microsomes. Future Medicinal Chemistry, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73877
561,BC011337-03,"October 01, 2011 -  September 30, 2012",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang|Kenichi  Hanada,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73878
562,BC011338-03,"October 01, 2011 -  September 30, 2012",Functional Analysis of the REL Transcription Factors in B-Cells,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Stella Maris  Ranuncolo|Alfonso  Fernandez; PhD|Louis  Staudt; MD|Thomas Alexander Waldmann; MD, PhD",NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Eric Alan Stahlberg (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73879
563,BC011340-03,"October 01, 2011 -  September 30, 2012",Preclinical development of new therapeutics for children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully|Brigitte  Widemann; MD|Nalini M Jayaprakash,Sil  Lutkewitte (Targepeutics)|Vinay  Jain (Arog Pharmaceuticals LLC)|Clinton  Stewart (St Jude Children's Research Hospital),Kevin A Camphausen; MD (Radiation Oncology Branch),"Russell R Lonser; MD (NINDS) |John D. Bacher; BS, DVM, MS (OD)","1. Marcus L, Murphy R, Fox E, McCully C, Cruz R, Warren KE, Meyer T, McNiff E, Balis FM, Widemann BC (2012). The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates. Cancer Chemother Pharmacol  69, 247-52.   https://doi.org/10.1007/s00280-011-1659-z",https://intramural.nih.gov/search/searchview.taf?ipid=73881
564,BC011341-03,"October 01, 2011 -  September 30, 2012","Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection",Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Theo  Heller; MD (NIDDK),"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73882
565,BC011342-03,"October 01, 2011 -  September 30, 2012",Pancreatic perfusion for locally unresectable pancreatic cancer,Itzhak  Avital,NULL,"Surgery Branch, NCI",Udo  Rudloff|Udai S Kammula,NULL,NULL,Bradford J Wood; MD (CC) |Elliot Brian Levy (CC),"1. Avital I (2011). Regional chemotherapy for pancreatic cancer. J Surg Oncol  104, 453.   https://doi.org/10.1002/jso.21975|2. Mullinax JE, Allins A, Avital I (2011). Laparoscopic appendectomy for Amyand's hernia: a modern approach to a historic diagnosis. J Gastrointest Surg  15, 533-5.   https://doi.org/10.1007/s11605-010-1386-5|3. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484",https://intramural.nih.gov/search/searchview.taf?ipid=73883
566,BC011343-03,"October 01, 2011 -  September 30, 2012",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Suzanne E Fioravanti|Austin Gerard Duffy|William D Figg; PharmD|Jane Beth Trepel|Douglas K Price,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Liang  Cao (Cancer Genetics Branch),Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73884
567,BC011344-03,"October 01, 2011 -  September 30, 2012",Immune suppressor mechanism analysis in patients with Hepatocellular Carcinoma,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Suzanne E Fioravanti|Austin Gerard Duffy|Fei  Zhao,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73885
568,BC011345-03,"October 01, 2011 -  September 30, 2012",Analysis of myeloid derived suppressor cells in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Fei  Zhao,"Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)|Jan  Buer (University of Essen)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73886
569,BC011346-03,"October 01, 2011 -  September 30, 2012",Immune suppressor mechanism in a murine model of hepatitis and liver cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tamar  Kapanadze|Chi  Ma|Tobias  Eggert|Jose  Medina Echeverz,"Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)|Dean  Felsher (Division of Oncology, Stanford University School of Medicine)","Masaki  Terabe (Vaccine Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Silvana Romina Goldszmid (Laboratory of Experimental Immunology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jimmy  Stauffer (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)",Cynthia E Dunbar; MD (NHLBI) |Francesco M. Marincola; MD (CC) |Ena  Wang (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73887
570,BC011347-03,"October 01, 2011 -  September 30, 2012",Genetic Correlation with Efficacy and Toxicity of Brain Tumor Therapies,Fabio  Iwamoto,"Howard A Fine; MD, PhD","Neuro-Oncology Branch, NCI",NULL,NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Preetha  Rajaraman (Radiation Epidemiology Branch)",NULL,"1. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|2. Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A (2011). Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro Oncol  13, 1244-51.   https://doi.org/10.1093/neuonc/nor117|3. Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA (2011). A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol  13, 509-16.   https://doi.org/10.1093/neuonc/nor017|4. Kreisl TN, Zhang W, Odia Y, Shih JH, Butman JA, Hammoud D, Iwamoto FM, Sul J, Fine HA (2011). A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol  13, 1143-50.   https://doi.org/10.1093/neuonc/nor091|5. Lassman AB, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, et al. [2 more authors] (2011). International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol  13, 649-59.   https://doi.org/10.1093/neuonc/nor040|6. Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA (2011). Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology  76, 236-41.   https://doi.org/10.1212/WNL.0b013e3182074a69",https://intramural.nih.gov/search/searchview.taf?ipid=73888
571,BC011348-03,"October 01, 2011 -  September 30, 2012",Aging and Primary Central Nervous System Tumors,Fabio  Iwamoto,"Howard A Fine; MD, PhD","Neuro-Oncology Branch, NCI",NULL,Lisa  DeAngelis (MSKCC)|Adilia  Hormigo (MSKCC)|Jacob  Scott (Moffitt Cancer Center),NULL,NULL,"1. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|2. Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A (2011). Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro Oncol  13, 1244-51.   https://doi.org/10.1093/neuonc/nor117|3. Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA (2011). A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol  13, 509-16.   https://doi.org/10.1093/neuonc/nor017|4. Kreisl TN, Zhang W, Odia Y, Shih JH, Butman JA, Hammoud D, Iwamoto FM, Sul J, Fine HA (2011). A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol  13, 1143-50.   https://doi.org/10.1093/neuonc/nor091|5. Lassman AB, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, et al. [2 more authors] (2011). International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol  13, 649-59.   https://doi.org/10.1093/neuonc/nor040|6. Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA (2011). Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology  76, 236-41.   https://doi.org/10.1212/WNL.0b013e3182074a69",https://intramural.nih.gov/search/searchview.taf?ipid=73889
572,BC011350-03,"October 01, 2011 -  September 30, 2012",Molecular Discovery Program,Jeffrey N Strathern,NULL,"Molecular Discovery Program, NCI",Claudia A Lipschultz,NULL,James  McMahon; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73891
573,BC011351-03,"October 01, 2011 -  September 30, 2012",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Ravi  Madan|William D Figg; PharmD|William Laurence Dahut; MD|Jane Beth Trepel,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73892
574,BC011352-03,"October 01, 2011 -  September 30, 2012",Molecular and clinical profiling,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",NULL,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Sigurdur  Kristinsson (Karolinska),Peter L Choyke; MD (Molecular Imaging Program)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Richard  Childs; MD (NHLBI),"1. Buadi F, Hsing AW, Katzmann JA, Pfeiffer RM, Waxman A, Yeboah ED, Biritwum RB, Tettey Y, Adjei A, Chu LW, DeMarzo A, Netto GJ, Dispenzieri A, Kyle RA, Rajkumar SV, Landgren O (2011). High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa. Am J Hematol  86, 554-8.   https://doi.org/10.1002/ajh.22040|2. Calvo KR, Landgren O, Roccaro AM, Ghobrial IM (2011). Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma. Semin Hematol  48, 39-45.   https://doi.org/10.1053/j.seminhematol.2010.11.007|3. Engels EA, Preiksaitis J, Zingone A, Landgren O (2012). Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant  12, 1268-74.   https://doi.org/10.1111/j.1600-6143.2011.03954.x|4. Kristinsson SY, Björkholm M, Schulman S, Landgren O (2011). Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance. Semin Hematol  48, 46-54.   https://doi.org/10.1053/j.seminhematol.2010.11.002|5. Kristinsson SY, Landgren O (2012). Thromboprophylaxis in multiple myeloma: is the evidence there? Expert Rev Anticancer Ther  12, 291-4.   https://doi.org/10.1586/era.11.214|6. Kristinsson SY, Minter AR, Korde N, Tan E, Landgren O (2011). Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management. Expert Rev Mol Diagn  11, 593-603.   https://doi.org/10.1586/erm.11.44|7. Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Bladé J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG, International Myeloma Working Group (2012). Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia  26, 149-57.   https://doi.org/10.1038/leu.2011.196|8. Kwok M, Korde N, Landgren O (2012). Bortezomib to treat the TEMPI syndrome. N Engl J Med  366, 1843-5.   https://doi.org/10.1056/NEJMc1202649|9. Landgren O (2011). Multiple myeloma precursor disease: current clinical dilemma and future opportunities. Semin Hematol  48, 1-3.   https://doi.org/10.1053/j.seminhematol.2010.11.008|10. Landgren O, Korde N (2011). Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities. Oncology (Williston Park)  25, 589-90.|11. Landgren O, Polliack A, Tadmor T (2011). Associations between multiple myeloma and other malignancies. Leuk Lymphoma  52, 161-2.   https://doi.org/10.3109/10428194.2010.538942|12. Landgren O, Thomas A, Mailankody S (2011). Myeloma and second primary cancers. N Engl J Med  365, 2241-2.   https://doi.org/10.1056/NEJMc1111010|13. Lidén Y, Olofsson N, Landgren O, Johansson E (2012). Pain and anxiety during bone marrow aspiration/biopsy: Comparison of ratings among patients versus health-care professionals. Eur J Oncol Nurs  16, 323-9.   https://doi.org/10.1016/j.ejon.2011.07.009|14. Ludwig H, Durie BG, McCarthy P, Palumbo A, San Miguel J, Barlogie B, Morgan G, Sonneveld P, Spencer A, Andersen KC, Facon T, Stewart KA, Einsele H, Mateos MV, Wijermans P, Waage A, Beksac M, Richardson PG, Hulin C, Niesvizky R, Lokhorst H, Landgren O, Bergsagel PL, Orlowski R, Hinke A, International Myeloma Working Group, et al. [2 more authors] (2012). IMWG consensus on maintenance therapy in multiple myeloma. Blood  119, 3003-15.   https://doi.org/10.1182/blood-2011-11-374249|15. Mailankody S, Pfeiffer RM, Kristinsson SY, Korde N, Bjorkholm M, Goldin LR, Turesson I, Landgren O (2011). Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood  118, 4086-92.   https://doi.org/10.1182/blood-2011-05-355743|16. Mena E, Choyke P, Tan E, Landgren O, Kurdziel K (2011). Molecular imaging in myeloma precursor disease. Semin Hematol  48, 22-31.   https://doi.org/10.1053/j.seminhematol.2010.11.006|17. Minter AR, Simpson H, Weiss BM, Landgren O (2011). Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunities. Semin Hematol  48, 55-65.   https://doi.org/10.1053/j.seminhematol.2010.11.001|18. Shebl FM, Yu K, Landgren O, Goedert JJ, Rabkin CS (2012). Increased levels of circulating cytokines with HIV-related immunosuppression. AIDS Res Hum Retroviruses  28, 809-15.   https://doi.org/10.1089/AID.2011.0144|19. Tembhare P, Yuan C, Korde N, Maric I, Landgren O (2012). Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression. Leuk Lymphoma  53, 721-4.   https://doi.org/10.3109/10428194.2011.623257|20. Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O (2012). Second malignancies after multiple myeloma: from 1960s to 2010s. Blood  119, 2731-7.   https://doi.org/10.1182/blood-2011-12-381426|21. Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O (2011). Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients. Am J Hematol  86, 475-8.   https://doi.org/10.1002/ajh.22025",https://intramural.nih.gov/search/searchview.taf?ipid=73893
575,BC011353-03,"October 01, 2011 -  September 30, 2012",Development and validation of preclinical mouse model for serous ovarian cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Zoe W Ohler,"Neal  Goodwin (Jackson Laboratory, West)|Leroy E Hood|Colin  Hill (GNS Healthcare, Inc.)",Christina M Annunziata (Medical Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch),NULL,"1. Weaver Z, Difilippantonio S, Carretero J, Martin P, El Meskini R, Iacovelli A, Gumprecht M, Kulaga A, Guerin T, Schlomer J, Baran M, Kozlov S, McCann T, Mena S, Alshahrour F, Alexander D, Wong K, Van Dyke T (2012) Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73894
576,BC011354-03,"October 01, 2011 -  September 30, 2012",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2012). Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom  82, 67-77.   https://doi.org/10.1002/cyto.b.20622|3. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|4. Dunleavy K, Roschewski M, Wilson WH (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep  7, 208-15.   https://doi.org/10.1007/s11899-012-0132-3|5. Dunleavy K, Wilson WH (2011). Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma. Clin Cancer Res  17, 7505-7.   https://doi.org/10.1158/1078-0432.CCR-11-2372|6. Dunleavy K, Wilson WH (2012). How I treat HIV-associated lymphoma. Blood  119, 3245-55.   https://doi.org/10.1182/blood-2011-08-373738|7. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|8. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|9. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|10. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|11. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|12. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011). NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood  117, 1447-52.   https://doi.org/10.1182/blood-2010-08-302737|13. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|14. Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses  54, e877-9.   https://doi.org/10.1111/j.1439-0507.2011.02016.x|15. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|16. Roschewski M, Wilson WH (2012). EBV-associated lymphomas in adults. Best Pract Res Clin Haematol  25, 75-89.   https://doi.org/10.1016/j.beha.2012.01.005|17. Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S (2012). Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia  26, 1895-8.   https://doi.org/10.1038/leu.2012.72|18. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|19. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|20. Weniger MA, Rizzatti EG, Pérez-Galán P, Liu D, Wang Q, Munson PJ, Raghavachari N, White T, Tweito MM, Dunleavy K, Ye Y, Wilson WH, Wiestner A (2011). Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res  17, 5101-12.   https://doi.org/10.1158/1078-0432.CCR-10-3367|21. Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED, Cancer Leukemia Group B (2012). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica  97, 758-65.   https://doi.org/10.3324/haematol.2011.056531",https://intramural.nih.gov/search/searchview.taf?ipid=73895
577,BC011356-03,"October 01, 2011 -  September 30, 2012",FLSC - Vaccine Branch HIV Vaccine Primate Study,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73896
578,BC011367-02,"October 01, 2011 -  September 30, 2012",A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73898
579,BC011368-02,"October 01, 2011 -  September 30, 2012",D-Loperamide as a Marker of PgP Function in Gliomas,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,Peter  Herscovitch; MD (CC) |Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73899
580,BC011369-02,"October 01, 2011 -  September 30, 2012",Enhancing Immune Reconstitution after HSCT,Kirsten  Williams,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73900
581,BC011370-02,"October 01, 2011 -  September 30, 2012",The Pathogenesis and Treatment of chronic GVHD,Kirsten  Williams,NULL,"Experimental Transplantation and Immunology Branch, NCI",Beryl Lauren Manning-Geist,Stephanie R Lee|Paul  Martin,NULL,NULL,"1. Williams KM, Ostrow LW, Loeb DM, Chung T, Cohn RD, Corse AM, Mammen AL, Chen AR (2012). Immunohistochemistry of affected tissue may guide cGVHD treatment decisions. Bone Marrow Transplant  47, 731-3.   https://doi.org/10.1038/bmt.2011.164",https://intramural.nih.gov/search/searchview.taf?ipid=73901
582,BC011372-02,"October 01, 2011 -  September 30, 2012",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Barbara Helen Rath|Muhammad  Jamal|Jenna Melanie Kahn|Kevin A Camphausen; MD,NULL,NULL,NULL,"1. Shankavaram UT, Bredel M, Burgan WE, Carter D, Tofilon P, Camphausen K (2012). Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma. J Cell Mol Med  16, 545-54.   https://doi.org/10.1111/j.1582-4934.2011.01345.x",https://intramural.nih.gov/search/searchview.taf?ipid=73902
583,BC011373-02,"October 01, 2011 -  September 30, 2012",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Thomas John Hayman|Heekyong  Bae|Jenna Melanie Kahn|Kevin A Camphausen; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73903
584,BC011374-02,"October 01, 2011 -  September 30, 2012",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Michael J Hunter; PhD,NULL,NULL,"Steven M Holland; MD (NIAID) |Harry Lewis Malech; MD (NIAID) |Helen C Su; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73904
585,BC011375-02,"October 01, 2011 -  September 30, 2012",Investigating the role of SIRT1 in hematopoetic stem cell maintenance,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Satyendra Kumar Singh|Carrie Antoinette Williams|Sandra  Burkett,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73905
586,BC011376-02,"October 01, 2011 -  September 30, 2012",Structural and Biochemical Studies of p53 Family Function,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Elisabeth Avery Russell|Joseph J Mitala|Bethanie Lynn Morrison; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73906
587,BC011378-02,"October 01, 2011 -  September 30, 2012",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Mary Elizabeth Olanich|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Ji  Luo (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Javed  Khan; MD (Pediatric Oncology Branch),NULL,"1. Reichek JL, Duan F, Smith LM, Gustafson DM, O'Connor RS, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG (2011). Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Clin Cancer Res  17, 1463-73.   https://doi.org/10.1158/1078-0432.CCR-10-0091",https://intramural.nih.gov/search/searchview.taf?ipid=73907
588,BC011379-02,"October 01, 2011 -  September 30, 2012",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),"1. Hayashi R, Tanoue K, Durell SR, Chatterjee DK, Jenkins LM, Appella DH, Appella E (2011). Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry  50, 4537-49.   https://doi.org/10.1021/bi101949t",https://intramural.nih.gov/search/searchview.taf?ipid=73908
589,BC011381-02,"October 01, 2011 -  September 30, 2012",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Devaiah Nanjappa Ballachanda,Brian  Albrecht (Constellation Pharmaceuticals)|Michael S Hewitt|Robert  Sims (Constellation Pharmaceuticals),Brian  Lewis (Lymphoid Malignancies Branch),Keiko  Ozato; PhD (NICHD) |Pamela Gehron Robey; PhD (NIDCR) |Natasha  Cherman; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73910
590,BC011382-02,"October 01, 2011 -  September 30, 2012",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian Eric Fisher,NULL,NULL,NULL,"1. Batchelor E, Loewer A, Mock C, Lahav G (2011). Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol  7, 488.   https://doi.org/10.1038/msb.2011.20",https://intramural.nih.gov/search/searchview.taf?ipid=73911
591,BC011383-02,"October 01, 2011 -  September 30, 2012",Transcription Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Murali  Palangat; PhD|Matthew L Ferguson|Joseph  Rodriguez,Eric  Drier (Mad City Labs)|Robert  Singer (Albert Einstein College of Medicine),Dinah  Singer; PhD (Molecular Regulation Section),"Carson C Chow; BASc, PhD (NIDDK) |S Stoney  Simons; PhD (NIDDK)","1. Larson DR (2011). What do expression dynamics tell us about the mechanism of transcription? Curr Opin Genet Dev  21, 591-9.   https://doi.org/10.1016/j.gde.2011.07.010|2. Larson DR, Zenklusen D, Wu B, Chao JA, Singer RH (2011). Real-time observation of transcription initiation and elongation on an endogenous yeast gene. Science  332, 475-8.   https://doi.org/10.1126/science.1202142",https://intramural.nih.gov/search/searchview.taf?ipid=73912
592,BC011385-02,"October 01, 2011 -  September 30, 2012",Detection of Specific Glycan Moieties on the Cell Surface,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Boopathy  Ramakrishna|Natalia  Mercer|Luke Anthony Verdi,NULL,NULL,NULL,"1. Mercer N, Ramakrishnan B, Boeggeman E, Qasba PK (2011). Applications of site-specific labeling to study HAMLET, a tumoricidal complex of α-lactalbumin and oleic acid. PLoS One  6, e26093.   https://doi.org/10.1371/journal.pone.0026093|2. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey AE, Griffiths GL, Qasba PK (2012). The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. Glycobiology  22, 379-88.   https://doi.org/10.1093/glycob/cwr110",https://intramural.nih.gov/search/searchview.taf?ipid=73914
593,BC011387-02,"October 01, 2011 -  September 30, 2012",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Mary Elizabeth Olanich|Bishwanath  Chatterjee; PhD,"James  Anderson (University of Nebraska Medical Center)|Julia  Bridge (University of Nebraska Medical Center)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Stephen  Master (University of Pennsylvania)|David  Parham (University of Oklahoma Health Sciences Center)|Erin  Rudzinski (Oregon Health and Science University)|Show all 9",Javed  Khan; MD (Pediatric Oncology Branch),NULL,"1. Duan F, Smith LM, Gustafson DM, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG (2012). Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group. Genes Chromosomes Cancer  51, 662-74.   https://doi.org/10.1002/gcc.21953",https://intramural.nih.gov/search/searchview.taf?ipid=73915
594,BC011388-02,"October 01, 2011 -  September 30, 2012",molecular analysis of medullary thyroid carcinoma tissues,Samuel A Wells,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Paola A Salerno|Anna  Tamburrino|Antonio  Fojo; MD, PhD",rebecca  chernock (washington university)|jeffrey  moley (Washington University)|Massimo  Santoro,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73916
595,BC011389-02,"October 01, 2011 -  September 30, 2012",small molecule therapy for thyroid cancer,Samuel A Wells,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Jean L Ward|Ann Wild Gramza|Antonio  Fojo; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73917
596,BC011390-02,"October 01, 2011 -  September 30, 2012",Vascular Biology in Cancer,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Shyam K Sharan,Tim  Blackwell (Vanderbilt University)|Matthew  Bogyoi (Stanford University)|Xiaolin  He (Northwestern University)|Deyu  Li (Vanderbilt University)|Kevin  Peters (Akebia Therapeutics),Peter F Johnson; PhD (Laboratory of Cancer Prevention)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Boelte KC, Gordy LE, Joyce S, Thompson MA, Yang L, Lin PC (2011). Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One  6, e18534.   https://doi.org/10.1371/journal.pone.0018534|2. Boutté AM, Friedman DB, Bogyo M, Min Y, Yang L, Lin PC (2011). Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis. FASEB J  25, 2626-37.   https://doi.org/10.1096/fj.10-180604|3. Boutté AM, McDonald WH, Shyr Y, Yang L, Lin PC (2011). Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics. PLoS One  6, e22446.   https://doi.org/10.1371/journal.pone.0022446|4. Gao Y, Majumdar D, Jovanovic B, Shaifer C, Lin PC, Zijlstra A, Webb DJ, Li D (2011). A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology. Biomed Microdevices  13, 539-48.   https://doi.org/10.1007/s10544-011-9523-9|5. Min Y, Ghose S, Boelte K, Li J, Yang L, Lin PC (2011). C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α. Oncogene  30, 4901-9.   https://doi.org/10.1038/onc.2011.187",https://intramural.nih.gov/search/searchview.taf?ipid=73918
597,BC011391-02,"October 01, 2011 -  September 30, 2012",Role of IKK alpha in lung squamous cell carcinoma development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Robert  Wiltrout; PhD|Howard A Young; PhD,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73919
598,BC011393-02,"October 01, 2011 -  September 30, 2012",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Ying  Xiao|Jonathan Stephen Williams|Mark  Udey; MD,NULL,NULL,Yosuke  Mukoyama; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73921
599,BC011394-02,"October 01, 2011 -  September 30, 2012",Molecular pathogenesis of Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Kenneth Michael Daily|Jonathan Stephen Williams,Boris  Bastian (UCSF)|Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering),Eric Alan Stahlberg (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73922
600,BC011397-02,"October 01, 2011 -  September 30, 2012",Alternative splicing in Ras transformed cells,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Valentin  Giroux,NULL,NULL,NULL,"1. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=73923
601,BC011398-02,"October 01, 2011 -  September 30, 2012",Membrane trafficking function in primary cilium assembly and signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Quanlong  Lu; PhD|Jeffrey Tate Gray|Vijay  Walia|Christine Antoinette Kettenhofen; PhD,Steve H Caplan; PhD (NICHD)|David  Stephens,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Ulrich  Baxa; PhD (Office Of The Director)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)",Jennifer A Lippincott Schwartz; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73924
602,BC011399-02,"October 01, 2011 -  September 30, 2012",Regulation of microRNA expression by Mutant p53,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Xiao Ling  Li|Murugan  Subramanian|Sven  Bilke|Princy  Francis|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73925
603,BC011400-02,"October 01, 2011 -  September 30, 2012",Function of Mutant p53-regulated microRNAs in cancer cells,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Xiao Ling  Li|Murugan  Subramanian|Sven  Bilke|Princy  Francis|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73926
604,BC011401-02,"October 01, 2011 -  September 30, 2012",Mechanisms regulating the context-dependant function of microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Toshifumi  Hara|Matthew Fletcher Jones|Azita  Halary|Sven  Bilke|Princy  Francis|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73927
605,BC011402-02,"October 01, 2011 -  September 30, 2012",MicroRNA phenotypic screening for the discovery of novel anti-cancer microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Toshifumi  Hara|Azita  Halary|Natasha  Caplen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73928
606,BC011403-02,"October 01, 2011 -  September 30, 2012",Mechanistic investigation of the RTK cooperation paradigm in vitro and in vivo,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Andrew L Smith|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Udayan  Guha (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73929
607,BC011404-02,"October 01, 2011 -  September 30, 2012",RTK effector gene discovery.,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Andrew L Smith|Alexandra Gesine Cauer|Kevin A Camphausen; MD,NULL,Udayan  Guha (Medical Oncology Branch)|Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73930
608,BC011405-02,"October 01, 2011 -  September 30, 2012",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|2. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|3. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW (2011). Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene  30, 4697-706.   https://doi.org/10.1038/onc.2011.179",https://intramural.nih.gov/search/searchview.taf?ipid=73931
609,BC011406-02,"October 01, 2011 -  September 30, 2012",miRNA profiling  of prostate cancer.,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Karlena C Lara-Otero,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|2. Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2012). MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol  18, 34-45.   https://doi.org/10.4261/1305-3825.DIR.4478-11.1|3. Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL (2011). Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology  258, 488-95.   https://doi.org/10.1148/radiol.10100667|4. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging  11, 31-6.   https://doi.org/10.1102/1470-7330.2011.0007",https://intramural.nih.gov/search/searchview.taf?ipid=73932
610,BC011407-02,"October 01, 2011 -  September 30, 2012",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Jacques  Grill (Gustave Roussy Institute)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Dannis  van Vuurden (VU University medical Center)|Gilbert  Vezina (Children's National Medical Center)|Show all 7,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73933
611,BC011408-02,"October 01, 2011 -  September 30, 2012",Compare substrate specificities of wild type and mutant EGFR kinases.,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Abhilash  Venugopalan|Tapan Kumar Maity,Heng  Zhu (Johns Hopkins Medical Institute)|Ileana  Cristea (Princeton University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73934
612,BC011409-02,"October 01, 2011 -  September 30, 2012",Gene Expression Profiling and RNA visualization with Single-Molecule FISH,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Murali  Palangat; PhD|Matthew L Ferguson|Joseph  Rodriguez,NULL,David  Levens; PhD (Laboratory of Pathology)|Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology)|Dinah  Singer; PhD (Molecular Regulation Section),"Robert Joseph Crouch; PhD (NICHD) |Elissa P Lei; BS, PhD (NIDDK)","1. Trcek T, Larson DR, Moldón A, Query CC, Singer RH (2011). Single-molecule mRNA decay measurements reveal promoter- regulated mRNA stability in yeast. Cell  147, 1484-97.   https://doi.org/10.1016/j.cell.2011.11.051",https://intramural.nih.gov/search/searchview.taf?ipid=73935
613,BC011410-02,"October 01, 2011 -  September 30, 2012",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Sahib  Singh|Tapan Kumar Maity|Xu  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73936
614,BC011411-02,"October 01, 2011 -  September 30, 2012",Development of ES/iPSC approach for non-germline GEM modeling,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",N Keith Collins|Serguei V Kozlov,NULL,Luis Manuel Alvarez; PhD (Cancer and Developmental Biology Laboratory),"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73937
615,BC011412-02,"October 01, 2011 -  September 30, 2012",Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Abhilash  Venugopalan|Tapan Kumar Maity|Roxanne  Nemati,NULL,"Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Harold  Varmus; MD (Office Of The Director)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73938
616,BC011413-02,"October 01, 2011 -  September 30, 2012",Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA (2011). Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a ""modified"" step-filtration process for clearance of packaging cells. Hum Gene Ther  22, 107-15.   https://doi.org/10.1089/hum.2010.064",https://intramural.nih.gov/search/searchview.taf?ipid=73939
617,BC011414-02,"October 01, 2011 -  September 30, 2012",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity|Xu  Zhang,Todd  Golub (Broad Institute of MIT and Harvard)|Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center),"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73940
618,BC011415-02,"October 01, 2011 -  September 30, 2012",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Frances  Hakim; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA (2011). Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a ""modified"" step-filtration process for clearance of packaging cells. Hum Gene Ther  22, 107-15.   https://doi.org/10.1089/hum.2010.064",https://intramural.nih.gov/search/searchview.taf?ipid=73941
619,BC011416-02,"October 01, 2011 -  September 30, 2012",Investigation of Rabs and trafficking regulators roles in tumorigenesis,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Akiko  Chiba|Vijay  Walia,NULL,Laufey Thora Amundadottir (Laboratory Translational Genomics),Jennifer A Lippincott Schwartz; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73942
620,BC011417-02,"October 01, 2011 -  September 30, 2012",New Chimeric Antigen Receptors for Treating Hematologic Malignancies,James N Kochenderfer|IRP Faculty Profile,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD,NULL,Richard A Morgan; PhD (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73943
621,BC011418-02,"October 01, 2011 -  September 30, 2012",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Julie A Hong|Mary R Zhang|Trevor Christopher Upham; MD,NULL,"Susan  Bates; MD (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, Wiegand G, Avital I, Fetsch P, Mani H, Zlott D, Robey R, Bates SE, Li X, Rao M, Schrump DS (2012). Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res  72, 4178-92.   https://doi.org/10.1158/0008-5472.CAN-11-3983",https://intramural.nih.gov/search/searchview.taf?ipid=73944
622,BC011419-02,"October 01, 2011 -  September 30, 2012",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Shangjin  Sun,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73945
623,BC011422-01,"October 01, 2011 -  September 30, 2012",Role of IKKalpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77739
624,BC011423-01,"October 01, 2011 -  September 30, 2012",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Hengmi  Cui,Stephen  Master (University of Pennsylvania)|Mariusz  Ratajczak (University of Louisville),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77748
625,BC011424-01,"October 01, 2011 -  September 30, 2012",Bone Marrow Stromal Cells as Mitigators of Radiation Injury,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Bradley T Scroggins|Ayla Oksuz White|Jason Andrew Horton; PhD|Kathryn Elizabeth Hudak,NULL,NULL,Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77733
626,BC011425-01,"October 01, 2011 -  September 30, 2012",Expression of class I in Treg cells,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Jocelyn D Weissman|Jie  Mu,NULL,Susan  Sharrow (Experimental Immunology Branch)|Alfred  Singer; MD (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77701
627,BC011426-01,"October 01, 2011 -  September 30, 2012",Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Andrea L Ferris|Mary J McWilliams|Barry  Johnson|Janani  Varadarajan|Steven J Smith|Vineet Narain KewalRamani; PhD,"C David  Allis (Rockefeller University)|Zandrea  Ambrose (University of Pittsburgh)|Peter  Cherepanov (Imperial College London)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Richard  Fishel (Ohio State University)|Thomas  Milne (Oxford University)|Show all 8",William Gregory Alvord (Office Of The Director)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Xiaolin  Wu; PhD (Office Of The Director),Henry L Levin; PhD (NICHD),"1. Hare S, Smith SJ, Métifiot M, Jaxa-Chamiec A, Pommier Y, Hughes SH, Cherepanov P (2011). Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol  80, 565-72.   https://doi.org/10.1124/mol.111.073189|2. Lee EG, Roy J, Jackson D, Clark P, Boyer PL, Hughes SH, Linial ML (2011). Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation. J Virol  85, 1655-61.   https://doi.org/10.1128/JVI.01873-09|3. MÃ©tifiot M, Johnson B, Smith S, Zhao XZ, Marchand C, Burke T, Hughes S, Pommier Y (2012) MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrob Agents Chemother, in press.|4. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2011). Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  21, 2986-90.   https://doi.org/10.1016/j.bmcl.2011.03.047",https://intramural.nih.gov/search/searchview.taf?ipid=77696
628,BC011427-01,"October 01, 2011 -  September 30, 2012",Immunohistochemical analysis of tumors,Markku Martti Miettinen,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Zengfeng  Wang; PhD|Jerzy P Lasota,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77749
629,BC011429-01,"October 01, 2011 -  September 30, 2012",Zbtb family members in lymphocyte differentiation and function,Damian  Kovalovsky; PhD,NULL,"Experimental Immunology Branch, NCI",Xianyu  Zhang; MS|Jun-Seock  Son,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77756
630,BC011431-01,"October 01, 2011 -  September 30, 2012",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yan  Wang,NULL,NULL,NULL,"1. Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH (2011). T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat Immunol  12, 96-104.   https://doi.org/10.1038/ni.1969|2. Lazarevic V, Glimcher LH (2011). T-bet in disease. Nat Immunol  12, 597-606.   https://doi.org/10.1038/ni.2059|3. Staton TL, Lazarevic V, Jones DC, Lanser AJ, Takagi T, Ishii S, Glimcher LH (2011). Dampening of death pathways by schnurri-2 is essential for T-cell development. Nature  472, 105-9.   https://doi.org/10.1038/nature09848",https://intramural.nih.gov/search/searchview.taf?ipid=77754
631,BC011432-01,"October 01, 2011 -  September 30, 2012",Regulation of T-bet expression in TH17 cells by microRNAs,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77755
632,BC011433-01,"October 01, 2011 -  September 30, 2012",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Walter Alexander Orellana,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77758
633,BC011435-01,"October 01, 2011 -  September 30, 2012",Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Jessica  Smith|Narasimhan Jayanth  Venkatachari; PhD|Taisuke  Izumi; PhD|Maria Ashley Hamscher,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77699
634,BC011436-01,"October 01, 2011 -  September 30, 2012","Mechanisms of Antiviral Drug Resistance, Host Factors and Retroviral Replication",Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Ryan C Burdick|Taisuke  Izumi; PhD|Mayu  Shigemi|Wei-Shau  Hu; PhD|Stephen H Hughes; PhD,"Jean L Mbisa (NCI)|Julie  Overbaugh (Fred Hutchinson Cancer Research Center)|Marcelo  Soares; PhD (Instituto Nacional de Cancer do Brasil)|Clifford  Tepper (University of California, Davis)|Dalton  Wamalwa (University of Nairobi)",Mary  Kearney (Host Virus Interaction Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Dwight V Nissley (Genome Recombination and Regulation Section)|Andrew G Stephen (Office Of The Director)|Timothy D Veenstra (Office Of The Director),NULL,"1. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Coffin JM, Pathak VK (2011). Recombinant origin of the retrovirus XMRV. Science  333, 97-101.   https://doi.org/10.1126/science.1205292",https://intramural.nih.gov/search/searchview.taf?ipid=77700
635,BC011437-01,"October 01, 2011 -  September 30, 2012",Focused siRNA screening using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee|Dennis  Hsu|Chih-Shia  Lee,Scott  Lowe (Cold Spring Harbor Laboratory)|Frank  McCormick (UCSF School of Medicine),Natasha  Caplen (Cancer Genetics Branch),NULL,"1. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=77743
636,BC011438-01,"October 01, 2011 -  September 30, 2012",Pooled shRNA screens for target discoveries in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee,"Stephen  Elledge; PhD (Dept of Genetics, Brigham and Woman Hospital)|Thomas  Westbrook; PhD (Department of Biochemistry, Baylor College of Medicine)",Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Terry Anne Van Dyke (Mouse Cancer Genetics Program),J Silvio  Gutkind; PhD (NIDCR),"1. Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, et al. [2 more authors] (2012). A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science  335, 348-53.   https://doi.org/10.1126/science.1212728|2. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110",https://intramural.nih.gov/search/searchview.taf?ipid=77744
637,BC011439-01,"October 01, 2011 -  September 30, 2012",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Frances  Hakim; PhD,NULL,Stefania  Pittaluga (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77734
638,BC011441-01,"October 01, 2011 -  September 30, 2012",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Andrew L Smith|Alexandra Gesine Cauer|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77745
639,BC011442-01,"October 01, 2011 -  September 30, 2012",Reporter Constructs for Target Gene Discovery,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra Gesine Cauer|Kevin A Camphausen; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77746
640,BC011443-01,"October 01, 2011 -  September 30, 2012",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77698
641,BC011446-01,"October 01, 2011 -  September 30, 2012",The ClpP protease as a therapeutic target in bacterial and mammalian cells,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Germaine Yeku Noukelak,NULL,NULL,Anton  Simeonov (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77717
642,BC011447-01,"October 01, 2011 -  September 30, 2012",Clinical Development of New Agents for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen|Brigitte  Widemann; MD,"Susan  Blaney (Baylor University/TCCC)|James  Boyett (St Jude Children's Research Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Mark  Kieran (Children's Hospital)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Show all 7",Kevin A Camphausen; MD (Radiation Oncology Branch),Russell R Lonser; MD (NINDS) |Joelle  Sarlls; PhD (NINDS),"1. Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R, Shih J, Camphausen K (2012). A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma. Cancer  118, 3607-13.   https://doi.org/10.1002/cncr.26659",https://intramural.nih.gov/search/searchview.taf?ipid=77729
643,BC011448-01,"October 01, 2011 -  September 30, 2012",Investigation of Immune Status and Function in Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Crystal L. Mackall; MD|Brigitte  Widemann; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77730
644,BC011449-01,"October 01, 2011 -  September 30, 2012",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Yeong Sang  Kim|Melissa Jessica Leyva|Olivia Rose O'Keefe,NULL,Michael Robert Kuehn; PhD (Laboratory of Protein Dynamics and Signaling)|Ji  Luo (Medical Oncology Branch)|Barry R O'Keefe (Molecular Targets Laboratory)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Kim J, Schneekloth JS, Sorensen EJ (2012). A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction. Chem Sci  3, 2849-2852.   https://doi.org/10.1039/C2SC20669B|2. Noblin DJ, Page CM, Tae HS, Gareiss PC, Schneekloth JS, Crews CM (2012). A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities. ACS Chem Biol  7, 2055-63.   https://doi.org/10.1021/cb300453k",https://intramural.nih.gov/search/searchview.taf?ipid=77750
645,BC011450-01,"October 01, 2011 -  September 30, 2012",Ipilimumab for treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Jedd  Wolchok (Memorial Sloan-Kettering),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77747
646,BC011451-01,"October 01, 2011 -  September 30, 2012",Synthesis and Study of Inhibitors of Ubiquitin Ligases,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Lindsey Blair Saunders,NULL,Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,"1. Kim J, Schneekloth JS, Sorensen EJ (2012). A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction. Chem Sci  3, 2849-2852.   https://doi.org/10.1039/C2SC20669B|2. Noblin DJ, Page CM, Tae HS, Gareiss PC, Schneekloth JS, Crews CM (2012). A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities. ACS Chem Biol  7, 2055-63.   https://doi.org/10.1021/cb300453k",https://intramural.nih.gov/search/searchview.taf?ipid=77751
647,BC011452-01,"October 01, 2011 -  September 30, 2012",Synthesis of Anti-Alzheimers Oligomeric Compounds,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,NULL,NULL,"1. Kim J, Schneekloth JS, Sorensen EJ (2012). A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction. Chem Sci  3, 2849-2852.   https://doi.org/10.1039/C2SC20669B|2. Noblin DJ, Page CM, Tae HS, Gareiss PC, Schneekloth JS, Crews CM (2012). A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities. ACS Chem Biol  7, 2055-63.   https://doi.org/10.1021/cb300453k",https://intramural.nih.gov/search/searchview.taf?ipid=77752
648,BC011454-01,"October 01, 2011 -  September 30, 2012",RGB-286638 as a radiation sensitizer,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht|Naga Venkata Gopal  Abbineni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77741
649,BC011455-01,"October 01, 2011 -  September 30, 2012",Therapeutic use of immunomodulators and ionizining radiation,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht|Naga Venkata Gopal  Abbineni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77742
650,BC011456-01,"October 01, 2011 -  September 30, 2012",Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77735
651,BC011457-01,"October 01, 2011 -  September 30, 2012",Characterization of the invading cells in glioblastoma,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77736
652,BC011458-01,"October 01, 2011 -  September 30, 2012",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Srinivas  Vourganti,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77757
653,BC011459-01,"October 01, 2011 -  September 30, 2012",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Nicholas John Kettenhofen; PhD|Dong  Kong; PhD,NULL,Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77753
654,BC011460-01,"October 01, 2011 -  September 30, 2012",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Upasana  Ray,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77719
655,BC011461-01,"October 01, 2011 -  September 30, 2012",The Role of RISC Proteins in HIV-1 Replication,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Wendy  Yuen|Hyun Jae  Yu|Ioannis N Kagiampakis|Christopher Lee Case; PhD|Eric O Freed; PhD|Show all 7,"Sara  Sawyer (University of Texas, Austin)|Derya  Unutmaz (New York University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77697
656,BC011462-01,"October 01, 2011 -  September 30, 2012",Establishing the Preclinical Model for Metastatic Melanoma,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Zoe W Ohler|Serguei V Kozlov,Marcus  Bosenberg (Yale University)|Martin  McMahon (University of Californial at San Francisco),Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77737
657,BC011463-01,"October 01, 2011 -  September 30, 2012",Adoption and Retooling of GEM model for Pancreatic Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Serguei V Kozlov,"Ross  Cagan (Mount Sinai School of Medicine)|Neal  Goodwin (Jackson Laboratory, West)",Scott E McNeil (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77738
658,BC011464-01,"October 01, 2011 -  September 30, 2012",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Shawn A Hill,Anuradha  Ganesan (Henry M. Jackson Foundation)|Deborah  McMahon (University of Pittsburgh)|John W Mellors,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Richard T Davey; MD (NIAID) |Alice K Pau; PharmD (NIAID) |Michael  Proschan; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77720
659,BC011465-01,"October 01, 2011 -  September 30, 2012",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Zuqin  Nie; PhD|Yeung  Ho|Hsin-Hao Timothy Hsiao,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Rafael Cristian Casellas; PhD (NIAMS) |Keji  Zhao; PhD (NHLBI),"1. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green D, Casellas R, Zhao K, Levens D (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell In press:In press",https://intramural.nih.gov/search/searchview.taf?ipid=77718
660,BC011466-01,"October 01, 2011 -  September 30, 2012",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Shawn A Hill,NULL,Stephen H Hughes; PhD (Retroviral Replication Laboratory),Joseph P Casazza (NIAID) |Richard T Davey; MD (NIAID) |Michele  Di Mascio; PhD (NIAID) |Dean  Follmann; PhD (NIAID) |Joseph A Kovacs; MD (CC),"1. Josefsson L, King MS, Makitalo B, Brännström J, Shao W, Maldarelli F, Kearney MF, Hu WS, Chen J, Gaines H, Mellors JW, Albert J, Coffin JM, Palmer SE (2011). Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A  108, 11199-204.   https://doi.org/10.1073/pnas.1107729108",https://intramural.nih.gov/search/searchview.taf?ipid=77721
661,BC011467-01,"October 01, 2011 -  September 30, 2012",Molecularly targeted natural products discovery from diverse natural sources,Kirk R Gustafson; PhD|IRP Faculty Profile,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Susanna Tsz Shan Chan,NULL,Susan  Bates; MD (Medical Oncology Branch)|Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|William Marston Linehan; MD (Urologic Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology),NULL,"1. Grkovic T, Blees JS, Colburn NH, Schmid T, Thomas CL, Henrich CJ, McMahon JB, Gustafson KR (2011). Cryptocaryols A-H, α-pyrone-containing 1,3-polyols from Cryptocarya sp. implicated in stabilizing the tumor suppressor Pdcd4. J Nat Prod  74, 1015-20.   https://doi.org/10.1021/np100918z",https://intramural.nih.gov/search/searchview.taf?ipid=77723
662,BC011468-01,"October 01, 2011 -  September 30, 2012",Adaptations and methodologies for enhanced identification of lead compounds,Kirk R Gustafson; PhD|IRP Faculty Profile,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Susanna Tsz Shan Chan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77724
663,BC011469-01,"October 01, 2011 -  September 30, 2012",Building Libraries with Chemical Diversity for Screening,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Ekaterina  Goncharo|Cheryl L Thomas|Jason R Evans,Sergazy  Adekenov (International Research and Production Holding Phytochemistry)|Jeff  Aube (University of Kansas)|Darkan  Balpanaov (Biomedpreparat)|Young Ho  Kim|Sergei  Kozmin (University of Chicago)|John  Porco (Boston University)|Show all 8,NULL,NULL,"1. Devkota KP, Ratnayake R, Colburn NH, Wilson JA, Henrich CJ, McMahon JB, Beutler JA (2011). Inhibitors of the oncogenic transcription factor AP-1 from Podocarpus latifolius. J Nat Prod  74, 374-7.   https://doi.org/10.1021/np100736y",https://intramural.nih.gov/search/searchview.taf?ipid=77725
664,BC011470-01,"October 01, 2011 -  September 30, 2012",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Ekaterina  Goncharo|Jason R Evans|Krishna Prasad Devkota; PhD,"William  Chain (University of Hawaii)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Kathlyn  Parker (Stony Brook University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)","William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77726
665,BC011471-01,"October 01, 2011 -  September 30, 2012",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Kirk R Gustafson; PhD,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Kyung  Lee; PhD (Chemistry Section)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77727
666,BC011472-01,"October 01, 2011 -  September 30, 2012",Isolation of antiviral proteins from natural product extracts.,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"Paul  Christou (Universitat de Lleida)|Edward  Karamov (Ivanovsky Institute of Virology)|Lynn  Morris (National Institute for Communicable Diseases)|Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Yutaka  Takebe (National Institute of Infectious Diseases)",Alexander  Wlodawer; PhD (Protein Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77728
667,CO020003-04,"October 01, 2011 -  September 30, 2012",Office of Cancer Genomics,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Daniela S Gerhard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73948
668,CP000101-08,"October 01, 2011 -  September 30, 2012",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch)|Blossom  Patterson (Biometry Research Group),NULL,"1. Hartman TJ, Mahabir S, Baer DJ, Stevens RG, Albert PS, Dorgan JF, Kesner JS, Meadows JW, Shields R, Taylor PR (2012). Moderate alcohol consumption and 24-hour urinary levels of melatonin in postmenopausal women. J Clin Endocrinol Metab  97, E65-8.   https://doi.org/10.1210/jc.2011-1904",https://intramural.nih.gov/search/searchview.taf?ipid=73991
669,CP000112-08,"October 01, 2011 -  September 30, 2012",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Farin  Kamangar|Nan  Hu,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Guo-Qing  Wang (CICAMS)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Mark J Roth (Laboratory of Pathology),NULL,"1. Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, Li XM, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Liao LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Chung CC, Wang C, Wheeler W, Yeager M, et al. [136 more authors] (2012). Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet  21, 2132-41.   https://doi.org/10.1093/hmg/dds029|2. Persson EC, Sewram V, Evans AA, London WT, Volkwyn Y, Shen YJ, Van Zyl JA, Chen G, Lin W, Shephard GS, Taylor PR, Fan JH, Dawsey SM, Qiao YL, McGlynn KA, Abnet CC (2012). Fumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohorts. Food Chem Toxicol  50, 679-83.   https://doi.org/10.1016/j.fct.2011.11.029",https://intramural.nih.gov/search/searchview.taf?ipid=73989
670,CP000176-08,"October 01, 2011 -  September 30, 2012",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wendy  Wang (NCI/DCP),Ping  Hu; MS (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73992
671,CP000185-08,"October 01, 2011 -  September 30, 2012",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Show all 10",NULL,NULL,"1. Agrawal A, Freedman ND, Bierut LJ (2011). Genome-wide association studies of alcohol intake--a promising cocktail? Am J Clin Nutr  93, 681-3.   https://doi.org/10.3945/ajcn.111.012641|2. Bergman JJ, Zhang YM, He S, Weusten B, Xue L, Fleischer DE, Lu N, Dawsey SM, Wang GQ (2011). Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc  74, 1181-90.   https://doi.org/10.1016/j.gie.2011.05.024|3. Deziel NC, Wei WQ, Abnet CC, Qiao YL, Sunderland D, Ren JS, Schantz MM, Zhang Y, Strickland PT, Abubaker S, Dawsey SM, Friesen MC, Roth MJ (2013). A multi-day environmental study of polycyclic aromatic hydrocarbon exposure in a high-risk region for esophageal cancer in China. J Expo Sci Environ Epidemiol  23, 52-9.   https://doi.org/10.1038/jes.2012.73|4. Etemadi A, Abnet CC, Golozar A, Malekzadeh R, Dawsey SM (2012). Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med  15, 18-21.   https://doi.org/012151/AIM.007|5. Etemadi A, Golozar A, Ghassabian A, Zarei M, Hashemi Taheri AP, Dawsey SM, Malekzadeh R (2011). Cavernous hemangioma of the liver: factors affecting disease progression in general hepatology practice. Eur J Gastroenterol Hepatol  23, 354-8.   https://doi.org/10.1097/MEG.0b013e3283451e7d|6. Islami F, Boffetta P, van Schooten FJ, Strickland P, Phillips DH, Pourshams A, Fazel-Tabar Malekshah A, Godschalk R, Jafari E, Etemadi A, Abubaker S, Kamangar F, Straif K, Møller H, Schüz J, Malekzadeh R (2012). Exposure to Polycyclic Aromatic Hydrocarbons Among Never Smokers in Golestan Province, Iran, an Area of High Incidence of Esophageal Cancer - a Cross-Sectional Study with Repeated Measurement of Urinary 1-OHPG in Two Seasons. Front Oncol  2, 14.   https://doi.org/10.3389/fonc.2012.00014|7. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, Kamangar F, Abnet CC, Boffetta P, Engstrand L, Dawsey SM, Malekzadeh R, Ye W (2011). Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One  6, e26957.   https://doi.org/10.1371/journal.pone.0026957|8. Xue L, Ren L, Zou S, Shan L, Liu X, Xie Y, Zhang Y, Lu J, Lin D, Dawsey SM, Wang G, Lu N (2012). Parameters predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma. Mod Pathol  25, 1364-77.   https://doi.org/10.1038/modpathol.2012.89",https://intramural.nih.gov/search/searchview.taf?ipid=73993
672,CP004410-36,"October 01, 2011 -  September 30, 2012",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,"Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (Dermatology Branch)","Jeffery P Struewing; MS, MD (NHGRI)","1. Kristinsson SY, Goldin LR, Turesson I, Björkholm M, Landgren O (2012). Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol  127, 173-7.   https://doi.org/10.1159/000335618|2. Tamura D, Merideth M, DiGiovanna JJ, Zhou X, Tucker MA, Goldstein AM, Brooks BP, Khan SG, Oh KS, Ueda T, Boyle J, Moslehi R, Kraemer KH (2011). High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies. Prenat Diagn  31, 1046-53.   https://doi.org/10.1002/pd.2829|3. Yang XR, Brown K, Landi MT, Ghiorzo P, Badenas C, Xu M, Hayward NK, Calista D, Landi G, Bruno W, Bianchi-Scarrà G, Aguilera P, Puig S, Goldstein AM, Tucker MA (2012). Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. Pigment Cell Melanoma Res  25, 243-7.   https://doi.org/10.1111/j.1755-148X.2012.00969.x",https://intramural.nih.gov/search/searchview.taf?ipid=73964
673,CP005782-18,"October 01, 2011 -  September 30, 2012",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Nutritional Epidemiology Branch),Barbara  Rehermann; MD (NIDDK),"1. Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RT, HALT-C Trial Group (2011). A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology  141, 141-9.   https://doi.org/10.1053/j.gastro.2011.03.045|2. Morgan TR, O'Brien TR (2011). IL28B-genotype testing now and in the era of direct-acting antiviral agents. Clin Gastroenterol Hepatol  9, 293-4.   https://doi.org/10.1016/j.cgh.2010.12.014|3. O'Brien TR (2011). Editorial: epidemic-assistance investigations by the centers for disease control and prevention: the first 60 years. Am J Epidemiol  174, 1211-2.   https://doi.org/10.1093/aje/kwr336|4. O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RM, HALT-C Trial Group (2011). An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One  6, e20904.   https://doi.org/10.1371/journal.pone.0020904|5. O'Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, Schadt EE, Prokunina-Olsson L (2011). Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun  12, 428-33.   https://doi.org/10.1038/gene.2011.11|6. Shebl FM, Pfeiffer RM, Buckett D, Muchmore B, Chen S, Dotrang M, Prokunina-Olsson L, Edlin BR, O'Brien TR (2011). IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association. J Infect Dis  204, 1843-7.   https://doi.org/10.1093/infdis/jir647|7. Uccellini L, Tseng FC, Monaco A, Shebl FM, Pfeiffer R, Dotrang M, Buckett D, Busch MP, Wang E, Edlin BR, Marincola FM, O'Brien TR (2012). HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology  56, 86-94.   https://doi.org/10.1002/hep.25652",https://intramural.nih.gov/search/searchview.taf?ipid=73963
674,CP005803-18,"October 01, 2011 -  September 30, 2012",Genetic Epidemiology,"Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI","Neil Edward Caporaso; MS, MD|Mary Louise McMaster; MD|Dilys  Parry; PhD|Thomas  Fears; PhD|Jorge R Toro","Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|Naoko  Ishibe; ScD (Clinical & Translational Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)","David  Ng; AB, MD (NHGRI)","1. Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Björkholm M (2012). Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol  30, 179-83.   https://doi.org/10.1200/JCO.2011.37.1203|2. Kristinsson SY, Goldin LR, Turesson I, Björkholm M, Landgren O (2012). Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol  127, 173-7.   https://doi.org/10.1159/000335618",https://intramural.nih.gov/search/searchview.taf?ipid=73962
675,CP005804-18,"October 01, 2011 -  September 30, 2012",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Andrea  Baccarelli|Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Office of the Director)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. Shi J, Chatterjee N, Rotunno M, Wang Y, Pesatori AC, Consonni D, Li P, Wheeler W, Broderick P, Henrion M, Eisen T, Wang Z, Chen W, Dong Q, Albanes D, Thun M, Spitz MR, Bertazzi PA, Caporaso NE, Chanock SJ, Amos CI, Houlston RS, Landi MT (2012). Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov  2, 131-9.   https://doi.org/10.1158/2159-8290.CD-11-0246",https://intramural.nih.gov/search/searchview.taf?ipid=73961
676,CP010119-17,"October 01, 2011 -  September 30, 2012",Studies of Occupational Cancer (Pesticides),"Gabriella  Andreotti| | |Laura Elizabeth Beane Freeman|IRP Faculty Profile  |Jay  Lubin; PhD| | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Shelia K Zahm; ScM, ScD| |Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Office of the Director, NCI","Stella  Koutros|Jonathan Nicholas Hofmann|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Dalsu  Baris|Joanne S Colt",Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Lisbeth  LopezCarrillo (Mexican National Institute of Public Health),"Ola Anders Landgren (Medical Oncology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Alavanja MC, Bonner MR (2012). Occupational pesticide exposures and cancer risk: a review. J Toxicol Environ Health B Crit Rev  15, 238-63.   https://doi.org/10.1080/10937404.2012.632358|2. Andreotti G, Koutros S, Berndt SI, Hughes Barry K, Hou L, Hoppin JA, Sandler DP, Lubin JH, Burdette LA, Yuenger J, Yeager M, Beane Freeman LE, Alavanja MC (2012). The Interaction between Pesticide Use and Genetic Variants Involved in Lipid Metabolism on Prostate Cancer Risk. J Cancer Epidemiol  2012, 358076.   https://doi.org/10.1155/2012/358076|3. Barry KH, Koutros S, Berndt SI, Andreotti G, Hoppin JA, Sandler DP, Burdette LA, Yeager M, Freeman LE, Lubin JH, Ma X, Zheng T, Alavanja MC (2011). Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. Environ Health Perspect  119, 1726-32.   https://doi.org/10.1289/ehp.1103454|4. Barry KH, Koutros S, Lubin JH, Coble JB, Barone-Adesi F, Beane Freeman LE, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC (2012). Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes Control  23, 807-18.   https://doi.org/10.1007/s10552-012-9949-2|5. Beane Freeman LE, Deroos AJ, Koutros S, Blair A, Ward MH, Alavanja M, Hoppin JA (2012). Poultry and livestock exposure and cancer risk among farmers in the agricultural health study. Cancer Causes Control  23, 663-70.   https://doi.org/10.1007/s10552-012-9921-1|6. Beard JD, Umbach DM, Hoppin JA, Richards M, Alavanja MC, Blair A, Sandler DP, Kamel F (2011). Suicide and pesticide use among pesticide applicators and their spouses in the agricultural health study. Environ Health Perspect  119, 1610-5.   https://doi.org/10.1289/ehp.1103413|7. Blair A, Thomas K, Coble J, Sandler DP, Hines CJ, Lynch CF, Knott C, Purdue MP, Zahm SH, Alavanja MC, Dosemeci M, Kamel F, Hoppin JA, Freeman LB, Lubin JH (2011). Impact of pesticide exposure misclassification on estimates of relative risks in the Agricultural Health Study. Occup Environ Med  68, 537-41.   https://doi.org/10.1136/oem.2010.059469|8. DellaValle CT, Hoppin JA, Hines CJ, Andreotti G, Alavanja MC (2012). Risk-accepting personality and personal protective equipment use within the Agricultural Health Study. J Agromedicine  17, 264-76.   https://doi.org/10.1080/1059924X.2012.686390|9. Endres SM, Green BJ, Henneberger PK, Germolec DR, Bledsoe TA, Beezhold DH, London SJ, Alavanja MC, Beane Freeman LE, Hoppin JA (2012). Fungal and atopic sensitization are low among farmers in the Agricultural Health Study. J Allergy Clin Immunol  130, 267-70.e1.   https://doi.org/10.1016/j.jaci.2012.04.018|10. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, Yoo S, Sandler DP, Alavanja MC (2012). Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev  21, 1856-67.   https://doi.org/10.1158/1055-9965.EPI-12-0551|11. Heltshe SL, Lubin JH, Koutros S, Coble JB, Ji BT, Alavanja MC, Blair A, Sandler DP, Hines CJ, Thomas KW, Barker J, Andreotti G, Hoppin JA, Beane Freeman LE (2012). Using multiple imputation to assign pesticide use for non-responders in the follow-up questionnaire in the Agricultural Health Study. J Expo Sci Environ Epidemiol  22, 409-16.   https://doi.org/10.1038/jes.2012.31|12. Hock JM, Nealley A, Morrison D, Farah C, Hosgood HD, Zahm S (2012). Unmet challenges in cancer disparities--letter. Cancer Epidemiol Biomarkers Prev  21, 248-9.   https://doi.org/10.1158/1055-9965.EPI-11-1039|13. Hoppin JA, Long S, Umbach DM, Lubin JH, Starks SE, Gerr F, Thomas K, Hines CJ, Weichenthal S, Kamel F, Koutros S, Alavanja M, Beane Freeman LE, Sandler DP (2012). Lifetime organophosphorous insecticide use among private pesticide applicators in the Agricultural Health Study. J Expo Sci Environ Epidemiol  22, 584-92.   https://doi.org/10.1038/jes.2012.79|14. Kamel F, Umbach DM, Bedlack RS, Richards M, Watson M, Alavanja MC, Blair A, Hoppin JA, Schmidt S, Sandler DP (2012). Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology  33, 457-62.   https://doi.org/10.1016/j.neuro.2012.04.001|15. Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schüz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, et al. [4 more authors] (2011). AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health  8, 1341-57.   https://doi.org/10.3390/ijerph8051341|16. Payne K, Andreotti G, Bell E, Blair A, Coble J, Alavanja M (2012). Determinants of high pesticide exposure events in the agricultural health cohort study from enrollment (1993-1997) through phase II (1999-2003). J Agric Saf Health  18, 167-79.   https://doi.org/10.13031/2013.41955|17. Starks SE, Hoppin JA, Kamel F, Lynch CF, Jones MP, Alavanja MC, Sandler DP, Gerr F (2012). Peripheral nervous system function and organophosphate pesticide use among licensed pesticide applicators in the Agricultural Health Study. Environ Health Perspect  120, 515-20.   https://doi.org/10.1289/ehp.1103944|18. Waggoner JK, Henneberger PK, Kullman GJ, Umbach DM, Kamel F, Beane Freeman LE, Alavanja MC, Sandler DP, Hoppin JA (2013). Pesticide use and fatal injury among farmers in the Agricultural Health Study. Int Arch Occup Environ Health  86, 177-87.   https://doi.org/10.1007/s00420-012-0752-x|19. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD (2012). Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev  21, 134-8.   https://doi.org/10.1097/CEJ.0b013e32834c9b6c|20. Whitehead T, Metayer C, Gunier RB, Ward MH, Nishioka MG, Buffler P, Rappaport SM (2011). Determinants of polycyclic aromatic hydrocarbon levels in house dust. J Expo Sci Environ Epidemiol  21, 123-32.   https://doi.org/10.1038/jes.2009.68",https://intramural.nih.gov/search/searchview.taf?ipid=73956
677,CP010120-17,"October 01, 2011 -  September 30, 2012",Studies of Occupational Cancer,"Michael  Alavanja; PhD| |Kenneth  Cantor; PhD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Show all 12",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)","Dale  Sandler; PhD (NIEHS) |Jane  Hoppin; ScD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Aschebrook-Kilfoy B, Ward MH, Zheng T, Holford TR, Boyle P, Leaderer B, Zhang Y (2012). Dietary nitrate and nitrite intake and non-Hodgkin lymphoma survival. Nutr Cancer  64, 488-92.   https://doi.org/10.1080/01635581.2012.658136|2. Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman DT (2012). The Diesel Exhaust in Miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer Inst  104, 869-83.   https://doi.org/10.1093/jnci/djs035|3. Karami S, Boffetta P, Stewart PS, Brennan P, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Slamova A, Chow WH, Rothman N, Moore LE (2011). Occupational exposure to dusts and risk of renal cell carcinoma. Br J Cancer  104, 1797-803.   https://doi.org/10.1038/bjc.2011.148|4. Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Schmidt LS, Lenz P, Karami S, Linehan WM, Merino M, Chanock S, Boffetta P, Chow WH, Waldman FM, Rothman N (2011). Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet  7, e1002312.   https://doi.org/10.1371/journal.pgen.1002312|5. Silverman D, Attfield M (2012) Re: The Diesel Exhaust in Miners Study: A Nested Case-Control Study of Lung Cancer and Diesel Exhaust and a Cohort Mortality Study with Emphasis on Lung Cancer - Reply. Journal of the National Cancer Institute 104:1848-9|6. Silverman D, Attfield M (2012) Re: The Diesel Exhaust in Miners Study: A Nested Case-Control Study of Lung Cancer and Diesel Exhaust and a Cohort Mortality Study with Emphasis on Lung Cancer - Reply. Journal of the National Cancer Institute 104:1848-9|7. Silverman DT, Samanic CM, Lubin JH, Blair AE, Stewart PA, Vermeulen R, Coble JB, Rothman N, Schleiff PL, Travis WD, Ziegler RG, Wacholder S, Attfield MD (2012). The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst  104, 855-68.   https://doi.org/10.1093/jnci/djs034",https://intramural.nih.gov/search/searchview.taf?ipid=73958
678,CP010121-17,"October 01, 2011 -  September 30, 2012",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Mustafa  Dosemeci; PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Show all 15","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13","Shelia K Zahm; ScM, ScD (Office of the Director)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, Hartge P, Landgren O, Lessin L, Virtamo J, Wallace RB, Manson JE, Colditz GA (2012). Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood  120, 4929-37.   https://doi.org/10.1182/blood-2012-03-417253|2. Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, Armstrong B (2011). A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol  152, 721-6.   https://doi.org/10.1111/j.1365-2141.2010.08518.x|3. Hosgood HD, Wang WC, Hong YC, Wang JC, Chen K, Chang IS, Chen CJ, Lu D, Yin Z, Wu C, Zheng W, Qian B, Park JY, Kim YH, Chatterjee N, Chen Y, Chang GC, Hsiao CF, Yeager M, Tsai YH, Wei H, Kim YT, Wu W, Zhao Z, Chow WH, et al. [59 more authors] (2012). Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet  131, 1197-203.   https://doi.org/10.1007/s00439-012-1144-8|4. Hosgood HD, Wei H, Sapkota A, Choudhury I, Bruce N, Smith KR, Rothman N, Lan Q (2011). Household coal use and lung cancer: systematic review and meta-analysis of case-control studies, with an emphasis on geographic variation. Int J Epidemiol  40, 719-28.   https://doi.org/10.1093/ije/dyq259|5. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, et al. [184 more authors] (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet  380, 2224-60.   https://doi.org/10.1016/S0140-6736(12)61766-8|6. McHale CM, Zhang L, Lan Q, Vermeulen R, Li G, Hubbard AE, Porter KE, Thomas R, Portier CJ, Shen M, Rappaport SM, Yin S, Smith MT, Rothman N (2011). Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect  119, 628-34.   https://doi.org/10.1289/ehp.1002546|7. Vermeulen R, Zhang L, Spierenburg A, Tang X, Bonventre JV, Reiss B, Shen M, Smith MT, Qiu C, Ge Y, Ji Z, Xiong J, He J, Hao Z, Liu S, Xie Y, Yue F, Guo W, Purdue M, Beane Freeman LE, Sabbisetti V, Li L, Huang H, Rothman N, Lan Q (2012). Elevated urinary levels of kidney injury molecule-1 among Chinese factory workers exposed to trichloroethylene. Carcinogenesis  33, 1538-41.   https://doi.org/10.1093/carcin/bgs191|8. Zhang L, Lan Q, Ji Z, Li G, Shen M, Vermeulen R, Guo W, Hubbard AE, McHale CM, Rappaport SM, Hayes RB, Linet MS, Yin S, Smith MT, Rothman N (2012). Leukemia-related chromosomal loss detected in hematopoietic progenitor cells of benzene-exposed workers. Leukemia  26, 2494-8.   https://doi.org/10.1038/leu.2012.143",https://intramural.nih.gov/search/searchview.taf?ipid=73959
679,CP010122-17,"October 01, 2011 -  September 30, 2012",Occupational Exposure Assessment,Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Joanne S Colt|Show all 20",Susan  Shortreed (McGill University)|Tye  Arbuckle (Health Canada)|Berit  Bakke (National Institute of Occupational Health)|Igor  Burstyn (Drexel University)|Paolo  Boffetta (International Agency for Research on Cancer)|Jerome  Lavoue (University of Montreal)|Show all 58,Nilanjan  Chatterjee (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Jay  Lubin; PhD (Biostatistics Branch)|Preetha  Rajaraman (Radiation Epidemiology Branch),NULL,"1. Friesen MC, Coble JB, Katki HA, Ji BT, Xue S, Lu W, Stewart PA (2011). Validity and reliability of exposure assessors' ratings of exposure intensity by type of occupational questionnaire and type of rater. Ann Occup Hyg  55, 601-11.   https://doi.org/10.1093/annhyg/mer019|2. Friesen MC, Coble JB, Lu W, Shu XO, Ji BT, Xue S, Portengen L, Chow WH, Gao YT, Yang G, Rothman N, Vermeulen R (2012). Combining a job-exposure matrix with exposure measurements to assess occupational exposure to benzene in a population cohort in shanghai, china. Ann Occup Hyg  56, 80-91.   https://doi.org/10.1093/annhyg/mer080",https://intramural.nih.gov/search/searchview.taf?ipid=73957
680,CP010123-17,"October 01, 2011 -  September 30, 2012",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| | |Melissa Charmaine Friesen|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  |Jay  Lubin; PhD| |Lee Elizabeth Moore; PhD, MD| | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Bu Tian  Ji|Nicole Cardello Deziel",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, Deng X, Shrubsole MJ, Murff H, Milne G, Zheng W, Dai Q (2011). Obesity, age, and oxidative stress in middle-aged and older women. Antioxid Redox Signal  14, 2453-60.   https://doi.org/10.1089/ars.2010.3337|2. Dorjgochoo T, Ou Shu X, Xiang YB, Yang G, Cai Q, Li H, Ji BT, Cai H, Gao YT, Zheng W (2012). Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies. Br J Nutr  108, 449-58.   https://doi.org/10.1017/S0007114511005745|3. Moore LE, Pfeiffer RM, Zhang Z, Lu KH, Fung ET, Bast RC (2012). Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer  118, 91-100.   https://doi.org/10.1002/cncr.26241|4. Takata Y, Cai Q, Beeghly-Fadiel A, Li H, Shrubsole MJ, Ji BT, Yang G, Chow WH, Gao YT, Zheng W, Shu XO (2012). Dietary B vitamin and methionine intakes and lung cancer risk among female never smokers in China. Cancer Causes Control  23, 1965-75.   https://doi.org/10.1007/s10552-012-0074-z|5. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner A, Johnson A, Jones M, Kida M, Schwenn M, Schned AR, Silverman DT, Rothman N, Moore LE (2012). Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev  21, 1143-8.   https://doi.org/10.1158/1055-9965.EPI-11-1030",https://intramural.nih.gov/search/searchview.taf?ipid=73960
681,CP010124-17,"October 01, 2011 -  September 30, 2012",Cervical cancer and human papillomavirus (HPV) infection,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD|Lauren  Wilson; PhD|Vikrant Vasant Sahasrabuddhe|Hannah  Yang,Robert  Burk (Albert Einstein College of Medicine)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Andrew  Glass (Kaiser Permanente)|Cosette  Wheeler (University of New Mexico)|Show all 27,Sholom  Wacholder; PhD (Biostatistics Branch)|Julia  Gage (Clinical Genetics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)|Arpita  Ghosh (Biostatistics Branch)|Joshua Neil Sampson (Biostatistics Branch),NULL,"1. Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J (2012). EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer  131, 1969-82.   https://doi.org/10.1002/ijc.27650|2. Arbyn M, Roelens J, Martin-Hirsch P, Leeson S, Wentzensen N (2011). Use of HC2 to triage women with borderline and mild dyskaryosis in the UK. Br J Cancer  105, 877-80.   https://doi.org/10.1038/bjc.2011.351|3. Roelens J, Reuschenbach M, von Knebel Doeberitz M, Wentzensen N, Bergeron C, Arbyn M (2012). p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol  120, 294-307.   https://doi.org/10.1002/cncy.21205|4. Sahasrabuddhe VV, Luhn P, Wentzensen N (2011). Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol  6, 1083-98.   https://doi.org/10.2217/fmb.11.87|5. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH (2012). Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila)  5, 11-7.   https://doi.org/10.1158/1940-6207.CAPR-11-0540|6. van der Marel J, Quint WG, Schiffman M, van de Sandt MM, Zuna RE, Dunn ST, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N (2012). Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer  131, E946-53.   https://doi.org/10.1002/ijc.27532|7. Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS (2012). Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol  50, 1564-70.   https://doi.org/10.1128/JCM.06240-11|8. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M (2012). Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res  18, 4154-62.   https://doi.org/10.1158/1078-0432.CCR-12-0270|9. Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS (2013). Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer  132, 148-54.   https://doi.org/10.1002/ijc.27577|10. Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R, Long R, Wang SS, Wentzensen N (2012). Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One  7, e29051.   https://doi.org/10.1371/journal.pone.0029051|11. Zuna RE, Tuller E, Wentzensen N, Mathews C, Allen RA, Shanesmith R, Dunn ST, Gold MA, Wang SS, Walker J, Schiffman M (2011). HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infect Agent Cancer  6, 19.   https://doi.org/10.1186/1750-9378-6-19",https://intramural.nih.gov/search/searchview.taf?ipid=73952
682,CP010125-17,"October 01, 2011 -  September 30, 2012",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Debra  Silverman; ScD, ScM|Michael  Alavanja; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Show all 12",James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|Manolis  Kogevinas|John  Reif (Colorado State University)|John W Brock (CDC)|Michele  Lynberg (Centers for Disease Control and Prevention)|Show all 27,"Shelia K Zahm; ScM, ScD (Office of the Director)|Jay  Lubin; PhD (Biostatistics Branch)",NULL,"1. Aschebrook-Kilfoy B, Heltshe SL, Nuckols JR, Sabra MM, Shuldiner AR, Mitchell BD, Airola M, Holford TR, Zhang Y, Ward MH (2012). Modeled nitrate levels in well water supplies and prevalence of abnormal thyroid conditions among the Old Order Amish in Pennsylvania. Environ Health  11, 6.   https://doi.org/10.1186/1476-069X-11-6|2. Baris D, Karagas MR, Koutros S, Colt JS, Johnson A, Schwenn M, Fischer AH, Figueroa JD, Berndt SI, Han S, Beane Freeman LE, Lubin JH, Cherala S, Cantor KP, Jacobs K, Chanock S, Chatterjee N, Rothman N, Silverman DT (2013). Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Int J Cancer  132, 162-73.   https://doi.org/10.1002/ijc.27590|3. Gunier RB, Ward MH, Airola M, Bell EM, Colt J, Nishioka M, Buffler PA, Reynolds P, Rull RP, Hertz A, Metayer C, Nuckols JR (2011). Determinants of agricultural pesticide concentrations in carpet dust. Environ Health Perspect  119, 970-6.   https://doi.org/10.1289/ehp.1002532|4. Inoue-Choi M, Ward MH, Cerhan JR, Weyer PJ, Anderson KE, Robien K (2012). Interaction of nitrate and folate on the risk of breast cancer among postmenopausal women. Nutr Cancer  64, 685-94.   https://doi.org/10.1080/01635581.2012.687427|5. Koutros S, Silverman DT, Baris D, Zahm SH, Morton LM, Colt JS, Hein DW, Moore LE, Johnson A, Schwenn M, Cherala S, Schned A, Doll MA, Rothman N, Karagas MR (2011). Hair dye use and risk of bladder cancer in the New England bladder cancer study. Int J Cancer  129, 2894-904.   https://doi.org/10.1002/ijc.26245|6. Lenz P, Pfeiffer R, Baris D, Schned AR, Takikita M, Poscablo MC, Schwenn M, Johnson A, Jones M, Kida M, Cantor KP, Rothman N, Silverman DT, Hewitt SM, Moore LE (2012). Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev  21, 1555-64.   https://doi.org/10.1158/1055-9965.EPI-12-0261|7. Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N (2011). GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis  32, 182-9.   https://doi.org/10.1093/carcin/bgq223|8. Nuckols JR, Freeman LE, Lubin JH, Airola MS, Baris D, Ayotte JD, Taylor A, Paulu C, Karagas MR, Colt J, Ward MH, Huang AT, Bress W, Cherala S, Silverman DT, Cantor KP (2011). Estimating water supply arsenic levels in the New England Bladder Cancer Study. Environ Health Perspect  119, 1279-85.   https://doi.org/10.1289/ehp.1002345|9. Pronk A, Stewart PA, Coble JB, Katki HA, Wheeler DC, Colt JS, Baris D, Schwenn M, Karagas MR, Johnson A, Waddell R, Verrill C, Cherala S, Silverman DT, Friesen MC (2012). Comparison of two expert-based assessments of diesel exhaust exposure in a case-control study: programmable decision rules versus expert review of individual jobs. Occup Environ Med  69, 752-8.   https://doi.org/10.1136/oemed-2011-100524|10. Schned AR, Lenz P, Moore LE, Johnson A, Jones M, Kida M, Silverman DT, Schwenn M, Kelsey KT, Andrew AS, Baris D, Karagas MR (2012). Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004. ISRN Pathol  2012.   https://doi.org/10.5402/2012/283670|11. Slusky DA, Metayer C, Aldrich MC, Ward MH, Lea CS, Selvin S, Buffler PA (2012). Reliability of maternal-reports regarding the use of household pesticides: experience from a case-control study of childhood leukemia. Cancer Epidemiol  36, 375-80.   https://doi.org/10.1016/j.canep.2011.12.009|12. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner A, Johnson A, Jones M, Kida M, Schwenn M, Schned AR, Silverman DT, Rothman N, Moore LE (2012). Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev  21, 1143-8.   https://doi.org/10.1158/1055-9965.EPI-11-1030|13. Whitehead TP, Nuckols JR, Ward MH, Rappaport SM (2012). Carpet-dust chemicals as measures of exposure: Implications of variability. Emerg Themes Epidemiol  9, 2.   https://doi.org/10.1186/1742-7622-9-2",https://intramural.nih.gov/search/searchview.taf?ipid=73965
683,CP010126-17,"October 01, 2011 -  September 30, 2012",Hormone-Related Cancers,Michael Blaise Cook|IRP Faculty Profile  |Jonine Danya Figueroa| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD|Roni T Falk|Britton Lindsay Trabert|Hannah  Yang|Barbara J Fuhrman|Sarah Jane Nyante,David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|Jolanta  Lissowsaka (Maria Sklodowsak-Curie Memorial Cancer Center)|Show all 11,"Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Brinton LA, Schwartz L, Spitz MR, Park Y, Hollenbeck AR, Gierach GL (2012). Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control  23, 487-96.   https://doi.org/10.1007/s10552-012-9904-2|2. Collaborative Group on Hormonal Factors in Breast Cancer (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol  13, 1141-51.|3. Cook MB, Chia VM, Berndt SI, Graubard BI, Chanock SJ, Rubertone MV, Erickson RL, Hayes RB, McGlynn KA (2011). Genetic contributions to the association between adult height and testicular germ cell tumors. Int J Epidemiol  40, 731-9.   https://doi.org/10.1093/ije/dyq260|4. Dallal CM, Brinton LA, Matthews CE, Lissowska J, Peplonska B, Hartman TJ, Gierach GL (2012). Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat  134, 1279-90.   https://doi.org/10.1007/s10549-012-2129-y|5. Dewdney SB, Kizer NT, Andaya AA, Babb SA, Luo J, Mutch DG, Schmidt AP, Brinton LA, Broaddus RR, Ramirez NC, Huettner PC, McMeekin DS, Darcy K, Ali S, Judson PL, Mannel RS, Lele SB, O'Malley DM, Goodfellow PJ (2012). Uterine serous carcinoma: increased familial risk for lynch-associated malignancies. Cancer Prev Res (Phila)  5, 435-43.   https://doi.org/10.1158/1940-6207.CAPR-11-0499|6. Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hultén K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W, Hankinson SE (2012). Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst  104, 1905-16.   https://doi.org/10.1093/jnci/djs461|7. Enewold L, Zhou J, Devesa SS, Erickson RL, Zhu K, McGlynn KA (2011). Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003. Mil Med  176, 1184-7.   https://doi.org/10.7205/milmed-d-10-00476|8. Enewold L, Zhou J, McGlynn KA, Devesa SS, Shriver CD, Potter JF, Zahm SH, Zhu K (2012). Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries. Cancer  118, 1397-403.   https://doi.org/10.1002/cncr.26208|9. Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, Karn T, Broeks A, van Leeuwen FE, van't Veer LJ, Udo R, Dunning AM, Greco D, Aittomäki K, Blomqvist C, Shah M, Nordestgaard BG, Flyger H, Hopper JL, Southey MC, Apicella C, Garcia-Closas M, Sherman M, Lissowska J, Seynaeve C, Huijts PE, kConFab Investigators, et al. [73 more authors] (2012). The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet  21, 3926-39.   https://doi.org/10.1093/hmg/dds159|10. Fuhrman BJ, Brinton LA, Pfeiffer RM, Xu X, Veenstra TD, Teter BE, Byrne C, Dallal CM, Barba M, Muti PC, Gierach GL (2012). Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev  21, 1582-91.   https://doi.org/10.1158/1055-9965.EPI-12-0247|11. Gaudet MM, Falk RT, Stevens RD, Gunter MJ, Bain JR, Pfeiffer RM, Potischman N, Lissowska J, Peplonska B, Brinton LA, Garcia-Closas M, Newgard CB, Sherman ME (2012). Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocrinol Metab  97, 3216-23.   https://doi.org/10.1210/jc.2012-1490|12. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Hall P, Czene K, Irwanto A, Familial Breast Cancer Study (FBCS), Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, kConFab Investigators, Australian Ovarian Cancer Study Group, et al. [153 more authors] (2012). Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet  44, 312-8.   https://doi.org/10.1038/ng.1049|13. Grouls S, Iglesias DM, Wentzensen N, Moeller MJ, Bouchard M, Kemler R, Goodyer P, Niggli F, Gröne HJ, Kriz W, Koesters R (2012). Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol  23, 63-72.   https://doi.org/10.1681/ASN.2010121257|14. Healey CS, Ahmed S, ANECS, AOCS Management Group, O'Mara TA, Ferguson K, LES, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, NSECG, Howarth K, Gorman M, Hodgson S, Tomlinson I, PECS, Yang HP, Lissowska J, Brinton LA, Chanock S, Garcia-Closas M, SASBAC, Hall P, Liu J, SEARCH, Shah M, Pharoah PD, Thompson DJ, WISE, Rebbeck TR, Strom BL, Dunning AM, et al. [2 more authors] (2011). Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis  32, 1862-6.   https://doi.org/10.1093/carcin/bgr214|15. Kim C, McGlynn KA, McCorkle R, Li Y, Erickson RL, Ma S, Niebuhr DW, Zhang G, Zhang Y, Bai Y, Dai L, Graubard BI, Zheng T, Aschebrook-Kilfoy B, Barry KH, Zhang Y (2012). Sexual functioning among testicular cancer survivors: a case-control study in the U.S. J Psychosom Res  73, 68-73.   https://doi.org/10.1016/j.jpsychores.2012.02.011|16. Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T, GENICA Network, Chang-Claude J, Investigators kConFab, Australian Ovarian Cancer Study Group, et al. [124 more authors] (2012). 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat  33, 1123-32.   https://doi.org/10.1002/humu.22089|17. Liu J, Cai ZQ, Wang Y, Li CY, Xu LF (2012) 1-(2,4-Dichloro-phen-yl)-5-(2-nitro-anilino)-1H-pyrazole-4-carbonitrile. Acta Crystallogr Sect E Struct Rep Online 68:o1142|18. Long J, Zheng W, Xiang YB, Lose F, Thompson D, Tomlinson I, Yu H, Wentzensen N, Lambrechts D, Dörk T, Dubrowinskaja N, Goodman MT, Salvesen HB, Fasching PA, Scott RJ, Delahanty R, Zheng Y, O'Mara T, Healey CS, Hodgson S, Risch H, Yang HP, Amant F, Turmanov N, Schwake A, et al. [33 more authors] (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev  21, 980-7.   https://doi.org/10.1158/1055-9965.EPI-11-1160|19. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, HEBON, EMBRACE, GEMO Study Collaborators, kConFab Investigators, SWE-BRCA Collaborators, Consortium of Investigators of Modifiers of BRCA1/2, et al. [108 more authors] (2012). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev  21, 134-47.   https://doi.org/10.1158/1055-9965.EPI-11-0775|20. McGlynn KA, Trabert B (2012). Adolescent and adult risk factors for testicular cancer. Nat Rev Urol  9, 339-49.   https://doi.org/10.1038/nrurol.2012.61|21. Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, Benítez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, GENICA Network, kConFab Investigators, AOCS Group, et al. [118 more authors] (2011). Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev  20, 2222-31.   https://doi.org/10.1158/1055-9965.EPI-11-0569|22. Milne RL, Lorenzo-Bermejo J, Burwinkel B, Malats N, Arias JI, Zamora MP, Benítez J, Humphreys MK, García-Closas M, Chanock SJ, Lissowska J, Sherman ME, Mannermaa A, Kataja V, Kosma VM, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Anton-Culver H, Ziogas A, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, AOCS Group, GENICA Network, et al. [59 more authors] (2011). 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet  48, 698-702.   https://doi.org/10.1136/jmedgenet-2011-100303|23. Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD (2011). Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res  13, R42.   https://doi.org/10.1186/bcr2864|24. Nyante SJ, Graubard BI, Li Y, McQuillan GM, Platz EA, Rohrmann S, Bradwin G, McGlynn KA (2012). Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004. Int J Androl  35, 456-66.   https://doi.org/10.1111/j.1365-2605.2011.01230.x|25. O'Mara TA, Ferguson K, Fahey P, Marquart L, Yang HP, Lissowska J, Chanock S, Garcia-Closas M, Thompson DJ, Healey CS, Dunning AM, Easton DF, ANECS, Webb PM, Spurdle AB (2011). CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk. Twin Res Hum Genet  14, 328-32.   https://doi.org/10.1375/twin.14.4.328|26. Persson EC, Quraishi SM, Welzel TM, Carreon JD, Gridley G, Graubard BI, McGlynn KA (2012). Risk of liver cancer among US male veterans with cirrhosis, 1969-1996. Br J Cancer  107, 195-200.   https://doi.org/10.1038/bjc.2012.193|27. Scollen S, Luccarini C, Baynes C, Driver K, Humphreys MK, Garcia-Closas M, Figueroa J, Lissowska J, Pharoah PD, Easton DF, Hesketh R, Metcalfe JC, Dunning AM (2011). TGF-β signaling pathway and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev  20, 1112-9.   https://doi.org/10.1158/1055-9965.EPI-11-0062|28. Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Australian National Endometrial Cancer Study Group, et al. [18 more authors] (2012). Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol  176, 269-78.   https://doi.org/10.1093/aje/kws129|29. Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM (2012). The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the ""molecular histology"" of the breast. Cancer Prev Res (Phila)  5, 528-35.   https://doi.org/10.1158/1940-6207.CAPR-11-0234|30. Sherman ME, Guido R, Wentzensen N, Yang HP, Mai PL, Greene MH (2012). New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research. Gynecol Oncol  127, 645-50.   https://doi.org/10.1016/j.ygyno.2012.08.023|31. Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, McGlynn KA (2012). Burden of extragonadal germ cell tumours in Europe and the United States. Eur J Cancer  48, 1116-7.   https://doi.org/10.1016/j.ejca.2012.02.061|32. Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, McGlynn KA (2012). Gonadal and extragonadal germ cell tumours in the United States, 1973-2007. Int J Androl  35, 616-25.   https://doi.org/10.1111/j.1365-2605.2011.01245.x|33. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, Nickels S, Brauch H, GENICA Network, Ko YD, Fischer HP, Schmutzler RK, Meindl A, Bartram CR, Schott S, Engel C, Godwin AK, kConFab Investigators, AOCS Group, et al. [129 more authors] (2012). 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res  72, 1795-803.   https://doi.org/10.1158/0008-5472.CAN-11-3364|34. Trabert B, Graubard BI, Erickson RL, McGlynn KA (2012). Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data. Br J Cancer  106, 1331-4.   https://doi.org/10.1038/bjc.2012.45|35. Trabert B, Longnecker MP, Brock JW, Klebanoff MA, McGlynn KA (2012). Maternal pregnancy levels of trans-nonachlor and oxychlordane and prevalence of cryptorchidism and hypospadias in boys. Environ Health Perspect  120, 478-82.   https://doi.org/10.1289/ehp.1103936|36. Trabert B, Sigurdson AJ, Sweeney AM, Amato RJ, Strom SS, McGlynn KA (2011). Baldness, acne and testicular germ cell tumours. Int J Androl  34, e59-67.   https://doi.org/10.1111/j.1365-2605.2010.01125.x|37. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, et al. [51 more authors] (2012). Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev  21, 1156-66.   https://doi.org/10.1158/1055-9965.EPI-12-0066|38. Welsh AW, Lannin DR, Young GS, Sherman ME, Figueroa JD, Henry NL, Ryden L, Kim C, Love RR, Schiff R, Rimm DL (2012). Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res  18, 118-26.   https://doi.org/10.1158/1078-0432.CCR-11-1236|39. White KL, Schildkraut JM, Palmieri RT, Iversen ES, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Phelan CM, Cunningham JM, Fridley BL, Sellers TA, Goode EL, Ovarian Cancer Association Consortium (2012). Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Res  72, 1064-9.   https://doi.org/10.1158/0008-5472.CAN-11-3512|40. Wishart GC, Bajdik CD, Dicks E, Provenzano E, Schmidt MK, Sherman M, Greenberg DC, Green AR, Gelmon KA, Kosma VM, Olson JE, Beckmann MW, Winqvist R, Cross SS, Severi G, Huntsman D, Pylkäs K, Ellis I, Nielsen TO, Giles G, Blomqvist C, Fasching PA, Couch FJ, Rakha E, Foulkes WD, et al. [12 more authors] (2012). PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer  107, 800-7.   https://doi.org/10.1038/bjc.2012.338",https://intramural.nih.gov/search/searchview.taf?ipid=73966
684,CP010127-17,"October 01, 2011 -  September 30, 2012",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager M, Hayes RB, Gunter MJ (2011). Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila)  4, 1465-75.   https://doi.org/10.1158/1940-6207.CAPR-11-0103|2. Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, Xue X, Schoen R, Limburg PJ, Schatzkin A, Sinha R, Hayes RB (2011). A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev  20, 537-44.   https://doi.org/10.1158/1055-9965.EPI-10-1099|3. Moore SC, Gunter MJ, Daniel CR, Reddy KS, George PS, Yurgalevitch S, Devasenapathy N, Ramakrishnan L, Chatterjee N, Chanock SJ, Berndt SI, Mathew A, Prabhakaran D, Sinha R (2012). Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring)  20, 1902-8.   https://doi.org/10.1038/oby.2011.238",https://intramural.nih.gov/search/searchview.taf?ipid=73984
685,CP010128-17,"October 01, 2011 -  September 30, 2012",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Carolyn  Westhoff (Columbia University School of Public Health)|Show all 8,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Catherine G Schairer (Biostatistics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Jay  Lubin; PhD (Biostatistics Branch)|Michael Fred Leitzmann (Nutritional Epidemiology Branch)",NULL,"1. Brinton LA (2012). Breast cancer risk after use of fertility drugs: stimulating new controversy. J Natl Cancer Inst  104, 962-4.   https://doi.org/10.1093/jnci/djs275|2. Brinton LA, Sahasrabuddhe VV, Scoccia B (2012) Fertility drugs and the risk of breast and gynecologic cancers. Semin Reprod Med 30:131-145.",https://intramural.nih.gov/search/searchview.taf?ipid=73967
686,CP010131-17,"October 01, 2011 -  September 30, 2012",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 14",David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Bhagia P, Colanta AB, Abramson DH, Carlson DL, Kleinerman RA, Kraus D, Dunkel IJ (2011). Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors. Pediatr Blood Cancer  57, 693-5.   https://doi.org/10.1002/pbc.23161|2. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM (2012). Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood  119, 34-43.   https://doi.org/10.1182/blood-2011-04-347872|3. Francis JH, Kleinerman RA, Seddon JM, Abramson DH (2012). Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol  124, 254-9.   https://doi.org/10.1016/j.ygyno.2011.10.019|4. Kim KP, Miller DL, Berrington de Gonzalez A, Balter S, Kleinerman RA, Ostroumova E, Simon SL, Linet MS (2012). Occupational radiation doses to operators performing fluoroscopically-guided procedures. Health Phys  103, 80-99.   https://doi.org/10.1097/HP.0b013e31824dae76|5. Kleinerman RA, Yu CL, Little MP, Li Y, Abramson D, Seddon J, Tucker MA (2012). Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol  30, 950-7.   https://doi.org/10.1200/JCO.2011.37.0239|6. Mills MB, Hudgins L, Balise RR, Abramson DH, Kleinerman RA (2012). Mutation risk associated with paternal and maternal age in a cohort of retinoblastoma survivors. Hum Genet  131, 1115-22.   https://doi.org/10.1007/s00439-011-1126-2|7. Neta G, Anderson WF, Gilbert E, Berrington A (2012). Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER. Breast Cancer Res Treat  131, 1021-7.   https://doi.org/10.1007/s10549-011-1820-8",https://intramural.nih.gov/search/searchview.taf?ipid=73968
687,CP010132-17,"October 01, 2011 -  September 30, 2012",Studies of Populations Exposed to Environmental Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Steven L Simon|Alina V Brenner|Maureen Cusack Hatch; MD|Daryl  Freedman|Alice  Sigurdson; PhD|Amy  de Gonzalez,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, Lubin JH, Zablotska LB, Tereschenko VP, McConnell RJ, Zamotaeva GA, O'Kane P, Bouville AC, Chaykovskaya LV, Greenebaum E, Paster IP, Shpak VM, Ron E (2011). I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect  119, 933-9.   https://doi.org/10.1289/ehp.1002674|2. Drozdovitch V, Schonfeld S, Akimzhanov K, Aldyngurov D, Land CE, Luckyanov N, Mabuchi K, Potischman N, Schwerin MJ, Semenova Y, Tokaeva A, Zhumadilov Z, Bouville A, Simon SL (2011). Behavior and food consumption pattern of the population exposed in 1949-1962 to fallout from Semipalatinsk nuclear test site in Kazakhstan. Radiat Environ Biophys  50, 91-103.   https://doi.org/10.1007/s00411-010-0334-9|3. Gerstenblith MR, Rajaraman P, Khaykin E, Doody MM, Alexander BH, Linet MS, Freedman DM (2012). Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int J Cancer  131, E149-55.   https://doi.org/10.1002/ijc.26480|4. Hatch M, Polyanskaya O, McConnell R, Gong Z, Drozdovitch V, Rozhko A, Prokopovich A, Petrenko S, Brenner A, Zablotska L (2011). Urinary Iodine and Goiter Prevalence in Belarus: experience of the Belarus-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl nuclear accident. Thyroid  21, 429-37.   https://doi.org/10.1089/thy.2010.0143|5. Nadyrov E, Rozhko A, Kravtsov V, Mabuchi K, Hatch M, Nakamura N, Nikonovich S, Aleksanin S (2012). Karyopathological traits of thyrocytes and exposure to radioiodines in Belarusian children and adolescents following the accident at the Chernobyl nuclear power plant. Radiat Environ Biophys  51, 187-93.   https://doi.org/10.1007/s00411-012-0407-z|6. Simon SL, Coleman CN, Noska MA, Bowman T (2012). RESPONSE OF THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES IN PROTECTING CIVILIAN AMERICANS IN JAPAN DURING THE FUKUSHIMA NUCLEAR CRISIS. Health Phys  102.   https://doi.org/10.1097/HP.0b013e31824c79e5|7. Tronko M, Mabuchi K, Bogdanova T, Hatch M, Likhtarev I, Bouville A, Oliynik V, McConnell R, Shpak V, Zablotska L, Tereshchenko V, Zamotayeva G, Brenner A (2012) Thyroid Cancer in Ukraine after the Chernobyl Accident (in the Framework of Ukraine U.S. Thyroid Project). Journal of Radiological Protector 32:N65-9|8. Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, Brenner AV, Lubin J, Romanov GN, McConnell RJ, O'Kane P, Evseenko VV, Drozdovitch VV, Luckyanov N, Minenko VF, Bouville A, Masyakin VB (2011). Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer  104, 181-7.   https://doi.org/10.1038/sj.bjc.6605967",https://intramural.nih.gov/search/searchview.taf?ipid=73953
688,CP010133-17,"October 01, 2011 -  September 30, 2012",Studies of Populations Exposed to Occupational Sources of Radiation,"Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Peter D Inskip; ScD|Alice  Sigurdson; PhD|Steven L Simon|Show all 8,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Lamart S, Bouville A, Simon SL, Eckerman KF, Melo D, Lee C (2011). Comparison of internal dosimetry factors for three classes of adult computational phantoms with emphasis on I-131 in the thyroid. Phys Med Biol  56, 7317-35.   https://doi.org/10.1088/0031-9155/56/22/020|2. Neta G, Brenner AV, Sturgis EM, Pfeiffer RM, Hutchinson AA, Aschebrook-Kilfoy B, Yeager M, Xu L, Wheeler W, Abend M, Ron E, Tucker MA, Chanock SJ, Sigurdson AJ (2011). Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis  32, 1231-7.   https://doi.org/10.1093/carcin/bgr100|3. Neta G, Yu CL, Brenner A, Gu F, Hutchinson A, Pfeiffer R, Sturgis EM, Xu L, Linet MS, Alexander BH, Chanock S, Sigurdson AJ (2012). Common genetic variants in the 8q24 region and risk of papillary thyroid cancer. Laryngoscope  122, 1040-2.   https://doi.org/10.1002/lary.23209",https://intramural.nih.gov/search/searchview.taf?ipid=73969
689,CP010134-17,"October 01, 2011 -  September 30, 2012",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",NULL,"Dale  Preston (Hirosoft)|Shoji  Tokuoka (Radiation Effects Research Foundation)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Kyoji  Furukawa; PhD|Kotaro  Ozasa (Radiation Effects Research Foundation)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Show all 10",NULL,NULL,"1. Douple EB, Mabuchi K, Cullings HM, Preston DL, Kodama K, Shimizu Y, Fujiwara S, Shore RE (2011). Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med Public Health Prep  5 Suppl 1, S122-33.   https://doi.org/10.1001/dmp.2011.21",https://intramural.nih.gov/search/searchview.taf?ipid=73995
690,CP010135-17,"October 01, 2011 -  September 30, 2012",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile  |Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Preetha  Rajaraman|Daryl  Freedman|Alice  Sigurdson; PhD|Gila I Neta|Mark Peter Little|Show all 7,"Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Howard  Fine (Neuro-Oncology Branch, National Cancer Institute)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Show all 13",Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Susan Shaw Devesa (Biostatistics Branch),NULL,"1. Bassig BA, Inskip PD, Burdette L, Shapiro WR, Selker RG, Fine HA, Loeffler JS, Black PM, Dubrow R, Brenner AV (2011). Selected human leukocyte antigen class II polymorphisms and risk of adult glioma. J Neuroimmunol  233, 185-91.   https://doi.org/10.1016/j.jneuroim.2010.11.005|2. Schüz J, Grell K, Kinsey S, Linet MS, Link MP, Mezei G, Pollock BH, Roman E, Zhang Y, McBride ML, Johansen C, Spix C, Hagihara J, Saito AM, Simpson J, Robison LL, Dockerty JD, Feychting M, Kheifets L, Frederiksen K (2012). Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. Blood Cancer J  2, e98.   https://doi.org/10.1038/bcj.2012.43",https://intramural.nih.gov/search/searchview.taf?ipid=73970
691,CP010136-17,"October 01, 2011 -  September 30, 2012",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Dalsu  Baris|Joanne S Colt|Mary Helen Ward; MS, PhD|Joseph B Coble|Claudine M Samanic|Show all 12",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)",NULL,"1. Beebe-Dimmer JL, Colt JS, Ruterbusch JJ, Keele GR, Purdue MP, Wacholder S, Graubard BI, Davis F, Chow WH, Schwartz KL (2012). Body mass index and renal cell cancer: the influence of race and sex. Epidemiology  23, 821-8.   https://doi.org/10.1097/EDE.0b013e31826b7fe9|2. Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, et al. [7 more authors] (2012). Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol  23, 1880-8.   https://doi.org/10.1093/annonc/mdr541|3. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P (2012). Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol  23, 2964-70.   https://doi.org/10.1093/annonc/mds140|4. Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, McCarthy BJ, Savage SA, Wacholder S, Rothman N, Graubard BI, Colt JS, Chow WH, Purdue MP (2011). Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer  105, 1772-5.   https://doi.org/10.1038/bjc.2011.444|5. Hofmann JN, Törner A, Chow WH, Ye W, Purdue MP, Duberg AS (2011). Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev  20, 326-30.   https://doi.org/10.1097/CEJ.0b013e32834572fa|6. Hosgood HD, Vermeulen R, Wei H, Reiss B, Coble J, Wei F, Jun X, Wu G, Rothman N, Lan Q (2012). Combustion-derived nanoparticle exposure and household solid fuel use in Xuanwei and Fuyuan, China. Int J Environ Health Res  22, 571-81.   https://doi.org/10.1080/09603123.2012.684147|7. Karami S, Colt JS, Schwartz K, Davis FG, Ruterbusch JJ, Munuo SS, Wacholder S, Stewart PA, Graubard BI, Rothman N, Chow WH, Purdue MP (2012). A case-control study of occupation/industry and renal cell carcinoma risk. BMC Cancer  12, 344.   https://doi.org/10.1186/1471-2407-12-344|8. Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Gao YT, Negri E, Hassan M, Cotterchio M, Su J, Maisonneuve P, et al. [2 more authors] (2012). Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol  23, 374-82.   https://doi.org/10.1093/annonc/mdr120|9. Purdue MP, Colt JS, Graubard B, Davis F, Ruterbusch JJ, Digaetano R, Karami S, Wacholder S, Schwartz K, Chow WH (2011). A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States. Cancer Causes Control  22, 1537-44.   https://doi.org/10.1007/s10552-011-9830-8|10. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, Yang AS, Vokonas P, Lissowska J, Fustinoni S, Pesatori AC, Bonzini M, Apostoli P, Costa G, Bertazzi PA, Chow WH, Schwartz J, Baccarelli A (2012). Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol  41, 126-39.   https://doi.org/10.1093/ije/dyq154",https://intramural.nih.gov/search/searchview.taf?ipid=73971
692,CP010142-14,"October 01, 2011 -  September 30, 2012",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Clinical Genetics Branch, NCI",Lisa  Mirabello|Rebecca  Troisi,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Michael  Pollak (McGill University)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Chester  Douglass (Harvard School of Dentistry),Ying  Gao (Genetic Epidemiology Branch)|Kenneth  Buetow; PhD (Center For Biomedical Informatics & Information Technology)|Meredith  Yeager (Office of the Director),NULL,"1. Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen R, Church T, Hayes R, Greene M, Berndt S (2012) Circulating Levels of Insulin-like Growth Factor (IGF)-1, IGF-2 and IGF Binding Protein (BP)-3 and Prevalence of Advanced Colorectal Adenoma in a Colorectal Cancer Early Detection Trial. International Journal of Cancer 131:E105-E113",https://intramural.nih.gov/search/searchview.taf?ipid=73972
693,CP010144-14,"October 01, 2011 -  September 30, 2012",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  |Christian Peter Kratz| |Jennifer T Loud| |June  Peters| | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Sholom  Wacholder; PhD|Alexander  Pemov|Renee C Bremer|Gladys M. Glenn; MD, PhD|Hormuzdiar Aspandiar Katki; MS|Show all 7",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|Lawrence  Einhorn (Indiana University Medical Center)|Show all 57,"Thomas  Fears; PhD (Genetic Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Margaret Anne Tucker (Human Genetics Program)","Jeffery P Struewing; MS, MD (NHGRI) |Pamela  Stratton; MD (NICHD)","1. Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA (2012). Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica  97, 353-9.   https://doi.org/10.3324/haematol.2011.055269|2. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H, SWE-BRCA, HEBON, EMBRACE, CEMO Study Collaborators, Breast Cancer Family Registry, kConFab investigators, CIMBA, et al. [154 more authors] (2011). Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet  20, 3304-21.   https://doi.org/10.1093/hmg/ddr226|3. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, Rosenquist R, Karlsson P, Nathanson K, Domchek S, Rebbeck T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Złowowcka-Perłowska E, CIMBA, SWE-BRCA, HEBON, EMBRACE, GEMO Collaborators Study, kConFab Investigators, et al. [156 more authors] (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res  14, R33.   https://doi.org/10.1186/bcr3121|4. Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM (2012). Correlates of tumor development in patients with myotonic dystrophy. J Neurol  259, 2161-6.   https://doi.org/10.1007/s00415-012-6476-8|5. de Vries Y, Lwiwski N, Levitus M, Kuyt B, Israels SJ, Arwert F, Zwaan M, Greenberg CR, Alter BP, Joenje H, Meijers-Heijboer H (2012). A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites. Anemia  2012, 865170.   https://doi.org/10.1155/2012/865170|6. Ewens KG, Jones MR, Ankener W, Stewart DR, Urbanek M, Dunaif A, Legro RS, Chua A, Azziz R, Spielman RS, Goodarzi MO, Strauss JF (2011). FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One  6, e16390.   https://doi.org/10.1371/journal.pone.0016390|7. Kratz CP, Bratslavsky G, Shi J (2011). The clinical utility of testicular cancer risk loci. Genome Med  3, 1.   https://doi.org/10.1186/gm215|8. Mai P, Wentzensen N, Greene M (2011) Challenges Related to Developing Serum-Based Biomarkers for Early Ovarian Cancer Detection. Cancer Prevention Research 4:303-306.|9. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, HEBON, EMBRACE, GEMO Study Collaborators, kConFab Investigators, SWE-BRCA Collaborators, Consortium of Investigators of Modifiers of BRCA1/2, et al. [108 more authors] (2012). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev  21, 134-47.   https://doi.org/10.1158/1055-9965.EPI-11-0775|10. Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi V, Capra F, Radice P, OCGN, HEBON, EMBRACE, GEMO Study Collaborators, BCFR, kConFab Investigators, Consortium of Investigators of Modifiers of BRCA1/2, et al. [128 more authors] (2011). Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst  103, 105-16.   https://doi.org/10.1093/jnci/djq494|11. Rochowski A, Olson SB, Alonzo TA, Gerbing RB, Lange BJ, Alter BP (2012). Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer  59, 922-4.   https://doi.org/10.1002/pbc.24168|12. Rochowski A, Rosenberg PS, Alonzo TA, Gerbing RB, Lange BJ, Alter BP (2012). Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy. Leuk Res  36, 29-31.   https://doi.org/10.1016/j.leukres.2011.09.009|13. Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM (2012). Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood  119, 3815-9.   https://doi.org/10.1182/blood-2011-08-375972",https://intramural.nih.gov/search/searchview.taf?ipid=73973
694,CP010145-13,"October 01, 2011 -  September 30, 2012",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  |Jennifer T Loud| |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",June  Peters|Michael E Stefanek,NULL,NULL,Paul Kj Han (NHGRI),"1. Freed M, De Zwart J, Loud J, El Khouli R, Myers K, Greene M, Duyn J, Badano A (2011) An anthropomorphic phantom for quantitative evaluation of breast MRI. Medical Physics 38:743.",https://intramural.nih.gov/search/searchview.taf?ipid=73974
695,CP010150-13,"October 01, 2011 -  September 30, 2012","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol|James Jerome Goedert; MD,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Neal David Freedman (Nutritional Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Bhatia K, Shiels MS, Berg A, Engels EA (2012). Sarcomas other than Kaposi sarcoma occurring in immunodeficiency:  interpretations from a systematic literature review. Curr Opin Oncol  24, 537-46.   https://doi.org/10.1097/CCO.0b013e328355e115|2. Chang CM, Warren JL, Engels EA (2012). Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults. Cancer  118, 5929-36.   https://doi.org/10.1002/cncr.27612|3. Engels EA, Preiksaitis J, Zingone A, Landgren O (2012). Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant  12, 1268-74.   https://doi.org/10.1111/j.1600-6143.2011.03954.x|4. Goedert JJ (2012). HIV-associated lung cancer:  ambiguities and challenges. AIDS  26, 1031-3.   https://doi.org/10.1097/QAD.0b013e3283522d94|5. Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA (2012). Increased risk of stomach and esophageal malignancies in people with AIDS. Gastroenterology  143, 943-950.e2.   https://doi.org/10.1053/j.gastro.2012.07.013|6. Sahasrabuddhe VV, Shiels MS, McGlynn KA, Engels EA (2012). The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer  118, 6226-33.   https://doi.org/10.1002/cncr.27694|7. Shebl FM, Engels EA, Goedert JJ (2012). Opportunistic intestinal infections and risk of colorectal cancer among people with AIDS. AIDS Res Hum Retroviruses  28, 994-99.   https://doi.org/10.1089/AID.2011.0185|8. Shebl FM, Warren JL, Eggers PW, Engels EA (2012). Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol  13, 65.   https://doi.org/10.1186/1471-2369-13-65|9. Shiels MS, Albanes D, Virtamo J, Engels EA (2011). Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev  20, 672-8.   https://doi.org/10.1158/1055-9965.EPI-10-1166|10. Shiels MS, Chaturvedi AK, Katki HA, Gochuico BR, Caporaso NE, Engels EA (2011). Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev  20, 2262-72.   https://doi.org/10.1158/1055-9965.EPI-11-0326|11. Shiels MS, Engels EA (2012). Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology. Cancer  118, 4869-76.   https://doi.org/10.1002/cncr.27454|12. Shiels MS, Engels EA, Shi J, Landi MT, Albanes D, Chatterjee N, Chanock SJ, Caporaso NE, Chaturvedi AK (2012). Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk. Cancer  118, 5630-6.   https://doi.org/10.1002/cncr.27605|13. Shiels MS, Landgren O, Costello R, Zingone A, Goedert JJ, Engels EA (2012). Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis  55, e103-8.   https://doi.org/10.1093/cid/cis692|14. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA (2011). Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst  103, 753-62.   https://doi.org/10.1093/jnci/djr076|15. Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA (2011). Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA  305, 1450-9.   https://doi.org/10.1001/jama.2011.396|16. Simard EP, Pfeiffer RM, Engels EA (2012). Mortality due to cancer among people with AIDS:  a novel approach using registry-linkage data and population attributable risk methods. AIDS  26, 1311-8.   https://doi.org/10.1097/QAD.0b013e328353f38e|17. Simard EP, Shiels MS, Bhatia K, Engels EA (2012). Long-term cancer risk among people diagnosed with AIDS during childhood. Cancer Epidemiol Biomarkers Prev  21, 148-54.   https://doi.org/10.1158/1055-9965.EPI-11-0823",https://intramural.nih.gov/search/searchview.taf?ipid=73975
696,CP010152-13,"October 01, 2011 -  September 30, 2012",PLCO Trial Etiologic and Early Marker Study,"Mark  Purdue|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Wen-Yi  Huang|Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Christine Dorothy Berg (Early Detection Research Group),NULL,"1. Cox DG, Dostal L, Hunter DJ, Le Marchand L, Hoover R, Ziegler RG, Thun MJ, Breast and Prostate Cancer Cohort Consortium (2011). N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium. Am J Epidemiol  174, 1316-22.   https://doi.org/10.1093/aje/kwr257|2. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, Buys SS, Isaacs C, Keefer LK, Veenstra TD, Berg CD, Hoover RN, Ziegler RG (2012). Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst  104, 326-39.   https://doi.org/10.1093/jnci/djr531|3. Huang WY, Su LJ, Hayes RB, Moore LE, Katki HA, Berndt SI, Weissfeld JL, Yegnasubramanian S, Purdue MP (2012). Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev  21, 2014-21.   https://doi.org/10.1158/1055-9965.EPI-12-0700-T|4. Meyer TE, Chu LW, Li Q, Yu K, Rosenberg PS, Menashe I, Chokkalingam AP, Quraishi SM, Huang WY, Weiss JM, Kaaks R, Hayes RB, Chanock SJ, Hsing AW (2012). The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. Prostate  72, 65-71.   https://doi.org/10.1002/pros.21407|5. Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P (2011). Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. PLoS One  6, e21731.   https://doi.org/10.1371/journal.pone.0021731",https://intramural.nih.gov/search/searchview.taf?ipid=73976
697,CP010158-12,"October 01, 2011 -  September 30, 2012",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Vikrant Vasant Sahasrabuddhe|Elna Christina Marianne Persson,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",Kelly Jen-Yi Yu (Early Detection Research Group),NULL,"1. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology  55, 476-82.   https://doi.org/10.1002/hep.24710|2. Chokkalingam AP, Yeboah ED, Demarzo A, Netto G, Yu K, Biritwum RB, Tettey Y, Adjei A, Jadallah S, Li Y, Chu LW, Chia D, Niwa S, Partin A, Thompson IM, Roehrborn C, Hoover RN, Hsing AW (2012). Prevalence of BPH and lower urinary tract symptoms in West Africans. Prostate Cancer Prostatic Dis  15, 170-6.   https://doi.org/10.1038/pcan.2011.43|3. Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, LaMere BJ, Schwartz L, Gage JC, Fetterman B, Lorey T, Wentzensen N (2013). Interrater agreement of anal cytology. Cancer Cytopathol  121, 72-8.   https://doi.org/10.1002/cncy.21218|4. Davila JA, Duan Z, McGlynn KA, El-Serag HB (2012). Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol  46, 71-7.   https://doi.org/10.1097/MCG.0b013e318224d669|5. Enewold L, Zhou J, McGlynn KA, Anderson WF, Shriver CD, Potter JF, Zahm SH, Zhu K (2012). Racial variation in breast cancer treatment among Department of Defense beneficiaries. Cancer  118, 812-20.   https://doi.org/10.1002/cncr.26346|6. Luo J, Chlebowski R, Liu S, McGlynn KA, Parekh N, White DL, Margolis KL (2013). Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control  24, 577-85.   https://doi.org/10.1007/s10552-012-9996-8|7. McGlynn KA, London WT (2011). The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis  15, 223-43, vii-x.   https://doi.org/10.1016/j.cld.2011.03.006|8. Persson EC, Graubard BI, Evans AA, London WT, Weber JP, LeBlanc A, Chen G, Lin W, McGlynn KA (2012). Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma. Int J Cancer  131, 2078-84.   https://doi.org/10.1002/ijc.27459|9. Persson EC, Sewram V, Evans AA, London WT, Volkwyn Y, Shen YJ, Van Zyl JA, Chen G, Lin W, Shephard GS, Taylor PR, Fan JH, Dawsey SM, Qiao YL, McGlynn KA, Abnet CC (2012). Fumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohorts. Food Chem Toxicol  50, 679-83.   https://doi.org/10.1016/j.fct.2011.11.029|10. Shebl FM, Capo-Ramos DE, Graubard BI, McGlynn KA, Altekruse SF (2012). Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiol Biomarkers Prev  21, 1330-5.   https://doi.org/10.1158/1055-9965.EPI-12-0124|11. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA (2011). Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology  54, 463-71.   https://doi.org/10.1002/hep.24397",https://intramural.nih.gov/search/searchview.taf?ipid=73977
698,CP010167-12,"October 01, 2011 -  September 30, 2012",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi|Patricia  Hartge; ScD,NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Kim FM, Hayes C, Williams PL, Whitford GM, Joshipura KJ, Hoover RN, Douglass CW, National Osteosarcoma Etiology Group (2011). An assessment of bone fluoride and osteosarcoma. J Dent Res  90, 1171-6.   https://doi.org/10.1177/0022034511418828",https://intramural.nih.gov/search/searchview.taf?ipid=73978
699,CP010168-12,"October 01, 2011 -  September 30, 2012",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 12",NULL,NULL,"1. Faupel-Badger JM, Wang Y, Staff AC, Karumanchi SA, Stanczyk FZ, Pollak M, Hoover RN, Troisi R (2012). Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies. Cancer Causes Control  23, 779-84.   https://doi.org/10.1007/s10552-012-9934-9|2. Troisi R, Altantsetseg D, Davaasambuu G, Rich-Edwards J, Davaalkham D, Tretli S, Hoover RN, Frazier AL (2012). Breast cancer incidence in Mongolia. Cancer Causes Control  23, 1047-53.   https://doi.org/10.1007/s10552-012-9973-2",https://intramural.nih.gov/search/searchview.taf?ipid=73979
700,CP010169-11,"October 01, 2011 -  September 30, 2012","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI","Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Patricia  Hartge; ScD|Hormuzdiar Aspandiar Katki; MS|Catherine G Schairer","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Ray  Greenberg (University of South Carolina)|Show all 11",Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73982
701,CP010170-12,"October 01, 2011 -  September 30, 2012",Multidisciplinary Studies of Hematopoietic Malignancies,Patricia  Hartge; ScD| | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Martha S Linet; PhD,"Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)|Anneclaire  De Roos (University of Washington, Seattle, WA)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Shelia K Zahm; ScM, ScD (Office of the Director)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)|Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, Dogan A, Wang SS (2012). LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leuk Lymphoma  53, 1105-12.   https://doi.org/10.3109/10428194.2011.638717|2. Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM (2011). Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  20, 42-9.   https://doi.org/10.1158/1055-9965.EPI-10-0638",https://intramural.nih.gov/search/searchview.taf?ipid=73980
702,CP010176-12,"October 01, 2011 -  September 30, 2012",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  |Denise  Whitby| | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Office Of The Director, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, North American AIDS Cohort Collaboration on Research and Design of IeDEA, et al. [1 more author] (2013). Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr  62, 405-13.   https://doi.org/10.1097/QAI.0b013e31828177d7|2. Aka P, Kawira E, Masalu N, Emmanuel B, Brubaker G, Magatti J, Mbulaiteye SM (2012). Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer  59, 1234-8.   https://doi.org/10.1002/pbc.24194|3. Baik S, Mbaziira M, Williams M, Ogwang MD, Kinyera T, Emmanuel B, Ziegler JL, Reynolds SJ, Mbulaiteye SM (2012). A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer  7, 5.   https://doi.org/10.1186/1750-9378-7-5|4. Emmanuel B, Ruder E, Lin SW, Abnet C, Hollenbeck A, Mbulaiteye S (2012). Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study. Ecancermedicalscience  6, 254.   https://doi.org/10.3332/ecancer.2012.254|5. Engels EA, Preiksaitis J, Zingone A, Landgren O (2012). Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant  12, 1268-74.   https://doi.org/10.1111/j.1600-6143.2011.03954.x|6. Guech-ongey M, Yagi M, Palacpac N, Emmanuel B, Stefan C, Talisuna A, Bhatia K, Biggar R, Nkrumah F, Neequaye J, Tougan T, Horii T, Mbulaiteye S (2011) Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. International Journal of Cancer 2011:N/A.|7. Mbulaiteye SM, Anderson WF, Ferlay J, Bhatia K, Chang C, Rosenberg PS, Devesa SS, Parkin DM (2012). Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol  87, 573-8.   https://doi.org/10.1002/ajh.23187|8. Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ (2011). HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer  6, 16.   https://doi.org/10.1186/1750-9378-6-16|9. Mbulaiteye SM, Goedert JJ (2011). Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies. J Infect Dis  203, 575-7.   https://doi.org/10.1093/infdis/jiq094|10. Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM (2011). Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med  135, 445-50.   https://doi.org/10.1043/2009-0443-EP.1|11. Shebl FM, Yu K, Landgren O, Goedert JJ, Rabkin CS (2012). Increased levels of circulating cytokines with HIV-related immunosuppression. AIDS Res Hum Retroviruses  28, 809-15.   https://doi.org/10.1089/AID.2011.0144",https://intramural.nih.gov/search/searchview.taf?ipid=73981
703,CP010180-11,"October 01, 2011 -  September 30, 2012",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi|Lisa Wey-Lan Chu,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73996
704,CP010181-10,"October 01, 2011 -  September 30, 2012",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Junmo  Nam,"Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Katherine  Flegal (Centers for Disease Control and Prevention)|Show all 12","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"1. Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell FA, Yasmeen S, Katki HA (2012). Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat  132, 347-53.   https://doi.org/10.1007/s10549-011-1900-9|2. Bhattacharjee S, Rajaraman P, Jacobs KB, Wheeler WA, Melin BS, Hartge P, GliomaScan Consortium, Yeager M, Chung CC, Chanock SJ, Chatterjee N (2012). A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am J Hum Genet  90, 821-35.   https://doi.org/10.1016/j.ajhg.2012.03.015|3. Ciampa J, Yeager M, Jacobs K, Thun MJ, Gapstur S, Albanes D, Virtamo J, Weinstein SJ, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Holmes C, Chatterjee N (2011). Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. Hum Hered  72, 182-93.   https://doi.org/10.1159/000331222|4. Ferguson J, Wheeler W, Fu Y, Prokunina-Olsson L, Zhao H, Sampson J (2013). Statistical tests for detecting associations with groups of genetic variants: generalization, evaluation, and implementation. Eur J Hum Genet  21, 680-6.   https://doi.org/10.1038/ejhg.2012.220|5. Gail M (2011) Personalized estimates of breast cancer risk in clinical practice and public health. STAT MED 30:1090-104.|6. Gail M (2012) The use of risk models for preventive interventions that have favorable and adverse effects. BIOMETRICS 31:2687-96|7. Ghosh A, Hartge P, Purdue MP, Chanock SJ, Amundadottir L, Wang Z, Wentzensen N, Chatterjee N, Wacholder S (2012). Assessing disease risk in genome-wide association studies using family history. Epidemiology  23, 616-22.   https://doi.org/10.1097/EDE.0b013e31825583a0|8. Han S, Rosenberg P, Chatterjee N (2012) Testing for gene-environment and gene-gene interactions under monotonicity constraints. J AM STAT ASSOC 500:1441-1452|9. Katki H, Kinney W, Fetterman B, Lorey T, Poitras N, Cheung L, Demuth F, Schiffman M, Wacholder S, Philip A Castle (2011) Response to Rao et al re. Cervical Cancer Risk for Women Undergoing Concurrent testing for human papillomavirus and Cervical Cytology: a population-based study in Routine Clinical Practice. LANCET ONCOL 2011:00-00.|10. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE (2011). Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol  12, 663-72.   https://doi.org/10.1016/S1470-2045(11)70145-0|11. Katki HA, Wentzensen N (2012). How might HPV testing be integrated into cervical screening? Lancet Oncol  13, 8-10.   https://doi.org/10.1016/S1470-2045(11)70334-5|12. Kovalchik SA, Pfeiffer RM (2012). Re: Assessment of impact of outmigration on incidence of second primary neoplasms in childhood cancer survivors estimated from SEER data. J Natl Cancer Inst  104, 1517-8.   https://doi.org/10.1093/jnci/djs360|13. Kristinsson SY, Tang M, Pfeiffer RM, Björkholm M, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2012). Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica  97, 854-8.   https://doi.org/10.3324/haematol.2011.054015|14. Kugler KG, Hackl WO, Mueller LA, Fiegl H, Graber A, Pfeiffer RM (2011). The Impact of Sample Storage Time on Estimates of Association in Biomarker Discovery Studies. J Clin Bioinforma  1.   https://doi.org/10.1186/2043-9113-1-9|15. Li Y, Graubard BI (2012). Pseudo semiparametric maximum likelihood estimation exploiting gene environment independence for population-based case-control studies with complex samples. Biostatistics  13, 711-23.   https://doi.org/10.1093/biostatistics/kxs008|16. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH (2011). Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst  103, 951-61.   https://doi.org/10.1093/jnci/djr154|17. Mechanic LE, Chen HS, Amos CI, Chatterjee N, Cox NJ, Divi RL, Fan R, Harris EL, Jacobs K, Kraft P, Leal SM, McAllister K, Moore JH, Paltoo DN, Province MA, Ramos EM, Ritchie MD, Roeder K, Schaid DJ, Stephens M, Thomas DC, Weinberg CR, Witte JS, Zhang S, Zöllner S, et al. [2 more authors] (2012). Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol  36, 22-35.   https://doi.org/10.1002/gepi.20652|18. Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, Picornell A, Maeder D, Yang Q, Prokunina-Olsson L, Wang Z, Real FX, Jacobs KB, Baris D, Thun M, Albanes D, Purdue MP, Kogevinas M, Hutchinson A, Fu YP, Tang W, Burdette L, Tardón A, Serra C, Carrato A, García-Closas R, et al. [17 more authors] (2012). Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One  7, e29396.   https://doi.org/10.1371/journal.pone.0029396|19. Park JH, Gail MH, Greene MH, Chatterjee N (2012). Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol  30, 2157-62.   https://doi.org/10.1200/JCO.2011.40.1943|20. Pearce M, Salotti J, McHugh K, Kim K, Craft A, Lubin J, Ron E, Parker L (2012) Socio-economic variation in CT scanning in Northern England, 1990-2002. BMC HEALTH SERVICES RESEARCH 12:1-6.|21. Pfeiffer RM, Forzani L, Bura E (2012). Sufficient dimension reduction for longitudinally measured predictors. Stat Med  31, 2414-27.   https://doi.org/10.1002/sim.4437|22. Wacholder S, Yeager M, Liao LM (2012). Invited commentary: more surprises from a gene desert. Am J Epidemiol  175, 488-91.   https://doi.org/10.1093/aje/kwr429|23. Wu L, Graubard B, Gail M (2012) Estimated Number of 40 to 49 Year Old U.S. Women Who Should Consider Screening Mammography. ANN INTERN MED 157:597|24. Wu LC, Grabaud BI, Gail MH (2012). Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years. Ann Intern Med  157, 597; author reply 597-8.   https://doi.org/10.7326/0003-4819-157-8-201210160-00019|25. Yu K, Wacholder S, Wheeler W, Wang Z, Caporaso N, Landi MT, Liang F (2012). A flexible Bayesian model for studying gene-environment interaction. PLoS Genet  8, e1002482.   https://doi.org/10.1371/journal.pgen.1002482",https://intramural.nih.gov/search/searchview.taf?ipid=73955
705,CP010182-10,"October 01, 2011 -  September 30, 2012",Epidemiologic Field Studies,"Nilanjan  Chatterjee| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, You WC, Gail MH (2012). Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst  104, 488-92.   https://doi.org/10.1093/jnci/djs003",https://intramural.nih.gov/search/searchview.taf?ipid=73985
706,CP010183-10,"October 01, 2011 -  September 30, 2012",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Catherine G Schairer|Philip Samuel Rosenberg; PhD|Jay  Lubin; PhD|Sholom  Wacholder; PhD|Mitchell Henry Gail; PhD, MD|Show all 7",Hans-Olov  Adami (Karolinska Institute)|Johan  Askling (Karolinska Institute)|Susan Shaw Devesa (NCI)|Christoffer  Johansen (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Joseph  McLaughlin (International Epidemiology Institute)|Show all 28,"Claudine M Samanic (Occupational and Environmental Epidemiology Branch)|Lynn Rachel Goldin; PhD (Genetic Epidemiology Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Dalsu  Baris (Occupational and Environmental Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,"1. Emmanuel B, Anderson WF (2012). Non-Hodgkin lymphoma in early life. J Natl Cancer Inst  104, 888-9.   https://doi.org/10.1093/jnci/djs252|2. Jemal A, Ma J, Rosenberg PS, Siegel R, Anderson WF (2012). Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol  30, 2739-44.   https://doi.org/10.1200/JCO.2012.42.6098|3. Moore LE, Pfeiffer RM, Zhang Z, Lu KH, Fung ET, Bast RC (2012). Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer  118, 91-100.   https://doi.org/10.1002/cncr.26241|4. Nuckols JR, Freeman LE, Lubin JH, Airola MS, Baris D, Ayotte JD, Taylor A, Paulu C, Karagas MR, Colt J, Ward MH, Huang AT, Bress W, Cherala S, Silverman DT, Cantor KP (2011). Estimating water supply arsenic levels in the New England Bladder Cancer Study. Environ Health Perspect  119, 1279-85.   https://doi.org/10.1289/ehp.1002345|5. Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD (2012). Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiol Biomarkers Prev  21, 155-65.   https://doi.org/10.1158/1055-9965.EPI-11-0833|6. van Bemmel DM, Boffetta P, Liao LM, Berndt SI, Menashe I, Yeager M, Chanock S, Karami S, Zaridze D, Matteev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Slamova A, Rothman N, Han SS, Rosenberg PS, Brennan P, Chow WH, Moore LE (2011). Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead. PLoS One  6, e20432.   https://doi.org/10.1371/journal.pone.0020432",https://intramural.nih.gov/search/searchview.taf?ipid=73954
707,CP010184-10,"October 01, 2011 -  September 30, 2012",Consultation and Collaboration,Sholom  Wacholder; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Junmo  Nam|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD",David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Scott R Diehl; PhD (NIDCR)|Show all 83,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Claudine M Samanic (Occupational and Environmental Epidemiology Branch)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)","Jane  Hoppin; ScD (NIEHS) |Joni L Rutter (NIDA) |Dale  Sandler; PhD (NIEHS) |Jeffery P Struewing; MS, MD (NHGRI) |Clarice  Weinberg; PhD (NIEHS)","1. Nyante SJ, Graubard BI, Li Y, McQuillan GM, Platz EA, Rohrmann S, Bradwin G, McGlynn KA (2012). Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004. Int J Androl  35, 456-66.   https://doi.org/10.1111/j.1365-2605.2011.01230.x",https://intramural.nih.gov/search/searchview.taf?ipid=73987
708,CP010185-10,"October 01, 2011 -  September 30, 2012",Biodefense Project,Steven L Simon| | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Choonsik  Lee|Amy  de Gonzalez|Andre  Bouville,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",NULL,NULL,"1. Sholom S, Dewitt R, Simon S, Bouville A, McKeever S (2011). Emergency Optically Stimulated Luminescence Dosimetry Using Different Materials. Radiat Meas  46, 1866-1869.   https://doi.org/10.1016/j.radmeas.2011.03.004",https://intramural.nih.gov/search/searchview.taf?ipid=73986
709,CP010187-08,"October 01, 2011 -  September 30, 2012",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Human Genetics Program, NCI",NULL,NULL,NULL,NULL,"1. Cote ML, Colt JS, Schwartz KL, Wacholder S, Ruterbusch JJ, Davis F, Purdue M, Graubard BI, Chow WH (2012). Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity. Cancer Epidemiol Biomarkers Prev  21, 770-9.   https://doi.org/10.1158/1055-9965.EPI-11-1109|2. Han SS, Yeager M, Moore LE, Wei MH, Pfeiffer R, Toure O, Purdue MP, Johansson M, Scelo G, Chung CC, Gaborieau V, Zaridze D, Schwartz K, Szeszenia-Dabrowska N, Davis F, Bencko V, Colt JS, Janout V, Matveev V, Foretova L, Mates D, Navratilova M, Boffetta P, Berg CD, Grubb RL, et al. [19 more authors] (2012). The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet  21, 1190-200.   https://doi.org/10.1093/hmg/ddr551|3. Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, Picornell A, Maeder D, Yang Q, Prokunina-Olsson L, Wang Z, Real FX, Jacobs KB, Baris D, Thun M, Albanes D, Purdue MP, Kogevinas M, Hutchinson A, Fu YP, Tang W, Burdette L, Tardón A, Serra C, Carrato A, García-Closas R, et al. [17 more authors] (2012). Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One  7, e29396.   https://doi.org/10.1371/journal.pone.0029396",https://intramural.nih.gov/search/searchview.taf?ipid=73994
710,CP010188-08,"October 01, 2011 -  September 30, 2012",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Catherine G Schairer|Ju-Hyun  Park|Arpita  Ghosh|Stephanie Ann Kovalchik|Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington),"Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Yikyung  Park (Nutritional Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,"1. Kovalchik SA, Pfeiffer RM (2012). Re: Assessment of impact of outmigration on incidence of second primary neoplasms in childhood cancer survivors estimated from SEER data. J Natl Cancer Inst  104, 1517-8.   https://doi.org/10.1093/jnci/djs360",https://intramural.nih.gov/search/searchview.taf?ipid=73988
711,CP010190-07,"October 01, 2011 -  September 30, 2012",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Mark H Greene; MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Shahinaz M Gadalla|Lisa  Mirabello|Bari Jane Ballew,"Immaculata  DeVivo (Harvard Medical School)|David  Hunter (Harvard School of Public Health)|Richard  Cawthon (University of Utah)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Show all 10",NULL,NULL,"1. Canudas S, Houghtaling BR, Bhanot M, Sasa G, Savage SA, Bertuch AA, Smith S (2011). A role for heterochromatin protein 1γ at human telomeres. Genes Dev  25, 1807-19.   https://doi.org/10.1101/gad.17325211|2. Gadalla SM, Katki HA, Shebl FM, Giri N, Alter BP, Savage SA (2012). The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell  11, 24-8.   https://doi.org/10.1111/j.1474-9726.2011.00755.x|3. Zeng XL, Thumati NR, Fleisig HB, Hukezalie KR, Savage SA, Giri N, Alter BP, Wong JM (2012). The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum Mol Genet  21, 721-9.   https://doi.org/10.1093/hmg/ddr504",https://intramural.nih.gov/search/searchview.taf?ipid=73997
712,CP010192-05,"October 01, 2011 -  September 30, 2012","Biorepository Processing, Storage, and Research",Marianne  Henderson| | |Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Human Genetics Program, NCI

Office of Division Operations and Analysis, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74004
713,CP010193-06,"October 01, 2011 -  September 30, 2012",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",Julie  Mendelsohn,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Kathy  Helzlsouer; MD (Epidemiology, Johns Hopkins University)|Show all 17",Geoffrey Scott Tobias (Human Genetics Program)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,"1. Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, et al. [38 more authors] (2012). Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis  33, 1384-90.   https://doi.org/10.1093/carcin/bgs151",https://intramural.nih.gov/search/searchview.taf?ipid=73998
714,CP010194-06,"October 01, 2011 -  September 30, 2012",Diet and Cancer in India,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,Barry Ira Graubard; PhD (Biostatistics Branch),NULL,"1. Moore SC, Gunter MJ, Daniel CR, Reddy KS, George PS, Yurgalevitch S, Devasenapathy N, Ramakrishnan L, Chatterjee N, Chanock SJ, Berndt SI, Mathew A, Prabhakaran D, Sinha R (2012). Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring)  20, 1902-8.   https://doi.org/10.1038/oby.2011.238|2. Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A, Tandon N, Reddy KS (2011). HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes  5, 95-102.   https://doi.org/10.1016/j.pcd.2011.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=73999
715,CP010195-06,"October 01, 2011 -  September 30, 2012","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein|Rashmi P Sinha; PhD|Amanda  Cross|Christian Cormac Abnet; PhD, MPH|Neal David Freedman|Alison Marian Mondul|Show all 7",David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Gao Y, Killian K, Zhang H, Yu K, Li QZ, Weinstein S, Virtamo J, Tucker M, Taylor P, Albanes D, Meltzer P, Caporaso N (2012). Leukocyte DNA methylation and colorectal cancer among male smokers. World J Gastrointest Oncol  4, 193-201.   https://doi.org/10.4251/wjgo.v4.i8.193|2. Lynch SM, Weinstein SJ, Virtamo J, Lan Q, Liu CS, Cheng WL, Rothman N, Albanes D, Stolzenberg-Solomon RZ (2011). Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila)  4, 1912-9.   https://doi.org/10.1158/1940-6207.CAPR-11-0002|3. Major JM, Kiruthu C, Weinstein SJ, Horst RL, Snyder K, Virtamo J, Albanes D (2012). Pre-diagnostic circulating vitamin D and risk of melanoma in men. PLoS One  7, e35112.   https://doi.org/10.1371/journal.pone.0035112|4. Major JM, Yu K, Wheeler W, Zhang H, Cornelis MC, Wright ME, Yeager M, Snyder K, Weinstein SJ, Mondul A, Eliassen H, Purdue M, Hazra A, McCarty CA, Hendrickson S, Virtamo J, Hunter D, Chanock S, Kraft P, Albanes D (2011). Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet  20, 3876-83.   https://doi.org/10.1093/hmg/ddr296|5. Mondul AM, Rohrmann S, Menke A, Feinleib M, Nelson WG, Platz EA, Albanes D (2011). Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control  22, 827-36.   https://doi.org/10.1007/s10552-011-9753-4|6. Mondul AM, Watters JL, Männistö S, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2011). Serum retinol and risk of prostate cancer. Am J Epidemiol  173, 813-21.   https://doi.org/10.1093/aje/kwq429|7. Mondul AM, Weinstein SJ, Bosworth T, Remaley AT, Virtamo J, Albanes D (2012). Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. PLoS One  7, e47730.   https://doi.org/10.1371/journal.pone.0047730|8. Mondul AM, Weinstein SJ, Virtamo J, Albanes D (2011). Serum total and HDL cholesterol and risk of prostate cancer. Cancer Causes Control  22, 1545-52.   https://doi.org/10.1007/s10552-011-9831-7|9. Murphy G, Kamangar F, Albanes D, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Dawsey SM, Freedman ND (2012). Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut  61, 1533-7.   https://doi.org/10.1136/gutjnl-2011-300653|10. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012). Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res  72, 1190-8.   https://doi.org/10.1158/0008-5472.CAN-11-2950|11. Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D (2011). Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study. PLoS One  6, e20796.   https://doi.org/10.1371/journal.pone.0020796",https://intramural.nih.gov/search/searchview.taf?ipid=74000
716,CP010196-06,"October 01, 2011 -  September 30, 2012",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Yikyung  Park|Amanda  Cross|Rachael Zoe Solomon|Neal David Freedman|Jacqueline M Major; MS|Steven  Moore,NULL,NULL,NULL,"1. Aschebrook-Kilfoy B, Ward MH, Gierach GL, Schatzkin A, Hollenbeck AR, Sinha R, Cross AJ (2012). Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Eur J Cancer Prev  21, 65-72.   https://doi.org/10.1097/CEJ.0b013e328347622f|2. Blank MM, Wentzensen N, Murphy MA, Hollenbeck A, Park Y (2012). Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study. Br J Cancer  106, 596-602.   https://doi.org/10.1038/bjc.2011.572|3. Brinton LA, Schwartz L, Spitz MR, Park Y, Hollenbeck AR, Gierach GL (2012). Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control  23, 487-96.   https://doi.org/10.1007/s10552-012-9904-2|4. Daniel CR, Cross AJ, Graubard BI, Park Y, Ward MH, Rothman N, Hollenbeck AR, Chow WH, Sinha R (2012). Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr  95, 155-62.   https://doi.org/10.3945/ajcn.111.019364|5. Daniel CR, Sinha R, Park Y, Graubard BI, Hollenbeck AR, Morton LM, Cross AJ (2012). Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women. J Nutr  142, 1074-80.   https://doi.org/10.3945/jn.112.158113|6. Daugherty SE, Moore SC, Pfeiffer RM, Inskip PD, Park Y, Hollenbeck A, Rajaraman P (2011). Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort. Cancer Prev Res (Phila)  4, 2027-34.   https://doi.org/10.1158/1940-6207.CAPR-11-0274|7. Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J (2012). Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst  104, 1353-62.   https://doi.org/10.1093/jnci/djs346|8. Dubrow R, Darefsky AS, Freedman ND, Hollenbeck AR, Sinha R (2012). Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP Diet and Health Study. Cancer Causes Control  23, 757-68.   https://doi.org/10.1007/s10552-012-9945-6|9. Eisenberg ML, Park Y, Brinton LA, Hollenbeck AR, Schatzkin A (2011). Fatherhood and incident prostate cancer in a prospective US cohort. Int J Epidemiol  40, 480-7.   https://doi.org/10.1093/ije/dyq163|10. Fondell E, O'Reilly ÉJ, Fitzgerald KC, Falcone GJ, McCullough ML, Thun MJ, Park Y, Kolonel LN, Ascherio A (2012). Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies. Amyotroph Lateral Scler  13, 573-9.   https://doi.org/10.3109/17482968.2012.703209|11. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R (2012). Association of coffee drinking with total and cause-specific mortality. N Engl J Med  366, 1891-904.   https://doi.org/10.1056/NEJMoa1112010|12. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA  306, 737-45.   https://doi.org/10.1001/jama.2011.1142|13. Gibson TM, Weinstein SJ, Pfeiffer RM, Hollenbeck AR, Subar AF, Schatzkin A, Mayne ST, Stolzenberg-Solomon R (2011). Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr  94, 1053-62.   https://doi.org/10.3945/ajcn.110.002659|14. Gierach GL, Freedman ND, Andaya A, Hollenbeck AR, Park Y, Schatzkin A, Brinton LA (2012). Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer  131, 452-60.   https://doi.org/10.1002/ijc.26372|15. Gunter MJ, Schaub JA, Xue X, Freedman ND, Gaudet MM, Rohan TE, Hollenbeck AR, Sinha R (2012). A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer  131, E530-6.   https://doi.org/10.1002/ijc.26482|16. Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE (2011). Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer  128, 944-50.   https://doi.org/10.1002/ijc.25413|17. Leitzmann MF, Moore SC, Koster A, Harris TB, Park Y, Hollenbeck A, Schatzkin A (2011). Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One  6, e18582.   https://doi.org/10.1371/journal.pone.0018582|18. Lew JQ, Chow WH, Hollenbeck AR, Schatzkin A, Park Y (2011). Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer  104, 537-41.   https://doi.org/10.1038/sj.bjc.6606089|19. Lian M, Schootman M, Doubeni CA, Park Y, Major JM, Stone RA, Laiyemo AO, Hollenbeck AR, Graubard BI, Schatzkin A (2011). Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study Cohort. Am J Epidemiol  174, 828-38.   https://doi.org/10.1093/aje/kwr162|20. Lin SW, Wheeler DC, Park Y, Cahoon EK, Hollenbeck AR, Freedman DM, Abnet CC (2012). Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int J Cancer  131, E1015-23.   https://doi.org/10.1002/ijc.27619|21. Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, Hollenbeck AR, Blair A, Chen H (2012). Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol  175, 1200-7.   https://doi.org/10.1093/aje/kwr451|22. Major JM, Cross AJ, Doubeni CA, Park Y, Lian M, Hollenbeck AR, Schatzkin A, Graubard BI, Sinha R (2011). Socioeconomic deprivation impact on meat intake and mortality: NIH-AARP Diet and Health Study. Cancer Causes Control  22, 1699-707.   https://doi.org/10.1007/s10552-011-9846-0|23. Major JM, Cross AJ, Watters JL, Hollenbeck AR, Graubard BI, Sinha R (2011). Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study. Cancer Causes Control  22, 1691-8.   https://doi.org/10.1007/s10552-011-9845-1|24. Moore SC, Patel AV, Matthews CE, Berrington de Gonzalez A, Park Y, Katki HA, Linet MS, Weiderpass E, Visvanathan K, Helzlsouer KJ, Thun M, Gapstur SM, Hartge P, Lee IM (2012). Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med  9, e1001335.   https://doi.org/10.1371/journal.pmed.1001335|25. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC (2012). A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut  61, 1261-8.   https://doi.org/10.1136/gutjnl-2011-300551|26. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Murray LJ, Cantwell MM, Abnet CC (2012). Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study. Int J Cancer  131, 1376-87.   https://doi.org/10.1002/ijc.27366|27. Park Y, Hartge P, Moore SC, Kitahara CM, Hollenbeck AR, Berrington de Gonzalez A (2012). Body mass index and mortality in non-Hispanic black adults in the NIH-AARP Diet and Health Study. PLoS One  7, e50091.   https://doi.org/10.1371/journal.pone.0050091|28. Park Y, Subar AF, Hollenbeck A, Schatzkin A (2011). Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med  171, 1061-8.   https://doi.org/10.1001/archinternmed.2011.18|29. Renehan AG, Flood A, Adams KF, Olden M, Hollenbeck AR, Cross AJ, Leitzmann MF (2012). Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol  176, 1130-40.   https://doi.org/10.1093/aje/kws192|30. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ (2011). Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol  106, 1340-50.   https://doi.org/10.1038/ajg.2011.38|31. Ruder EH, Thiébaut AC, Thompson FE, Potischman N, Subar AF, Park Y, Graubard BI, Hollenbeck AR, Cross AJ (2011). Adolescent and mid-life diet: risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr  94, 1607-19.   https://doi.org/10.3945/ajcn.111.020701|32. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND (2012). Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr  96, 374-81.   https://doi.org/10.3945/ajcn.111.031328|33. Smith L, Brinton LA, Spitz MR, Lam TK, Park Y, Hollenbeck AR, Freedman ND, Gierach GL (2012). Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst  104, 778-89.   https://doi.org/10.1093/jnci/djs179|34. Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Potischman N (2012). Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer  130, 159-69.   https://doi.org/10.1002/ijc.25990|35. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA (2013). Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer  132, 417-26.   https://doi.org/10.1002/ijc.27623|36. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, Hartge P, Hollenbeck A, Park Y, Wentzensen N (2012). Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer  131, 938-48.   https://doi.org/10.1002/ijc.26469|37. Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, et al. [12 more authors] (2012). Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr  95, 713-25.   https://doi.org/10.3945/ajcn.111.014415",https://intramural.nih.gov/search/searchview.taf?ipid=74006
717,CP010197-06,"October 01, 2011 -  September 30, 2012","Physical Activity, Energy Balance, and Cancer",Demetrius  Albanes; MD|IRP Faculty Profile  |Amanda  Cross| | |Charles E Matthews|IRP Faculty Profile  | |Steven  Moore|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Courneya KS, Vallance JK, Culos-Reed SN, McNeely ML, Bell GJ, Mackey JR, Yasui Y, Yuan Y, Matthews CE, Lau DC, Cook D, Friedenreich CM (2012). The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors. BMC Cancer  12, 525.   https://doi.org/10.1186/1471-2407-12-525|2. Koster A, Caserotti P, Patel KV, Matthews CE, Berrigan D, Van Domelen DR, Brychta RJ, Chen KY, Harris TB (2012). Association of sedentary time with mortality independent of moderate to vigorous physical activity. PLoS One  7, e37696.   https://doi.org/10.1371/journal.pone.0037696|3. Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG (2012). Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab  97, 3724-33.   https://doi.org/10.1210/jc.2012-1732|4. Matthews CE, Moore SC, George SM, Sampson J, Bowles HR (2012). Improving self-reports of active and sedentary behaviors in large epidemiologic studies. Exerc Sport Sci Rev  40, 118-26.   https://doi.org/10.1097/JES.0b013e31825b34a0",https://intramural.nih.gov/search/searchview.taf?ipid=74001
718,CP010198-06,"October 01, 2011 -  September 30, 2012",Lower Gastrointestinal Cancer Studies,Amanda  Cross,NULL,"Nutritional Epidemiology Branch, NCI",Rashmi P Sinha; PhD,Philip  Schoenfeld (University of Michigan School of Medicine)|Andrew P Flood,Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"1. Bobe G, Murphy G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Cross AJ (2012). Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial. Int J Cancer  130, 1649-59.   https://doi.org/10.1002/ijc.26184|2. Bobe G, Murphy G, Albert PS, Sansbury LB, Young MR, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2011). Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols? Eur J Cancer Prev  20, 86-95.   https://doi.org/10.1097/CEJ.0b013e3283429e45|3. Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ (2012). Obesity, weight change, and risk of adenoma recurrence: a prospective trial. Endoscopy  44, 813-8.   https://doi.org/10.1055/s-0032-1309837|4. Laiyemo AO, Doubeni C, Sanderson AK, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ (2011). Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc  74, 253-61.   https://doi.org/10.1016/j.gie.2011.02.023|5. Martínez ME, Thompson P, Messer K, Ashbeck EL, Lieberman DA, Baron JA, Ahnen DJ, Robertson DJ, Jacobs ET, Greenberg ER, Cross AJ, Atkin W (2012). One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med  157, 856-64.   https://doi.org/10.7326/0003-4819-157-12-201212180-00005",https://intramural.nih.gov/search/searchview.taf?ipid=74002
719,CP010199-06,"October 01, 2011 -  September 30, 2012",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Amanda  Cross|Yikyung  Park|Charles E Matthews,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Laurence  Freedman (Biometry Research Group)|Richard P Troiano (Risk Factor Monitoring and Methods Branch),NULL,"1. Cross AJ, Harnly JM, Ferrucci LM, Risch A, Mayne ST, Sinha R (2012). Developing a heme iron database for meats according to meat type, cooking method and doneness level. Food Nutr Sci  3, 905-913.   https://doi.org/10.4236/fns.2012.37120|2. Cross AJ, Major JM, Sinha R (2011). Urinary biomarkers of meat consumption. Cancer Epidemiol Biomarkers Prev  20, 1107-11.   https://doi.org/10.1158/1055-9965.EPI-11-0048|3. Daniel CR, Schwartz KL, Colt JS, Dong LM, Ruterbusch JJ, Purdue MP, Cross AJ, Rothman N, Davis FG, Wacholder S, Graubard BI, Chow WH, Sinha R (2011). Meat-cooking mutagens and risk of renal cell carcinoma. Br J Cancer  105, 1096-104.   https://doi.org/10.1038/bjc.2011.343|4. Ferrucci LM, Sinha R, Huang WY, Berndt SI, Katki HA, Schoen RE, Hayes RB, Cross AJ (2012). Meat consumption and the risk of incident distal colon and rectal adenoma. Br J Cancer  106, 608-16.   https://doi.org/10.1038/bjc.2011.549",https://intramural.nih.gov/search/searchview.taf?ipid=74003
720,CP010200-05,"October 01, 2011 -  September 30, 2012",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Laboratory Translational Genomics, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,"1. Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Figueiredo JC, Jiao S, Harrison TA, Liu Y, Chen LS, Stelling DL, Warnick GS, Hoffmeister M, Küry S, Fuchs CS, Giovannucci E, Hazra A, Kraft P, Hunter DJ, Gallinger S, Zanke BW, et al. [21 more authors] (2012). Characterization of Gene-Environment Interactions for Colorectal Cancer Susceptibility Loci. Cancer Res  72, 2036-2044.   https://doi.org/10.1158/0008-5472.CAN-11-4067",https://intramural.nih.gov/search/searchview.taf?ipid=74005
721,CP010201-03,"October 01, 2011 -  September 30, 2012",Laboratory of Translational Genomics,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, Li XM, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Liao LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Chung CC, Wang C, Wheeler W, Yeager M, et al. [136 more authors] (2012). Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet  21, 2132-41.   https://doi.org/10.1093/hmg/dds029|2. Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L (2013). Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. PLoS One  8, e60083.   https://doi.org/10.1371/journal.pone.0060083|3. Aoude LG, Wadt K, Bojesen A, Crüger D, Borg A, Trent JM, Brown KM, Gerdes AM, Jönsson G, Hayward NK (2013). A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS One  8, e72144.   https://doi.org/10.1371/journal.pone.0072144|4. Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G, Foss F, Kim C, Dai M, Zhao P, Holford T, Leaderer B, Boyle P, Deng Q, Chanock SJ, Rothman N, Zhang Y (2012). Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol  87, 766-9.   https://doi.org/10.1002/ajh.23244|5. Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, Dogan A, Wang SS (2012). LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leuk Lymphoma  53, 1105-12.   https://doi.org/10.3109/10428194.2011.638717|6. Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Deming SL, Bandera EV, Nyante S, Palmer JR, Rebbeck TR, Ingles SA, Press MF, Rodriguez-Gil JL, Chanock SJ, Le Marchand L, Kolonel LN, Henderson BE, Stram DO, Haiman CA (2011). Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet  20, 4491-503.   https://doi.org/10.1093/hmg/ddr367|7. Chung CC, Boland J, Yeager M, Jacobs KB, Zhang X, Deng Z, Matthews C, Berndt SI, Chanock SJ (2012). Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. Prostate  72, 476-86.   https://doi.org/10.1002/pros.21450|8. Ciampa J, Yeager M, Amundadottir L, Jacobs K, Kraft P, Chung C, Wacholder S, Yu K, Wheeler W, Thun MJ, Divers WR, Gapstur S, Albanes D, Virtamo J, Weinstein S, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Chatterjee N (2011). Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res  71, 3287-95.   https://doi.org/10.1158/0008-5472.CAN-10-2646|9. Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, Baris D, Mumy A, Albanes D, Purdue MP, Hutchinson A, Carrato A, Tardón A, Serra C, García-Closas R, Lloreta J, et al. [14 more authors] (2012). Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A  109, 4974-9.   https://doi.org/10.1073/pnas.1202189109|10. Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, et al. [27 more authors] (2011). A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet  20, 4282-9.   https://doi.org/10.1093/hmg/ddr342|11. Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM (2012). Inherited genetic variation and overall survival following follicular lymphoma. Am J Hematol  87, 724-6.   https://doi.org/10.1002/ajh.23184|12. Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, Agnarsson BA, Johannsson OT, Reynisdottir I (2012). The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer  12, 621.   https://doi.org/10.1186/1471-2407-12-621|13. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, et al. [104 more authors] (2011). A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet  43, 1210-4.   https://doi.org/10.1038/ng.985|14. He C, Chasman DI, Dreyfus J, Hwang SJ, Ruiter R, Sanna S, Buring JE, Fernández-Rhodes L, Franceschini N, Hankinson SE, Hofman A, Lunetta KL, Palmieri G, Porcu E, Rivadeneira F, Rose LM, Splansky GL, Stolk L, Uitterlinden AG, Chanock SJ, Crisponi L, Demerath EW, Murabito JM, Ridker PM, Stricker BH, et al. [1 more author] (2012). Reproductive aging-associated common genetic variants and the risk of breast cancer. Breast Cancer Res  14, R54.   https://doi.org/10.1186/bcr3155|15. Hosgood HD, Wang WC, Hong YC, Wang JC, Chen K, Chang IS, Chen CJ, Lu D, Yin Z, Wu C, Zheng W, Qian B, Park JY, Kim YH, Chatterjee N, Chen Y, Chang GC, Hsiao CF, Yeager M, Tsai YH, Wei H, Kim YT, Wu W, Zhao Z, Chow WH, et al. [59 more authors] (2012). Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet  131, 1197-203.   https://doi.org/10.1007/s00439-012-1144-8|16. Jia J, Parikh H, Xiao W, Hoskins JW, Pflicke H, Liu X, Collins I, Zhou W, Wang Z, Powell J, Thorgeirsson SS, Rudloff U, Petersen GM, Amundadottir LT (2013). An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. BMC Med Genomics  6, 33.   https://doi.org/10.1186/1755-8794-6-33|17. Kim HK, Chanock SJ (2012). Genome-wide association studies in melanoma: off to a good start. Pigment Cell Melanoma Res  25, 231-3.   https://doi.org/10.1111/j.1755-148X.2012.00981.x|18. Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T, GENICA Network, Chang-Claude J, Investigators kConFab, Australian Ovarian Cancer Study Group, et al. [124 more authors] (2012). 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat  33, 1123-32.   https://doi.org/10.1002/humu.22089|19. Liang XS, Pfeiffer RM, Wheeler W, Maeder D, Burdette L, Yeager M, Chanock S, Tucker MA, Goldstein AM, Yang XR (2012). Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations. Int J Cancer  130, 2062-6.   https://doi.org/10.1002/ijc.26231|20. Lindström S, Schumacher FR, Campa D, Albanes D, Andriole G, Berndt SI, Bueno-de-Mesquita HB, Chanock SJ, Diver WR, Ganziano JM, Gapstur SM, Giovannucci E, Haiman CA, Henderson B, Hunter DJ, Johansson M, Kolonel LN, Le Marchand L, Ma J, Stampfer M, Stevens VL, Trichopoulos D, Virtamo J, Willett WC, Yeager M, et al. [2 more authors] (2012). Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev  21, 212-6.   https://doi.org/10.1158/1055-9965.EPI-11-0870-T|21. Lindström S, Schumacher FR, Cox D, Travis RC, Albanes D, Allen NE, Andriole G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Crawford ED, Diver WR, Gaziano JM, Giles GG, Giovannucci E, Gonzalez CA, Henderson B, Hunter DJ, Johansson M, Kolonel LN, Ma J, Le Marchand L, Pala V, Stampfer M, Stram DO, et al. [12 more authors] (2012). Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev  21, 437-44.   https://doi.org/10.1158/1055-9965.EPI-11-1038|22. Major JM, Yu K, Chung CC, Weinstein SJ, Yeager M, Wheeler W, Snyder K, Wright ME, Virtamo J, Chanock S, Albanes D (2012). Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men. J Nutr  142, 866-71.   https://doi.org/10.3945/jn.111.156349|23. Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, Picornell A, Maeder D, Yang Q, Prokunina-Olsson L, Wang Z, Real FX, Jacobs KB, Baris D, Thun M, Albanes D, Purdue MP, Kogevinas M, Hutchinson A, Fu YP, Tang W, Burdette L, Tardón A, Serra C, Carrato A, García-Closas R, et al. [17 more authors] (2012). Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One  7, e29396.   https://doi.org/10.1371/journal.pone.0029396|24. Meyer TE, Chu LW, Li Q, Yu K, Rosenberg PS, Menashe I, Chokkalingam AP, Quraishi SM, Huang WY, Weiss JM, Kaaks R, Hayes RB, Chanock SJ, Hsing AW (2012). The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. Prostate  72, 65-71.   https://doi.org/10.1002/pros.21407|25. Prescott J, Thompson DJ, Kraft P, Chanock SJ, Audley T, Brown J, Leyland J, Folkerd E, Doody D, Hankinson SE, Hunter DJ, Jacobs KB, Dowsett M, Cox DG, Easton DF, De Vivo I (2012). Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. PLoS One  7, e37815.   https://doi.org/10.1371/journal.pone.0037815|26. Sriram KB, Larsen JE, Savarimuthu Francis SM, Wright CM, Clarke BE, Duhig EE, Brown KM, Hayward NK, Yang IA, Bowman RV, Fong KM (2012). Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS One  7, e30398.   https://doi.org/10.1371/journal.pone.0030398|27. Stark MS, Woods SL, Gartside MG, Bonazzi VF, Dutton-Regester K, Aoude LG, Chow D, Sereduk C, Niemi NM, Tang N, Ellis JJ, Reid J, Zismann V, Tyagi S, Muzny D, Newsham I, Wu Y, Palmer JM, Pollak T, Youngkin D, Brooks BR, Lanagan C, Schmidt CW, Kobe B, MacKeigan JP, et al. [5 more authors] (2011). Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet  44, 165-9.   https://doi.org/10.1038/ng.1041|28. Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't Veer LJ, Tollenaar RA, Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, GENICA Network, kConFab Investigators, Australian Ovarian Cancer Study Group, et al. [76 more authors] (2011). Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer  105, 1934-9.   https://doi.org/10.1038/bjc.2011.448|29. Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, Barbalic M, Broer L, Byrne EM, Ernst F, Esko T, Franceschini N, Gudbjartsson DF, Hottenga JJ, Kraft P, McArdle PF, Porcu E, Shin SY, Smith AV, van Wingerden S, Zhai G, Zhuang WV, Albrecht E, Alizadeh BZ, Aspelund T, LifeLines Cohort Study, et al. [154 more authors] (2012). Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet  44, 260-8.   https://doi.org/10.1038/ng.1051|30. Tang W, Fu YP, Figueroa JD, Malats N, Garcia-Closas M, Chatterjee N, Kogevinas M, Baris D, Thun M, Hall JL, De Vivo I, Albanes D, Porter-Gill P, Purdue MP, Burdett L, Liu L, Hutchinson A, Myers T, Tardón A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, et al. [13 more authors] (2012). Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet  21, 1918-30.   https://doi.org/10.1093/hmg/ddr619|31. Wang S, Xiong W, Ma W, Chanock S, Jedrychowski W, Wu R, Perera FP (2012). Gene-environment interactions on growth trajectories. Genet Epidemiol  36, 206-13.   https://doi.org/10.1002/gepi.21613|32. Wang Z, Parikh H, Jia J, Myers T, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Ghosh A, Thun MJ, Gapstur SM, Ryan Diver W, Virtamo J, Albanes D, Cancel-Tassin G, Valeri A, Cussenot O, Offit K, Giovannucci E, Ma J, Stampfer MJ, Michael Gaziano J, Hunter DJ, Dutra-Clarke A, Kirchhoff T, et al. [11 more authors] (2012). Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Hum Genet  131, 1173-85.   https://doi.org/10.1007/s00439-012-1139-5|33. Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, Zaridze D, Lin J, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Jinga V, et al. [67 more authors] (2012). A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet  21, 456-62.   https://doi.org/10.1093/hmg/ddr479|34. Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, Bonazzi V, Stark MS, Symmons J, Law MH, Schmidt C, Lanagan C, O'Connor L, Holland EA, Schmid H, Maskiell JA, et al. [22 more authors] (2011). A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature  480, 99-103.   https://doi.org/10.1038/nature10630|35. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC (2012). 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res  72, 1467-77.   https://doi.org/10.1158/0008-5472.CAN-11-3073",https://intramural.nih.gov/search/searchview.taf?ipid=74010
722,CP010202-04,"October 01, 2011 -  September 30, 2012","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73951
723,CP010206-03,"October 01, 2011 -  September 30, 2012","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Julia  Gage|Lisa  Mirabello,Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Sameer K Antani; PhD|S  Goldie (Harvard),"Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Arpita  Ghosh (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)",NULL,"1. Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, Burk R, Schiffman M (2012). A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis  12, 33.   https://doi.org/10.1186/1471-2334-12-33|2. Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, Bell L, Shrestha N, Eklund C, Reilly M, Hutchinson M, Wacholder S, Castle PE, Burk RD, Schiffman M (2012). Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer  131, 2903-9.   https://doi.org/10.1002/ijc.27563|3. Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE (2011). Comparative performance of human papillomavirus DNA testing using novel sample collection methods. J Clin Microbiol  49, 4185-9.   https://doi.org/10.1128/JCM.01254-11|4. Markt SC, Rodriguez AC, Burk RD, Hildesheim A, Herrero R, Wacholder S, Hutchinson M, Schiffman M (2012). Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting. J Infect Dis  205, 498-505.   https://doi.org/10.1093/infdis/jir746|5. Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD (2011). A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev  20, 1398-409.   https://doi.org/10.1158/1055-9965.EPI-11-0206",https://intramural.nih.gov/search/searchview.taf?ipid=74011
724,CP010207-03,"October 01, 2011 -  September 30, 2012",PLCO EEMS and Extended Follow Up,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Christine Dorothy Berg (Early Detection Research Group)|Philip  Prorok (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74012
725,CP010209-03,"October 01, 2011 -  September 30, 2012",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S, CVT Vaccine Group (2011). Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst  103, 1444-51.   https://doi.org/10.1093/jnci/djr319",https://intramural.nih.gov/search/searchview.taf?ipid=74014
726,CP010210-03,"October 01, 2011 -  September 30, 2012","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,"1. Castro FA, Ivansson EL, Schmitt M, Juko-Pecirep I, Kjellberg L, Hildesheim A, Gyllensten UB, Pawlita M (2012). Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer  130, 349-55.   https://doi.org/10.1002/ijc.26016|2. Hildesheim A, Wang CP (2012). Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol  22, 107-16.   https://doi.org/10.1016/j.semcancer.2012.01.007|3. Hsu WL, Tse KP, Liang S, Chien YC, Su WH, Yu KJ, Cheng YJ, Tsang NM, Hsu MM, Chang KP, Chen IH, Chen TI, Yang CS, Goldstein AM, Chen CJ, Chang YS, Hildesheim A (2012). Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma. PLoS One  7, e42767.   https://doi.org/10.1371/journal.pone.0042767|4. Plummer M, Peto J, Franceschi S, International Collaboration of Epidemiological Studies of Cervical Cancer (2012) Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 130:2638-44",https://intramural.nih.gov/search/searchview.taf?ipid=74015
727,CP010211-03,"October 01, 2011 -  September 30, 2012",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Cindy M Chang,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Kelly Jen-Yi Yu (Early Detection Research Group)",NULL,"1. Hsu WL, Pan WH, Chien YC, Yu KJ, Cheng YJ, Chen JY, Liu MY, Hsu MM, Lou PJ, Chen IH, Yang CS, Hildesheim A, Chen CJ (2012). Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a case-control study in Taiwan. PLoS One  7, e41779.   https://doi.org/10.1371/journal.pone.0041779",https://intramural.nih.gov/search/searchview.taf?ipid=74016
728,CP010212-03,"October 01, 2011 -  September 30, 2012",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Rabkin CC, Kaslow RA, D'Souza G (2011). Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk. J Acquir Immune Defic Syndr  56, 188-92.   https://doi.org/10.1097/QAI.0b013e3181ff976b|2. Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O (2011). B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev  20, 1303-14.   https://doi.org/10.1158/1055-9965.EPI-11-0037|3. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS (2012). Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev  21, 20-38.   https://doi.org/10.1158/1055-9965.EPI-11-0834|4. Lochhead P, Frank B, Hold GL, Rabkin CS, Ng MT, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Müller H, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow WH, El-Omar EM (2011). Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology  140, 435-41.   https://doi.org/10.1053/j.gastro.2010.11.001|5. Lochhead P, Ng MT, Hold GL, Rabkin CS, Vaughan TL, Gammon MD, Risch HA, Lissowska J, Mukhopadhya I, Chow WH, El-Omar EM (2011). Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. Eur J Cancer Prev  20, 54-7.   https://doi.org/10.1097/CEJ.0b013e328341e320|6. Palmer AJ, Lochhead P, Hold GL, Rabkin CS, Chow WH, Lissowska J, Vaughan TL, Berry S, Gammon M, Risch H, El-Omar EM (2012). Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prev  21, 541-4.   https://doi.org/10.1097/CEJ.0b013e3283529b79|7. Rabkin CS, Engels EA, Landgren O, Schuurman R, Camargo MC, Ruth Pfeiffer, Goedert JJ (2011). Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Am J Hematol  86, 875-8.   https://doi.org/10.1002/ajh.22119|8. Wong HL, Rabkin CS, Shu XO, Pfeiffer RM, Cai Q, Ji BT, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH (2011). Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women. Cancer Sci  102, 1911-5.   https://doi.org/10.1111/j.1349-7006.2011.02033.x",https://intramural.nih.gov/search/searchview.taf?ipid=74017
729,CP010213-03,"October 01, 2011 -  September 30, 2012",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol  29, 4294-301.   https://doi.org/10.1200/JCO.2011.36.4596|2. Koshiol J, Rotunno M, Gillison ML, Van Doorn LJ, Chaturvedi AK, Tarantini L, Song H, Quint WG, Struijk L, Goldstein AM, Hildesheim A, Taylor PR, Wacholder S, Bertazzi PA, Landi MT, Caporaso NE (2011). Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst  103, 501-7.   https://doi.org/10.1093/jnci/djr003",https://intramural.nih.gov/search/searchview.taf?ipid=74018
730,CP010214-03,"October 01, 2011 -  September 30, 2012",Microbes and Human Malignancies,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",Roberto  Flores,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Barbara J Fuhrman (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Amodio E, Cusi MG, Valenti RM, Valentini M, Mammina C, Gori-Savellini G, Vitale F, Romano N, Goedert JJ, Calamusa G (2012). Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily. Int J Infect Dis  16, e633-5.   https://doi.org/10.1016/j.ijid.2012.04.012|2. Amodio E, Valentini M, Gori-Savellini G, Valenti RM, Romano N, Goedert JJ, Cusi MG (2011). Prevalence of toscana and sicilian phlebovirus antibodies in classic Kaposi sarcoma case patients and control subjects in sicily. J Infect Dis  204, 1423-6.   https://doi.org/10.1093/infdis/jir546|3. An P, Li R, Wang J, Yoshimura T, Takahashi M, Samudralal R, O'Brien S, Phair J, Goedert J, Kirk G, Buchbinder S, Donifield S, Nelson G, Winkler C (2011) Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with Pneumocystis pneumonia. PLoS Genetics 10:e1002328.|4. Calamusa G, Valenti RM, Vitale F, Mammina C, Romano N, Goedert JJ, Gori-Savellini G, Cusi MG, Amodio E (2012). Seroprevalence of and risk factors for Toscana and Sicilian virus infection in a sample population of Sicily (Italy). J Infect  64, 212-7.   https://doi.org/10.1016/j.jinf.2011.11.012|5. Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ (2012). Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med  10, 253.   https://doi.org/10.1186/1479-5876-10-253|6. Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ (2012). Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest  42, 855-63.   https://doi.org/10.1111/j.1365-2362.2012.02659.x|7. Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ (2012). Association of fecal microbial diversity and taxonomy with selected enzymatic functions. PLoS One  7, e39745.   https://doi.org/10.1371/journal.pone.0039745|8. Flores R, Shi J, Gail MH, Ravel J, Goedert JJ (2012). Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. Eur J Clin Invest  42, 848-54.   https://doi.org/10.1111/j.1365-2362.2012.02660.x|9. Goedert JJ (2012). HIV-associated lung cancer:  ambiguities and challenges. AIDS  26, 1031-3.   https://doi.org/10.1097/QAD.0b013e3283522d94|10. Goedert JJ, Bower M (2012). Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection. Curr Opin Oncol  24, 531-6.   https://doi.org/10.1097/CCO.0b013e3283560697|11. Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M (2011). The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis  203, 1807-14.   https://doi.org/10.1093/infdis/jir192|12. Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, Poizot-Martin I, Rouveix E, Engels EA, Costagliola D, Goedert JJ, FHDH-ANRS CO4 (2011). HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood  118, 44-9.   https://doi.org/10.1182/blood-2011-02-339275|13. Seich Al Basatena NK, Macnamara A, Vine AM, Thio CL, Astemborski J, Usuku K, Osame M, Kirk GD, Donfield SM, Goedert JJ, Bangham CR, Carrington M, Khakoo SI, Asquith B (2011). KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog  7, e1002270.   https://doi.org/10.1371/journal.ppat.1002270|14. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA (2012). Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis  54, 1026-34.   https://doi.org/10.1093/cid/cir1012|15. Valenti RM, Amodio E, Nam JM, Preiss L, Graubard BI, Romano N, Goedert JJ (2011). Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls. Br J Cancer  104, 433-6.   https://doi.org/10.1038/sj.bjc.6606088",https://intramural.nih.gov/search/searchview.taf?ipid=74019
731,CP010215-03,"October 01, 2011 -  September 30, 2012",Human microbiome and cancer,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74020
732,CP010216-03,"October 01, 2011 -  September 30, 2012",Immune responses to HPV infection and HPV vaccination,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74021
733,CP010217-02,"October 01, 2011 -  September 30, 2012",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Anil Kumar Chaturvedi|Felipe A Castro,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Gonzalez P, Cortes B, Quint W, Kreimer AR, Porras C, Rodríguez AC, Jimenez S, Herrero R, Struijk L, Hildesheim A, Melchers W (2012). Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. J Clin Microbiol  50, 3870-6.   https://doi.org/10.1128/JCM.01698-12|2. Porras C, Wentzensen N, Rodríguez AC, Morales J, Burk RD, Alfaro M, Hutchinson M, Herrero R, Hildesheim A, Sherman ME, Wacholder S, Solomon D, Schiffman M (2012). Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy. Int J Cancer  130, 1879-87.   https://doi.org/10.1002/ijc.26194|3. Safaeian M, Hildesheim A, Gonzalez P, Yu K, Porras C, Li Q, Rodriguez AC, Sherman ME, Schiffman M, Wacholder S, Burk R, Herrero R, Burdette L, Chanock SJ, Wang SS (2012). Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One  7, e33619.   https://doi.org/10.1371/journal.pone.0033619|4. Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, Hildesheim A, Burk RD, Plummer M (2011). Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis  204, 385-90.   https://doi.org/10.1093/infdis/jir286",https://intramural.nih.gov/search/searchview.taf?ipid=74022
734,CP010218-02,"October 01, 2011 -  September 30, 2012",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Felipe A Castro,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Castro FA, Koshiol J, Hsing AW, Gao YT, Rashid A, Chu LW, Shen MC, Wang BS, Han TQ, Zhang BH, Niwa S, Yu K, Zhang H, Chanock S, Andreotti G (2012). Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China. BMC Cancer  12, 468.   https://doi.org/10.1186/1471-2407-12-468",https://intramural.nih.gov/search/searchview.taf?ipid=74023
735,CP010219-02,"October 01, 2011 -  September 30, 2012",Studies of other risk factors for radiosensitive tumors,Martha S Linet; PhD|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kitahara CM, Platz EA, Beane Freeman LE, Black A, Hsing AW, Linet MS, Park Y, Schairer C, Berrington de González A (2012). Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies. Cancer Causes Control  23, 463-471.   https://doi.org/10.1007/s10552-012-9896-y",https://intramural.nih.gov/search/searchview.taf?ipid=74024
736,CP010220-02,"October 01, 2011 -  September 30, 2012",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cook MB (2011). Non-acid reflux: the missing link between gastric atrophy and esophageal squamous cell carcinoma? Am J Gastroenterol  106, 1930-2.   https://doi.org/10.1038/ajg.2011.288|2. Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC, Corley DA (2012). Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology  142, 744-53.   https://doi.org/10.1053/j.gastro.2011.12.049|3. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Pandeya N, Vaughan TL, Chow WH, Gammon MD (2012). Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol  41, 1706-18.   https://doi.org/10.1093/ije/dys176|4. Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, Bansal A, Early DS, Sharma P (2012). Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc  75, 236-41.   https://doi.org/10.1016/j.gie.2011.09.017",https://intramural.nih.gov/search/searchview.taf?ipid=74025
737,CP010221-02,"October 01, 2011 -  September 30, 2012",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Laboratory Translational Genomics, NCI",Alison Marian Mondul|Jacqueline M Major; MS|Mark  Purdue|Stephanie Joan Weinstein,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Kevin  Jacobs (Office of the Director)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)|Meredith  Yeager (Office of the Director)|Zhaoming  Wang (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74026
738,CP010222-02,"October 01, 2011 -  September 30, 2012",Studies of Populations Exposed to Diagnostic Medical Radiation,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 14",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington de González A, Kim KP, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Smith-Bindman R, Yee J, Kuntz KM, van Ballegooijen M, Zauber AG, Berg CD (2011). Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol  196, 816-23.   https://doi.org/10.2214/AJR.10.4907|2. Berrington de Gonzalez A, Iulian Apostoaei A, Veiga LH, Rajaraman P, Thomas BA, Owen Hoffman F, Gilbert E, Land C (2012). RadRAT: a radiation risk assessment tool for lifetime cancer risk projection. J Radiol Prot  32, 205-22.   https://doi.org/10.1088/0952-4746/32/3/205|3. Kim KP, Miller DL, Berrington de Gonzalez A, Balter S, Kleinerman RA, Ostroumova E, Simon SL, Linet MS (2012). Occupational radiation doses to operators performing fluoroscopically-guided procedures. Health Phys  103, 80-99.   https://doi.org/10.1097/HP.0b013e31824dae76|4. Lee C, Kim KP, Long DJ, Bolch WE (2012). Organ doses for reference pediatric and adolescent patients undergoing computed tomography estimated by Monte Carlo simulation. Med Phys  39, 2129-46.   https://doi.org/10.1118/1.3693052|5. Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann S, Williams AE (2012). Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA  307, 2400-9.   https://doi.org/10.1001/jama.2012.5960",https://intramural.nih.gov/search/searchview.taf?ipid=74027
739,CP010224-01,"October 01, 2011 -  September 30, 2012",Esophageal cancer genetic project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77683
740,CP010225-01,"October 01, 2011 -  September 30, 2012",Barretts esophagus early detection project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77684
741,SC000167-21,"October 01, 2011 -  September 30, 2012",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Yan  Li|Xiaoyang  Wang|Florent Raphael  Suau|Xu  Naizhen|Danlei  Yang; MD,NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Shioko  Kimura; PhD (Endocrinology Section)",NULL,"1. Demelash A, Rudrabhatla P, Pant HC, Wang X, Amin ND, McWhite CD, Naizhen X, Linnoila RI (2012). Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway. Mol Biol Cell  23, 2856-66.   https://doi.org/10.1091/mbc.E10-12-1010|2. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA (2011). Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene  30, 1812-21.   https://doi.org/10.1038/onc.2010.556|3. Koshiol J, Gulley ML, Zhao Y, Rubagotti M, Marincola FM, Rotunno M, Tang W, Bergen AW, Bertazzi PA, Roy D, Pesatori AC, Linnoila I, Dittmer D, Goldstein AM, Caporaso NE, McShane LM, Wang E, Landi MT (2011). Epstein-Barr virus microRNAs and lung cancer. Br J Cancer  105, 320-6.   https://doi.org/10.1038/bjc.2011.221|4. Kurotani R, Kumaki N, Naizhen X, Ward JM, Linnoila RI, Kimura S (2011). Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans. Lung Cancer  71, 42-8.   https://doi.org/10.1016/j.lungcan.2010.04.001|5. Li Y, Linnoila I (2012) Multi-directional differentiation of Ascl1-defined progenitors in lung development and injury repair. Am J Resp Cell Mol Biol, in press.|6. Maier CR, Hollander MC, Hobbs EA, Dogan I, Linnoila RI, Dennis PA (2011). Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res (Phila)  4, 1743-51.   https://doi.org/10.1158/1940-6207.CAPR-11-0365|7. Wang X, Keefe K, JensenTaubman S, Yang D, Yan K, Linnoila I (2012) Novel method for isolation of murine Clara cell secretory protein-expressing cells with traces of stemness. PlosONE, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=76483
742,SC000550-32,"October 01, 2011 -  September 30, 2012",Lymphoma Disease Discovery and Defintion,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Stefania  Pittaluga|Theresa M Davies Hill|Alison Rozmus Huppmann; MD|Ewa Beata Bajor-Dattilo; MD, PhD|Madhu Parameswar Menon|Moses Osemwingie Evbuomwan|Show all 11","Wing  Chan (Pathology, University of Nebraska)|Andreas  Chott (Pathology, University of Vienna)|Elias  Campo (University of Barcelona)|Nancy  Harris|Steven  Swerdlow (University of Pittsburgh Med Center)|Stefan D Dojcinov|Show all 13","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Susan  Bates; MD (Medical Oncology Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|George W Wright (Biometrics Research Branch)","Jeffrey  Cohen; MD (NIAID) |Katherine Rainsford Calvo (CC) |Vemulkonda Koneti Rao; MD, FRCPA (NIAID) |Adrian U Wiestner; MD, PhD (NHLBI)","1. Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, López-Guillermo A, Campo E (2011). High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica  96, 996-1001.   https://doi.org/10.3324/haematol.2010.037408|2. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E (2012). In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica  97, 270-8.   https://doi.org/10.3324/haematol.2011.052621|3. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE (2011). Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood  117, 5835-49.   https://doi.org/10.1182/blood-2010-11-316745|4. da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, Gatter K, Liu Q, Jaffe ES, Chapel H (2011). Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol  31, 784-91.   https://doi.org/10.1007/s10875-011-9565-z|5. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011). Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood  117, 4726-35.   https://doi.org/10.1182/blood-2010-12-323238|6. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|7. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|8. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|9. Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011). Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol  35, 1214-25.   https://doi.org/10.1097/PAS.0b013e31822067d1|10. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|11. Herrinton LJ, Liu L, Abramson O, Jaffe ES (2012). The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. Pharmacoepidemiol Drug Saf  21, 49-52.   https://doi.org/10.1002/pds.2216|12. Jaffe ES, Pittaluga S (2011). Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematology Am Soc Hematol Educ Program  2011, 506-14.   https://doi.org/10.1182/asheducation-2011.1.506|13. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES (2011). Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood  118, 2976-84.   https://doi.org/10.1182/blood-2011-05-355255|14. Maldonado NI, Cabanillas F, Jaffe ES, Raffeld M, Lozada L (2011). Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab. J Clin Oncol  29, e658-60.   https://doi.org/10.1200/JCO.2011.34.8656|15. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|16. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|17. Schiffenbauer AI, Wahl C, Pittaluga S, Jaffe ES, Hoffman R, Khosroshahi A, Stone JH, Deshpande V, Gahl WA, Gill F (2012). IgG4-related disease presenting as recurrent mastoiditis. Laryngoscope  122, 681-4.   https://doi.org/10.1002/lary.22486|18. Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM, McGaughey DS, Jaffe ES, Chong EA, Reynolds CW, Berry DA, Santos CF, Popa MA, McCord AM, Kwak LW (2011). Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol  29, 2787-94.   https://doi.org/10.1200/JCO.2010.33.3005|19. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011). Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol  24, 1421-32.   https://doi.org/10.1038/modpathol.2011.102|20. Sohani AR, Jaffe ES, Harris NL, Ferry JA, Pittaluga S, Hasserjian RP (2011). Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells:  a morphologic variant mimicking peripheral T-cell lymphoma. Am J Surg Pathol  35, 1666-78.   https://doi.org/10.1097/PAS.0b013e31822832de|21. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|22. Song JY, Strom T, Raffeld M, Pittaluga S, Jaffe ES (2011). Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. J Clin Oncol  29, e789-91.   https://doi.org/10.1200/JCO.2011.36.9280|23. Vela-Chávez T, Adam P, Kremer M, Bink K, Bacon CM, Menon G, Ferry JA, Fend F, Jaffe ES, Quintanilla-Martínez L (2011). Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus. Leuk Lymphoma  52, 458-66.   https://doi.org/10.3109/10428194.2010.540361|24. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2011). CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology  58, 803-5.   https://doi.org/10.1111/j.1365-2559.2011.03829.x|25. Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR (2012). MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica  97, 586-94.   https://doi.org/10.3324/haematol.2011.048132",https://intramural.nih.gov/search/searchview.taf?ipid=76484
743,SC000892-29,"October 01, 2011 -  September 30, 2012",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Natascia  Marino|Joji  Nakayama|Devin  Matthews,Maximillian  Murone (Debio Pharmaceuticals)|George  Sledge Jr (Indiana University)|Fernando  VidalVanaclocha (CEU-San Pablo University School of Medicine),Maria  Merino; PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Timothy D Veenstra (Office Of The Director)|Cari E Graff-Cherry (Office Of The Director)|Natasha  Caplen (Cancer Genetics Branch)|Chand  Khanna; MD (Pediatric Oncology Branch),NULL,"1. Marino N, Marshall JC, Steeg PS (2011). Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1. Naunyn Schmiedebergs Arch Pharmacol  384, 351-62.   https://doi.org/10.1007/s00210-011-0646-6|2. Marshall J, Collins J, Nakayama J, Horak C, Liewehr D, Steinberg S, Albaugh M, VidalVanaclocha F, Palmieri D, Barbier M, Murone M, Steeg P (2012) Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer. JNCI, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=76486
744,SC003657-38,"October 01, 2011 -  September 30, 2012",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI",Jay T Linton|Hong G Zhang; PhD|Naoko  Okiyama|Vadim Andre Villarroel|Gaku  Tsuji,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology),Keiko  Ozato; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76487
745,SC003669-23,"October 01, 2011 -  September 30, 2012",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Yoichi  Ogawa,"Esther  von Stebut (Dermatology, University of Mainz)|Sarah  Millar (University of Pennsylvania)|Keisuke  Nagao (Keio University Schiool of Medicine)",NULL,Maria Irene Morasso; PhD (NIAMS),"1. Becker MR, Choi YS, Millar SE, Udey MC (2011). Wnt signaling influences the development of murine epidermal Langerhans cells. J Invest Dermatol  131, 1861-8.   https://doi.org/10.1038/jid.2011.131|2. Hwang J, Kita R, Kwon HS, Choi EH, Lee SH, Udey MC, Morasso MI (2011). Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation. Proc Natl Acad Sci U S A  108, 11566-71.   https://doi.org/10.1073/pnas.1019658108",https://intramural.nih.gov/search/searchview.taf?ipid=76488
746,SC004002-43,"October 01, 2011 -  September 30, 2012",IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD|Sigrid Priscilla Dubois|Carolyn  Goldman|Michael N Petrus|Mei  Zhang; MD, PhD|Kayhan  Garmestani; PhD|Show all 11","Nicole  Urquhart (Dept of, University of the West Indies)|Bana  Jabri (University of Chicago)|Richard  Bamford; PhD|Sandor  Damjanovich MD (University of Debrecen)|Georgy  Vamosi (University of Debrecen)","Martin W Brechbiel; PhD (Radiation Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Steven J Jacobson; PhD (NINDS) |Bibiana  Bielekova; MD (NINDS),"1. Bielekova B, Richert N, Herman ML, Ohayon J, Waldmann TA, McFarland H, Martin R, Blevins G (2011). Intrathecal effects of daclizumab treatment of multiple sclerosis. Neurology  77, 1877-86.   https://doi.org/10.1212/WNL.0b013e318239f7ef|2. Chen J, Petrus M, Bamford R, Shih JH, Morris JC, Janik JE, Waldmann TA (2012). Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood  119, 137-43.   https://doi.org/10.1182/blood-2011-04-346759|3. DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, Marietta EV, Kasarda DD, Waldmann TA, Murray JA, Semrad C, Kupfer SS, Belkaid Y, Guandalini S, Jabri B (2011). Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature  471, 220-4.   https://doi.org/10.1038/nature09849|4. Elliott NE, Cleveland SM, Grann V, Janik J, Waldmann TA, Davé UP (2011). FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. Blood  118, 3911-21.   https://doi.org/10.1182/blood-2010-12-319467|5. Ju W, Zhang M, Jiang JK, Thomas CJ, Oh U, Bryant BR, Chen J, Sato N, Tagaya Y, Morris JC, Janik JE, Jacobson S, Waldmann TA (2011). CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. Blood  117, 1938-46.   https://doi.org/10.1182/blood-2010-09-305425|6. Müller JR, Waldmann TA, Dubois S (2012). Selective dependence of H2-M3-restricted CD8 responses on IL-15. J Immunol  188, 2575-82.   https://doi.org/10.4049/jimmunol.1102393|7. Sato N, Sabzevari H, Fu S, Ju W, Petrus MN, Bamford RN, Waldmann TA, Tagaya Y (2011). Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα. Blood  117, 4032-40.   https://doi.org/10.1182/blood-2010-09-307504|8. Steel J, Waldmann T, John M (2011) Interleukin-15 biology and its therapeutic implications in cancer. Trends in Pharmacological Sciences 33 (1):35-41.|9. Wuest SC, Edwan JH, Martin JF, Han S, Perry JS, Cartagena CM, Matsuura E, Maric D, Waldmann TA, Bielekova B (2011). A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med  17, 604-9.   https://doi.org/10.1038/nm.2365|10. Zhang M, Ju W, Yao Z, Yu P, Wei BR, Simpson RM, Waitz R, Fassò M, Allison JP, Waldmann TA (2012). Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice. J Immunol  188, 6156-64.   https://doi.org/10.4049/jimmunol.1102604",https://intramural.nih.gov/search/searchview.taf?ipid=76490
747,SC004020-35,"October 01, 2011 -  September 30, 2012","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Charles D Pendleton|Masaki  Terabe|Yongjun  Sui|Alison Elizabeth Hogg|Zheng  Xia|Yichuan  Wang|Show all 15,"Charles  Delisi|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Mark  Smyth (University of Melbourne)|Show all 30","Lee Jay Helman; MD (Pediatric Oncology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Crystal L. Mackall; MD (Pediatric Oncology Branch)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Bernard  Moss; MD, PhD (NIAID) |Gary J Nabel; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID)","1. Berzofsky JA (2012). A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses. Vaccine  30, 4323-7.   https://doi.org/10.1016/j.vaccine.2011.11.034|2. Isakov D, Dzutsev A, Berzofsky JA, Belyakov IM (2011). Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells. Eur J Immunol  41, 3513-28.   https://doi.org/10.1002/eji.201141453|3. Lai D, Zhu J, Wang T, Hu-Li J, Terabe M, Berzofsky JA, Clayberger C, Krensky AM (2011). KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med  208, 1093-103.   https://doi.org/10.1084/jem.20101527|4. Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK (2011). A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models. J Immunol  187, 4935-46.   https://doi.org/10.4049/jimmunol.1102095|5. O'Konek JJ, Illarionov P, Khursigara DS, Ambrosino E, Izhak L, Castillo BF, Raju R, Khalili M, Kim HY, Howell AR, Besra GS, Porcelli SA, Berzofsky JA, Terabe M (2011). Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity. J Clin Invest  121, 683-94.   https://doi.org/10.1172/JCI42314|6. Sui Y, Gagnon S, Dzutsev A, Zhu Q, Yu H, Hogg A, Wang Y, Xia Z, Belyakov IM, Venzon D, Klinman D, Strober W, Kelsall B, Franchini G, Berzofsky JA (2011). TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques. Vaccine  30, 59-68.   https://doi.org/10.1016/j.vaccine.2011.10.043|7. Yu H, Tawab-Amiri A, Dzutsev A, Sabatino M, Aleman K, Yarchoan R, Terabe M, Sui Y, Berzofsky JA (2011). IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. J Leukoc Biol  90, 205-14.   https://doi.org/10.1189/jlb.1010579|8. Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters R, Kirk J, Eppler B, Klinman D, Sui Y, Gagnon S, Belyakov I, Mumper R, Berzofsky J (2012) Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nature Medicine, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=76491
748,SC006321-33,"October 01, 2011 -  September 30, 2012",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Janet W Gamson|Rajani  Choudhuri|Angela  Thetford|Show all 9,NULL,Deborah E Citrin (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) |Bruce J Baum; DMD, PhD (CC) |Ana Paola  Cotrim Boehm; DDS, PhD (NIDCR)","1. Choudhuri R, DeGraff W, Mitchell J, Cook J (2011) Guggulsterone Mediated Enhancement of Radiation Response in Human Tumor Cell Lines. Frontiers in Radiation Oncology 1:19:1-9.|2. Cotrim AP, Yoshikawa M, Sunshine AN, Zheng C, Sowers AL, Thetford AD, Cook JA, Mitchell JB, Baum BJ (2012). Pharmacological protection from radiation ± cisplatin-induced oral mucositis. Int J Radiat Oncol Biol Phys  83, 1284-90.   https://doi.org/10.1016/j.ijrobp.2011.09.026|3. Matsumoto S, Batra S, Saito K, Yasui H, Choudhuri R, Gadisetti C, Subramanian S, Devasahayam N, Munasinghe JP, Mitchell JB, Krishna MC (2011) Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 71:6350-9|4. Saleh AD, Savage JE, Cao L, Soule BP, Ly D, DeGraff W, Harris CC, Mitchell JB, Simone NL (2011). Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One  6, e24429.   https://doi.org/10.1371/journal.pone.0024429|5. Urick ME, Chung EJ, Shield WP, Gerber N, White A, Sowers A, Thetford A, Camphausen K, Mitchell J, Citrin DE (2011). Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res  17, 5038-47.   https://doi.org/10.1158/1078-0432.CCR-11-0358|6. Zheng C, Cotrim AP, Rowzee A, Swaim W, Sowers A, Mitchell JB, Baum BJ (2011). Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands. Clin Cancer Res  17, 2842-51.   https://doi.org/10.1158/1078-0432.CCR-10-2982",https://intramural.nih.gov/search/searchview.taf?ipid=76492
749,SC006330-32,"October 01, 2011 -  September 30, 2012",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|John  Ondos|Jason Yulin Cheng; PhD|Show all 7,"Thomas  Fearon (Radiology, Children's National Medical Center)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)|Wei  Chen (University of Texas)",NULL,NULL,"1. Li G, Xie H, Ning H, Citrin D, Kaushal A, Camphausen K, Miller RW (2010). Correction of motion-induced misalignment in co-registered PET/CT and MRI (T1/T2/FLAIR) head images for stereotactic radiosurgery. J Appl Clin Med Phys  12, 3306.   https://doi.org/10.1120/jacmp.v12i1.3306",https://intramural.nih.gov/search/searchview.taf?ipid=76478
750,SC006353-30,"October 01, 2011 -  September 30, 2012",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane E Milenic|Kwamena  Baidoo|Kwon Joong  Yong|Young-Seung  Kim|Francois  Guerard; PhD|Yang  Zhou|Show all 8,"Andrew  Scott (Ludwig Institute for Cancer Research)|Ruby  Meredith (UAB)|Silvia  Jurisson (University of Missouri, Columbia)|Tom  Quinn (U. Missouri, Co.)|Lynn  Francesconi (Hunter College)|Marty  Pomper (Johns Hopkins)","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|James B Mitchell; PhD (Radiation Biology Branch)",Peter  Herscovitch; MD (CC),"1. Dadwal M, Kang CS, Song HA, Sun X, Dai A, Baidoo KE, Brechbiel MW, Chong HS (2011). Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates. Bioorg Med Chem Lett  21, 7513-5.   https://doi.org/10.1016/j.bmcl.2011.06.107|2. Nayak TK, Brechbiel MW (2011). 86Y based PET radiopharmaceuticals: radiochemistry and biological applications. Med Chem  7, 380-8.   https://doi.org/10.2174/157340611796799249|3. Nayak TK, Garmestani K, Milenic DE, Baidoo KE, Brechbiel MW (2011). HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. PLoS One  6, e18198.   https://doi.org/10.1371/journal.pone.0018198|4. Ray GL, Baidoo KE, Keller LM, Albert PS, Brechbiel MW, Milenic DE (2011). Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease. Pharmaceuticals (Basel)  5, 1-15.   https://doi.org/10.3390/ph5010001|5. Song HA, Kang CS, Baidoo KE, Milenic DE, Chen Y, Dai A, Brechbiel MW, Chong HS (2011). Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications. Bioconjug Chem  22, 1128-35.   https://doi.org/10.1021/bc100586y|6. Wong KJ, Baidoo KE, Nayak TK, Garmestani K, Brechbiel MW, Milenic DE (2011). In Vitro and In Vivo Pre-Clinical Analysis of a F(ab')(2) Fragment of Panitumumab for Molecular Imaging and Therapy of HER1 Positive Cancers. EJNMMI Res  1.   https://doi.org/10.1186/2191-219X-1-1|7. Yong K, Brechbiel MW (2011). Towards translation of 212Pb as a clinical therapeutic; getting the lead in! Dalton Trans  40, 6068-76.   https://doi.org/10.1039/c0dt01387k",https://intramural.nih.gov/search/searchview.taf?ipid=76493
751,SC006387-25,"October 01, 2011 -  September 30, 2012",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Janet W Gamson|Rajani  Choudhuri|Angela  Thetford|Show all 9,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section),Tracey Ann Rouault; MD (NICHD),"1. Fabre KM, Saito K, DeGraff W, Sowers AL, Thetford A, Cook JA, Krishna MC, Mitchell JB (2011). The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther  12, 915-23.   https://doi.org/10.4161/cbt.12.10.17714|2. Flores-Santana W, Moody T, Chen W, Gorczynski MJ, Shoman ME, Velázquez C, Thetford A, Mitchell JB, Cherukuri MK, King SB, Wink DA (2012). Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells. Br J Pharmacol  165, 1058-67.   https://doi.org/10.1111/j.1476-5381.2011.01527.x|3. Jeong SY, Crooks DR, Wilson-Ollivierre H, Ghosh MC, Sougrat R, Lee J, Cooperman S, Mitchell JB, Beaumont C, Rouault TA (2011). Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS One  6, e25404.   https://doi.org/10.1371/journal.pone.0025404",https://intramural.nih.gov/search/searchview.taf?ipid=76494
752,SC006538-19,"October 01, 2011 -  September 30, 2012",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Douglas K Price|Kelie M Reece; PhD|Emily  Richardson|William Laurence Dahut; MD|Andrea Borghese Apolo|Show all 7,"Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Edward  Goetzl (University of California, San Francisco)","Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|John J Wright (Investigational Drug Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",NULL,"1. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682",https://intramural.nih.gov/search/searchview.taf?ipid=76495
753,SC006581-29,"October 01, 2011 -  September 30, 2012",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Yulia  Demchenko|Wei-Dong  Chen,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|John  Shaughnessy (Universiy of Arkansas for Medical Sciences)|Brendan  Weiss|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|Carlo  Croce (The Ohio State University)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch),NULL,"1. Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM (2011). A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood  117, 2396-404.   https://doi.org/10.1182/blood-2010-04-278788|2. Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O (2011). Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients. Am J Hematol  86, 475-8.   https://doi.org/10.1002/ajh.22025|3. Zingone A, Kuehl WM (2011). Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. Semin Hematol  48, 4-12.   https://doi.org/10.1053/j.seminhematol.2010.11.003",https://intramural.nih.gov/search/searchview.taf?ipid=76496
754,SC006663-23,"October 01, 2011 -  September 30, 2012",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,NULL,"Surgery Branch, NCI",Marybeth S Hughes,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Joanna H Shih (Biometrics Research Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76497
755,SC006732-24,"October 01, 2011 -  September 30, 2012","Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance","Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Marianne  Poruchynsky|Julia  Wilkerson|Wilfred D Stein|Susan  Bates; MD|William D Figg; PharmD|Douglas K Price|Show all 8,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)",Robert  Innis; MD (NIMH),"1. Amiri-Kordestani L, Basseville A, Kurdziel K, Fojo AT, Bates SE (2012). Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist Updat  15, 50-61.   https://doi.org/10.1016/j.drup.2012.02.002|2. Fojo T, Amiri-Kordestani L, Bates SE (2011). Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer. J Natl Cancer Inst  103, 1738-40.   https://doi.org/10.1093/jnci/djr386|3. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|4. Kelly RJ, Robey RW, Chen CC, Draper D, Luchenko V, Barnett D, Oldham RK, Caluag Z, Frye AR, Steinberg SM, Fojo T, Bates SE (2012). A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors. Oncologist  17, 512.   https://doi.org/10.1634/theoncologist.2012-0080|5. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|6. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762",https://intramural.nih.gov/search/searchview.taf?ipid=76498
756,SC006737-21,"October 01, 2011 -  September 30, 2012",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Victoria Y Wang|Kathleen M Wyvill|Karen O Aleman|Thomas S Uldrick|Mark Niccolo Polizzotto; MD|Show all 8,Jean  Chmielewski (Purdue University)|Indira  Hewlett (Food and Drug  Administration)|Shixing  Tang (FDA),"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Frank  Maldarelli (Host Virus Interaction Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)",Paul T Wingfield; PhD (NIAMS),"1. Uldrick TS, Polizzotto MN, Yarchoan R (2012). Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol  24, 495-505.   https://doi.org/10.1097/CCO.0b013e328355e0f3|2. Yu H, Tawab-Amiri A, Dzutsev A, Sabatino M, Aleman K, Yarchoan R, Terabe M, Sui Y, Berzofsky JA (2011). IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. J Leukoc Biol  90, 205-14.   https://doi.org/10.1189/jlb.1010579",https://intramural.nih.gov/search/searchview.taf?ipid=76499
757,SC006738-21,"October 01, 2011 -  September 30, 2012",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Ravikiran S Yedidi|Kenji  Maeda|Darshan  Desai; BS,"Arun  Ghosh|Masao 		  Matsuoka (Institute for Virus Research, Kyoto University)|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Hiroyuki  Hayakawa (Yamasa Corporation)|Eiichi  Kodama (Kyoto University)|Show all 11",NULL,NULL,"1. Ghosh AK, Chapsal BD, Baldridge A, Steffey MP, Walters DE, Koh Y, Amano M, Mitsuya H (2011). Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. J Med Chem  54, 622-34.   https://doi.org/10.1021/jm1012787|2. Ghosh AK, Chapsal BD, Parham GL, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2011). Design of HIV-1 protease inhibitors with C3-substituted hexahydrocyclopentafuranyl urethanes as P2-ligands: synthesis, biological evaluation, and protein-ligand X-ray crystal structure. J Med Chem  54, 5890-901.   https://doi.org/10.1021/jm200649p|3. Ide K, Aoki M, Amano M, Koh Y, Yedidi RS, Das D, Leschenko S, Chapsal B, Ghosh AK, Mitsuya H (2011). Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. Antimicrob Agents Chemother  55, 1717-27.   https://doi.org/10.1128/AAC.01540-10|4. Kirby KA, Singh K, Michailidis E, Marchand B, Kodama EN, Ashida N, Mitsuya H, Parniak MA, Sarafianos SG (2011). The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase. Cell Mol Biol (Noisy-le-grand)  57, 40-6.|5. Koh Y, Aoki M, Danish ML, Aoki-Ogata H, Amano M, Das D, Shafer RW, Ghosh AK, Mitsuya H (2011). Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1. J Virol  85, 10079-89.   https://doi.org/10.1128/JVI.05121-11",https://intramural.nih.gov/search/searchview.taf?ipid=76479
758,SC006741-20,"October 01, 2011 -  September 30, 2012",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom  80, 309-17.   https://doi.org/10.1002/cyto.b.20593|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|3. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2012). Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom  82, 67-77.   https://doi.org/10.1002/cyto.b.20622|4. Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH (2012). Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep  7, 241-7.   https://doi.org/10.1007/s11899-012-0130-5|5. Dunleavy K, Roschewski M, Wilson WH (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep  7, 208-15.   https://doi.org/10.1007/s11899-012-0132-3|6. Dunleavy K, Wilson WH (2011). Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma. Clin Cancer Res  17, 7505-7.   https://doi.org/10.1158/1078-0432.CCR-11-2372|7. Dunleavy K, Wilson WH (2012). How I treat HIV-associated lymphoma. Blood  119, 3245-55.   https://doi.org/10.1182/blood-2011-08-373738|8. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|9. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|10. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|11. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|12. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|13. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011). NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood  117, 1447-52.   https://doi.org/10.1182/blood-2010-08-302737|14. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|15. Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses  54, e877-9.   https://doi.org/10.1111/j.1439-0507.2011.02016.x|16. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|17. Roschewski M, Wilson WH (2012). EBV-associated lymphomas in adults. Best Pract Res Clin Haematol  25, 75-89.   https://doi.org/10.1016/j.beha.2012.01.005|18. Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S (2012). Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia  26, 1895-8.   https://doi.org/10.1038/leu.2012.72|19. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA (2011). A novel role for IL-22R1 as a driver of inflammation. Blood  117, 575-84.   https://doi.org/10.1182/blood-2010-05-285908|20. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|21. Weniger MA, Rizzatti EG, Pérez-Galán P, Liu D, Wang Q, Munson PJ, Raghavachari N, White T, Tweito MM, Dunleavy K, Ye Y, Wilson WH, Wiestner A (2011). Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res  17, 5101-12.   https://doi.org/10.1158/1078-0432.CCR-10-3367|22. Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED, Cancer Leukemia Group B (2012). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica  97, 758-65.   https://doi.org/10.3324/haematol.2011.056531",https://intramural.nih.gov/search/searchview.taf?ipid=76480
759,SC006891-24,"October 01, 2011 -  September 30, 2012",Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Lauren M Long|Fernanda  Arnaldez|Crystal L. Mackall; MD|Su-Young  Kim|Brigitte  Widemann; MD,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|2. Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, et al. [12 more authors] (2012). The first European interdisciplinary ewing sarcoma research summit. Front Oncol  2, 54.   https://doi.org/10.3389/fonc.2012.00054|3. Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH (2011). R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. J Clin Oncol  29, 4541-7.   https://doi.org/10.1200/JCO.2010.34.0000",https://intramural.nih.gov/search/searchview.taf?ipid=76500
760,SC006892-24,"October 01, 2011 -  September 30, 2012",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Xiaolin  Wan|Lauren M Long|Arnulfo G Mendoza|Choh L Yeung|Fernanda  Arnaldez|Barbara A Dickens,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)","Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ (2011). Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia  13, 145-53.   https://doi.org/10.1593/neo.101202|2. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|3. Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, et al. [12 more authors] (2012). The first European interdisciplinary ewing sarcoma research summit. Front Oncol  2, 54.   https://doi.org/10.3389/fonc.2012.00054|4. Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH (2011). R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. J Clin Oncol  29, 4541-7.   https://doi.org/10.1200/JCO.2010.34.0000|5. Wiener L, Battles H, Zadeh S, Smith CJ, Helman LJ, Kim SY (2012). Gastrointestinal stromal tumor: psychosocial characteristics and considerations. Support Care Cancer  20, 1343-9.   https://doi.org/10.1007/s00520-012-1426-7",https://intramural.nih.gov/search/searchview.taf?ipid=76501
761,SC007263-20,"October 01, 2011 -  September 30, 2012",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sireesha  Garimella|Kathryn Jill Chavez,Mauricio A Cuello|Sandra M Swain; MD,"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Chavez KJ, Garimella SV, Lipkowitz S (2010). Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis  32, 35-48.   https://doi.org/10.3233/BD-2010-0307|2. Garimella SV, Rocca A, Lipkowitz S (2012). WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis. Mol Cancer Res  10, 75-85.   https://doi.org/10.1158/1541-7786.MCR-11-0500",https://intramural.nih.gov/search/searchview.taf?ipid=76502
762,SC007281-19,"October 01, 2011 -  September 30, 2012",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Christopher H Switzer|Yuk Sing Robert Cheng|Julie Lynn Heinecke; PhD|James B Mitchell; PhD,"Piero  del Soldato (Pharma, CTG Pharma)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Larry K Keefer; PhD (Chemical Biology Laboratory)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office of the Director),NULL,"1. Switzer CH, Glynn SA, Ridnour LA, Cheng RY, Vitek MP, Ambs S, Wink DA (2011). Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharmacol Sci  32, 644-51.   https://doi.org/10.1016/j.tips.2011.07.001|2. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA (2011). Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol  89, 873-91.   https://doi.org/10.1189/jlb.1010550",https://intramural.nih.gov/search/searchview.taf?ipid=76503
763,SC009144-28,"October 01, 2011 -  September 30, 2012",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Suzanne Laurie Sanford|Weixin  Zhou; PhD|Yeung  Ho,"Demetrios T Braddock; MD, PhD|John  Cleveland|Juhong  Liu (FDA)","Lino  Tessarollo (Mouse Cancer Genetics Program)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Liu J, Chung HJ, Vogt M, Jin Y, Malide D, He L, Dundr M, Levens D (2011). JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J  30, 846-58.   https://doi.org/10.1038/emboj.2011.11",https://intramural.nih.gov/search/searchview.taf?ipid=76504
764,SC009163-25,"October 01, 2011 -  September 30, 2012",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Victoria M Virador|Minshu R Yu|Giovanna  Casagrande|Andrea Katherine McCollum|Marco  Mineo|Mario Andrew Cedillo|Show all 10,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Riccardo  Alessandro (U-Palermo)|Thomas  Conrads (USUHS),"David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Robert  Callahan; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)",David John Sandstrom; PhD (NIMH),"1. Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011). Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells. Gynecol Oncol  122, 656-62.   https://doi.org/10.1016/j.ygyno.2011.04.052",https://intramural.nih.gov/search/searchview.taf?ipid=76505
765,SC009172-24,"October 01, 2011 -  September 30, 2012",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes|Sukhbir  Kaur|Thomas W Miller; PhD|Gema  Martin-Manso|David Ricardo Soto Pantoja; PhD|Erica  Stein|Show all 7,"Willaim  Frazier (Biochemistry and Molecular Biophysics, Washington University)|Deane  Mosher (University of Wisconsin)|Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)","David Anderson Wink (Radiation Biology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",Jurgen B Schnermann; MD (NIDDK),"1. Englund EA, Wang D, Fujigaki H, Sakai H, Micklitsch CM, Ghirlando R, Martin-Manso G, Pendrak ML, Roberts DD, Durell SR, Appella DH (2012). Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds. Nat Commun  3, 614.   https://doi.org/10.1038/ncomms1629|2. Roberts DD (2011). Emerging functions of matricellular proteins. Cell Mol Life Sci  68, 3133-6.   https://doi.org/10.1007/s00018-011-0779-2|3. Soto-Pantoja DR, Isenberg JS, Roberts DD (2011). Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation. J Genet Syndr Gene Ther  2.   https://doi.org/10.4172/2157-7412.1000105",https://intramural.nih.gov/search/searchview.taf?ipid=76458
766,SC009173-24,"October 01, 2011 -  September 30, 2012",Host Colonization and Vascular Dissemination of ICandida albicansI,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Michael L Pendrak|John M Sipes|Dhammika  Navarathna; PhD|Gema  Martin-Manso|Erica  Stein,Ken  Nickerson (University of Nebraska)|Joachim  Morschhuser (Universitt Wrzburg),NULL,Martin J Lizak; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Pendrak ML, Roberts DD (2011). Ribosomal RNA processing in Candida albicans. RNA  17, 2235-48.   https://doi.org/10.1261/rna.028050.111",https://intramural.nih.gov/search/searchview.taf?ipid=76476
767,SC009174-24,"October 01, 2011 -  September 30, 2012",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes|Sukhbir  Kaur|Thomas W Miller; PhD|Erica  Stein|Maria  Tsokos; MD|Maria  Merino; PhD,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University),David Anderson Wink (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76456
768,SC009179-24,"October 01, 2011 -  September 30, 2012",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Beiyang  Wei|Sandra  Jensen-Taubman|Liliana  Guedez; PhD|Dimitra  Bourmpoulia; PhD|Huiying  Han|Laurie Ann  Shuman Moss,"Dong-Wan  Seo (Laboratory of Molecular Biochemistry, Kangwon National University)|Junseo  Oh (Korea University Graduate School Of Medicine)","Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Arian  Laurence (NIAMS),"1. Bourboulia D, Jensen-Taubman S, Rittler MR, Han HY, Chatterjee T, Wei B, Stetler-Stevenson WG (2011). Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment. Am J Pathol  179, 2589-600.   https://doi.org/10.1016/j.ajpath.2011.07.035|2. Gonçalves AN, Meschiari CA, Stetler-Stevenson WG, Nonato MC, Alves CP, Espreafico EM, Gerlach RF (2012). Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli. J Biotechnol  157, 20-4.   https://doi.org/10.1016/j.jbiotec.2011.09.030|3. Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A, Stetler-Stevenson WG (2011). An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides  32, 1840-8.   https://doi.org/10.1016/j.peptides.2011.08.010",https://intramural.nih.gov/search/searchview.taf?ipid=76506
769,SC009374-21,"October 01, 2011 -  September 30, 2012",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Minshu R Yu|John Lawrence Hays|Jung-Min  Lee|Marco  Mineo|Saawan C Mehta|William D Figg; PharmD|Show all 7,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Riccardo  Alessandro (U-Palermo)|Yiling  Lu (MD Anderson Cancer Center),David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Eric Christopher Polley (Biometrics Research Branch),NULL,"1. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De Leo G, Alessandro R (2012). Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer  130, 2033-43.   https://doi.org/10.1002/ijc.26217",https://intramural.nih.gov/search/searchview.taf?ipid=76507
770,SC009375-20,"October 01, 2011 -  September 30, 2012",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Minshu R Yu|Nicole Dupas Houston|John Lawrence Hays|Andrea Katherine McCollum|Jung-Min  Lee|Mario Andrew Cedillo|Show all 13,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Joyce  Liu (DFCI)|Ursula  Matulonis (DFCI)|Thomas  Conrads (USUHS)|Laura  Havriletsky (Duke University)|Show all 7,Chad Andrew Hamilton (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|James Halpern Doroshow (Developmental Therapeutics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert F Murphy (Pediatric Oncology Branch),Bradford J Wood; MD (CC),"1. Han JJ, Yu M, Houston N, Steinberg SM, Kohn EC (2011). Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol  120, 5-10.   https://doi.org/10.1016/j.ygyno.2010.09.006|2. Jain L, Woo S, Gardner ER, Dahut WL, Kohn EC, Kummar S, Mould DR, Giaccone G, Yarchoan R, Venitz J, Figg WD (2011). Population pharmacokinetic analysis of sorafenib in patients with solid tumours. Br J Clin Pharmacol  72, 294-305.   https://doi.org/10.1111/j.1365-2125.2011.03963.x|3. Lee JM, Han JJ, Altwerger G, Kohn EC (2011). Proteomics and biomarkers in clinical trials for drug development. J Proteomics  74, 2632-41.   https://doi.org/10.1016/j.jprot.2011.04.023|4. Mannel RS, Brady MF, Kohn EC, Hanjani P, Hiura M, Lee R, Degeest K, Cohn DE, Monk BJ, Michael H (2011). A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol  122, 89-94.   https://doi.org/10.1016/j.ygyno.2011.03.013|5. Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC (2012). L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med  16, 2369-78.   https://doi.org/10.1111/j.1582-4934.2012.01547.x",https://intramural.nih.gov/search/searchview.taf?ipid=76508
771,SC009389-19,"October 01, 2011 -  September 30, 2012",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,Massimo  Santoro|Ginesa  GarciaRostan (University of Valladolid),"Sheueyann  Cheng; PhD (Gene Regulation Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K (2011). LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells. Cancer Res  71, 7301-11.   https://doi.org/10.1158/0008-5472.CAN-11-2381",https://intramural.nih.gov/search/searchview.taf?ipid=76509
772,SC010051-17,"October 01, 2011 -  September 30, 2012",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane E Milenic|Kwamena  Baidoo|Ambika  Bumb|Young-Seung  Kim|Yang  Zhou,NULL,NULL,Lacy Henry Bryant (CC),"1. Bumb A, Sarkar SK, Wu XS, Brechbiel MW, Neuman KC (2011). Quantitative characterization of fluorophores in multi-component nanoprobes by single-molecule fluorescence. Biomed Opt Express  2, 2761-9.   https://doi.org/10.1364/BOE.2.002761|2. Nwe K, Milenic D, Bryant LH, Regino CA, Brechbiel MW (2011). Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI. J Inorg Biochem  105, 722-7.   https://doi.org/10.1016/j.jinorgbio.2011.01.017|3. Nwe K, Milenic DE, Ray GL, Kim YS, Brechbiel MW (2012). Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography. Mol Pharm  9, 374-81.   https://doi.org/10.1021/mp2003219",https://intramural.nih.gov/search/searchview.taf?ipid=76512
773,SC010058-17,"October 01, 2011 -  September 30, 2012",Regulation of Apoptosis in Ewing Sarcoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Guang  Li,NULL,Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76513
774,SC010074-17,"October 01, 2011 -  September 30, 2012",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Wanping  Xu|Shinji  Tsutsumi|Kristin  Eckfeld|Mehdi  Mollapour|Alok  Mishra|Thomas L Prince|Show all 10,"YunJin  Jung (Pusan National University)|Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Show all 12",Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Jane Beth Trepel (Medical Oncology Branch)|James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB (2012). Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy. Curr Mol Med  12, 1125-41.   https://doi.org/10.2174/156652412803306729|2. De Leon JT, Iwai A, Feau C, Garcia Y, Balsiger HA, Storer CL, Suro RM, Garza KM, Lee S, Kim YS, Chen Y, Ning YM, Riggs DL, Fletterick RJ, Guy RK, Trepel JB, Neckers LM, Cox MB (2011). Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc Natl Acad Sci U S A  108, 11878-83.   https://doi.org/10.1073/pnas.1105160108|3. Koga F, Yoshida S, Tatokoro M, Kawakami S, Fujii Y, Kumagai J, Neckers L, Kihara K (2011). ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One  6, e27616.   https://doi.org/10.1371/journal.pone.0027616|4. Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes DaGama EM, Caldas-Lopes E, Beebe K, Perna F, Hatzi K, Vu LP, Zhao X, Zatorska D, Taldone T, Smith-Jones P, Alpaugh M, Gross SS, Pillarsetty N, Ku T, Lewis JS, Larson SM, Levine R, Erdjument-Bromage H, Guzman ML, Nimer SD, et al. [3 more authors] (2011). Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol  7, 818-26.   https://doi.org/10.1038/nchembio.670|5. Neckers L, Workman P (2012). Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res  18, 64-76.   https://doi.org/10.1158/1078-0432.CCR-11-1000|6. Xu W, Trepel J, Neckers L (2011). Ras, ROS and proteotoxic stress: a delicate balance. Cancer Cell  20, 281-2.   https://doi.org/10.1016/j.ccr.2011.08.020",https://intramural.nih.gov/search/searchview.taf?ipid=76514
775,SC010093-16,"October 01, 2011 -  September 30, 2012",Targeting the Epigenome for Lung Cancer Therapy,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Julie A Hong|Tricia M Frary|Mahadev  Rao|Mary R Zhang,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Sacha  Ghnatic (Ludwig Cancer Inst)|Xinmin  Li (Functional Genomics, University of Chicago)",William D Figg; PharmD (Medical Oncology Branch)|Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,"1. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS (2012). Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res  18, 77-90.   https://doi.org/10.1158/1078-0432.CCR-11-0962|2. Schrump DS (2012). Targeting epigenetic mediators of gene expression in thoracic malignancies. Biochim Biophys Acta  1819, 836-45.   https://doi.org/10.1016/j.bbagrm.2012.03.009",https://intramural.nih.gov/search/searchview.taf?ipid=76482
776,SC010098-10,"October 01, 2011 -  September 30, 2012",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Nancy A Harold|Anna C Couvillon; NP|Melony A Avella|Philip M Arlen; MD|William D Figg; PharmD|Antonio  Fojo; MD, PhD","Anthony  D'Amico (Radiation Oncology, Harvard Medical School)|Phil  Kantoff (DFCI)","James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Bilusic M, Dahut WL (2011). Cabazitaxel: a new drug for metastatic prostate cancer. Asian J Androl  13, 185-6.   https://doi.org/10.1038/aja.2010.161|2. Jain L, Woo S, Gardner ER, Dahut WL, Kohn EC, Kummar S, Mould DR, Giaccone G, Yarchoan R, Venitz J, Figg WD (2011). Population pharmacokinetic analysis of sorafenib in patients with solid tumours. Br J Clin Pharmacol  72, 294-305.   https://doi.org/10.1111/j.1365-2125.2011.03963.x|3. Madan RA, Aragon-Ching JB, Gulley JL, Dahut WL (2011). From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev Vaccines  10, 743-53.   https://doi.org/10.1586/erv.11.70|4. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762|5. Tanno T, Rabel A, Alleyne M, Lee YT, Dahut WL, Gulley JL, Miller JL (2011). Hepcidin, anaemia, and prostate cancer. BJU Int  107, 678-9.   https://doi.org/10.1111/j.1464-410X.2011.10108.x",https://intramural.nih.gov/search/searchview.taf?ipid=76538
777,SC010100-13,"October 01, 2011 -  September 30, 2012",The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Galina Ivanovna Belova|Gregory P Riddick|Serdar  Bozdag,NULL,Kenneth  Buetow; PhD (Laboratory of Population Genetics),John Keenam Park (NINDS) |Russell R Lonser; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76515
778,SC010282-15,"October 01, 2011 -  September 30, 2012",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Mohammed Zulfiqar Farooqui; DO (NHLBI)","1. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom  80, 309-17.   https://doi.org/10.1002/cyto.b.20593|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|3. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984",https://intramural.nih.gov/search/searchview.taf?ipid=76516
779,SC010288-15,"October 01, 2011 -  September 30, 2012",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","J  Foley|Miriam E Mossoba|David Charles Halverson; MD|Ronald E Gress; MD|Steven  Pavletic; MD, MS|Frances  Hakim; PhD","Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Robert  Korngold (Cancer Center, Hackensack University)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)",David F Stroncek; MD (CC) |Susan  Leitman; MD (CC) |Hanh M Khuu; MD (CC),"1. Amarnath S, Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, Fowler DH (2011). Host-based Th2 cell therapy for prolongation of cardiac allograft viability. PLoS One  6, e18885.   https://doi.org/10.1371/journal.pone.0018885|2. Amarnath S, Fowler DH (2012). Harnessing autophagy for adoptive T-cell therapy. Immunotherapy  4, 1-4.   https://doi.org/10.2217/imt.11.144|3. Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, Mitchell SA, Hakim FT, Martires KJ, Avila DN, Taylor TN, Salit RB, Rowley SD, Zhang D, Fowler DH, Bishop MR, Gress RE, Pavletic SZ (2012). Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia  26, 633-43.   https://doi.org/10.1038/leu.2011.254|4. Hardy NM, Mossoba ME, Steinberg SM, Fellowes V, Yan XY, Hakim FT, Babb RR, Avila D, Gea-Banacloche J, Sportès C, Levine BL, June CH, Khuu HM, Carpenter AE, Krumlauf MC, Dwyer AJ, Gress RE, Fowler DH, Bishop MR (2011). Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer. Clin Cancer Res  17, 6878-87.   https://doi.org/10.1158/1078-0432.CCR-11-1579|5. Mariotti J, Taylor J, Massey PR, Ryan K, Foley J, Buxhoeveden N, Felizardo TC, Amarnath S, Mossoba ME, Fowler DH (2011). The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection. Biol Blood Marrow Transplant  17, 620-31.   https://doi.org/10.1016/j.bbmt.2010.11.029|6. Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH (2011). Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts. Clin Cancer Res  17, 3697-705.   https://doi.org/10.1158/1078-0432.CCR-11-0493",https://intramural.nih.gov/search/searchview.taf?ipid=76517
780,SC010292-14,"October 01, 2011 -  September 30, 2012",Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Joell J Gills|Shigeru  Kawabata|Yoon Soo Chang; MD|Ajaikumar B Kunnamakkara|Colleen R Maier|Willie  Wilson|Show all 16,"William  Travis (Memorial Sloan Kettering Cancer Center)|William  Pao (Memorial Sloan Kettering Cancer Center)|Pasi  Janne (Oncology, Dana-Farber Cancer Center)|Alan  Kozikowski (University of Illinois at Chicago)","Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Joanna H Shih (Biometrics Research Branch)|Jin  Jen (Molecular Genetics and Carcinogenesis Section)|Jonathan S Wiest; PhD (Laboratory of Cancer Biology and Genetics)","Carter  Van Waes; MD, PhD (NIDCD) |J Silvio  Gutkind; PhD (NIDCR) |Mones S Abu Asab (NEI)","1. Hollander MC, Blumenthal GM, Dennis PA (2011). PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer  11, 289-301.   https://doi.org/10.1038/nrc3037|2. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA (2011). Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene  30, 1812-21.   https://doi.org/10.1038/onc.2010.556|3. Hollander MC, Zhou X, Maier CR, Patterson AD, Ding X, Dennis PA (2011). A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. Carcinogenesis  32, 1279-84.   https://doi.org/10.1093/carcin/bgr097|4. Maier CR, Hollander MC, Hobbs EA, Dogan I, Linnoila RI, Dennis PA (2011). Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res (Phila)  4, 1743-51.   https://doi.org/10.1158/1940-6207.CAPR-11-0365|5. West L, Vidwans SJ, Campbell NP, Shrager J, Simon GR, Bueno R, Dennis PA, Otterson GA, Salgia R (2012). A novel classification of lung cancer into molecular subtypes. PLoS One  7, e31906.   https://doi.org/10.1371/journal.pone.0031906|6. Zhang C, Elkahloun AG, Liao H, Delaney S, Saber B, Morrow B, Prendergast GC, Hollander MC, Gills JJ, Dennis PA (2011). Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cells. Mol Cancer Ther  10, 1137-48.   https://doi.org/10.1158/1535-7163.MCT-10-1028|7. Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J, Shih JH, Fukuoka J, Hollander MC, Harris CC, Travis WD, Jen J, Dennis PA (2011). Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PLoS One  6, e23849.   https://doi.org/10.1371/journal.pone.0023849",https://intramural.nih.gov/search/searchview.taf?ipid=76518
781,SC010354-13,"October 01, 2011 -  September 30, 2012",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Patricia O Whitcomb|Diane  Cole|Nalini M Jayaprakash|Andrea F Gillespie|Wendy J Goodspeed|Anne D Goodwin|Show all 15,"Gregory  Reaman (Children's National Medical Center)|David  Viskochil (University of Utah)|John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Larry  Baker (SARC)|Peter Charles Adamson; MD|Susan  Blaney (Texas Children's Cancer Center)|Show all 7","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Jeffrey M Solomon; BS, MS, PhD (CC)","1. Kim A, Dombi E, Solomon J, Fox E, Balis FM, Widemann BC (2011). Automated volumetric growth plate measurement using magnetic resonance imaging for monitoring skeletal toxicity in children treated on investigational drug trials. Clin Cancer Res  17, 5982-90.   https://doi.org/10.1158/1078-0432.CCR-10-2259|2. Marcus L, Murphy R, Fox E, McCully C, Cruz R, Warren KE, Meyer T, McNiff E, Balis FM, Widemann BC (2012). The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates. Cancer Chemother Pharmacol  69, 247-52.   https://doi.org/10.1007/s00280-011-1659-z|3. Widemann BC, Arceci RJ, Jayaprakash N, Fox E, Zannikos P, Goodspeed W, Goodwin A, Wright JJ, Blaney SM, Adamson PC, Balis FM (2011). Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group. Pediatr Blood Cancer  56, 226-33.   https://doi.org/10.1002/pbc.22775",https://intramural.nih.gov/search/searchview.taf?ipid=76520
782,SC010355-13,"October 01, 2011 -  September 30, 2012",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Ombretta  Salvucci|Kan  Jiang|Inn-Inn  Chen|Georgina  Espigol Frigole|Hidetaka  Ohnuki|Hyeong Il  Kwak|Show all 7,Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Amparo  AcherPalmer (University of Frankfurt)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling),Dragan  Maric; PhD (NINDS) |Xuri  Li (NEI) |Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI) |Jinfang  Zhu; PhD (NIAID),"1. Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G (2012). Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res  72, 1157-69.   https://doi.org/10.1158/0008-5472.CAN-11-3067|2. Noberini R, Mitra S, Salvucci O, Valencia F, Duggineni S, Prigozhina N, Wei K, Tosato G, Huang Z, Pasquale EB (2011). PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity. PLoS One  6, e28611.   https://doi.org/10.1371/journal.pone.0028611",https://intramural.nih.gov/search/searchview.taf?ipid=76521
783,SC010356-13,"October 01, 2011 -  September 30, 2012",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Ombretta  Salvucci|Kan  Jiang|Georgina  Espigol Frigole|Hidetaka  Ohnuki|Hyeong Il  Kwak|David  Sanchez Martin; PhD,Frederick  Wang (Harvard Univ)|Stefan  RoseJohn (Univ. of Kiel),"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David A Davis; MD (HIV and AIDS Malignancy Branch)",Joshua  Farber; MD (NIAID) |Dragan  Maric; PhD (NINDS) |Manfred  Boehm; MD (NHLBI),"1. Sakakibara S, Sakakibara K, Tosato G (2011). NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells. J Virol  85, 3179-86.   https://doi.org/10.1128/JVI.02333-10|2. Sakakibara S, Tosato G (2011). Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies. J Interferon Cytokine Res  31, 791-801.   https://doi.org/10.1089/jir.2011.0043|3. Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R (2011). High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood  117, 6977-86.   https://doi.org/10.1182/blood-2010-11-317610",https://intramural.nih.gov/search/searchview.taf?ipid=76522
784,SC010357-13,"October 01, 2011 -  September 30, 2012",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI",Vladimir  Majerciak|Xiaohong  Wang|Masahiko  Ajiro; PhD|Nishi Raj Sharma; PhD|Xiaofan  Li; PhD|Robert  Yarchoan; MD,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)","Michael John Kruhlak; PhD (Experimental Immunology Branch)|Barbara K Felber (Vaccine Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|George N Pavlakis; MD, PhD (Vaccine Branch)",John Philip McCoy (NHLBI) |Chuxia  Deng; PhD (NIDDK) |Jun  Zhu; PhD (NHLBI),"1. Kang JG, Majerciak V, Uldrick TS, Wang X, Kruhlak M, Yarchoan R, Zheng ZM (2011). Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol  225, 378-89.   https://doi.org/10.1002/path.2962|2. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol  85, 2620-30.   https://doi.org/10.1128/JVI.02144-10|3. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol  85, 1528-40.   https://doi.org/10.1128/JVI.01709-10|4. Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM (2011). Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci  7, 1145-60.   https://doi.org/10.7150/ijbs.7.1145|5. Wang X, Meyers C, Guo M, Zheng ZM (2011). Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer  129, 1362-72.   https://doi.org/10.1002/ijc.25800|6. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM (2011). Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol  85, 8080-92.   https://doi.org/10.1128/JVI.00670-11|7. Zheng ZM, Wang X (2011). Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta  1809, 668-77.   https://doi.org/10.1016/j.bbagrm.2011.05.005",https://intramural.nih.gov/search/searchview.taf?ipid=76523
785,SC010366-12,"October 01, 2011 -  September 30, 2012",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Xinyu  Wen|Jianbin Na He|John Frederick Shern|Catherine A House|Show all 13,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Peter  Ambros (Children’s Cancer Research Institute)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Daniel  Catchpoole (The Children's Hospital at Westmead)","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697|2. Gonzalez-Bosquet J, Calcei J, Wei JS, Garcia-Closas M, Sherman ME, Hewitt S, Vockley J, Lissowska J, Yang HP, Khan J, Chanock S (2011). Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One  6, e14522.   https://doi.org/10.1371/journal.pone.0014522|3. Guo X, Chen QR, Song YK, Wei JS, Khan J (2011). Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics  4, 35.   https://doi.org/10.1186/1755-8794-4-35|4. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187",https://intramural.nih.gov/search/searchview.taf?ipid=76525
786,SC010372-12,"October 01, 2011 -  September 30, 2012",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Mary T Sproull|Andrea A Francesconi|Cody Daniel Schlaff,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76527
787,SC010373-12,"October 01, 2011 -  September 30, 2012",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Mary T Sproull|Ira  Gordon|Andrea A Francesconi|Anita T Tandle|Tamalee  Scott|William Tristram Arscott|Show all 7,NULL,"Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)",NULL,"1. Arscott WT, Camphausen KA (2011). Analysis of urinary exosomes to identify new markers of non-small-cell lung cancer. Biomark Med  5, 822.|2. Arscott WT, Camphausen KA (2011). EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Biomark Med  5, 821.   https://doi.org/10.2217/bmm.11.80|3. Arscott WT, Camphausen KA (2011). Exosome characterization from ascitic fluid holds promise for identifying markers of colorectal cancer. Biomark Med  5, 821-2.|4. de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV (2011). Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res  17, 4872-81.   https://doi.org/10.1158/1078-0432.CCR-11-0271|5. Gordon IK, Graves C, Kil WJ, Kramp T, Tofilon P, Camphausen K (2012). Radiosensitization by the novel DNA intercalating agent vosaroxin. Radiat Oncol  7, 26.   https://doi.org/10.1186/1748-717X-7-26|6. Hayman TJ, Williams ES, Jamal M, Shankavaram UT, Camphausen K, Tofilon PJ (2012). Translation initiation factor eIF4E is a target for tumor cell radiosensitization. Cancer Res  72, 2362-72.   https://doi.org/10.1158/0008-5472.CAN-12-0329|7. Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ (2012). The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells. Neoplasia  14, 150-8.   https://doi.org/10.1593/neo.111794|8. Kil WJ, Tofilon PJ, Camphausen K (2012). Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol  7, 25.   https://doi.org/10.1186/1748-717X-7-25|9. Kramp TR, Camphausen K (2012). Combination radiotherapy in an orthotopic mouse brain tumor model. J Vis Exp   e3397  https://doi.org/10.3791/3397|10. Shankavaram UT, Bredel M, Burgan WE, Carter D, Tofilon P, Camphausen K (2012). Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma. J Cell Mol Med  16, 545-54.   https://doi.org/10.1111/j.1582-4934.2011.01345.x|11. Urick ME, Chung EJ, Shield WP, Gerber N, White A, Sowers A, Thetford A, Camphausen K, Mitchell J, Citrin DE (2011). Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res  17, 5038-47.   https://doi.org/10.1158/1078-0432.CCR-11-0358|12. Wuthrick EJ, Kamrava M, Curran WJ, Werner-Wasik M, Camphausen KA, Hyslop T, Axelrod R, Andrews DW, Glass J, Machtay M, Dicker AP (2011). A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies. Cancer  117, 5548-59.   https://doi.org/10.1002/cncr.26216",https://intramural.nih.gov/search/searchview.taf?ipid=76528
788,SC010375-12,"October 01, 2011 -  September 30, 2012",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Anne G M Gegonne Bosselut|Devaiah Nanjappa Ballachanda,NULL,Kenneth  Buetow; PhD (Laboratory of Population Genetics)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Daoud M Meerzaman (Center For Biomedical Informatics & Information Technology)|Alfred  Singer; MD (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section)|Jaime Andres Rodriguez Canales (Laboratory of Pathology),Natasha  Cherman; PhD (NIDCR) |Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76529
789,SC010376-12,"October 01, 2011 -  September 30, 2012",TNF Signaling and Cell Death,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Swati Suresh Choksi|Elena  Pobezinskaya|Siriporn  Jitkaew|Jie  Zhao|Zhenyu  Cai,NULL,NULL,Chuxia  Deng; PhD (NIDDK),"1. Cao X, Pobezinskaya YL, Morgan MJ, Liu ZG (2011). The role of TRADD in TRAIL-induced apoptosis and signaling. FASEB J  25, 1353-8.   https://doi.org/10.1096/fj.10-170480|2. Choksi S, Lin Y, Pobezinskaya Y, Chen L, Park C, Morgan M, Li T, Jitkaew S, Cao X, Kim YS, Kim HS, Levitt P, Shih G, Birre M, Deng CX, Liu ZG (2011). A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2. Mol Cell  42, 597-609.   https://doi.org/10.1016/j.molcel.2011.03.030|3. Huang Y, Chen L, Zhou Y, Liu H, Yang J, Liu Z, Wang C (2011). UXT-V1 protects cells against TNF-induced apoptosis through modulating complex II formation. Mol Biol Cell  22, 1389-97.   https://doi.org/10.1091/mbc.E10-10-0827|4. Morgan MJ, Liu ZG (2011). Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res  21, 103-15.   https://doi.org/10.1038/cr.2010.178|5. Pobezinskaya YL, Choksi S, Morgan MJ, Cao X, Liu ZG (2011). The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J Immunol  186, 5212-6.   https://doi.org/10.4049/jimmunol.1002374|6. Sun SC, Liu ZG (2011). A special issue on NF-κB signaling and function. Cell Res  21, 1-2.   https://doi.org/10.1038/cr.2011.1",https://intramural.nih.gov/search/searchview.taf?ipid=76530
790,SC010378-12,"October 01, 2011 -  September 30, 2012",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Zhenhua  Zhang|Yang-Jo  Chung|Sarah H Beachy; PhD|Sheryl Maxine Gough|Masahiro  Onozawa|Deborah Ann Silverman|Show all 7,"Trang  Hoang (U. Montreal)|Adolfo  Ferrando (Genetics, Columbia U.)",David  Levens; PhD (Laboratory of Pathology)|Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Aplan P, Khan J (2011) Molecular and Genetic Basis of Childhood Cancer, in Principles and Practice of Pediatric Oncology, 6th Edition., pp. 38-77.|2. Castiel A, Danieli MM, David A, Moshkovitz S, Aplan PD, Kirsch IR, Brandeis M, Krämer A, Izraeli S (2011). The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr. J Cell Sci  124, 532-9.   https://doi.org/10.1242/jcs.079731|3. Gough SM, Slape CI, Aplan PD (2011). NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood  118, 6247-57.   https://doi.org/10.1182/blood-2011-07-328880|4. Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C (2011). Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev  25, 275-86.   https://doi.org/10.1101/gad.2007311|5. Novak RL, Harper DP, Caudell D, Slape C, Beachy SH, Aplan PD (2012). Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol  40, 1016-27.   https://doi.org/10.1016/j.exphem.2012.08.001|6. Slape CI, Saw J, Jowett JB, Aplan PD, Strasser A, Jane SM, Curtis DJ (2012). Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood  120, 2475-83.   https://doi.org/10.1182/blood-2012-05-430736",https://intramural.nih.gov/search/searchview.taf?ipid=76531
791,SC010379-12,"October 01, 2011 -  September 30, 2012",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Zhenhua  Zhang|Masahiro  Onozawa,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76532
792,SC010384-12,"October 01, 2011 -  September 30, 2012",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer|Laura M Tuschong|Michael J Hunter; PhD,David  Russell (University of Washington)|Derek  Persons (St. Jude's Cancer Research Center)|Punam  Malik,NULL,Harry Lewis Malech; MD (NIAID),"1. Hunter MJ, Zhao H, Tuschong LM, Bauer TR, Burkholder TH, Persons DA, Hickstein DD (2011). Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters. Hum Gene Ther  22, 689-96.   https://doi.org/10.1089/hum.2010.130",https://intramural.nih.gov/search/searchview.taf?ipid=76533
793,SC010437-12,"October 01, 2011 -  September 30, 2012",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Jeffrey C Hanson|Wusheng  Yan|Michael D Armani|Michael  Tangrea|Qiang  Du; PhD|Adele R Blackler; PhD|Show all 7,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Gannot G, Richardson AM, Rodriguez-Canales J, Pinto PA, Merino MJ, Chuaqui RF, Gillespie JW, Emmert-Buck MR (2011). Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer. Am J Cancer Res  1, 120-127.|2. Rodriguez-Canales J, Eberle FC, Jaffe ES, Emmert-Buck MR (2011). Why is it crucial to reintegrate pathology into cancer research? Bioessays  33, 490-8.   https://doi.org/10.1002/bies.201100017|3. Yan W, Wistuba II, Emmert-Buck MR, Erickson HS (2011). Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res  1, 275-300.   https://doi.org/10.1158/1538-7445.am2011-275|4. Zhu L, Yan W, Rodriguez-Canales J, Rosenberg AM, Hu N, Goldstein AM, Taylor PR, Erickson HS, Emmert-Buck MR, Tangrea MA (2011). MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. Am J Cancer Res  1, 574-584.",https://intramural.nih.gov/search/searchview.taf?ipid=76534
794,BC010906-05,"October 01, 2011 -  September 30, 2012",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD|Sigrid Priscilla Dubois|Carolyn  Goldman|Michael N Petrus|Mei  Zhang; MD, PhD|Kayhan  Garmestani; PhD|Show all 11",NULL,"Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Perera PY, Lichy JH, Waldmann TA, Perera LP (2012). The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect  14, 247-61.   https://doi.org/10.1016/j.micinf.2011.10.006|2. Sneller MC, Kopp WC, Engelke KJ, Yovandich JL, Creekmore SP, Waldmann TA, Lane HC (2011). IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood. Blood  118, 6845-8.   https://doi.org/10.1182/blood-2011-09-377804|3. Steel JC, Waldmann TA, Morris JC (2012). Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci  33, 35-41.   https://doi.org/10.1016/j.tips.2011.09.004|4. Waldmann TA, Lugli E, Roederer M, Perera LP, Smedley JV, Macallister RP, Goldman CK, Bryant BR, Decker JM, Fleisher TA, Lane HC, Sneller MC, Kurlander RJ, Kleiner DE, Pletcher JM, Figg WD, Yovandich JL, Creekmore SP (2011). Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques. Blood  117, 4787-95.   https://doi.org/10.1182/blood-2010-10-311456|5. Yokoyama S, Perera PY, Waldmann TA, Hiroi T, Perera LP (2013). Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J Clin Immunol  33, 586-94.   https://doi.org/10.1007/s10875-012-9849-y",https://intramural.nih.gov/search/searchview.taf?ipid=73657
795,BC009255-38,"October 01, 2011 -  September 30, 2012",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,"1. Bothmer A, Robbiani DF, Di Virgilio M, Bunting SF, Klein IA, Feldhahn N, Barlow J, Chen HT, Bosque D, Callen E, Nussenzweig A, Nussenzweig MC (2011) Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol Cell 42:319-29.|2. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH (2012). An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol  188, 5859-66.   https://doi.org/10.4049/jimmunol.1102328|3. Langer HF, Orlova VV, Xie C, Kaul S, Schneider D, Lonsdorf AS, Fahrleitner M, Choi EY, Dutoit V, Pellegrini M, Grossklaus S, Nawroth PP, Baretton G, Santoso S, Hwang ST, Arnold B, Chavakis T (2011). A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res  71, 4096-105.   https://doi.org/10.1158/0008-5472.CAN-10-2794|4. Liu Y, Belkina NV, Park C, Nambiar R, Loughhead SM, Patino-Lopez G, Ben-Aissa K, Hao JJ, Kruhlak MJ, Qi H, von Andrian UH, Kehrl JH, Tyska MJ, Shaw S (2012). Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice. Blood  119, 445-53.   https://doi.org/10.1182/blood-2011-07-368860",https://intramural.nih.gov/search/searchview.taf?ipid=73196
796,BC010469-10,"October 01, 2011 -  September 30, 2012",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",Tanya R Johnson|Nancy  Shulley|Jennifer A Wilson|Anthony  Wamiru|Girma M Woldemichael|Curtis  Henrich,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Donald  Smee (Animal, Dairy and Veterinary Sciences Dept, Utah State University)|Peter  Wipf (Univ. of Pittsburgh)|John  Porco (Boston University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|Show all 22",Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|William Marston Linehan; MD (Urologic Oncology Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Joseph John Barchi (Chemical Biology Laboratory),Michael P Bray (NIAID),"1. Alexandre KB, Gray ES, Pantophlet R, Moore PL, McMahon JB, Chakauya E, O'Keefe BR, Chikwamba R, Morris L (2011). Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. J Virol  85, 9039-50.   https://doi.org/10.1128/JVI.02675-10|2. Best AM, Chang J, Dull AB, Beutler JA, Martinez ED (2011) Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assay. J Biomed Biotechnol 2011:868095.|3. Devkota KP, Ratnayake R, Colburn NH, Wilson JA, Henrich CJ, McMahon JB, Beutler JA (2011). Inhibitors of the oncogenic transcription factor AP-1 from Podocarpus latifolius. J Nat Prod  74, 374-7.   https://doi.org/10.1021/np100736y|4. Diyabalanage T, Ratnayake R, Wilson JA, Henrich CJ, Beutler JA, Colburn NH, McMahon JB, Gustafson KR (2011). Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii. Bioorg Med Chem Lett  21, 4397-9.   https://doi.org/10.1016/j.bmcl.2011.06.044|5. Grkovic T, Blees JS, Colburn NH, Schmid T, Thomas CL, Henrich CJ, McMahon JB, Gustafson KR (2011). Cryptocaryols A-H, α-pyrone-containing 1,3-polyols from Cryptocarya sp. implicated in stabilizing the tumor suppressor Pdcd4. J Nat Prod  74, 1015-20.   https://doi.org/10.1021/np100918z|6. Grkovic T, Whitson EL, Rabe DC, Gardella RS, Bottaro DP, Linehan WM, McMahon JB, Gustafson KR, McKee TC (2011). Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression. Bioorg Med Chem Lett  21, 2113-5.   https://doi.org/10.1016/j.bmcl.2011.01.127|7. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|8. Popplewell WL, Ratnayake R, Wilson JA, Beutler JA, Colburn NH, Henrich CJ, McMahon JB, McKee TC (2011). Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula. J Nat Prod  74, 1686-91.   https://doi.org/10.1021/np2005083|9. Sloman DL, Mitasev B, Scully SS, Beutler JA, Porco JA (2011) Synthesis and biological evaluation of ABCD ring fragments of the kibdelones. Angew Chem Int Ed Engl 50:2511-5.|10. Tai BH, Nhut ND, Nhiem NX, Quang TH, Thanh Ngan NT, Thuy Luyen BT, Huong TT, Wilson J, Beutler JA, Ban NK, Cuong NM, Kim YH (2011) An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds. Pharm Biol 49:1046-51.|11. Van Wyk AW, Zuck KM, McKee TC (2011). Lithothamnin A, the first bastadin-like metabolite from the red alga Lithothamnion fragilissimum. J Nat Prod  74, 1275-80.   https://doi.org/10.1021/np1006795|12. Versiani MA, Diyabalanage T, Ratnayake R, Henrich CJ, Bates SE, McMahon JB, Gustafson KR (2011). Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2. J Nat Prod  74, 262-6.   https://doi.org/10.1021/np100797y|13. Whitson EL, Pluchino KM, Hall MD, McMahon JB, McKee TC (2011). New candidaspongiolides, tedanolide analogues that selectively inhibit melanoma cell growth. Org Lett  13, 3518-21.   https://doi.org/10.1021/ol201329p|14. Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB (2011). Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells. Cancer Res  71, 134-42.   https://doi.org/10.1158/0008-5472.CAN-10-0757",https://intramural.nih.gov/search/searchview.taf?ipid=73368
797,BC010517-10,"October 01, 2011 -  September 30, 2012",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Igor V Filippov|Markus  Sitzmann|Iwona Elzbieta Weidlich|Alexey Vladimirovich Zakharov; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 13,NULL,"Christopher P Austin; AB, MD (NCATS) |Evan  Bolton; PhD (NLM)","1. Liao C, Sitzmann M, Pugliese A, Nicklaus MC (2011). Software and resources for computational medicinal chemistry. Future Med Chem  3, 1057-85.   https://doi.org/10.4155/fmc.11.63|2. O'Boyle NM, Guha R, Willighagen EL, Adams SE, Alvarsson J, Bradley JC, Filippov IV, Hanson RM, Hanwell MD, Hutchison GR, James CA, Jeliazkova N, Lang AS, Langner KM, Lonie DC, Lowe DM, Pansanel J, Pavlov D, Spjuth O, Steinbeck C, Tenderholt AL, Theisen KJ, Murray-Rust P (2011). Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on. J Cheminform  3, 37.   https://doi.org/10.1186/1758-2946-3-37",https://intramural.nih.gov/search/searchview.taf?ipid=73371
798,BC010548-10,"October 01, 2011 -  September 30, 2012",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kathryn  Compton|Cody John Peer|Shawn D Spencer,"Alex  Sparreboom|Steve  Grant (Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)","Andrea Borghese Apolo (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Austin Gerard Duffy (Medical Oncology Branch)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,"1. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|2. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603",https://intramural.nih.gov/search/searchview.taf?ipid=73524
799,BC010571-09,"October 01, 2011 -  September 30, 2012",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,"Alexander  Erkine (Butler University)|Keith  Wilkinson; PhD (Biochemistry, Emory University)","Munira A Basrai; PhD (Cancer Genetics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)",Marta Liliana Catalfamo; PhD (NIAID),"1. Chernova TA, Romanyuk AV, Karpova TS, Shanks JR, Ali M, Moffatt N, Howie RL, O'Dell A, McNally JG, Liebman SW, Chernoff YO, Wilkinson KD (2011). Prion induction by the short-lived, stress-induced protein Lsb2 is regulated by ubiquitination and association with the actin cytoskeleton. Mol Cell  43, 242-52.   https://doi.org/10.1016/j.molcel.2011.07.001|2. Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G (2011). Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis  203, 1043-53.   https://doi.org/10.1093/infdis/jiq162",https://intramural.nih.gov/search/searchview.taf?ipid=73397
800,BC010639-09,"October 01, 2011 -  September 30, 2012",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|Iwona Elzbieta Weidlich|Alexey Vladimirovich Zakharov; PhD|Laura  Guasch Pamies|Terrence R Burke; PhD|John Stephen Schneekloth,Julieta  Comin (University of Buenos Aires)|Iwona Elzbieta Weidlich,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)","Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73400
801,BC010685-08,"October 01, 2011 -  September 30, 2012",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Willie J Young|Jeannette Marie McNulty,NULL,NULL,"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73421
802,BC010687-08,"October 01, 2011 -  September 30, 2012",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Helen G Lynch|Catherine R Neely|Martha A Pruden|Judith C Horn|Maryann Elisabeth Williamson|Claire D Roque,"Elizabeth  Brunt (Pathology, St. Louis University)|Arthur  Mccullough (Gastroenterology/Hepatology, Cleveland Clinic Foundation)|Joel  Lavine (Pediatrics, University of California San Diego Medical Center)|Arun  Sanyal (Hepatology, Virginia Commonwealth University Medical Center)|James  Tonascia (n/a, Johns Hopkins Center for Clinical Trials)|Hari  Conjeevaram (Gastroenterology, The University of Michigan)|Show all 9","Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Jay  Hoofnagle; MD (NIDDK) |Marc Gregory Ghany; MD (NIDDK) |Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Michael  Polis; MD (NIAID) |Shyamasundaran  Kottilil; MD, PhD (NIAID)","1. Arora M, Uzel G, Shea YR, Kleiner DE, Holland SM, Heller T (2011). GI involvement in disseminated Mycobacterium genavense: endoscopy and histology. Gastrointest Endosc  74, 688-90.   https://doi.org/10.1016/j.gie.2011.04.021|2. Lo DJ, Weaver TA, Kleiner DE, Mannon RB, Jacobson LM, Becker BN, Swanson SJ, Hale DA, Kirk AD (2011). Chemokines and their receptors in human renal allotransplantation. Transplantation  91, 70-7.   https://doi.org/10.1097/TP.0b013e3181fe12fc|3. Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N, Drug-Induced Liver Injury Network (2011). Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr  53, 182-9.   https://doi.org/10.1097/MPG.0b013e31821d6cfd|4. Noureddin M, Kleiner DE, Gharib AM, Bratslavsky G, Heller T (2011). To resect or not to resect? That is the question. Telangiectatic adenoma. Gut  60, 1177, 1235.   https://doi.org/10.1136/gut.2010.221440|5. O'Connell ML, Birkenkamp KE, Kleiner DE, Folio LR, Holland SM, Olivier KN (2012). Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest  141, 1203-1209.   https://doi.org/10.1378/chest.11-0425|6. Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH, DILIN Research Group (2011). Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol  9, 517-523.e3.   https://doi.org/10.1016/j.cgh.2011.02.019|7. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC (2011). Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology  141, 1220-30, 1230.e1-3.   https://doi.org/10.1053/j.gastro.2011.06.063",https://intramural.nih.gov/search/searchview.taf?ipid=73423
803,BC010858-06,"October 01, 2011 -  September 30, 2012",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Poonam  Mannan|Langston  Lim,NULL,Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Srinivasa M Srinivasula (Laboratory of Immune Cell Biology)|Benu Brata  Das (Developmental Therapeutics Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Sukhbir  Kaur (Laboratory of Pathology),Kevin G Chen; MD (NINDS),"1. Hari D, Xin HW, Jaiswal K, Wiegand G, Kim BK, Ambe C, Burka D, Koizumi T, Ray S, Garfield S, Thorgeirsson S, Avital I (2011). Isolation of live label-retaining cells and cells undergoing asymmetric cell division via nonrandom chromosomal cosegregation from human cancers. Stem Cells Dev  20, 1649-58.   https://doi.org/10.1089/scd.2010.0455|2. Hunt RC, Geetha S, Allen CE, Hershko K, Fathke R, Kong PL, Plum E, Struble EB, Soejima K, Friedman S, Garfield S, Balaji S, Kimchi-Sarfaty C (2011). Detection of a secreted metalloprotease within the nuclei of liver cells. Mol Biosyst  7, 2012-8.   https://doi.org/10.1039/c0mb00303d|3. Kedei N, Lubart E, Lewin NE, Telek A, Lim L, Mannan P, Garfield SH, Kraft MB, Keck GE, Kolusheva S, Jelinek R, Blumberg PM (2011). Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells. Chembiochem  12, 1242-51.   https://doi.org/10.1002/cbic.201100064|4. Kedei N, Telek A, Czap A, Lubart ES, Czifra G, Yang D, Chen J, Morrison T, Goldsmith PK, Lim L, Mannan P, Garfield SH, Kraft MB, Li W, Keck GE, Blumberg PM (2011). The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line. Biochem Pharmacol  81, 1296-308.   https://doi.org/10.1016/j.bcp.2011.03.018",https://intramural.nih.gov/search/searchview.taf?ipid=73531
804,BC010859-06,"October 01, 2011 -  September 30, 2012",DNA Sequencing and Digital Gene Expression Core,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Patricia  Johnson|Steven W Shema,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73533
805,BC010903-05,"October 01, 2011 -  September 30, 2012",Transgenic Core Facility,Deborah A Swing,Terry Anne Van Dyke,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,"1. Berquam-Vrieze KE, Swing DA, Tessarollo L, Dupuy AJ (2012). Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1. Genesis  50, 112-8.   https://doi.org/10.1002/dvg.20798|2. Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L, Liu Y, Swing DA, Beal MF, Troncoso JC, McCaffery JM, Jenkins NA, Copeland NG, Galter D, Thomas B, Lee MK, Dawson TM, Dawson VL, Moore DJ (2011). Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One  6, e18568.   https://doi.org/10.1371/journal.pone.0018568|3. Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L, Borchelt DR (2011). Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet  20, 2770-82.   https://doi.org/10.1093/hmg/ddr176|4. Tebbenkamp AT, Swing D, Tessarollo L, Borchelt DR (2011). Premature death and neurologic abnormalities in transgenic mice expressing a mutant huntingtin exon-2 fragment. Hum Mol Genet  20, 1633-42.   https://doi.org/10.1093/hmg/ddr040",https://intramural.nih.gov/search/searchview.taf?ipid=73644
806,BC010905-05,"October 01, 2011 -  September 30, 2012",Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mark E Dudley|Steven A Feldman|Kenichi  Hanada|Marybeth S Hughes|Udai S Kammula|King F Kwong|Show all 18,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section),Yardena Rachel Samuels; PhD (NHGRI),"1. Langan RC, Prieto PA, Sherry RM, Zlott D, Wunderlich J, Csako G, Costello R, White DE, Rosenberg SA, Yang JC (2011). Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. J Immunother  34, 397-402.   https://doi.org/10.1097/CJI.0b013e3182187508|2. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|3. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011). Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res  17, 4550-7.   https://doi.org/10.1158/1078-0432.CCR-11-0116",https://intramural.nih.gov/search/searchview.taf?ipid=73670
807,BC010915-05,"October 01, 2011 -  September 30, 2012",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD,NULL,"Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)|James Stephen Shaw; PhD (Human Immunology Section)|David M Segal; PhD (Immune Targeting Section)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Philip Jeffrey Tofilon (Radiation Oncology Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Jeffrey Burnett Kopp; MD (NIDDK)","1. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol  85, 2620-30.   https://doi.org/10.1128/JVI.02144-10|2. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol  85, 1528-40.   https://doi.org/10.1128/JVI.01709-10",https://intramural.nih.gov/search/searchview.taf?ipid=73693
808,BC010923-05,"October 01, 2011 -  September 30, 2012",Tissue Array Research Program,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Kristofferson R Ylaya|Catherine Margaret Conway; PhD|Haruhisa  Kitano; MD, PhD|Elaine S Jaffe; MD",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)","Yoke Peng  Loh; PhD (NICHD) |Alfredo A Molinolo; MD, PhD (NIDCR)","1. Abedi-Ardekani B, Kamangar F, Sotoudeh M, Villar S, Islami F, Aghcheli K, Nasrollahzadeh D, Taghavi N, Dawsey SM, Abnet CC, Hewitt SM, Fahimi S, Saidi F, Brennan P, Boffetta P, Malekzadeh R, Hainaut P (2011). Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran. PLoS One  6, e29488.   https://doi.org/10.1371/journal.pone.0029488|2. Brennan DJ, O'Connor DP, Laursen H, McGee SF, McCarthy S, Zagozdzon R, Rexhepaj E, Culhane AC, Martin FM, Duffy MJ, Landberg G, Ryden L, Hewitt SM, Kuhar MJ, Bernards R, Millikan RC, Crown JP, Jirström K, Gallagher WM (2012). The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer. Oncogene  31, 3483-94.   https://doi.org/10.1038/onc.2011.519|3. Burton ER, Gaffar A, Lee SJ, Adeshuko F, Whitney KD, Chung JY, Hewitt SM, Huang GS, Goldberg GL, Libutti SK, Kwon M (2011). Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. Mol Cancer Res  9, 1126-38.   https://doi.org/10.1158/1541-7786.MCR-11-0162|4. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011). Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica  96, 558-66.   https://doi.org/10.3324/haematol.2010.033167|5. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|6. Hipp J, Cheng J, Daignault S, Sica J, Dugan MC, Lucas D, Yagi Y, Hewitt S, Balis UJ (2011). Automated area calculation of histopathologic features using SIVQ. Anal Cell Pathol (Amst)  34, 265-75.   https://doi.org/10.3233/ACP-2011-0025|7. Hipp J, Flotte T, Monaco J, Cheng J, Madabhushi A, Yagi Y, Rodriguez-Canales J, Emmert-Buck M, Dugan MC, Hewitt S, Toner M, Tompkins RG, Lucas D, Gilbertson JR, Balis UJ (2011). Computer aided diagnostic tools aim to empower rather than replace pathologists: Lessons learned from computational chess. J Pathol Inform  2, 25.   https://doi.org/10.4103/2153-3539.82050|8. Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011). Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells. Gynecol Oncol  122, 656-62.   https://doi.org/10.1016/j.ygyno.2011.04.052|9. Kwak JT, Hewitt SM, Sinha S, Bhargava R (2011). Multimodal microscopy for automated histologic analysis of prostate cancer. BMC Cancer  11, 62.   https://doi.org/10.1186/1471-2407-11-62|10. Lee TK, Murthy SR, Cawley NX, Dhanvantari S, Hewitt SM, Lou H, Lau T, Ma S, Huynh T, Wesley RA, Ng IO, Pacak K, Poon RT, Loh YP (2011). An N-terminal truncated carboxypeptidase E  splice isoform induces tumor growth  and is a biomarker for predicting  future metastasis in human cancers. J Clin Invest  121, 880-92.   https://doi.org/10.1172/JCI40433|11. Lipkin S, Lee J, Imagawa D, Hewitt SM, Tucker C, Zell JA, Wong V, Garcia A, Gonzalez R, Della Zanna G, Richmond E, Rodriguez LM, Bigg M, Schnoll-Sussmans F, Meyskens F (2011). Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasms. Cancer Prev Res (Phila)  4, 512-3.   https://doi.org/10.1158/1940-6207.CAPR-10-0373|12. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724|13. Takikita M, Hu N, Shou JZ, Giffen C, Wang QH, Wang C, Hewitt SM, Taylor PR (2011). Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma. Anticancer Res  31, 945-52.|14. Takikita M, Xie R, Chung JY, Cho H, Ylaya K, Hong SM, Moskaluk CA, Hewitt SM (2011). Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma. J Transl Med  9, 126.   https://doi.org/10.1186/1479-5876-9-126|15. Xie R, Chung JY, Ylaya K, Williams RL, Guerrero N, Nakatsuka N, Badie C, Hewitt SM (2011). Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem  59, 356-65.   https://doi.org/10.1369/0022155411398488",https://intramural.nih.gov/search/searchview.taf?ipid=73600
809,BC010930-05,"October 01, 2011 -  September 30, 2012",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Kenneth E Nakahara|Peter D Aplan; MD|Walter M Kuehl; MD, PhD|Ester K Rozenblum",Geula  Klorin (Rambam: Human Health Care Campus)|Alexei  Protopopov (Dana-Farber Cancer Institute)|Frederic  Kaye; MD (NCI),Ola Anders Landgren (Lymphoid Malignancies Branch)|Adriana  Zingone; MD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73610
810,BC010934-05,"October 01, 2011 -  September 30, 2012",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Xiao Y Yan|Jeremy J Rose|Susan  Dhamala|Steven  Pavletic; MD, MS|Claude  Sportes|Michael R Bishop; MD|Show all 11",NULL,NULL,Austin John Barrett; MD (NHLBI) |Ping  Jin (CC) |David F Stroncek; MD (CC),"1. Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, Mitchell SA, Hakim FT, Martires KJ, Avila DN, Taylor TN, Salit RB, Rowley SD, Zhang D, Fowler DH, Bishop MR, Gress RE, Pavletic SZ (2012). Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia  26, 633-43.   https://doi.org/10.1038/leu.2011.254|2. Hardy NM, Mossoba ME, Steinberg SM, Fellowes V, Yan XY, Hakim FT, Babb RR, Avila D, Gea-Banacloche J, Sportès C, Levine BL, June CH, Khuu HM, Carpenter AE, Krumlauf MC, Dwyer AJ, Gress RE, Fowler DH, Bishop MR (2011). Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer. Clin Cancer Res  17, 6878-87.   https://doi.org/10.1158/1078-0432.CCR-11-1579|3. Jamshed S, Fowler DH, Neelapu SS, Dean RM, Steinberg SM, Odom J, Bryant K, Hakim F, Bishop MR (2011). EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant  46, 676-81.   https://doi.org/10.1038/bmt.2010.173|4. Le RQ, Melenhorst JJ, Battiwalla M, Hill B, Memon S, Savani BN, Shenoy A, Hensel NF, Koklanaris EK, Keyvanfar K, Hakim FT, Douek DC, Barrett AJ (2011). Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation. Blood  117, 5250-6.   https://doi.org/10.1182/blood-2011-01-329706|5. Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM, Mitchell SA, Datiles M, Hakim FT, Pavletic SZ, Cowen EW (2011). Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood  118, 4250-7.   https://doi.org/10.1182/blood-2011-04-350249|6. Memon SA, Sportès C, Flomerfelt FA, Gress RE, Hakim FT (2012). Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood. J Immunol Methods  375, 84-92.   https://doi.org/10.1016/j.jim.2011.09.012",https://intramural.nih.gov/search/searchview.taf?ipid=73594
811,BC010936-05,"October 01, 2011 -  September 30, 2012",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Samir N. Khleif; MD|Masaki  Terabe,Cliburn  Chan (Duke University)|Marcin  Moniuszko|Kent  Weinhold (DUMC),"Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Myong-Hee  Sung (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)",NULL,"1. Brocca-Cofano E, McKinnon K, Demberg T, Venzon D, Hidajat R, Xiao P, Daltabuit-Test M, Patterson LJ, Robert-Guroff M (2011). Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia. Vaccine  29, 3310-9.   https://doi.org/10.1016/j.vaccine.2011.02.066|2. Demberg T, Ettinger AC, Aladi S, McKinnon K, Kuddo T, Venzon D, Patterson LJ, Phillips TM, Robert-Guroff M (2011). Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory. Vaccine  29, 6017-28.   https://doi.org/10.1016/j.vaccine.2011.06.032",https://intramural.nih.gov/search/searchview.taf?ipid=73713
812,BC010937-05,"October 01, 2011 -  September 30, 2012",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Marjorie P Duberstein|Bruce K Huang|Duane Howard Hamilton|Jeffrey  Schlom; PhD|Kwong Yok Tsang|James L Gulley; MD, PhD|Show all 7","Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)",NULL,NULL,"1. Palena C, Schlom J (2011) Target: Brachyury, a master driver of epithelial-to-mesenchymal transition (EMT), in Encyclopedia of Cancer Therapeutic Targets., in press.|2. Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C (2011). IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res  71, 5296-306.   https://doi.org/10.1158/0008-5472.CAN-11-0156|3. Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, Schlom J (2011). Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp Biol Med (Maywood)  236, 537-45.   https://doi.org/10.1258/ebm.2011.010367|4. Palena C, Hamilton D, Fernando R (2012) The influence of interleuken-8 on the epithelial-mesenchymal transition and the modulation of the tumor microenvironment. Future Oncol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73726
813,BC010947-05,"October 01, 2011 -  September 30, 2012",Cell and Cancer Biology Branch Confocal Microscopy Core,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ross G Lake|Zhenggang  Liu; PhD|Juanjuan  Yin|Orla Majella Casey,Massimo  Santoro|Ginesa  GarciaRostan (University of Valladolid),"Susan  Bates; MD (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Marianne  Poruchynsky (Medical Oncology Branch)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics)|Olga  Aprelikova; PhD (Laboratory of Cancer Biology and Genetics)|Philip L Martin (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73660
814,BC010948-05,"October 01, 2011 -  September 30, 2012",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mona E El gamil|Yili  Li|Xin  Yao|Yong-Chen  Lu; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73604
815,BC010953-05,"October 01, 2011 -  September 30, 2012",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jennifer B Dwyer|Shelley B Hoover|Bih-Rong  Wei|Joshua David Webster; DVM, PhD|John  Hickerson|Beverly  Mock; PhD|Show all 8",NULL,"Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Stephen I Katz; PhD, MD (Dermatology Branch)|Timothy D Veenstra (Office Of The Director)",NULL,"1. Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW (2011). Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res  71, 3121-31.   https://doi.org/10.1158/0008-5472.CAN-10-4417|2. Webster JD, Simpson ER, Michalowski AM, Hoover SB, Simpson RM (2011). Quantifying histological features of cancer biospecimens for biobanking quality assurance using automated morphometric pattern recognition image analysis algorithms. J Biomol Tech  22, 108-18.|3. Wei BR, Martin PL, Hoover SB, Spehalski E, Kumar M, Hoenerhoff MJ, Rozenberg J, Vinson C, Simpson RM (2011). Capacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice. Comp Med  61, 109-18.",https://intramural.nih.gov/search/searchview.taf?ipid=73625
816,BC010965-05,"October 01, 2011 -  September 30, 2012",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",Marzeena  Dyba|Yun Xing M Wang,Marzena E Pazgier|Vadim  Gaponenko|Jose  CasasFinet (MedImmune),Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Anil K Patri (Office Cancer Nanotechnology Research)|Anu  Puri; PhD (Membrane Structure and Function Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Johannessen L, Remsberg J, Gaponenko V, Adams KM, Barchi JJ, Tarasov SG, Jiang S, Tarasova NI (2011). Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors. Chembiochem  12, 914-21.   https://doi.org/10.1002/cbic.201000563|2. Stagno JR, Altieri AS, Bubunenko M, Tarasov SG, Li J, Court DL, Byrd RA, Ji X (2011). Structural basis for RNA recognition by NusB and NusE in the initiation of transcription antitermination. Nucleic Acids Res  39, 7803-15.   https://doi.org/10.1093/nar/gkr418|3. Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI (2011). Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles. Proc Natl Acad Sci U S A  108, 9798-803.   https://doi.org/10.1073/pnas.1014598108|4. Tu C, Zhou X, Tarasov SG, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2011). The Era GTPase recognizes the GAUCACCUCC sequence and binds helix 45 near the 3' end of 16S rRNA. Proc Natl Acad Sci U S A  108, 10156-61.   https://doi.org/10.1073/pnas.1017679108",https://intramural.nih.gov/search/searchview.taf?ipid=73645
817,BC010978-05,"October 01, 2011 -  September 30, 2012",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Carole A Parent; PhD|Stanley  Lipkowitz; MD, PhD|Ying  Zhang|Carol  Clayberger|Show all 7",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine)|Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter),NULL,"Paul E Love; MD, PhD (NICHD)","1. Balagopalan L, Ashwell BA, Bernot KM, Akpan IO, Quasba N, Barr VA, Samelson LE (2011). Enhanced T-cell signaling in cells bearing linker for activation of T-cell (LAT) molecules resistant to ubiquitylation. Proc Natl Acad Sci U S A  108, 2885-90.   https://doi.org/10.1073/pnas.1007098108|2. Balagopalan L, Sherman E, Barr VA, Samelson LE (2011). Imaging techniques for assaying lymphocyte activation in action. Nat Rev Immunol  11, 21-33.   https://doi.org/10.1038/nri2903|3. Sherman E, Barr V, Manley S, Patterson G, Balagopalan L, Akpan I, Regan CK, Merrill RK, Sommers CL, Lippincott-Schwartz J, Samelson LE (2011). Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity  35, 705-20.   https://doi.org/10.1016/j.immuni.2011.10.004",https://intramural.nih.gov/search/searchview.taf?ipid=73550
818,BC010981-05,"October 01, 2011 -  September 30, 2012","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu|Zhigang  Kang,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,"1. Giaccone G, Rajan A, Berman A, Kelly RJ, Szabo E, Lopez-Chavez A, Trepel J, Lee MJ, Cao L, Espinoza-Delgado I, Spittler J, Loehrer PJ (2011). Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors. J Clin Oncol  29, 2052-9.   https://doi.org/10.1200/JCO.2010.32.4467|2. Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331|3. Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH (2011). Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Eur J Cancer  47, 997-1005.   https://doi.org/10.1016/j.ejca.2010.12.016",https://intramural.nih.gov/search/searchview.taf?ipid=73563
819,BC010989-05,"October 01, 2011 -  September 30, 2012",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Hui  Xu|Mary Alexandra Black|Richard A Morgan; PhD|James Chung-Yin Yang; MD, PhD|Maria  Parkhurst|Paul  Robbins|Show all 10",NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch),NULL,"1. Morgan RA, Johnson LA, Davis JL, Zheng Z, Woolard KD, Reap EA, Feldman SA, Chinnasamy N, Kuan CT, Song H, Zhang W, Fine HA, Rosenberg SA (2012). Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Hum Gene Ther  23, 1043-53.   https://doi.org/10.1089/hum.2012.041|2. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|3. Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC (2011). Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods  366, 43-51.   https://doi.org/10.1016/j.jim.2011.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=73576
820,BC010991-05,"October 01, 2011 -  September 30, 2012",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Uma  Shankavaram; PhD|Shuping  Zhao|Seth  Johnson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73561
821,BC011016-05,"October 01, 2011 -  September 30, 2012",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS|Janet R Fields|Jacek Tadeusz Lubkowski,"TOZSER  JOZSEF (University of Debrecen)|Robert  Ulrich (Molecular Immunology, USAMRIID)|Gregory  Plano; PhD (Microbiology and Immunology, University of Miami School of Medicine)|Honggao  Yan",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Robert  Shoemaker (Screening Technologies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,"1. Austin BP, Tözsér J, Bagossi P, Tropea JE, Waugh DS (2011). The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: insights into their use as tools for the removal of affinity tags. Protein Expr Purif  77, 53-61.   https://doi.org/10.1016/j.pep.2010.11.005|2. Lountos GT, Tropea JE, Waugh DS (2011). Structure of human dual-specificity phosphatase 27 at 2.38 Å resolution. Acta Crystallogr D Biol Crystallogr  67, 471-9.   https://doi.org/10.1107/S090744491100970X|3. Sun P, Tropea JE, Waugh DS (2011). Enhancing the solubility of recombinant proteins in Escherichia coli by using hexahistidine-tagged maltose-binding protein as a fusion partner. Methods Mol Biol  705, 259-74.   https://doi.org/10.1007/978-1-61737-967-3_16|4. Tu C, Zhou X, Tarasov SG, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2011). The Era GTPase recognizes the GAUCACCUCC sequence and binds helix 45 near the 3' end of 16S rRNA. Proc Natl Acad Sci U S A  108, 10156-61.   https://doi.org/10.1073/pnas.1017679108",https://intramural.nih.gov/search/searchview.taf?ipid=73648
822,BC011020-05,"October 01, 2011 -  September 30, 2012",Cell Production Facility Core,Mark E Dudley,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Azam V Nahvi|Linda L Parker|Thomas E Shelton|Michelle  Pelletier|Mary B Ganges|Katherine  Hogan|Show all 11,NULL,NULL,David F Stroncek; MD (CC),"1. Dudley ME (2011). Adoptive cell therapy for patients with melanoma. J Cancer  2, 360-2.   https://doi.org/10.7150/jca.2.360|2. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA (2011). T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther  19, 620-6.   https://doi.org/10.1038/mt.2010.272|3. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|4. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011). Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res  17, 4550-7.   https://doi.org/10.1158/1078-0432.CCR-11-0116",https://intramural.nih.gov/search/searchview.taf?ipid=73570
823,BC011021-04,"October 01, 2011 -  September 30, 2012",Basic Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73182
824,BC011029-05,"October 01, 2011 -  September 30, 2012",Preclinical development and clinical monitoring of adoptive immune therapy,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Vicki  Fellowes|Jeremy J Rose|Daniel H Fowler|Nancy M Hardy|Claude  Sportes,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73595
825,BC011030-05,"October 01, 2011 -  September 30, 2012",Peptide Synthesis Core Facility and Peptide Epitope Identification,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Richard A Morgan; PhD|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73727
826,BC011040-05,"October 01, 2011 -  September 30, 2012",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Marbin A Pineda|Lisa  Adams; MSc|Holly S Stevenson|Sven  Bilke|Jonathan Keith Killian|Yonghong  Wang|Show all 9,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Su-Young  Kim (Pediatric Oncology Branch)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)","Xin Xin  Quan; PhD, MD (NIDCD)","1. Nader N, Ng SS, Wang Y, Abel BS, Chrousos GP, Kino T (2012). Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. PLoS One  7, e26751.   https://doi.org/10.1371/journal.pone.0026751",https://intramural.nih.gov/search/searchview.taf?ipid=73573
827,BC011041-05,"October 01, 2011 -  September 30, 2012",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Marbin A Pineda|Lisa  Adams; MSc|Holly S Stevenson|Sven  Bilke|Jonathan Keith Killian|Yonghong  Wang|Show all 8,NULL,"Frank  Cuttitta; PhD (Radiation Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73574
828,BC011042-05,"October 01, 2011 -  September 30, 2012",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73698
829,BC011044-05,"October 01, 2011 -  September 30, 2012",Tissue ProcessingSequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Robert A Worrell,Catherine  Stolle (Childrenâ€™s Hospital of Philadelphia)|William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Joel  Moss; MD, PhD (NHLBI)","1. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011). Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer  50, 466-77.   https://doi.org/10.1002/gcc.20872|2. Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011). Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab  96, 375-84.   https://doi.org/10.1210/jc.2010-1588|3. Ricketts C, Shuch B, Vocke C, Metwalli A, Bratslavsky G, Middelton L, Pautler S, Peterson J, Stolle C, Zbar B, Merino M, Schmidt L, Pinto P, Srinivasan R, Pacak K, Linehan W (2012) Succinate Dehydrogenase Kidney Cancer (SDH-RCC): An Aggressive Example of the Warburg Effect in Cancer. J Urol, in press.|4. SanzOrtega J, Vocke C, Stratton P, Linehan W, Merino M (2012) Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome. Am J Surg Pathol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73655
830,BC011047-05,"October 01, 2011 -  September 30, 2012",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Mario A Anzano|Anthony W Vieira|Valery  Bliskovsky; PhD|Tina M Wellington|Maudeline  Etienne|Susan  Walters|Show all 16,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Alasdair M Gilfillan; PhD (NIAID) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID)","1. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187|2. Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM (2011). mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. Blood  118, 6803-13.   https://doi.org/10.1182/blood-2011-06-359984|3. Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood  117, 1228-38.   https://doi.org/10.1182/blood-2010-05-287821",https://intramural.nih.gov/search/searchview.taf?ipid=73569
831,BC011048-05,"October 01, 2011 -  September 30, 2012",Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu|Zhigang  Kang,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Chand  Khanna; MD (Pediatric Oncology Branch),NULL,"1. Kang Z, Chen JJ, Yu Y, Li B, Sun SY, Zhang B, Cao L (2011). Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response. Clin Cancer Res  17, 3181-92.   https://doi.org/10.1158/1078-0432.CCR-10-2874",https://intramural.nih.gov/search/searchview.taf?ipid=73564
832,BC011052-05,"October 01, 2011 -  September 30, 2012",Cytopathology Core,Armando  Filie,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Keith R Brosky|Tangi Y Howard|Dana K Erickson|Patricia A Fetsch|May Ester Owens|Mark J Roth,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73577
833,BC011068-05,"October 01, 2011 -  September 30, 2012",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Jeffrey C Hanson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73575
834,BC011075-05,"October 01, 2011 -  September 30, 2012",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,"1. Ohnuma S, Chufan E, Nandigama K, Jenkins LM, Durell SR, Appella E, Sauna ZE, Ambudkar SV (2011). Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites. Biochemistry  50, 3724-35.   https://doi.org/10.1021/bi200073f",https://intramural.nih.gov/search/searchview.taf?ipid=73571
835,BC011077-05,"October 01, 2011 -  September 30, 2012",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73572
836,BC011079-05,"October 01, 2011 -  September 30, 2012",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Trinh  Pham|Liqiang  Xi; MD|Thu A Pham|Winnifred Theresa Navarro|Elaine S Jaffe; MD|Michael R Emmert-Buck; MD, PhD|Show all 9",NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Samuel A Wells (Medical Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)",Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |Yardena Rachel Samuels; PhD (NHGRI),"1. Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM (2011). Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica  96, 1221-5.   https://doi.org/10.3324/haematol.2011.041152|2. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011). Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood  117, 4726-35.   https://doi.org/10.1182/blood-2010-12-323238|3. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|4. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|5. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2011). Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood  118, 2653-5.   https://doi.org/10.1182/blood-2011-05-356352|6. Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331|7. Maldonado NI, Cabanillas F, Jaffe ES, Raffeld M, Lozada L (2011). Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab. J Clin Oncol  29, e658-60.   https://doi.org/10.1200/JCO.2011.34.8656|8. Niemela JE, Lu L, Fleisher TA, Davis J, Caminha I, Natter M, Beer LA, Dowdell KC, Pittaluga S, Raffeld M, Rao VK, Oliveira JB (2011). Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood  117, 2883-6.   https://doi.org/10.1182/blood-2010-07-295501|9. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011). Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol  24, 1421-32.   https://doi.org/10.1038/modpathol.2011.102|10. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|11. Venkataraman G, Berkowitz J, Morris JC, Janik JE, Raffeld MA, Pittaluga S (2011). Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells. Hum Pathol  42, 1042-6.   https://doi.org/10.1016/j.humpath.2010.10.014",https://intramural.nih.gov/search/searchview.taf?ipid=73733
837,BC011083-04,"October 01, 2011 -  September 30, 2012",Protein Chemistry Core,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Suzanne I Specht|Gisela Esta Sterneck; PhD,Rueben  Shaw (Salk Institute)|Robert  Rottapel (University of Toronto),Udayan  Guha (Medical Oncology Branch),NULL,"1. Sarkar TR, Sharan S, Wang J, Pawar SA, Cantwell CA, Johnson PF, Morrison DK, Wang JM, Sterneck E (2012). Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells. Mol Cell Biol  32, 320-32.   https://doi.org/10.1128/MCB.05790-11",https://intramural.nih.gov/search/searchview.taf?ipid=73184
838,BC011086-05,"October 01, 2011 -  September 30, 2012",Brain Tumor Animal Therapeutics Core,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Rolanda  Bailey|Lincoln A Edwards|Hua  Song|Lin  Tang|Dionne  Davis,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",John Keenam Park (NINDS) |Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73581
839,BC011087-05,"October 01, 2011 -  September 30, 2012",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Cynthia A Harris|Hong  Jin|Charisma D Roque|Elaine S Jaffe; MD|Stefania  Pittaluga,NULL,"James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011). Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood  117, 4726-35.   https://doi.org/10.1182/blood-2010-12-323238|2. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|3. Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011). Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol  35, 1214-25.   https://doi.org/10.1097/PAS.0b013e31822067d1|4. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES (2011). Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood  118, 2976-84.   https://doi.org/10.1182/blood-2011-05-355255|5. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682|6. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011). Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol  29, 917-24.   https://doi.org/10.1200/JCO.2010.32.2537|7. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011). Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol  24, 1421-32.   https://doi.org/10.1038/modpathol.2011.102|8. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|9. Song JY, Strom T, Raffeld M, Pittaluga S, Jaffe ES (2011). Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. J Clin Oncol  29, e789-91.   https://doi.org/10.1200/JCO.2011.36.9280|10. Venkataraman G, Berkowitz J, Morris JC, Janik JE, Raffeld MA, Pittaluga S (2011). Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells. Hum Pathol  42, 1042-6.   https://doi.org/10.1016/j.humpath.2010.10.014|11. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2011). CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology  58, 803-5.   https://doi.org/10.1111/j.1365-2559.2011.03829.x",https://intramural.nih.gov/search/searchview.taf?ipid=73730
840,BC011093-05,"October 01, 2011 -  September 30, 2012",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Catharine S Mccoy|Gregory A Jasper|Linda Shonk Weaver|Constance M Yuan|Prashant Ramesh  Tembhare,NULL,"Richard  Little; MD, PhD (Clinical Investigations Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Nancy M Hardy (Experimental Transplantation and Immunology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Calvo KR, McCoy CS, Stetler-Stevenson M (2011). Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods Mol Biol  699, 295-316.   https://doi.org/10.1007/978-1-61737-950-5_14|2. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984",https://intramural.nih.gov/search/searchview.taf?ipid=73641
841,BC011104-05,"October 01, 2011 -  September 30, 2012",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Constance M Yuan|Prashant Ramesh  Tembhare,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leuk Lymphoma  52 Suppl 2, 82-6.   https://doi.org/10.3109/10428194.2011.565843|2. Kreitman RJ, Arons E, Stetler-Stevenson M, Miller KB (2011). Response of hairy cell leukemia to bendamustine. Leuk Lymphoma  52, 1153-6.   https://doi.org/10.3109/10428194.2011.562575",https://intramural.nih.gov/search/searchview.taf?ipid=73640
842,BC011137-04,"October 01, 2011 -  September 30, 2012",Center for Applied Preclinical Research (CAPR),Terry Anne Van Dyke,NULL,"Office of the Director, NCI",N Keith Collins|Zoe W Ohler|Serguei V Kozlov,"David  Gandara (University of Califormia at Davis)|Neal  Goodwin (Jackson Laboratory, West)|Marcus  Bosenberg (Yale University)|Martin  McMahon (University of Californial at San Francisco)|Ross  Cagan (Mount Sinai School of Medicine)|Leroy E Hood|Show all 7","Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Timothy D Veenstra (Office Of The Director)","Christopher P Austin; AB, MD (NHGRI)","1. França A, Aggarwal P, Barsov EV, Kozlov SV, Dobrovolskaia MA, González-Fernández Á (2011). Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro. Nanomedicine (Lond)  6, 1175-88.   https://doi.org/10.2217/nnm.11.41|2. Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, Householder DB, Baran ML, Yi M, Song Y, Sun W, McDunn JE, Martin PL, Van Dyke T, Difilippantonio S (2012). Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res  72, 4141-53.   https://doi.org/10.1158/0008-5472.CAN-11-3834|3. Van Dyke T, Merlino G (2012). β-catenin in metastatic melanoma--the smoking gun reloaded. Pigment Cell Melanoma Res  25, 125-6.   https://doi.org/10.1111/j.1755-148X.2011.00964.x|4. Weaver Z, Difilippantonio S, Carretero J, Martin P, El Meskini R, Iacovelli A, Gumprecht M, Kulaga A, Guerin T, Schlomer J, Baran M, Kozlov S, McCann T, Mena S, Alshahrour F, Alexander D, Wong K, Van Dyke T (2012) Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=73186
843,BC011138-05,"October 01, 2011 -  September 30, 2012",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73731
844,BC011139-05,"October 01, 2011 -  September 30, 2012",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73732
845,BC011236-04,"October 01, 2011 -  September 30, 2012",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Roberta M Matthai|Guity  Mohammadi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73783
846,BC011237-04,"October 01, 2011 -  September 30, 2012",CIP Genomics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Sara Elizabeth Bass|Hong  Lou|Ying  Qi,Robert  Lanford (Texas Biomedical Research Institute)|Effie  Petersdorf (Fred Hutchinson),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Michael  Dean; PhD (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF, Chanock SJ, Anderson SK, Dean M (2012). Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts. Hum Genet  131, 1453-1466.   https://doi.org/10.1007/s00439-012-1182-2|2. Sato A, Tichy H, Grant PR, Grant BR, Sato T, O'hUigin C (2011). Spectrum of MHC class II variability in Darwin's finches and their close relatives. Mol Biol Evol  28, 1943-56.   https://doi.org/10.1093/molbev/msr015",https://intramural.nih.gov/search/searchview.taf?ipid=73784
847,BC011257-03,"October 01, 2011 -  September 30, 2012",Applied Molecular Pathology Laboratory,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Joon Yong Chung|Jennifer  Martinez,NULL,"Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Gonzalez-Bosquet J, Calcei J, Wei JS, Garcia-Closas M, Sherman ME, Hewitt S, Vockley J, Lissowska J, Yang HP, Khan J, Chanock S (2011). Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One  6, e14522.   https://doi.org/10.1371/journal.pone.0014522|2. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724",https://intramural.nih.gov/search/searchview.taf?ipid=73817
848,BC011265-03,"October 01, 2011 -  September 30, 2012",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Susan W Reid|Bradley D St Croix,NULL,"Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Mark  Udey; MD (Dermatology Branch)|Teizo  Yoshimura; PhD (Laboratory of Molecular Immunoregulation)|Jairaj K Acharya; MBBS, PhD (Laboratory of Cell and Developmental Signaling)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Suh YH, Yoshimoto-Furusawa A, Weih KA, Tessarollo L, Roche KW, Mackem S, Roche PA (2011). Deletion of SNAP-23 results in pre-implantation embryonic lethality in mice. PLoS One  6, e18444.   https://doi.org/10.1371/journal.pone.0018444|2. Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood  117, 1228-38.   https://doi.org/10.1182/blood-2010-05-287821",https://intramural.nih.gov/search/searchview.taf?ipid=73824
849,BC011288-03,"October 01, 2011 -  September 30, 2012",Behavioral Science Core,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Lori  Wiener; PhD, LCSW-C|Pamela  Wolters|Stacia Martin Peron; PhD|Sima Lehimgar Zadeh|Katherine Mcintyre Burns|Nia Malika Billings|Show all 10",NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch),Steven M Holland; MD (NIAID) |Maryland  Pao; MD (NIMH) |John F Tisdale; MD (NHLBI) |Robert A Sokolic (NHGRI),"1. Martin S, Gillespie A, Wolters PL, Widemann BC (2011). Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute. Contemp Clin Trials  32, 10-5.   https://doi.org/10.1016/j.cct.2010.10.004|2. Wiener L, Battles H, Mamalian C, Zadeh S (2011) ShopTalk: a pilot study of the feasibility and utility of a therapeutic board game for youth living with cancer. Support Care Cancer 19:1049-54.|3. Wiener LS, Kohrt BA, Battles HB, Pao M (2011). The HIV experience: youth identified barriers for transitioning from pediatric to adult care. J Pediatr Psychol  36, 141-54.   https://doi.org/10.1093/jpepsy/jsp129",https://intramural.nih.gov/search/searchview.taf?ipid=73839
850,BC011309-03,"October 01, 2011 -  September 30, 2012",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Jung-Hyun  Park,NULL,Dinah  Singer; PhD (Molecular Regulation Section)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Richard J Hodes; MD (Immune Regulation Section)|David M Segal; PhD (Immune Targeting Section)|James Stephen Shaw; PhD (Human Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73854
851,BC011310-03,"October 01, 2011 -  September 30, 2012",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,Dinah  Singer; PhD (Molecular Regulation Section)|James Stephen Shaw; PhD (Human Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73855
852,BC011331-03,"October 01, 2011 -  September 30, 2012",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Bao D Quoe  Tran|Yongmei  Zhao|Yuliya  Kriga|Yelena  Levin|Jessica Leigh Dickens|Jyoti Umesha Shetty|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73873
853,BC011380-02,"October 01, 2011 -  September 30, 2012",Multivalent Inhibition of Integrin alphaVbeta3,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73909
854,BC011392-02,"October 01, 2011 -  September 30, 2012",LGD Core,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73920
855,BC011428-01,"October 01, 2011 -  September 30, 2012",CCR FACS Core Laboratory,Karen Marie Wolcott,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Subhadra  Banerjee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77759
856,BC011430-01,"October 01, 2011 -  September 30, 2012",CPTR - Mass Spectrometry,Lisa Marie Jenkins,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77732
857,BC011434-01,"October 01, 2011 -  September 30, 2012",Collaborative Protein Technology Resource: Automated Capillary Immunoassays,Jinqiu  Chen,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",Michelle Anne Herrmann,NULL,Christina M Annunziata (Medical Oncology Branch)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Liang  Cao (Cancer Genetics Branch)|Natasha  Caplen (Cancer Genetics Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics),"Adrian U Wiestner; MD, PhD (NHLBI)","1. Kohn E, Yang Y, Du Z, Nagano Y, Van Schyndle C, Herrmann M, Heldman M, Chen J, Stuelten C, Flanders K, Wakefield L (2012) Biological responses to TGF-#946; in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. Molecular Cancer Research In Press.",https://intramural.nih.gov/search/searchview.taf?ipid=77740
858,BC011440-01,"October 01, 2011 -  September 30, 2012",Sisene CRADA,Frank  Cuttitta; PhD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Ingalill R Avis|Changge  Fang; PhD|William G Stetler-Stevenson; MD, PhD","Oliver  Rixe (University of Cincinnati College of Medicine)|Mary  Sunday (Dept Pathology, Duke University)|Stefanie  Vogel (University of Maryland)","Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David  Salomon; PhD (Laboratory of Cancer Prevention)|Bradley D St Croix (Mouse Cancer Genetics Program)|Robert J Fisher (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77716
859,BC011453-01,"October 01, 2011 -  September 30, 2012",Development and Excecution of Collaborative High-Throughput Microscopy Assays,Ty Cole Voss,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Laurent L Ozbun,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77731
860,CO020007-04,"October 01, 2011 -  September 30, 2012",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Craig W Reynolds,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73950
861,CP010178-11,"October 01, 2011 -  September 30, 2012",Core Genotyping Facility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI",Gilles F Thomas,NULL,Meredith  Yeager (Office of the Director)|Tabassum  Bandey (Office of the Director)|Ian K Barrow (Office of the Director)|Michael  Beerman (Office of the Director)|Merideth  Brown (Office of the Director)|Laura Ann Burdett (Office of the Director),Jun  Lu (NIEHS),"1. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, et al. [164 more authors] (2012). Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet  44, 651-8.   https://doi.org/10.1038/ng.2270|2. Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T, GENICA Network, Chang-Claude J, Investigators kConFab, Australian Ovarian Cancer Study Group, et al. [124 more authors] (2012). 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat  33, 1123-32.   https://doi.org/10.1002/humu.22089",https://intramural.nih.gov/search/searchview.taf?ipid=73983
862,CP010203-04,"October 01, 2011 -  September 30, 2012",Applied Molecular Pathology Laboratory,Mark E Sherman; MD| | |Margaret Anne Tucker|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Human Genetics Program, NCI",Karen E Berliner,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74007
863,CP010223-01,"October 01, 2011 -  September 30, 2012",Endogenous Hormone Measurement Production Assay Infrastructure at the FFRDC,Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77682
864,SC006536-19,"October 01, 2011 -  September 30, 2012",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Merrill E Goldsmith|Kathryn  Compton|Gareth  Peters|Diana  Roame|Paula A Carter|Cody John Peer,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Steve  Grant (Virginia Commonwealth University)|Mark  Ratain (University of Chicago)",William Laurence Dahut; MD (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Heidi H Kong (Dermatology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch),NULL,"1. Guo D, Cain JP, O'Connell S, Gardner ER, Pisle S, Figg WD, Tabibi SE, Yalkowsky SH (2012). Preformulation study of NSC-726796. AAPS PharmSciTech  13, 661-73.   https://doi.org/10.1208/s12249-012-9784-5|2. Holkova B, Perkins EB, Ramakrishnan V, Tombes MB, Shrader E, Talreja N, Wellons MD, Hogan KT, Roodman GD, Coppola D, Kang L, Dawson J, Stuart RK, Peer C, Figg WD, Kolla S, Doyle A, Wright J, Sullivan DM, Roberts JD, Grant S (2011). Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms. Clin Cancer Res  17, 3388-97.   https://doi.org/10.1158/1078-0432.CCR-10-2876|3. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|4. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682|5. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|6. Peer CJ, Spencer SD, VanDenBerg DA, Pacanowski MA, Horenstein RB, Figg WD (2012). A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci  880, 132-9.   https://doi.org/10.1016/j.jchromb.2011.11.029|7. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|8. Rajan A, Carter CA, Kelly RJ, Gutierrez M, Kummar S, Szabo E, Yancey MA, Ji J, Mannargudi B, Woo S, Spencer S, Figg WD, Giaccone G (2012). A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors. Clin Cancer Res  18, 2344-51.   https://doi.org/10.1158/1078-0432.CCR-11-2425|9. Waldmann TA, Lugli E, Roederer M, Perera LP, Smedley JV, Macallister RP, Goldman CK, Bryant BR, Decker JM, Fleisher TA, Lane HC, Sneller MC, Kurlander RJ, Kleiner DE, Pletcher JM, Figg WD, Yovandich JL, Creekmore SP (2011). Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques. Blood  117, 4787-95.   https://doi.org/10.1182/blood-2010-10-311456",https://intramural.nih.gov/search/searchview.taf?ipid=76536
865,SC006537-19,"October 01, 2011 -  September 30, 2012",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Alesia J Holly|Tristan  Sissung|Kathryn  Compton|Stephen T Pisle|Cody John Peer|Shawn D Spencer,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Alex  Sparreboom|Steve  Grant (Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)","William Laurence Dahut; MD (Medical Oncology Branch)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Susan  Bates; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)",NULL,"1. Chen X, Peer CJ, Alfaro R, Tian T, Spencer SD, Figg WD (2012). Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization. J Pharm Biomed Anal  62, 140-8.   https://doi.org/10.1016/j.jpba.2012.01.008|2. Franke RM, Lancaster CS, Peer CJ, Gibson AA, Kosloske AM, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A (2011). Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clin Pharmacol Ther  89, 693-701.   https://doi.org/10.1038/clpt.2011.25|3. Guo D, Cain JP, O'Connell S, Gardner ER, Pisle S, Figg WD, Tabibi SE, Yalkowsky SH (2012). Preformulation study of NSC-726796. AAPS PharmSciTech  13, 661-73.   https://doi.org/10.1208/s12249-012-9784-5|4. Holkova B, Perkins EB, Ramakrishnan V, Tombes MB, Shrader E, Talreja N, Wellons MD, Hogan KT, Roodman GD, Coppola D, Kang L, Dawson J, Stuart RK, Peer C, Figg WD, Kolla S, Doyle A, Wright J, Sullivan DM, Roberts JD, Grant S (2011). Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms. Clin Cancer Res  17, 3388-97.   https://doi.org/10.1158/1078-0432.CCR-10-2876|5. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE (2011). A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res  17, 569-80.   https://doi.org/10.1158/1078-0432.CCR-10-1725|6. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682|7. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|8. Peer CJ, Sissung TM, Figg WD (2011). CHIP and gp78-mediated ubiquitination of CYP3A4: Implications for the pharmacology of anticancer agents. Cancer Biol Ther  11, 549-51.   https://doi.org/10.4161/cbt.11.6.14834|9. Peer CJ, Spencer SD, VanDenBerg DA, Pacanowski MA, Horenstein RB, Figg WD (2012). A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci  880, 132-9.   https://doi.org/10.1016/j.jchromb.2011.11.029|10. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|11. Pluta RM, Oldfield EH, Bakhtian KD, Fathi AR, Smith RK, Devroom HL, Nahavandi M, Woo S, Figg WD, Lonser RR (2011). Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One  6, e14504.   https://doi.org/10.1371/journal.pone.0014504|12. Waldmann TA, Lugli E, Roederer M, Perera LP, Smedley JV, Macallister RP, Goldman CK, Bryant BR, Decker JM, Fleisher TA, Lane HC, Sneller MC, Kurlander RJ, Kleiner DE, Pletcher JM, Figg WD, Yovandich JL, Creekmore SP (2011). Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques. Blood  117, 4787-95.   https://doi.org/10.1182/blood-2010-10-311456",https://intramural.nih.gov/search/searchview.taf?ipid=76537
866,SC006743-19,"October 01, 2011 -  September 30, 2012",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sunmin T Lee|Min Jung Lee|Sylvia Vania  Alarcon Velasco|Michael  Landau|Kevin  Tyan|Reid Phillip Schlesinger,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Judith  Karp (Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)|Marc  Cox (University of Texas at El Paso)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Gennady  Bratslavsky (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)",NULL,"1. De Leon JT, Iwai A, Feau C, Garcia Y, Balsiger HA, Storer CL, Suro RM, Garza KM, Lee S, Kim YS, Chen Y, Ning YM, Riggs DL, Fletterick RJ, Guy RK, Trepel JB, Neckers LM, Cox MB (2011). Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc Natl Acad Sci U S A  108, 11878-83.   https://doi.org/10.1073/pnas.1105160108|2. Giaccone G, Rajan A, Berman A, Kelly RJ, Szabo E, Lopez-Chavez A, Trepel J, Lee MJ, Cao L, Espinoza-Delgado I, Spittler J, Loehrer PJ (2011). Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors. J Clin Oncol  29, 2052-9.   https://doi.org/10.1200/JCO.2010.32.4467|3. Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH (2011). Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Eur J Cancer  47, 997-1005.   https://doi.org/10.1016/j.ejca.2010.12.016|4. Mollapour M, Tsutsumi S, Kim YS, Trepel J, Neckers L (2011). Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity. Oncotarget  2, 407-17.|5. Mollapour M, Tsutsumi S, Truman AW, Xu W, Vaughan CK, Beebe K, Konstantinova A, Vourganti S, Panaretou B, Piper PW, Trepel JB, Prodromou C, Pearl LH, Neckers L (2011). Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell  41, 672-81.   https://doi.org/10.1016/j.molcel.2011.02.011|6. Rajan A, Kelly RJ, Trepel JB, Kim YS, Alarcon SV, Kummar S, Gutierrez M, Crandon S, Zein WM, Jain L, Mannargudi B, Figg WD, Houk BE, Shnaidman M, Brega N, Giaccone G (2011). A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas. Clin Cancer Res  17, 6831-9.   https://doi.org/10.1158/1078-0432.CCR-11-0821",https://intramural.nih.gov/search/searchview.taf?ipid=76535
867,SC009372-21,"October 01, 2011 -  September 30, 2012",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Catharine S Mccoy|Gregory A Jasper|Linda Shonk Weaver|Constance M Yuan|Prashant Ramesh  Tembhare,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) |Steven M Holland; MD (NIAID)","1. Arons E, Roth L, Sapolsky J, Suntum T, Stetler-Stevenson M, Kreitman RJ (2011). Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood  117, 4844-51.   https://doi.org/10.1182/blood-2010-11-316737|2. Calvo KR, McCoy CS, Stetler-Stevenson M (2011). Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods Mol Biol  699, 295-316.   https://doi.org/10.1007/978-1-61737-950-5_14|3. Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM (2011). Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica  96, 1221-5.   https://doi.org/10.3324/haematol.2011.041152|4. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom  80, 309-17.   https://doi.org/10.1002/cyto.b.20593|5. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|6. Kreitman RJ, Arons E, Stetler-Stevenson M, Miller KB (2011). Response of hairy cell leukemia to bendamustine. Leuk Lymphoma  52, 1153-6.   https://doi.org/10.3109/10428194.2011.562575|7. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|8. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514",https://intramural.nih.gov/search/searchview.taf?ipid=76481
868,SC009431-18,"October 01, 2011 -  September 30, 2012",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Michael Andrew Arnold; MD, PhD",NULL,Crystal L. Mackall; MD (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76511
869,SC010353-13,"October 01, 2011 -  September 30, 2012",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Cynthia P Love|Vicki  Richmond|Kelly D Richards|Nirali Niranjan Shah|Brigitte  Widemann; MD|Carol J Thiele|Show all 9,"David  Loeb (Pediatric Hematology-Oncology, Johns Hopkins University)|Civin  Curt (Pediatric Oncology, Johns Hopkins University)|Ching-Hon  Pui (St Jude Children's Research Hospital)|Deepa  Bhowjani (St Jude Children's Research Hospital)|Sima  Jeha (Pediatric Oncology, St Jude Children's Cancer Research Hospital)|Lewis  Silverman (Dana Farber/Children's Hospital)|Show all 22","Ira H Pastan; MD (Molecular Biology Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Frances  Hakim; PhD (Experimental Transplantation and Immunology Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)",Austin John Barrett; MD (NHLBI) |Susan  Leitman; MD (CC) |Roger  Kurlander; MD (CC) |Hanh M Khuu; MD (CC) |David F Stroncek; MD (CC) |Minocher  Battiwalla; MD (NHLBI),"1. Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu RS, Giralt S (2011). National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. Biol Blood Marrow Transplant  17, 443-54.   https://doi.org/10.1016/j.bbmt.2010.12.713|2. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE (2011). Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood  117, 5835-49.   https://doi.org/10.1182/blood-2010-11-316745|3. FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I (2011). Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates. Cancer Res  71, 6300-9.   https://doi.org/10.1158/0008-5472.CAN-11-1374|4. Larochelle A, Gillette JM, Desmond R, Ichwan B, Cantilena A, Cerf A, Barrett AJ, Wayne AS, Lippincott-Schwartz J, Dunbar CE (2012). Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood  119, 1848-55.   https://doi.org/10.1182/blood-2011-08-371583|5. Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S (2012). Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations. Clin Lymphoma Myeloma Leuk  12, 20-5.   https://doi.org/10.1016/j.clml.2011.06.016|6. Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS (2012). Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. Am J Hematol  87, 916-22.   https://doi.org/10.1002/ajh.23174|7. Sokolic R, Maric I, Kesserwan C, Garabedian E, Hanson IC, Dodds M, Buckley R, Issekutz AC, Kamani N, Shaw K, Tan B, Bali P, Hershfield MS, Kohn DB, Wayne AS, Candotti F (2011). Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood  118, 2688-94.   https://doi.org/10.1182/blood-2011-01-329359|8. Wei H, Xiang L, Wayne AS, Chertov O, FitzGerald DJ, Bera TK, Pastan I (2012). Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proc Natl Acad Sci U S A  109, 6898-903.   https://doi.org/10.1073/pnas.1204523109|9. Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL (2011). Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother  34, 187-95.   https://doi.org/10.1097/CJI.0b013e31820d2a21",https://intramural.nih.gov/search/searchview.taf?ipid=76519
870,BC010686-08,"October 01, 2011 -  September 30, 2012",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Earle J Barnes|Joseph  Chinquee|Mary E Grissette|Silke  Williams|Kathleen Renee Gittens; RN|Kathleen C Benard|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73422
871,BC010694-08,"October 01, 2011 -  September 30, 2012",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug|Valerie M Zgonc|Veronica  Krevinko|Elaine S Jaffe; MD|Stefania  Pittaluga|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Blanche P Alter (Clinical Genetics Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Neelam K Giri; MD (Clinical Genetics Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Mohammed Zulfiqar Farooqui; DO (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73407
872,BC010882-05,"October 01, 2011 -  September 30, 2012",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73637
873,BC010950-05,"October 01, 2011 -  September 30, 2012",Research Nursing,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,Paulo  Zucali (IRCCS)|Martin  Gutierrez (Micheal and Dianne Bienes Cancer Center),James Halpern Doroshow (Developmental Therapeutics Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73586
874,BC010951-05,"October 01, 2011 -  September 30, 2012",Medical Directors Office,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73585
875,BC010963-05,"October 01, 2011 -  September 30, 2012",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Juan Carlos Gea-Banacloche; MD|Claude  Sportes|Steven  Pavletic; MD, MS|Daniele N Avila|Jennifer Sproul Wilder|Bazetta A Blacklock-Schuver|Show all 16","Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73590
876,BC010987-05,"October 01, 2011 -  September 30, 2012",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73638
877,BC010988-05,"October 01, 2011 -  September 30, 2012",Center for Cancer Research Clinical Trials Data Management Service,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73639
878,BC010990-05,"October 01, 2011 -  September 30, 2012",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Sharon L Smith|Deborah S Mcnally|Peter  Guion|Christine  Ko|Lester Lee Greer|Aparna Hemant Kesarwala|Show all 18,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73562
879,BC011022-04,"October 01, 2011 -  September 30, 2012",Clinical Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73183
880,BC011089-05,"October 01, 2011 -  September 30, 2012",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Lindsay A. Middelton|James Q Peterson|Sarah M Fowler; RN|Cristiane  Leite|Celene  Chua|Rabindra  Gautam|Show all 20,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Medical Oncology Branch),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73701
881,BC011092-05,"October 01, 2011 -  September 30, 2012",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Lindsay A. Middelton|James Q Peterson|Sarah M Fowler; RN|Cristiane  Leite|Ramaprasad  Srinivasan; MD, PhD|Gennady  Bratslavsky|Show all 25",NULL,Maria  Merino; PhD (Laboratory of Pathology)|William Laurence Dahut; MD (Medical Oncology Branch),"Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73702
882,BC011098-05,"October 01, 2011 -  September 30, 2012",Brain Tumor Clinical and Clinical Research Program,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Cheryl L Royce|Nancy B Garren|Laurie  Rosenblatt|Tetiana  Wiggington|Irene S Haggarty|Julie A Peretti|Show all 21,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"John Keenam Park (NINDS) |John Anthony Butman; MD, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73582
883,BC011242-04,"October 01, 2011 -  September 30, 2012",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Reto  Bale (Innsbruck)|Show all 23,Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Udai S Kammula (Surgery Branch),"Elliot Brian Levy (CC) |Nadine  Abi Jaoudeh (CC) |Aradhana M Venkatesan (CC) |Matthew R Dreher; BS, MS, PhD (CC) |Karel  Pacak; MD, PhD (NICHD) |Karen T Adams (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73811
884,BC011291-03,"October 01, 2011 -  September 30, 2012",General Surgical Pathology,Markku Martti Miettinen,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Martha Maria Nicacio Quezado; MD|Chyi-Chia Richard Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73840
885,BC011317-03,"October 01, 2011 -  September 30, 2012",Dermatology Consultation Service,Edward W Cowen,Mark  Udey; MD,"Dermatology Branch, NCI",Susan L Booher|Olanda M Hathaway,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Kristin  Baird (Pediatric Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73862
886,BC011349-03,"October 01, 2011 -  September 30, 2012",Development of FISH Molecular  Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Elaine S Jaffe; MD|Maria  Merino; PhD|Maria  Tsokos; MD|Markku Martti Miettinen,NULL,Giuseppe  Giaccone; MD (Medical Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73890
887,SC003800-42,"October 01, 2011 -  September 30, 2012",Surgical Consultants  Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI","David  Danforth|David  Schrump; MD|James Chung-Yin Yang; MD, PhD|Marybeth S Hughes|Richard  Sherry; MD|Udai S Kammula|Show all 9",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76489
888,SC006329-32,"October 01, 2011 -  September 30, 2012",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|John  Ondos|Jason Yulin Cheng; PhD|Show all 12,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76477
889,SC007202-29,"October 01, 2011 -  September 30, 2012",Biostatistics and Data Management Section,Seth M Steinberg; PhD,William Laurence Dahut; MD,"Biostatistics and Data Management Section, NCI",David J Venzon; PhD|David J Liewehr,NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|Susan  Bates; MD (Medical Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch)",Zenaide Maria Quezado; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74028
890,SC009394-19,"October 01, 2011 -  September 30, 2012",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Mones S Abu Asab|David D Roberts; PhD,NULL,NULL,"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=76510
891,BC010764-07,"October 01, 2011 -  September 30, 2012",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Joanne A Derdak|Vicki  Richmond|Sherri L Depollar|Colleen Elizabeth Annesley|Nirali Niranjan Shah|Jessica Carolyn Shand|Show all 15,"Kenneth  Cohen (Pediatric Oncology, Johns Hopkins University)|James F Casella; MD (The Johns Hopkins University School of Medicine)|Ido  PazPriel (Johns Hopkins University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73447
892,BC010843-06,"October 01, 2011 -  September 30, 2012",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Sanjeeve  Balasubramaniam|Cliona Mary Grant; MD|Nicolas  Acquavella Pesantes|Nikhil  Prakash|Andrew Scott Brohl|Elisabet Esteve Manasanch; MD|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73479
893,BC011023-05,"October 01, 2011 -  September 30, 2012",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Adam R Metwalli|Graham Dalton Fowler|Katherine Anne Klos|Brett F Holt|Lambros  Stamatakis|Andrew C Harbin|Show all 9,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology),Bradford J Wood; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73728
894,BC011136-04,"October 01, 2011 -  September 30, 2012",The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Tracy J Litzi|Sharon Ann Romano|Michael P Stany|Christina M Annunziata,"Gustavo  Rodriguez (Gynecologic Oncology, Evanston Northwestern Hospital)|Andrew  Berchuck (Gyn Oncology, Duke Univ)|Robert  Bast (Medicine, MD Anderson Cancer Center)|Anna  Lockshin (University of Pittsburgh Cancer Institute)|John I Risinger; PhD (NCI)|Kathleen  Darcy (Gynecologic Oncology Group)|Show all 11",Chad Andrew Hamilton (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Day RS, McDade KK, Chandran UR, Lisovich A, Conrads TP, Hood BL, Kolli VS, Kirchner D, Litzi T, Maxwell GL (2011) Identifier mapping performance for integrating transcriptomics and proteomics experimental results. BMC Bioinformatics 12:213.|2. Han JJ, Yu M, Houston N, Steinberg SM, Kohn EC (2011). Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol  120, 5-10.   https://doi.org/10.1016/j.ygyno.2010.09.006|3. Lee JM, Han JJ, Altwerger G, Kohn EC (2011). Proteomics and biomarkers in clinical trials for drug development. J Proteomics  74, 2632-41.   https://doi.org/10.1016/j.jprot.2011.04.023",https://intramural.nih.gov/search/searchview.taf?ipid=73185
895,BC011241-04,"October 01, 2011 -  September 30, 2012",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Stefania  Pittaluga|Nancy Ellen Diener|Ewa Beata Bajor-Dattilo; MD, PhD|Moses Osemwingie Evbuomwan|Mary A Lee|Xiangrong  Zhao|Show all 11",NULL,"Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Thomas Arthur Fleisher; MD (CC) |Raul Cipriano Braylan; MD (CC) |Charles  Bolan; BS, MS, MD (NHLBI)","1. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E (2012). In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica  97, 270-8.   https://doi.org/10.3324/haematol.2011.052621|2. da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, Gatter K, Liu Q, Jaffe ES, Chapel H (2011). Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol  31, 784-91.   https://doi.org/10.1007/s10875-011-9565-z|3. Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES (2011). Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol  24, 1586-97.   https://doi.org/10.1038/modpathol.2011.116|4. Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011). Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol  35, 1214-25.   https://doi.org/10.1097/PAS.0b013e31822067d1|5. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES (2011). Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood  118, 2976-84.   https://doi.org/10.1182/blood-2011-05-355255|6. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011). Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol  24, 1421-32.   https://doi.org/10.1038/modpathol.2011.102|7. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|8. Song JY, Strom T, Raffeld M, Pittaluga S, Jaffe ES (2011). Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. J Clin Oncol  29, e789-91.   https://doi.org/10.1200/JCO.2011.36.9280|9. Summers TA, Jaffe ES (2011). Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma  52 Suppl 2, 6-10.   https://doi.org/10.3109/10428194.2011.565435|10. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2011). CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology  58, 803-5.   https://doi.org/10.1111/j.1365-2559.2011.03829.x",https://intramural.nih.gov/search/searchview.taf?ipid=73765
896,BC011271-03,"October 01, 2011 -  September 30, 2012",Developmental Therapeutics Clinic,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",William D Figg; PharmD|Jane Beth Trepel,NULL,James Halpern Doroshow (Developmental Therapeutics Branch)|Shivaani  Kummar; PhD (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73828
897,BC011384-02,"October 01, 2011 -  September 30, 2012",Anatomic Pathology Residency Program,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","George  Miles|Stephanie  Hart-Gouleau; MD|Jinping  Lai; MD, PhD|Phyu Phyu Aung; MD, PhD|Yi-Shan  Lee; MD, PhD|Meghna  Alimchandani; MD|Show all 10",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73913
898,SC000853-59,"October 01, 2011 -  September 30, 2012",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Zucali PA, Di Tommaso L, Petrini I, Battista S, Lee HS, Merino M, Lorenzi E, Voulaz E, De Vincenzo F, Simonelli M, Roncalli M, Giordano L, Alloisio M, Santoro A, Giaccone G (2013). Reproducibility of the WHO classification of thymomas: practical implications. Lung Cancer  79, 236-41.   https://doi.org/10.1016/j.lungcan.2012.11.015",https://intramural.nih.gov/search/searchview.taf?ipid=76485
899,BC010569-09,"October 01, 2011 -  September 30, 2012",Comparative Oncology Program,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Melissa C Paoloni|Anita C Epps|Lee Jay Helman; MD,"Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Susan  Lana (Department of Clinical Sciences, Colorado State University)|Steven  Suter (Department of Clinical Sciences, North Carolina State University)|William  Kisseberth (Veterinary Medicine, Ohio State University)|Lisa  Barber (Veterinary Medicine, Tufts University)|Show all 34","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Caryn  Steakley; BA, BSN, MSW (Office of the Director)|Joseph E Tomaszewski (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Briggs J, Paoloni M, Chen QR, Wen X, Khan J, Khanna C (2011). A compendium of canine normal tissue gene expression. PLoS One  6, e17107.   https://doi.org/10.1371/journal.pone.0017107",https://intramural.nih.gov/search/searchview.taf?ipid=73395
900,BC010856-06,"October 01, 2011 -  September 30, 2012",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73530
901,BC010931-05,"October 01, 2011 -  September 30, 2012",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jennifer B Dwyer|Shelley B Hoover|Bih-Rong  Wei|Joshua David Webster; DVM, PhD|John  Hickerson|Matti  Kiupel; PhD|Show all 10","Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Boris  Bastian (UCSF)|Marcus  Bosenberg (Yale University)|Glen  Esplin (Univsity of Utah)|Michael  Goldschmidt (University of Pennsylvania)|Matti  Kiupel; PhD|Show all 11","Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Peter L Choyke; MD (Molecular Imaging Program)|Mark  Raffeld; MD (Laboratory of Pathology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)","Kanta  Subbarao; MD, MPH (NIAID) |Jeffery K Taubenberger; BS, MD, PhD (NIAID) |Robert S Balaban; PhD (NHLBI)","1. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|2. Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K (2011). Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol  179, 422-35.   https://doi.org/10.1016/j.ajpath.2011.03.035|3. Memoli MJ, Davis AS, Proudfoot K, Chertow DS, Hrabal RJ, Bristol T, Taubenberger JK (2011). Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis  203, 348-57.   https://doi.org/10.1093/infdis/jiq067|4. Morens DM, Holmes EC, Davis AS, Taubenberger JK (2011). Global rinderpest eradication: lessons learned and why humans should celebrate too. J Infect Dis  204, 502-5.   https://doi.org/10.1093/infdis/jir327",https://intramural.nih.gov/search/searchview.taf?ipid=73624
902,BC010470-10,"October 01, 2011 -  September 30, 2012",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Michael N Edmonson|Cu  Nguyen|Ying  Hu; PhD|Richard Phillip Finney|Jenny M Kelley|Sharon I Greenblum|Show all 8,David  Parkinson (Nodality)|TCGA Consortia  NA (NA)|TARGET Consortia  NA (NA),Dinah  Singer; PhD (Molecular Regulation Section)|James Halpern Doroshow (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73341
903,BC011161-04,"October 01, 2011 -  September 30, 2012",The automated measurement of foci in fluorescence microscopy,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI",Brenda L Youngren,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73736
904,BC011235-04,"October 01, 2011 -  September 30, 2012",Support of NCI CCR Clinical Research and Bioinformatics,Jeffrey D Shilling,Robert  Wiltrout; PhD,"Office of the Director, NCI",Susan M Fox|Ave M Cline|Rohit  Paul|James  Waters|Christopher William Lemieux|Jason Edward Levine,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73791
905,BC011445-01,"October 01, 2011 -  September 30, 2012","Coordination of DNA Replication, Transcription and Chromatin Assembly",Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,NULL,Mirit I Aladjem; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=77722
906,CO020005-04,"October 01, 2011 -  September 30, 2012",National Cancer Informatics Program (NCIP),Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Dwayne D Forquer|George  Komatsoulis,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73949
907,CP010205-04,"October 01, 2011 -  September 30, 2012",Scientific Computing,Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,"Marianne  Henderson (Office of Division Operations and Analysis)|Karen E Berliner (Human Genetics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74009
908,BC011234-04,"October 01, 2011 -  September 30, 2012",CCR New Space Activation,Darren W Henderson,Robert  Wiltrout; PhD,"Office of the Director, NCI",Debra L Borris|Monica I Gonzales|M Beth Cassell|Darrell  Bell,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73758
909,CO020002-04,"October 01, 2011 -  September 30, 2012",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Daryl E Paunil (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73947
910,BC011133-04,"October 01, 2011 -  September 30, 2012",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Viola D Black|Terry  Moody; PhD,NULL,"Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73187
911,BC011285-03,"October 01, 2011 -  September 30, 2012",CCR Education and Outreach,Kimberly R Martin,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73836
912,CP010204-04,"October 01, 2011 -  September 30, 2012","Communications, Education and Outreach",Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Catherine B McClave|Jennifer K Loukissas|Alyssa Marie Voss|Wendy  Schneider-Levinson|Saloni  Nayar|Victoria Anne McCallum,NULL,Jackie Ann Lavigne (Office of Education)|Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74008
913,CP010208-03,"October 01, 2011 -  September 30, 2012",Special Studies Institutional Review Board Support,Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=74013
914,BC010857-06,"October 01, 2011 -  September 30, 2012",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73532
915,BC011193-04,"October 01, 2011 -  September 30, 2012",Office of Policy and Intellectual Property,Eric A Hale,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73756
916,CO020001-04,"October 01, 2011 -  September 30, 2012",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Karen M Maurey  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73946
